Clustering O 0 5.337847386321926e-10
of O 0 1.8581603168307554e-15
missense O 0 1.780211889013117e-08
mutations O 0 1.8517418709507183e-08
in O 0 8.319207952731111e-14
the O 0 1.1348691986157178e-09
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
telangiectasia I-Disease 1 1.0
gene O 0 2.9607740543724503e-06
in O 0 1.2860204776630503e-15
a O 0 4.386866981872031e-14
sporadic B-Disease 0 6.269118557611364e-07
T I-Disease 0 0.4556315839290619
- I-Disease 0 8.975128730526194e-05
cell I-Disease 0 3.316836227895692e-05
leukaemia I-Disease 0 0.0012319607194513083
. O 0 4.144701509084525e-12

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
telangiectasia I-Disease 1 1.0
( O 0 1.210747541335877e-05
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.999998927116394
T I-Disease 1 1.0
) O 0 5.226193284559033e-14
is O 0 4.1940772855825637e-16
a O 0 5.2877353103747415e-15
recessive B-Disease 0 5.994552765287153e-08
multi I-Disease 0 3.921992330901958e-08
- I-Disease 1 0.830778181552887
system I-Disease 0 2.2047468064556597e-06
disorder I-Disease 0 4.38072529505007e-05
caused O 0 9.746988542072999e-15
by O 0 5.530424523591749e-18
mutations O 0 3.968775828810944e-12
in O 0 1.120103796303776e-17
the O 0 7.637778141708791e-17
ATM O 0 1.7512061245561483e-11
gene O 0 9.1229922921654e-12
at O 0 4.5106774489590135e-14
11q22 O 0 8.625852636334752e-12
- O 0 1.231639373822091e-10
q23 O 0 6.460887380654867e-11
( O 0 4.65185094797023e-16
ref O 0 6.880153669008848e-10
. O 0 3.05347288320529e-15
3 O 0 4.8563537123158616e-15
) O 0 2.9919128579394523e-15
. O 0 2.644469116342557e-13

The O 0 1.6088125623370253e-11
risk O 0 6.047774087081237e-11
of O 0 3.26918030525632e-16
cancer B-Disease 0 3.1095300556671646e-08
, O 0 2.2738904400902704e-13
especially O 0 1.1662337762174957e-12
lymphoid B-Disease 0 5.40104174717726e-08
neoplasias I-Disease 0 3.8530367874045623e-07
, O 0 8.603628741518307e-14
is O 0 3.9557084499398107e-16
substantially O 0 2.6729597268210226e-12
elevated O 0 1.4112896962181765e-10
in O 0 1.2367415034783558e-12
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.00016796618001535535
and O 0 4.5621813618557105e-12
has O 0 1.597200149916489e-11
long O 0 5.894376241440125e-14
been O 0 1.4004156653215326e-15
associated O 0 5.2723494651076355e-14
with O 0 7.868648224315655e-13
chromosomal O 1 1.0
instability O 1 0.9999997615814209
. O 0 2.723831438178337e-10

By O 0 4.576783965920886e-14
analysing O 0 2.1747366407698365e-10
tumour B-Disease 1 0.9999915361404419
DNA O 0 8.090752512401878e-10
from O 0 4.4276277445263586e-18
patients O 0 1.1290019568240212e-15
with O 0 2.2384544991045315e-16
sporadic B-Disease 0 8.934311335906386e-05
T I-Disease 1 0.9861149787902832
- I-Disease 0 0.0049841804429888725
cell I-Disease 0 0.00026156060630455613
prolymphocytic I-Disease 0 6.003539601806551e-05
leukaemia I-Disease 0 0.00019812695973087102
( O 0 1.7904673240993346e-13
T B-Disease 0 2.867060970856983e-07
- I-Disease 0 2.7722313333811144e-09
PLL I-Disease 0 2.9376240329170855e-10
) O 0 2.443165951192543e-16
, O 0 2.0032936353133817e-17
a O 0 6.318841434319847e-16
rare O 0 3.0454493636124236e-13
clonal B-Disease 0 7.426258913367789e-11
malignancy I-Disease 0 6.237651728469018e-09
with O 0 1.8160361242841578e-16
similarities O 0 2.2061436878717533e-12
to O 0 5.754185766515844e-15
a O 0 1.9338605153004784e-13
mature B-Disease 0 7.391519687982573e-12
T I-Disease 0 1.2075718132109614e-06
- I-Disease 0 8.273168816685939e-08
cell I-Disease 0 1.8486774422399321e-07
leukaemia I-Disease 0 2.129587755916873e-06
seen O 0 1.0810743793221445e-11
in O 0 1.3246647973409048e-13
A B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999834299087524
T I-Disease 1 1.0
, O 0 7.755097020285817e-13
we O 0 9.644463674137339e-15
demonstrate O 0 3.4509241032918674e-18
a O 0 1.153707186678009e-19
high O 0 3.514412903642303e-18
frequency O 0 1.3429387094383751e-16
of O 0 2.206514623742858e-19
ATM O 0 1.6205340888642006e-11
mutations O 0 9.335406753185893e-11
in O 0 4.9419300439000266e-14
T B-Disease 0 2.5295407795056235e-06
- I-Disease 0 6.528892981805257e-08
PLL I-Disease 0 5.305028238922205e-08
. O 0 3.067124679234645e-12

In O 0 6.777828217294571e-14
marked O 0 5.506497239112689e-15
contrast O 0 2.4879259249825387e-15
to O 0 6.099317493566726e-17
the O 0 4.1071376915274843e-17
ATM O 0 4.284254895292605e-11
mutation O 0 1.6700247087997333e-11
pattern O 0 1.3979799262653358e-10
in O 0 4.790963632761436e-13
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999983310699463
T I-Disease 1 1.0
, O 0 3.3750244623782094e-14
the O 0 1.4816162381005078e-18
most O 0 4.9176556269350927e-20
frequent O 0 2.3531038495867493e-16
nucleotide O 0 1.1705559109086595e-14
changes O 0 9.060136301408065e-15
in O 0 4.8235588200596616e-17
this O 0 2.105531418636927e-15
leukaemia B-Disease 0 5.73161651473697e-09
were O 0 5.128314815855536e-15
missense O 0 1.823812212364828e-08
mutations O 0 1.4555960881068586e-08
. O 0 1.1192438035406704e-12

These O 0 5.717497330616494e-13
clustered O 0 3.976688423001917e-11
in O 0 1.4533437895801384e-15
the O 0 2.4447321680515753e-16
region O 0 9.331168209804602e-15
corresponding O 0 4.1667420103623404e-17
to O 0 2.6852883339317145e-17
the O 0 1.2210204100616741e-17
kinase O 0 6.483895018116748e-12
domain O 0 4.007845270936894e-12
, O 0 9.914729864749557e-15
which O 0 2.8775579043459646e-15
is O 0 2.0909375571164377e-17
highly O 0 4.204693884046886e-18
conserved O 0 3.3238087846290676e-14
in O 0 2.242847688425025e-16
ATM O 0 4.131538167140292e-11
- O 0 4.435417311210443e-12
related O 0 5.698899333125493e-14
proteins O 0 2.2410391684740683e-12
in O 0 1.2503547154628977e-14
mouse O 0 3.76841384763793e-08
, O 0 3.2073050270330083e-13
yeast O 0 1.1945991938711042e-11
and O 0 1.69750024041522e-13
Drosophila O 0 1.0275349147936819e-11
. O 0 2.7629878636761807e-13

The O 0 2.1368723576633414e-13
resulting O 0 2.6103196447619433e-15
amino O 0 7.714239911736556e-15
- O 0 2.876924230527794e-13
acid O 0 7.88619014112802e-15
substitutions O 0 1.2396484678255316e-16
are O 0 4.205784521684537e-18
predicted O 0 8.18287562817828e-14
to O 0 2.7805992604836266e-16
interfere O 0 2.204584258203024e-11
with O 0 1.351708306239095e-14
ATP O 0 6.590600894890164e-12
binding O 0 6.306737901015658e-13
or O 0 3.490225008962941e-14
substrate O 0 3.5906125295248614e-10
recognition O 0 4.784566839943771e-11
. O 0 4.377731510629701e-10

Two O 0 8.633644878663568e-14
of O 0 4.16494636668861e-17
seventeen O 0 3.0463977694628053e-12
mutated O 0 2.5502386868936355e-09
T B-Disease 0 5.89808308859574e-08
- I-Disease 0 6.05660521735274e-11
PLL I-Disease 0 4.911812623298317e-10
samples O 0 3.5052926273398954e-12
had O 0 4.3637341732693374e-14
a O 0 7.439785679213201e-18
previously O 0 4.885491560998115e-14
reported O 0 1.1833499735658393e-09
A B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999949932098389
T I-Disease 1 0.9999995231628418
allele O 0 1.1414257983233256e-08
. O 0 1.3581556018715801e-11

In O 0 6.194196089208404e-14
contrast O 0 6.941699819129621e-13
, O 0 4.131356189904277e-15
no O 0 1.3725468414008558e-14
mutations O 0 3.094157417261878e-13
were O 0 3.436608543379749e-16
detected O 0 1.5888741060690603e-12
in O 0 1.1937460318781469e-17
the O 0 4.1476960113221844e-17
p53 O 0 3.4486102125017015e-13
gene O 0 5.804124542097e-13
, O 0 4.851904976162874e-17
suggesting O 0 2.9513632202324616e-16
that O 0 1.2761823223295896e-16
this O 0 9.743080120296131e-16
tumour B-Disease 1 0.9999998807907104
suppressor O 0 4.460808611383982e-09
is O 0 8.169526388929552e-14
not O 0 1.1230025156322432e-13
frequently O 0 1.6020514775894057e-11
altered O 0 2.357102424355162e-08
in O 0 1.0615798198181439e-13
this O 0 1.2625276258476648e-12
leukaemia B-Disease 0 1.118083036999451e-05
. O 0 1.2914596692406577e-12

Occasional O 0 1.0781585757513312e-07
missense O 0 1.7420896369912953e-07
mutations O 0 2.9127305012366378e-09
in O 0 5.602773544996454e-17
ATM O 0 1.822529974160325e-11
were O 0 4.70873814657595e-14
also O 0 1.0556677331342162e-13
found O 0 4.363831582058272e-15
in O 0 6.13818360035149e-16
tumour B-Disease 1 1.0
DNA O 0 4.029582001408016e-09
from O 0 1.0319149485926853e-18
patients O 0 7.781266581764854e-16
with O 0 9.820769982218295e-16
B B-Disease 0 2.4496209789504064e-06
- I-Disease 0 1.222020102886745e-07
cell I-Disease 0 7.768841896904632e-05
non I-Disease 0 2.2835500601559033e-07
- I-Disease 1 0.9233701229095459
Hodgkins I-Disease 1 0.9798827767372131
lymphomas I-Disease 0 0.00023759675968904048
( O 0 1.1123670344212466e-13
B B-Disease 0 3.262750736254816e-09
- I-Disease 0 3.1028957181433725e-11
NHL I-Disease 0 1.3934277343086166e-10
) O 0 1.7182150685326168e-16
and O 0 5.231593648993371e-16
a O 0 4.9909578355464106e-15
B B-Disease 0 2.6682978049308304e-09
- I-Disease 0 4.6950863336059356e-11
NHL I-Disease 0 1.1665020338558207e-10
cell O 0 1.2026570850309781e-09
line O 0 3.460073338956704e-10
. O 0 5.085519136881211e-13

The O 0 2.243876844043851e-14
evidence O 0 4.858058366122211e-15
of O 0 5.745748399983916e-20
a O 0 2.1508032650248605e-17
significant O 0 7.478915127217777e-17
proportion O 0 8.84202921384164e-14
of O 0 3.3772149901649715e-17
loss O 0 1.9723242136726604e-11
- O 0 1.3862239264458842e-12
of O 0 1.661802707332705e-17
- O 0 5.6202154041784524e-11
function O 0 1.65112812745144e-12
mutations O 0 2.2763575746598264e-11
and O 0 5.992791983142065e-16
a O 0 5.029312652068388e-16
complete O 0 2.427830885550625e-13
absence O 0 3.851420694682677e-15
of O 0 2.4919184307026486e-20
the O 0 1.585431106609154e-17
normal O 0 1.8249263438705225e-15
copy O 0 1.889476056626989e-14
of O 0 2.5806610810037224e-19
ATM O 0 1.989180521688727e-12
in O 0 2.9884550576905235e-16
the O 0 1.6027442284404604e-16
majority O 0 1.2092445642909733e-13
of O 0 3.780805251935981e-15
mutated O 0 0.0011213436955586076
tumours B-Disease 1 0.9999997615814209
establishes O 0 3.151261751543899e-10
somatic O 0 5.422169657709475e-12
inactivation O 0 8.362145975659985e-10
of O 0 3.4723674682025975e-19
this O 0 2.9090196792397496e-18
gene O 0 1.3856708207075907e-13
in O 0 8.278904989547207e-18
the O 0 5.314017035427258e-17
pathogenesis O 0 6.540659507059399e-12
of O 0 8.113853506021438e-18
sporadic B-Disease 0 2.8860034717581584e-07
T I-Disease 0 0.00017689334345050156
- I-Disease 0 6.45023305878567e-08
PLL I-Disease 0 6.009799324857568e-09
and O 0 6.92665868239073e-14
suggests O 0 1.518074640332375e-14
that O 0 2.1959029718185992e-17
ATM O 0 9.801393637681732e-14
acts O 0 1.1993523841373455e-15
as O 0 4.826561551857678e-16
a O 0 1.9105695758109276e-12
tumour B-Disease 1 0.9999995231628418
suppressor O 0 2.1177481812628685e-06
. O 0 1.6337363753504697e-11

As O 0 1.0763528875698883e-14
constitutional O 0 1.2313931883715934e-13
DNA O 0 1.1650194142731607e-09
was O 0 3.7837212475601983e-14
not O 0 1.1509571037564119e-16
available O 0 2.220601426856575e-17
, O 0 3.8234588136048327e-16
a O 0 2.577558527944515e-14
putative O 0 5.725453888771881e-09
hereditary O 0 0.00024751515593379736
predisposition O 0 1.146900740423007e-05
to O 0 4.8087745591063324e-11
T B-Disease 0 8.087864989647642e-05
- I-Disease 0 1.7850577194167272e-07
PLL I-Disease 0 1.655773651521031e-08
will O 0 3.725671030366251e-14
require O 0 3.0051916346348804e-16
further O 0 4.056720305273438e-16
investigation O 0 3.3730082275022126e-15
. O 0 2.8622090320670063e-15
. O 0 1.463895058775519e-13

Myotonic B-Disease 1 0.9999814033508301
dystrophy I-Disease 1 0.9999951124191284
protein O 0 2.4845489221547723e-08
kinase O 0 1.8582643757092399e-10
is O 0 1.3964460454142253e-16
involved O 0 9.50699522958631e-18
in O 0 1.0613255232930701e-19
the O 0 7.22853362523572e-20
modulation O 0 3.147046029021681e-17
of O 0 2.5446174289818058e-20
the O 0 2.0207549217360086e-17
Ca2 O 0 7.0370202720493324e-12
+ O 0 6.956737963470516e-11
homeostasis O 0 2.681890487465921e-09
in O 0 6.014635268785859e-14
skeletal O 0 5.411388337961398e-05
muscle O 0 1.9102528767689364e-06
cells O 0 2.370336704693443e-10
. O 0 3.3072608779209645e-13

Myotonic B-Disease 1 0.9999821186065674
dystrophy I-Disease 1 0.9999977350234985
( O 0 7.877399843536637e-10
DM B-Disease 1 0.9999983310699463
) O 0 5.483361703063905e-13
, O 0 1.5036192184061806e-15
the O 0 1.263288627987807e-16
most O 0 2.2272121484329804e-15
prevalent O 0 8.645007909535707e-08
muscular B-Disease 0 7.504304085159674e-05
disorder I-Disease 0 0.015486749820411205
in O 0 6.38808743654907e-15
adults O 0 5.797485972194871e-13
, O 0 4.956483171076687e-15
is O 0 2.0757128942782603e-15
caused O 0 3.8461055629386565e-15
by O 0 3.725805940215436e-18
( O 0 4.141545427159485e-17
CTG O 0 7.357592833601156e-12
) O 0 2.8323715024065855e-16
n O 0 2.7149697420791874e-12
- O 0 4.075096649014398e-10
repeat O 0 1.9283569185901683e-10
expansion O 0 1.996937263172658e-14
in O 0 1.6912457256076777e-18
a O 0 8.875834088331811e-19
gene O 0 2.1040850304701516e-16
encoding O 0 3.777399014817716e-17
a O 0 6.810305038091165e-17
protein O 0 3.675029031091626e-12
kinase O 0 1.4533031722496759e-10
( O 0 2.8665377092406547e-14
DM B-Disease 1 0.9999899864196777
protein O 0 3.9409339791518505e-08
kinase O 0 9.446770032894847e-10
; O 0 7.283857389038962e-15
DMPK O 0 4.004009797331509e-12
) O 0 1.579466968956524e-17
and O 0 1.0910307138782522e-17
involves O 0 2.7099665065010705e-16
changes O 0 2.3401799161687498e-14
in O 0 2.4055637763837603e-16
cytoarchitecture O 0 4.4841630408853916e-10
and O 0 2.21657720932307e-13
ion O 0 9.920841925747936e-11
homeostasis O 0 2.636089391216956e-07
. O 0 2.2831670581924257e-11

To O 0 2.1415879594872955e-14
obtain O 0 9.379883615700038e-15
clues O 0 6.655600685379418e-14
to O 0 4.924780316047735e-16
the O 0 2.3732425873033123e-16
normal O 0 1.8381856366905813e-13
biological O 0 1.4121141051186975e-13
role O 0 2.289284628631907e-15
of O 0 3.198859836770421e-18
DMPK O 0 3.488727640110767e-10
in O 0 1.1391511055980222e-15
cellular O 0 4.2887329972096655e-12
ion O 0 3.4518564222263404e-12
homeostasis O 0 6.79598155528538e-09
, O 0 4.081375537014209e-13
we O 0 2.793053765701159e-12
have O 0 5.733172996676833e-15
compared O 0 5.607416344338592e-16
the O 0 1.215727198603886e-16
resting O 0 1.055257660767528e-12
[ O 0 2.4175144054178936e-15
Ca2 O 0 1.6985787505263e-13
+ O 0 2.949128300507725e-13
] O 0 5.833290664739033e-13
i O 0 1.7878030869958317e-12
, O 0 1.5130590275448735e-18
the O 0 4.400616368418593e-19
amplitude O 0 2.467187937925573e-17
and O 0 9.608214475643117e-16
shape O 0 8.026012580236719e-14
of O 0 1.972776336897371e-18
depolarization O 0 6.916766862226104e-15
- O 0 1.0258703608823083e-11
induced O 0 5.003645067724882e-11
Ca2 O 0 7.423757789060126e-13
+ O 0 7.995515328377417e-14
transients O 0 9.71552525930175e-12
, O 0 1.1217383316639603e-15
and O 0 7.562370371834987e-17
the O 0 1.1900398284640878e-18
content O 0 1.2859413330220412e-16
of O 0 3.6847719398697296e-19
ATP O 0 2.37628910011679e-14
- O 0 5.633858722424445e-14
driven O 0 2.3011770982662993e-13
ion O 0 3.370271997680391e-13
pumps O 0 3.754235149752011e-13
in O 0 2.635533486261099e-15
cultured O 0 4.738238881113466e-12
skeletal O 0 2.31984191856327e-08
muscle O 0 2.414755617685671e-10
cells O 0 2.2598805151426843e-14
of O 0 2.1029825010772192e-19
wild O 0 6.315046575944283e-12
- O 0 4.2643971687184035e-10
type O 0 3.5082425853261157e-08
and O 0 7.751622152323001e-13
DMPK O 0 1.8331369755486548e-09
[ O 0 3.3651911552495806e-13
- O 0 6.956579062800117e-11
/ O 0 4.2365130070720625e-08
- O 0 2.751440852932774e-08
] O 0 5.064725305814477e-10
knockout O 0 4.102628459179414e-09
mice O 0 1.0365955205315913e-08
. O 0 8.631937395767175e-13

In O 0 4.892098445091753e-12
vitro O 0 1.4488072075380387e-08
- O 0 5.675475023281251e-08
differentiated O 0 5.836916505685963e-10
DMPK O 0 1.149220185681088e-08
[ O 0 8.313933742842838e-12
- O 0 6.394467177983643e-10
/ O 0 5.394884539100531e-08
- O 0 1.5205415815344736e-09
] O 0 4.719352079268768e-12
myotubes O 0 9.075368928579408e-12
exhibit O 0 1.1145863962683245e-13
a O 0 1.2329947328572734e-15
higher O 0 1.204404829788599e-15
resting O 0 2.3398061374697854e-13
[ O 0 5.1870239399791525e-15
Ca2 O 0 4.800961603095011e-13
+ O 0 1.61629195270796e-12
] O 0 5.828255846690444e-12
i O 0 8.255093830733529e-11
than O 0 2.1876183609371866e-16
do O 0 2.9103494787741102e-12
wild O 0 3.0990199555852582e-12
- O 0 7.870077853300295e-12
type O 0 2.0730505853605585e-11
myotubes O 0 1.470248402191121e-11
because O 0 4.680065403685034e-15
of O 0 5.416686824243015e-21
an O 0 2.1394521963510403e-18
altered O 0 4.5615944355148486e-10
open O 0 7.503252359708501e-12
probability O 0 3.3207780583921443e-15
of O 0 1.5321388789515982e-18
voltage O 0 2.6109224157688793e-11
- O 0 1.9318321942130012e-10
dependent O 0 1.714010010311906e-11
l O 0 1.983681136019655e-10
- O 0 4.189768323947796e-12
type O 0 3.688591099226812e-11
Ca2 O 0 2.3214219175421436e-12
+ O 0 1.216453478745938e-12
and O 0 9.375201895193974e-14
Na O 0 1.1609091465913934e-09
+ O 0 2.6337085724109643e-12
channels O 0 1.9987514421337949e-10
. O 0 3.0633009150127233e-12

The O 0 1.2452581283836639e-12
mutant O 0 3.0782851961896895e-11
myotubes O 0 5.085953880268335e-10
exhibit O 0 8.590027127108879e-12
smaller O 0 7.14916610611814e-14
and O 0 9.963855234591465e-14
slower O 0 1.40765437500745e-11
Ca2 O 0 6.971482419126929e-11
+ O 0 1.2819773020922298e-11
responses O 0 4.278972602677136e-14
upon O 0 8.773971758979581e-18
triggering O 0 5.822344072561674e-16
by O 0 2.1607609893158658e-18
acetylcholine O 0 3.9779057868852274e-13
or O 0 4.622334958369334e-13
high O 0 1.3646622894214477e-12
external O 0 8.323335354276651e-10
K O 0 4.436981004829477e-09
+ O 0 6.40056480039064e-11
. O 0 3.549305164010641e-12

In O 0 3.177388975300795e-14
addition O 0 3.2179823516715993e-15
, O 0 1.0154764602441323e-15
we O 0 4.771005825517571e-15
observed O 0 1.3877898980888784e-16
that O 0 1.1496534174801915e-17
these O 0 4.7970069841411994e-17
Ca2 O 0 7.865861607891933e-12
+ O 0 5.150479001625463e-11
transients O 0 6.937955099317605e-09
partially O 0 5.202193884001893e-11
result O 0 3.782377768602558e-15
from O 0 2.66464133586325e-20
an O 0 3.820491340380426e-20
influx O 0 3.179956236872716e-16
of O 0 4.083559073602783e-19
extracellular O 0 4.115644321655773e-14
Ca2 O 0 9.791664007385847e-13
+ O 0 1.999316375433588e-13
through O 0 2.5594982502618365e-16
the O 0 1.699499743214135e-16
l O 0 2.6303551350914667e-12
- O 0 7.051124007589893e-13
type O 0 1.0968093620833397e-11
Ca2 O 0 8.741659306144012e-12
+ O 0 1.3667077886081458e-11
channel O 0 2.1309829456583884e-09
. O 0 1.115753149594223e-11

Neither O 0 1.1332701443933502e-10
the O 0 5.731727429073225e-16
content O 0 7.15579278367769e-15
nor O 0 2.762903295906727e-13
the O 0 1.535749977274729e-17
activity O 0 1.377395215639292e-15
of O 0 2.7702087428884244e-19
Na O 0 1.3386063368869827e-09
+ O 0 1.674974828974607e-12
/ O 0 1.3376179330837346e-10
K O 0 6.447981905355338e-12
+ O 0 4.768218155384862e-13
ATPase O 0 1.1350158313216951e-10
and O 0 5.871030116059994e-13
sarcoplasmic O 0 7.245856359361369e-09
reticulum O 0 1.1410382860788104e-08
Ca2 O 0 3.162714534710176e-10
+ O 0 7.324188477930704e-11
- O 0 7.027085163757718e-11
ATPase O 0 3.2666344629284083e-10
are O 0 5.892170398238885e-15
affected O 0 1.7538440589149468e-14
by O 0 2.90562873503665e-16
DMPK O 0 6.928420948071334e-09
absence O 0 4.407049378207795e-12
. O 0 1.0657977728449272e-13

In O 0 1.7828790744092715e-12
conclusion O 0 8.875861200532964e-13
, O 0 8.210951043434792e-15
our O 0 2.659053261865746e-15
data O 0 3.3438114253268305e-15
suggest O 0 3.176346447149314e-14
that O 0 2.5671067766501075e-15
DMPK O 0 2.4225796368959607e-10
is O 0 5.218296687559357e-17
involved O 0 7.089621100765416e-18
in O 0 5.779560570744758e-19
modulating O 0 1.741934796852375e-15
the O 0 7.106788407198342e-18
initial O 0 1.850067029516304e-17
events O 0 1.1876866857370122e-17
of O 0 2.74426086255446e-19
excitation O 0 4.3489585305374334e-15
- O 0 1.2450699360400108e-09
contraction O 0 2.0712324216853872e-11
coupling O 0 1.4023162839271741e-11
in O 0 2.1883551896040472e-14
skeletal O 0 5.747795057686744e-06
muscle O 0 5.026696499044192e-07
. O 0 1.6282037296113522e-13
. O 0 6.24212541464747e-13

Constitutional O 0 4.727849045593757e-08
RB1 O 0 4.026168426207732e-06
- O 0 1.9494906666750467e-07
gene O 0 3.541467918921626e-08
mutations O 0 4.72352912339602e-09
in O 0 5.739165966536894e-16
patients O 0 1.3980524095173752e-13
with O 0 6.438263550762047e-15
isolated O 0 3.5089215089101344e-05
unilateral B-Disease 0 0.000535832135938108
retinoblastoma I-Disease 1 0.512311577796936
. O 0 5.367536415334939e-10

In O 0 1.3280750197491864e-13
most O 0 2.793507460264631e-15
patients O 0 8.15731962772008e-14
with O 0 2.0306789053298278e-15
isolated O 0 4.0625476685818285e-05
unilateral B-Disease 0 0.013971550390124321
retinoblastoma I-Disease 1 0.9499586820602417
, O 0 1.3572041268616886e-09
tumor B-Disease 0 1.333227714894747e-06
development O 0 7.659698613229904e-15
is O 0 1.0520313813840308e-17
initiated O 0 1.1557616334519159e-16
by O 0 1.4709661067681286e-19
somatic O 0 1.4934839397966909e-15
inactivation O 0 9.212696577831636e-12
of O 0 2.763916418742825e-20
both O 0 1.6987867797005633e-16
alleles O 0 1.2624703147514206e-15
of O 0 4.065887600586506e-18
the O 0 8.330333561086707e-15
RB1 O 0 8.540653517741248e-09
gene O 0 2.4332308390384583e-10
. O 0 1.132115343312201e-12

However O 0 5.633735231796999e-12
, O 0 2.883017190509696e-16
some O 0 8.809146787347786e-19
of O 0 1.4215710164895246e-19
these O 0 9.335827738047447e-16
patients O 0 3.777085930264587e-15
can O 0 1.6065217571571981e-15
transmit O 0 1.2254781391052294e-11
retinoblastoma B-Disease 0 2.1547404685406946e-05
predisposition O 0 2.5085657398449257e-05
to O 0 7.967797428787282e-13
their O 0 4.1905012988265045e-13
offspring O 0 3.424564451459666e-11
. O 0 1.797054367293216e-12

To O 0 1.9670690179799874e-14
determine O 0 1.892757589319594e-15
the O 0 3.336187328090709e-18
frequency O 0 2.5402509617826995e-14
and O 0 3.582107839652593e-15
nature O 0 1.3374341070119655e-14
of O 0 5.630345460046317e-18
constitutional O 0 1.0527251813330363e-11
RB1 O 0 5.613967246631546e-08
- O 0 2.384110270314821e-11
gene O 0 1.9602115763905914e-10
mutations O 0 4.116796833986136e-11
in O 0 2.715770766684906e-17
patients O 0 1.0256339946443111e-14
with O 0 4.53043512772843e-16
isolated O 0 9.688701538834721e-06
unilateral B-Disease 0 1.3745253454544581e-05
retinoblastoma I-Disease 0 8.022665861062706e-05
, O 0 3.4320807372305306e-13
we O 0 3.996101206557058e-14
analyzed O 0 2.6514363180875616e-15
DNA O 0 1.36144361843199e-12
from O 0 3.8043086890691685e-18
peripheral O 0 7.762320564097536e-09
blood O 0 1.97046134964296e-09
and O 0 1.2515084454878256e-12
from O 0 7.038808639815925e-15
tumor B-Disease 0 3.4601896459207637e-07
tissue O 0 3.977271134658622e-08
. O 0 2.7369538926902415e-11

The O 0 2.0996821902680152e-13
analysis O 0 8.777508342557028e-13
of O 0 1.0164264923977727e-14
tumors B-Disease 1 1.0
from O 0 2.3248746237349276e-15
54 O 0 2.5838829340041336e-11
( O 0 2.2575958555257026e-15
71 O 0 1.9433321271633552e-11
% O 0 1.6615682843471074e-17
) O 0 6.675168872290622e-17
of O 0 6.741006245195249e-18
76 O 0 1.089728973724391e-09
informative O 0 1.0521365112481362e-08
patients O 0 1.5420617671679793e-08
showed O 0 7.158650339178507e-10
loss O 0 1.4253173294398458e-12
of O 0 1.2157908915110526e-18
constitutional O 0 2.916363331384453e-11
heterozygosity O 0 9.908541187542141e-07
( O 0 2.7392296330502885e-12
LOH O 1 0.9998912811279297
) O 0 5.240140461305887e-13
at O 0 2.8142711685358313e-13
intragenic O 0 4.505408934818433e-09
loci O 0 2.384474215300081e-11
. O 0 2.1638444074739693e-12

Three O 0 2.2395095760491257e-12
of O 0 1.6504823436032227e-16
13 O 0 3.9258442959162754e-13
uninformative O 0 1.0152984231126538e-07
patients O 0 8.734534762133705e-10
had O 0 4.2869336552842086e-12
constitutional O 0 2.6748720426128525e-12
deletions O 0 1.057655595104734e-06
. O 0 2.353124639586923e-10

For O 0 3.1699916671658335e-14
39 O 0 2.1023894430927115e-11
randomly O 0 2.5049967308787835e-11
selected O 0 5.387221335695358e-09
tumors B-Disease 1 1.0
, O 0 1.0223549784527108e-10
SSCP O 0 1.9422882360231597e-06
, O 0 1.9053828610379742e-13
hetero O 0 7.468706764157673e-10
- O 0 2.0501730521593764e-11
duplex O 0 3.22817078624027e-10
analysis O 0 6.0171446038921e-15
, O 0 2.476890187484391e-18
sequencing O 0 1.0757242197164361e-15
, O 0 5.968924050526317e-17
and O 0 3.4018743691908103e-16
Southern O 0 1.2330106553826159e-12
blot O 0 4.902380279503404e-09
analysis O 0 3.2297146050240186e-15
were O 0 1.5799542610553791e-18
used O 0 2.651869840137878e-16
to O 0 1.4875932491650108e-15
identify O 0 1.262390365852628e-12
mutations O 0 7.873464658025853e-10
. O 0 3.451981539157045e-12

Mutations O 0 1.4383635615899948e-08
were O 0 1.013715986966559e-14
detected O 0 6.151909710816472e-12
in O 0 8.931783757784286e-17
21 O 0 1.1869780332240953e-13
( O 0 2.0753715400005169e-16
91 O 0 1.2573727866185824e-12
% O 0 9.670679383559529e-18
) O 0 1.158180309563021e-16
of O 0 6.056775263790879e-16
23 O 0 1.7625538021093234e-05
tumors B-Disease 1 1.0
with O 0 2.87087482320203e-06
LOH O 1 0.9999984502792358
. O 0 3.1340243733524176e-09

In O 0 2.301361412635622e-13
6 O 0 3.355173940327444e-13
( O 0 2.343867484692533e-16
38 O 0 2.450067058956673e-13
% O 0 1.2575183483835351e-17
) O 0 3.439756329569983e-16
of O 0 9.796823302008232e-16
16 O 0 3.637154804891907e-05
tumors B-Disease 1 1.0
without O 0 1.1811152944574133e-07
LOH O 1 0.9999954700469971
, O 0 9.317195046086926e-14
one O 0 3.664997213321478e-16
mutation O 0 9.176450865725026e-15
was O 0 6.946431438346608e-16
detected O 0 1.7586730682861429e-12
, O 0 2.248005324980416e-15
and O 0 1.1284040786182017e-14
in O 0 3.9715844943493165e-16
9 O 0 4.4754065904595297e-13
( O 0 4.359651117121547e-17
56 O 0 1.474403010705977e-13
% O 0 1.984036332985749e-18
) O 0 2.7263479251776217e-17
of O 0 8.927559842704345e-17
the O 0 4.502713935039537e-08
tumors B-Disease 1 1.0
without O 0 1.233394755217887e-07
LOH O 1 0.9999945163726807
, O 0 3.046216165598914e-13
both O 0 1.7332789459885596e-14
mutations O 0 3.3362503731870774e-11
were O 0 3.238832067668264e-15
found O 0 5.488946631742285e-14
. O 0 2.6754575117859947e-13

Thus O 0 1.6575270886734494e-12
, O 0 1.8959877494639484e-15
a O 0 2.8685474854904286e-16
total O 0 3.1365232990132716e-17
of O 0 1.2715451395438112e-18
45 O 0 5.957536438998268e-14
mutations O 0 1.3661213653370918e-11
were O 0 1.5037626846116218e-15
identified O 0 3.5466001663264635e-11
in O 0 3.804712187666093e-12
tumors B-Disease 1 1.0
of O 0 2.967191777857362e-15
36 O 0 7.232101029153171e-10
patients O 0 9.589377035490454e-12
. O 0 2.689743230661207e-13

Thirty O 0 4.19108150961911e-11
- O 0 5.054890950262347e-10
nine O 0 1.415511994727267e-13
of O 0 3.462209431786505e-19
the O 0 2.085870910428428e-17
mutations O 0 7.962460037017408e-14
- O 0 1.0056933313472988e-13
including O 0 1.4513937079773222e-15
34 O 0 5.895591225499666e-14
small O 0 2.402529333789781e-15
mutations O 0 1.6035494113109117e-11
, O 0 4.928558082992489e-16
2 O 0 5.610173833628599e-17
large O 0 1.452229941254499e-15
structural O 0 2.276385968613681e-09
alterations O 0 2.784325303650803e-08
, O 0 2.6322409421401793e-13
and O 0 2.8098408474085124e-13
hypermethylation O 0 1.6164206328994624e-07
in O 0 1.0831259500410084e-11
3 O 0 4.236852646499756e-08
tumors O 1 1.0
- O 0 8.955531427545793e-09
were O 0 1.0818694437487661e-13
not O 0 1.0291259726726617e-14
detected O 0 2.5572001113860487e-12
in O 0 5.3172183071159e-18
the O 0 1.4873817490085484e-17
corresponding O 0 7.383416794626285e-16
peripheral O 0 9.271012429978853e-11
blood O 0 1.6788521961519365e-11
DNA O 0 3.467619746899686e-09
. O 0 3.3034735971021467e-12

In O 0 4.741012270270684e-13
6 O 0 4.675412617824448e-13
( O 0 6.601104576080502e-16
17 O 0 2.2840433158092394e-14
% O 0 1.3108728213821855e-18
) O 0 1.210570658062807e-18
of O 0 7.662601175316897e-20
the O 0 2.283223472619592e-15
36 O 0 7.84240207496456e-12
patients O 0 1.479569030769963e-14
, O 0 7.223882440350123e-18
a O 0 2.6453225401533984e-16
mutation O 0 1.6348257654303505e-13
was O 0 6.988429237695607e-15
detected O 0 3.9053065252134256e-13
in O 0 4.9481824301733295e-18
constitutional O 0 8.990182730206353e-14
DNA O 0 1.4324935904141967e-08
, O 0 8.575215868335609e-15
and O 0 5.591228485925378e-15
1 O 0 6.755142017401229e-17
of O 0 1.1274158971428646e-19
these O 0 5.688359342173805e-16
mutations O 0 4.637462831282024e-13
is O 0 2.1709812193742647e-18
known O 0 4.033617878683771e-17
to O 0 7.498169244900052e-17
be O 0 4.496413520006369e-16
associated O 0 1.8436141014429447e-13
with O 0 1.3795342364113228e-13
reduced O 0 8.604466583683745e-10
expressivity O 0 6.783669050491881e-06
. O 0 7.990618583475495e-11

The O 0 3.7780674720438653e-14
presence O 0 9.23689259574225e-15
of O 0 2.596995054668289e-19
a O 0 2.1692366871905842e-16
constitutional O 0 1.275405562412013e-13
mutation O 0 3.725831709128213e-12
was O 0 5.1495869471829964e-14
not O 0 6.525593706415149e-16
associated O 0 1.1801007016747946e-15
with O 0 3.349144119769617e-17
an O 0 9.469497478058057e-18
early O 0 7.58497865210872e-13
age O 0 1.456275556957834e-13
at O 0 2.038621008115804e-13
treatment O 0 1.2890289530220755e-11
. O 0 1.3590560968279597e-13

In O 0 6.830616367664577e-12
1 O 0 1.7355898619328403e-12
patient O 0 1.8739813520407544e-11
, O 0 2.851703282422211e-15
somatic O 0 6.448741280556947e-13
mosaicism O 0 3.1605573713733293e-09
was O 0 2.6104368232998665e-13
demonstrated O 0 7.793145160058911e-17
by O 0 6.112208798390514e-21
molecular O 0 1.4126859169443564e-16
analysis O 0 1.254332975106267e-16
of O 0 1.8366335426976694e-20
DNA O 0 1.4505774185991083e-11
and O 0 2.740248199063208e-16
RNA O 0 7.874001450858259e-11
from O 0 2.694278132828941e-16
peripheral O 0 7.619346433784813e-07
blood O 0 6.430332888385237e-08
. O 0 4.3637239655058835e-11

In O 0 4.46645498364262e-12
2 O 0 3.233430233631762e-12
patients O 0 1.3940690507356635e-13
without O 0 8.041112467180832e-16
a O 0 1.124909983007483e-14
detectable O 0 1.392647330789032e-09
mutation O 0 6.189980195081546e-10
in O 0 6.771273706942128e-15
peripheral O 0 8.391474693780765e-06
blood O 0 9.321448501964369e-09
, O 0 7.273361803789534e-15
mosaicism O 0 8.46301986823228e-11
was O 0 3.3261804768813796e-14
suggested O 0 4.8006751026709316e-14
because O 0 7.672946208524961e-15
1 O 0 1.6332390027283913e-17
of O 0 3.4076858863335574e-20
the O 0 1.6476963463605849e-15
patients O 0 1.0471049076638331e-13
showed O 0 8.585085420342864e-11
multifocal O 1 0.9999978542327881
tumors B-Disease 1 1.0
and O 0 2.2304999514055623e-10
the O 0 1.1132722373561536e-15
other O 0 1.690532390690011e-15
later O 0 1.2207050474610792e-11
developed O 0 2.5940355766196355e-11
bilateral B-Disease 0 2.8636674628823577e-11
retinoblastoma I-Disease 0 5.05525122207473e-06
. O 0 5.2964063690374985e-11

In O 0 2.1177421795359752e-12
conclusion O 0 3.6149192363457705e-13
, O 0 7.903238881477176e-14
our O 0 1.2771771148805365e-14
results O 0 8.067074556409768e-16
emphasize O 0 4.779768381356917e-15
that O 0 1.4738047703935725e-16
the O 0 1.489033049665388e-18
manifestation O 0 7.908327876600103e-16
and O 0 1.8667773682916306e-16
transmissibility O 0 1.4073422332019914e-12
of O 0 1.6524461985904185e-18
retinoblastoma B-Disease 0 3.2446526021523425e-10
depend O 0 5.451867798357546e-13
on O 0 2.9986673951223897e-14
the O 0 7.156632325677317e-17
nature O 0 3.3999301109395065e-15
of O 0 3.222740902946345e-20
the O 0 1.0299452454385587e-17
first O 0 1.0152706974123985e-16
mutation O 0 9.529007365954184e-16
, O 0 6.558578592131885e-18
its O 0 1.964786392565568e-17
time O 0 2.3914208354997198e-14
in O 0 1.0691168465671504e-16
development O 0 6.142821635133299e-16
, O 0 6.941610232689955e-16
and O 0 2.4069874799494172e-15
the O 0 5.159863325599631e-17
number O 0 2.1032204162952858e-14
and O 0 4.723042161362823e-13
types O 0 4.3112768129821566e-13
of O 0 2.70890938622184e-18
cells O 0 1.6483392613082098e-13
that O 0 1.9705452835471664e-15
are O 0 2.52782689427061e-16
affected O 0 1.0767681370019502e-13
. O 0 1.2170184632742838e-14
. O 0 4.009280700403156e-13

Hereditary B-Disease 1 0.9999511241912842
deficiency I-Disease 1 0.9998916387557983
of I-Disease 0 6.550134368479474e-16
the I-Disease 0 1.6836983806407975e-14
fifth I-Disease 0 3.3784200480571625e-13
component I-Disease 0 1.0684702634374682e-13
of I-Disease 0 1.3256073896335926e-17
complement I-Disease 0 1.0032569393303437e-12
in O 0 8.172795597292774e-15
man O 0 3.99942079454263e-09
. O 0 6.729628247888197e-13

I O 0 0.0003664641117211431
. O 0 6.74617514628828e-11

Clinical O 0 6.421008947654627e-06
, O 0 1.559218682986585e-12
immunochemical O 0 4.602499714678743e-08
, O 0 2.0839992058430123e-12
and O 0 1.2158087037139609e-12
family O 0 4.215402766433174e-12
studies O 0 3.1879913205828947e-12
. O 0 1.0987346151175928e-13

The O 0 1.4314582505448037e-12
first O 0 7.035322167501731e-14
recognized O 0 3.692886450736184e-14
human O 0 4.965970126433183e-13
kindred O 0 1.6041628025931232e-09
with O 0 1.3836453094384638e-09
hereditary B-Disease 1 0.9999853372573853
deficiency I-Disease 1 0.9998313188552856
of I-Disease 0 4.167950024928913e-17
the I-Disease 0 3.0916902474557514e-14
fifth I-Disease 0 1.2350913477718328e-12
component I-Disease 0 1.4977929107488214e-13
of I-Disease 0 1.3974045161336027e-17
complement I-Disease 0 4.140263132335065e-11
( O 0 4.078943485194076e-15
C5 O 0 1.0383353031551135e-11
) O 0 2.3647944395060756e-15
is O 0 6.138538401277271e-15
described O 0 1.1653939098466015e-11
. O 0 5.313605024731549e-12

The O 0 5.636677648072907e-13
proband O 0 1.9488340108342328e-10
, O 0 3.208188956735445e-15
a O 0 2.2857057026715207e-16
20 O 0 8.940140531902337e-16
- O 0 7.891674510054902e-13
year O 0 1.992700462604007e-16
- O 0 1.4103686968303109e-11
old O 0 6.206481162340793e-11
black O 0 2.666369187075135e-13
female O 0 3.343612496251036e-12
with O 0 6.491938497193983e-12
systemic B-Disease 1 0.9999988079071045
lupus I-Disease 1 0.8469170928001404
erythematosus I-Disease 1 0.9999994039535522
since O 0 2.7867587348850975e-08
age O 0 4.987459334415689e-10
11 O 0 3.8684016385147346e-13
, O 0 2.323559096864547e-14
lacked O 0 3.3025586709811705e-09
serum O 0 4.316327295583733e-10
hemolytic O 0 3.8691308490435006e-10
complement O 0 2.533884018406096e-13
activity O 0 2.2224715557489505e-12
, O 0 1.0290042540381412e-14
even O 0 2.373097107277039e-13
during O 0 3.505170329334839e-13
remission O 0 2.6709225109389223e-11
. O 0 7.039590535929535e-14

C5 O 0 1.754631568928744e-07
was O 0 1.1819148437730576e-10
undetectable O 0 2.747845562200979e-10
in O 0 6.838554380975484e-16
her O 0 1.2365292166929831e-12
serum O 0 1.416482382776696e-12
by O 0 1.5033653599849105e-17
both O 0 9.062473942935897e-14
immunodiffusion O 0 1.2085821481377934e-06
and O 0 3.736522549702137e-11
hemolytic O 0 5.477811981791092e-09
assays O 0 1.6761526888675604e-10
. O 0 7.456500694669188e-12

Other O 0 1.9653654653164696e-15
complement O 0 1.889655542908512e-15
components O 0 2.3528269227525564e-15
were O 0 6.616988032028296e-16
normal O 0 1.3977919299454356e-12
during O 0 9.127851503343363e-15
remission O 0 3.405326693371735e-13
of O 0 1.4044901245812167e-18
lupus O 0 9.148062751762609e-09
, O 0 1.7961547098830147e-14
but O 0 6.2795662766901295e-12
C1 O 0 7.467990809084668e-11
, O 0 2.248878827707272e-16
C4 O 0 1.0802005123711211e-11
, O 0 9.090466687776758e-14
C2 O 0 1.3888076452750475e-11
, O 0 3.4603150897492656e-15
and O 0 4.705229803871058e-13
C3 O 0 4.582333623659451e-09
levels O 0 8.737191525831633e-12
fell O 0 2.832188350510023e-08
during O 0 7.874297568155608e-12
exacerbations O 0 7.100382936187088e-05
. O 0 1.8841097085275926e-11

A O 0 1.9251000099584914e-11
younger O 0 6.237927709096258e-12
half O 0 7.27222779607975e-14
- O 0 4.315757126671649e-11
sister O 0 5.864838059643773e-10
, O 0 1.253918013665407e-14
who O 0 1.4310167634201676e-11
had O 0 1.908736724232085e-09
no O 0 5.055023066802278e-11
underlying O 0 8.204111001663961e-11
disease O 0 1.7353736438963097e-06
, O 0 1.1318524344497687e-15
was O 0 6.1579435127467885e-12
also O 0 3.702877848094088e-12
found O 0 1.3744082911701372e-12
to O 0 1.499565310250292e-13
lack O 0 4.059315383830864e-11
immunochemically O 0 4.920838364341762e-06
detectable O 0 6.104372118898027e-08
C5 O 0 1.8278450752973185e-08
. O 0 2.1850342715734605e-11

By O 0 1.0768221167176129e-12
hemolytic O 0 2.0454889337884197e-08
assay O 0 3.727653255514163e-11
, O 0 3.844635384792766e-13
she O 0 1.5241639547691754e-11
exhibited O 0 1.17795435406777e-13
1 O 0 2.271953328679459e-16
- O 0 6.533275439743469e-13
2 O 0 1.1989499376082813e-15
% O 0 2.115324682051364e-19
of O 0 5.302888905499453e-21
the O 0 7.893494741506905e-17
normal O 0 5.216001675717452e-12
serum O 0 2.093137729114458e-12
C5 O 0 2.125064853903888e-13
level O 0 6.386702283570425e-14
and O 0 1.495080745133031e-14
normal O 0 2.1580316472615685e-13
concentrations O 0 6.17664082315679e-14
of O 0 5.4065539425185973e-20
other O 0 1.6085130852940787e-17
complement O 0 2.7277461092287646e-14
components O 0 1.5080676507919777e-12
. O 0 1.7030530631567675e-12

C5 O 0 4.783576645905896e-09
levels O 0 1.6175008381302813e-12
of O 0 1.8180852129956468e-19
other O 0 1.0054343122454487e-17
family O 0 1.3083012822938806e-16
members O 0 9.347177111001012e-20
were O 0 1.9536045650450763e-18
either O 0 1.133848361710855e-16
normal O 0 1.318660214659137e-13
or O 0 4.829766512771852e-16
approximately O 0 5.590290396936294e-15
half O 0 3.321988517601682e-11
- O 0 9.021041336154667e-08
normal O 0 1.0760400570575257e-08
, O 0 6.434682295461056e-14
consistent O 0 5.946572444529008e-13
with O 0 1.1712974882539806e-14
autosomal O 0 3.4402692250523614e-08
codominant O 0 3.7272357422679647e-10
inheritance O 0 2.1184966216176992e-13
of O 0 4.851420910068408e-18
the O 0 6.202346875501595e-16
gene O 0 7.241877320041112e-09
determining O 0 3.671357973189515e-08
C5 B-Disease 1 0.9999964237213135
deficiency I-Disease 1 0.9999998807907104
. O 0 9.31102157181174e-12

Normal O 0 5.523417257791152e-06
hemolytic O 0 1.5511010360569344e-06
titers O 0 3.775550538875905e-08
were O 0 1.5933647901523323e-13
restored O 0 1.1915431315234759e-11
to O 0 4.161664976932815e-14
both O 0 1.8437107743296544e-11
homozygous O 0 0.0006736876093782485
C5 B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999992847442627
deficient I-Disease 1 1.0
( O 0 1.127998583427825e-08
C5D B-Disease 1 1.0
) O 0 2.2862850393261247e-13
sera O 0 2.5533791660897753e-12
by O 0 3.455691248559587e-19
addition O 0 3.9693562021279966e-17
of O 0 7.121547894265702e-19
highly O 0 4.0551592235516486e-15
purified O 0 1.240597251664366e-12
human O 0 1.0248533792445169e-11
C5 O 0 6.291008824987898e-10
. O 0 3.5209858032653196e-12

In O 0 3.0774363092567203e-13
specific O 0 3.758154269555003e-13
C5 O 0 7.706372345817059e-11
titrations O 0 1.1872657301736922e-09
, O 0 1.5930244861954435e-13
however O 0 9.782865977806671e-14
, O 0 2.710908618896654e-15
it O 0 1.469281985032149e-14
was O 0 2.45329364462199e-13
noted O 0 1.2919124049628333e-13
that O 0 6.288086726796227e-16
when O 0 2.0373675009978214e-15
limited O 0 1.2108587973302032e-15
amounts O 0 1.200363344429673e-16
of O 0 1.176067817339878e-18
C5 O 0 2.6326523968646376e-13
were O 0 6.372094395713725e-16
assayed O 0 4.3494437110096207e-13
in O 0 3.8375869922927894e-17
the O 0 3.962651737827132e-18
presence O 0 4.1511803607600537e-16
of O 0 1.8014406588604607e-19
low O 0 1.452053504291586e-14
dilutions O 0 2.7295665727677942e-11
of O 0 1.3833183582207637e-16
either O 0 6.063008428647265e-11
C5D B-Disease 1 0.9999995231628418
serum O 0 1.0970538255605788e-08
, O 0 1.6223058984919268e-15
curving O 0 1.2337782705207356e-11
rather O 0 4.819459709990543e-16
than O 0 5.273827307313512e-18
linear O 0 4.1147261379409494e-14
dose O 0 2.2560917706509337e-13
- O 0 3.5595964110318734e-12
response O 0 2.084180132080546e-14
plots O 0 1.016541018028505e-10
were O 0 4.99986228634508e-13
consistently O 0 3.173382780510825e-12
obtained O 0 3.529652465657674e-16
, O 0 1.1757895744613305e-18
suggesting O 0 2.5498684451810657e-17
some O 0 3.3613402361572213e-18
inhibitory O 0 6.160360307809476e-13
effect O 0 3.914122498338557e-12
. O 0 7.54950138862065e-13

Further O 0 3.540868293017141e-11
studies O 0 1.3865087734616505e-13
suggested O 0 5.884401581453258e-14
that O 0 1.0652012117753407e-15
low O 0 5.142620812699505e-13
dilutions O 0 1.184386420050032e-07
of O 0 2.418853352749266e-14
C5D B-Disease 1 0.9999998807907104
serum O 0 1.4373205958762014e-09
contain O 0 1.0814392568906793e-15
a O 0 8.368865513373779e-17
factor O 0 1.0348099872652117e-15
( O 0 1.2355265937459553e-17
or O 0 1.8410495366121693e-16
factors O 0 6.5164925491551385e-15
) O 0 1.8746190735858578e-17
interfering O 0 1.7966480218714956e-14
at O 0 9.267174023606592e-15
some O 0 7.218128902881449e-17
step O 0 1.3252612440610434e-13
in O 0 6.154616833621611e-17
the O 0 3.1339774356111804e-16
hemolytic O 0 5.800829434854382e-12
assay O 0 4.4288527110015324e-14
of O 0 1.1770237279352596e-18
C5 O 0 1.460709808318028e-13
, O 0 1.6022001421207475e-16
rather O 0 3.930211699436272e-17
than O 0 1.437237274454002e-18
a O 0 5.872981290335312e-16
true O 0 1.330716458113881e-14
C5 O 0 1.6232463507029338e-12
inhibitor O 0 1.0412977988552563e-12
or O 0 9.681103778336718e-15
inactivator O 0 1.548068553347548e-07
. O 0 1.8751505556635628e-11

Of O 0 1.5533434998341034e-13
clinical O 0 6.454365930608219e-09
interest O 0 1.0528961735681644e-14
are O 0 2.3128165803351706e-16
( O 0 5.884078480735528e-17
a O 0 3.571667417423855e-16
) O 0 8.728574598037569e-17
the O 0 2.8537241442156823e-17
documentation O 0 1.2021598994049754e-12
of O 0 3.681884509190887e-15
membranous O 1 0.9999781847000122
glomerulonephritis B-Disease 1 1.0
, O 0 2.0781305920536397e-06
vasculitis B-Disease 1 1.0
, O 0 1.2893456968754435e-08
and O 0 7.2257203100889456e-06
arthritis B-Disease 1 1.0
in O 0 1.1652504861622143e-13
an O 0 3.4753166785198497e-15
individual O 0 1.055015026485721e-14
lacking O 0 6.127925424037617e-12
C5 O 0 7.696493724458631e-13
( O 0 2.587919415102995e-17
and O 0 8.577530094696406e-17
its O 0 1.3486153149741785e-18
biologic O 0 6.031651957408291e-13
functions O 0 3.1326403941039395e-15
) O 0 1.0425357615422283e-16
, O 0 1.4524626635567571e-15
and O 0 1.7677421755134953e-13
( O 0 2.2083209843686046e-15
b O 0 1.9599264919345494e-11
) O 0 3.885621370463744e-18
a O 0 9.70290733284133e-17
remarkable O 0 1.755470700986854e-14
propensity O 0 9.209727598602502e-12
to O 0 3.1854902049488487e-10
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 9.821712094613879e-15
the O 0 4.323696884616317e-16
proband O 0 2.1841469605154984e-11
, O 0 5.4788160965173e-16
even O 0 1.5441991904805948e-15
during O 0 1.8211005872153504e-16
periods O 0 2.4744193493638584e-15
of O 0 1.4773760779688183e-20
low O 0 2.5220393299002584e-15
- O 0 1.3098931695451708e-14
dose O 0 1.3201334590642964e-15
or O 0 1.1342327029106717e-17
alternate O 0 4.50763067144774e-15
- O 0 5.192199101222705e-12
day O 0 1.852322481054984e-14
corticosteroid O 0 1.7247049621804678e-10
therapy O 0 3.189513236856456e-11
. O 0 1.649344926585826e-14

Other O 0 9.391412581145116e-15
observations O 0 2.381013138388899e-13
indicate O 0 1.705711445568539e-13
that O 0 3.720428743455694e-15
the O 0 6.613458339857969e-15
C5D B-Disease 1 0.9999998807907104
state O 0 6.936800038461616e-14
is O 0 1.611585002478529e-16
compatible O 0 3.0030615055912134e-15
with O 0 8.602143151607942e-16
normal O 0 3.662349503524842e-12
coagulation O 0 9.544879535187956e-14
function O 0 1.294987012588622e-12
and O 0 6.214499892470563e-15
the O 0 3.344445733890316e-17
capacity O 0 5.020093227833117e-16
to O 0 3.689996067270709e-16
mount O 0 1.7649738007913252e-12
a O 0 5.7326574043337075e-12
neutrophilic O 0 0.0014963254798203707
leukocytosis O 0 0.0006838710978627205
during O 0 9.399213629635028e-10
pyogenic B-Disease 0 0.002187547739595175
infection I-Disease 1 0.5249258875846863
. O 0 6.33330329369644e-14
. O 0 7.273313353504951e-13

Susceptibility O 0 0.00013044039951637387
to O 0 2.0955706503400506e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 1.0515708304126292e-08
twins O 0 9.616903753340011e-07
: O 0 1.9116529885487062e-15
the O 0 1.1340937779267934e-18
role O 0 2.549004306138744e-16
of O 0 1.333340184192468e-19
genes O 0 1.5036774519213043e-14
, O 0 5.319049271401786e-16
HLA O 0 4.110649598487726e-09
, O 0 4.309507123986117e-14
and O 0 1.0227804931109419e-13
the O 0 1.9105385473000037e-14
environment O 0 1.3616943683736338e-10
. O 0 4.0060394780085107e-13

OBJECTIVE O 0 1.2301243357271119e-11
To O 0 5.199345728262861e-15
determine O 0 1.585034288878722e-14
the O 0 4.693719918901908e-17
relative O 0 5.534910366405271e-14
effects O 0 1.8147787959887918e-13
of O 0 1.5338464899286374e-18
genetic O 0 4.3531997451218274e-11
and O 0 1.030480801871795e-15
environmental O 0 1.8302317347356498e-15
factors O 0 2.7470721082445252e-16
in O 0 5.606475078975956e-16
susceptibility O 0 3.1550420942494384e-08
to O 0 1.5146135456944876e-09
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 8.667558226704841e-09
AS B-Disease 1 0.9999847412109375
) O 0 3.358823635890573e-13
. O 0 4.4317620320061257e-13

METHODS O 0 5.443897777013262e-09
Twins O 0 2.697084777736336e-09
with O 0 2.500456718645982e-15
AS B-Disease 1 0.9946245551109314
were O 0 1.7838482105440043e-16
identified O 0 2.914388802716713e-15
from O 0 6.514316674542056e-19
the O 0 8.00399071887182e-16
Royal O 0 3.3719749215066486e-10
National O 0 4.131313346977805e-13
Hospital O 0 1.30504185236191e-08
for O 0 5.986103810990545e-14
Rheumatic B-Disease 1 0.9985827207565308
Diseases I-Disease 0 0.01171448640525341
database O 0 8.531666040312302e-09
. O 0 7.487616082713089e-11

Clinical O 0 7.116385631888988e-07
and O 0 6.95908012205565e-13
radiographic O 0 1.2662373194416432e-07
examinations O 0 6.010561492963973e-11
were O 0 1.1179705173563364e-15
performed O 0 3.3921089136364213e-13
to O 0 4.397115847599748e-16
establish O 0 9.703302397690017e-12
diagnoses O 0 1.2439460988389328e-05
, O 0 3.3256511693807722e-12
and O 0 3.3303089175262812e-09
disease O 0 0.00033772498136386275
severity O 0 5.438332562057724e-10
was O 0 5.8560711245763276e-15
assessed O 0 2.4807967133632953e-17
using O 0 6.571228665239659e-17
a O 0 2.9726864805862006e-15
combination O 0 4.166128501751666e-14
of O 0 1.152317910989832e-18
validated O 0 2.1902877081481087e-11
scoring O 0 3.114901782688695e-12
systems O 0 2.7859945253561058e-11
. O 0 1.7657145277155673e-12

HLA O 0 1.5259716974469484e-06
typing O 0 1.51410599613655e-08
for O 0 6.556037129330653e-15
HLA O 0 4.109616824621298e-08
- O 0 6.5160152828980245e-09
B27 O 0 3.125748826438013e-10
, O 0 6.719783421111486e-15
HLA O 0 8.394950706813731e-11
- O 0 2.0288623212016965e-12
B60 O 0 7.587235961031835e-13
, O 0 1.3098794105537338e-16
and O 0 8.689177375125097e-16
HLA O 0 9.669244294130408e-10
- O 0 3.347787672081104e-11
DR1 O 0 3.230928200537164e-07
was O 0 5.934148504071861e-15
performed O 0 7.75240486052945e-17
by O 0 2.500374090644016e-20
polymerase O 0 2.8261898030179644e-14
chain O 0 2.1278676520450346e-13
reaction O 0 6.381873391089776e-16
with O 0 1.3144287053994285e-17
sequence O 0 4.335214912748464e-13
- O 0 9.545862771033128e-14
specific O 0 2.6955222124702206e-16
primers O 0 9.109325273259916e-12
, O 0 8.334625477030445e-15
and O 0 1.578799956980341e-15
zygosity O 0 1.9117880889485406e-11
was O 0 2.4339487504187584e-15
assessed O 0 7.866320865767802e-17
using O 0 2.325319061922352e-14
microsatellite O 0 2.2194766913230524e-08
markers O 0 2.729295545123023e-07
. O 0 4.440108697378875e-11

Genetic O 0 1.4878930869599571e-06
and O 0 7.563446024268661e-15
environmental O 0 1.3001823391455502e-15
variance O 0 4.016469034922118e-16
components O 0 1.0366798971995703e-13
were O 0 1.5811806489577176e-15
assessed O 0 1.3175726667065098e-15
with O 0 5.211714315116905e-16
the O 0 1.200487620044903e-15
program O 0 3.493848277098116e-14
Mx O 0 7.696816816706031e-13
, O 0 3.283197465966314e-19
using O 0 1.3832588797988181e-18
data O 0 6.836468032947278e-16
from O 0 5.472102706937626e-19
this O 0 3.4467049114132243e-16
and O 0 8.223493229691375e-14
previous O 0 1.9923614895476366e-13
studies O 0 2.3993797264787106e-14
of O 0 1.7567457639187478e-19
twins O 0 9.55021617343732e-10
with O 0 4.688859299743428e-14
AS B-Disease 1 0.9999954700469971
. O 0 3.027273223765725e-11

RESULTS O 0 1.731969057061633e-08
Six O 0 2.559951220188622e-13
of O 0 7.639960078728584e-18
8 O 0 3.726513889135141e-12
monozygotic O 0 1.991377729382293e-09
( O 0 2.777216390886794e-13
MZ O 0 0.0059212991036474705
) O 0 2.2432554078188893e-11
twin O 0 5.814813630422577e-05
pairs O 0 1.7929208979694522e-06
were O 0 5.03723895928232e-10
disease O 0 7.72135354054626e-06
concordant O 0 8.54095006525002e-12
, O 0 2.8237652559097437e-14
compared O 0 4.607782322471783e-14
with O 0 2.2679466404927975e-14
4 O 0 7.14016194260092e-13
of O 0 2.3643409327721597e-17
15 O 0 8.25398289213547e-13
B27 O 0 5.863171614883811e-10
- O 0 1.3179780877781155e-10
positive O 0 5.40219961592172e-14
dizygotic O 0 4.017496404995491e-12
( O 0 1.4480802474365614e-16
DZ O 0 1.6167621408325061e-10
) O 0 1.6521019764774913e-15
twin O 0 1.5774185777028826e-11
pairs O 0 6.742026641831655e-13
( O 0 3.428058539870605e-16
27 O 0 1.8178342132361275e-13
% O 0 3.0148334503781455e-18
) O 0 5.653678239892968e-17
and O 0 2.1747985966898316e-14
4 O 0 2.50470607118412e-14
of O 0 9.01857551812029e-17
32 O 0 8.244869231788243e-10
DZ O 0 6.725975708832266e-06
twin O 0 4.2049720150316716e-08
pairs O 0 4.18055650860949e-12
overall O 0 1.0147147743366433e-13
( O 0 1.0828670368023948e-16
12 O 0 1.6209697040176331e-15
. O 0 7.45331395343371e-16
5 O 0 1.3387049952460258e-14
% O 0 1.2216778697561435e-16
) O 0 4.976129676771777e-15
. O 0 3.102685480500106e-13

Nonsignificant O 0 3.4442811625012837e-07
increases O 0 1.0407701610259945e-11
in O 0 8.567065929075365e-17
similarity O 0 2.5082197332559203e-14
with O 0 2.3388465645487853e-17
regard O 0 1.3493120500313125e-15
to O 0 2.1619031976942427e-14
age O 0 5.6306175000298e-13
at O 0 4.4956169863163975e-12
disease O 0 1.0307026059308555e-06
onset O 0 9.17365142183435e-11
and O 0 1.5507052293726314e-14
all O 0 3.859402392023773e-17
of O 0 4.807737088329176e-19
the O 0 2.4575917269655835e-14
disease O 0 1.0483026002816587e-08
severity O 0 3.2821074417294094e-12
scores O 0 2.926859058935416e-13
assessed O 0 3.999667977594651e-15
were O 0 1.0590028576013943e-14
noted O 0 8.024161890496373e-10
in O 0 3.526175879065008e-11
disease O 0 0.13190427422523499
- O 0 1.166122001450276e-05
concordant O 0 5.574812166742049e-05
MZ O 1 0.7943695783615112
twins O 0 3.698005173191632e-07
compared O 0 1.295001866158385e-12
with O 0 6.402169918338918e-13
concordant O 0 1.1975177585554775e-05
DZ O 0 0.0037919185124337673
twins O 0 2.4151502657332458e-05
. O 0 3.7654119405816644e-11

HLA O 0 6.936092631804058e-06
- O 0 1.1083400153211187e-07
B27 O 0 1.6191268326082309e-09
and O 0 1.495851036895264e-14
B60 O 0 6.70286796986691e-13
were O 0 7.86893277127e-17
associated O 0 1.2914675347886059e-15
with O 0 2.971654582698208e-15
the O 0 4.775235653946275e-13
disease O 0 2.4753069283178775e-07
in O 0 1.3473972294836482e-17
probands O 0 1.7285952669254812e-09
, O 0 1.3138090875636221e-14
and O 0 9.643948678105408e-15
the O 0 1.2836385151362528e-15
rate O 0 3.313682336338053e-13
of O 0 1.973453797819052e-18
disease O 0 9.447418403141228e-10
concordance O 0 1.3646868838701042e-14
was O 0 8.461937070101608e-15
significantly O 0 7.79808238381835e-13
increased O 0 6.321538886973344e-13
among O 0 2.3153479594738638e-14
DZ O 0 1.4756984455743805e-05
twin O 0 1.887494107677412e-07
pairs O 0 6.996762544342339e-12
in O 0 1.2395972488020023e-15
which O 0 4.5454305331584996e-14
the O 0 2.4915158623712392e-15
co O 0 1.4255371327820399e-09
- O 0 7.421740999546955e-11
twin O 0 3.0759036984129295e-10
was O 0 1.9479231934600195e-14
positive O 0 2.2714323372424486e-17
for O 0 3.7550238723059754e-20
both O 0 1.046592744957111e-15
B27 O 0 1.8404161528096097e-10
and O 0 1.7747769399945046e-12
DR1 O 0 0.00021275220206007361
. O 0 3.14703159365326e-11

Additive O 0 3.654006264230958e-11
genetic O 0 2.805646548420526e-10
effects O 0 3.9331894945843215e-13
were O 0 4.450184711676496e-17
estimated O 0 3.2003995094035965e-17
to O 0 1.210688014312213e-15
contribute O 0 4.9724484715830096e-15
97 O 0 1.6906606323252582e-12
% O 0 3.510609444467723e-17
of O 0 4.4476150906132364e-20
the O 0 6.170931482279117e-17
population O 0 4.2457825589631304e-16
variance O 0 2.886157296228681e-13
. O 0 3.3108852031532576e-12

CONCLUSION O 0 5.0104066728895447e-11
Susceptibility O 0 8.446837007625163e-09
to O 0 1.7219659725897785e-11
AS B-Disease 1 0.9999988079071045
is O 0 9.38443319906633e-14
largely O 0 4.477912096976849e-15
genetically O 0 2.306238967159091e-13
determined O 0 9.138039283596022e-12
, O 0 4.414378696702146e-15
and O 0 7.182946330626058e-16
the O 0 6.454363926553677e-17
environmental O 0 2.892902117943713e-14
trigger O 0 5.542624735913049e-13
for O 0 7.088380660718831e-17
the O 0 1.1892538820043597e-12
disease O 0 3.2412531254522037e-06
is O 0 5.607504647523343e-15
probably O 0 6.740792277658281e-13
ubiquitous O 0 2.0905065178933313e-10
. O 0 1.8473857860135112e-11

HLA O 0 4.497569534578361e-06
- O 0 4.046211543595746e-08
B27 O 0 1.3444960422770436e-10
accounts O 0 1.4201158517296547e-15
for O 0 9.287788644947002e-19
a O 0 2.760348522512124e-17
minority O 0 1.944241141238305e-14
of O 0 4.1456511277901344e-19
the O 0 6.020996062703265e-17
overall O 0 2.897850145608394e-14
genetic O 0 3.795869434747301e-12
susceptibility O 0 2.1918631840089908e-11
to O 0 2.2338599340535753e-13
AS B-Disease 1 0.9999991655349731
. O 0 1.4293971561940566e-10

Cell O 0 4.504905973590212e-06
cycle O 0 5.541476255643829e-08
- O 0 1.6488017617888318e-09
dependent O 0 4.3778192876375854e-12
colocalization O 0 4.400351194533414e-10
of O 0 2.6072031458511987e-16
BARD1 O 0 1.6644265965481964e-09
and O 0 5.494435744053672e-14
BRCA1 O 0 5.996576932926212e-12
proteins O 0 3.7221981952825084e-14
in O 0 6.2375518643515865e-18
discrete O 0 1.7746212485625357e-12
nuclear O 0 2.023602618805853e-08
domains O 0 3.765530554034058e-09
. O 0 5.205148811970872e-12

Germ O 0 8.03965303930454e-05
- O 0 4.356489171186695e-06
line O 0 8.381231708654013e-09
mutations O 0 7.805154959850125e-12
of O 0 2.397196298548582e-19
the O 0 3.779517920674832e-17
BRCA1 O 0 5.56240036669875e-12
gene O 0 5.446920041743408e-13
predispose O 0 1.4525035904947026e-12
women O 0 2.9038701781711196e-14
to O 0 2.359090731397502e-15
early O 0 2.1442070341493036e-11
- O 0 0.010674256831407547
onset O 1 0.8693696856498718
breast B-Disease 1 0.999996542930603
and I-Disease 1 0.999987006187439
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
by O 0 1.3533417629557605e-17
compromising O 0 1.6271552247953958e-12
the O 0 4.365044797936536e-16
genes O 0 1.3760371965140794e-12
presumptive O 0 1.545374180185466e-12
function O 0 1.2832523739914233e-14
as O 0 1.141286237430034e-16
a O 0 1.267649095366757e-14
tumor B-Disease 0 1.6052096318830422e-09
suppressor O 0 1.5149957732774055e-08
. O 0 2.8830686102376823e-11

Although O 0 1.0074223573408592e-11
the O 0 1.1822815997557376e-15
biochemical O 0 1.8733228943773605e-12
properties O 0 3.7363620769385875e-13
of O 0 4.202162215064106e-17
BRCA1 O 0 3.788681174343722e-11
polypeptides O 0 4.277932608848234e-12
are O 0 1.1541674115660649e-15
not O 0 2.3578325910092977e-14
understood O 0 2.881667411744511e-14
, O 0 1.974479857466281e-16
their O 0 6.84797484318683e-17
expression O 0 9.666417074064276e-15
pattern O 0 1.1713304805260893e-11
and O 0 6.786297953844051e-15
subcellular O 0 8.635980819349243e-11
localization O 0 7.490236729468247e-13
suggest O 0 3.313920860816e-14
a O 0 1.6115234602409552e-16
role O 0 2.4780292767301142e-14
in O 0 8.258694584902372e-16
cell O 0 2.0940993383788964e-09
- O 0 1.2447209485344501e-07
cycle O 0 1.0868728139712402e-09
regulation O 0 3.641378518159932e-11
. O 0 1.2967066114442927e-13

When O 0 1.4431443817741751e-09
resting O 0 4.5881888566245976e-11
cells O 0 2.891932570150968e-13
are O 0 1.8361539508748354e-16
induced O 0 3.6683061102604775e-12
to O 0 5.674640055406245e-16
proliferate O 0 2.0184584559324037e-10
, O 0 1.115628026564881e-14
the O 0 4.280797048118051e-16
steady O 0 1.3634544339911903e-13
- O 0 5.868239515193288e-14
state O 0 1.3159502809751626e-15
levels O 0 1.732834327806634e-16
of O 0 6.845950313467728e-21
BRCA1 O 0 7.594062030147168e-15
increase O 0 1.63368766549264e-17
in O 0 7.627987156349762e-19
late O 0 3.6311529531227486e-16
G1 O 0 5.6746027012532715e-14
and O 0 1.155435525767223e-16
reach O 0 3.663108462197999e-17
a O 0 6.0971743513176624e-18
maximum O 0 1.716347890279513e-16
during O 0 1.3571903034737248e-14
S O 0 1.2934775472928095e-10
phase O 0 3.3656532964256025e-13
. O 0 1.0146721516387375e-13

Moreover O 0 7.468389101594752e-11
, O 0 2.0531517905633158e-14
in O 0 5.4439646082651665e-15
S O 0 1.4434087258763384e-09
phase O 0 7.477599404471028e-14
cells O 0 3.916687463180642e-14
, O 0 7.524276256172307e-16
BRCA1 O 0 5.793344103055542e-12
polypeptides O 0 1.0123069917045147e-11
are O 0 5.587241501842652e-15
hyperphosphorylated O 0 2.251101527406263e-09
and O 0 3.5620939249463024e-13
accumulate O 0 5.8473963518435035e-12
into O 0 2.19702914579711e-14
discrete O 0 5.030000305161764e-10
subnuclear O 0 1.8340423366680625e-06
foci O 0 9.898661446072765e-09
termed O 0 1.1057392501623298e-10
" O 0 1.5934142026663434e-12
BRCA1 O 0 4.680095200271239e-10
nuclear O 0 1.652232239912621e-10
dots O 0 2.854367409099723e-09
. O 0 7.317430689157689e-11

" O 0 1.7178368449943804e-10
BRCA1 O 0 9.420413782379455e-09
associates O 0 8.168385412510304e-11
in O 0 8.078129924558213e-16
vivo O 0 5.023279014970683e-10
with O 0 7.611459769246416e-16
a O 0 3.0548942044907827e-15
structurally O 0 1.4768927400488074e-11
related O 0 2.364066245281321e-13
protein O 0 1.0932390548390458e-09
termed O 0 1.6871488650593847e-09
BARD1 O 0 1.1115427696495317e-05
. O 0 2.0190002447684208e-11

Here O 0 2.5468044340115625e-11
we O 0 1.4037385078109754e-13
show O 0 4.375767123318032e-15
that O 0 7.559573177875578e-17
the O 0 2.381021857004904e-17
steady O 0 2.7748587593814066e-14
- O 0 9.630057845990206e-14
state O 0 8.409292278363859e-15
levels O 0 2.2552288219546005e-15
of O 0 5.447004366942148e-20
BARD1 O 0 1.2654695867586607e-11
, O 0 3.7976265586448426e-17
unlike O 0 5.415192804871069e-16
those O 0 2.104644642969962e-18
of O 0 9.627935135598581e-20
BRCA1 O 0 3.5469092940498825e-12
, O 0 2.4316748904718542e-15
remain O 0 4.855779423977623e-15
relatively O 0 1.1740928028590382e-15
constant O 0 2.6564083167846496e-14
during O 0 2.563414094164905e-14
cell O 0 3.143925675352932e-10
cycle O 0 6.810328967432611e-10
progression O 0 1.7314264466605778e-09
. O 0 3.720815973037861e-13

However O 0 5.410067949185304e-10
, O 0 2.335459028859205e-13
immunostaining O 0 1.2253725145683347e-08
revealed O 0 1.6576828451575487e-11
that O 0 3.569212864173478e-14
BARD1 O 0 5.016684845315922e-09
resides O 0 7.511700463036508e-12
within O 0 4.644495102098037e-15
BRCA1 O 0 1.032808647632999e-11
nuclear O 0 1.2462085400080647e-12
dots O 0 2.0604928895918972e-13
during O 0 3.970618728558681e-14
S O 0 1.0795866804691467e-11
phase O 0 4.121689055816823e-16
of O 0 4.643455916748848e-20
the O 0 4.7722388804956467e-17
cell O 0 6.322820739201873e-12
cycle O 0 1.4984702660560817e-13
, O 0 5.922854309028237e-18
but O 0 1.6263761829710593e-16
not O 0 6.49075788827254e-17
during O 0 4.992435765764304e-18
the O 0 1.2782962154721934e-17
G1 O 0 2.2616680663695155e-12
phase O 0 4.882475717130075e-13
. O 0 5.238581378581852e-13

Nevertheless O 0 2.0368267072967683e-08
, O 0 3.567662929405274e-13
BARD1 O 0 1.418755779525327e-09
polypeptides O 0 1.8860009040611025e-11
are O 0 4.152401570511758e-15
found O 0 3.045922643271702e-15
exclusively O 0 6.39810439524374e-17
in O 0 5.1315578667825563e-17
the O 0 1.8561746002871504e-17
nuclear O 0 2.1556444712469806e-14
fractions O 0 3.229748208409223e-17
of O 0 3.6859226256499733e-20
both O 0 7.796980631123197e-17
G1 O 0 1.0048114006426176e-13
- O 0 4.144385355731028e-12
and O 0 1.7001645317288316e-12
S O 0 7.577929950208784e-11
- O 0 2.0711759130681573e-12
phase O 0 1.9582466616145655e-13
cells O 0 2.683358635117983e-13
. O 0 4.587901442760188e-14

Therefore O 0 2.1136354819151215e-11
, O 0 2.7239923980197124e-14
progression O 0 4.940693340560465e-11
to O 0 2.8299425824907746e-15
S O 0 2.100788210057658e-09
phase O 0 7.12047947188689e-14
is O 0 1.0247139898086509e-16
accompanied O 0 4.599076030795959e-16
by O 0 4.860829158958009e-19
the O 0 3.1575785611203495e-18
aggregation O 0 1.0085743275701359e-14
of O 0 6.590932107430672e-18
nuclear O 0 1.219849221634206e-10
BARD1 O 0 1.9387570715512226e-10
polypeptides O 0 1.616157034589616e-11
into O 0 2.606934037131109e-13
BRCA1 O 0 1.9553871022370828e-10
nuclear O 0 3.4253108682769096e-10
dots O 0 4.2562389723777017e-10
. O 0 8.144982951985291e-12

This O 0 1.272966215944138e-12
cell O 0 2.620743844161666e-09
cycle O 0 1.0967813324214148e-09
- O 0 2.5862312291735634e-10
dependent O 0 2.6381932662772334e-12
colocalization O 0 1.4251394508946191e-10
of O 0 5.009818056438432e-17
BARD1 O 0 2.4479431814938835e-08
and O 0 7.79360679725033e-13
BRCA1 O 0 5.4566167556613365e-11
indicates O 0 2.355350233902427e-15
a O 0 2.170825006315584e-17
role O 0 5.229022798119336e-15
for O 0 1.4638089875225837e-16
BARD1 O 0 1.6727362828206083e-09
in O 0 1.0113907121197564e-14
BRCA1 O 0 1.6101473931939836e-08
- O 0 2.028092715988805e-08
mediated O 0 9.281987400910907e-10
tumor B-Disease 0 1.9050714783475087e-08
suppression O 0 2.2413150502220702e-10
. O 0 7.467018323104035e-12

Ethnic O 0 1.000015004137822e-08
differences O 0 5.108784950635936e-09
in O 0 4.032031666553228e-14
the O 0 8.842838299712857e-14
HFE O 0 1.0731274642239441e-06
codon O 0 1.4471659426362748e-09
282 O 0 3.324675951210665e-11
( O 0 5.2203755234641117e-14
Cys O 0 3.6397781514097005e-05
/ O 0 5.0616105085055096e-08
Tyr O 0 3.375810186945216e-10
) O 0 1.8060827830577823e-14
polymorphism O 0 7.707754573482717e-11
. O 0 3.7080226042429665e-12

Recent O 0 1.2846705643720924e-10
studies O 0 6.617367244443617e-12
have O 0 5.978162030077089e-14
shown O 0 3.1768225203232525e-12
that O 0 5.748430065288801e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 3.0353736885091465e-11
HH B-Disease 0 7.605988230352523e-07
) O 0 2.606130855079534e-15
is O 0 1.117279867866969e-15
likely O 0 1.3317880394954525e-14
to O 0 6.195654785822694e-16
be O 0 4.175210897231895e-15
caused O 0 1.0339819278559759e-14
by O 0 1.5014568888756282e-17
homozygosity O 0 7.298529836052836e-11
for O 0 5.77350627040536e-17
a O 0 2.1163065671105964e-14
Cys282Tyr O 0 3.3346264416422855e-08
mutation O 0 1.6655904086504414e-11
in O 0 4.664535994274302e-17
the O 0 4.223393625282627e-16
HFE O 0 4.670832165487582e-09
gene O 0 9.716863424991118e-11
located O 0 3.0033770609394494e-11
4 O 0 1.7592073631167437e-11
. O 0 2.8694945725105114e-12

5 O 0 1.851103471894877e-11
Mb O 0 1.2644967739561253e-08
telomeric O 0 5.352738412511826e-07
to O 0 1.4552878216736453e-12
HLA O 0 8.292077495752892e-07
- O 0 8.555021224765369e-08
A O 0 7.157568288063132e-11
. O 0 2.6318203259073636e-12

Population O 0 1.526129483203631e-12
studies O 0 2.2210706513456184e-14
of O 0 1.2292767433861057e-20
this O 0 3.0129578183391815e-19
polymorphism O 0 9.796366327733189e-14
are O 0 4.175921233619841e-18
facilitated O 0 1.9833128229193673e-15
by O 0 7.379748910354103e-18
the O 0 6.833205367913573e-17
fact O 0 3.764858162638024e-15
that O 0 2.0472928213155104e-15
the O 0 1.3297009079617705e-15
Cys282Tyr O 0 6.634552462969623e-09
mutation O 0 1.1284311159098781e-12
creates O 0 6.2695511048114615e-15
a O 0 8.292762567678295e-15
Rsal O 0 3.2203681943343554e-09
restriction O 0 5.668642777401089e-10
site O 0 8.957811575838193e-11
. O 0 3.8992793369163614e-12

We O 0 7.648505162549668e-10
have O 0 1.398894648258148e-14
studied O 0 6.279056593248844e-14
the O 0 1.1400590984476992e-16
codon O 0 2.6256984867606414e-12
282 O 0 2.1937181617689289e-13
( O 0 2.0472303526356504e-15
Cys O 0 4.804629043064779e-06
/ O 0 9.088024222059232e-10
Tyr O 0 8.907779028288765e-13
) O 0 6.983834626587234e-18
polymorphism O 0 8.49356612738503e-15
in O 0 7.033241297394414e-18
different O 0 4.156646899643396e-16
ethnic O 0 1.3727132494936733e-12
groups O 0 8.25225142126601e-13
. O 0 1.3725770737008092e-12

In O 0 5.370741151073874e-14
agreement O 0 2.1836478887029762e-14
with O 0 2.0418867394087783e-16
previous O 0 1.7311908403669883e-14
observations O 0 9.20978855786965e-14
the O 0 1.4571957777868958e-16
Tyr O 0 1.5764221525382816e-12
allele O 0 7.177883402942082e-15
appeared O 0 4.721529157231119e-13
to O 0 3.4772507723757865e-16
be O 0 3.5483114368153835e-15
rare O 0 1.1468857547686229e-12
or O 0 1.432496157284524e-12
absent O 0 1.7701293555938413e-11
in O 0 9.15463299106965e-15
Asiatic O 0 1.6502953170682844e-10
( O 0 5.860847940412589e-17
Indian O 0 7.404864482002393e-13
, O 0 1.8257627465542887e-14
Chinese O 0 2.206849476380987e-13
) O 0 4.599377045129589e-15
populations O 0 1.1952670624093553e-11
. O 0 9.534258148605201e-13

The O 0 4.0900527458137895e-15
highest O 0 3.2354947975607513e-17
allele O 0 6.423638997532109e-16
frequency O 0 1.3305844056774041e-14
( O 0 1.2560752490868751e-17
7 O 0 9.087787903729419e-16
. O 0 1.3393063939325323e-16
5 O 0 8.761638396784742e-16
% O 0 4.3047173908974105e-18
) O 0 2.32507615801937e-17
was O 0 1.7241989899632187e-13
found O 0 4.2327385628600223e-13
in O 0 5.559743000726515e-14
Swedes O 0 4.166048711340409e-06
. O 0 5.76256316969781e-12

Saamis O 0 4.405478293278975e-08
( O 0 2.6114561088672744e-14
2 O 0 6.005266660872753e-15
% O 0 1.0511648269743203e-17
) O 0 5.550230701614841e-17
and O 0 4.845066574777224e-15
Mordvinians O 0 1.3377283725191091e-09
( O 0 4.767890226579333e-17
1 O 0 3.4144837780996707e-17
. O 0 4.684543838930735e-17
8 O 0 3.8951831812981627e-16
% O 0 1.2040210936714005e-19
) O 0 7.417964654654052e-18
had O 0 3.015921117444781e-14
significantly O 0 1.278679310871833e-13
lower O 0 4.43725536254159e-15
frequencies O 0 1.2867222444598505e-15
of O 0 2.973396457977761e-18
the O 0 9.749772739370624e-16
Tyr O 0 1.2561085505069514e-10
allele O 0 4.723026223590887e-12
. O 0 1.6157246981313156e-12

Comparisons O 0 1.3076455066332593e-12
with O 0 1.9479955194858032e-16
allele O 0 1.017364708441799e-15
frequencies O 0 1.269908746335971e-15
based O 0 5.471840250801069e-16
on O 0 1.16768828086573e-14
prevalence O 0 5.784420498144982e-09
estimates O 0 2.0356914938457482e-13
of O 0 3.5549059588866727e-17
HH B-Disease 0 0.00024381214461755008
showed O 0 1.5441037337637908e-09
some O 0 1.606343324372903e-16
disagreements O 0 1.2521364153861292e-12
with O 0 8.95976628529022e-17
the O 0 1.3957796025383036e-17
RFLP O 0 1.3089936252985712e-11
data O 0 6.8699339870559404e-15
, O 0 3.921362852115425e-16
particularly O 0 8.97204932181659e-16
in O 0 1.3504964138498108e-15
Finns O 0 1.2983734620775067e-07
. O 0 2.333238637020063e-12

The O 0 4.4508923456587635e-12
newly O 0 6.535571563104359e-12
described O 0 3.302652747637358e-13
HFE O 0 2.887738270729301e-09
marker O 0 1.5113915327602534e-11
provides O 0 3.166978898027392e-16
a O 0 2.0573432708988216e-17
new O 0 5.387394573205612e-17
approach O 0 8.690043889830138e-15
to O 0 8.8508854938766e-18
the O 0 1.782465652596377e-18
screening O 0 5.795205623975591e-14
of O 0 9.337126866558493e-20
HH B-Disease 0 4.5196860143370543e-10
as O 0 2.8909367897478463e-15
well O 0 3.821317143737259e-15
as O 0 7.337146031695743e-16
studies O 0 4.943907272908802e-15
of O 0 7.781514204485076e-21
the O 0 1.0738126185557159e-17
relationship O 0 9.71499102545752e-15
between O 0 2.827308627662169e-16
the O 0 3.246846428717388e-16
HFE O 0 1.0270584382965353e-08
Tyr O 0 3.3580586228376674e-11
allele O 0 8.240015115547339e-13
and O 0 2.3714274359314114e-13
different O 0 2.1230526017768092e-12
disorders O 0 6.016586553414527e-07
including O 0 4.256112823286529e-12
cancer B-Disease 0 9.876846161205322e-05

Autosomal B-Disease 1 0.9999252557754517
dominant I-Disease 1 0.9994913339614868
neurohypophyseal I-Disease 1 0.9999511241912842
diabetes I-Disease 1 0.9999985694885254
insipidus I-Disease 1 0.9984214305877686
associated O 0 3.3299851764923005e-09
with O 0 1.9286802989642964e-14
a O 0 3.276681226696554e-14
missense O 0 2.0200925376911982e-09
mutation O 0 5.6749223376062474e-12
encoding O 0 2.7804177688516007e-13
Gly23 O 0 1.2969449514343978e-08
- O 0 5.831945149026296e-09
- O 0 6.667855956266067e-08
> O 0 2.938441989730478e-10
Val O 0 1.688621580342442e-07
in O 0 4.942910569239768e-14
neurophysin O 0 2.4995022940288436e-08
II O 0 3.169594586793778e-09
. O 0 6.383003392333719e-13

Autosomal B-Disease 1 0.9999593496322632
dominant I-Disease 1 0.9998389482498169
neurohypophyseal I-Disease 1 0.9999560117721558
diabetes I-Disease 1 0.9999970197677612
insipidus I-Disease 1 0.999430239200592
( O 0 1.0112230497405506e-10
ADNDI B-Disease 0 1.2907157724839635e-06
) O 0 4.039801262609166e-13
is O 0 1.0710418012552236e-12
an O 0 1.3363148088085808e-10
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 9.935972183905406e-11
by O 0 6.266463563839601e-16
progressive O 0 1.020302176080179e-09
degeneration O 0 7.135182386264205e-05
of O 0 7.59750238681134e-17
the O 0 5.514233191019962e-15
magnocellular O 0 1.1917937470240503e-10
neurons O 0 4.868452646231147e-13
of O 0 4.131618267192114e-18
the O 0 6.875564294465679e-17
hypothalamus O 0 2.090136467765638e-13
leading O 0 1.2353900996804612e-13
to O 0 7.111514453997326e-16
decreased O 0 9.096304438849234e-12
ability O 0 1.0429232076471923e-13
to O 0 5.871726622782192e-16
produce O 0 1.6447238536387854e-14
the O 0 1.0926144802011605e-15
hormone O 0 1.4403879971354103e-14
arginine O 0 6.390540359261024e-14
vasopressin O 0 5.534717412299887e-15
( O 0 2.881675702079482e-16
AVP O 0 1.780141138663094e-11
) O 0 9.545789587386486e-14
. O 0 2.7202762611922005e-13

Affected O 0 2.0398377431618542e-10
individuals O 0 3.7970631493860205e-16
are O 0 7.862210770740149e-17
not O 0 1.4573752428925953e-14
symptomatic O 0 3.0768510569240126e-12
at O 0 2.4384492905774047e-13
birth O 0 9.339547364650702e-13
, O 0 6.765880986980138e-14
but O 0 3.0648703019942047e-10
usually O 0 8.605390178217931e-09
develop O 0 2.956565481326834e-07
diabetes B-Disease 1 0.9546314477920532
insipidus I-Disease 0 0.010288039222359657
at O 0 1.0803375971590867e-09
1 O 0 6.681274457298603e-12
- O 0 3.3880617138493108e-06
6 O 0 6.198933033552123e-11
yr O 0 4.735605241279472e-10
of O 0 8.840366932858477e-16
age O 0 4.302021412716517e-12
. O 0 2.359597163926336e-13

The O 0 3.426155030256811e-13
genetic O 0 6.882722863865709e-11
locus O 0 2.259743634618408e-13
of O 0 1.0288855608994293e-16
the O 0 1.447271447650722e-12
disease O 0 3.918339189112885e-06
is O 0 6.443444745421283e-16
the O 0 9.217458060042211e-16
AVP O 0 1.4232149680992734e-08
- O 0 1.2237870805620332e-07
neurophysin O 0 4.2961346480296925e-07
II O 0 7.112458400015953e-10
( O 0 2.6944734798024013e-16
NPII O 0 1.3734838787138326e-11
) O 0 6.937000652921217e-17
gene O 0 1.6235024934661835e-13
, O 0 2.916312838056401e-15
and O 0 1.7563748239547532e-14
mutations O 0 1.485855882776832e-10
that O 0 3.0931176673784644e-14
cause O 0 3.22326665141634e-14
ADNDI B-Disease 0 1.9234649428767625e-09
have O 0 3.1530846184880945e-13
been O 0 7.165766596631609e-14
found O 0 1.1012853870756133e-14
in O 0 4.1825055912957634e-18
both O 0 3.698548188362221e-17
the O 0 7.825459466996663e-19
signal O 0 3.9705374160427224e-17
peptide O 0 1.6232575797128364e-17
of O 0 3.2707311109650585e-21
the O 0 1.7289573653628224e-17
prepro O 0 7.160394499550193e-11
- O 0 4.897487623778396e-11
AVP O 0 1.0619338741690854e-10
- O 0 3.2389500803642335e-11
NPII O 0 2.1955506857018747e-10
precursor O 0 3.474750055829784e-13
and O 0 1.451682334454099e-14
within O 0 6.297839718260798e-14
NPII O 0 1.979589825396033e-08
itself O 0 3.117172318878314e-12
. O 0 5.352908329266104e-13

An O 0 2.997752260726176e-14
affected O 0 7.925196089664244e-12
girl O 0 4.056332603141755e-09
who O 0 9.11213704317404e-13
presented O 0 1.9349690527295385e-15
at O 0 7.686305612169056e-15
9 O 0 1.2776790666050794e-14
months O 0 8.388169923637296e-17
of O 0 3.2916372931537693e-19
age O 0 8.647807405066932e-13
and O 0 2.4195654702886815e-13
her O 0 1.3873196862135284e-11
similarly O 0 1.9304368758903123e-13
affected O 0 5.629350067690164e-13
younger O 0 1.3201808353111022e-12
brother O 0 1.0225533093877193e-11
and O 0 1.0433485028900086e-14
father O 0 5.93098365016774e-14
were O 0 4.291356769643454e-17
all O 0 6.2544685350589085e-18
found O 0 3.760364123457248e-16
to O 0 7.024504450328507e-17
have O 0 7.528500832996738e-15
a O 0 1.7082622725837012e-15
novel O 0 1.928413808846563e-12
missense O 0 1.7352482784005474e-09
mutation O 0 7.990096431709226e-12
( O 0 4.163850186940855e-17
G1758 O 0 6.914558444044705e-13
- O 0 9.346969725987364e-11
- O 0 9.774232534454086e-10
> O 0 1.8589431209636853e-12
T O 0 2.904724529483038e-13
) O 0 1.503644781595831e-19
encoding O 0 1.1944422904792481e-18
the O 0 5.4600093263821e-19
amino O 0 9.583647740845884e-17
acid O 0 4.198525267346833e-17
substitution O 0 2.8759431419111427e-16
Gly23 O 0 6.425441342189364e-12
- O 0 2.2953372535994276e-10
- O 0 8.021227237975381e-09
> O 0 9.492714253545032e-11
Val O 0 4.1546744711240535e-08
within O 0 1.5291248085455567e-12
NPII O 0 1.3141740140554248e-08
. O 0 2.8466643105240497e-12

The O 0 1.42085497013833e-12
mutation O 0 7.964230837320674e-12
was O 0 1.9666027686941713e-15
confirmed O 0 9.354717234515708e-17
by O 0 1.2175360358083864e-18
restriction O 0 2.1991455531611415e-11
endonuclease O 0 9.044322268891847e-07
analysis O 0 6.060791868378601e-10
. O 0 2.0240926990044983e-12

A O 0 5.172933262298507e-12
T1 O 0 3.12737086227699e-10
- O 0 1.968940418692333e-12
weighted O 0 2.437337712300064e-13
magnetic O 0 2.7854534474856633e-14
resonance O 0 3.9869523698124465e-13
imaging O 0 1.9988123656222712e-10
of O 0 4.284914157637299e-16
the O 0 6.050754108909498e-14
fathers O 0 1.712242153617538e-11
pituitary O 0 1.1742877503717608e-11
gland O 0 3.778734269932471e-12
demonstrates O 0 7.622905128304436e-13
an O 0 6.756746244863769e-15
attenuated O 0 5.307776154950261e-05
posterior O 0 0.001686356496065855
pituitary O 0 1.0857526831387077e-05
bright O 0 7.373536003996151e-09
spot O 0 8.044458610356742e-08
. O 0 4.819646418074974e-11

This O 0 4.729839024782134e-13
mutation O 0 1.0742789470497005e-11
may O 0 6.756154168833638e-15
be O 0 5.412254328463036e-18
valuable O 0 1.2558500905241382e-17
for O 0 5.18810451248311e-18
developing O 0 5.087808971869501e-13
models O 0 2.715252189755546e-10
of O 0 5.4568136745585406e-15
dominantly B-Disease 0 0.00023282461916096509
inherited I-Disease 1 0.639273464679718
neurodegeneration I-Disease 1 0.9999998807907104
, O 0 6.705780272427478e-14
as O 0 1.1040477573929787e-16
the O 0 3.09773547660168e-17
early O 0 1.8605088850836074e-14
age O 0 7.408672776014567e-15
of O 0 1.3014904218867262e-18
onset O 0 2.753963723733932e-10
of O 0 3.2634236575885428e-16
symptoms O 0 7.306981331112183e-08
suggests O 0 5.280216622418439e-15
that O 0 2.3844123048996364e-17
this O 0 1.15170818375261e-16
mutation O 0 1.3588797784496592e-13
may O 0 7.463390257374247e-15
be O 0 1.1741241430780866e-15
particularly O 0 3.397687167695177e-15
deleterious O 0 7.964651616183815e-13
to O 0 2.883921874636923e-14
the O 0 1.4652994055207487e-14
magnocellular O 0 2.310598379295925e-09
neuron O 0 3.5403702192127184e-10
. O 0 3.5342639459565867e-14
. O 0 2.753229230972182e-13

Frequent O 0 1.279102068707516e-08
inactivation O 0 4.055877766973026e-08
of O 0 1.7678550638295406e-15
PTEN O 0 1.7860683598769356e-08
/ O 0 3.3958730227823253e-07
MMAC1 O 0 2.4607418325217623e-08
in O 0 3.643910802438033e-13
primary O 0 1.8765684217214584e-05
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 1.1933359855831327e-10

Sporadic B-Disease 1 0.9987441301345825
prostate I-Disease 1 0.9999617338180542
carcinoma I-Disease 1 1.0
is O 0 7.990161310367228e-11
the O 0 1.884386150943643e-15
most O 0 2.2559344003996633e-15
common O 0 1.1017549719771758e-12
male B-Disease 0 1.9038780274538425e-10
cancer I-Disease 0 1.3214280336626416e-08
in O 0 2.0122337041121813e-15
the O 0 4.4191175241695135e-13
Western O 0 1.7291362382820807e-05
world O 0 1.6694842730480275e-10
, O 0 7.821118529021103e-15
yet O 0 4.299914475858462e-15
many O 0 1.6527921668816188e-19
of O 0 1.7051124715365916e-21
the O 0 2.6751227805118053e-19
major O 0 1.1337446001748164e-16
genetic O 0 3.395772974878336e-13
events O 0 8.343587535598648e-17
involved O 0 3.810499738907434e-16
in O 0 5.575227768853948e-17
the O 0 8.905557235457128e-16
progression O 0 2.3531189149994525e-11
of O 0 1.355200112089801e-19
this O 0 2.5787291274776206e-14
often O 0 4.980225121187232e-10
fatal O 0 5.641197731165448e-07
cancer B-Disease 0 2.7705339107342297e-06
remain O 0 1.1144375895201508e-13
to O 0 2.5543506722226945e-14
be O 0 1.7606498941072357e-12
elucidated O 0 7.472845027223229e-07
. O 0 1.2877904471964019e-11

Numerous O 0 3.1618219153983773e-10
cytogenetic O 0 4.652141342376126e-06
and O 0 2.672339086129405e-11
allelotype O 0 1.0657034010819189e-07
studies O 0 2.0341020534608845e-11
have O 0 1.4370300197193153e-13
reported O 0 7.508760865686248e-13
frequent O 0 9.884011664684778e-11
loss O 0 1.7553318824511943e-12
of O 0 4.315321432760034e-18
heterozygosity O 0 1.4783879676016909e-09
on O 0 2.6241914457408866e-12
chromosomal O 0 0.009262367151677608
arm O 0 7.050958083709702e-05
10q O 0 4.021266875042784e-09
in O 0 1.5540466049429602e-12
sporadic B-Disease 1 0.9283587336540222
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 3.119684024999181e-11

Deletion O 0 1.4911714742993354e-06
mapping O 0 4.7968615746185606e-09
studies O 0 1.0881957140940202e-10
have O 0 4.967941205982762e-13
unambiguously O 0 4.9503717097776345e-11
identified O 0 2.5185258392679266e-11
a O 0 1.7474564140531126e-14
region O 0 5.179318345732709e-13
of O 0 1.553562484585446e-17
chromosome O 0 3.907115186940757e-10
10q23 O 0 5.760780307645375e-13
to O 0 1.685708061599365e-16
be O 0 1.46440667514599e-16
the O 0 2.84284804264959e-17
minimal O 0 2.102051605695765e-12
area O 0 1.7156552220565224e-11
of O 0 2.8147929217730986e-16
loss O 0 7.226475529087395e-10
. O 0 4.022917415857918e-12

A O 0 6.891651745805083e-12
new O 0 6.603154980265591e-13
tumor B-Disease 0 1.1368185559579302e-10
suppressor O 0 3.006976265207406e-11
gene O 0 7.47388956279238e-11
, O 0 1.5146041769408848e-14
PTEN O 0 1.6700201221908628e-09
/ O 0 2.8075927360760033e-08
MMAC1 O 0 3.996202924128056e-09
, O 0 1.8209878524240268e-14
was O 0 3.2906305718477524e-13
isolated O 0 5.169301431351414e-09
recently O 0 1.351021605699998e-08
at O 0 2.0954865447009308e-12
this O 0 4.71918053815629e-16
region O 0 3.9848065304251903e-14
of O 0 4.226515735786647e-18
chromosome O 0 1.718226672053902e-10
10q23 O 0 7.865842309093263e-13
and O 0 2.940195143762473e-15
found O 0 2.2651439778769225e-15
to O 0 3.185187327066501e-17
be O 0 1.3036526099693939e-17
inactivated O 0 6.141332017581269e-13
by O 0 1.607120940323152e-17
mutation O 0 1.0404639389643977e-12
in O 0 1.9484879950292487e-14
three O 0 8.853560551358441e-09
prostate B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999994039535522
cell O 0 2.304431978572552e-09
lines O 0 8.64937543809674e-09
. O 0 1.2071809697700164e-11

We O 0 1.5985474988156056e-07
screened O 0 7.262518124662165e-07
80 O 0 8.537054618784623e-09
prostate B-Disease 1 0.9646689891815186
tumors I-Disease 1 1.0
by O 0 7.434605536727704e-15
microsatellite O 0 1.7774704375028705e-08
analysis O 0 4.74113456827574e-11
and O 0 8.239947352911559e-14
found O 0 3.2109823019889e-14
chromosome O 0 3.54446298700406e-11
10q23 O 0 2.474941367298922e-13
to O 0 4.1598039502564906e-16
be O 0 1.3630629946552756e-15
deleted O 0 1.9725171496176586e-10
in O 0 7.541610700734572e-14
23 O 0 7.094430945486785e-12
cases O 0 1.4112499959872266e-13
. O 0 1.2296052847790562e-12

We O 0 4.534064679262428e-09
then O 0 1.0586748491747677e-12
proceeded O 0 4.365282549496918e-14
with O 0 9.697087951795897e-19
sequence O 0 4.626122957472091e-15
analysis O 0 1.2387220255394722e-16
of O 0 3.888019974520297e-20
the O 0 5.4253833391454775e-17
entire O 0 7.933510077183514e-13
PTEN O 0 7.323609718667967e-09
/ O 0 1.6908478173149888e-08
MMAC1 O 0 1.5417199739076182e-09
coding O 0 2.354371133606037e-07
region O 0 6.042331912592402e-11
and O 0 4.724427229638173e-14
tested O 0 5.328041542576427e-14
for O 0 7.734104800040997e-21
homozygous O 0 6.402185241164934e-16
deletion O 0 5.723605590131006e-14
with O 0 1.4264069573348145e-17
new O 0 8.040964236415062e-15
intragenic O 0 5.031237648722708e-10
markers O 0 3.3016267497743e-09
in O 0 7.621454228628425e-16
these O 0 1.3814892435107273e-15
23 O 0 4.107308162202075e-14
cases O 0 4.2592630883186826e-16
with O 0 1.4641616708659967e-15
10q23 O 0 2.417088529327316e-09
loss O 0 4.055413557052523e-12
of O 0 4.1112154934240237e-16
heterozygosity O 0 8.612914115246895e-08
. O 0 4.2382524573225666e-11

The O 0 1.5557458112686675e-16
identification O 0 2.1167243502299618e-16
of O 0 6.785943529905834e-20
the O 0 8.949040730595612e-17
second O 0 3.1932095178764316e-14
mutational O 0 6.183218381750066e-10
event O 0 7.057202044968847e-14
in O 0 3.4334262405969146e-15
10 O 0 1.2385343706839639e-14
( O 0 1.1690514745152174e-15
43 O 0 3.803785411649052e-11
% O 0 2.164106330390051e-14
) O 0 2.22388565895848e-10
tumors B-Disease 1 1.0
establishes O 0 5.455593736769515e-07
PTEN O 0 1.0431172370317654e-07
/ O 0 4.086901128630416e-08
MMAC1 O 0 2.6833524291447475e-10
as O 0 4.4128778072591703e-16
a O 0 1.747218006042196e-16
main O 0 2.9932743024659036e-13
inactivation O 0 7.946511504375309e-11
target O 0 2.574600688892703e-14
of O 0 3.486984008120351e-18
10q O 0 3.7213254699963727e-10
loss O 0 1.2672738726460242e-11
in O 0 1.541261150823925e-13
sporadic B-Disease 1 0.9956285953521729
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 1.1958861093237794e-13
. O 0 4.469145322913426e-13

Risk O 0 1.6554484005837367e-08
reversals O 0 3.097556239284316e-11
in O 0 8.33690590148269e-17
predictive O 0 1.5079296318554203e-12
testing O 0 5.862539620427043e-12
for O 0 7.152125300422668e-14
Huntington B-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
. O 0 1.7546489435027457e-12

The O 0 1.3995077518811944e-15
first O 0 1.0268896733430123e-16
predictive O 0 1.4740937420362754e-13
testing O 0 2.335776537465417e-12
for O 0 2.8024745745607385e-14
Huntington B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
( O 0 2.8073509432380815e-16
HD B-Disease 0 6.508198979737756e-10
) O 0 2.7319114784501823e-14
was O 0 7.917964379858602e-14
based O 0 1.422273006418295e-16
on O 0 9.072131558490607e-16
analysis O 0 5.848075874708076e-16
of O 0 2.4847232518431444e-20
linked O 0 8.366639934304868e-15
polymorphic O 0 2.390671719561168e-15
DNA O 0 2.1992282127347718e-12
markers O 0 8.748259820549886e-13
to O 0 5.77789098939638e-17
estimate O 0 7.21216367335041e-15
the O 0 6.178354667270617e-16
likelihood O 0 9.191607842689783e-14
of O 0 4.957781034001395e-18
inheriting O 0 2.9456764718410744e-13
the O 0 1.4870761884902713e-16
mutation O 0 9.056610950281593e-15
for O 0 3.3187485409807434e-17
HD B-Disease 0 3.465406805958082e-08
. O 0 1.6440779293525054e-10

Limits O 0 5.637261490942791e-12
to O 0 6.860659823316453e-16
accuracy O 0 8.905871781142091e-14
included O 0 7.837656741437125e-17
recombination O 0 1.7487183131500203e-16
between O 0 9.819187254834236e-18
the O 0 7.468448314618776e-18
DNA O 0 4.523225977798306e-12
markers O 0 2.756979020079875e-11
and O 0 4.241513078804583e-14
the O 0 3.4020836922079006e-15
mutation O 0 6.818735159841438e-11
, O 0 3.2146834971552227e-14
pedigree O 0 2.4100728079901046e-09
structure O 0 1.1891875017263492e-13
, O 0 4.931414238385961e-17
and O 0 3.543315007835212e-18
whether O 0 2.1544575835349973e-17
DNA O 0 4.299837395860262e-13
samples O 0 8.172759386634279e-16
were O 0 1.0402151890517721e-17
available O 0 1.5505902592084205e-17
from O 0 5.174229798478452e-18
family O 0 4.149047235337336e-14
members O 0 1.2288104165676168e-16
. O 0 2.8340385797138122e-14

With O 0 5.202244952634723e-14
direct O 0 1.0637201704319019e-13
tests O 0 9.53927800466381e-13
for O 0 4.618038207488742e-19
the O 0 4.120238743505222e-18
HD B-Disease 0 1.329805102839865e-11
mutation O 0 3.047472864337042e-12
, O 0 1.2043956183052976e-15
we O 0 5.279695273639404e-14
have O 0 1.6277974777867724e-16
assessed O 0 1.6050991454699498e-17
the O 0 1.7196099556072742e-18
accuracy O 0 2.40034467996475e-11
of O 0 9.712530586651649e-18
results O 0 2.2903079714871322e-14
obtained O 0 3.0315110658884396e-17
by O 0 2.4728388636392595e-19
linkage O 0 9.007694221595253e-13
approaches O 0 1.4163674133006992e-14
when O 0 1.220090397664091e-15
requested O 0 1.4994894033927239e-15
to O 0 1.88998783393372e-14
do O 0 3.5073122791468014e-12
so O 0 5.037816796684372e-17
by O 0 3.7498726050413015e-19
the O 0 1.1657821655668322e-16
test O 0 1.2434495707397408e-12
individuals O 0 2.890625333086163e-17
. O 0 6.900983419693557e-14

For O 0 1.7273385345228758e-14
six O 0 9.385999617095688e-16
such O 0 6.467447690456612e-18
individuals O 0 3.286168750425393e-18
, O 0 3.0696346953553756e-16
there O 0 1.0405304242744936e-14
was O 0 3.5179680484909506e-14
significant O 0 1.783514823669921e-16
disparity O 0 1.1912600897043268e-13
between O 0 9.113442414119383e-16
the O 0 6.124574216108836e-15
tests O 0 1.370680999257523e-11
. O 0 2.666952860538429e-14

Three O 0 1.431483577507553e-11
went O 0 6.314252072592286e-12
from O 0 5.846754106263665e-18
a O 0 1.934902772401416e-15
decreased O 0 1.876392929922588e-10
risk O 0 2.0579714419145106e-13
to O 0 1.9871591465932899e-16
an O 0 1.7884602718545795e-17
increased O 0 1.3961086627045649e-11
risk O 0 1.6205958450199454e-11
, O 0 1.1996361401746757e-15
while O 0 3.7451037661212776e-16
in O 0 1.736703746363259e-18
another O 0 4.444944092362054e-16
three O 0 2.3811684334094484e-16
the O 0 1.4527611632613255e-16
risk O 0 6.956302802665557e-14
was O 0 1.7241102209103465e-13
decreased O 0 1.7338447344528163e-10
. O 0 2.5236551130097817e-12

Knowledge O 0 4.576594637116516e-13
of O 0 4.595754478774446e-19
the O 0 1.2060580776286006e-18
potential O 0 4.1225180396831116e-18
reasons O 0 7.996170520273519e-18
for O 0 1.7949651271338776e-19
these O 0 1.5558221765828184e-17
changes O 0 4.8790286996105645e-14
in O 0 2.5202025389541374e-15
results O 0 4.138879343418278e-12
and O 0 1.2465257030248346e-14
impact O 0 4.136781435931441e-15
of O 0 9.048718972258457e-19
these O 0 9.947457523765569e-16
risk O 0 4.136955077685628e-15
reversals O 0 9.073698823552911e-14
on O 0 5.20657091930294e-15
both O 0 3.033343229917086e-14
patients O 0 7.067115718583511e-14
and O 0 8.383723662408701e-17
the O 0 2.3251117267857098e-17
counseling O 0 1.091456374404027e-15
team O 0 2.0717080894164175e-17
can O 0 1.60326925651886e-17
assist O 0 2.3803850933693607e-18
in O 0 1.8266856941676962e-18
the O 0 3.9807894925547046e-17
development O 0 5.341698800062468e-17
of O 0 4.029964975427964e-21
strategies O 0 2.0011713214721421e-16
for O 0 3.600909138194836e-20
the O 0 1.0724167512720327e-17
prevention O 0 1.945362274047291e-13
and O 0 1.3307911981835644e-16
, O 0 9.332160085385836e-16
where O 0 1.5027893209354493e-13
necessary O 0 6.405831675651216e-14
, O 0 7.237654071106845e-16
management O 0 5.207381741591699e-16
of O 0 8.115973658788704e-22
a O 0 2.03551744869212e-16
risk O 0 5.039532633972603e-15
reversal O 0 4.391452479435287e-15
in O 0 1.2561560646327216e-18
any O 0 4.37217529334009e-17
predictive O 0 2.5625417586494503e-12
testing O 0 8.723752623063241e-12
program O 0 8.292449843114169e-14
. O 0 6.582195624324234e-16
. O 0 8.001922963216807e-14

A O 0 3.062391312758095e-11
novel O 0 2.2819480680058568e-11
common O 0 1.4580773654432333e-12
missense O 0 7.500087662037913e-09
mutation O 0 1.0899113556117612e-10
G301C O 0 2.5535058009035216e-12
in O 0 5.753037851583857e-17
the O 0 4.0493302075064405e-16
N O 0 6.952629583167891e-10
- O 0 1.5353227578174256e-09
acetylgalactosamine O 0 9.870159800584588e-08
- O 0 1.5951203025110772e-08
6 O 0 1.187941845587348e-11
- O 0 4.454633606432168e-10
sulfate O 0 1.3051655312068533e-09
sulfatase O 0 2.1622386103814506e-09
gene O 0 2.171361701552854e-11
in O 0 6.457276899329064e-15
mucopolysaccharidosis B-Disease 0 9.846392856616148e-08
IVA I-Disease 0 0.0005561392172239721
. O 0 4.817948817681383e-10

Mucopolysaccharidosis B-Disease 0 0.007529385853558779
IVA I-Disease 1 0.6921108961105347
( O 0 6.756279162800638e-07
MPS B-Disease 1 0.9999991655349731
IVA I-Disease 1 0.9999998807907104
) O 0 2.3457964737350068e-11
is O 0 1.2441494232420802e-12
an O 0 8.608677139199106e-12
autosomal B-Disease 1 0.9999990463256836
recessive I-Disease 1 0.9999982118606567
lysosomal I-Disease 1 0.9999983310699463
storage I-Disease 1 0.999925971031189
disorder I-Disease 1 0.99998939037323
caused O 0 2.4704540496633953e-11
by O 0 1.8206975848209146e-16
a O 0 6.182827166911764e-11
genetic B-Disease 1 1.0
defect I-Disease 1 0.9999996423721313
in O 0 2.063673803240698e-14
N O 0 1.063276666712909e-08
- O 0 3.643176427203798e-08
acetylgalactosamine O 0 2.188121470680926e-06
- O 0 5.513653036359756e-07
6 O 0 5.402973068946437e-10
- O 0 3.456316832739503e-08
sulfate O 0 4.01091249102592e-08
sulfatase O 0 3.20349222704408e-08
( O 0 4.665662031933448e-15
GALNS O 0 2.043350072478134e-10
) O 0 1.956506008907958e-14
. O 0 1.7582728892642785e-13

In O 0 1.546476922215101e-12
previous O 0 3.30295686634674e-12
studies O 0 4.798938481841153e-13
, O 0 2.8548051170750564e-15
we O 0 2.326198587053463e-13
have O 0 1.5509232556532547e-15
found O 0 4.200241303158411e-16
two O 0 1.6736356914313985e-17
common O 0 1.943141888349138e-16
mutations O 0 8.213194664305479e-14
in O 0 4.6292253082856385e-17
Caucasians O 0 3.229544132121731e-10
and O 0 2.1900777632394286e-12
Japanese O 0 3.6052401952701985e-08
, O 0 1.221829034432284e-13
respectively O 0 4.097724763674204e-13
. O 0 9.659312195584024e-13

To O 0 1.5115628204404735e-13
characterize O 0 2.3138727045513008e-11
the O 0 7.483431903939231e-15
mutational O 0 6.637789762287127e-10
spectrum O 0 5.465587157122906e-14
in O 0 3.8131590253151184e-17
various O 0 1.6478268291391315e-17
ethnic O 0 9.096399306539327e-14
groups O 0 2.8179437678698543e-14
, O 0 1.89334267732791e-15
mutations O 0 2.38937043978496e-13
in O 0 3.027557142560436e-18
the O 0 1.1912804546263101e-17
GALNS O 0 2.324196390901534e-11
gene O 0 9.5263141992874e-13
in O 0 6.135397920746207e-16
Colombian O 0 3.4868052889436285e-10
MPS B-Disease 1 0.9999949932098389
IVA I-Disease 1 1.0
patients O 0 2.0259592758975487e-07
were O 0 2.0577848066749126e-15
investigated O 0 2.2602620729922362e-12
, O 0 1.3777927705530858e-14
and O 0 1.1658285014454206e-13
genetic O 0 2.0575073589323978e-10
backgrounds O 0 2.2601908680145583e-14
were O 0 2.8883545568685824e-17
extensively O 0 1.0230243708371153e-13
analyzed O 0 1.1902267095086766e-13
to O 0 6.62211019907902e-17
identify O 0 4.972182503237572e-15
racial O 0 2.2682225191237183e-15
origin O 0 6.034470504009509e-17
, O 0 2.531056662331354e-18
based O 0 7.782975987723822e-19
on O 0 1.8400725370470707e-17
mitochondrial O 0 3.73311581300384e-12
DNA O 0 8.497309800237218e-11
( O 0 1.638569222246785e-16
mtDNA O 0 6.737346683154122e-13
) O 0 4.828092458030722e-15
lineages O 0 2.338024392145588e-11
. O 0 1.1709948332175313e-12

Three O 0 4.546616902412204e-11
novel O 0 6.76935035803794e-11
missense O 0 7.540468232036801e-07
mutations O 0 1.3626042346004397e-05
never O 0 3.6031160277616436e-08
identified O 0 5.4822453000868965e-12
previously O 0 1.450503942217879e-13
in O 0 6.937848347612961e-17
other O 0 1.1711052964782486e-14
populations O 0 3.0101816594907405e-09
and O 0 2.318253878794141e-12
found O 0 6.0286185765701106e-12
in O 0 4.703708634341743e-15
16 O 0 3.184681928976654e-14
out O 0 1.893530295125727e-15
of O 0 1.8743534245321364e-18
19 O 0 2.749247877964489e-12
Colombian O 0 7.880055635789418e-11
MPS B-Disease 1 0.9998981952667236
IVA I-Disease 1 0.9999988079071045
unrelated O 0 3.2716354625428323e-10
alleles O 0 1.4592402806934412e-12
account O 0 3.26149833052361e-14
for O 0 5.603310352126777e-16
84 O 0 2.798730414088624e-10
. O 0 4.17992680398771e-12

2 O 0 6.258493614845484e-13
% O 0 1.2069107767630509e-16
of O 0 2.1115032368683397e-19
the O 0 9.356073148975805e-17
alleles O 0 4.740925991494676e-15
in O 0 8.520101922617054e-17
this O 0 9.473481179888112e-16
study O 0 7.52850337409558e-14
. O 0 5.080243070296718e-14

The O 0 7.399274877702144e-13
G301C O 0 1.8177398475316409e-10
and O 0 4.0272127267097085e-14
S162F O 0 4.8858528334250195e-11
mutations O 0 4.211737729409304e-12
account O 0 2.758171151529313e-16
for O 0 8.336651791598514e-17
68 O 0 2.1770576452695423e-09
. O 0 3.115258268363008e-12

4 O 0 2.37113124273991e-11
% O 0 8.197056314968032e-15
and O 0 1.9153190318477176e-13
10 O 0 4.560700233267878e-13
. O 0 1.6235682503279447e-12

5 O 0 3.665137637831606e-12
% O 0 3.804399513500427e-16
of O 0 1.3824412117633094e-18
mutations O 0 2.7563161822397042e-11
, O 0 8.358089983735283e-15
respectively O 0 4.593345747028665e-15
, O 0 2.6619863252038507e-15
whereas O 0 1.898519183659783e-13
the O 0 1.286874392753001e-15
remaining O 0 4.1028709292859067e-13
F69V O 0 6.417343101361439e-09
is O 0 1.7601233470870034e-15
limited O 0 1.873005628022571e-15
to O 0 1.3763703057731143e-16
a O 0 1.2033393682200715e-15
single O 0 5.767549659434559e-14
allele O 0 5.102340425167107e-12
. O 0 5.782535908438469e-12

The O 0 2.5115209391357585e-12
skewed O 0 7.822435477145007e-10
prevalence O 0 6.182327894066475e-08
of O 0 1.208075612501648e-17
G301C O 0 1.4440515623548311e-11
in O 0 7.189110745248599e-17
only O 0 1.2798150084123469e-15
Colombian O 0 1.2575304567195161e-13
patients O 0 1.5921905949643658e-15
and O 0 2.5801996693182826e-18
haplotype O 0 1.0082555043687894e-13
analysis O 0 8.785395950419551e-17
by O 0 1.0012995465560258e-19
restriction O 0 2.419796134300878e-13
fragment O 0 5.115837007491075e-12
length O 0 1.2701413705518139e-11
polymorphisms O 0 1.3331377668457378e-10
in O 0 3.3743467513171112e-15
the O 0 5.568262034593525e-15
GALNS O 0 2.1713639775100546e-09
gene O 0 1.0140424090698819e-11
suggest O 0 1.1170999157173248e-13
that O 0 2.348279467556544e-16
G301C O 0 1.2462987456288155e-12
originated O 0 1.182088179782232e-14
from O 0 6.328094537213758e-19
a O 0 4.0392073035189145e-17
common O 0 2.2865792053983766e-15
ancestor O 0 1.2248062535979293e-13
. O 0 3.8767483689396143e-13

Investigation O 0 1.7793934728449479e-12
of O 0 2.0711932522031645e-18
the O 0 2.2108304385888537e-17
genetic O 0 1.0090328095638257e-13
background O 0 1.1415610202120791e-15
by O 0 1.5788457356369815e-18
means O 0 5.0231174663270596e-17
of O 0 1.3899971447674634e-19
mtDNA O 0 5.387346818652716e-12
lineages O 0 1.7415654422064941e-12
indicate O 0 7.302894725579046e-13
that O 0 1.7757275955643942e-13
all O 0 3.104850428950652e-14
our O 0 9.13848329149071e-14
patients O 0 1.8400884453846113e-15
are O 0 2.1345192789186862e-19
probably O 0 1.891169826059966e-15
of O 0 2.3730490870105693e-19
native O 0 3.4736368512491844e-13
American O 0 1.3567323653429497e-10
descent O 0 2.4127324138589756e-08

Low O 0 7.730575207753887e-11
frequency O 0 1.2379688203376094e-12
of O 0 6.058484682157556e-16
BRCA1 O 0 6.659716111911962e-10
germline O 0 6.822000603312617e-11
mutations O 0 1.888593725851706e-10
in O 0 2.2701181788596734e-15
45 O 0 1.9643051074602624e-11
German O 0 0.0243765190243721
breast B-Disease 1 0.9999953508377075
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.75872094665408e-11
. O 0 1.0493007287712408e-12

In O 0 4.017471576765741e-13
this O 0 5.029830930352989e-16
study O 0 2.2060562300258834e-15
we O 0 1.0278072482529052e-15
investigated O 0 3.9951867497872023e-14
45 O 0 4.279611604332545e-13
German O 0 3.2446674595121294e-05
breast B-Disease 1 0.9999483823776245
/ I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.151738767230531e-14
for O 0 1.3806870305177835e-17
germline O 0 2.2907012398043491e-10
mutations O 0 5.431737004624182e-11
in O 0 1.6014906527657485e-17
the O 0 6.671633833224815e-16
BRCA1 O 0 2.3499535650728376e-10
gene O 0 1.2509918101422102e-10
. O 0 2.4906725987206e-13

We O 0 6.695467513750941e-10
identified O 0 2.3349835519964612e-12
four O 0 1.752893391486596e-15
germline O 0 1.8774230434170924e-11
mutations O 0 1.0701484143282869e-10
in O 0 2.1032272772621586e-15
three O 0 4.398953423745411e-12
breast B-Disease 0 0.0005647700163535774
cancer I-Disease 0 1.6651181795168668e-05
families O 0 3.665937928112699e-14
and O 0 2.619980404502953e-12
in O 0 2.2573325587221804e-12
one O 0 6.0767131799366325e-05
breast B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 6.874476031829002e-13
. O 0 7.866166679301623e-18
among O 0 6.957741188314855e-20
these O 0 1.6125917060994245e-18
were O 0 1.4346971268699434e-16
one O 0 1.6408156859718014e-15
frameshift O 0 1.8848518301695094e-09
mutation O 0 3.912077693041249e-12
, O 0 1.5708880339782754e-15
one O 0 1.1822190463725828e-14
nonsense O 0 1.945890559795771e-08
mutation O 0 1.7867141099969786e-10
, O 0 4.934204086981531e-15
one O 0 2.3311098873695507e-14
novel O 0 1.833428157557715e-12
splice O 0 2.709693269764557e-08
site O 0 1.5026576649646017e-09
mutation O 0 2.7994884188586866e-10
, O 0 9.154144253059084e-15
and O 0 9.522363027757684e-15
one O 0 2.954362828596485e-14
missense O 0 9.586575089315374e-09
mutation O 0 8.032599585483524e-10
. O 0 8.016439617154758e-13

The O 0 6.915055686266061e-14
missense O 0 6.664023777247507e-10
mutation O 0 8.754545005595915e-11
was O 0 2.582412094494918e-13
also O 0 1.147412514394125e-13
found O 0 7.604051936727085e-14
in O 0 4.466686369326888e-15
2 O 0 4.64776585273885e-11
. O 0 1.0972949111842656e-11

8 O 0 7.947417030029769e-12
% O 0 2.8279232559445203e-16
of O 0 6.084578251744858e-19
the O 0 1.483953813288455e-16
general O 0 9.801202038829063e-15
population O 0 9.697916323548532e-16
, O 0 5.160869574271189e-16
suggesting O 0 1.640266562982426e-13
that O 0 2.627033044767281e-14
it O 0 1.317011278680058e-13
is O 0 1.0548747070076789e-13
not O 0 1.587112941070501e-10
disease O 0 2.0697941138791975e-08
associated O 0 1.7944374285094877e-12
. O 0 4.89529033628755e-12

The O 0 6.099365261989786e-13
average O 0 1.558428733283712e-11
age O 0 5.40365549615146e-13
of O 0 7.880050740447203e-16
disease O 0 4.3355281377444044e-05
onset O 0 3.861118980097444e-09
in O 0 1.9308842363414047e-15
those O 0 1.0568962019582781e-14
families O 0 2.376151669021098e-15
harbouring O 0 1.800946371199874e-11
causative O 0 4.7981743578340286e-11
mutations O 0 1.627234319512283e-10
was O 0 1.5527421742041886e-13
between O 0 1.570559173436504e-14
32 O 0 2.86132117999216e-10
. O 0 9.481345396300522e-12

3 O 0 1.164110335905022e-10
and O 0 1.8889087342877087e-12
37 O 0 8.267195261701943e-11
. O 0 2.2540283441813136e-12

4 O 0 1.1068723021478988e-10
years O 0 4.35752948752411e-14
, O 0 1.2404060593875117e-15
whereas O 0 3.701941571755511e-14
the O 0 1.9739376240311403e-16
family O 0 8.365810689049506e-15
harbouring O 0 2.3474872219708676e-12
the O 0 6.868486275400185e-17
missense O 0 1.896910406529173e-11
mutation O 0 1.7274390468405287e-12
had O 0 1.852803087549256e-14
an O 0 1.5882025959310282e-18
average O 0 4.670013941526774e-12
age O 0 8.023169802140462e-13
of O 0 2.0008355523178946e-16
onset O 0 7.525393641572009e-09
of O 0 4.817805348765437e-16
51 O 0 1.5036304645832388e-08
. O 0 9.98237430216431e-12

2 O 0 1.212974720665727e-10
years O 0 7.056047911756236e-13
. O 0 8.026996493708249e-13

These O 0 4.966557764010671e-13
findings O 0 2.149770026707229e-13
show O 0 2.2874638381381596e-12
that O 0 4.262680770969647e-14
BRCA1 O 0 1.2258580817103848e-09
is O 0 2.569389530442958e-15
implicated O 0 1.8945860369911846e-14
in O 0 7.981938050653932e-18
a O 0 3.106279259712618e-17
small O 0 1.246501414355072e-15
fraction O 0 7.340964858562615e-13
of O 0 4.313642151809738e-11
breast B-Disease 1 0.9999953508377075
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.3174125351278314e-14
suggesting O 0 1.2352551673319636e-14
the O 0 7.563895858320658e-18
involvement O 0 1.0541610240454976e-16
of O 0 1.017820217469785e-20
another O 0 3.366271192137548e-16
susceptibility O 0 7.265358453745208e-12
gene O 0 4.543931619860331e-10
( O 0 1.8804996080278025e-13
s O 0 3.385059699212434e-08
) O 0 3.3258559101190244e-11

Paternal O 0 5.1809897740895394e-06
transmission O 0 3.889556410285877e-06
of O 0 2.395249797115806e-11
congenital B-Disease 1 0.9999629259109497
myotonic I-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999998807907104
. O 0 3.418865901494428e-08

We O 0 3.147671012726505e-09
report O 0 8.18902390152922e-15
a O 0 6.864400003174173e-17
rare O 0 5.2873719332403694e-15
case O 0 1.0290578204017256e-13
of O 0 1.0305323861782827e-14
paternally O 0 0.010946301743388176
transmitted O 1 0.9173665642738342
congenital B-Disease 1 0.9999932050704956
myotonic I-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999998807907104
( O 0 1.4818498428326166e-08
DM B-Disease 1 0.9999996423721313
) O 0 6.763701265732891e-10
. O 0 1.7861611495417762e-11

The O 0 1.2106205794781832e-12
proband O 0 5.289402804642407e-10
is O 0 7.947219394373285e-16
a O 0 3.508710105432403e-16
23 O 0 1.0073285115113143e-14
year O 0 5.32332744952991e-18
old O 0 3.7800934604703684e-10
, O 0 1.4733868639038583e-11
mentally B-Disease 1 0.9999995231628418
retarded I-Disease 1 0.9999996423721313
male O 0 2.221161594206933e-06
who O 0 5.7661264207808927e-08
suffers O 0 0.014558601193130016
severe O 0 1.3612850580102531e-06
muscular B-Disease 0 0.000969289627391845
weakness I-Disease 0 0.0001419621694367379
. O 0 4.913684042984201e-11

He O 0 5.989062024092107e-10
presented O 0 1.8480606856028509e-13
with O 0 2.6130683988129233e-12
respiratory O 0 0.01745791919529438
and O 0 8.417284924622237e-11
feeding O 0 2.039723625557599e-07
difficulties O 0 5.008326531275031e-10
at O 0 4.073132347896802e-13
birth O 0 9.800277993646245e-13
. O 0 3.551402607323423e-13

His O 0 4.109503015659044e-10
two O 0 3.6787545232286334e-11
sibs O 0 0.001135466736741364
suffer O 0 1.0343522660605231e-07
from O 0 2.9863397453706864e-13
childhood O 0 5.656267148879124e-06
onset O 0 0.009877551347017288
DM B-Disease 1 0.9999996423721313
. O 0 2.783964170305353e-08

Their O 0 5.897876588153994e-13
late O 0 2.3454586254960386e-13
father O 0 7.147420540620439e-14
had O 0 6.419282389447025e-15
the O 0 2.0081194897250773e-19
adult O 0 3.4237458186801004e-16
type O 0 7.003674983713237e-13
of O 0 4.7477801423991887e-17
DM B-Disease 1 1.0
, O 0 2.755353020397755e-12
with O 0 5.329779315371014e-14
onset O 0 4.226372030124992e-10
around O 0 7.835251002695498e-13
30 O 0 6.945805692756823e-13
years O 0 6.769052786554427e-15
. O 0 3.259309258574726e-14

Only O 0 5.193354969158792e-13
six O 0 4.391349670811314e-16
other O 0 1.2198930869638562e-18
cases O 0 5.633549295994857e-17
of O 0 8.111374445725617e-19
paternal O 0 2.7867375962387086e-08
transmission O 0 2.617743575683562e-06
of O 0 5.428103577514651e-14
congenital B-Disease 1 0.9999961853027344
DM I-Disease 1 1.0
have O 0 4.797710971615743e-06
been O 0 5.6222949906814534e-11
reported O 0 8.540596008188572e-11
recently O 0 1.8062665807505596e-09
. O 0 3.551878409446818e-12

We O 0 2.080934036197135e-11
review O 0 1.180439006633928e-14
the O 0 6.791129668003206e-18
sex O 0 7.977262276583855e-15
related O 0 6.051555423253424e-16
effects O 0 1.902662597787208e-13
on O 0 9.574125211164394e-14
transmission O 0 1.609119522072433e-07
of O 0 8.918672143040998e-14
congenital B-Disease 1 0.9999586343765259
DM I-Disease 1 0.9999998807907104
. O 0 3.2641466418681375e-08

Decreased O 0 3.381832769377979e-08
fertility O 0 1.4122349123457667e-10
of O 0 5.7592934049662895e-18
males O 0 9.305214908542493e-16
with O 0 1.1524075947390256e-15
adult O 0 9.460257022197993e-10
onset O 0 1.4257479961088393e-05
DM B-Disease 1 1.0
and O 0 7.652460332074895e-10
contraction O 0 7.724318146912212e-13
of O 0 2.328535396321794e-19
the O 0 2.5223062908624313e-17
repeat O 0 8.387831173985866e-14
upon O 0 2.2176120788408697e-18
male O 0 7.926449617111017e-16
transmission O 0 2.991483579947718e-12
contribute O 0 2.814406462990914e-16
to O 0 1.8673836585934075e-15
the O 0 1.2150424201116342e-14
almost O 0 5.822686625391038e-13
absent O 0 1.497496679610244e-12
occurrence O 0 1.650611613536468e-12
of O 0 3.304876722108229e-17
paternal O 0 1.5201994107982841e-09
transmission O 0 3.748327515040728e-08
of O 0 1.5123415486508612e-13
congenital B-Disease 1 0.9999401569366455
DM I-Disease 1 0.9999998807907104
. O 0 1.9794657646343694e-07

Also O 0 5.812774706015489e-10
the O 0 1.74726559870592e-15
fathers O 0 7.846788709520592e-15
of O 0 2.958528041563485e-19
the O 0 2.6164792154148174e-16
reported O 0 1.5591420515770338e-11
congenitally O 0 1.1441634306663673e-08
affected O 0 3.179323193602812e-10
children O 0 5.015144115966264e-13
showed O 0 4.71983866920378e-12
, O 0 6.207385001002084e-17
on O 0 2.7315141776462727e-15
average O 0 7.882252793176003e-14
, O 0 4.926810018747593e-16
shorter O 0 3.150490979209053e-11
CTG O 0 3.4687908101460607e-09
repeat O 0 1.5057849411803659e-09
lengths O 0 2.4334442794149425e-10
and O 0 7.76108642413717e-14
hence O 0 1.3513353576324189e-13
less O 0 1.248691227457785e-14
severe O 0 3.5646721130433434e-08
clinical O 0 3.933079995022126e-07
symptoms O 0 2.4796875663923856e-07
than O 0 8.043624713962829e-17
the O 0 2.1416683852656373e-15
mothers O 0 1.6883041731134696e-13
of O 0 9.898196238222851e-19
children O 0 3.7476515353475e-14
with O 0 5.304147312340524e-12
congenital B-Disease 1 0.999957799911499
DM I-Disease 1 1.0
. O 0 2.3844506813475164e-08

We O 0 3.8268851976219764e-10
conclude O 0 3.189704631065965e-13
that O 0 6.415019378502613e-16
paternal O 0 1.2781886660206965e-10
transmission O 0 1.652820280639844e-08
of O 0 4.038487074050842e-15
congenital B-Disease 1 0.999947190284729
DM I-Disease 1 1.0
is O 0 6.353012560467164e-10
rare O 0 1.2011502903419569e-10
and O 0 1.3734458991117304e-13
preferentially O 0 4.378010974581681e-12
occurs O 0 1.2139913369273864e-13
with O 0 2.500684252871438e-16
onset O 0 2.074165839083264e-11
of O 0 1.3844058691156994e-16
DM B-Disease 1 1.0
past O 0 8.420556696364656e-08
30 O 0 6.150228980608685e-13
years O 0 2.1764479815963725e-16
in O 0 1.0001401081709255e-17
the O 0 5.413269113638516e-17
father O 0 9.860873646490645e-14
. O 0 1.5803296190737434e-16
. O 0 1.1725715952132405e-14

The O 0 4.695415497385502e-12
RB1 O 0 3.860922248577481e-08
gene O 0 2.2152947878884e-11
mutation O 0 1.118735854822861e-12
in O 0 7.50789655803143e-18
a O 0 5.4133394544308294e-14
child O 0 2.9132124490516276e-10
with O 0 1.528053378274663e-10
ectopic B-Disease 1 0.9999648332595825
intracranial I-Disease 1 0.9999419450759888
retinoblastoma I-Disease 1 0.9997885823249817
. O 0 2.7470107966109936e-07

The O 0 4.052768537432527e-12
RB1 O 0 3.0058913580433e-08
gene O 0 1.1476243566566069e-10
mutation O 0 7.231983241429152e-12
was O 0 4.987474836067301e-15
investigated O 0 5.768449377831133e-15
in O 0 6.35754739893802e-17
a O 0 2.1929576210499846e-12
child O 0 1.2136233129567131e-09
with O 0 8.311099725100135e-11
ectopic B-Disease 0 0.4191443622112274
intracranial I-Disease 0 0.0001484018430346623
retinoblastoma I-Disease 0 8.807280948985863e-08
using O 0 3.9410743548837224e-13
DNA O 0 1.4857319818872838e-09
obtained O 0 2.3765417276933086e-15
from O 0 3.6458737715644235e-19
both O 0 2.2758407334513234e-15
the O 0 7.117054578867962e-15
pineal B-Disease 0 4.6933990027753225e-09
and I-Disease 0 3.5921879359968045e-10
retinal I-Disease 0 0.01818856969475746
tumours I-Disease 1 1.0
of O 0 4.352891728028009e-15
the O 0 4.685124900885573e-13
patient O 0 3.160449013606126e-09
. O 0 8.986963733956244e-13

A O 0 1.2028645440809171e-11
nonsense O 0 6.355727055762372e-10
mutation O 0 1.834211602047553e-12
in O 0 9.776205295844756e-18
exon O 0 9.948313006713505e-12
17 O 0 5.156521477173159e-12
( O 0 3.8879238442423973e-16
codon O 0 1.5509610739802837e-12
556 O 0 2.880041108485783e-14
) O 0 2.268550109116069e-16
of O 0 2.1778484211208916e-19
the O 0 1.40020118069742e-16
RB1 O 0 9.542782536398065e-11
gene O 0 1.01925423396515e-12
was O 0 4.396447432725246e-15
found O 0 1.261429920064176e-16
to O 0 6.578828800707796e-17
be O 0 2.111684689482256e-15
present O 0 6.588023740396935e-16
homozygously O 0 4.622624227845762e-10
in O 0 1.1132636611475627e-15
both O 0 1.1435142146609765e-14
the O 0 1.080499050319227e-15
retinal B-Disease 0 1.0499674907293866e-08
and I-Disease 0 1.987035362638334e-11
the I-Disease 0 5.052376702771588e-13
pineal I-Disease 0 5.4232288675848395e-05
tumours I-Disease 1 0.9999998807907104
. O 0 3.5541319887144596e-10

The O 0 7.668528084672083e-15
same O 0 3.717859216070639e-16
mutation O 0 6.364251082380387e-15
was O 0 2.6218944029257325e-16
present O 0 3.798537449935386e-18
heterozygously O 0 1.2585491676597726e-11
in O 0 3.402753447114995e-18
the O 0 7.496706458704813e-18
DNA O 0 1.8524305353539994e-12
from O 0 2.4910169330819365e-19
the O 0 2.4846796645947417e-17
constitutional O 0 1.1115971153535104e-13
cells O 0 1.1568396522838864e-13
of O 0 5.489582067256637e-19
the O 0 1.989078787949564e-15
patient O 0 3.1268427517355812e-12
, O 0 3.409032326990701e-16
proving O 0 4.07799851829746e-13
it O 0 7.970022685983673e-15
to O 0 1.1847873349719526e-15
be O 0 5.899634240811853e-16
of O 0 3.836765188354218e-18
germline O 0 2.2750740180654816e-10
origin O 0 1.1258341264461236e-12
. O 0 9.010237759891904e-13

The O 0 1.3486539901345906e-14
initial O 0 4.6190345622529935e-15
mutation O 0 2.6300212075986047e-14
was O 0 6.796424020970239e-16
shown O 0 3.965165837493701e-16
to O 0 5.1556132716123335e-17
have O 0 3.0887493490628845e-14
occurred O 0 6.665338420086542e-12
in O 0 8.415540999234431e-17
the O 0 1.543521987639265e-15
paternally O 0 1.1202445221458746e-10
derived O 0 1.0637526287344407e-13
RB1 O 0 1.3040856172708004e-09
allele O 0 1.4569800227404173e-11
. O 0 5.299283581394754e-12

The O 0 4.12647780528852e-13
mutation O 0 3.2063709326513035e-12
is O 0 1.1765805121553445e-16
in O 0 8.703993519928514e-19
an O 0 3.3710480278261437e-18
area O 0 6.477640472624113e-12
of O 0 1.2746193562903645e-18
the O 0 4.65131665546897e-17
gene O 0 1.4809361419468314e-13
that O 0 7.171170190379059e-17
encodes O 0 6.62785070018124e-16
the O 0 4.807577028880647e-17
protein O 0 2.303987892398468e-13
- O 0 8.647333717137773e-12
binding O 0 1.370792043244029e-13
region O 0 5.683853656290004e-14
known O 0 3.927460028203822e-14
as O 0 3.68013148980325e-14
the O 0 2.4712843533711282e-14
pocket O 0 2.0483530533965677e-05
region O 0 1.089663470565938e-07
and O 0 2.606226900958575e-10
has O 0 5.303540592804801e-12
been O 0 6.1803144897523265e-15
detected O 0 1.9506756778440992e-13
in O 0 4.82642516631828e-19
other O 0 1.2944989879518515e-18
cases O 0 1.7432359916605903e-17
of O 0 1.1157102574994735e-19
retinoblastoma B-Disease 0 8.477305524223766e-10
. O 0 2.6133893768660876e-14
. O 0 2.2243616453962445e-13

Low O 0 1.7979705546622426e-07
levels O 0 8.868656677096798e-12
of O 0 1.8121669373381042e-17
beta O 0 1.1234390255912812e-14
hexosaminidase O 0 5.052722129583742e-10
A O 0 1.2418994868937383e-12
in O 0 1.787732068365402e-15
healthy O 0 2.906564420569746e-13
individuals O 0 5.72405220214908e-18
with O 0 1.4106086904022014e-14
apparent O 0 5.2931192762173396e-09
deficiency O 0 4.400634225021349e-06
of O 0 3.7674657026945387e-19
this O 0 2.002325536211674e-15
enzyme O 0 2.023128713168898e-11
. O 0 2.2543279092415713e-13

Appreciable O 0 2.117155784020497e-09
beta O 0 6.7692435858079936e-12
hexosaminidase O 0 1.260229476329755e-09
A O 0 1.438783228842333e-12
( O 0 3.8250782347208645e-16
hex O 0 4.710934333601591e-12
A O 0 2.4854432205921595e-13
) O 0 2.9276028872707944e-16
activity O 0 1.2006972564641838e-13
has O 0 1.2990576699740096e-14
been O 0 2.343940276586438e-15
detected O 0 1.2335470101973445e-12
in O 0 1.0534741464997234e-15
cultured O 0 2.4132098541684854e-09
skin O 0 0.001046094810590148
fibroblasts O 0 6.933234999451088e-07
and O 0 3.855925854168163e-07
melanoma B-Disease 1 0.9367956519126892
tissue O 0 2.290239763169666e-06
from O 0 3.604644929983483e-14
healthy O 0 6.080596963442542e-12
individuals O 0 1.7305146155840148e-17
previously O 0 1.0779230156035546e-13
reported O 0 2.9003872220600968e-11
as O 0 3.004786350291333e-11
having O 0 4.976631657882535e-07
deficiency B-Disease 0 6.131554982857779e-06
of I-Disease 0 1.4591405259359174e-19
hex I-Disease 0 1.0541718539758271e-11
A I-Disease 0 1.88825219566216e-13
activity O 0 6.519703396948295e-14
indistinguishable O 0 5.59015910682947e-16
from O 0 2.1795686983010605e-19
that O 0 6.972361631491124e-18
of O 0 2.2449855532617807e-18
patients O 0 5.842477109746502e-13
with O 0 1.269873234344132e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9950966238975525
( O 0 4.096157735781125e-15
TSD B-Disease 0 1.7451559086723023e-09
) O 0 6.521743052285284e-14
. O 0 1.94488373431341e-13

Identification O 0 7.383999661714213e-11
and O 0 9.141325256435337e-14
quantitation O 0 4.752853111078537e-10
of O 0 1.0013311655349406e-17
hex O 0 6.252543621743101e-12
A O 0 4.2949991436655455e-14
, O 0 6.009431415995284e-17
amounting O 0 7.784859060252396e-16
to O 0 6.400479105050927e-15
3 O 0 4.038924576732494e-12
. O 0 2.397159077141553e-12

5 O 0 2.9792088934721406e-11
% O 0 3.485136035015837e-14
- O 0 6.279972808442835e-08
6 O 0 3.011006999287247e-10
. O 0 7.311302605006453e-12

9 O 0 1.337824712122071e-10
% O 0 1.8122655306496756e-15
of O 0 2.3103892767302767e-18
total O 0 1.5393352096601054e-15
beta O 0 3.2879938599269035e-14
hexosaminidase O 0 1.6355151677416302e-09
activity O 0 4.923797480849146e-11
, O 0 3.785639692482435e-15
has O 0 3.2401422158794295e-15
been O 0 2.681490582303361e-17
obtained O 0 1.7153978898896082e-17
by O 0 1.4203737501010365e-18
cellulose O 0 4.348210680404918e-08
acetate O 0 2.103824272126076e-06
gel O 0 2.5365995952597586e-06
electrophoresis O 0 2.756118111513217e-10
, O 0 1.5214262141793888e-13
DEAE O 0 4.067781667060899e-10
- O 0 4.164924915367463e-12
cellulose O 0 4.423545529874673e-09
ion O 0 8.808981322161458e-11
- O 0 1.15416654011824e-09
exchange O 0 1.1942683170521051e-12
chromatography O 0 2.1639824941731625e-14
, O 0 2.569192277645366e-16
radial O 0 1.234436706500086e-12
immunodiffusion O 0 6.111749994985871e-11
, O 0 2.2173374383338898e-14
and O 0 3.988351803766582e-13
radioimmunoassay O 0 1.335557442416757e-07
. O 0 1.2968686888270575e-11

Previous O 0 2.0304875558707636e-09
family O 0 1.570878518410146e-12
studies O 0 3.6824486331337586e-14
suggested O 0 2.089661112875639e-14
that O 0 4.119378508755391e-16
these O 0 2.2196104644827365e-17
individuals O 0 2.1601757590324845e-18
may O 0 2.2497212019733162e-15
be O 0 2.5350488427626882e-17
compound O 0 2.1422252670768097e-14
heterozygotes O 0 2.9146810290835157e-13
for O 0 8.530276078715334e-18
the O 0 4.286432398020803e-17
common O 0 9.293331036292515e-16
mutant O 0 3.4062249548716395e-12
TSD B-Disease 0 1.0641845044068177e-10
gene O 0 5.145179282628476e-10
and O 0 8.278290840367866e-14
a O 0 1.1588045146116322e-14
rare O 0 2.8515332456402476e-12
( O 0 8.464003830492908e-15
allelic O 0 4.721855285244603e-12
) O 0 3.0343793206181677e-14
mutant O 0 2.1541693429050213e-10
gene O 0 1.2106853297666476e-08
. O 0 3.122863079241256e-11

Thus O 0 1.368724317912795e-11
, O 0 1.4300104882788295e-14
the O 0 3.019071857662418e-16
postulated O 0 3.3971998391474356e-12
rate O 0 1.4220173432874517e-13
mutant O 0 1.2621152766564142e-13
gene O 0 1.7619197116916507e-12
appears O 0 1.3781133725236216e-14
to O 0 2.293459371133154e-18
code O 0 3.065866722229074e-16
for O 0 1.465316023744691e-18
the O 0 1.1448879803404368e-16
expression O 0 3.852978388272678e-15
of O 0 2.9069343569155035e-18
low O 0 1.3086653614068078e-13
amounts O 0 6.49415449039103e-16
of O 0 2.1494006975782156e-17
hex O 0 5.1115479904328964e-11
A O 0 3.650075901251437e-12
. O 0 2.972241593471314e-13

Heterozygotes O 0 8.382474159240871e-10
for O 0 1.0486507173815838e-15
the O 0 2.128505519735085e-16
rare O 0 1.3660254500366502e-14
mutant O 0 1.2085316081211772e-10
may O 0 1.0073411289140966e-12
be O 0 7.335547521705596e-17
indistinguishable O 0 1.0870062750573898e-15
from O 0 1.258064680498611e-18
heterozygotes O 0 4.4586217855767385e-13
for O 0 4.056715821954518e-18
the O 0 1.040330828901407e-16
common O 0 1.656653126854736e-14
TSD B-Disease 0 3.3344722538686256e-09
mutant O 0 1.2128689164114803e-09
. O 0 6.232171896602967e-12

However O 0 2.3414683820305315e-12
, O 0 1.1174163460505953e-15
direct O 0 2.1200961925166122e-14
visualization O 0 2.362591233762146e-10
and O 0 5.3684014698907045e-12
quantitation O 0 6.202498958884917e-09
of O 0 2.2141221211184472e-17
hex O 0 1.7568457539446358e-12
A O 0 6.638832482342392e-16
by O 0 8.344815800580592e-20
the O 0 9.083371636069835e-19
methods O 0 3.625551058374435e-14
described O 0 3.3396210601631393e-13
may O 0 3.101382337251414e-14
prevent O 0 8.559662988171304e-14
false O 0 1.795962772217167e-14
- O 0 2.4401930476258826e-10
positive O 0 2.7492778561545583e-13
prenatal O 0 6.488559023409834e-08
diagnosis O 0 8.005519447351617e-08
of O 0 2.5008821475611854e-18
TSD B-Disease 0 7.553546121918941e-10
in O 0 8.534880159387359e-15
fetuses O 0 7.616881431138367e-11
having O 0 1.7192665477047675e-13
the O 0 6.675779662454931e-17
incomplete O 0 5.002103332235608e-13
hex B-Disease 0 6.873411839691812e-10
A I-Disease 0 3.5166285439203193e-09
deficiency I-Disease 0 4.1051695006899536e-05
of O 0 2.1437158471196566e-19
the O 0 2.743439554510666e-15
type O 0 9.196877215345012e-08
described O 0 1.4877722318007436e-11
in O 0 3.5525117461458755e-14
the O 0 3.565615142551992e-13
four O 0 4.449279486506974e-12
healthy O 0 2.1191050650348764e-11
individuals O 0 5.195601503822818e-14

The O 0 2.5015098499558963e-12
tumor B-Disease 0 4.690962618347783e-10
suppressor O 0 2.9022922953814145e-10
gene O 0 5.96903637628543e-10
Smad4 O 0 2.9504748866315822e-08
/ O 0 8.267896589586599e-09
Dpc4 O 0 6.608217306691699e-10
is O 0 8.186488731918087e-16
required O 0 1.8994389587377564e-17
for O 0 1.4678783190896506e-18
gastrulation O 0 3.037877172040737e-10
and O 0 2.05866833996593e-11
later O 0 2.517757356768069e-11
for O 0 1.0017027516097117e-15
anterior O 0 2.317825043007815e-08
development O 0 1.0839101155252912e-13
of O 0 1.0327025279334123e-18
the O 0 3.707762212762453e-15
mouse O 0 9.499172115567944e-09
embryo O 0 1.3472221949140106e-10
. O 0 6.714771533938846e-12

Mutations O 0 1.5300300049148063e-07
in O 0 1.6140383910586038e-14
the O 0 6.733310198465958e-14
SMAD4 O 0 2.781767079795827e-06
/ O 0 4.096079351256776e-07
DPC4 O 0 1.1364597263252563e-08
tumor B-Disease 0 6.067902430517691e-11
suppressor O 0 2.313447827403947e-12
gene O 0 9.821933197318167e-12
, O 0 1.6358027332317136e-16
a O 0 1.7092186852777146e-17
key O 0 2.1019691792256018e-14
signal O 0 2.8681785814660757e-14
transducer O 0 4.620235400862316e-14
in O 0 7.745049041127036e-16
most O 0 9.471353856641083e-15
TGFbeta O 0 6.963099394852179e-07
- O 0 8.257018957458229e-10
related O 0 1.879241987717828e-12
pathways O 0 5.641948496934446e-13
, O 0 3.4229213512199566e-17
are O 0 4.119356607080722e-19
involved O 0 9.844240901227243e-18
in O 0 5.098287587210877e-18
50 O 0 1.0034160875037703e-15
% O 0 2.1518044844382947e-17
of O 0 1.1919946589108006e-16
pancreatic B-Disease 0 8.103903326173167e-08
cancers I-Disease 0 0.0009709334117360413
. O 0 3.809274423671738e-11

Homozygous O 0 9.430917202735145e-08
Smad4 O 0 1.1725436479537166e-06
mutant O 0 2.3137245364068804e-07
mice O 0 0.00021136316354386508
die O 0 3.929840488581249e-07
before O 0 1.8673928234898968e-13
day O 0 1.0822120516352715e-13
7 O 0 2.322573340249323e-12
. O 0 5.647288192633937e-13

5 O 0 8.732460067550907e-12
of O 0 1.5257314370107277e-15
embryogenesis O 0 1.045766317986363e-08
. O 0 9.114682619770775e-11

Mutant O 0 1.2223062839655796e-10
embryos O 0 3.2232575983281997e-12
have O 0 1.5024396657348227e-13
reduced O 0 6.754328135205948e-14
size O 0 5.042715897629613e-11
, O 0 7.216114511487959e-11
fail O 0 2.303759627508839e-09
to O 0 6.439639555784861e-15
gastrulate O 0 5.8106937039781315e-09
or O 0 3.139628585325377e-14
express O 0 3.58167077065181e-15
a O 0 1.577528851694088e-16
mesodermal O 0 3.855954184422972e-12
marker O 0 5.696247917796882e-10
, O 0 1.010928401537145e-13
and O 0 4.568370421537127e-13
show O 0 9.20377107860304e-09
abnormal O 0 1.610024646936381e-08
visceral O 0 2.2033240509866658e-10
endoderm O 0 3.421657623903229e-08
development O 0 2.931924494853355e-11
. O 0 1.6412376015531582e-12

Growth B-Disease 1 0.9999973773956299
retardation I-Disease 1 0.999998927116394
of O 0 1.989859593508255e-16
the O 0 1.5632072662675155e-14
Smad4 O 0 2.469907485647127e-06
- O 0 8.935572992641028e-08
deficient O 0 3.113482804906198e-08
embryos O 0 1.9783590998051492e-12
results O 0 2.756818482264195e-13
from O 0 1.2191355135998495e-17
reduced O 0 9.059367297135912e-13
cell O 0 1.0184434406923515e-09
proliferation O 0 1.2301835938810513e-10
rather O 0 6.137079942890997e-17
than O 0 2.141543805247942e-17
increased O 0 7.606039414834523e-14
apoptosis O 0 9.276407419989141e-11
. O 0 2.2677758108879953e-12

Aggregation O 0 5.55959500658787e-10
of O 0 9.593748211695198e-16
mutant O 0 6.9702627003565e-10
Smad4 O 0 1.0671007544260647e-07
ES O 0 7.50610545940944e-11
cells O 0 2.5926873495341063e-13
with O 0 2.5944953752413385e-15
wild O 0 5.164725869200026e-10
- O 0 8.925605925469426e-07
type O 0 5.841516781401879e-07
tetraploid O 0 2.4987777180740522e-08
morulae O 0 6.385185713497776e-08
rescues O 0 1.0434625385968843e-09
the O 0 7.503040716668168e-15
gastrulation B-Disease 0 3.775440404751862e-09
defect I-Disease 0 9.581675897152309e-09
. O 0 6.264083219145733e-13

These O 0 2.2370430161067212e-11
results O 0 8.161603446028842e-13
indicate O 0 1.350317562842998e-13
that O 0 3.359384126062101e-15
Smad4 O 0 6.104975636134213e-09
is O 0 2.4453944419372097e-16
initially O 0 1.1122110109523624e-15
required O 0 1.3724682053104873e-18
for O 0 2.1469718368058185e-20
the O 0 1.176022942791647e-18
differentiation O 0 2.95219802414154e-15
of O 0 1.742404054759515e-18
the O 0 8.279008552559898e-16
visceral O 0 4.0796164189893513e-13
endoderm O 0 1.1901803327607485e-11
and O 0 4.895955043698842e-15
that O 0 2.927814910205404e-16
the O 0 1.5738561697743525e-16
gastrulation B-Disease 0 7.198160817400989e-11
defect I-Disease 0 1.3988549207866185e-10
in O 0 1.0580165459678318e-16
the O 0 1.9069259094283168e-15
epiblast O 0 1.0666831862238269e-08
is O 0 4.1145320657520745e-13
secondary O 0 8.763829072166995e-12
and O 0 4.74153648202108e-13
non O 0 3.8964895220962303e-13
- O 0 2.246038093289826e-07
cell O 0 1.1030970625824921e-07
autonomous O 0 2.7984543571335507e-09
. O 0 6.507164945768196e-11

Rescued O 0 1.626723999947899e-08
embryos O 0 2.8933589898971768e-11
show O 0 3.5289806987748307e-07
severe O 0 3.4718489132501418e-06
anterior O 0 4.723355687019648e-06
truncations O 0 4.309043788452982e-07
, O 0 3.1615311063548646e-11
indicating O 0 2.4291430412298753e-12
a O 0 3.713043802001763e-14
second O 0 1.975001481531024e-14
important O 0 1.3605375394532573e-16
role O 0 1.7483332625601103e-14
for O 0 3.980108028078859e-16
Smad4 O 0 2.6841212275030557e-07
in O 0 8.6956361707545e-14
anterior O 0 4.4549923750025755e-09
patterning O 0 6.488457771069989e-09
during O 0 2.25897772709871e-12
embryogenesis O 0 4.1778183690333037e-10
. O 0 7.895292059023618e-12

Prevalence O 0 1.5685480320826173e-05
of O 0 1.4303325302053756e-14
p16 O 0 4.4589518188864474e-10
and O 0 2.5005271291067555e-12
CDK4 O 0 1.232397206507585e-08
germline O 0 4.921039686855977e-10
mutations O 0 5.455849105828747e-10
in O 0 2.592368263752546e-15
48 O 0 2.5014312843296693e-10
melanoma B-Disease 1 0.8929735422134399
- O 0 0.35189181566238403
prone O 1 0.9673750400543213
families O 0 1.072606153201816e-11
in O 0 7.843056174135221e-13
France O 0 1.8435980564390775e-07
. O 0 1.9922332013255772e-12

The O 0 1.2365736212771594e-09
French O 0 2.5920419375324855e-06
Familial B-Disease 0 0.04924195632338524
Melanoma I-Disease 1 0.9997449517250061
Study O 0 4.4270206944752033e-10
Group O 0 5.250357874159173e-12
. O 0 5.61151168934626e-13

Germline O 0 2.9905348242209584e-07
mutations O 0 2.8458938317044158e-08
in O 0 1.7536158047114854e-15
the O 0 6.280583073674738e-16
p16 O 0 2.4301394230263895e-12
and O 0 7.242270612427618e-15
CDK4 O 0 1.1574197156249966e-10
genes O 0 2.377284133436852e-12
have O 0 4.292607461435678e-14
been O 0 9.513793595430312e-15
reported O 0 4.02147119858004e-14
in O 0 2.6324950616196507e-18
a O 0 1.088470490620727e-16
subset O 0 7.936415739005775e-13
of O 0 8.686427165024481e-16
melanoma B-Disease 0 0.0006638807826675475
pedigrees O 0 7.105681820718246e-09
, O 0 2.5979197092185213e-13
but O 0 8.201728358969707e-12
their O 0 2.461274118000477e-14
prevalence O 0 6.789544926277813e-08
is O 0 6.3952317359426865e-15
not O 0 2.0152690890303145e-14
well O 0 7.708180238031898e-15
known O 0 6.4509064322954e-13
. O 0 2.0294816174826202e-12

We O 0 2.193255820015505e-11
searched O 0 1.6671969252195218e-13
for O 0 1.278763841351985e-18
such O 0 3.779070912271808e-17
germline O 0 4.0168014747710146e-11
mutations O 0 2.516712116484854e-10
in O 0 6.13240588273915e-15
48 O 0 3.234539303065276e-09
French O 0 6.641011509600503e-07
melanoma B-Disease 1 0.9896580576896667
- O 0 0.00042127943015657365
prone O 0 9.914761903928593e-05
families O 0 1.263043544298475e-15
selected O 0 5.682760586741352e-17
according O 0 3.289643322588422e-18
to O 0 2.716434000100051e-17
two O 0 9.432692573010877e-17
major O 0 1.5109733702124793e-15
criteria O 0 7.962209230561726e-16
families O 0 2.641587327515257e-19
with O 0 1.2044725791894896e-17
at O 0 5.842571536979462e-15
least O 0 5.999813886274803e-16
three O 0 4.1717222332199506e-16
affected O 0 2.1760507231441103e-15
members O 0 7.235517356051141e-19
( O 0 1.752263179121504e-17
n O 0 7.244242965914749e-12
= O 0 6.663070650780867e-10
20 O 0 2.2767178360682053e-15
) O 0 5.785720750202562e-17
or O 0 4.0581753490581435e-16
families O 0 5.360887405040228e-17
with O 0 1.1593384947694932e-16
two O 0 4.522819772137022e-16
affected O 0 1.4387919753045464e-15
members O 0 3.0649481231661853e-20
, O 0 2.7670101388572584e-18
one O 0 1.2162130638161844e-18
of O 0 5.506183990086327e-22
them O 0 5.892228774029074e-18
affected O 0 1.188848328558445e-15
before O 0 5.999810974599047e-17
the O 0 4.250964299561571e-18
age O 0 1.6649754412902133e-17
of O 0 4.846066194339343e-22
50 O 0 6.544187138398565e-17
( O 0 8.20790476884933e-17
n O 0 2.4865851044886256e-10
= O 0 1.1886455553167252e-07
28 O 0 5.355839469839418e-13
) O 0 1.403741646068045e-16
, O 0 5.913491170433341e-16
and O 0 4.290049559577824e-16
one O 0 6.551705217549937e-17
additional O 0 1.824493748262492e-16
minor O 0 2.7010856658987725e-12
criterion O 0 6.103877958629766e-10
. O 0 6.904440560950853e-12

Sixteen O 0 6.68732152986351e-11
different O 0 1.3927295189515576e-13
p16 O 0 7.898639381442862e-11
germline O 0 1.242305130294552e-11
mutations O 0 3.001257922741196e-11
were O 0 1.3847815546975863e-15
found O 0 1.8171885708424124e-14
in O 0 3.3335826025162284e-16
21 O 0 1.411805351445028e-12
families O 0 3.7464611364192526e-16
, O 0 5.296615074398164e-16
while O 0 2.05125630023395e-15
one O 0 1.1947129729269969e-15
germline O 0 1.6099606023334267e-11
mutation O 0 9.74265459974255e-12
, O 0 3.672134259995484e-16
Arg24His O 0 2.0206424033997195e-10
, O 0 2.0910753190843748e-15
was O 0 1.8124195720614633e-13
detected O 0 7.521291749135184e-12
in O 0 1.3004495515706293e-16
the O 0 6.541647310106223e-15
CDK4 O 0 2.943471066885195e-08
gene O 0 1.0140511763623294e-09
. O 0 8.365115783219579e-13

The O 0 2.2620972003656488e-14
frequency O 0 6.285790843992695e-14
of O 0 7.026832302008353e-18
p16 O 0 1.423545959930439e-12
gene O 0 2.8444714032099805e-12
mutation O 0 3.5849548698542455e-13
in O 0 3.815557518219277e-18
our O 0 2.769906528315725e-16
sample O 0 7.702503105582045e-16
( O 0 4.669803894005346e-18
44 O 0 1.3876634784215007e-15
% O 0 6.177685701493827e-19
) O 0 4.217995361887045e-18
is O 0 9.017503657482543e-18
among O 0 9.961117385877923e-18
the O 0 9.461274376326993e-16
highest O 0 8.570837724437841e-14
rates O 0 2.2452159922914383e-11
yet O 0 8.488727705783725e-14
reported O 0 1.0013032070155248e-12
and O 0 1.4428599780886772e-14
the O 0 3.4770916890003803e-16
CDK4 O 0 7.08720304665178e-10
mutation O 0 5.314676650158834e-13
is O 0 2.8235562055313834e-17
the O 0 8.4944599853724e-18
second O 0 2.8514858067130036e-15
mutation O 0 5.684894829188769e-14
detected O 0 1.0765962774050841e-12
in O 0 1.3835446086619092e-17
this O 0 1.8239310801574987e-15
gene O 0 5.544555092829029e-11
worldwide O 0 1.3788956955418374e-12
. O 0 4.612385993973955e-12

In O 0 2.910547779351458e-13
summary O 0 2.245950758705817e-09
, O 0 4.129848047741691e-13
our O 0 3.705813189950821e-14
results O 0 2.2109015125940622e-14
show O 0 4.114576721329054e-14
frequent O 0 2.8458702408529213e-13
involvement O 0 2.2848539263397617e-14
of O 0 2.2279812531083164e-19
the O 0 1.1765754167227712e-17
p16 O 0 4.4881261792965865e-13
gene O 0 2.784245490411452e-12
in O 0 4.772915249538919e-16
familial B-Disease 0 5.475652287145749e-08
melanoma I-Disease 0 0.0077360463328659534
and O 0 5.730522393415649e-13
confirm O 0 9.672213030498256e-10
the O 0 9.632216212994752e-16
role O 0 7.981223510864985e-14
of O 0 4.475921857409655e-19
the O 0 5.4867823090373285e-17
CDK4 O 0 2.5130076838908444e-11
gene O 0 1.3119918291972649e-13
as O 0 3.2811867325858535e-16
a O 0 8.697675826091489e-14
melanoma B-Disease 0 1.512621452093299e-06
- O 0 4.273958964517988e-09
predisposing O 0 2.9407440038653476e-08
gene O 0 3.2148879114402007e-09
. O 0 1.6414433289153874e-13
. O 0 5.221473752502204e-13

Progression O 0 6.169606336925426e-08
of O 0 1.1637832472206509e-15
somatic O 0 3.7202927370694194e-12
CTG O 0 9.116639887452038e-09
repeat O 0 1.4282041105317944e-09
length O 0 9.079039603454575e-12
heterogeneity O 0 1.2008685712494582e-10
in O 0 7.94864780955971e-15
the O 0 5.3303050687213745e-15
blood O 0 6.60975451888951e-14
cells O 0 1.499136237240531e-13
of O 0 1.2711743617899347e-14
myotonic B-Disease 1 0.9999982118606567
dystrophy I-Disease 1 0.9999996423721313
patients O 0 2.731529775701347e-07
. O 0 2.565773114804326e-13

The O 0 4.3345370153401175e-13
genetic O 0 1.226799477976881e-11
basis O 0 6.636886424146076e-15
of O 0 4.874468358925842e-15
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
( O 0 5.060628305297854e-11
DM B-Disease 1 0.9999998807907104
) O 0 4.641949259871769e-13
is O 0 3.719717129900882e-16
the O 0 4.481066920819734e-18
expansion O 0 7.0954488859658726e-15
of O 0 6.893940876915611e-19
an O 0 1.1389505440779802e-16
unstable O 0 4.282910914810145e-09
CTG O 0 5.487497745093606e-08
repeat O 0 2.666415310770276e-09
in O 0 1.7067836706951504e-15
the O 0 4.109035707073824e-16
34 O 0 8.738815877526451e-14
UTR O 0 1.064471752930396e-12
of O 0 3.744285568690177e-18
the O 0 1.0282783468023443e-14
DM B-Disease 1 0.9999960660934448
protein O 0 9.816362167569537e-10
kinase O 0 7.02783525818873e-11
gene O 0 1.2955262730651729e-11
on O 0 2.6810344444733528e-14
chromosome O 0 3.6564360428315013e-09
19 O 0 3.094507289302939e-12
. O 0 2.1022629980143454e-13

One O 0 7.447897008329429e-13
of O 0 1.582487708476476e-18
the O 0 1.2022736849671398e-17
principal O 0 2.1170634281066596e-16
features O 0 1.790899124555186e-15
of O 0 1.9364207149998997e-18
the O 0 3.959169214804055e-14
DM B-Disease 1 0.9999998807907104
mutation O 0 2.8883111458100075e-09
is O 0 1.0132085692325283e-16
an O 0 1.0149869041519407e-18
extraordinarily O 0 1.1845490137819131e-13
high O 0 5.696514007030862e-12
level O 0 3.800204508713767e-14
of O 0 1.7362734056495783e-18
somatic O 0 2.410242686858022e-13
mosaicism O 0 1.282080691611398e-10
, O 0 2.9109000857652093e-15
due O 0 1.8145059063253837e-16
to O 0 2.506030685129838e-17
an O 0 9.502498675776472e-18
extremely O 0 1.3568138583150424e-12
high O 0 2.0520098207438275e-13
degree O 0 5.6389971630956687e-14
of O 0 2.9941233293816553e-18
somatic O 0 7.63636604037693e-13
instability O 0 1.339428790103625e-09
both O 0 3.158223330209861e-14
within O 0 8.117984095275949e-15
and O 0 2.5561392669941167e-14
between O 0 1.453832612293999e-14
different O 0 8.66841185420339e-14
tissues O 0 9.37779159881913e-11
. O 0 1.982291067403885e-12

This O 0 3.1584374872439813e-12
instability O 0 5.6421797789418804e-11
appears O 0 2.5228778078147454e-14
to O 0 1.2973322883449987e-17
be O 0 1.7005364321322355e-17
biased O 0 1.1011184368817095e-12
towards O 0 1.885456562360956e-16
further O 0 2.448764309578302e-16
expansion O 0 2.3603523446207898e-14
and O 0 3.776163934901501e-15
continuous O 0 2.948540324117059e-15
throughout O 0 3.414617662244896e-15
the O 0 3.2233619108591705e-16
life O 0 1.9919405152316424e-16
of O 0 4.351016975030004e-22
an O 0 1.170164591199605e-19
individual O 0 2.0039108206178017e-19
, O 0 2.7344825847575907e-17
features O 0 7.875555134255474e-13
that O 0 3.0528368461651967e-12
could O 0 2.9478280927364153e-10
be O 0 1.808253347336769e-15
associated O 0 5.371437750969696e-14
with O 0 6.258893736269108e-15
the O 0 1.2125551925653167e-15
progressive O 0 2.664823656878257e-13
nature O 0 6.368665360703685e-13
of O 0 4.289703731907328e-17
the O 0 1.3866206360207967e-12
disease O 0 9.990390026359819e-07
. O 0 1.4195053823790743e-13

Although O 0 1.4414998058057127e-12
increasing O 0 1.5210977009211257e-14
measured O 0 1.030155642864003e-13
allele O 0 1.50899908887836e-13
size O 0 7.237668797621666e-12
between O 0 2.0781496315458448e-11
patients O 0 1.5071319192649923e-10
clearly O 0 4.293090609028792e-14
correlates O 0 1.2833838758564845e-15
with O 0 1.630144685492953e-18
an O 0 5.44827473541727e-19
increased O 0 1.7587725709405228e-13
severity O 0 4.494440375424347e-09
of O 0 3.716639488626593e-16
symptoms O 0 7.648475275345845e-07
and O 0 4.555352785628733e-17
an O 0 2.791254285623305e-19
earlier O 0 6.701538195902357e-13
age O 0 1.3888353357985328e-13
of O 0 4.645001710518556e-18
onset O 0 3.326287162375152e-11
, O 0 1.5260565123740162e-16
this O 0 2.7020359289218306e-18
correlation O 0 2.2157604323926917e-14
is O 0 2.824311719215665e-16
not O 0 1.3968409745258826e-15
precise O 0 1.069141411687291e-12
and O 0 3.631641564078372e-14
measured O 0 4.9775938579244006e-14
allele O 0 5.990900727977436e-14
length O 0 4.937041331309899e-10
cannot O 0 6.113805017804452e-10
be O 0 1.920005448092683e-16
used O 0 1.2256977557749144e-15
as O 0 1.0181368451476702e-16
an O 0 6.713598442778917e-18
accurate O 0 1.9060343581234207e-12
predictor O 0 1.5496312566476433e-11
of O 0 1.7772258687343538e-16
age O 0 2.6913150527607677e-12
of O 0 1.3040560590413605e-16
onset O 0 1.4898475342306483e-08
. O 0 1.0643808751042982e-11

In O 0 4.373649879763075e-14
order O 0 4.825753800063353e-15
to O 0 4.146414543117217e-17
further O 0 2.561207403930718e-16
characterize O 0 4.70561827350946e-12
the O 0 3.342062725807224e-16
dynamics O 0 9.183428757025824e-13
of O 0 7.944036138678385e-16
DM B-Disease 1 0.9999979734420776
CTG O 0 1.5510773891946883e-06
repeat O 0 2.6037834111036773e-09
somatic O 0 5.0304847093451954e-12
instability O 0 1.6689430393235227e-10
, O 0 3.809397272587023e-15
we O 0 5.0219180756146814e-14
have O 0 2.630279235010162e-16
studied O 0 1.752737156259475e-14
repeat O 0 1.478054366453683e-14
length O 0 4.443437856023599e-15
changes O 0 5.166841262428451e-15
over O 0 6.669852417057621e-16
time O 0 2.9398811062972784e-15
in O 0 5.838602869984221e-16
111 O 0 1.8375934107695002e-09
myotonic B-Disease 1 0.9999974966049194
dystrophy I-Disease 1 0.9999996423721313
patients O 0 7.567674958908199e-11
with O 0 4.0789238843222806e-17
varying O 0 1.2354584044173278e-13
clinical O 0 2.9250009081494e-09
severity O 0 2.9175331595077125e-10
and O 0 7.208780623759077e-15
CTG O 0 1.4588633079348767e-10
repeat O 0 3.0522548464390065e-12
size O 0 1.1291920733690324e-14
over O 0 1.60662458272183e-13
time O 0 1.9314903138261535e-13
intervals O 0 4.918817631850703e-13
of O 0 4.370369992332708e-19
1 O 0 5.4102603202609706e-15
- O 0 1.2648404545956282e-10
7 O 0 2.6886866756441197e-13
years O 0 3.062431738930162e-15
. O 0 7.83944713615356e-14

We O 0 4.491457872290994e-09
have O 0 9.169732200387404e-15
found O 0 4.610421507728838e-17
a O 0 1.715246577876057e-18
direct O 0 1.1594318272123687e-15
progression O 0 1.467615612371631e-10
of O 0 2.317051802974085e-19
the O 0 2.5052182283321883e-17
size O 0 1.1996962159864597e-14
heterogeneity O 0 8.9972595346266e-12
over O 0 8.165756753501091e-14
time O 0 3.806970946709613e-15
related O 0 2.1226109645155832e-16
to O 0 1.8133840508914148e-17
initial O 0 1.1752347885603942e-16
CTG O 0 8.596825508411232e-13
repeat O 0 6.282965142080654e-13
size O 0 1.2924200826300997e-13
and O 0 1.1294684263384036e-13
the O 0 6.392399363646187e-16
time O 0 2.0134489507519365e-13
interval O 0 3.4899754527278892e-12
and O 0 2.56130629502731e-15
always O 0 3.297288860676893e-14
biased O 0 2.586661353859432e-13
towards O 0 7.217994965796665e-16
further O 0 2.374212810604833e-15
expansion O 0 5.710602130060138e-12
. O 0 1.6394729540972208e-12

Attempts O 0 3.472984400065826e-11
to O 0 4.138404986333091e-16
mathematically O 0 7.767954506086687e-15
model O 0 2.765087421183199e-12
the O 0 2.3618539646296823e-16
dynamics O 0 8.734596379511572e-11
have O 0 2.700327517146661e-09
proved O 0 9.421833979672556e-09
only O 0 3.3594149597554468e-12
partially O 0 1.1406243727307697e-09
successful O 0 2.0499157858916255e-14
suggesting O 0 7.089621722805237e-14
that O 0 6.05959429531846e-16
individual O 0 1.9022732517476388e-18
specific O 0 5.524881255434786e-17
genetic O 0 6.012877695749097e-11
and O 0 8.275448875423239e-14
/ O 0 5.935796743017363e-09
or O 0 1.8911418316210592e-14
environmental O 0 6.910141404393999e-13
factors O 0 2.0312321703103153e-12
also O 0 2.2656673412391193e-11
play O 0 1.824644602077541e-11
a O 0 2.4197473960250928e-15
role O 0 8.622125908207268e-14
in O 0 4.62536211012722e-16
somatic O 0 2.1669160064387294e-13
mosaicism O 0 1.5104527351095243e-10
. O 0 4.828073823305882e-15
. O 0 8.263366797463603e-14

Aspartylglucosaminuria B-Disease 1 0.9999352693557739
among O 0 1.5436185316075601e-12
Palestinian O 0 7.305900884269079e-10
Arabs O 0 8.119154237817838e-09
. O 0 4.019575644553797e-11

Aspartylglucosaminuria B-Disease 1 0.9999970197677612
( O 0 4.199287140238539e-09
AGU B-Disease 1 0.9999957084655762
) O 0 1.463107792473023e-13
is O 0 1.6747295087513243e-15
a O 0 4.077218841410171e-14
rare O 0 1.9225407932310645e-09
disorder B-Disease 0 0.00015501856978517026
of I-Disease 0 2.479765384575564e-17
glycoprotein I-Disease 0 1.0440626851959678e-07
metabolism I-Disease 0 1.6445128494524397e-05
caused O 0 2.0456214847031085e-12
by O 0 2.0218430282009853e-16
the O 0 4.676360427363635e-12
deficiency B-Disease 0 3.726310023921542e-05
of I-Disease 0 5.7709496205680805e-18
the I-Disease 0 3.492963568125368e-13
lysosomal I-Disease 0 0.00012418994447216392
enzyme I-Disease 0 2.6642394956866156e-09
aspartylglucosaminidase I-Disease 0 1.6318195683595604e-09
( O 0 1.263680322492397e-14
AGA O 0 1.1132113286738132e-10
) O 0 1.6293718219269337e-13
. O 0 1.115697269814253e-12

AGU B-Disease 1 0.999990701675415
is O 0 6.850831013593961e-11
inherited O 0 3.07851549807836e-10
as O 0 6.122425293521652e-15
an O 0 2.378175273083736e-14
autosomal O 0 0.17263787984848022
recessive O 0 0.0014768207911401987
trait O 0 1.411443099641474e-05
and O 0 1.405723315528462e-10
occurs O 0 1.8914026161248598e-13
with O 0 3.4154608438392183e-17
a O 0 1.2062209743066306e-15
high O 0 1.022277287777637e-13
frequency O 0 1.4221246576184843e-11
in O 0 7.581966738473556e-14
Finland O 0 2.1586345155810704e-07
because O 0 3.5260663746455867e-12
of O 0 1.753745941728536e-19
a O 0 9.310429984519619e-17
founder O 0 7.133800928454948e-14
effect O 0 4.566950116691171e-13
. O 0 1.8082621988310676e-13

While O 0 1.1550374372226724e-11
very O 0 1.1686158497056093e-13
few O 0 8.546107072883447e-14
patients O 0 1.8226948271006516e-13
with O 0 1.709368052920518e-14
AGU B-Disease 1 1.0
have O 0 6.249497586097164e-10
been O 0 1.5212752390268702e-13
reported O 0 6.190903367210565e-13
from O 0 7.109471781105464e-18
non O 0 4.2105608008460166e-14
- O 0 2.678821608981252e-10
Finnish O 0 7.381186772903447e-10
origin O 0 6.433654065225725e-13
, O 0 8.669458380350381e-13
we O 0 1.7138931940330338e-10
diagnosed O 0 2.2712239033939596e-10
the O 0 5.035321292037973e-16
disorder O 0 4.801035569101941e-09
in O 0 4.1081716672931756e-17
8 O 0 9.814563305945642e-14
patients O 0 3.3681096242100042e-15
originating O 0 3.37004842968671e-16
from O 0 4.3609627774188724e-18
3 O 0 3.1236653388739513e-16
unrelated O 0 1.5142169134774e-14
families O 0 1.5444988019159065e-16
, O 0 2.7107507729834443e-17
all O 0 2.568875980322738e-18
Palestinian O 0 8.847928290099498e-15
Arabs O 0 3.409296093050476e-14
from O 0 6.99586017833253e-18
the O 0 4.93896375040061e-17
region O 0 3.136516247463986e-14
of O 0 8.829804589170532e-19
Jerusalem O 0 8.017526198500491e-09
. O 0 8.475696706977676e-12

The O 0 3.124481793084777e-12
clinical O 0 2.2694668366796122e-09
diagnosis O 0 0.00010349544754717499
of O 0 1.1418359882825815e-14
AGU B-Disease 1 1.0
is O 0 9.109404341955951e-10
often O 0 1.2820268457947037e-10
difficult O 0 2.2853878078182843e-12
, O 0 2.1545982373263558e-16
in O 0 6.135766049206018e-18
particular O 0 1.2698747591389625e-15
early O 0 1.178059267568617e-14
in O 0 3.2727344687378886e-17
the O 0 1.0716939310742818e-15
course O 0 7.0761326485813125e-12
of O 0 3.2176689933216876e-19
the O 0 4.7843314325470704e-14
disease O 0 1.6050505280418292e-07
, O 0 1.2625755321253373e-16
and O 0 4.369511785002559e-15
most O 0 6.263496963290741e-17
of O 0 5.242833573544186e-19
the O 0 2.6982806282025134e-15
patients O 0 3.2722905467111665e-14
are O 0 1.925887231643527e-17
diagnosed O 0 2.731540688083456e-11
after O 0 1.1321885741809307e-16
the O 0 3.239609061578692e-16
age O 0 3.2256776459974046e-14
of O 0 1.0622415611979872e-18
5 O 0 7.152767012583508e-14
years O 0 1.004048376423072e-14
. O 0 1.2393006813913449e-13

However O 0 4.692967126018743e-10
, O 0 7.815395466209685e-14
since O 0 9.60740073109069e-14
these O 0 1.1463307686171865e-15
patients O 0 1.0258056035194248e-15
excrete O 0 5.065127428539786e-15
early O 0 7.932706411264368e-17
large O 0 3.882616057862216e-17
amounts O 0 5.615679150739058e-16
of O 0 4.044928084635331e-17
aspartylglucosamine O 0 2.1024327168106538e-08
in O 0 2.0202711997486774e-15
urine O 0 4.7140758093963675e-14
, O 0 4.0184884971259926e-18
biochemical O 0 5.1404406854185444e-14
screening O 0 1.7506842329984007e-12
is O 0 3.1107054171436053e-15
easy O 0 1.6337292846682616e-12
by O 0 2.9036787063733928e-16
urine O 0 2.6177012489060625e-13
chromatography O 0 7.384804573407067e-14
. O 0 1.1709490188994802e-14
. O 0 9.148324459085089e-13

Detection O 0 5.936640068426868e-11
of O 0 1.4787769199684043e-17
heterozygous O 0 1.3011221874220658e-12
carriers O 0 6.72744629101607e-13
of O 0 1.8146592457586163e-15
the O 0 2.771366496290284e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.9547586205953538e-12
ATM O 0 9.27362527047837e-12
) O 0 1.4230760995314105e-16
gene O 0 2.4099459542759397e-15
by O 0 3.880940768967612e-18
G2 O 0 5.8472402267306656e-12
phase O 0 4.701076767449353e-13
chromosomal O 0 3.2875530564524524e-07
radiosensitivity O 0 3.812769122646387e-08
of O 0 2.6696245718606584e-14
peripheral O 0 5.257676093606278e-05
blood O 0 4.309356143039622e-07
lymphocytes O 0 2.57566767913886e-07
. O 0 1.1971111602004925e-10

In O 0 1.1981978786934633e-07
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
telangiectasia I-Disease 1 1.0
( O 0 2.5679184545879252e-05
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
) O 0 5.753481024939333e-12
patients O 0 2.937732956204142e-12
, O 0 5.09298570690027e-16
mutations O 0 1.6782815371804705e-12
in O 0 5.975983706182212e-18
a O 0 1.0887237402370663e-16
single O 0 7.7269590643516445e-16
gene O 0 4.962088682655685e-13
, O 0 5.295523990082982e-16
ATM O 0 1.884834736204377e-12
, O 0 6.558563405095839e-15
result O 0 5.095203874430892e-15
in O 0 2.9234766192078043e-14
an O 0 2.927537252617185e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 4.3536028115909176e-09
embraces O 0 5.533905278465312e-11
a O 0 2.8842410366514484e-14
variety O 0 1.2148013545348457e-14
of O 0 2.1886441310712014e-17
clinical O 0 9.382156856974078e-11
features O 0 4.1011537915691676e-11
and O 0 1.3340119807414563e-11
manifests O 0 5.340533223985311e-11
extreme O 0 4.566136010963895e-11
radiosensitivity O 0 6.231468230311066e-09
and O 0 9.431807412993085e-14
a O 0 2.2550824970129623e-15
strong O 0 1.957002370215049e-14
pre O 0 3.4134459148127405e-11
- O 0 7.570107207754972e-09
disposition O 0 4.170191691965641e-10
to O 0 3.223133294549124e-13
malignancy B-Disease 0 5.6294826578096036e-08
. O 0 8.652030372528763e-13

Heterozygotes O 0 7.003899682445081e-10
for O 0 2.8743967773868116e-16
the O 0 2.514890318885873e-16
ATM O 0 3.2475546557497736e-11
gene O 0 9.578304815960337e-11
have O 0 1.572982331410691e-13
no O 0 2.323022925008935e-14
clinical O 0 2.703249408174402e-13
expression O 0 1.1411082811017717e-15
of O 0 3.563257439048804e-16
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
but O 0 2.508032252990233e-07
may O 0 4.887230377337293e-12
be O 0 1.1105290406883406e-13
cancer B-Disease 0 1.2146417205372018e-10
prone O 0 3.806890132990182e-12
with O 0 3.345849624825941e-17
a O 0 1.7557988415506202e-14
moderate O 0 1.3436500523322792e-10
increase O 0 3.939849206428814e-13
in O 0 1.642344538089948e-14
in O 0 2.409488895297601e-13
vitro O 0 1.683054762224856e-08
radiosensitivity O 0 3.787133806554266e-08
. O 0 3.010429579231033e-12

We O 0 3.811458260116751e-09
performed O 0 2.0945354825552265e-12
a O 0 1.9664454323242188e-15
blind O 0 1.0188824474876776e-13
chromosomal O 0 6.891816006771023e-10
analysis O 0 7.264381560482744e-14
on O 0 8.419917459654216e-15
G2 O 0 1.0685941020938117e-10
- O 0 6.725160428544541e-10
phase O 0 1.5762569201271948e-12
lymphocytes O 0 5.458412042670668e-13
from O 0 8.811509049741115e-17
7 O 0 5.902949570119054e-14
unrelated O 0 2.14485429417266e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
patients O 0 6.10227672837027e-08
, O 0 3.8084655363450435e-16
13 O 0 1.158724448822293e-15
obligate O 0 3.226888548035767e-11
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999973773956299
T I-Disease 1 0.9999996423721313
heterozygotes O 0 4.307217249532869e-09
( O 0 1.832942663683337e-15
parents O 0 2.2285976825764517e-15
of O 0 3.587500088100954e-20
the O 0 5.089914616896432e-17
patients O 0 9.356756863382917e-16
) O 0 2.4187468350474262e-18
, O 0 9.197402437433598e-16
and O 0 8.225411454385045e-13
14 O 0 1.2736553890550784e-13
normal O 0 6.305450953036917e-13
controls O 0 3.8725158191255105e-08
following O 0 1.3031872944050532e-14
X O 0 4.619798901067673e-12
- O 0 4.423103728981928e-14
irradiation O 0 1.6912725831364633e-13
with O 0 4.137396805367621e-15
1 O 0 1.6236680333502301e-15
Gy O 0 1.1051888570978718e-10
in O 0 1.2440014727118674e-17
order O 0 3.0281374924782034e-16
to O 0 1.3460666267502954e-17
evaluate O 0 3.171125389001998e-16
this O 0 1.3679156100141486e-18
cytogenetic O 0 3.339162442644178e-13
method O 0 1.8901671508086536e-15
as O 0 1.5022181018343301e-18
a O 0 5.8634134204029065e-19
tool O 0 8.431868882781738e-16
for O 0 2.949556427715038e-20
detection O 0 5.704268420868254e-15
of O 0 2.5897153482899395e-18
ATM O 0 1.945069438846758e-09
carriers O 0 8.265176737465296e-11
. O 0 1.2584652070435354e-11

Both O 0 1.2053238407361277e-08
A B-Disease 1 0.999994158744812
- I-Disease 1 0.9999958276748657
T I-Disease 1 0.9999998807907104
homozygotes O 0 3.0077153496677056e-06
and O 0 6.858904178126679e-13
heterozygotes O 0 4.542681508734603e-11
showed O 0 1.6439883308849712e-12
significantly O 0 1.1116861554569257e-13
increased O 0 1.2447201675944673e-14
levels O 0 1.1314028187734543e-16
of O 0 1.4631144825443811e-19
radiation O 0 5.329896246575316e-12
- O 0 1.0502153591218644e-09
induced O 0 1.0151276264025455e-08
chromatid O 0 1.8438709448176382e-09
damage O 0 9.070563744550952e-11
relative O 0 3.552972532069182e-14
to O 0 1.2523343743974408e-16
that O 0 5.93396448616407e-16
of O 0 5.25404817809645e-18
normal O 0 1.703372339012521e-11
controls O 0 3.470643605396617e-06
. O 0 1.375124753649759e-11

These O 0 1.243748485278695e-12
results O 0 4.40341495634277e-14
show O 0 1.9912587542942652e-14
that O 0 5.1224046169962896e-17
the O 0 3.016480201541616e-17
G2 O 0 2.678354066310007e-12
- O 0 9.702636263875242e-12
phase O 0 1.7284861964037695e-13
chromosomal O 0 1.5716120627118357e-09
radiosensitivity O 0 5.39796436715978e-11
assay O 0 7.39715743085928e-13
can O 0 7.630825801156847e-15
be O 0 6.229939217776684e-19
used O 0 1.1897817687924865e-17
for O 0 2.119386171170742e-20
the O 0 1.1357172232765053e-18
detection O 0 3.3797336267517644e-14
of O 0 8.488471859482006e-17
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999984502792358
T I-Disease 1 0.9999996423721313
heterozygotes O 0 4.9751402002584655e-06
. O 0 3.804627099479596e-11

In O 0 6.845451939671565e-14
combination O 0 4.660953155551095e-13
with O 0 2.1013737309455498e-16
molecular O 0 8.482970185672012e-13
genetic O 0 2.6481983272930165e-10
analyses O 0 5.558738148600528e-13
, O 0 2.166954065746632e-16
this O 0 2.0381514564602848e-16
test O 0 3.665256900070579e-12
may O 0 4.756159879051045e-15
be O 0 1.3302583615201822e-16
of O 0 8.632301776238543e-20
value O 0 4.590907456810875e-16
in O 0 1.247329071423658e-15
studies O 0 5.2443770490575095e-14
of O 0 9.744473897914792e-20
familial B-Disease 0 2.31491548152718e-10
and I-Disease 0 1.8328825870245202e-12
sporadic I-Disease 0 5.874606472389132e-07
cancers I-Disease 0 0.0009663163800723851
aimed O 0 1.7196873265679091e-12
at O 0 2.937284963866471e-12
determination O 0 1.7161532950477933e-14
of O 0 6.848640266045659e-21
the O 0 1.3498608421815302e-18
potential O 0 1.4363008646415613e-17
involvement O 0 5.236145392293679e-16
of O 0 2.2969351840671017e-18
ATM O 0 4.4684558275776e-09
mutations O 0 5.511894052290245e-09
in O 0 7.67066345473211e-15
tumor B-Disease 0 2.6911900476989103e-06
risk O 0 3.472341858490324e-11
or O 0 8.232120937885518e-15
development O 0 1.2629339848219123e-13
. O 0 2.817836194685553e-14
. O 0 3.5654178177566e-13

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
telangiectasia I-Disease 1 1.0
: O 0 2.5416396418065368e-12
identification O 0 2.1058335129375653e-14
and O 0 4.616759431756668e-16
detection O 0 1.474149375160251e-14
of O 0 1.20689515855911e-19
founder O 0 1.3236545919666914e-13
- O 0 4.9765573606475044e-11
effect O 0 5.374227538684773e-13
mutations O 0 1.2813538424749638e-11
in O 0 9.950673403463828e-18
the O 0 1.412836066769147e-17
ATM O 0 1.4345085449368744e-12
gene O 0 9.199698294826142e-13
in O 0 2.5464287965834987e-16
ethnic O 0 1.295306310128419e-11
populations O 0 5.369239275410109e-09
. O 0 5.118686724481236e-12

To O 0 1.8662819228389138e-13
facilitate O 0 1.0058578929082913e-14
the O 0 3.9837670118876505e-17
evaluation O 0 1.5546185957043292e-16
of O 0 5.9899880161244026e-21
ATM O 0 1.1000767218818583e-13
heterozygotes O 0 6.396065046956195e-14
for O 0 1.1890868130008501e-18
susceptibility O 0 1.8845158072933188e-11
to O 0 3.075181914126944e-14
other O 0 1.346219034685514e-12
diseases O 0 4.559371154755354e-05
, O 0 1.7327284486882272e-16
such O 0 7.485202202798993e-15
as O 0 8.242211912978803e-10
breast B-Disease 0 0.0001935716427396983
cancer I-Disease 0 2.8699752874672413e-05
, O 0 6.694393439110949e-14
we O 0 2.0869905196369e-12
have O 0 2.8852631513089e-15
attempted O 0 8.10040240179638e-14
to O 0 4.3889693758806316e-17
define O 0 8.292605019550106e-15
the O 0 3.398264958316129e-18
most O 0 2.473226811346547e-18
common O 0 1.116814793839367e-16
mutations O 0 6.041366950974847e-14
and O 0 3.2115180079763913e-16
their O 0 1.258968362910116e-16
frequencies O 0 1.0543321857930943e-12
in O 0 3.3041780422848888e-09
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
telangiectasia I-Disease 1 1.0
( O 0 4.537890845313086e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
T I-Disease 1 0.9999998807907104
) O 0 2.8647558907328105e-14
homozygotes O 0 3.8962019374699786e-12
from O 0 1.7060658036549075e-17
10 O 0 5.776064839301659e-16
ethnic O 0 1.0336497283103263e-12
populations O 0 2.7583280104437335e-09
. O 0 4.307481888538023e-12

Both O 0 1.7858433915690641e-12
genomic O 0 1.6145196291006414e-09
mutations O 0 6.3264371519267115e-09
and O 0 5.206056600897367e-14
their O 0 1.5520469242671263e-16
effects O 0 8.16803086755788e-14
on O 0 8.837197970844562e-16
cDNA O 0 2.5446179451743545e-12
were O 0 8.87247157796596e-14
characterized O 0 6.48770828726164e-11
. O 0 2.9292954780574254e-12

Protein O 0 1.1439097447052404e-09
- O 0 2.319298572639461e-11
truncation O 0 2.7375712807753416e-10
testing O 0 2.275932220463517e-11
of O 0 2.02203279687519e-19
the O 0 8.761996665251651e-18
entire O 0 1.782971531443596e-15
ATM O 0 5.501149666006788e-13
cDNA O 0 1.0603662045638451e-12
detected O 0 1.4797406355793186e-11
92 O 0 6.206000882462426e-13
( O 0 1.4242817979922678e-16
66 O 0 1.5792601601449796e-12
% O 0 6.536178044835582e-17
) O 0 4.441791541611492e-16
truncating O 0 2.5253191204832603e-10
mutations O 0 3.4716352015351504e-10
in O 0 1.2226710158867992e-16
140 O 0 1.470866106050104e-14
mutant O 0 7.768206911062947e-11
alleles O 0 3.5957970542094264e-12
screened O 0 8.166960441258198e-09
. O 0 1.0942183790996207e-11

The O 0 5.180523436447426e-13
haplotyping O 0 3.3360356144207515e-10
of O 0 5.863642487394038e-17
patients O 0 1.691824306516987e-13
with O 0 3.589877672877757e-15
identical O 0 3.6387717283759002e-09
mutations O 0 2.7342534281160624e-07
indicates O 0 1.1121029444560726e-11
that O 0 1.1331647425949498e-13
almost O 0 6.918960846966082e-14
all O 0 2.907314330601686e-16
of O 0 1.2363598489661318e-19
these O 0 4.114319604477915e-17
represent O 0 2.789745363429401e-17
common O 0 9.782823964972487e-15
ancestry O 0 6.376724235451769e-13
and O 0 6.053201695313884e-14
that O 0 1.854593003692076e-13
very O 0 4.689401211094291e-12
few O 0 4.8492434026603526e-12
spontaneously O 0 1.0103351532134153e-12
recurring O 0 1.1510924158297797e-10
ATM O 0 1.7188577672300198e-08
mutations O 0 8.695744924125393e-08
exist O 0 2.1242940739796268e-10
. O 0 5.515093590147124e-12

Assays O 0 3.805267767553744e-10
requiring O 0 5.064048139158395e-14
minimal O 0 5.423260243122251e-14
amounts O 0 1.1487552151402447e-16
of O 0 4.672367430121225e-19
genomic O 0 9.930681277303677e-12
DNA O 0 1.947081385011984e-09
were O 0 3.448664204499342e-16
designed O 0 9.213144163593492e-14
to O 0 5.269365495089401e-17
allow O 0 1.5709967506570555e-14
rapid O 0 6.023934335293996e-14
screening O 0 1.7353307647186705e-13
for O 0 9.270661456773785e-18
common O 0 1.0218576676555673e-14
ethnic O 0 5.1991980165588814e-11
mutations O 0 7.549505909310028e-08
. O 0 2.5876792028589612e-12

These O 0 1.765438273002018e-12
rapid O 0 1.923173252593724e-11
assays O 0 3.284837896480597e-12
detected O 0 1.3707019894115824e-11
mutations O 0 7.0617739086897835e-12
in O 0 8.705131637733326e-17
76 O 0 1.430039940630845e-11
% O 0 5.685796670461667e-17
of O 0 1.8584765198547936e-18
Costa O 0 5.93162852169371e-10
Rican O 0 1.283990600474405e-12
patients O 0 1.7806343557838847e-14
( O 0 1.9964115753350018e-18
3 O 0 1.175557587522637e-16
) O 0 2.087510713274753e-17
, O 0 5.7066811942185075e-16
50 O 0 5.823457391491722e-15
% O 0 6.220564966010259e-17
of O 0 9.03406546770708e-18
Norwegian O 0 7.528219612140674e-06
patients O 0 1.100833400130563e-11
( O 0 1.2383577021104793e-17
1 O 0 9.877273035500568e-17
) O 0 1.0880097179323105e-16
, O 0 5.3130872182443e-16
25 O 0 3.603252746631376e-16
% O 0 2.3064090904178246e-18
of O 0 4.2581681121187185e-19
Polish O 0 2.455387537736442e-08
patients O 0 2.429573903173221e-12
( O 0 9.229023666279703e-18
4 O 0 8.795695474011469e-16
) O 0 3.6121982086477695e-16
, O 0 1.3389604603829177e-14
and O 0 6.931288225667243e-13
14 O 0 6.015840088450033e-14
% O 0 9.473472080901374e-18
of O 0 1.1685191738648722e-18
Italian O 0 9.476908147121321e-10
patients O 0 2.307874926593418e-14
( O 0 1.118975811461468e-18
1 O 0 8.788547177681133e-17
) O 0 1.597763012966115e-16
, O 0 5.880692995924471e-16
as O 0 8.406048671571467e-16
well O 0 4.386730694270818e-15
as O 0 4.0954995911811082e-16
in O 0 1.6456415503096644e-16
patients O 0 2.5917848698101247e-15
of O 0 4.5059171066314466e-20
Amish O 0 5.6248030233518875e-08
/ O 0 1.5240331663335382e-07
Mennonite O 0 8.157025055410827e-10
and O 0 4.120502550275518e-12
Irish O 0 1.816997073633697e-11
English O 0 9.397841879699165e-12
backgrounds O 0 1.3506381776884346e-11
. O 0 1.1548429313529285e-12

Additional O 0 1.7747015337334082e-13
mutations O 0 5.232904040641806e-11
were O 0 1.2313495831154687e-15
observed O 0 7.835930594169739e-15
in O 0 3.2335452982930864e-17
Japanese O 0 3.463663730829403e-11
, O 0 2.6533154871508248e-17
Utah O 0 1.2105679473919397e-15
Mormon O 0 1.6454280715371767e-16
, O 0 3.688250914701569e-16
and O 0 5.764775372422417e-15
African O 0 3.6845259814369e-15
American O 0 2.254094771893169e-14
patients O 0 1.5286692267926782e-13
. O 0 5.460918989143998e-14

These O 0 4.254655303201002e-14
assays O 0 1.6493653231391958e-12
should O 0 8.61649453671239e-16
facilitate O 0 1.5249566930315657e-16
screening O 0 3.6335905530086865e-13
for O 0 4.7663674730984065e-15
A B-Disease 1 0.999998927116394
- I-Disease 1 0.9999960660934448
T I-Disease 1 0.9999998807907104
heterozygotes O 0 2.929825271280606e-09
in O 0 9.247888777463506e-16
the O 0 1.47286059335518e-16
populations O 0 2.0339720847254578e-13
studied O 0 4.700412693618705e-13
. O 0 5.684086060954907e-16
. O 0 1.75793675270949e-14

The O 0 8.70994609769582e-10
von B-Disease 1 0.9436978101730347
Hippel I-Disease 1 0.996915340423584
- I-Disease 1 0.9716008305549622
Lindau I-Disease 0 0.2577091157436371
tumor I-Disease 0 3.4755481692627654e-07
suppressor O 0 3.5501077078059495e-10
gene O 0 6.004763353217868e-11
is O 0 1.4651331382471586e-16
required O 0 1.270435518111102e-17
for O 0 1.0515413595891544e-18
cell O 0 1.2759622525226888e-10
cycle O 0 4.3489836731858134e-11
exit O 0 1.4284143529455506e-12
upon O 0 1.8180394895533122e-16
serum O 0 1.2589770892468266e-10
withdrawal O 0 1.671925237145544e-10
. O 0 7.567583712453363e-12

The O 0 2.712421758553629e-13
inactivation O 0 1.2129938165017506e-09
of O 0 7.379668012090195e-17
the O 0 2.5649119872288295e-13
von B-Disease 1 0.9982408285140991
Hippel I-Disease 1 0.9998652935028076
- I-Disease 1 0.9999675750732422
Lindau I-Disease 1 0.9996564388275146
( I-Disease 0 3.9733979995126845e-11
VHL I-Disease 0 1.65215271863417e-06
) I-Disease 0 3.003677493361445e-13
tumor I-Disease 0 2.1562081287118673e-10
suppressor O 0 7.329475359973969e-10
gene O 0 1.941800054083842e-09
predisposes O 0 1.6600489871620994e-08
affected O 0 9.27012373114211e-12
individuals O 0 2.841505164555947e-16
to O 0 6.399843830340486e-15
the O 0 1.8857697521579286e-12
human O 0 5.554360541282222e-06
VHL B-Disease 1 0.9999922513961792
cancer I-Disease 1 0.9999902248382568
syndrome I-Disease 1 0.9999990463256836
and O 0 2.8251118688892886e-14
is O 0 7.278492705867527e-16
associated O 0 1.621220345471297e-11
with O 0 2.0542869488826554e-11
sporadic B-Disease 1 0.9995173215866089
renal I-Disease 1 0.9997183680534363
cell I-Disease 1 0.9894591569900513
carcinomas I-Disease 1 1.0
( O 0 5.809770997622365e-10
RCC B-Disease 0 1.3852397387381643e-05
) O 0 1.5785721341199377e-10
and O 0 6.772689076228744e-09
brain B-Disease 0 0.00015330754104070365
hemangioblastomas I-Disease 0 0.00015817627718206495
. O 0 1.2038935126579275e-10

VHL O 0 0.0005992659134790301
- O 0 1.7764892618288286e-05
negative O 0 9.797044953074874e-09
786 O 0 5.371141309495897e-10
- O 0 1.989221090070714e-07
0 O 0 2.7470423505371322e-11
RCC B-Disease 0 1.9823195862578302e-10
cells O 0 4.699070993430254e-12
are O 0 6.772875022728912e-15
tumorigenic O 0 5.0351502522971714e-08
in O 0 1.9511203416811007e-11
nude O 1 0.9360999464988708
mice O 1 0.7709909081459045
which O 0 1.439551819762408e-12
is O 0 3.2211493019822647e-16
suppressed O 0 1.1142110674990666e-15
by O 0 5.153995409731756e-19
the O 0 3.4343526564131944e-17
reintroduction O 0 8.25656546171033e-13
of O 0 1.8067769953794842e-16
VHL B-Disease 0 1.0182164942307281e-06
. O 0 1.695756816216809e-12

Remarkably O 0 4.893001559480581e-09
, O 0 1.1037251977175436e-13
this O 0 7.701856713564171e-16
occurs O 0 1.2743975974399452e-15
without O 0 1.2263231340965066e-17
affecting O 0 8.214805043344799e-15
the O 0 1.585342778278112e-14
growth O 0 1.3717395275225641e-12
rate O 0 2.39456241293845e-13
and O 0 1.0888862646838207e-15
cell O 0 1.0657643170763897e-11
cycle O 0 5.681233478452286e-13
profile O 0 1.555397283680652e-14
of O 0 2.05099394108432e-19
these O 0 7.1493498275644e-16
cells O 0 2.5259210277876407e-14
in O 0 1.162065808510754e-16
culture O 0 1.8651369511346605e-12
. O 0 4.074593310324226e-13

The O 0 2.294331716799769e-13
786 O 0 3.964357054436762e-12
- O 0 1.4825586314159978e-09
0 O 0 8.568820132615063e-12
cell O 0 3.6554231863661357e-10
line O 0 1.5696639821261016e-10
, O 0 7.516530139869667e-16
like O 0 1.5368725714802467e-13
many O 0 4.0097757064575315e-14
cancer B-Disease 0 8.374528154275751e-11
cells O 0 5.7869625534427965e-15
, O 0 2.6374947910504662e-15
fails O 0 2.5027317458042875e-12
to O 0 2.0891608393351228e-16
exit O 0 5.07277293088082e-12
the O 0 2.4535143115278263e-16
cell O 0 9.350103157002021e-12
cycle O 0 7.75999490360002e-13
upon O 0 9.680798449429012e-17
serum O 0 1.011245687881912e-11
withdrawal O 0 1.3899822959295705e-10
. O 0 1.3066487995760934e-11

Here O 0 1.5634371575146133e-10
, O 0 1.8486024817572326e-14
it O 0 5.233649821472831e-16
is O 0 3.507796285922491e-18
shown O 0 5.958410667658829e-18
that O 0 3.0169370740734444e-19
reintroduction O 0 1.3373217904431595e-14
of O 0 1.8110870065195068e-19
the O 0 2.211801680976889e-16
wild O 0 1.365543095266375e-11
- O 0 1.2207669319863612e-09
type O 0 2.4199209303077396e-09
VHL B-Disease 0 2.9498671949568234e-08
gene O 0 1.4301251849424546e-10
restores O 0 1.5596880453827566e-09
the O 0 2.1081754319817814e-15
ability O 0 1.8720288719794448e-13
of O 0 4.462068980973168e-16
VHL O 0 5.4824351536808535e-05
- O 0 4.3371116476009774e-07
negative O 0 4.787060747801775e-10
RCC B-Disease 0 8.426722430954214e-09
cancer I-Disease 0 1.341417754652241e-09
cells O 0 1.833160393502429e-14
to O 0 1.2627200571219626e-16
exit O 0 8.160233556583907e-13
the O 0 2.9560718631513585e-17
cell O 0 3.839677881201098e-11
cycle O 0 9.513372728475744e-12
and O 0 5.414410358186043e-15
enter O 0 5.251516994701777e-13
G0 O 0 4.165850997495113e-10
/ O 0 3.101674028727075e-09
quiescence O 0 6.558201898210214e-11
in O 0 4.3028870532835564e-14
low O 0 4.6513864981889697e-10
serum O 0 7.37741867595787e-09
. O 0 2.4680789096481748e-12

Both O 0 5.252326351623537e-10
VHL O 0 2.0681779915321385e-06
- O 0 4.1223711377824657e-07
positive O 0 3.805642953547128e-11
and O 0 5.826688957710768e-12
VHL O 0 9.216753937835165e-07
- O 0 7.039151928012188e-09
negative O 0 1.3977739105053288e-11
RCC B-Disease 0 4.0956682489934337e-10
cells O 0 5.386946097529766e-12
exit O 0 2.2758789210847175e-12
the O 0 4.492005309085952e-17
cell O 0 1.2526428462208972e-12
cycle O 0 4.3749346593374705e-14
by O 0 2.9526216100983386e-18
contact O 0 2.112236947848789e-11
inhibition O 0 4.9852313249720837e-11
. O 0 1.8730763468033373e-12

The O 0 1.969522635258958e-12
cyclin O 0 8.57363458006688e-10
- O 0 2.1505842245916895e-11
dependent O 0 1.6203291963376443e-12
kinase O 0 6.70090649634858e-11
inhibitor O 0 4.357600218163338e-12
, O 0 1.1301950027302289e-16
p27 O 0 3.8344780367398357e-13
, O 0 9.451133406714889e-17
accumulates O 0 3.015311253722758e-14
upon O 0 1.2468947850584553e-17
serum O 0 6.369208681517372e-14
withdrawal O 0 1.8551697992478383e-13
, O 0 7.669810810191581e-16
only O 0 1.2084039899699418e-15
in O 0 2.3532730907400777e-17
the O 0 1.8728902991928465e-16
presence O 0 9.731687569507208e-14
of O 0 5.383837779289695e-18
VHL B-Disease 0 7.78788256106111e-10
, O 0 1.7705942625018426e-16
as O 0 1.3055686084222505e-17
a O 0 8.666398409242163e-17
result O 0 2.5522248842228823e-16
of O 0 7.869516851255342e-21
the O 0 1.5082357373930768e-18
stabilization O 0 1.7260061834605803e-16
of O 0 2.2099417687299847e-20
the O 0 3.035538111982593e-17
protein O 0 6.925107189081903e-12
. O 0 1.512837706670045e-13

We O 0 2.424381181920232e-11
propose O 0 6.144820167020698e-14
that O 0 2.6592762432891106e-15
the O 0 2.938893042364306e-16
loss O 0 8.69236933408353e-14
of O 0 3.8633631809508605e-18
wild O 0 1.6892618859287722e-08
- O 0 1.6636646478218609e-06
type O 0 1.4295642358774785e-06
VHL B-Disease 0 2.7357114049664233e-06
gene O 0 1.6278445258421925e-08
results O 0 1.1271119129165064e-13
in O 0 6.24309552541934e-19
a O 0 2.317337056208324e-17
specific O 0 2.252967667501905e-15
cellular O 0 1.1700718172136249e-10
defect O 0 1.0919142034993001e-08
in O 0 6.713890612897438e-15
serum O 0 9.184098104242366e-08
- O 0 7.482044850348757e-08
dependent O 0 4.936252295806298e-09
growth O 0 3.738420684129551e-10
control O 0 1.845614008288976e-07
, O 0 6.349438254902098e-14
which O 0 3.193708928502133e-14
may O 0 3.27053108987313e-14
initiate O 0 7.030120843104504e-13
tumor B-Disease 0 3.4020339323426185e-10
formation O 0 1.5117243665641739e-13
. O 0 8.519940395551595e-13

This O 0 4.531219691995825e-13
is O 0 6.190362418089131e-16
corrected O 0 4.402260674052361e-12
by O 0 2.2613492020308227e-19
the O 0 1.551844078901413e-18
reintroduction O 0 4.934124398121853e-13
of O 0 6.504737902369176e-17
wild O 0 8.225962133678877e-09
- O 0 2.3904143745312467e-05
type O 0 1.7878252037917264e-05
VHL B-Disease 0 1.9182351024937816e-05
, O 0 3.163385352278336e-13
implicating O 0 1.831501394988777e-09
VHL B-Disease 0 1.1808889155418001e-07
as O 0 9.687457372474072e-15
the O 0 1.2251594398671547e-16
first O 0 6.721907885622318e-16
tumor B-Disease 0 6.318947101680017e-13
suppressor O 0 5.764385279868889e-13
involved O 0 4.369311885227007e-15
in O 0 1.0841359318620512e-16
the O 0 1.5787570494676066e-16
regulation O 0 4.4359313314604187e-13
of O 0 3.6004305366622916e-19
cell O 0 3.527810682468768e-11
cycle O 0 1.0091242078069662e-11
exit O 0 1.32627329257895e-12
, O 0 6.4958181689785555e-15
which O 0 1.8396894928664545e-14
is O 0 5.524128653426261e-15
consistent O 0 1.999338262764945e-14
with O 0 3.708013119803298e-17
its O 0 4.522595308406e-16
gatekeeper O 0 8.686060759544034e-09
function O 0 2.6824195642483062e-11
in O 0 5.2414445362908204e-15
the O 0 7.826016581741896e-14
kidney O 0 2.200321452816567e-10
. O 0 5.627046968165921e-15
. O 0 5.120207643288799e-13

Piebaldism B-Disease 1 0.9999997615814209
with O 0 0.0007450023549608886
deafness B-Disease 1 1.0
: O 0 2.0605921483007883e-12
molecular O 0 1.4418627966930608e-12
evidence O 0 4.026214244271485e-14
for O 0 8.007834924963374e-17
an O 0 1.7256862442933257e-13
expanded O 1 0.8659339547157288
syndrome O 1 0.9999945163726807
. O 0 3.392629926990409e-11

In O 0 9.762436898371613e-14
a O 0 5.173098277869159e-13
South O 0 1.2229762758053653e-09
African O 0 1.8983272798752532e-13
girl O 0 6.639543081998767e-12
of O 0 1.858867238617133e-17
Xhosa O 0 8.552798469452227e-09
stock O 0 9.63977075246758e-12
with O 0 1.574599520594907e-14
severe O 0 3.355422328876756e-10
piebaldism B-Disease 0 4.080818598595215e-07
and O 0 1.9001704376631068e-10
profound O 0 2.6611364223327882e-09
congenital O 1 0.9999651908874512
sensorineural B-Disease 1 0.9999843835830688
deafness I-Disease 1 1.0
we O 0 2.3105272703105584e-05
identified O 0 7.974901121421407e-12
a O 0 1.3161058174001022e-15
novel O 0 8.395417878687833e-14
missense O 0 5.806145841891208e-11
substitution O 0 2.0041002819944087e-13
at O 0 1.9165086049188415e-15
a O 0 1.2742358339993543e-17
highly O 0 2.1578874052268872e-17
conserved O 0 1.0707715503112045e-13
residue O 0 1.7821039782761616e-12
in O 0 8.899570863189633e-18
the O 0 2.477127671038255e-17
intracellular O 0 3.232534411586746e-13
kinase O 0 2.793086942287637e-11
domain O 0 6.778154426623217e-13
of O 0 4.0076516866389966e-17
the O 0 1.6803553110045742e-14
KIT O 0 2.2253463516364036e-09
proto O 0 1.4377153911837581e-09
- O 0 4.532333119922072e-10
oncogene O 0 4.186513358206412e-10
, O 0 8.08174463766062e-14
R796G O 0 2.334148985205786e-10
. O 0 7.128350644133863e-13

Though O 0 2.2191061488374686e-10
auditory B-Disease 0 8.28544732822678e-10
anomalies I-Disease 0 1.0046684337794431e-06
have O 0 5.4595078458063995e-12
been O 0 3.1952825801928597e-13
observed O 0 1.7645024981069457e-12
in O 0 1.2363716414597395e-15
mice O 0 3.858610853058053e-08
with O 0 6.008336731790076e-15
dominant O 0 7.09787961739039e-09
white O 0 1.1534044552785616e-10
spotting O 0 1.008481547160045e-07
( O 0 1.8095456231527474e-13
W O 0 0.00021869114425498992
) O 0 3.248904983477012e-15
due O 0 1.0350592690615886e-14
to O 0 5.4237779496596125e-14
KIT O 0 1.832089651543356e-06
mutations O 0 0.00010524012759560719
, O 0 2.089758144308007e-09
deafness B-Disease 1 1.0
is O 0 1.507926117305658e-09
not O 0 1.2927320672262432e-11
typical O 0 1.0458645234578956e-11
in O 0 2.390554490201268e-14
human O 0 1.0345555141733076e-11
piebaldism B-Disease 0 1.0828036778320893e-07
. O 0 6.685812927592627e-12

Thus O 0 2.3686621240803785e-12
, O 0 1.157955554664423e-15
the O 0 4.3950845567131136e-17
occurrence O 0 2.9152830323397882e-12
of O 0 5.727948920974642e-15
sensorineural B-Disease 1 0.9999895095825195
deafness I-Disease 1 1.0
in O 0 7.6415894445514e-11
this O 0 3.1530607660403e-13
patient O 0 3.177386305452945e-12
extends O 0 3.793143980878634e-14
considerably O 0 6.862354651540614e-14
the O 0 1.3908638335940234e-16
phenotypic O 0 1.2436962267339813e-12
range O 0 1.491772308979955e-12
of O 0 4.8763422075634054e-17
piebaldism B-Disease 0 8.213826063752094e-09
due O 0 4.6244492203683166e-14
to O 0 6.077399139627982e-15
KIT O 0 5.00026076100113e-10
gene O 0 2.508239449472427e-10
mutation O 0 1.2962869709934322e-12
in O 0 7.223252128723358e-17
humans O 0 1.191158499960765e-12
and O 0 7.696636703620127e-14
tightens O 0 0.0006127043743617833
the O 0 1.1572363178130856e-14
clinical O 0 2.9829485236054776e-12
similarity O 0 9.10282117153223e-14
between O 0 2.26113814731112e-15
piebaldism B-Disease 0 1.080265432662486e-09
and O 0 8.40178926051708e-15
the O 0 5.134785690968861e-18
various O 0 6.779097829685254e-17
forms O 0 1.4156929209648006e-13
of O 0 3.41763103277673e-13
Waardenburg B-Disease 1 0.9999790191650391
syndrome I-Disease 1 0.9999467134475708
. O 0 2.0942696497350602e-14
. O 0 6.915375932482759e-13

Cycloheximide O 0 1.4751290677850193e-07
facilitates O 0 2.125759204080202e-12
the O 0 9.065311884474026e-17
identification O 0 8.111850835583999e-16
of O 0 2.858068248638627e-19
aberrant O 0 1.353402090918665e-12
transcripts O 0 8.944017748646615e-11
resulting O 0 1.6896248668848285e-13
from O 0 2.3441881660724078e-17
a O 0 2.3903262995252778e-14
novel O 0 9.640304179936443e-12
splice O 0 2.561580174642586e-07
- O 0 1.808532346103675e-08
site O 0 2.729489967379095e-10
mutation O 0 1.907395422162672e-11
in O 0 9.887526766373775e-17
COL17A1 O 0 1.9492205072246804e-10
in O 0 1.4273385281406717e-16
a O 0 4.504177995748142e-14
patient O 0 5.973118701041447e-12
with O 0 2.3996923155175653e-13
generalized O 0 6.390454655047506e-05
atrophic B-Disease 1 0.999936580657959
benign I-Disease 1 0.999521017074585
epidermolysis I-Disease 1 0.9982155561447144
bullosa I-Disease 1 0.9793720841407776
. O 0 9.190350702681371e-09

Patients O 0 1.1981292402651889e-07
with O 0 5.03424003872599e-11
generalized O 0 0.0003433345118537545
atrophic B-Disease 1 0.9999581575393677
benign I-Disease 1 0.9997386336326599
epidermolysis I-Disease 1 0.9987413287162781
bullosa I-Disease 1 0.8884890675544739
often O 0 2.6119928975276707e-07
show O 0 9.960245961337932e-10
decreased O 0 9.6682295502859e-10
expression O 0 7.684524132474391e-13
of O 0 1.0549903354753086e-15
type O 0 3.6438302686292445e-07
XVII O 0 9.788844401725783e-09
collagen O 0 5.840230414833059e-07
, O 0 9.515037412491378e-13
a O 0 2.7727757698388367e-13
transmembrane O 0 4.716232265833398e-11
hemidesmosomal O 0 2.9514495014648645e-11
protein O 0 6.420905473980554e-13
encoded O 0 2.412659424322469e-15
by O 0 1.3361126297351303e-15
COL17A1 O 0 3.760221645165984e-08
. O 0 4.3131136683027815e-12

This O 0 1.0626237303273944e-12
report O 0 5.714987538112462e-14
documents O 0 6.434970180784004e-16
a O 0 2.4505505961849427e-15
novel O 0 5.685092153984161e-13
splice O 0 2.1639973368792198e-08
- O 0 5.225389454466267e-09
site O 0 1.8068514739955077e-10
mutation O 0 3.933418174506542e-11
in O 0 1.4057458054305875e-16
COL17A1 O 0 2.3919183300691316e-10
in O 0 4.7621280864322885e-17
a O 0 2.9376349443277494e-14
patient O 0 2.007208635412816e-11
with O 0 1.9470551202143555e-13
generalized O 0 2.9370579795795493e-05
atrophic B-Disease 1 0.9999841451644897
benign I-Disease 1 0.9998838901519775
epidermolysis I-Disease 1 0.9966055154800415
bullosa I-Disease 0 0.021087119355797768
, O 0 3.4525889092140716e-11
and O 0 3.34448960225605e-14
applies O 0 8.533219127777793e-15
a O 0 2.556432785086164e-17
new O 0 7.879355246988168e-17
methodology O 0 6.991469238943303e-15
to O 0 4.273289490704071e-17
define O 0 2.280222722878672e-13
and O 0 7.060590939087516e-15
characterize O 0 2.4678778118292222e-11
the O 0 3.173353667988428e-15
resulting O 0 1.559113047813667e-14
mRNA O 0 9.464538527903521e-13
splice O 0 1.3192621217683609e-08
variants O 0 1.1433302304908466e-08
. O 0 1.1914573494475889e-10

Mutational O 0 1.1475016208351008e-06
analysis O 0 1.0046711379496642e-10
of O 0 2.239581847017768e-16
COL17A1 O 0 3.7075829073529576e-09
identified O 0 1.1803935433263302e-11
a O 0 6.919224443619268e-14
maternally O 0 4.022799038327918e-10
inherited O 0 1.3913755703143238e-09
G O 0 1.2943913718643785e-09
- O 0 6.107986338932392e-11
to O 0 1.2020062679571342e-12
- O 0 6.407121588836162e-08
T O 0 1.275462402361427e-08
transversion O 0 4.195848182786399e-11
at O 0 8.310496049462011e-15
the O 0 2.1666636260899523e-17
- O 0 8.886562140450124e-14
1 O 0 1.3167975025195966e-17
position O 0 6.608735681190773e-17
of O 0 2.825696147625452e-20
exon O 0 8.566446163538188e-13
32 O 0 3.2385361753428654e-11
. O 0 5.575962326413719e-13

This O 0 1.3059648848456895e-13
acceptor O 0 2.473818133848227e-13
splice O 0 2.1819993034633e-10
- O 0 6.902468874248058e-11
site O 0 2.518500599041351e-12
mutation O 0 1.2109900755785663e-12
led O 0 3.047317283019356e-15
to O 0 1.0529588990048865e-17
the O 0 6.9278212642275935e-18
formation O 0 3.920179322094984e-17
of O 0 5.345461484402728e-20
aberrant O 0 3.7511145448490546e-13
transcripts O 0 4.2173005539158925e-12
present O 0 2.0009596532325792e-14
at O 0 1.1712181788650633e-12
extremely O 0 1.3179322216894107e-11
low O 0 7.500903009827198e-09
levels O 0 6.603690511086668e-11
. O 0 3.1718213125420114e-12

Based O 0 4.533971288689376e-12
on O 0 1.4411498524494887e-13
our O 0 1.9470231786019145e-15
recent O 0 1.6161722152835032e-15
finding O 0 4.14376008744431e-16
that O 0 7.652421753180042e-16
cycloheximide O 0 2.0695996028052832e-09
stabilized O 0 9.258227962050114e-09
mutant O 0 4.0949944823953643e-11
COL17A1 O 0 2.6592020252458326e-10
transcripts O 0 1.135729314413747e-12
in O 0 1.1053541733652204e-16
keratinocytes O 0 2.1779889090162152e-12
homozygous O 0 5.018490302683733e-14
for O 0 5.8270709299976595e-18
a O 0 3.1511698750998378e-15
frameshift O 0 7.731084217255102e-09
mutation O 0 2.0469691913715948e-11
, O 0 5.73229599993907e-16
the O 0 6.703339996976218e-17
effects O 0 4.460952549197039e-13
of O 0 9.048443934704783e-19
the O 0 6.306099411815182e-17
splice O 0 5.175740946938845e-10
- O 0 4.643775815271756e-12
site O 0 7.270286396564643e-14
mutation O 0 7.292030409947019e-15
on O 0 7.62781241444536e-19
splicing O 0 3.161019555375337e-14
of O 0 7.783422148266718e-19
COL17A1 O 0 1.3278655518894622e-12
transcripts O 0 1.2746655774886328e-14
were O 0 2.8912758279198746e-17
determined O 0 3.5382937899064437e-16
using O 0 5.514461889915721e-16
reverse O 0 9.929290722965334e-10
transcriptase O 0 1.2316170305837204e-08
polymerase O 0 5.847711898043784e-11
chain O 0 1.5275164813588482e-11
reaction O 0 2.134455433851646e-14
of O 0 5.1457225696304603e-20
total O 0 8.056399691343098e-17
RNA O 0 1.8359903874998196e-11
from O 0 6.574764366049955e-17
keratinocytes O 0 7.806762181150617e-12
incubated O 0 1.2629153365445456e-12
for O 0 2.131812918696317e-16
2 O 0 1.364901030739829e-13
. O 0 5.128623220551631e-13

5 O 0 2.025731318799906e-11
h O 0 2.3149289429813535e-10
in O 0 1.1829351121443239e-16
the O 0 1.2220974157628304e-16
presence O 0 2.0152316501740458e-13
or O 0 1.4257890454763035e-14
absence O 0 8.675900133676886e-15
of O 0 6.2731749144190655e-19
10 O 0 1.0351061311593955e-15
microg O 0 5.22617157883154e-11
cycloheximide O 0 1.6829431945253326e-11
per O 0 1.581802053503647e-15
ml O 0 7.959860548467645e-11
. O 0 1.4083412170837195e-12

Using O 0 9.219858763172967e-14
this O 0 3.221654874772657e-15
approach O 0 5.414728561359272e-12
, O 0 2.0983079640143898e-14
an O 0 1.618276033366246e-15
abnormally O 0 2.490715855785197e-09
spliced O 0 2.46981162490556e-05
transcript O 0 1.633543251955416e-05
was O 0 1.0965966329434806e-10
identified O 0 6.925539785748724e-13
that O 0 1.635408697475118e-17
contains O 0 1.9487740370629198e-18
an O 0 2.0734928660048502e-19
extra O 0 8.773043166023929e-16
264 O 0 7.564369290181169e-15
bases O 0 2.798834514844417e-12
upstream O 0 3.259408530836144e-14
from O 0 9.159435029297148e-19
exon O 0 5.053877645154123e-14
32 O 0 3.3925117489536083e-12
, O 0 2.8035102840969937e-15
resulting O 0 5.72113263508985e-16
in O 0 1.2939917194412033e-16
a O 0 1.3690883550552396e-13
premature O 0 6.587031701338342e-12
termination O 0 1.2791428073005706e-13
codon O 0 1.8268097538159944e-12
27 O 0 5.248692648042452e-13
bp O 0 1.8417336883000401e-13
downstream O 0 9.28260560865285e-14
from O 0 6.172459367588564e-18
the O 0 2.0021334979606638e-16
cryptic O 0 3.638814943807134e-12
splice O 0 5.881431786036728e-09
site O 0 5.626996646412863e-10
. O 0 3.85510113415366e-12

Three O 0 4.1750080497816866e-13
other O 0 1.8197949653364967e-16
splice O 0 4.810636958230141e-11
variants O 0 2.71713532749851e-12
, O 0 7.813629063701481e-16
including O 0 4.168806653171273e-18
one O 0 4.834221757181899e-18
derived O 0 2.776683499133183e-19
from O 0 9.399237790803568e-20
the O 0 1.8194391784114254e-18
skipping O 0 2.537916708386656e-14
of O 0 2.742837594912986e-19
exon O 0 5.480978084587695e-13
32 O 0 1.0475175414581539e-11
, O 0 4.81800980134308e-15
were O 0 1.8259497714290425e-15
also O 0 1.113951487476117e-12
identified O 0 8.925987032837313e-11
. O 0 1.8102646118234311e-12

These O 0 6.471762362125766e-12
results O 0 1.9877534947893016e-13
indicate O 0 1.240387763475851e-14
the O 0 1.2305125557449039e-17
usefulness O 0 2.1887736577613087e-13
of O 0 5.498614879545716e-19
cycloheximide O 0 9.212600127206372e-10
treatment O 0 2.226255855011794e-12
in O 0 5.717851346084653e-19
evaluating O 0 2.5478875990769074e-15
the O 0 1.0839705619139896e-16
abnormal O 0 1.3076897149768424e-13
processing O 0 8.330842627888007e-15
of O 0 3.8941517739282734e-19
mRNA O 0 3.871108281475709e-14
due O 0 8.34305514892152e-15
to O 0 6.610705694537629e-16
splice O 0 5.525844670728475e-08
- O 0 6.909928185194758e-10
site O 0 3.401727163843127e-11
mutations O 0 8.618045166386423e-11
, O 0 1.1741016967049844e-15
because O 0 5.131996444560777e-14
( O 0 5.609127350892046e-16
i O 0 3.153436886615957e-11
) O 0 2.603703675551732e-17
aberrant O 0 4.301719503069061e-15
splicing O 0 2.5373240834791755e-12
often O 0 4.186337013807259e-14
generates O 0 3.640764924189513e-16
a O 0 3.517422686327861e-15
premature O 0 1.6192162357025336e-13
termination O 0 4.2287499863553554e-14
codon O 0 2.5162760330238454e-13
, O 0 2.7384626006708365e-15
( O 0 8.911126080038631e-17
ii O 0 3.08108952847691e-13
) O 0 2.91865815317334e-17
transcripts O 0 3.5323096715406815e-14
with O 0 1.6175354089329906e-15
premature O 0 1.941562823059087e-13
termination O 0 4.732812262892927e-15
codons O 0 3.5479090368731314e-13
can O 0 1.48322955480229e-12
occur O 0 5.897640232080392e-13
at O 0 1.977559392282724e-12
low O 0 4.5561338035682297e-10
or O 0 3.2487116295720764e-12
undetectable O 0 3.347050414603814e-09
levels O 0 3.518432832409768e-13
due O 0 9.627666163760339e-15
to O 0 1.6079941333535866e-14
nonsense O 0 3.7021044563267935e-10
- O 0 2.181715225146874e-11
mediated O 0 2.4552690609802585e-13
mRNA O 0 2.1011905865404856e-15
decay O 0 5.832998878829362e-14
, O 0 1.1070927084894599e-16
and O 0 1.330441002999434e-16
( O 0 2.4542794122354072e-18
iii O 0 1.02055654034529e-14
) O 0 9.764247076601322e-17
the O 0 6.548257528756816e-17
levels O 0 3.902083588142529e-16
of O 0 1.9782454095383272e-20
these O 0 2.4384720320885495e-17
transcripts O 0 7.262210039056527e-13
can O 0 9.13968607827581e-14
be O 0 1.6581814760470703e-16
increased O 0 8.753453940931898e-16
by O 0 1.1144534248010997e-15
cycloheximide O 0 1.8997344852778042e-07
. O 0 6.738070171263821e-12

A O 0 1.4802317357953676e-11
deletion O 0 2.2233566099316704e-09
mutation O 0 5.6500949752180674e-11
in O 0 7.902356823717553e-16
COL17A1 O 0 1.2637228152811986e-08
in O 0 6.08698162336027e-15
five O 0 3.6100181681876856e-14
Austrian O 0 2.4374398321924673e-07
families O 0 5.176333198338677e-14
with O 0 1.6720381589702127e-12
generalized O 0 1.7201822629431263e-05
atrophic B-Disease 1 0.9999513626098633
benign I-Disease 1 0.999707043170929
epidermolysis I-Disease 1 0.9985281229019165
bullosa I-Disease 0 0.007101038936525583
represents O 0 4.62611286083936e-12
propagation O 0 4.983011074079224e-13
of O 0 5.646800150381528e-18
an O 0 6.104019188168477e-17
ancestral O 0 4.91244933620294e-10
allele O 0 7.941939328404146e-10
. O 0 2.3967031484439794e-11

Patients O 0 1.6687798165548884e-07
with O 0 1.1728916449182947e-10
generalized O 0 0.002178462687879801
atrophic B-Disease 1 0.9999761581420898
benign I-Disease 1 0.9999164342880249
epidermolysis I-Disease 1 0.9991183876991272
bullosa I-Disease 0 0.17309775948524475
, O 0 9.830048233738786e-12
a O 0 4.3528193067110185e-14
usually O 0 2.1054682723307093e-14
nonlethal O 0 1.2421606278290032e-11
form O 0 3.114983314692066e-13
of O 0 3.4279984450005796e-13
junctional B-Disease 1 0.9987056255340576
epidermolysis I-Disease 1 0.9958679676055908
bullosa I-Disease 0 0.0044003864750266075
, O 0 7.659330635012562e-12
have O 0 5.447792824492259e-13
generalized O 0 3.8384625339338285e-11
blistering B-Disease 0 5.4859672360407785e-09
, O 0 1.1369278999154298e-12
nail B-Disease 1 0.8014143705368042
dystrophy I-Disease 0 0.3809008002281189
, O 0 1.3214965580155003e-11
patchy B-Disease 0 0.0005403112154453993
alopecia I-Disease 1 0.9999874830245972
, O 0 6.646328487569519e-10
and O 0 1.8591763684128182e-09
dental B-Disease 1 0.9381695985794067
abnormalities I-Disease 1 0.7119845151901245
. O 0 7.924348677246229e-12

Skin B-Disease 1 0.999962329864502
fragility I-Disease 0 6.09604649071116e-06
in O 0 1.2407089795452735e-15
most O 0 3.8688365523460627e-17
cases O 0 7.95522703209839e-16
is O 0 1.3228195593587174e-16
due O 0 2.4107447063452005e-16
to O 0 5.135555465246903e-16
mutations O 0 5.286792596585765e-13
in O 0 1.5736625185211477e-18
the O 0 5.8221380384146995e-18
gene O 0 6.999023756393274e-14
encoding O 0 7.248827731641538e-13
type O 0 2.826156162427651e-07
XVII O 0 1.1175439240673768e-08
collagen O 0 5.524495350073266e-07
( O 0 2.592387025532328e-12
COL17A1 O 0 1.8695274661695294e-07
) O 0 1.4549380580528015e-12
. O 0 2.4997833664164304e-12

Recently O 0 5.224874044529315e-08
, O 0 2.3227240443512986e-12
we O 0 3.865600981672879e-12
reported O 0 1.4126286945748134e-13
five O 0 2.2203071358469634e-15
Austrian O 0 3.6868030406367325e-08
families O 0 3.973041073381239e-15
with O 0 1.2656348679588453e-13
generalized O 0 3.1706897516414756e-06
atrophic B-Disease 1 0.9999469518661499
benign I-Disease 1 0.9993066787719727
epidermolysis I-Disease 1 0.9963222742080688
bullosa I-Disease 0 0.09342867881059647
who O 0 1.392970006008909e-07
share O 0 1.7460214047151923e-13
the O 0 1.0478829878940161e-15
same O 0 6.941538001955377e-14
COL17A1 O 0 4.333158898361944e-08
mutation O 0 5.962687010807599e-10
. O 0 1.3225549128081937e-12

Affected O 0 9.93741755550559e-10
individuals O 0 2.552021543375982e-15
in O 0 3.5977862077480336e-16
three O 0 9.494795493456346e-15
families O 0 1.77517194618616e-17
are O 0 3.0055651501084302e-19
homozygous O 0 6.393960551247095e-16
for O 0 3.0397311732256854e-18
4003delTC O 0 4.763884599301438e-12
, O 0 8.79271021226799e-16
whereas O 0 2.569910328650577e-14
those O 0 2.959264780315813e-17
in O 0 7.099255273359821e-18
two O 0 1.2514987234554152e-16
others O 0 8.10807200984806e-17
are O 0 3.737764076740809e-18
compound O 0 1.6798315126062557e-12
heterozygotes O 0 2.29371813209589e-10
. O 0 1.1680949176667843e-12

To O 0 1.1055329015522558e-13
determine O 0 2.42715488549608e-13
if O 0 2.0294641753801704e-14
the O 0 2.0064675273237477e-17
occurrence O 0 1.4888153101848267e-13
of O 0 2.464956866377395e-18
4003delTC O 0 2.629831075129374e-10
in O 0 7.082788919777973e-16
these O 0 7.87752221475075e-17
unrelated O 0 1.0567832924664091e-14
families O 0 7.376849642307104e-18
signifies O 0 1.7423831942984423e-19
propagation O 0 1.428062145740533e-17
of O 0 7.142544646269139e-21
an O 0 4.715250541027505e-19
ancestral O 0 3.201892917470417e-11
allele O 0 5.416027327141693e-13
or O 0 3.243408756088868e-14
a O 0 1.9495968966824762e-13
mutational O 0 6.309364266599005e-07
hot O 0 5.336743313932857e-08
spot O 0 4.607132730871655e-10
, O 0 7.886791534520571e-15
haplotypes O 0 2.3306586695304166e-12
were O 0 6.713861602018994e-16
determined O 0 2.119456428531551e-15
for O 0 9.240786174590207e-19
polymorphisms O 0 1.8559750958324628e-11
both O 0 5.410410617787131e-13
within O 0 6.312803470069628e-13
and O 0 1.316020643155058e-11
flanking O 0 5.8894434914691374e-05
COL17A1 O 0 3.088137600570917e-05
. O 0 3.1231607577897336e-11

Five O 0 5.31962841832101e-12
intragenic O 0 1.306121183430875e-10
polymorphisms O 0 1.326177969523945e-11
were O 0 7.26911816872379e-15
chosen O 0 2.585680568057059e-16
based O 0 1.438511422110548e-16
on O 0 2.2973254700485446e-14
their O 0 3.3508680991620535e-14
informativeness O 0 5.853490137042172e-08
. O 0 4.272599201521343e-12

One O 0 7.169379564846146e-13
of O 0 2.3945745495970954e-18
these O 0 2.1286517652673845e-16
, O 0 2.476185201300647e-15
not O 0 2.61590286243377e-14
previously O 0 8.535925059231092e-14
reported O 0 5.412433739040989e-13
, O 0 2.0735601600428135e-15
was O 0 4.3828022401647473e-14
2988 O 0 3.910063245404771e-12
A O 0 4.0218933598009515e-14
or O 0 2.3132942010383037e-15
C O 0 1.9022219563402665e-11
that O 0 2.0898702294284483e-16
introduces O 0 5.281263978657719e-15
a O 0 4.2475160648292455e-16
new O 0 4.97646838407156e-16
restriction O 0 1.1262543767607061e-13
site O 0 4.5165833014804493e-14
for O 0 6.874069413662673e-17
Eco0109 O 0 5.885917864212331e-10
I O 0 9.503814624167717e-08
. O 0 2.1190503778772962e-13

All O 0 3.4982108355896546e-13
the O 0 2.074652197270061e-15
4003delTC O 0 4.373506418131612e-11
alleles O 0 4.577639469197613e-14
showed O 0 3.212184207859736e-13
the O 0 1.4297020726639501e-18
same O 0 3.730256999091584e-18
haplotype O 0 7.554971459631382e-14
for O 0 1.3405010867553396e-18
these O 0 2.6061478288257036e-17
five O 0 2.4320724665614717e-16
polymorphic O 0 7.394957042550221e-13
markers O 0 5.037100336835465e-08
. O 0 4.814179957457476e-11

Fourteen O 0 3.540017237679827e-11
microsatellite O 0 1.8315633731891268e-10
polymorphisms O 0 8.744393230342151e-12
were O 0 1.1704169975053098e-15
selected O 0 6.629313949597622e-17
based O 0 6.252920962850883e-17
on O 0 1.6108181411997324e-14
their O 0 2.500981455556806e-15
high O 0 2.2228931274349308e-14
heterozygosity O 0 1.2218372147376755e-11
and O 0 1.024932498898054e-13
their O 0 5.129388006599707e-16
location O 0 4.4467684742754976e-12
within O 0 1.3122271010686942e-13
10q23 O 0 5.380739187543782e-10
- O 0 8.583125321592888e-10
q25 O 0 5.676303316271003e-10
near O 0 3.041860652253092e-10
COL17A1 O 0 7.334222118515754e-08
. O 0 5.4445024877392e-12

Three O 0 5.3821117701469134e-11
families O 0 5.0239204615019906e-14
shared O 0 6.809954618443304e-13
microsatellite O 0 1.091932322339062e-09
polymorphisms O 0 9.391866173658059e-10
covering O 0 2.2302192037582103e-10
at O 0 1.8236451845149437e-12
most O 0 3.7960514214700845e-15
19 O 0 2.149343664202899e-13
cM O 0 2.828909253117101e-13
, O 0 6.426525706992176e-14
whereas O 0 3.1513069063959787e-12
the O 0 2.3644347046133767e-14
others O 0 1.0586277405903732e-13
shared O 0 2.0320051048153438e-14
smaller O 0 2.0570727738387917e-13
regions O 0 9.556370278440696e-11
consistent O 0 9.082052818132347e-12
with O 0 2.9994651625158493e-16
cross O 0 1.2221040152082807e-13
- O 0 1.1193554763644364e-11
over O 0 3.1369362402805523e-13
events O 0 1.199996590810215e-13
during O 0 4.540143184095149e-15
passage O 0 1.84046667206534e-16
of O 0 1.3631947803983833e-20
this O 0 5.4296251213266494e-18
mutation O 0 4.15140191281532e-16
through O 0 2.056675198477093e-18
several O 0 2.9843196840233504e-16
generations O 0 3.916807403045973e-14
. O 0 5.253697799609096e-14

These O 0 5.5220407239875424e-12
results O 0 5.608857562428016e-13
indicate O 0 2.2034007647955822e-13
that O 0 8.483106964552335e-15
4003delTC O 0 1.2850786212936782e-08
occurs O 0 2.5372489076110408e-14
on O 0 1.5386475247860533e-16
a O 0 3.4947375028740555e-16
single O 0 2.5106164553318237e-15
ancestral O 0 1.05935598834761e-11
allele O 0 1.1160419376848862e-12
. O 0 2.2227826743386088e-14
. O 0 3.881801564215026e-13

The O 0 4.697825461974503e-12
haptoglobin O 0 7.686240088844443e-09
- O 0 5.82351666889025e-10
gene O 0 1.0893419499780066e-10
deletion O 0 5.836769262357322e-11
responsible O 0 4.730603455076372e-14
for O 0 4.476765532003622e-16
anhaptoglobinemia B-Disease 0 4.659969192744029e-07
. O 0 2.4101163773049272e-11

We O 0 5.1489226216006045e-09
have O 0 4.882302990171471e-15
found O 0 6.797068824801336e-17
an O 0 4.085584632127772e-19
allelic O 0 1.5096390934207782e-12
deletion O 0 6.543011688009415e-10
of O 0 2.068643881555276e-17
the O 0 1.4316035243185543e-15
haptoglobin O 0 2.3458826547972933e-10
( O 0 5.095179456059209e-17
Hp O 0 2.5149875688561295e-15
) O 0 2.5508704917751124e-17
gene O 0 3.3471584336662585e-13
from O 0 3.11203006748527e-18
an O 0 5.888228942177074e-18
individual O 0 1.6708871026047828e-16
with O 0 3.0511704274260865e-13
anhaptoglobinemia B-Disease 0 2.9116240511939395e-06
. O 0 3.349576171984836e-11

The O 0 2.4717004159548195e-13
Hp O 0 4.536687431971886e-12
gene O 0 1.346332680757234e-11
cluster O 0 7.320662088680652e-13
consists O 0 2.0940208761584516e-15
of O 0 5.002997207825381e-18
coding O 0 1.8045254535081767e-07
regions O 0 2.0247976906251353e-10
of O 0 3.98765939297808e-17
the O 0 1.0425402217000912e-15
alpha O 0 4.468644074226229e-16
chain O 0 3.639719081682813e-11
and O 0 1.3211259699202416e-15
beta O 0 4.113142361030129e-17
chain O 0 2.9974964567761053e-13
of O 0 2.511684557674457e-19
the O 0 5.023462566078617e-17
haptoglobin O 0 4.016661135641808e-12
gene O 0 4.552843020123876e-13
( O 0 3.749717250182506e-18
Hp O 0 1.2614016768093409e-15
) O 0 1.8603224478379608e-16
and O 0 1.0541616196155386e-15
of O 0 1.1424393065244175e-18
the O 0 5.6961986321006435e-16
alpha O 0 4.904869218435746e-16
chain O 0 8.967470516152432e-11
and O 0 4.91978843325221e-15
beta O 0 4.3999012625072344e-16
chain O 0 7.412287797436967e-12
of O 0 3.840499081639282e-18
the O 0 2.5743539905468153e-15
haptoglobin O 0 3.065993015027857e-10
- O 0 1.4810168716405947e-11
related O 0 9.274787968888143e-13
gene O 0 1.1158935754596033e-11
( O 0 6.4784395145904e-17
Hpr O 0 1.0957973244074548e-11
) O 0 4.822273447562203e-16
, O 0 5.310736701815669e-16
in O 0 4.75084170328237e-17
tandem O 0 3.8328457074854327e-10
from O 0 1.2841031391776014e-16
the O 0 7.38412491417019e-15
5 O 0 5.169313328085012e-12
side O 0 3.4200361986869154e-10
. O 0 2.711817966363772e-12

Southern O 0 3.991691144289433e-10
blot O 0 2.2095701979196747e-07
and O 0 5.547314909807926e-15
PCR O 0 2.7982591938036094e-11
analyses O 0 6.592860480637841e-13
have O 0 1.0239369429586634e-15
indicated O 0 3.677226844420525e-14
that O 0 1.0200300299592326e-16
the O 0 1.3162099561305001e-17
individual O 0 1.2058833357241987e-18
with O 0 1.8120562605721446e-17
anhaptoglobinemia B-Disease 0 2.32808303884946e-11
was O 0 4.392407085566843e-15
homozygous O 0 1.739649501960683e-16
for O 0 1.381697162802318e-19
the O 0 3.1939337694275145e-18
gene O 0 3.744866558779564e-13
deletion O 0 7.81969432782359e-13
and O 0 2.8898657165860432e-16
that O 0 2.7120128851620777e-17
the O 0 2.396621408022858e-18
gene O 0 8.867091224685e-14
deletion O 0 1.618376385594672e-13
was O 0 4.550372800999139e-15
included O 0 2.506529044905289e-16
at O 0 1.0838764883172852e-14
least O 0 1.0206066211682963e-15
from O 0 1.1600721708856032e-17
the O 0 9.021499767021787e-17
promoter O 0 3.9613434060781216e-11
region O 0 1.1594418730231232e-13
of O 0 3.049276217109088e-19
Hp O 0 3.063835738391883e-14
to O 0 2.846930145885315e-16
Hpr O 0 1.0994107534079145e-11
alpha O 0 1.226193481807295e-15
but O 0 2.2293937664919286e-14
not O 0 8.224462065976445e-15
to O 0 2.068377800713275e-15
Hpr O 0 6.562437704360491e-09
beta O 0 4.0986943114669494e-13
( O 0 8.905833156439696e-15
Hpdel O 0 4.671624864727164e-09
) O 0 2.6359836080395993e-13
. O 0 2.4403860009181155e-12

In O 0 3.14047900640442e-14
addition O 0 3.643504175801374e-15
, O 0 1.886926318049164e-14
we O 0 1.1731589007538124e-12
found O 0 1.7634500689873447e-15
seven O 0 2.4459249294076522e-17
individuals O 0 1.0975368409477421e-20
with O 0 1.948507312674402e-17
hypohaptoglobinemia B-Disease 0 1.5920276208447603e-10
in O 0 8.735040503449773e-16
three O 0 1.2899560044942306e-15
families O 0 1.1726412630114077e-17
, O 0 7.586352653898615e-17
and O 0 5.091373697322526e-16
the O 0 1.9996669446357042e-17
genotypes O 0 1.0470164943647987e-14
of O 0 1.500481978975552e-19
six O 0 1.2423144246176757e-15
of O 0 6.071845615672194e-20
the O 0 5.4586403011092945e-17
seven O 0 6.288514875481285e-17
individuals O 0 2.495856909017652e-20
were O 0 5.701583908760609e-18
found O 0 1.313237234445107e-15
to O 0 3.271527327674043e-15
be O 0 4.548121319662701e-13
Hp2 O 0 2.802387143674423e-06
/ O 0 8.324468012688158e-07
Hpdel O 0 1.9012894370007416e-07
. O 0 1.0869857097750568e-11

The O 0 2.8620389478511976e-12
phenotypes O 0 4.699954314624222e-10
and O 0 6.434930713283826e-13
genotypes O 0 9.558565961312326e-13
in O 0 1.8087284798806193e-16
one O 0 1.8112842429802815e-15
of O 0 4.0135837296838594e-19
these O 0 2.692973172694577e-16
three O 0 4.255917308177028e-16
families O 0 5.89675154946433e-17
showed O 0 2.2432447880586098e-13
the O 0 1.2921118687811153e-17
father O 0 2.2117956405731838e-14
to O 0 1.0248937857865954e-16
be O 0 1.640533941637721e-15
hypohaptoglobinemic B-Disease 0 8.638468412813793e-11
( O 0 4.500394574858465e-16
Hp2 O 0 2.8873514690275215e-10
) O 0 2.8949316088853344e-15
and O 0 7.324708602238911e-14
Hp2 O 0 4.142591336631085e-08
/ O 0 2.735088600047675e-09
Hpdel O 0 6.604121693953857e-10
, O 0 3.667306648652167e-15
the O 0 2.5165505034624913e-16
mother O 0 1.2968829569276474e-12
to O 0 8.242136149574735e-17
be O 0 7.426494243345679e-16
Hp2 O 0 2.789856401452795e-10
- O 0 7.15056399508418e-12
1 O 0 1.963731750519453e-15
and O 0 6.989388926024846e-15
Hp1 O 0 1.7276328145854336e-09
/ O 0 9.134693002010863e-12
Hp2 O 0 4.315647665620315e-12
, O 0 1.1935963452744993e-16
one O 0 5.51555016181682e-18
of O 0 1.0607097745687296e-20
the O 0 2.781870934870141e-17
two O 0 3.8294433660749803e-16
children O 0 1.4188210824604377e-16
to O 0 9.468888673127218e-17
be O 0 4.152227505241097e-15
hypohaptoglobinemic B-Disease 0 7.996873718774111e-10
( O 0 2.790140557238854e-16
Hp2 O 0 1.3675141574687188e-10
) O 0 9.238684705700404e-16
and O 0 6.300286965852005e-15
Hp2 O 0 1.1089909435213485e-08
/ O 0 7.818483083177341e-10
Hpdel O 0 9.023631841742485e-10
, O 0 5.57340479513278e-15
and O 0 2.320204295822004e-16
the O 0 3.934424613014066e-18
other O 0 2.1315109315982863e-17
child O 0 3.754818704630692e-15
to O 0 1.8478381086377185e-17
be O 0 1.146649994159183e-15
Hp1 O 0 6.703162913623828e-09
and O 0 1.2619522397547267e-12
Hp1 O 0 7.064865030770306e-07
/ O 0 2.2877172156654524e-08
Hpdel O 0 3.67758667962903e-09
, O 0 5.278303174990591e-15
showing O 0 2.0817008666439325e-14
an O 0 2.8708105523847e-18
anomalous O 0 1.7485619072457603e-12
inheritance O 0 1.8682212027387735e-11
of O 0 2.2896327591732284e-16
Hp O 0 2.4348650873307065e-10
phenotypes O 0 2.107627183889349e-09
in O 0 2.3915758425290673e-14
the O 0 6.963737041437018e-14
child O 0 2.9828917114116393e-12
with O 0 4.6095668514850585e-14
Hp1 O 0 6.631568680859345e-07
. O 0 6.241974385284843e-12

The O 0 5.0363888406956825e-12
Hp2 O 0 1.9917781912681676e-07
/ O 0 2.677741228751529e-08
Hpdel O 0 4.4806771626326736e-09
individuals O 0 5.186031746760562e-16
had O 0 2.4339941954304445e-12
an O 0 6.427092112630049e-17
extremely O 0 1.6050794374167232e-11
low O 0 1.3920843366932445e-09
level O 0 5.6680907119547805e-14
of O 0 1.410551290519699e-19
Hp O 0 1.2032603103999395e-13
( O 0 1.228688390883653e-16
mean O 0 5.868835690862884e-13
+ O 0 3.4388561876569357e-13
/ O 0 5.988147755431328e-10
- O 0 2.7820504233666554e-10
SD O 0 1.7730608092847433e-09
= O 0 1.7935062324170303e-09
0 O 0 6.8361060322414454e-15
. O 0 1.129771966021357e-17
049 O 0 1.7304969956999372e-11
+ O 0 1.6835706819536694e-13
/ O 0 8.576182819464151e-11
- O 0 1.882565110744583e-11
0 O 0 2.0008719006192437e-14
. O 0 1.2481273668892206e-17
043 O 0 2.9051804364965683e-12
mg O 0 4.430618605289968e-14
/ O 0 5.583646067210124e-13
ml O 0 1.2104491129046047e-13
; O 0 1.087342335379213e-15
n O 0 4.263612032873176e-12
= O 0 1.71755092787107e-11
6 O 0 2.4719841296405023e-16
) O 0 1.3387992660425883e-18
, O 0 4.196425386643806e-18
compared O 0 1.5662788975783462e-17
with O 0 4.343849386618273e-16
the O 0 5.481432263654013e-15
level O 0 2.111475472344284e-15
( O 0 1.6290559607104683e-19
1 O 0 3.2412003171948665e-18
. O 0 6.5650868491914524e-18
64 O 0 1.447915261300304e-15
+ O 0 4.101661755872383e-15
/ O 0 8.380962590592844e-12
- O 0 6.601278226305018e-13
1 O 0 3.8556963581817393e-16
. O 0 6.121508433295809e-17
07 O 0 1.3215070923948587e-14
mg O 0 4.857428597125927e-15
/ O 0 6.613537706845127e-14
ml O 0 1.877383306052218e-15
) O 0 9.988585365683818e-19
obtained O 0 9.640335420840878e-17
from O 0 1.0296544914532463e-17
52 O 0 7.62961482186908e-12
healthy O 0 1.0015171201041562e-12
volunteers O 0 5.8015950476066145e-15
having O 0 1.2921490320869783e-13
phenotype O 0 8.794786188377757e-13
Hp2 O 0 2.6894484903006166e-11
, O 0 3.3007333413327265e-16
whereas O 0 2.6500609483394574e-15
the O 0 4.973676219370275e-17
serum O 0 1.3880045116737572e-12
Hp O 0 2.4395829594740098e-14
level O 0 3.1002096201359405e-15
of O 0 3.6376895948850356e-20
an O 0 4.1800351336783125e-17
individual O 0 5.550402556658905e-16
with O 0 1.2774068640971498e-13
Hp1 O 0 3.6072119655727874e-06
/ O 0 2.457703089930874e-07
Hpdel O 0 3.5549629018305495e-08
was O 0 6.007444541822338e-11
0 O 0 1.4549881481931703e-12
. O 0 8.513681974036194e-14

50 O 0 1.8720405000477447e-12
mg O 0 2.1039287933372064e-12
/ O 0 1.7269326593738477e-11
ml O 0 4.596277243355817e-13
, O 0 5.857252417900392e-16
which O 0 5.880891519271484e-17
was O 0 2.2492405107757494e-15
approximately O 0 5.942002961182411e-17
half O 0 1.724764062582991e-14
the O 0 2.633974416242559e-16
level O 0 9.05445993658182e-17
of O 0 6.45479445402923e-21
Hp O 0 6.750979305745683e-14
in O 0 5.276871265793258e-16
control O 0 2.515208450404316e-07
sera O 0 8.233460579987195e-10
from O 0 4.357337658384359e-18
the O 0 1.1072026242492559e-16
Hp1 O 0 1.6806352975962113e-09
phenotype O 0 9.48130571450101e-13
( O 0 6.852122761047992e-19
1 O 0 3.0612823301099888e-18
. O 0 1.7321130593997122e-17
26 O 0 3.905793857149299e-15
+ O 0 8.136368945396103e-15
/ O 0 3.5229218847687704e-11
- O 0 2.8833088260710182e-12
0 O 0 2.697518933824695e-15
. O 0 2.4127477076548854e-18
33 O 0 3.4612770544795504e-16
mg O 0 3.4257464046223967e-15
/ O 0 2.8009102741137493e-13
ml O 0 5.1570571001514215e-14
; O 0 1.2176028736562419e-15
n O 0 8.091102787766147e-11
= O 0 6.120191020642096e-09
9 O 0 9.209121095907213e-14
) O 0 2.720758334906356e-17
, O 0 1.684453890354612e-17
showing O 0 1.157496865147661e-14
a O 0 8.431515775921851e-16
gene O 0 6.045614529825993e-12
- O 0 1.0198347721868117e-10
dosage O 0 1.0427617103125897e-10
effect O 0 1.1043722360215558e-12
. O 0 3.7960769510431147e-13

The O 0 5.850625973274903e-14
other O 0 1.1004065083365202e-16
allele O 0 1.0503288167050366e-14
( O 0 3.003894813957744e-17
Hp2 O 0 9.067998088529983e-12
) O 0 3.295346939707128e-17
of O 0 4.307275498640519e-20
individuals O 0 5.853784314289753e-18
with O 0 4.93917574686544e-15
Hp2 O 0 9.431057605979731e-07
/ O 0 3.0635627368269525e-09
Hpdel O 0 2.63959493151944e-10
was O 0 7.961427334448115e-14
found O 0 8.157186156503417e-16
to O 0 1.113271681490782e-16
have O 0 1.0425453631900811e-13
, O 0 1.4056769045942843e-15
in O 0 5.3892239658483344e-17
all O 0 1.1879999721222106e-16
exons O 0 5.6393904303286835e-12
, O 0 2.674833655079683e-14
no O 0 1.033690040302352e-14
mutation O 0 2.6703449522064745e-16
, O 0 5.4062443960237435e-20
by O 0 1.2346960527121638e-19
DNA O 0 1.827959875480567e-12
sequencing O 0 3.064475539646394e-12
. O 0 8.34258606207533e-13

On O 0 1.4542583717108704e-12
the O 0 1.9682004316513705e-16
basis O 0 8.37138808336982e-17
of O 0 2.6842204747801815e-19
the O 0 1.3014023312873924e-16
present O 0 2.2034308778756483e-16
study O 0 8.217867332146919e-17
, O 0 2.688978552080436e-17
the O 0 1.4465999250123365e-17
mechanism O 0 8.049188079299954e-15
of O 0 7.362083227602114e-20
anhaptoglobinemia B-Disease 0 5.542823977577882e-10
and O 0 5.270378588845964e-14
the O 0 1.309929438437181e-16
mechanism O 0 5.120593263508366e-15
of O 0 3.191275727926652e-20
anomalous O 0 7.833334268779815e-14
inheritance O 0 3.6723711094657774e-13
of O 0 1.4523781124632644e-17
Hp O 0 2.1530343480291592e-11
phenotypes O 0 1.3262146936199315e-09
were O 0 1.6079159488244232e-12
well O 0 1.5533095643061046e-11
explained O 0 5.481763043491128e-09
. O 0 1.9179230686255933e-12

However O 0 3.4420750971708713e-11
, O 0 5.458520869463732e-15
the O 0 2.9545401231802573e-16
mechanism O 0 2.1831273022535937e-14
of O 0 6.115203579948868e-18
hypohaptoglobinemia B-Disease 0 7.134529766972264e-08
remains O 0 1.5864054514480586e-09
unknown O 0 2.5656070601343117e-09

ATM O 0 1.7683998976281146e-07
mutations O 0 1.8287206557943136e-06
and O 0 1.1715434178327655e-10
phenotypes O 0 5.499536541719863e-07
in O 0 1.5231308436725044e-09
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
telangiectasia I-Disease 1 1.0
families O 0 5.202077102417491e-10
in O 0 6.769026528533062e-15
the O 0 8.156413133059929e-15
British O 0 1.415204398114156e-09
Isles O 0 8.718555322140276e-10
: O 0 1.6076183736563168e-16
expression O 0 1.9890768821254328e-17
of O 0 7.684580592038652e-21
mutant O 0 1.7079145443830296e-14
ATM O 0 1.8455315129849853e-13
and O 0 1.4182373444108815e-15
the O 0 1.9508958132367612e-16
risk O 0 9.043566134674108e-14
of O 0 1.0699247042405942e-16
leukemia B-Disease 0 1.4238105904951226e-05
, O 0 4.848963897075009e-09
lymphoma B-Disease 1 1.0
, O 0 6.305664879135975e-10
and O 0 8.292109328067454e-07
breast B-Disease 1 0.6809511780738831
cancer I-Disease 0 0.0005148086347617209
. O 0 1.403062735438887e-11

We O 0 1.219435247223899e-10
report O 0 3.520362525929544e-15
the O 0 8.065554843644773e-19
spectrum O 0 1.0117331437175297e-16
of O 0 1.5202330615999694e-18
59 O 0 1.007902311958575e-12
ATM O 0 6.346326797412871e-10
mutations O 0 1.1233776131547302e-09
observed O 0 5.1409095730425847e-11
in O 0 1.1965085866538772e-10
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 0 6.884149570396403e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
) O 0 1.3910630460023388e-12
patients O 0 2.36571694308893e-13
in O 0 1.9474892187764718e-17
the O 0 7.136683720387633e-15
British O 0 2.221323214257609e-08
Isles O 0 2.245926822297406e-07
. O 0 5.38878533809517e-12

Of O 0 1.430581320722643e-13
51 O 0 3.0798605332726936e-10
ATM O 0 6.90057677665834e-10
mutations O 0 1.7849190181440378e-10
identified O 0 2.1963179430532775e-13
in O 0 3.648588630033611e-18
families O 0 6.3910513570327456e-18
native O 0 7.567510935382535e-16
to O 0 8.182086807570325e-16
the O 0 4.136024188476596e-15
British O 0 3.782691937459504e-09
Isles O 0 8.509937643452758e-09
, O 0 2.7986285367604356e-14
11 O 0 1.4746378802367563e-15
were O 0 9.164437404051563e-18
founder O 0 1.2033767435488691e-14
mutations O 0 2.542546251663169e-12
, O 0 7.543560020007735e-16
and O 0 2.2941629031333812e-15
2 O 0 5.295847450789714e-16
of O 0 1.8582061868908536e-19
these O 0 1.3227540466542032e-16
11 O 0 1.6969667176551506e-16
conferred O 0 1.5694077909633893e-16
a O 0 7.46982368436688e-16
milder O 0 2.9215161401197065e-09
clinical O 0 4.725845048625388e-09
phenotype O 0 6.590072671591729e-12
with O 0 5.035994153835448e-16
respect O 0 8.4448795206098e-15
to O 0 3.381442261612966e-14
both O 0 4.4231868168154165e-11
cerebellar B-Disease 0 2.5885989089147188e-05
degeneration I-Disease 0 0.0012803788995370269
and O 0 2.0789969138595987e-12
cellular O 0 7.384960420964148e-10
features O 0 1.247990724095871e-07
. O 0 4.09574651971667e-10

We O 0 1.325896059611864e-09
report O 0 1.8820164068671097e-14
, O 0 1.1727940101833217e-16
in O 0 2.940405062349604e-17
two O 0 4.217413310941831e-12
A B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
T I-Disease 1 1.0
families O 0 8.4395367755917e-14
, O 0 3.8167972965213716e-17
an O 0 2.166198616168848e-19
ATM O 0 1.6302688365943396e-11
mutation O 0 7.011961540917544e-13
( O 0 1.2428631067528719e-17
7271T O 0 1.424398793359316e-12
- O 0 1.3534440061746533e-11
- O 0 6.171539668198278e-11
> O 0 6.172003554939798e-13
G O 0 2.5021493123972283e-12
) O 0 6.8208316558484536e-18
that O 0 2.4326015974557096e-16
may O 0 5.9251458143919685e-15
be O 0 1.49817281640767e-17
associated O 0 1.1319689014800162e-15
with O 0 1.4476875020817212e-17
an O 0 2.1697238634841535e-17
increased O 0 1.6103814462486987e-11
risk O 0 2.199499055111076e-10
of O 0 4.208294733602227e-15
breast B-Disease 0 0.0034814514219760895
cancer I-Disease 0 3.4389090615150053e-06
in O 0 8.777126923620879e-16
both O 0 1.1070000168270089e-12
homozygotes O 0 3.6928980762240826e-08
and O 0 1.804843980431764e-13
heterozygotes O 0 1.1487494983031254e-11
( O 0 1.87490700523092e-15
relative O 0 6.943981847862268e-12
risk O 0 7.141023449647177e-12
12 O 0 1.3594851274860735e-15
. O 0 1.7906660316760134e-16
7 O 0 6.635016429508422e-14
; O 0 2.253855061569096e-13
P O 0 3.9248587313522876e-07
= O 0 1.7179457856286717e-09
. O 0 1.2722651919952325e-15
0025 O 0 9.12337566605359e-12
) O 0 1.200876328758354e-16
, O 0 3.91302288630742e-17
although O 0 7.56733782302394e-16
there O 0 1.718247758710425e-16
is O 0 2.6724009427061996e-18
a O 0 2.0400173112244084e-17
less O 0 9.1397978442732e-16
severe O 0 2.8321128553443486e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
phenotype O 0 5.341611313269823e-07
in O 0 2.6680643159959923e-16
terms O 0 2.7889582183584954e-17
of O 0 1.6766366173907402e-20
the O 0 6.493578326007162e-18
degree O 0 4.980041274922197e-15
of O 0 1.509658880957459e-16
cerebellar B-Disease 0 2.6822528980119387e-06
degeneration I-Disease 0 0.022296100854873657
. O 0 1.043016298329924e-10

This O 0 2.1646111281452968e-13
mutation O 0 8.706610736194942e-13
( O 0 1.536020399160585e-16
7271T O 0 1.1982384485673125e-12
- O 0 1.8907408624868616e-11
- O 0 8.277956098368122e-11
> O 0 2.762868059336121e-12
G O 0 4.35524056055514e-12
) O 0 5.192955099595121e-18
also O 0 1.211357170340544e-16
allows O 0 1.515446233569574e-16
expression O 0 6.868096243197754e-16
of O 0 4.014395400659927e-19
full O 0 2.5052770243301286e-16
- O 0 7.967595089556842e-14
length O 0 4.5651884236861534e-14
ATM O 0 8.069144853163623e-14
protein O 0 2.4283914180738e-13
at O 0 9.58200727625507e-16
a O 0 3.5223354244823767e-16
level O 0 3.371244334329115e-16
comparable O 0 1.4828736874620283e-15
with O 0 8.345405877108387e-16
that O 0 1.0415435603827045e-13
in O 0 3.082310882224215e-14
unaffected O 0 1.314635245108775e-08
individuals O 0 3.5154376646159705e-15
. O 0 9.983163520030716e-14

In O 0 2.082157586809092e-14
addition O 0 3.2659906968143153e-15
, O 0 3.681154366790354e-15
we O 0 8.132897296158487e-14
have O 0 5.947493719914089e-16
studied O 0 1.750563994977472e-12
18 O 0 2.134551433177756e-12
A B-Disease 1 0.9999988079071045
- I-Disease 1 0.999998927116394
T I-Disease 1 1.0
patients O 0 3.3525722642480105e-08
, O 0 3.189395889674273e-16
in O 0 1.0053044283456656e-16
15 O 0 7.296900002360784e-15
families O 0 5.538175371367493e-17
, O 0 9.871438434331864e-16
who O 0 8.969672227188141e-12
developed O 0 4.596740210693895e-10
leukemia B-Disease 0 1.7213782257385901e-06
, O 0 5.530700342148975e-10
lymphoma B-Disease 1 1.0
, O 0 9.16062104644455e-12
preleukemic O 0 8.551098289899528e-06
T O 0 2.0608244085451588e-05
- O 0 2.9184823446826158e-08
cell O 0 1.4595305231068778e-07
proliferation O 0 2.2046101548767183e-06
, O 0 5.024682492998922e-12
or O 0 1.6073641972980113e-08
Hodgkin B-Disease 1 0.9999992847442627
lymphoma I-Disease 1 1.0
, O 0 1.7098825827455144e-11
mostly O 0 2.1851071570645059e-13
in O 0 2.065242941939882e-12
childhood O 0 6.164460728541599e-07
. O 0 5.099197973590375e-12

A O 0 7.791534084589102e-11
wide O 0 1.3912566845103447e-12
variety O 0 3.990716109891594e-14
of O 0 2.694060749763962e-17
ATM O 0 1.3296232170834088e-10
mutation O 0 1.4544997151144656e-12
types O 0 1.528400310772584e-14
, O 0 1.7474379699106862e-16
including O 0 1.9298017282348137e-15
missense O 0 1.8053649242233405e-08
mutations O 0 2.391423770120582e-08
and O 0 5.890824801698877e-14
in O 0 4.839318926834512e-16
- O 0 7.301679816329454e-10
frame O 0 6.173594080394196e-09
deletions O 0 4.0208045226641786e-10
, O 0 1.0237114162012922e-13
were O 0 2.6167700124135216e-15
seen O 0 1.243511153423138e-12
in O 0 2.9496413610693713e-16
these O 0 1.5981365333200305e-14
patients O 0 7.703803279980256e-14
. O 0 1.330762113189738e-14

We O 0 8.23541998484778e-11
also O 0 3.194633464964061e-15
show O 0 1.6216694802870073e-14
that O 0 1.0012973007606627e-16
25 O 0 3.397268826063462e-17
% O 0 1.4234532724357375e-20
of O 0 1.565577603515266e-20
all O 0 7.163333918007095e-14
A B-Disease 1 1.0
- I-Disease 1 0.999998927116394
T I-Disease 1 1.0
patients O 0 5.92037396884848e-09
carried O 0 2.9315967513786345e-13
in O 0 9.74393085901253e-17
- O 0 5.79775775999547e-11
frame O 0 1.5829054733629278e-09
deletions O 0 4.821386623277135e-10
or O 0 2.2428329606396548e-14
missense O 0 2.1110618808606318e-10
mutations O 0 1.0443300391127508e-10
, O 0 1.069875735148331e-16
many O 0 6.694290392920704e-18
of O 0 3.6405927403411553e-19
which O 0 5.3695532720686445e-14
were O 0 2.413733207989703e-14
also O 0 1.1539556202949663e-12
associated O 0 8.495956217192957e-13
with O 0 1.5364020404428822e-15
expression O 0 2.4252827563353997e-15
of O 0 1.2821536275022272e-18
mutant O 0 1.947635412322124e-12
ATM O 0 8.810018686800092e-12
protein O 0 3.9842062982131665e-10
. O 0 1.2205811448368076e-12

The O 0 2.5886999249942477e-13
DMPK O 0 3.7770020444582997e-10
gene O 0 1.4671139303423786e-11
of O 0 2.4361315543238327e-15
severely O 0 3.687776916194707e-05
affected O 0 1.3292766425365699e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 3.8321047668432584e-07
is O 0 1.4911043066104983e-15
hypermethylated O 0 2.3607700863625958e-11
proximal O 0 1.971687570156977e-12
to O 0 3.9229378887050206e-14
the O 0 2.3450223611765552e-15
largely O 0 6.41630195155618e-13
expanded O 0 4.979351375666852e-10
CTG O 0 7.776072834531078e-07
repeat O 0 2.32636434560618e-08
. O 0 2.5950142642366947e-12

Using O 0 1.9927986940736914e-13
methylation O 0 1.6109075184900234e-10
- O 0 1.6745542452678563e-11
sensitive O 0 3.0281797902542706e-11
restriction O 0 4.872844905356999e-10
enzymes O 0 4.088101385191223e-12
, O 0 4.458870372806099e-16
we O 0 1.7330401038732576e-15
characterized O 0 1.2547731675410431e-16
the O 0 2.2183554557176134e-19
methylation O 0 1.2088623288150635e-12
pattern O 0 1.899574247898883e-12
on O 0 9.86910867021044e-15
the O 0 3.8101802486676414e-16
5 O 0 2.617100736427777e-14
side O 0 1.0265211938939242e-13
of O 0 1.241605983507308e-19
the O 0 1.2389630328827456e-16
CTG O 0 2.984920921544898e-10
repeat O 0 5.371832752926187e-12
in O 0 1.6495561329277348e-17
the O 0 5.347366641619681e-17
DMPK O 0 2.6375101755404806e-11
gene O 0 9.821198758766525e-13
of O 0 9.86160073394774e-19
normal O 0 2.950309538774648e-13
individuals O 0 9.368390364605087e-18
and O 0 9.027701504033567e-16
of O 0 1.9588068693535448e-17
patients O 0 8.948649655483865e-13
affected O 0 2.6686704061862354e-12
with O 0 7.918521394145728e-11
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
, O 0 8.700828821534348e-14
showing O 0 1.1829731259242054e-13
expansions O 0 4.1385850909486654e-13
of O 0 3.713418910542454e-18
the O 0 2.639416073533076e-16
repetitive O 0 6.474898128772111e-08
sequence O 0 8.232867720892045e-09
. O 0 6.732803117109887e-12

The O 0 6.244945560023377e-14
gene O 0 2.0129507869587338e-12
segment O 0 7.126896186919474e-13
analyzed O 0 7.010220176703261e-14
corresponds O 0 8.087472168570836e-16
to O 0 3.3119964972510446e-16
the O 0 2.5991497154073825e-16
genomic O 0 1.7232236970698978e-08
SacI O 0 3.4168061802120064e-07
- O 0 3.44282546915764e-10
HindIII O 0 3.8030617544038137e-10
fragment O 0 5.642101803121635e-12
carrying O 0 2.2314740794103852e-14
exons O 0 3.3478369815959086e-12
11 O 0 1.4379272512271557e-12
- O 0 5.190678997735176e-10
15 O 0 8.367637095371694e-13
. O 0 2.6920428234690486e-13

There O 0 1.431261684690932e-12
is O 0 5.07892019541552e-16
constitutive O 0 2.553040312253292e-14
methylation O 0 2.2785220932242112e-10
in O 0 1.754197928104486e-15
intron O 0 5.9590547607513145e-08
12 O 0 2.306819828473e-13
at O 0 1.2228302316111034e-15
restriction O 0 4.932553389173921e-13
sites O 0 1.3799104545651752e-13
of O 0 1.2587901385753354e-17
SacII O 0 2.4039680468490587e-08
and O 0 5.765415814033836e-14
HhaI O 0 5.196969521392703e-10
, O 0 4.0676602651828196e-16
localized O 0 7.210121714083806e-13
1 O 0 5.392849134513685e-15
, O 0 9.571121844091667e-16
159 O 0 2.8382485706308913e-13
- O 0 2.7717830201196003e-12
1 O 0 3.717263381331805e-16
, O 0 3.978269238664378e-17
232 O 0 3.24799865822345e-16
bp O 0 3.983831426096311e-15
upstream O 0 6.150887506373528e-16
of O 0 3.15133001292373e-20
the O 0 1.2973224448957093e-17
CTG O 0 1.7408421926212725e-11
repeat O 0 3.663996460834956e-13
, O 0 2.990084206450559e-17
whereas O 0 1.6515908979729418e-16
most O 0 2.6213219194955907e-18
, O 0 2.0699396765284526e-16
if O 0 8.403234976351454e-14
not O 0 1.5799968145348113e-14
all O 0 1.5544101792771903e-17
, O 0 3.810687078772565e-17
of O 0 1.5655410912460401e-21
the O 0 9.97011649055704e-20
other O 0 1.0266843624620857e-19
sites O 0 2.4000562093420353e-15
of O 0 2.025900900214641e-19
SacII O 0 1.247593972575345e-10
, O 0 1.3376119839308889e-15
HhaI O 0 1.7381358852208706e-10
, O 0 1.2920892146202432e-14
and O 0 3.98479128383214e-14
HpaII O 0 3.0228279879196407e-09
in O 0 6.343620853796179e-16
this O 0 9.529734755497638e-16
region O 0 3.972454147311427e-13
are O 0 3.224198091196788e-16
unmethylated O 0 4.927275809585296e-10
, O 0 3.867070051899674e-15
in O 0 7.231413423519051e-17
normal O 0 2.592311402430797e-13
individuals O 0 1.3104528204261617e-18
and O 0 6.927269700195143e-17
most O 0 2.3924927427904525e-18
of O 0 1.1966993820275698e-19
the O 0 1.073740045037493e-15
patients O 0 5.650410085026973e-14
. O 0 8.896224414686044e-15

In O 0 2.784008917497416e-14
a O 0 1.3018152069096196e-15
number O 0 1.6696010418930547e-15
of O 0 1.9053243487960712e-17
young O 0 4.007019976243198e-12
and O 0 2.5947776913226583e-11
severely O 0 0.0005000731907784939
affected O 0 1.6363201904567859e-09
patients O 0 1.5862828411927765e-11
, O 0 6.785258538538651e-16
however O 0 8.539080595772793e-15
, O 0 9.975990755036116e-17
complete O 0 4.561928342102937e-16
methylation O 0 2.3990438541982018e-12
of O 0 1.580489989748978e-19
these O 0 5.034262897900599e-17
restriction O 0 8.314691166480537e-13
sites O 0 1.7843113054791249e-12
was O 0 1.8261930596202847e-12
found O 0 5.551739386407909e-15
in O 0 1.0921632895729598e-17
the O 0 1.0538434528647262e-16
mutated O 0 2.8022546089134792e-11
allele O 0 5.413396727410591e-12
. O 0 2.3356074019265094e-12

In O 0 1.2988298181111982e-14
most O 0 5.397000787095313e-17
of O 0 1.0333601623697861e-19
these O 0 9.925430167274425e-17
patients O 0 7.159911799021069e-16
, O 0 2.0095689169534234e-18
the O 0 5.791528219847175e-17
onset O 0 1.1271452521333103e-11
of O 0 1.1742304424042446e-17
the O 0 1.2301408156001337e-11
disease O 0 9.83287682174705e-05
was O 0 1.257969006740467e-10
congenital O 1 0.9892951846122742
. O 0 1.339428151725386e-10

Preliminary O 0 4.911543172170241e-09
in O 0 3.2056844158356856e-13
vivo O 0 7.668316648334894e-09
footprinting O 0 7.2450134780410735e-09
data O 0 2.9476082490619004e-14
gave O 0 8.778934809567675e-16
evidence O 0 2.3234269253140618e-17
for O 0 1.5454453198754325e-19
protein O 0 2.908898165746021e-14
- O 0 2.8870579538153862e-11
DNA O 0 1.75548926506508e-08
contact O 0 1.3809764443095673e-10
in O 0 2.0082384614582196e-15
normal O 0 2.86288093925835e-11
genes O 0 1.84983885848089e-12
at O 0 6.159696437266736e-15
an O 0 8.820886961781751e-18
Sp1 O 0 2.612114136102406e-10
consensus O 0 1.3870284154692968e-15
binding O 0 1.4214717185441483e-14
site O 0 2.206192991965547e-13
upstream O 0 1.597180368647852e-13
of O 0 1.8082645887212934e-18
the O 0 1.6842040487223965e-16
CTG O 0 2.0013492252335396e-10
repeat O 0 1.1006276619263122e-11
and O 0 2.8116594292638497e-16
for O 0 2.6004338641945222e-20
a O 0 1.7099679247970498e-18
significant O 0 1.9664733447068088e-17
reduction O 0 3.9157888459269e-15
of O 0 1.2692618625592234e-19
this O 0 1.6964296458270322e-16
interaction O 0 1.9850007478250083e-15
in O 0 1.0313099941875977e-16
cells O 0 1.4846519060798466e-14
with O 0 6.40917008660623e-17
a O 0 2.8951101634306156e-14
hypermethylated O 0 1.0493743651807108e-09
DMPK O 0 3.5081521021496087e-10
gene O 0 3.140951040925266e-11
. O 0 1.4896809100942848e-14
. O 0 1.508719906818945e-13

The O 0 3.454855151963088e-11
hemochromatosis B-Disease 1 0.9999939203262329
gene O 0 2.6433850663920566e-09
product O 0 2.6033796497152047e-14
complexes O 0 1.1640330626477846e-13
with O 0 1.3970747026797656e-16
the O 0 1.3929133886285828e-16
transferrin O 0 7.015500680385145e-11
receptor O 0 2.1997987199179336e-12
and O 0 3.5083806519675687e-13
lowers O 0 1.582777138520175e-11
its O 0 5.8657205305288935e-18
affinity O 0 5.446077412838084e-17
for O 0 1.029472801231699e-19
ligand O 0 1.0892602297300335e-15
binding O 0 1.0262025604279579e-12
. O 0 1.21641162854208e-12

We O 0 2.5485380916734357e-08
recently O 0 2.6777269637734413e-11
reported O 0 1.8061318770874052e-13
the O 0 9.955040089917496e-18
positional O 0 9.082846237282172e-13
cloning O 0 4.847921109690789e-12
of O 0 4.041931467769993e-19
a O 0 9.641033561277873e-17
candidate O 0 6.143531321688156e-14
gene O 0 1.7433351984230683e-10
for O 0 3.881759497170734e-12
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 1.9224929928896017e-05
HFE O 0 0.0030612125992774963
. O 0 1.389457437994679e-10

The O 0 4.38744431952888e-14
gene O 0 7.915372459040004e-13
product O 0 1.655844549203287e-14
, O 0 3.7261791971950444e-16
a O 0 1.2069844950992416e-16
member O 0 6.78059800444418e-17
of O 0 5.473750088826313e-20
the O 0 9.792180635014993e-18
major O 0 5.98534391655774e-16
histocompatibility O 0 1.666106624409816e-13
complex O 0 9.37116188684875e-14
class O 0 3.5784938380578613e-12
I O 0 8.628514791553243e-09
- O 0 2.459981220462315e-12
like O 0 4.301201322193249e-12
family O 0 1.4444906859187312e-13
, O 0 7.377922991869953e-17
was O 0 5.89952147955075e-16
found O 0 1.7325963644880147e-16
to O 0 5.384128202402763e-17
have O 0 1.7591442828790958e-14
a O 0 2.378564230613115e-15
mutation O 0 1.2231115100770629e-13
, O 0 2.734014565967008e-16
Cys O 0 1.8329771478420298e-08
- O 0 1.4076229071235957e-10
282 O 0 2.019932311692063e-11
- O 0 1.6195787821970953e-08
- O 0 3.21189830287949e-08
> O 0 5.9089486775798505e-12
Tyr O 0 4.966955666207973e-13
( O 0 6.8912102503159965e-18
C282Y O 0 1.3524561516282257e-14
) O 0 3.737193322118147e-18
, O 0 5.6360182646872055e-18
in O 0 2.7877440412963595e-18
85 O 0 8.94294082282596e-15
% O 0 4.65161584669653e-18
of O 0 4.9867062992514554e-18
patient O 0 1.8944661811515218e-11
chromosomes O 0 1.1139207611865487e-10
. O 0 7.818176661622545e-12

This O 0 4.0126620559285953e-13
mutation O 0 1.9596414334993595e-12
eliminates O 0 3.0912037252833757e-12
the O 0 1.8788448614027054e-15
ability O 0 1.3795263759455723e-13
of O 0 5.628112072392424e-18
HFE O 0 7.179028038706292e-09
to O 0 7.025342086504002e-15
associate O 0 5.317667963952721e-13
with O 0 8.574235004182688e-15
beta2 O 0 1.0075664391706596e-07
- O 0 9.821127378017991e-08
microglobulin O 0 1.2160133167071763e-07
( O 0 5.935484275029681e-15
beta2m O 0 1.1688226775330435e-10
) O 0 1.8090883100645248e-15
and O 0 3.009116097098187e-15
prevents O 0 9.226390268110563e-13
cell O 0 1.0554046525612648e-08
- O 0 3.4359220535407076e-07
surface O 0 4.214590987317024e-08
expression O 0 5.624282151117654e-10
. O 0 4.6256184646487064e-12

A O 0 6.4599718803404205e-12
second O 0 2.78577227068701e-14
mutation O 0 3.3790518668731784e-13
that O 0 2.2076304407583555e-15
has O 0 2.0454838723423657e-13
no O 0 2.794991885504694e-13
effect O 0 1.5742790372089838e-13
on O 0 1.4956755452211201e-12
beta2m O 0 1.7509267991044908e-06
association O 0 8.326898207210881e-16
, O 0 5.4679354950886753e-17
H63D O 0 1.1223313077513009e-11
, O 0 8.003197154879361e-16
was O 0 1.6360236733056754e-13
found O 0 3.051122451479954e-14
in O 0 1.1132461381534663e-16
eight O 0 2.0089675027159214e-14
out O 0 4.311118519464974e-14
of O 0 1.0264970189780395e-18
nine O 0 7.948105877880057e-14
patients O 0 3.3662195760673246e-16
heterozygous O 0 2.409788353208191e-16
for O 0 8.561405159912389e-19
the O 0 3.923876687084198e-16
C282Y O 0 1.2424834772151172e-10
mutant O 0 4.939056941211106e-10
. O 0 6.3240628012106725e-12

In O 0 1.0342881472070672e-13
this O 0 1.858550163744729e-15
report O 0 1.5744284199395615e-14
, O 0 8.954611031014993e-16
we O 0 3.8237106894396106e-14
demonstrate O 0 2.3796895138835424e-15
in O 0 1.8199337993305076e-16
cultured O 0 2.8716024783742577e-12
293 O 0 5.32648957492915e-13
cells O 0 2.559052958688718e-13
overexpressing O 0 4.825066457492255e-10
wild O 0 9.212208773590191e-11
- O 0 1.62411273318952e-09
type O 0 7.371991728177818e-08
or O 0 4.0469326701613254e-14
mutant O 0 3.136435338876864e-12
HFE O 0 2.5912069365197077e-11
proteins O 0 2.68123522516317e-13
that O 0 2.395565028897456e-15
both O 0 1.0498836797154308e-15
the O 0 1.1888937507002414e-15
wild O 0 1.7688679687655195e-10
- O 0 1.0394881400088707e-08
type O 0 8.128142781060888e-07
and O 0 7.296747928098313e-11
H63D O 0 2.478365956903872e-07
HFE O 0 7.478264052451777e-08
proteins O 0 8.29132817958822e-10
form O 0 1.4600949572660116e-12
stable O 0 7.23460137283527e-13
complexes O 0 1.7800782278320354e-13
with O 0 5.191989564753312e-16
the O 0 1.4651785339191755e-15
transferrin O 0 1.4645144819080969e-10
receptor O 0 2.4772378159204633e-12
( O 0 1.3272057606573961e-14
TfR O 0 1.6629073229523783e-08
) O 0 1.9512783587267296e-13
. O 0 1.900030913853934e-12

The O 0 9.163045756183097e-13
C282Y O 0 3.075657228901463e-10
mutation O 0 8.695666409153091e-11
nearly O 0 1.6109604427348712e-13
completely O 0 4.88117934960286e-10
prevents O 0 1.9905829762301153e-10
the O 0 3.249129955427803e-14
association O 0 3.0878620502869e-16
of O 0 2.6561165287925522e-20
the O 0 1.643927665167679e-17
mutant O 0 5.055017819263763e-13
HFE O 0 5.8386843970748e-11
protein O 0 6.14649086835839e-12
with O 0 2.8003360281271582e-15
the O 0 7.105799374471436e-14
TfR O 0 1.2478752978495322e-05
. O 0 4.4204518517831914e-12

Studies O 0 2.9041305471544376e-10
on O 0 1.1958398443842003e-14
cell O 0 3.2493933758981353e-12
- O 0 7.784652263087555e-12
associated O 0 2.697449739703234e-13
transferrin O 0 7.823144042296004e-12
at O 0 1.505829932046867e-14
37 O 0 2.939826387968886e-14
degrees O 0 2.245496404920319e-13
C O 0 8.84690029567814e-11
suggest O 0 3.5260916365562056e-13
that O 0 7.782902943539831e-15
the O 0 9.106597329114384e-16
overexpressed O 0 1.8943678625760185e-08
wild O 0 1.4360409528180185e-09
- O 0 3.808435788954512e-09
type O 0 1.682020744908641e-09
HFE O 0 1.2848916375318709e-09
protein O 0 6.762274767924126e-12
decreases O 0 1.2063925704762501e-13
the O 0 5.151698639363426e-18
affinity O 0 5.635010427828871e-17
of O 0 1.3349330238595154e-19
the O 0 5.043335414859081e-17
TfR O 0 2.2859830695054484e-10
for O 0 1.6271757688383776e-17
transferrin O 0 5.047193218921109e-10
. O 0 1.882054191312821e-12

The O 0 2.6724191436178213e-12
overexpressed O 0 9.95204718634568e-09
H63D O 0 2.682954525212722e-09
protein O 0 4.033568618000416e-11
does O 0 3.829232503999025e-12
not O 0 6.3631588333949024e-15
have O 0 3.615839232711101e-15
this O 0 1.1560433049941024e-17
effect O 0 4.662672852662588e-15
, O 0 2.7851216223285765e-16
providing O 0 2.3269305315165914e-17
the O 0 7.84150925242203e-18
first O 0 6.082747907844431e-18
direct O 0 3.84781855472558e-17
evidence O 0 8.7034134578696e-15
for O 0 1.4737984507336926e-17
a O 0 1.4157732196882003e-14
functional O 0 5.791148463551998e-11
consequence O 0 7.189396105354573e-14
of O 0 9.317598166271881e-19
the O 0 1.8978183994212017e-15
H63D O 0 7.015029268586659e-08
mutation O 0 1.1606517830164975e-10
. O 0 1.860946428422841e-13

Addition O 0 3.1975260655382753e-13
of O 0 1.7116076821484412e-16
soluble O 0 8.096721904049531e-11
wild O 0 7.604927354520896e-09
- O 0 2.115559937010403e-06
type O 0 1.5033404451969545e-05
HFE O 0 0.0006878137355670333
/ O 0 5.302812860463746e-05
beta2m O 0 2.3215997657644039e-07
heterodimers O 0 1.4771478484831846e-09
to O 0 4.164174227335761e-14
cultured O 0 7.390744266588811e-12
cells O 0 6.328080854461904e-12
also O 0 9.962277720430499e-14
decreased O 0 7.019535777294528e-13
the O 0 1.3023204355928772e-17
apparent O 0 1.3412857775813676e-15
affinity O 0 5.0057678492871274e-17
of O 0 1.780561844717798e-19
the O 0 2.1645486906997767e-17
TfR O 0 1.8548709443400035e-11
for O 0 5.198122845848561e-20
its O 0 1.6452623676149428e-19
ligand O 0 5.3674148526900063e-17
under O 0 2.4697408158192585e-16
steady O 0 1.8556679223834596e-14
- O 0 6.226699792713161e-14
state O 0 9.655697194490415e-14
conditions O 0 7.144069225084593e-10
, O 0 4.584552922996345e-17
both O 0 1.7329533094659436e-16
in O 0 4.894288387261111e-17
293 O 0 1.4657215667416602e-14
cells O 0 3.7885164704811944e-14
and O 0 4.691594792646586e-15
in O 0 7.870802093575251e-15
HeLa O 0 3.2693680651618706e-08
cells O 0 3.6167294853450827e-11
. O 0 2.777057555268525e-13

Furthermore O 0 4.0555236252570737e-11
, O 0 8.332877201027312e-15
at O 0 1.6290291801591104e-14
4 O 0 1.2899074271547056e-14
degrees O 0 3.272632512207885e-11
C O 0 6.79862850461177e-08
, O 0 2.8401654400718457e-13
the O 0 1.3016974650947866e-13
added O 0 3.234697787402041e-10
soluble O 0 2.776862940978564e-12
complex O 0 7.156860553410999e-14
of O 0 5.454248633801128e-17
HFE O 0 4.722784012756165e-07
/ O 0 4.448564627779206e-09
beta2m O 0 1.6271994168759463e-11
inhibited O 0 6.438488522712837e-14
binding O 0 7.218824740447619e-15
of O 0 2.13574229130374e-18
transferrin O 0 1.6753272380487516e-11
to O 0 2.6650053623861018e-14
HeLa O 0 9.128158673377129e-09
cell O 0 4.106887718791086e-09
TfR O 0 2.548542887836902e-08
in O 0 4.330448266601526e-16
a O 0 1.0000119256162263e-14
concentration O 0 3.338691545451411e-09
- O 0 1.0055885901749662e-08
dependent O 0 1.3186318703617417e-10
manner O 0 1.6962989346502866e-10
. O 0 1.7075711504499491e-12

Scatchard O 0 1.6805933000796358e-06
plots O 0 7.124134060454423e-10
of O 0 1.9668119593623635e-16
these O 0 1.9524740738455123e-16
data O 0 2.0068370454469873e-15
indicate O 0 4.9035367509064204e-14
that O 0 3.963035496691797e-15
the O 0 2.4520839375777098e-15
added O 0 1.1802950283801295e-10
heterodimer O 0 1.173543900945262e-12
substantially O 0 2.8036002339137944e-12
reduced O 0 2.264739096128135e-14
the O 0 7.139068303422611e-18
affinity O 0 6.899871625422815e-16
of O 0 1.2885671723816571e-18
TfR O 0 4.5909218093775905e-10
for O 0 1.5467982316699059e-16
transferrin O 0 1.5771615125004246e-09
. O 0 5.213694059813534e-12

These O 0 1.327517401561451e-10
results O 0 2.0044608334268688e-12
establish O 0 4.2410438225518043e-14
a O 0 4.173441180707285e-16
molecular O 0 3.7423246467861715e-13
link O 0 7.170406046697053e-09
between O 0 1.1430203571832775e-12
HFE O 0 7.170449407567503e-07
and O 0 1.5408759880021494e-13
a O 0 5.773377097880903e-16
key O 0 2.199486049563916e-14
protein O 0 9.170751181022951e-14
involved O 0 1.5793239527373362e-15
in O 0 5.441781698480974e-16
iron O 0 5.6185061048097396e-09
transport O 0 8.052901227795228e-12
, O 0 1.894852513556391e-15
the O 0 1.705084337314501e-16
TfR O 0 1.2642380475824666e-09
, O 0 7.012727118941426e-16
and O 0 3.423223569928559e-16
raise O 0 4.561475708871748e-16
the O 0 1.5012671543226238e-18
possibility O 0 2.715076762150974e-17
that O 0 9.69044139013791e-17
alterations O 0 1.0633926031400343e-11
in O 0 1.0531551889642454e-18
this O 0 1.4799844382266092e-17
regulatory O 0 1.5767589057330555e-12
mechanism O 0 7.542823245339225e-13
may O 0 3.628747421904194e-14
play O 0 2.9483184014848784e-13
a O 0 4.65390976742765e-16
role O 0 7.184019309611992e-15
in O 0 2.3142275188496146e-17
the O 0 1.1077982604647431e-16
pathogenesis O 0 1.843071806284513e-10
of O 0 1.0394393611351353e-14
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 7.808706459222492e-10
. O 0 3.1068320659188853e-12

Genomic O 0 1.6007344783020017e-08
organization O 0 4.0310726219690285e-13
of O 0 7.106110119096048e-18
the O 0 1.8626597558465702e-15
UBE3A O 0 6.607729030605469e-09
/ O 0 2.8957305442389725e-09
E6 O 0 2.446427088687031e-11
- O 0 5.858926677149157e-09
AP O 0 1.5218356566037983e-06
gene O 0 3.9417847458311783e-11
and O 0 3.6991305235134584e-15
related O 0 4.493366128396209e-14
pseudogenes O 0 1.1230711915999336e-09
. O 0 1.1968959677532975e-11

The O 0 1.8810135740676692e-12
UBE3A O 0 2.8970066345834766e-09
gene O 0 3.753177890003512e-12
encodes O 0 9.696095245063582e-14
the O 0 3.0747226105112954e-15
E6 O 0 2.0663620554223217e-12
- O 0 9.568704717466403e-10
AP O 0 4.694019395401483e-08
ubiquitin O 0 1.7259058629958898e-14
- O 0 9.274283171132897e-15
protein O 0 5.7668209569900365e-15
ligase O 0 2.4600854343139475e-15
and O 0 6.553786562789798e-15
has O 0 4.169252698074319e-14
recently O 0 5.5808324270472526e-14
been O 0 2.2533958955963014e-16
shown O 0 1.446512310041855e-16
to O 0 6.3809415555861225e-18
be O 0 1.4930681524987074e-15
mutated O 0 1.2725560161186422e-08
in O 0 7.444506877618551e-08
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.1514367176678206e-08
who O 0 1.0769453905046245e-12
lack O 0 6.05241632636519e-14
15q11 O 0 5.699495042588154e-11
- O 0 1.5564154132174934e-10
q13 O 0 7.368298332588452e-11
deletions O 0 2.1573928754570204e-10
or O 0 1.8282387322793303e-12
chromosome O 0 1.6225476429099217e-07
15 O 0 1.2012642616743285e-11
paternal O 0 9.863742178595203e-08
uniparental B-Disease 0 0.00029143397114239633
disomy I-Disease 0 6.160658085718751e-05
. O 0 4.1296177588634464e-10

Previous O 0 1.7382915940000743e-10
UBE3A O 0 2.3178061692163965e-09
cDNA O 0 1.612179313659201e-11
analysis O 0 3.4052439687459746e-12
has O 0 2.7865374802515594e-14
shown O 0 4.3510303731264174e-16
a O 0 1.1747865228428395e-16
coding O 0 1.9111858762244083e-08
region O 0 1.6477303462630877e-12
of O 0 5.8552356026744776e-18
approximately O 0 1.1349962819367978e-14
2 O 0 7.063969201248632e-12
. O 0 6.8367165227678495e-12

6 O 0 1.31586561091801e-10
kb O 0 2.637442486630448e-09
and O 0 1.4780310655937434e-11
a O 0 7.0104681608451624e-12
3 O 0 4.4695380729820045e-09
- O 0 0.0002130489592673257
untranslated O 0 0.02507282979786396
region O 0 1.3972343140267185e-06
( O 0 1.9530087792753344e-14
UTR O 0 9.841380314845605e-12
) O 0 4.922636528597793e-17
of O 0 2.6335181806398023e-19
< O 0 9.814788277896433e-14
50 O 0 5.154300939644351e-15
bp O 0 4.138638216855117e-14
, O 0 6.039053084603053e-17
whereas O 0 1.0857671717346752e-15
Northern O 0 3.7060289732882e-12
analysis O 0 1.5737205375648822e-13
has O 0 1.3314983542274915e-14
indicated O 0 3.753315221149316e-15
mRNA O 0 2.1110968486168615e-15
sizes O 0 3.4924241775445564e-13
of O 0 1.3622357081636042e-16
5 O 0 2.927876691094511e-12
- O 0 1.14453460042796e-08
8 O 0 1.616261811887565e-11
kb O 0 3.970252393514784e-08
. O 0 2.5091567712465235e-11

We O 0 1.7386928008455982e-10
have O 0 7.737666090200531e-16
analyzed O 0 1.7589083842032855e-15
additional O 0 2.480228936590839e-17
cDNA O 0 6.323673681050967e-13
clones O 0 2.969711629385863e-11
and O 0 9.113483283459088e-15
provide O 0 2.9843865863912937e-17
evidence O 0 3.1610284915729306e-16
for O 0 5.599453107600817e-20
an O 0 1.068064085529748e-18
additional O 0 1.887567013770467e-14
0 O 0 3.590872876824136e-10
. O 0 2.7526793778404057e-12

5 O 0 1.2658219958328054e-11
kb O 0 1.20090742905532e-10
of O 0 6.847716630486815e-16
5 O 0 2.0439717626774545e-12
- O 0 2.7952320458268787e-09
UTR O 0 6.5310454822054e-09
and O 0 1.2369491281943867e-12
> O 0 8.847650802105977e-13
2 O 0 8.610027228401866e-15
kb O 0 2.4983974958314725e-11
of O 0 4.928370147557317e-16
3 O 0 1.4478408923157549e-11
- O 0 1.28180616343343e-07
UTR O 0 7.73757790284435e-07
. O 0 1.4505165298051015e-11

We O 0 1.0936300043340452e-07
have O 0 1.160685452914964e-13
established O 0 8.4891235454558e-16
the O 0 3.701920272847355e-18
genomic O 0 1.1843236894654163e-12
organization O 0 7.704883268163829e-16
of O 0 1.3361149874066713e-19
UBE3A O 0 1.7645909039520902e-11
and O 0 1.1879597909967752e-15
the O 0 5.43468126282088e-18
sequence O 0 1.8538000453281744e-14
of O 0 1.83018694290548e-18
intron O 0 3.083129973546761e-09
- O 0 9.0737173330524e-10
exon O 0 4.083398619236789e-10
borders O 0 1.123798654134589e-07
. O 0 3.6047189538868096e-11

We O 0 3.5009907151106745e-07
have O 0 2.1439729332162205e-12
also O 0 2.3329881321081103e-13
mapped O 0 5.273343220424387e-11
two O 0 8.006861101771828e-16
highly O 0 1.9590095947780693e-16
homologous O 0 4.640185059649228e-14
processed O 0 2.2764250337189984e-13
pseudogenes O 0 4.40051467487379e-12
, O 0 8.532539637947506e-14
UBE3AP1 O 0 8.160323528016988e-10
and O 0 3.70627939688499e-14
UBE3AP2 O 0 3.3265789428638115e-11
, O 0 4.157201970921644e-16
to O 0 3.062874048947306e-16
chromosomes O 0 1.1301558105157594e-13
2 O 0 5.286444008646652e-15
and O 0 1.0962980062602032e-13
21 O 0 3.0394371915154483e-13
, O 0 5.395544393351848e-15
respectively O 0 1.524359285987823e-14
, O 0 1.9910156558384032e-14
and O 0 2.044610140916614e-13
determined O 0 1.260782927711701e-12
their O 0 2.6495844393670677e-16
genomic O 0 7.350306474585011e-10
organization O 0 4.611312633823195e-12
. O 0 4.873069721182677e-13

These O 0 3.0073551288145595e-11
results O 0 4.166675338090897e-11
will O 0 8.035662657198198e-14
form O 0 5.000407652743335e-16
the O 0 1.4136508727597362e-16
basis O 0 3.1420456891315736e-16
for O 0 7.344530868594045e-18
studies O 0 3.535975037213335e-15
of O 0 1.1644070263953238e-19
mutation O 0 2.517263673440344e-14
and O 0 1.72213246356477e-16
imprinting O 0 4.1652372523293124e-11
of O 0 1.2831832349271036e-15
UBE3A O 0 3.184163404057472e-07
. O 0 3.749859450730142e-11

Mutation O 0 1.1087069040627284e-09
spectrum O 0 6.097271125493631e-13
and O 0 6.946915644730906e-14
genotype O 0 6.623062341615249e-12
- O 0 2.3529866943761135e-09
phenotype O 0 1.604126054211008e-09
analyses O 0 6.145532693846434e-11
in O 0 5.1621352320768005e-14
Cowden B-Disease 1 0.9966244697570801
disease I-Disease 1 0.998005211353302
and O 0 1.5470656700156127e-10
Bannayan B-Disease 1 0.9997499585151672
- I-Disease 1 0.9999887943267822
Zonana I-Disease 1 0.9999943971633911
syndrome I-Disease 1 0.9999995231628418
, O 0 3.940247650727202e-13
two O 0 1.1238344239591913e-12
hamartoma B-Disease 0 0.006478643510490656
syndromes I-Disease 0 8.557370165362954e-05
with O 0 1.270549556406722e-13
germline O 0 2.531898530833132e-07
PTEN O 0 1.5598011486872565e-06
mutation O 0 4.259694890151877e-07
. O 0 2.663911626010762e-11

The O 0 5.721433882222016e-10
tumour B-Disease 1 0.9999768733978271
suppressor O 0 8.349180546929347e-08
gene O 0 5.595926499957216e-10
PTEN O 0 1.0587646731563538e-10
, O 0 1.190569012463321e-14
which O 0 5.215174974102031e-16
maps O 0 5.29759847101019e-11
to O 0 4.595584980268685e-13
10q23 O 0 3.2121189263989436e-08
. O 0 6.6699926831725875e-12

3 O 0 1.4760077925515813e-12
and O 0 1.2163819815418932e-15
encodes O 0 7.096342082208752e-15
a O 0 1.2503684373966432e-15
403 O 0 2.067964702744899e-14
amino O 0 1.4421391530505638e-14
acid O 0 1.1019703826200579e-14
dual O 0 1.9861779321922457e-12
specificity O 0 6.592791590431801e-11
phosphatase O 0 4.972542342329689e-07
( O 0 6.580215684810027e-15
protein O 0 2.447953471873543e-11
tyrosine O 0 1.6704844452153367e-10
phosphatase O 0 1.1787371967386662e-08
; O 0 3.650900382793504e-14
PTPase O 0 5.338004777782901e-12
) O 0 5.825539901401885e-17
, O 0 3.0622067458035474e-17
was O 0 9.568388257012641e-15
shown O 0 3.7934766954203156e-14
recently O 0 1.1018081412517144e-11
to O 0 1.0135575071021276e-14
play O 0 9.030561888556665e-12
a O 0 5.344394191249529e-15
broad O 0 5.771139859403474e-13
role O 0 6.059141361390574e-13
in O 0 2.7188121139208946e-14
human O 0 6.6357323282029146e-12
malignancy B-Disease 0 6.631999838191405e-08
. O 0 4.859397931787635e-13

Somatic O 0 1.1659225584992328e-08
PTEN O 0 2.5062942832221324e-09
deletions O 0 1.0074617806665742e-09
and O 0 3.30045506983373e-13
mutations O 0 1.0381136054948836e-11
were O 0 1.2648082315649609e-15
observed O 0 1.4609438604620134e-13
in O 0 1.7178299120635884e-14
sporadic B-Disease 0 0.20571818947792053
breast I-Disease 1 0.9998645782470703
, I-Disease 0 3.6987419349543416e-08
brain I-Disease 0 0.0002036113291978836
, I-Disease 0 2.69567423938355e-10
prostate I-Disease 0 0.004133322276175022
and I-Disease 0 2.4205407456179273e-08
kidney I-Disease 0 1.062372348314966e-06
cancer I-Disease 0 3.203308907018254e-08
cell O 0 6.356212223224134e-10
lines O 0 2.7601512897490466e-07
and O 0 8.572170751008912e-12
in O 0 1.877920536699014e-15
several O 0 4.018145679466484e-13
primary O 0 3.945950766137685e-08
tumours B-Disease 1 0.9999998807907104
such O 0 1.5345468222949937e-13
as O 0 7.303936344627004e-10
endometrial B-Disease 0 0.05995393916964531
carcinomas I-Disease 1 1.0
, O 1 0.994709849357605
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9744005799293518
thyroid B-Disease 1 0.9999788999557495
tumours I-Disease 1 1.0
. O 0 5.413993253711169e-09

In O 0 3.578462802770674e-14
addition O 0 6.820477427331656e-15
, O 0 1.5443995137726205e-15
PTEN O 0 1.0307029535416845e-11
was O 0 1.3240679271042926e-14
identified O 0 5.804071454307031e-16
as O 0 2.534332090761911e-18
the O 0 2.731562140886911e-18
susceptibility O 0 3.1325238084890794e-13
gene O 0 2.029505036249546e-12
for O 0 3.0707375322527007e-15
two O 0 2.4415711119551986e-10
hamartoma B-Disease 1 0.999806821346283
syndromes I-Disease 1 0.9999364614486694
Cowden B-Disease 1 0.9998681545257568
disease I-Disease 1 0.9999966621398926
( O 0 1.8819996017334362e-13
CD B-Disease 0 1.4653275814957567e-10
; O 0 1.4159103577104926e-11
MIM O 0 8.567903569201007e-05
158350 O 0 1.741402755328636e-08
) O 0 1.137627996363258e-13
and O 0 3.784851338589634e-12
Bannayan B-Disease 0 0.0002427810541121289
- I-Disease 0 5.633556065731682e-05
Zonana I-Disease 0 0.00039724810631014407
( I-Disease 0 6.7251468337335e-14
BZS I-Disease 0 2.7745377106924707e-09
) I-Disease 0 2.7305036673401983e-15
or I-Disease 0 2.3339560874789146e-15
Ruvalcaba I-Disease 0 4.554922128363614e-08
- I-Disease 0 8.88023450329456e-08
Riley I-Disease 0 5.329216605787224e-07
- I-Disease 1 0.7968670129776001
Smith I-Disease 0 0.002267198171466589
syndrome I-Disease 1 0.9914692044258118
( O 0 1.9079520898439154e-15
MIM O 0 5.769921358478314e-07
153480 O 0 7.735505569428369e-10
) O 0 4.968971401334531e-14
. O 0 1.9862147408560016e-13

Constitutive O 0 8.163989449749831e-12
DNA O 0 5.512985068456544e-10
from O 0 3.185041412406447e-17
37 O 0 1.7885380202147146e-14
CD B-Disease 0 8.072469965701365e-14
families O 0 6.053105387667781e-15
and O 0 3.477665543234233e-14
seven O 0 9.266679356365395e-15
BZS B-Disease 0 1.1633873864269617e-09
families O 0 5.007222032803996e-16
was O 0 3.639322797657253e-15
screened O 0 2.3766086754833937e-12
for O 0 8.629257735040736e-16
germline O 0 6.263761065383733e-09
PTEN O 0 1.2121900283545983e-07
mutations O 0 5.850933959550275e-08
. O 0 3.480091215202208e-12

PTEN O 0 3.314923446851026e-08
mutations O 0 9.220058494463501e-09
were O 0 4.0740912569557294e-15
identified O 0 9.235946290533578e-14
in O 0 4.358553613884812e-17
30 O 0 8.277592207592971e-15
of O 0 6.249075524260216e-19
37 O 0 1.6276921217112106e-12
( O 0 3.2087625039198546e-16
81 O 0 3.6347964568750335e-13
% O 0 8.459858193168695e-18
) O 0 1.6796286149693452e-17
CD B-Disease 0 2.1312865141893782e-14
families O 0 4.954552465352539e-16
, O 0 2.1732858686379293e-17
including O 0 2.9692509678916964e-16
missense O 0 4.8613912895234535e-09
and O 0 4.9615988401141564e-12
nonsense O 0 9.050284077716242e-09
point O 0 4.93479519400597e-12
mutations O 0 5.036033656063976e-12
, O 0 1.4682494253996664e-16
deletions O 0 7.100333342113796e-12
, O 0 1.0194825872714662e-14
insertions O 0 7.585330800974344e-12
, O 0 3.690631394920709e-15
a O 0 4.563479788824952e-15
deletion O 0 2.2167498392455798e-10
/ O 0 6.243766614844048e-10
insertion O 0 9.39373253662501e-13
and O 0 3.1504275100138757e-13
splice O 0 6.111153538768122e-07
site O 0 1.7042386390997422e-09
mutations O 0 5.192229579620289e-08
. O 0 4.776440094139689e-12

These O 0 2.539021781450962e-13
mutations O 0 3.2721937139046364e-12
were O 0 1.1886527168871884e-16
scattered O 0 7.66983387066357e-14
over O 0 1.1161143623900083e-12
the O 0 2.8089162601246075e-15
entire O 0 1.2336358605653797e-13
length O 0 1.8111339793354386e-13
of O 0 1.4949685616989447e-19
PTEN O 0 1.8568547849491523e-13
, O 0 3.962185207961652e-17
with O 0 4.287983527105463e-18
the O 0 4.919630636969837e-18
exception O 0 2.7762760572604e-15
of O 0 3.9327570685979474e-19
the O 0 6.572284809445766e-16
first O 0 9.0174883619204e-14
, O 0 4.0421577760310634e-14
fourth O 0 7.746981224923677e-13
and O 0 1.3260746328596328e-14
last O 0 3.353830342785191e-13
exons O 0 3.5091576311430117e-09
. O 0 2.1888093768018813e-11

A O 0 5.417282941677648e-11
hot O 0 1.9401749096203957e-09
spot O 0 1.8767999307445216e-11
for O 0 1.4538533063676915e-16
PTEN O 0 6.704272137447731e-10
mutation O 0 9.601603366549138e-12
in O 0 9.390537298325582e-18
CD B-Disease 0 2.0240367270673437e-14
was O 0 1.0589059570322284e-14
identified O 0 3.9629296175733904e-15
in O 0 1.0687529201848515e-18
exon O 0 2.3147278364887836e-12
5 O 0 8.745619246158798e-14
that O 0 2.546721446466775e-15
contains O 0 5.389311924925951e-15
the O 0 7.850530901081561e-15
PTPase O 0 1.3276548749274752e-09
core O 0 8.137365564361843e-14
motif O 0 1.2614980240965856e-11
, O 0 5.056128656387275e-16
with O 0 2.4541308919564233e-17
13 O 0 4.1725499432280957e-16
of O 0 7.960309940123267e-20
30 O 0 6.8961911613878765e-15
( O 0 1.7204843227378703e-16
43 O 0 2.5735819725314357e-12
% O 0 8.590661090612317e-17
) O 0 1.7788808917039499e-16
CD B-Disease 0 7.365902050630868e-13
mutations O 0 2.3639479262982377e-10
identified O 0 1.5889802494617467e-12
in O 0 3.7123442374906255e-17
this O 0 1.2660343117561115e-15
exon O 0 1.3181296054654013e-09
. O 0 4.0924177241441484e-11

Seven O 0 7.868347900313877e-13
of O 0 2.798558807420031e-18
30 O 0 1.6952337411846275e-15
( O 0 3.612375489996652e-17
23 O 0 2.675720117410632e-15
% O 0 4.554618269924301e-19
) O 0 4.73724889243047e-18
were O 0 9.417376496788845e-17
within O 0 3.772692158608942e-16
the O 0 3.926944336016688e-17
core O 0 1.189892487248349e-14
motif O 0 1.3688645486217843e-12
, O 0 2.255184458603988e-16
the O 0 1.0478499833875753e-17
majority O 0 5.7941640275603525e-15
( O 0 1.705708891764203e-16
five O 0 1.3177529788451566e-16
of O 0 1.0808720596616396e-19
seven O 0 1.5111059308687246e-15
) O 0 1.1574332992954365e-17
of O 0 4.5514550149396246e-20
which O 0 2.845943458380882e-15
were O 0 1.6740501671518027e-14
missense O 0 2.060343895493588e-09
mutations O 0 4.139167619765516e-10
, O 0 1.9507702406023307e-15
possibly O 0 1.2160625018900126e-14
pointing O 0 5.770174702629527e-12
to O 0 1.0316613116903833e-14
the O 0 6.462916444691883e-16
functional O 0 1.2029649195180458e-12
significance O 0 1.729118489558236e-14
of O 0 7.613832751900484e-18
this O 0 4.213338391286653e-15
region O 0 4.268349909630764e-11
. O 0 1.9169429498616664e-12

Germline O 0 5.631468411593232e-07
PTEN O 0 4.102096884395223e-09
mutations O 0 1.049934916785844e-09
were O 0 1.347979561326163e-15
identified O 0 4.4234180120866773e-13
in O 0 7.158898138811222e-17
four O 0 1.4436085858074606e-14
of O 0 2.206801655415414e-18
seven O 0 5.14499230166391e-14
( O 0 4.073747785095618e-16
57 O 0 2.140185598187294e-12
% O 0 2.8284844152720763e-16
) O 0 2.2432822269148785e-14
BZS B-Disease 0 1.0014182549866746e-07
families O 0 3.598855425907682e-13
studied O 0 1.776634811490041e-10
. O 0 3.3370630477674856e-12

Interestingly O 0 1.1110757869303711e-09
, O 0 7.504364967977906e-13
none O 0 4.301098458512134e-14
of O 0 2.552795175624401e-19
these O 0 4.697376851302781e-16
mutations O 0 1.5895477642469125e-11
was O 0 3.4472950752664766e-13
observed O 0 3.341957651370117e-14
in O 0 1.823060674394856e-16
the O 0 3.866878198937121e-15
PTPase O 0 1.5467042757677518e-08
core O 0 2.1301885602675874e-11
motif O 0 3.220842970108606e-08
. O 0 1.2564528410752285e-11

It O 0 2.111012406547097e-11
is O 0 1.685522508444357e-15
also O 0 3.3438372598317218e-15
worthy O 0 5.0778520074596934e-17
of O 0 1.2435114715965063e-19
note O 0 2.207294676898064e-14
that O 0 7.449363074130361e-16
a O 0 1.3013732674693897e-15
single O 0 5.2170903908814806e-14
nonsense O 0 1.951326045190882e-10
point O 0 7.096403000818319e-13
mutation O 0 9.761878534252783e-14
, O 0 1.0817853492589715e-16
R233X O 0 1.2364915948775979e-12
, O 0 3.302246248055641e-15
was O 0 5.221192063225265e-14
observed O 0 1.2575154472956908e-14
in O 0 4.427002809573575e-18
the O 0 6.682070040141152e-18
germline O 0 4.727022877401739e-14
DNA O 0 8.89209886278941e-12
from O 0 5.355850679025938e-20
two O 0 1.3109685261790579e-17
unrelated O 0 7.957689039238703e-15
CD B-Disease 0 4.880839656051794e-12
families O 0 2.5486713163113545e-14
and O 0 2.850899786968446e-14
one O 0 9.922436001097087e-14
BZS B-Disease 0 3.260190055698331e-07
family O 0 2.8830573345350885e-11
. O 0 2.3786857900054414e-12

Genotype O 0 3.0921533777927834e-08
- O 0 1.4139018844616658e-08
phenotype O 0 1.3035533763527951e-09
studies O 0 4.074577860443268e-13
were O 0 4.528879763479035e-16
not O 0 7.20306315136511e-15
performed O 0 6.984788615549409e-12
on O 0 3.576852423731354e-14
this O 0 6.212766439544007e-16
small O 0 6.325829752596226e-14
group O 0 9.307923084633102e-14
of O 0 2.513623045100217e-17
BZS B-Disease 0 4.96267844596332e-08
families O 0 6.534630827984347e-14
. O 0 1.7194043769059447e-13

However O 0 2.2059175666666597e-11
, O 0 2.109930441896845e-14
genotype O 0 1.8676360371422396e-12
- O 0 7.968401494196087e-10
phenotype O 0 3.7840755529039427e-10
analysis O 0 1.8473840079219483e-13
inthe O 0 7.372877482147988e-12
group O 0 1.0725861320534484e-14
of O 0 5.384698150524327e-19
CD B-Disease 0 1.4512519875067853e-12
families O 0 7.609460242095304e-15
revealed O 0 4.3315779565608614e-13
two O 0 2.0460815377311572e-16
possible O 0 8.107426676621371e-16
associations O 0 2.3989460336983156e-17
worthy O 0 1.372275182714548e-17
of O 0 4.2149834680297685e-20
follow O 0 3.6420069434231483e-13
- O 0 1.4266507246396554e-11
up O 0 2.0889807082497686e-13
in O 0 1.7235651403857118e-16
independent O 0 3.598764488450465e-14
analyses O 0 1.4744673537681052e-10
. O 0 3.7708847004137847e-13

The O 0 5.49847439714618e-13
first O 0 2.6041990693883785e-14
was O 0 2.143647604801839e-14
an O 0 1.3895214848959724e-17
association O 0 2.773111330411221e-15
noted O 0 7.888428625590915e-12
in O 0 2.9843439832810247e-15
the O 0 7.84358692497997e-15
group O 0 1.4861865391978583e-15
of O 0 1.4785489942280244e-20
CD B-Disease 0 1.5247320821285687e-13
families O 0 8.214929557188045e-15
with O 0 4.8146920478275845e-12
breast B-Disease 0 0.002317371778190136
disease I-Disease 1 0.6332478523254395
. O 0 5.98640624918656e-12

A O 0 5.753828945416484e-13
correlation O 0 2.8238813197523083e-12
was O 0 5.974673609587117e-14
observed O 0 4.359705261055722e-15
between O 0 4.536779603026712e-17
the O 0 1.3833922089058525e-16
presence O 0 3.2262716803677094e-12
/ O 0 1.0152790252959676e-07
absence O 0 8.56380718156904e-15
of O 0 4.181893173912093e-21
a O 0 3.197897453486746e-17
PTEN O 0 1.0158117402792044e-11
mutation O 0 8.184971255452422e-13
and O 0 1.7312220535310946e-16
the O 0 1.0856873752753434e-17
type O 0 1.1964629287319895e-10
of O 0 9.32618215036059e-16
breast O 0 1.1165870091645047e-05
involvement O 0 1.0043196496667406e-08
( O 0 2.2279040591544064e-12
unaffected O 0 2.1040096953583998e-07
versus O 0 1.5920678109182518e-09
benign O 0 0.00042163461330346763
versus O 0 8.344257729220317e-09
malignant O 1 0.5871173143386841
) O 0 4.1709132675427085e-11
. O 0 2.3281453154222476e-11

Specifically O 0 1.9702864340054305e-11
and O 0 6.693203103710172e-15
more O 0 2.57572524258983e-18
directly O 0 8.545723875178109e-16
, O 0 8.51218391156568e-15
an O 0 6.679703145536393e-17
association O 0 8.017563257181268e-15
was O 0 2.3990987148281295e-12
also O 0 1.2405878191054653e-12
observed O 0 2.3653651194839587e-13
between O 0 1.7481113611037533e-16
the O 0 1.3651370069390064e-18
presence O 0 2.2670185676683147e-16
of O 0 9.967530904907958e-20
a O 0 1.1212292648626605e-15
PTEN O 0 6.252171225185066e-09
mutation O 0 1.3616074490130359e-08
and O 0 3.5096732187156476e-09
malignant B-Disease 1 0.9987356066703796
breast I-Disease 1 0.999933123588562
disease I-Disease 1 0.999985933303833
. O 0 8.612840440846981e-10

Secondly O 0 5.518524659464674e-08
, O 0 1.23261034083548e-13
there O 0 1.8353223603970008e-14
appeared O 0 4.6261505043387885e-11
to O 0 2.8990996886121834e-14
be O 0 3.7617021178765545e-14
an O 0 3.5558977815283483e-16
interdependent O 0 8.872624301936582e-10
association O 0 2.3520563345287918e-14
between O 0 2.3593711416546904e-14
mutations O 0 2.1153021001474315e-10
upstream O 0 1.3668660387572418e-12
and O 0 7.291307890843011e-15
within O 0 5.595727819062075e-16
the O 0 3.142345327036665e-16
PTPase O 0 1.1406802585822717e-10
core O 0 1.4060484005394558e-13
motif O 0 3.970193271363165e-11
, O 0 4.250257169325679e-15
the O 0 1.7206475089291147e-17
core O 0 1.7774378228475364e-14
motif O 0 3.942925846933676e-12
containing O 0 5.369035332597222e-16
the O 0 1.012216124551032e-15
majority O 0 6.016712193572527e-14
of O 0 8.04816295767554e-18
missense O 0 5.182628992628224e-09
mutations O 0 2.7554780679395208e-09
, O 0 4.351929075083454e-15
and O 0 1.136477446100014e-15
the O 0 1.6508025286747297e-17
involvement O 0 8.76729329461973e-15
of O 0 2.274473456424742e-19
all O 0 6.055455083533244e-17
major O 0 3.056024993475367e-15
organ O 0 1.0257817815648163e-12
systems O 0 1.8610432205717897e-12
( O 0 1.0621782570657086e-15
central O 0 4.37027081190422e-11
nervous O 0 5.0589662237143784e-08
system O 0 6.001348289846886e-12
, O 0 4.621521874502606e-14
thyroid O 0 8.24745338690036e-09
, O 0 8.663545575382514e-12
breast O 0 0.05646899715065956
, O 0 6.538354227814125e-06
skin O 1 0.9999998807907104
and O 1 0.8501907587051392
gastrointestinal O 1 0.9999672174453735
tract O 0 0.4522169232368469
) O 0 2.570865395568056e-11
. O 0 4.709876585962114e-11

However O 0 3.642080040333617e-11
, O 0 2.83616785113662e-15
these O 0 3.13712151603227e-17
observations O 0 4.9064464784868284e-14
would O 0 2.284166779331631e-13
need O 0 1.4069865234098578e-14
to O 0 8.054098541053424e-16
be O 0 1.611376738252623e-15
confirmed O 0 4.843793484257501e-14
by O 0 6.548999840638521e-19
studying O 0 1.813903718839445e-16
a O 0 3.1721036458816275e-17
larger O 0 1.4541971488047175e-16
number O 0 1.0810886911296344e-15
of O 0 1.6900590316213938e-18
CD B-Disease 0 2.8325513809490666e-11
families O 0 1.367047886566622e-13
. O 0 3.059644009505147e-13

Molecular O 0 2.3289851469598943e-06
defects O 0 0.00218753213994205
leading O 0 3.214030604159479e-12
to O 0 2.0043362653735138e-14
human O 0 1.1111001008146104e-11
complement B-Disease 0 2.2258109311223961e-07
component I-Disease 0 0.0005812160670757294
C6 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
in O 0 9.867786663538014e-16
an O 0 8.831834531752768e-17
African O 0 1.2992615338637548e-13
- O 0 5.853146439749324e-11
American O 0 9.6170673421353e-13
family O 0 2.2484976120590305e-12
. O 0 1.287916848906681e-13

Complement B-Disease 0 8.18558874016162e-06
component I-Disease 0 0.00045644358033314347
C6 I-Disease 1 0.9999986886978149
deficiency I-Disease 1 1.0
( O 0 2.464935265449053e-13
C6D B-Disease 0 1.8592663764138706e-07
) O 0 3.0122773849936e-13
was O 0 2.1239254799354512e-10
diagnosed O 0 4.7470230413182435e-08
in O 0 7.863591169746378e-17
a O 0 1.0342111688528208e-13
16 O 0 2.0656675155106274e-13
- O 0 3.2049768654979216e-12
year O 0 1.0437101859584862e-15
- O 0 2.3316548344864962e-12
old O 0 1.3253743935681683e-10
African O 0 5.068854797024179e-16
- O 0 4.903877660491867e-16
American O 0 2.0820006316039658e-16
male O 0 7.917236439743732e-15
with O 0 4.0034941101206936e-14
meningococcal B-Disease 1 0.9999990463256836
meningitis I-Disease 1 1.0
. O 0 1.528717430421267e-11

The O 0 1.0602312430774141e-11
patients O 0 1.3909364111885925e-11
father O 0 3.720526924738676e-12
and O 0 7.379327319556941e-14
two O 0 2.1948177121784186e-14
brothers O 0 1.750297823344127e-11
also O 0 1.2096091272714715e-13
had O 0 6.640514418725096e-13
C6D B-Disease 0 1.5390829236072712e-11
, O 0 4.1746672608984354e-16
but O 0 6.311665582948945e-15
gave O 0 1.8476728122756442e-13
no O 0 1.9073645115587345e-13
history O 0 2.0070140753329635e-14
of O 0 4.1983968889157646e-17
meningitis B-Disease 1 0.9999998807907104
or O 0 3.9449224594444166e-14
other O 0 2.6598154221116853e-14
neisserial B-Disease 0 0.00013150909217074513
infection I-Disease 0 0.0002438505325699225
. O 0 3.91530254398309e-12

By O 0 9.923275791912643e-16
using O 0 1.1229885522941077e-15
exon O 0 5.991314757682054e-13
- O 0 2.3554628733601923e-11
specific O 0 1.0426029614304944e-13
polymerase O 0 2.3571347998463388e-11
chain O 0 3.13935617952954e-12
reaction O 0 6.039128497005138e-15
( O 0 1.3443828385748978e-18
PCR O 0 1.2481727077687937e-13
) O 0 3.125940019384023e-17
/ O 0 1.6411615718758127e-13
single O 0 3.9438354302994696e-16
- O 0 3.5449190783319595e-13
strand O 0 7.330278745110164e-12
conformation O 0 2.453385869569287e-14
polymorphism O 0 2.2947670493830103e-15
as O 0 6.278657053928761e-19
a O 0 2.9937690892843295e-18
screening O 0 3.4150620157290257e-14
step O 0 1.2141381912646166e-15
and O 0 3.9490535606410078e-19
nucleotide O 0 1.5744808565729525e-16
sequencing O 0 1.5417909434626529e-16
of O 0 2.3072516514198923e-20
target O 0 1.8138710816011962e-14
exons O 0 4.675959272559815e-12
, O 0 4.627575449570043e-13
we O 0 1.340160079264796e-12
determined O 0 1.449894925528803e-14
that O 0 3.714003098578264e-16
the O 0 4.1141154563027366e-17
proband O 0 5.712554387860003e-11
was O 0 5.541752444443307e-15
a O 0 5.251803623504287e-18
compound O 0 6.169620275276767e-15
heterozygote O 0 2.3423382916436253e-13
for O 0 9.175771432804764e-18
two O 0 1.461082536696138e-14
C6 O 0 4.0241823207054495e-09
gene O 0 2.4181860958094603e-09
mutations O 0 9.052773464190977e-08
. O 0 1.1215950911080963e-11

The O 0 1.8723798553277327e-12
first O 0 3.5441584342749957e-15
, O 0 1.850343208579223e-16
1195delC O 0 4.4676476060323544e-12
located O 0 4.907579130943897e-14
in O 0 4.7741691891731004e-17
exon O 0 2.9505026893916764e-12
7 O 0 2.057316990378144e-12
, O 0 2.1907429331307097e-15
is O 0 1.8298886863920118e-16
a O 0 3.1422135075342484e-16
novel O 0 6.313860160611987e-14
mutation O 0 2.4196944903472073e-13
, O 0 1.7337467411095045e-16
while O 0 5.018370045181046e-16
the O 0 2.6967355871671623e-16
second O 0 2.4131485858495082e-14
, O 0 4.986958887123305e-16
1936delG O 0 9.026268773214274e-13
in O 0 1.5341457431947438e-17
exon O 0 6.885945806611726e-13
12 O 0 4.337836784652077e-13
, O 0 8.46074275364598e-15
has O 0 1.7519727259652368e-13
been O 0 6.231876773383485e-15
described O 0 1.0678381735709092e-14
before O 0 1.1839153145527543e-15
to O 0 6.11304048610343e-16
cause O 0 1.712634720184899e-14
C6D B-Disease 0 2.4299565137830825e-10
in O 0 3.42890683013239e-17
an O 0 7.305049537956889e-18
unrelated O 0 5.234988224162018e-12
African O 0 1.1878256624825445e-12
- O 0 4.772617717696548e-11
American O 0 3.895263289439149e-13
individual O 0 2.570778198608334e-14
. O 0 3.091968684126173e-13

Both O 0 9.475566165040306e-11
mutations O 0 3.040268481413477e-08
result O 0 5.229726699439163e-13
in O 0 4.9113875604813416e-15
premature O 0 3.2059872118184174e-11
termination O 0 3.211744889139445e-12
codons O 0 3.3431571400122095e-10
and O 0 1.2478692558437476e-11
C6 O 0 2.252991038176333e-07
null O 0 2.261650955404093e-08
alleles O 0 2.609302107714484e-09
. O 0 9.581794385704612e-11

Allele O 0 2.0894321429293372e-12
- O 0 2.0032747975653326e-13
specific O 0 3.431538786492636e-16
PCR O 0 7.239422169375009e-12
indicated O 0 1.0204752760043304e-13
that O 0 3.049919143240195e-17
the O 0 2.6979483332068386e-17
probands O 0 2.10408446221777e-09
two O 0 4.604903155840112e-13
brothers O 0 7.89081411323167e-10
also O 0 2.889199296474132e-12
inherited O 0 3.5516634772081446e-11
the O 0 1.0797074715602383e-16
1195delC O 0 7.079913478397204e-12
mutation O 0 5.74576844436514e-13
from O 0 4.093495994301382e-18
their O 0 1.7068414012844617e-16
heterozygous O 0 1.7481958589082858e-11
mother O 0 1.0861308519238833e-09
and O 0 2.7432199612190903e-15
the O 0 8.082040305098772e-17
1936delG O 0 3.815047583399789e-11
mutation O 0 3.113842734006611e-13
from O 0 1.2919731919514208e-18
their O 0 1.0013693812792406e-17
homozygous O 0 3.8731540354499175e-14
father O 0 4.4105623558769735e-13
. O 0 1.424157575316597e-15
. O 0 5.738712592151876e-14

PAX6 O 0 0.00010091723379446194
mutations O 0 1.658791347836086e-06
reviewed O 0 1.3103845120099322e-08
. O 0 1.323787884865979e-10

Mutations O 0 2.127979996657814e-06
in O 0 9.91813493719752e-15
PAX6 O 0 3.915816115807047e-09
are O 0 2.9117983112662133e-16
responsible O 0 1.913725042895927e-15
for O 0 3.2561349390774195e-17
human O 0 4.189290928047207e-11
aniridia B-Disease 1 1.0
and O 0 2.554244815655693e-09
have O 0 5.0475658375237487e-11
also O 0 3.0885618498496803e-13
been O 0 1.0662668427504577e-14
found O 0 2.3550088796246834e-15
in O 0 5.1977144486855674e-17
patients O 0 1.5977524885817454e-14
with O 0 5.254116149181745e-15
Peters B-Disease 1 1.0
anomaly I-Disease 1 0.9999997615814209
, O 0 6.687040504660402e-11
with O 0 1.2221577083693091e-09
congenital B-Disease 1 0.9999974966049194
cataracts I-Disease 1 0.9999823570251465
, O 0 7.373166521773555e-10
with O 0 2.8139546248695524e-09
autosomal B-Disease 1 0.9920405745506287
dominant I-Disease 0 4.32358356192708e-05
keratitis I-Disease 0 0.03706271946430206
, O 0 7.142283986460995e-10
and O 0 6.449166201072387e-11
with O 0 4.205929771128325e-10
isolated B-Disease 1 0.9998869895935059
foveal I-Disease 1 0.9999998807907104
hypoplasia I-Disease 1 0.9999998807907104
. O 0 7.3610992856743e-09

No O 0 7.239532324315734e-12
locus O 0 8.79345695651429e-14
other O 0 9.132201017527514e-16
than O 0 4.432365864853564e-15
chromosome O 0 4.105614266336488e-07
11p13 O 0 2.127977349886123e-09
has O 0 4.911536021640073e-12
been O 0 1.3296763016546528e-14
implicated O 0 2.485647050600587e-13
in O 0 3.624209696999163e-14
aniridia B-Disease 1 1.0
, O 0 1.8452576706212698e-12
and O 0 4.910528499666236e-14
PAX6 O 0 1.7085999282073772e-09
is O 0 1.1176981750879705e-14
clearly O 0 3.129709829513029e-14
the O 0 2.312911350417951e-18
major O 0 1.0365601690924759e-15
, O 0 3.986720231962922e-15
if O 0 3.727691983215764e-13
not O 0 2.3940130951314968e-14
only O 0 5.551482523666654e-16
, O 0 2.425133678536683e-16
gene O 0 3.156745264493166e-12
responsible O 0 3.875646548481826e-13
. O 0 5.653862794607889e-13

Twenty O 0 9.667210781882929e-11
- O 0 3.178912466594852e-09
eight O 0 1.4843956142387982e-12
percent O 0 2.532316168891058e-15
of O 0 6.206739903521869e-19
identified O 0 3.767879563042198e-13
PAX6 O 0 9.399070410864852e-10
mutations O 0 2.2439361133108626e-11
are O 0 1.0969411244957355e-15
C O 0 8.735567269546607e-10
- O 0 7.638789156771963e-08
T O 0 1.4355028099544143e-07
changes O 0 3.417672178249176e-12
at O 0 2.0150463193651866e-14
CpG O 0 7.108416633094805e-10
dinucleotides O 0 3.928410027831397e-11
, O 0 9.985552830568331e-16
20 O 0 9.933535875532954e-17
% O 0 8.244387673163558e-20
are O 0 2.0112234203501972e-20
splicing O 0 5.0699674493392966e-12
errors O 0 6.007140562758195e-09
, O 0 2.1100259872132952e-15
and O 0 1.3251277241399853e-16
more O 0 5.1863581403395546e-20
than O 0 1.3383456401946642e-17
30 O 0 2.104535519649193e-15
% O 0 1.1853460954757322e-18
are O 0 1.2597550240803632e-18
deletion O 0 4.9376240672093646e-14
or O 0 4.3791711899143694e-16
insertion O 0 1.045943713584574e-12
events O 0 1.4139995598017041e-11
. O 0 5.739246577984858e-11

There O 0 1.9120286950946586e-11
is O 0 6.598385600319816e-16
a O 0 3.1246679082461452e-15
noticeably O 0 6.281740683178327e-10
elevated O 0 1.3179788371786572e-09
level O 0 3.9341698843987916e-14
of O 0 4.601333295018233e-19
mutation O 0 1.7745459507216566e-13
in O 0 2.705513230780881e-17
the O 0 2.1918786719640797e-16
paired O 0 5.662142629758726e-12
domain O 0 1.545249659565956e-13
compared O 0 1.4679421906678295e-15
with O 0 1.2896853774675828e-15
the O 0 2.8359512224603598e-15
rest O 0 8.060126662780796e-15
of O 0 5.3918068631604254e-20
the O 0 2.798720603947846e-17
gene O 0 1.3628675011451152e-12
. O 0 1.1367863844268661e-13

Increased O 0 3.611644316947604e-10
mutation O 0 1.9497485570507678e-10
in O 0 3.5065959641356157e-16
the O 0 3.318129809882554e-16
homeodomain O 0 4.0881523166724776e-10
is O 0 5.750780905826119e-16
accounted O 0 1.1936334294357213e-15
for O 0 7.672428468734939e-20
by O 0 1.017010622200067e-17
the O 0 1.5692228730830918e-15
hypermutable O 0 3.824427885490422e-09
CpG O 0 3.197971665258592e-09
dinucleotide O 0 4.2190244353701445e-11
in O 0 3.2082380846463858e-15
codon O 0 4.91801347909937e-12
240 O 0 2.8230073985911763e-13
. O 0 3.121299605498423e-13

Very O 0 1.779221388276131e-11
nearly O 0 2.3902399021646578e-14
all O 0 2.7627004484565183e-15
mutations O 0 1.69313660314252e-11
appear O 0 6.130526316629192e-14
to O 0 1.228656950079442e-14
cause O 0 2.3559211873025454e-11
loss O 0 9.330582834143897e-11
of O 0 1.3013514555438173e-18
function O 0 3.300165316803133e-13
of O 0 3.3843303771146373e-19
the O 0 2.887164740275486e-17
mutant O 0 1.268263922701851e-13
allele O 0 9.677442478422211e-16
, O 0 1.4074307392511335e-16
and O 0 3.9490251780062395e-18
more O 0 1.2729221529256419e-20
than O 0 1.257268208966299e-18
80 O 0 1.943491051211864e-15
% O 0 2.4423247912276377e-18
of O 0 2.4688234187531974e-19
exonic O 0 2.838600909882416e-09
substitutions O 0 1.3362096151769975e-11
result O 0 2.9164938151159114e-13
in O 0 8.161206492508441e-15
nonsense O 0 2.304547486176034e-08
codons O 0 7.22928772400877e-10
. O 0 3.1334340504229896e-12

In O 0 2.1360480251990735e-14
a O 0 3.8438008392287367e-16
gene O 0 1.2428176468916394e-14
with O 0 6.221368902847599e-18
such O 0 6.990208218643078e-17
extraordinarily O 0 3.152230809277262e-13
high O 0 8.037900179431665e-14
sequence O 0 5.230696518282452e-12
conservation O 0 1.0188645073298547e-14
throughout O 0 1.6054244259740302e-16
evolution O 0 3.325912560360163e-15
, O 0 4.0605136893881574e-16
there O 0 3.1457289589631498e-15
are O 0 7.144034166424787e-16
presumed O 0 4.161249036321868e-12
undiscovered O 0 5.7356537054575885e-12
missense O 0 1.4190048025497504e-09
mutations O 0 9.323476213296544e-09
, O 0 3.1666906950670887e-15
these O 0 6.40325673784321e-17
are O 0 1.1154730737985816e-17
hypothesized O 0 1.638293721604317e-13
to O 0 2.8983644640139666e-14
exist O 0 5.52171416229319e-12
in O 0 8.641544477336251e-16
as O 0 1.0281298788673496e-13
- O 0 1.1333513683098317e-08
yet O 0 1.0315697948626301e-12
unidentified O 0 8.227294171457566e-13
phenotypes O 0 7.1642435907348645e-12
. O 0 2.0902143100934908e-15
. O 0 1.0084517449620092e-13

Genetic O 0 1.0058984116767533e-05
heterogeneity O 0 1.8738912643812e-08
and O 0 4.054871889647149e-12
penetrance O 0 2.989195335700856e-09
analysis O 0 1.0578128000274245e-12
of O 0 6.937024062132552e-18
the O 0 1.283893832042379e-14
BRCA1 O 0 1.2130661808384957e-08
and O 0 7.019459666302019e-12
BRCA2 O 0 7.965852866220757e-09
genes O 0 6.618283143744463e-10
in O 0 7.333145375654215e-12
breast B-Disease 0 0.08476314693689346
cancer I-Disease 0 0.00011857158096972853
families O 0 9.928858950292163e-13
. O 0 7.857524526866388e-12

The O 0 8.446137940154586e-07
Breast B-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.9999995231628418
Linkage O 0 0.00012090001109754667
Consortium O 0 2.721899650115489e-10
. O 0 1.1755130289309301e-12

The O 0 8.393556100269768e-15
contribution O 0 5.543525707918384e-16
of O 0 9.263378131480255e-18
BRCA1 O 0 1.667518456649475e-09
and O 0 1.6355727536221387e-11
BRCA2 O 0 3.686996569740586e-05
to O 0 3.4371582842140924e-06
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 9.63468860248895e-10
assessed O 0 1.794291915025413e-14
by O 0 1.2550125866975405e-16
linkage O 0 2.5488978039334143e-08
and O 0 1.3652708792059182e-13
mutation O 0 1.2787866468869091e-13
analysis O 0 1.43891267749953e-15
in O 0 2.4622879681309925e-18
237 O 0 1.1761952445132418e-15
families O 0 3.2896446874364327e-17
, O 0 1.0689817183422837e-17
each O 0 9.957535590427991e-20
with O 0 1.2273901970867e-17
at O 0 1.8525406767421967e-15
least O 0 5.000560118673841e-16
four O 0 2.7056294860528917e-15
cases O 0 3.666707034028806e-14
of O 0 4.413637542873298e-15
breast B-Disease 0 0.007589787244796753
cancer I-Disease 0 8.429859121861227e-07
, O 0 1.0402441271383216e-15
collected O 0 2.647533296145732e-16
by O 0 4.510588934016025e-15
the O 0 2.1033391917057997e-08
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 8.35822538647335e-06
Consortium O 0 3.203169673948736e-11
. O 0 1.2523411940714574e-13

Families O 0 1.5166522551735007e-12
were O 0 3.5275928521068657e-16
included O 0 1.0041623235303014e-16
without O 0 1.4272017124673554e-17
regard O 0 6.967287374741479e-17
to O 0 4.1245653944172416e-17
the O 0 4.581423533302934e-17
occurrence O 0 1.2693059277257834e-11
of O 0 2.870969724433868e-14
ovarian B-Disease 0 1.8749622086033924e-06
or I-Disease 0 2.994147898366384e-13
other I-Disease 0 9.471639618452432e-12
cancers I-Disease 0 0.004086487926542759
. O 0 2.301758957046207e-11

Overall O 0 3.5649825349537423e-06
, O 0 4.230390260318018e-09
disease O 0 0.00014618632849305868
was O 0 2.297129500505868e-13
linked O 0 1.1110047777596055e-11
to O 0 1.1779379724505702e-14
BRCA1 O 0 1.2324054277090823e-10
in O 0 2.1597320179928804e-17
an O 0 2.3673270134244455e-18
estimated O 0 7.728904593152369e-16
52 O 0 1.396606029609171e-12
% O 0 1.516272355390943e-17
of O 0 6.363072903391329e-19
families O 0 4.591766136461154e-16
, O 0 3.164032546859927e-16
to O 0 1.5759537145193297e-15
BRCA2 O 0 7.65889174997314e-12
in O 0 1.5450821958583279e-16
32 O 0 2.011079833479784e-14
% O 0 5.358285239589743e-19
of O 0 1.6149787037780082e-20
families O 0 1.595594740970042e-16
, O 0 7.822456735198647e-16
and O 0 7.267838090182252e-16
to O 0 5.212270709884133e-16
neither O 0 2.3490177901777654e-13
gene O 0 3.0131105943631553e-13
in O 0 4.207311248941126e-17
16 O 0 4.790827878790979e-16
% O 0 1.9966769969140547e-19
( O 0 6.738897761813851e-18
95 O 0 1.473186698498774e-12
% O 0 1.842893378048785e-13
confidence O 0 1.4384066560069186e-07
interval O 0 1.5734544334122802e-08
[ O 0 1.369836796077939e-11
CI O 0 1.3849431752532837e-06
] O 0 2.7448622801767852e-12
6 O 0 6.338547444079481e-14
% O 0 2.0703581637439555e-16
- O 0 6.9377175115903356e-09
28 O 0 6.204409902510477e-11
% O 0 4.119408088734096e-17
) O 0 6.599637769787486e-18
, O 0 1.620912357240126e-17
suggesting O 0 1.76939422857382e-14
other O 0 4.0249684282126635e-15
predisposition O 0 2.3595301268386493e-09
genes O 0 8.404386908633654e-11
. O 0 2.770715514660571e-12

The O 0 4.5435261998051646e-13
majority O 0 1.1036747145538872e-13
( O 0 6.659936837618825e-16
81 O 0 1.5025198966955866e-13
% O 0 2.179619673306309e-18
) O 0 6.105856025436713e-18
of O 0 1.0769056950202354e-17
the O 0 5.927495294599794e-08
breast B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.684273142102144e-15
were O 0 9.344980326089224e-17
due O 0 7.72604096004616e-17
to O 0 2.6438899956813546e-16
BRCA1 O 0 2.3588605027602405e-12
, O 0 1.0869517870160797e-16
with O 0 2.5109110507439008e-17
most O 0 9.863943516237643e-17
others O 0 1.2168738959260112e-15
( O 0 5.524818389708232e-17
14 O 0 2.9348387191622735e-15
% O 0 1.686632642729046e-18
) O 0 8.872085140359599e-17
due O 0 1.0792308514147742e-14
to O 0 3.989647154312159e-12
BRCA2 O 0 1.567298454574484e-06
. O 0 3.29462811199388e-11

Conversely O 0 3.1300922964661027e-10
, O 0 1.8480666487147995e-14
the O 0 6.158233267259693e-17
majority O 0 1.926264095130606e-15
of O 0 7.309533477262386e-19
families O 0 9.252081987599109e-17
with O 0 1.5516866440969676e-15
male B-Disease 0 1.3206354065875558e-10
and I-Disease 0 4.1254905741583414e-11
female I-Disease 0 1.5577169554248371e-09
breast I-Disease 0 2.6392160634713946e-06
cancer I-Disease 0 1.2126993169658817e-05
were O 0 9.175579946448659e-14
due O 0 6.241375688845197e-13
to O 0 1.699393013462891e-12
BRCA2 O 0 2.6657049900791208e-08
( O 0 1.1701005459962156e-14
76 O 0 4.384481319674727e-11
% O 0 4.2401497898638893e-16
) O 0 1.1183293840402644e-14
. O 0 1.2661424643109487e-12

The O 0 1.2131857747132296e-13
largest O 0 4.665484155014525e-15
proportion O 0 4.925330231012916e-14
( O 0 1.4892909149495453e-15
67 O 0 2.434639512563508e-12
% O 0 6.93739422545667e-18
) O 0 7.409791283021416e-18
of O 0 1.7698082382606672e-19
families O 0 9.546836350702703e-16
due O 0 1.0731748623034375e-15
to O 0 1.2909547092786026e-16
other O 0 3.208393713715554e-17
genes O 0 9.681261868565993e-13
was O 0 3.057230467048977e-12
found O 0 5.427803389038144e-14
in O 0 8.921738476425442e-17
families O 0 4.798745717788786e-17
with O 0 4.719412148727805e-17
four O 0 1.8621116725901375e-16
or O 0 3.681993657327075e-17
five O 0 2.007018760483953e-17
cases O 0 1.679751170048901e-16
of O 0 2.950900329961677e-17
female O 0 2.8290569886735284e-08
breast B-Disease 0 0.00012040897854603827
cancer I-Disease 0 0.0001333055697614327
only O 0 9.343939511019528e-11
. O 0 1.0473362455076796e-10

These O 0 2.3379415807836534e-13
estimates O 0 3.9579033410050424e-13
were O 0 6.649075228257065e-15
not O 0 2.305683652358871e-14
substantially O 0 4.2403872080321037e-11
affected O 0 1.4479499684753178e-13
either O 0 1.1101000989686863e-15
by O 0 3.171365469902985e-17
changing O 0 5.838422193621406e-13
the O 0 5.71679106183958e-16
assumed O 0 1.7901771644929232e-13
penetrance O 0 5.000427155676945e-12
model O 0 1.6882976679004347e-13
for O 0 5.199278481787783e-18
BRCA1 O 0 8.503531212511461e-12
or O 0 3.5224428917875596e-16
by O 0 4.915972430710821e-18
including O 0 1.1537718683555208e-14
or O 0 3.996286266315374e-13
excluding O 0 8.645066329471263e-10
BRCA1 O 0 2.152966374069365e-07
mutation O 0 3.4321448461049897e-10
data O 0 3.796310921871937e-12
. O 0 2.2574273179920556e-12

Among O 0 1.318282912303112e-13
those O 0 5.034479235409284e-15
families O 0 1.5363258074776293e-15
with O 0 1.9343843204750605e-13
disease O 0 3.228088303330878e-07
due O 0 6.066208563845332e-16
to O 0 9.258229990958297e-16
BRCA1 O 0 1.5414429455073986e-10
that O 0 4.253503338392736e-14
were O 0 1.845846363601809e-15
tested O 0 1.7679300474211963e-14
by O 0 1.427308386454632e-20
one O 0 9.621808312198977e-19
of O 0 9.008100874124216e-22
the O 0 3.8978823584908875e-19
standard O 0 5.244601957480829e-16
screening O 0 1.2919708841175118e-14
methods O 0 1.2552149058109481e-14
, O 0 1.4514703644590487e-16
mutations O 0 3.679296315317257e-14
were O 0 2.0865313314294903e-17
detected O 0 3.3588618540171533e-13
in O 0 4.548300574598351e-18
the O 0 3.504402942895615e-16
coding O 0 1.7899699500389943e-08
sequence O 0 3.322921660053879e-10
or O 0 1.5863643847157955e-15
splice O 0 8.687475738788919e-11
sites O 0 4.776950102841626e-12
in O 0 1.3115537564624392e-17
an O 0 1.2025436973985925e-18
estimated O 0 3.174564501586528e-15
63 O 0 2.0229783126435308e-11
% O 0 4.633642452756672e-17
( O 0 5.891782510088602e-17
95 O 0 7.252081747621819e-12
% O 0 2.898966873846054e-14
CI O 0 0.00011724176874849945
51 O 0 1.186002851483181e-09
% O 0 2.1115084642775797e-14
- O 0 5.084501708552125e-09
77 O 0 6.415378644986092e-11
% O 0 3.36830063013961e-16
) O 0 2.305348184960111e-15
. O 0 3.18891397663168e-13

The O 0 2.0833532585174362e-14
estimated O 0 8.222199111578737e-16
sensitivity O 0 5.535968276675074e-13
was O 0 2.570686176948944e-13
identical O 0 2.751037651805774e-15
for O 0 7.865229406119418e-20
direct O 0 7.438909364072263e-17
sequencing O 0 9.888070180361086e-14
and O 0 1.2936174102878557e-15
other O 0 5.596600130648849e-17
techniques O 0 5.889092685729125e-11
. O 0 1.3491107102997502e-12

The O 0 1.816947742434849e-12
penetrance O 0 3.815480820179573e-09
of O 0 3.5729485547565773e-16
BRCA2 O 0 6.341507874374486e-11
was O 0 2.9796800081152057e-15
estimated O 0 1.5266547748879482e-18
by O 0 6.131480943440263e-19
maximizing O 0 2.19578908956233e-14
the O 0 3.339402661188019e-14
LOD O 0 5.022647019359283e-05
score O 0 5.360763499773213e-10
in O 0 1.4315379851442605e-15
BRCA2 O 0 6.198451196759436e-10
- O 0 4.888742882735997e-11
mutation O 0 3.489203283940645e-12
families O 0 1.9560887538606956e-17
, O 0 6.852805495246078e-18
over O 0 1.5718463194091956e-16
all O 0 3.4427492675495467e-16
possible O 0 3.1258019583075766e-14
penetrance O 0 7.416099401247322e-10
functions O 0 1.923741894949149e-11
. O 0 6.5750820586740755e-12

The O 0 3.300119983599796e-14
estimated O 0 2.035946687932097e-14
cumulative O 0 5.537520854186073e-13
risk O 0 5.0914644028621225e-11
of O 0 6.4268777338850544e-15
breast B-Disease 1 0.749674379825592
cancer I-Disease 0 0.194799542427063
reached O 0 1.961291372365448e-11
28 O 0 3.353843082160718e-13
% O 0 1.94446057968167e-17
( O 0 6.162768863994444e-17
95 O 0 2.912759443363111e-12
% O 0 8.737044054007385e-15
CI O 0 5.1222657930338755e-05
9 O 0 3.906887834081996e-12
% O 0 8.525243147909092e-16
- O 0 4.443921272634377e-11
44 O 0 3.938870239629695e-14
% O 0 1.2975784521254157e-19
) O 0 2.3781770575087726e-20
by O 0 2.4872850560496153e-19
age O 0 1.1779103803523133e-15
50 O 0 4.698200590843985e-16
years O 0 1.3489510551771046e-16
and O 0 4.698308058149168e-16
84 O 0 1.0057810670199754e-14
% O 0 5.872994239847802e-19
( O 0 4.001096611156759e-18
95 O 0 1.665201180070519e-13
% O 0 1.6851497080684467e-15
CI O 0 3.333111862957594e-06
43 O 0 9.310880191848447e-12
% O 0 3.1925240882276016e-16
- O 0 3.30096817935388e-11
95 O 0 1.136691543841828e-12
% O 0 6.682732611811807e-18
) O 0 7.168756125799869e-19
by O 0 2.9839523165697033e-18
age O 0 6.136457580139046e-14
70 O 0 4.932738719982781e-14
years O 0 1.0190237495239386e-14
. O 0 1.323094194968788e-13

The O 0 1.4230350231514421e-09
corresponding O 0 0.00012650642020162195
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 4.162201605595328e-08
were O 0 7.856111052494119e-13
0 O 0 1.5575675471612982e-10
. O 0 3.592593616260492e-13

4 O 0 8.089829804311388e-13
% O 0 2.483534482667499e-16
( O 0 1.8623105929838443e-16
95 O 0 1.873144217859335e-12
% O 0 1.1306792091145268e-14
CI O 0 9.510824020253494e-05
0 O 0 3.933784287896147e-12
% O 0 1.8814044361506303e-16
- O 0 4.570289893063295e-12
1 O 0 5.344921363380076e-16
% O 0 2.923290664456609e-19
) O 0 3.92434774369558e-20
by O 0 1.5904935760350704e-19
age O 0 1.2921180560920972e-15
50 O 0 1.5606555583380882e-16
years O 0 1.1047724337840241e-16
and O 0 1.4411265039862976e-15
27 O 0 9.195688678023065e-15
% O 0 1.442520657972137e-19
( O 0 5.393187608548535e-19
95 O 0 1.6804964266935868e-14
% O 0 7.106252791208101e-16
CI O 0 5.2396071623661555e-06
0 O 0 5.189562972060524e-13
% O 0 2.2943629087880516e-16
- O 0 2.1786131926271324e-11
47 O 0 6.473292821912446e-12
% O 0 2.9818928436395994e-18
) O 0 1.0191538264876766e-18
by O 0 6.658507800392579e-18
age O 0 4.154638330415572e-14
70 O 0 5.536673211375097e-14
years O 0 6.645423669221452e-15
. O 0 1.2016983816452026e-13

The O 0 4.19137467788655e-12
lifetime O 0 9.207887924356228e-11
risk O 0 6.958755099928382e-11
of O 0 2.179165686807638e-15
breast B-Disease 0 0.013203032314777374
cancer I-Disease 0 4.663370873458916e-06
appears O 0 4.0968809833334674e-13
similar O 0 4.450681681788518e-15
to O 0 1.5348680849512283e-14
the O 0 1.636640787629727e-14
risk O 0 4.324164995257035e-13
in O 0 5.015822395068832e-17
BRCA1 O 0 3.388877069590568e-12
carriers O 0 1.786785339640256e-14
, O 0 1.2497199277964016e-15
but O 0 2.260634882685509e-14
there O 0 4.863488482588821e-16
was O 0 7.924604673472779e-16
some O 0 7.207913305034481e-19
suggestion O 0 2.046482964644311e-13
of O 0 6.071084351014704e-19
a O 0 2.1094970659597118e-13
lower O 0 9.008974816149262e-11
risk O 0 5.930627083178264e-12
in O 0 1.3672081621409014e-15
BRCA2 O 0 1.2683820660441825e-10
carriers O 0 2.2523068547481047e-14
< O 0 5.253858735869074e-14
50 O 0 3.8325144957834876e-15
years O 0 1.8009691286881779e-16
of O 0 1.8843554857039745e-17
age O 0 1.4356690749423029e-12
. O 0 2.5695586066895593e-13

Eye B-Disease 1 0.8017213940620422
movement I-Disease 0 5.141298515809467e-06
abnormalities I-Disease 0 0.0001805266656447202
correlate O 0 5.819009163410271e-10
with O 0 1.5900253119358054e-13
genotype O 0 2.629294282296968e-10
in O 0 3.1001787508672107e-12
autosomal O 1 0.9972952008247375
dominant O 1 0.841032087802887
cerebellar B-Disease 1 0.9987534284591675
ataxia I-Disease 1 0.9999953508377075
type I-Disease 1 0.9999873638153076
I I-Disease 1 0.9992051720619202
. O 0 6.951701436719304e-10

We O 0 1.4815720872363158e-09
compared O 0 2.5120671601902567e-12
horizontal O 0 1.4754049288967508e-06
eye O 1 0.7838597297668457
movements O 0 0.00016720188432373106
( O 0 5.504405525130762e-12
visually O 0 9.854852350832388e-11
guided O 0 3.361454864458935e-11
saccades O 0 1.8081667718661265e-08
, O 0 1.4757986499525089e-13
antisaccades O 0 1.3079717309238958e-09
, O 0 8.803358432854513e-14
and O 0 2.9456764718410744e-13
smooth O 0 1.894140920499776e-11
pursuit O 0 5.442399799598409e-14
) O 0 6.221110905214544e-17
in O 0 1.8145257255728604e-17
control O 0 1.4817141291700864e-08
subjects O 0 1.7734242893641117e-11
( O 0 2.610090734107948e-15
n O 0 3.610005072651745e-10
= O 0 3.7756731074978234e-08
14 O 0 6.24868673514481e-14
) O 0 7.626016295142777e-17
and O 0 5.953670919440178e-15
patients O 0 5.460395353376005e-15
with O 0 2.3406943206011063e-17
three O 0 2.1708025070029226e-15
forms O 0 9.342677862898482e-14
of O 0 7.56598542904453e-15
autosomal O 0 0.12645746767520905
dominant O 0 0.00043541635386645794
cerebellar B-Disease 0 0.0004313022072892636
ataxias I-Disease 0 0.00021801410184707493
type I-Disease 0 0.499322772026062
I I-Disease 0 0.00023669459915254265
spinocerebellar B-Disease 1 0.6548949480056763
ataxias I-Disease 0 1.4407766002477729e-06
1 I-Disease 0 4.178832301894586e-13
and I-Disease 0 8.564219347801175e-14
2 I-Disease 0 1.5384027534401205e-14
( O 0 1.483999076611574e-16
SCA1 B-Disease 0 5.437088002047119e-10
, O 0 3.2442872986617605e-14
n O 0 7.043943206497261e-10
= O 0 2.8253670514288842e-09
11 O 0 7.959783751717263e-15
; O 0 1.4361153776610024e-16
SCA2 B-Disease 0 3.199890352689749e-11
, O 0 6.441825747821725e-15
n O 0 1.0583588172519143e-10
= O 0 1.7098420457273278e-09
10 O 0 1.5989406005210353e-15
) O 0 1.217672647995272e-15
and O 0 4.723773889409033e-12
SCA3 B-Disease 1 0.9999998807907104
/ O 0 3.2715994166210294e-05
Machado B-Disease 0 5.768895583457834e-09
- I-Disease 0 3.680521487581245e-08
Joseph I-Disease 0 6.650644763794844e-07
disease I-Disease 0 4.4432181312004104e-06
( O 0 4.936875417138934e-16
MJD B-Disease 1 0.9999974966049194
) O 0 1.3575527488718549e-14
( O 0 4.603692889754087e-16
n O 0 7.891566289330854e-10
= O 0 1.7795031226341962e-07
16 O 0 1.0681319923596527e-13
) O 0 7.36957627626815e-15
. O 0 2.1626630878918834e-13

In O 0 7.371144710235922e-13
SCA1 B-Disease 0 5.417853943257001e-10
, O 0 4.808533514366554e-16
saccade O 0 2.1825050447454863e-12
amplitude O 0 1.5640902134117333e-14
was O 0 3.747051158394486e-14
significantly O 0 2.183828069551516e-13
increased O 0 9.798122735252615e-14
, O 0 3.9147606326322276e-14
resulting O 0 7.618090321981699e-14
in O 0 7.682234433011373e-14
hypermetria B-Disease 0 4.211660325381672e-06
. O 0 1.1328439054880679e-11

The O 0 4.1963585384330315e-12
smooth O 0 1.266940996558219e-10
pursuit O 0 5.7411922438355134e-12
gain O 0 2.0826651167538124e-11
was O 0 4.152521382305707e-11
decreased O 0 3.0727855815371186e-09
. O 0 1.8498433687619276e-11

In O 0 1.6148767165071604e-13
SCA2 B-Disease 0 1.1823032552982227e-09
, O 0 2.0972105904795745e-15
saccade O 0 6.731522284031399e-11
velocity O 0 6.343706809852634e-12
was O 0 2.8351932346987185e-12
markedly O 0 8.252079020110159e-09
decreased O 0 9.464343975196243e-08
. O 0 2.6125960769785017e-11

The O 0 1.721914847036335e-13
percentage O 0 7.037818543003879e-14
of O 0 3.3475972506651122e-18
errors O 0 2.4529137054862815e-10
in O 0 6.80480276500536e-16
antisaccades O 0 7.558222137049597e-08
was O 0 3.5052659559664523e-12
greatly O 0 3.163101833410231e-13
increased O 0 5.765569635217058e-14
and O 0 2.799076956002712e-14
was O 0 7.33113792112175e-14
significantly O 0 1.487980745562556e-13
correlated O 0 4.0058386973186935e-14
with O 0 6.411503408266031e-14
age O 0 1.0549844851881485e-11
at O 0 3.5733666026160904e-11
disease O 0 2.43877298089501e-06
onset O 0 2.0464168137834804e-09
. O 0 3.906403412551329e-12

In O 0 9.062624884207098e-15
addition O 0 1.5524089514427387e-15
, O 0 5.391712125130894e-17
a O 0 2.3233561186536273e-17
correlation O 0 1.1317779802537051e-13
between O 0 4.772118572700379e-14
smooth O 0 1.163417834293412e-10
pursuit O 0 9.003263087316304e-13
gain O 0 1.619840980099374e-12
and O 0 1.2351043107640576e-14
the O 0 2.0835250262112275e-17
number O 0 7.679735918751033e-16
of O 0 9.936373105034011e-18
trinucleotide O 0 8.101770276880416e-08
repeats O 0 2.262909859496176e-09
was O 0 2.7059214244284924e-13
found O 0 4.9954174640137045e-14
. O 0 7.101558788724302e-14

In O 0 1.950975318798509e-11
SCA3 B-Disease 1 0.9999929666519165
, O 0 1.9636384532284445e-11
gaze B-Disease 0 1.6032858596304322e-08
- I-Disease 0 2.5483824828143042e-08
evoked I-Disease 0 2.1768034597080543e-10
nystagmus I-Disease 0 6.9316192785606745e-09
was O 0 8.452847796713847e-13
often O 0 1.2754773526894576e-15
present O 0 4.470412834530051e-18
as O 0 4.830242770281335e-17
was O 0 2.0199408145476008e-14
saccade O 0 6.810689512359858e-11
hypometria O 0 2.8431959009367347e-09
and O 0 1.7107756183909473e-12
smooth O 0 3.9032919257886434e-11
pursuit O 0 1.891623793368047e-12
gain O 0 1.552805085035247e-12
was O 0 6.703689253012568e-12
markedly O 0 2.1048482068408703e-08
decreased O 0 3.633121181678689e-08
. O 0 7.260316046281412e-12

Three O 0 1.940441947748117e-12
major O 0 1.118248966732252e-13
criteria O 0 3.2531604770040176e-14
, O 0 1.3419760035542614e-16
saccade O 0 1.2672134175328864e-11
amplitude O 0 5.080647613232327e-15
, O 0 2.1219550433770532e-16
saccade O 0 4.834234683566419e-13
velocity O 0 1.144817747544824e-13
, O 0 6.047334975714611e-15
and O 0 3.64223913209465e-15
presence O 0 1.27269858063786e-13
of O 0 1.0987419165415981e-15
gaze B-Disease 0 6.878414637867536e-08
- I-Disease 0 1.4761064370816257e-08
evoked I-Disease 0 2.6230967051232845e-11
nystagmus I-Disease 0 1.7426062329239933e-11
, O 0 2.614881367169161e-17
permitted O 0 6.000546569774178e-16
the O 0 3.1174956633827143e-18
correct O 0 6.918878515363609e-15
assignment O 0 1.3535754844921986e-15
of O 0 8.216126530547801e-21
90 O 0 6.128590952223835e-16
% O 0 9.11979343241631e-19
of O 0 1.5848543045207328e-20
the O 0 5.3398852892875065e-17
SCA1 B-Disease 0 3.700584630395021e-11
, O 0 2.673718790314507e-16
90 O 0 8.769094404302948e-16
% O 0 7.992232003184425e-19
of O 0 1.1870508694817642e-20
the O 0 1.2986599297717586e-16
SCA2 B-Disease 0 6.652847717170118e-10
, O 0 3.1002924176065346e-15
and O 0 2.3820963580031655e-15
93 O 0 2.968421881455012e-14
% O 0 4.0698270999525783e-19
of O 0 7.945288695628473e-21
the O 0 3.10695629050038e-16
patients O 0 1.3163575555920261e-14
with O 0 2.8182861385871345e-15
SCA3 B-Disease 1 1.0
to O 0 2.6053196058861694e-12
their O 0 1.549605272387327e-14
genetically O 0 4.701511749360954e-11
confirmed O 0 8.409895002614576e-09
patient O 0 6.310817646237865e-09
group O 0 1.565116647937216e-14
and O 0 1.9532024110070767e-14
, O 0 1.3151830597073633e-14
therefore O 0 2.3027302178783848e-14
, O 0 1.8231320316267063e-14
may O 0 4.784525098160131e-13
help O 0 5.2220682341059046e-14
orient O 0 1.3558069111851978e-09
diagnoses O 0 4.520716601064123e-08
of O 0 7.267775952374637e-18
SCA1 B-Disease 0 1.1480036921085457e-09
, O 0 5.079504118753533e-15
SCA2 B-Disease 0 2.1634916080870426e-10
, O 0 1.5937714337296502e-14
and O 0 1.7202680252514924e-12
SCA3 B-Disease 1 0.9999997615814209
at O 0 1.3897324263600908e-11
early O 0 1.8293122550604168e-13
clinical O 0 2.917576250038856e-11
stages O 0 9.592733508576035e-14
of O 0 1.585267035334654e-18
the O 0 1.6224437700447514e-13
diseases O 0 2.6563816390989814e-06
. O 0 2.6443555461649892e-15
. O 0 6.24263770017397e-13

Genetic O 0 2.992617282870924e-07
basis O 0 1.037597742101215e-13
and O 0 4.063763892449626e-14
molecular O 0 4.335510839226231e-10
mechanism O 0 9.014122781536571e-09
for O 0 2.761979013554683e-11
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999856948852539
fibrillation I-Disease 1 1.0
. O 0 3.3928538414329523e-06

Ventricular B-Disease 0 1.0047421710623894e-05
fibrillation I-Disease 0 1.1355689366610022e-06
causes O 0 2.3385014411014815e-11
more O 0 1.5289110134062632e-17
than O 0 3.881519878114461e-17
300 O 0 5.205157750709565e-16
, O 0 2.6719347271693525e-16
000 O 0 1.0471157878020406e-15
sudden O 0 2.0779295710308954e-13
deaths O 0 4.380230715899519e-13
each O 0 1.3387490561794063e-17
year O 0 1.2239023073158089e-17
in O 0 1.3941360277483852e-16
the O 0 1.734032805311616e-14
USA O 0 7.603071061623723e-09
alone O 0 1.5718922691254633e-11
. O 0 1.554146622593372e-13

In O 0 2.938425056660948e-14
approximately O 0 4.429120881632633e-15
5 O 0 1.1920739189600488e-13
- O 0 6.672888908099139e-10
12 O 0 8.542733848874301e-14
% O 0 1.1008000684642638e-18
of O 0 2.7559763734352393e-21
these O 0 2.378144426526077e-17
cases O 0 1.2838973366411982e-16
, O 0 7.471814608839622e-17
there O 0 2.6995983997102043e-15
are O 0 2.811884422390464e-16
no O 0 1.5744870685008294e-12
demonstrable O 0 2.1631457514104113e-07
cardiac O 0 6.801755262131337e-06
or O 0 3.4941984201897203e-12
non O 0 1.4853543395254576e-10
- O 0 0.000534804945345968
cardiac O 0 0.018586602061986923
causes O 0 7.153473646770436e-11
to O 0 2.9669425384126324e-15
account O 0 5.180041106241106e-16
for O 0 2.387168594777755e-18
the O 0 1.0108381342947473e-16
episode O 0 1.4151861106592722e-12
, O 0 1.6750244244477346e-14
which O 0 1.200441774386633e-15
is O 0 1.6998953340702824e-16
therefore O 0 1.0608986020406441e-15
classified O 0 1.875436785037099e-11
as O 0 2.9341111940084375e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999701976776123
fibrillation I-Disease 1 1.0
( O 0 6.13343260624788e-08
IVF B-Disease 1 0.9999995231628418
) O 0 4.998551572654719e-11
. O 0 9.138875420311443e-12

A O 0 2.0033369494548703e-12
distinct O 0 1.2537505552517349e-14
group O 0 3.6673346007394265e-15
of O 0 1.827007053835673e-17
IVF B-Disease 1 0.9999998807907104
patients O 0 8.722364497337765e-10
has O 0 1.412401774448244e-14
been O 0 1.6172144893250996e-15
found O 0 1.1649736461488984e-15
to O 0 5.4143222799944184e-17
present O 0 5.2953799944819484e-17
with O 0 1.306027528226095e-16
a O 0 6.63165133701557e-14
characteristic O 0 1.0243379755525694e-10
electrocardiographic O 0 4.2575751990625577e-07
pattern O 0 1.7634016558076837e-07
. O 0 1.831765121529383e-11

Because O 0 1.7283495815090255e-11
of O 0 3.1260937922598968e-18
the O 0 1.1837425231402369e-17
small O 0 4.038870409399034e-16
size O 0 5.595776121115892e-14
of O 0 1.71973454968704e-18
most O 0 8.100405038186429e-17
pedigrees O 0 9.948762733774652e-13
and O 0 5.553007712367304e-16
the O 0 4.0228615528703767e-17
high O 0 5.824946475412995e-15
incidence O 0 2.7931537083247804e-09
of O 0 1.0792051413178471e-16
sudden B-Disease 0 3.6230993760710817e-09
death I-Disease 0 3.377697288531323e-10
, O 0 2.3801446246861022e-14
however O 0 1.7311842335099997e-14
, O 0 1.575081455872115e-16
molecular O 0 1.4082974424210054e-13
genetic O 0 2.5400999012492598e-11
studies O 0 4.72817475750671e-15
of O 0 1.8696688939280955e-18
IVF B-Disease 1 1.0
have O 0 3.4137779408860425e-11
not O 0 4.2863732989438866e-14
yet O 0 8.927637478567917e-15
been O 0 3.585643609284317e-14
done O 0 3.400047257628991e-11
. O 0 2.143812335769421e-13

Because O 0 3.534347037259522e-09
IVF B-Disease 1 0.99997878074646
causes O 0 7.753264696930273e-09
cardiac O 0 3.372988794581033e-05
rhythm O 0 9.287550710723735e-06
disturbance O 0 4.337870507242769e-09
, O 0 1.855943885717675e-14
we O 0 1.667310664803679e-14
investigated O 0 5.4425526043420935e-15
whether O 0 1.6240759591236719e-16
malfunction O 0 7.84542777965136e-11
of O 0 6.146653762319959e-20
ion O 0 1.2819790801837927e-12
channels O 0 4.7831871796688574e-08
could O 0 5.559780333896924e-07
cause O 0 2.3982774099984283e-10
the O 0 4.542033592226831e-14
disorder O 0 5.74529479546726e-10
by O 0 8.834314145225624e-20
studying O 0 4.422334030142758e-15
mutations O 0 1.2920165154764462e-12
in O 0 7.35552244457365e-18
the O 0 6.443981817249401e-17
cardiac O 0 5.040828431751576e-12
sodium O 0 3.8939709204495465e-13
channel O 0 7.392895184921144e-10
gene O 0 6.3414655748772475e-09
SCN5A O 0 1.8994185779774853e-08
. O 0 1.3149987826074905e-12

We O 0 8.378645333095847e-08
have O 0 3.2336381293983363e-13
now O 0 4.880980771740807e-15
identified O 0 6.413897377484856e-15
a O 0 2.342928866307857e-16
missense O 0 8.777086835110026e-10
mutation O 0 3.3085435433011234e-12
, O 0 4.843158037493493e-17
a O 0 3.7305030356929816e-16
splice O 0 5.7527902441734113e-08
- O 0 1.6549842385416014e-08
donor O 0 4.504987691483081e-13
mutation O 0 4.994765018251357e-12
, O 0 4.389741631700511e-16
and O 0 3.787760874740596e-16
a O 0 2.5122069714485305e-15
frameshift O 0 8.865485567888243e-10
mutation O 0 2.4427785098521393e-13
in O 0 2.164968857091923e-18
the O 0 6.367183060457528e-17
coding O 0 2.8526379480808828e-08
region O 0 3.954977404602156e-12
of O 0 6.509773695220338e-18
SCN5A O 0 2.3380877789414e-10
in O 0 2.4413027434063794e-16
three O 0 5.384834762876649e-14
IVF B-Disease 1 0.9999892711639404
families O 0 6.426341392622853e-14
. O 0 7.630276076774078e-14

We O 0 4.809811229855576e-11
show O 0 3.98520158659179e-14
that O 0 2.721308575449826e-17
sodium O 0 2.063869467851514e-15
channels O 0 1.9296701416664577e-14
with O 0 5.1324780224959603e-17
the O 0 4.14824989146035e-17
missense O 0 2.2685828215962545e-10
mutation O 0 1.5002983664441638e-12
recover O 0 1.422453429730016e-14
from O 0 6.950582586348062e-19
inactivation O 0 4.234969579880454e-12
more O 0 6.689028593646678e-19
rapidly O 0 1.1873804416366769e-14
than O 0 1.2330928298604773e-16
normal O 0 7.39174520203445e-12
and O 0 1.2443212997796053e-14
that O 0 1.1903458828091905e-15
the O 0 1.165933969752848e-15
frameshift O 0 1.2559174811244134e-09
mutation O 0 1.5677945595406195e-13
causes O 0 1.7072647854091908e-16
the O 0 1.4676479492890546e-19
sodium O 0 2.0160456488363572e-14
channel O 0 5.94539903420177e-11
to O 0 5.8261941549443e-14
be O 0 3.834607598899448e-14
non O 0 1.212190460178229e-14
- O 0 2.039321378433101e-09
functional O 0 2.3994969566842883e-08
. O 0 3.949414146414698e-12

Our O 0 3.207524246207072e-10
results O 0 1.050582364159336e-12
indicate O 0 2.692052852339144e-13
that O 0 8.231053676371978e-15
mutations O 0 7.413715474857696e-12
in O 0 3.700540039277249e-16
cardiac O 0 3.6975811301687145e-10
ion O 0 2.96645477279589e-12
- O 0 1.8101784959867473e-08
channel O 0 7.577850347217918e-09
genes O 0 3.942897744413365e-11
contribute O 0 3.4559090361158855e-15
to O 0 1.0414624781538285e-16
the O 0 4.734522753285679e-17
risk O 0 5.563906379420507e-16
of O 0 3.946174972109323e-20
developing O 0 2.136008384057142e-13
IVF B-Disease 1 0.9999912977218628
. O 0 4.532355986694566e-15
. O 0 1.497118367590946e-14

Molecular O 0 1.4230214784305417e-09
heterogeneity O 0 2.2335235883019777e-09
in O 0 3.295674280354155e-13
mucopolysaccharidosis B-Disease 0 1.2495829082581622e-07
IVA I-Disease 0 1.817722113628406e-05
in O 0 3.589830169237196e-11
Australia O 0 2.82029219533797e-07
and O 0 1.1191462687132336e-11
Northern O 0 3.3614865969866514e-05
Ireland O 0 1.6767610588885873e-07
: O 0 3.6978415934776215e-14
nine O 0 3.165410404767314e-15
novel O 0 3.679527724718447e-14
mutations O 0 1.840463328614539e-12
including O 0 1.6149573847486833e-16
T312S O 0 8.025745866502287e-12
, O 0 1.546208352631482e-16
a O 0 1.1847595417033708e-16
common O 0 1.7108830719318448e-16
allele O 0 1.7085034652154318e-15
that O 0 7.85217382736188e-16
confers O 0 8.876915695565923e-12
a O 0 8.999714168345108e-12
mild O 0 1.221646215299188e-07
phenotype O 0 1.4286604255175916e-07
. O 0 5.151883433751614e-11

Mucopolysaccharidosis B-Disease 0 0.004040805622935295
IVA I-Disease 0 0.43590736389160156
( O 0 4.0663044842403906e-07
MPS B-Disease 1 0.9999985694885254
IVA I-Disease 1 0.9999998807907104
) O 0 1.4489376712334412e-11
is O 0 1.3848102352331804e-12
an O 0 5.22783422454709e-12
autosomal B-Disease 1 0.9999992847442627
recessive I-Disease 1 0.999998927116394
lysosomal I-Disease 1 0.9999986886978149
storage I-Disease 1 0.999618649482727
disorder I-Disease 1 0.9999746084213257
caused O 0 9.366596907811608e-12
by O 0 8.322352816657677e-17
a O 0 6.959073595158571e-11
genetic B-Disease 1 1.0
defect I-Disease 1 0.9999996423721313
in O 0 8.345537802489922e-15
N O 0 7.725895478927214e-09
- O 0 3.935613612782163e-09
acetylgalactosamine O 0 1.0767154208224383e-06
- O 0 1.3868645964976167e-07
6 O 0 3.0555372121376934e-10
- O 0 1.6644835909573885e-07
sulfate O 0 3.986863816862751e-08
sulfatase O 0 3.237948220657927e-08
( O 0 7.607544253568615e-15
GALNS O 0 3.0512450899244925e-10
) O 0 6.00256674335338e-14
. O 0 2.2818501103395727e-13

Previous O 0 4.098276232267217e-11
studies O 0 8.299855621578603e-14
of O 0 2.546356608531441e-19
patients O 0 2.4417043958420556e-15
from O 0 1.8064364420193688e-19
a O 0 1.9672706541730813e-15
British O 0 8.988902067130766e-09
- O 0 1.759410395152372e-07
Irish O 0 4.236797371270917e-11
population O 0 1.2076713064705668e-15
showed O 0 7.474705262296849e-14
that O 0 1.1729768501859205e-17
the O 0 3.757005124969405e-18
I113F O 0 3.679192909535056e-13
mutation O 0 2.2226716283192238e-15
is O 0 9.629004783528188e-19
the O 0 2.939245750626535e-20
most O 0 3.0352337922352345e-19
common O 0 4.1643584067092075e-17
single O 0 1.8730911783502438e-15
mutation O 0 6.958499748632718e-12
among O 0 2.1630976090175613e-12
MPS B-Disease 1 0.9999997615814209
IVA I-Disease 1 1.0
patients O 0 0.05166875198483467
and O 0 2.466610683066195e-12
produces O 0 1.4951478640237714e-12
a O 0 3.496933645430467e-11
severe O 0 4.906733011011966e-07
clinical O 0 5.626637999966988e-08
phenotype O 0 1.8687515535020793e-08
. O 0 4.09482040289455e-12

We O 0 1.0190657206976539e-08
studied O 0 2.2286191989073778e-11
mutations O 0 2.4796013766564817e-12
in O 0 9.244491943734445e-18
the O 0 8.134090479707548e-18
GALNS O 0 9.682928070464669e-12
gene O 0 6.527866084054396e-14
from O 0 7.376226982101005e-19
23 O 0 6.618152596451652e-15
additional O 0 7.63515295367119e-14
MPS B-Disease 1 0.9999992847442627
IVA I-Disease 1 1.0
patients O 0 1.1758410067841396e-07
( O 0 7.474067187083726e-17
15 O 0 1.3080475694563984e-15
from O 0 8.054336206587023e-18
Australia O 0 7.920843668463018e-12
, O 0 2.01973073978877e-16
8 O 0 3.1144694198029666e-15
from O 0 9.497860674081887e-18
Northern O 0 2.1219557666540823e-08
Ireland O 0 1.5854670354364941e-10
) O 0 4.186498392112557e-17
, O 0 4.124295650819488e-18
with O 0 4.818042187118423e-17
various O 0 1.7302203100160243e-14
clinical O 0 3.420651095709104e-09
phenotypes O 0 9.925119059950305e-11
( O 0 1.4578700795403812e-14
severe O 0 1.0672223993424268e-08
, O 0 2.248383906356191e-14
16 O 0 1.1438414234885008e-14
cases O 0 5.1899135928787105e-15
; O 0 1.1657916682177093e-15
intermediate O 0 6.8410891270701425e-15
, O 0 3.0792752537841096e-16
4 O 0 1.8687208695072378e-14
cases O 0 5.742635100086657e-13
; O 0 4.456039703892856e-12
mild O 0 3.663109371387918e-09
, O 0 8.049591944609205e-14
3 O 0 1.3383739917108978e-13
cases O 0 1.2234661797127372e-13
) O 0 2.572588138610027e-14
. O 0 1.3922203234012498e-12

We O 0 6.989116840827592e-09
found O 0 1.4434661148657324e-13
two O 0 1.7200970698622974e-16
common O 0 2.967280557498146e-16
mutations O 0 8.470956683499786e-13
that O 0 1.4581862769395913e-15
together O 0 3.283341954980583e-15
accounted O 0 4.659972765736625e-14
for O 0 1.343132699835631e-17
32 O 0 1.110613743983066e-13
% O 0 1.167418713457447e-18
of O 0 4.181783152428275e-20
the O 0 3.5314304407535197e-16
44 O 0 5.855091530972828e-14
unrelated O 0 2.1271035266826575e-14
alleles O 0 4.577604910253365e-14
in O 0 2.5343649298322293e-15
these O 0 6.668612466701959e-14
patients O 0 1.2944634513595288e-12
. O 0 1.1855753466634422e-13

One O 0 2.3578799503154446e-12
is O 0 1.5413919115351573e-15
the O 0 1.553243358305123e-16
T312S O 0 1.935918092499378e-11
mutation O 0 7.171349018092465e-13
, O 0 5.548621669887303e-17
a O 0 1.8569830204434107e-16
novel O 0 4.1817742844896255e-13
mutation O 0 5.4900203307062245e-12
found O 0 8.08840231662604e-15
exclusively O 0 7.348406275938305e-16
in O 0 6.1184560971308186e-15
milder O 0 5.155873168405378e-07
patients O 0 6.300014954163657e-10
. O 0 7.695759719587858e-13

The O 0 3.880667217692063e-14
other O 0 7.404063222715609e-16
is O 0 2.8060232190932604e-16
the O 0 3.4976835893437243e-17
previously O 0 3.783461377851981e-14
described O 0 3.127269019372221e-14
I113F O 0 7.50781901925901e-12
that O 0 1.009732518070564e-15
produces O 0 1.3829610267840527e-14
a O 0 7.954540888824302e-13
severe O 0 6.09041439503244e-09
phenotype O 0 3.493550559952041e-09
. O 0 3.913063015975604e-12

The O 0 1.432130130631093e-12
I113F O 0 4.177117263193253e-10
and O 0 5.180283760004671e-14
T312S O 0 3.2125371807190106e-11
mutations O 0 3.977118547687786e-12
accounted O 0 1.7179152929846717e-14
for O 0 1.3331227390889431e-17
8 O 0 4.286863900426936e-14
( O 0 2.1455353818374288e-16
18 O 0 3.6868036530320666e-15
% O 0 8.268012468445955e-19
) O 0 6.64425150797135e-17
and O 0 1.6038048439217384e-13
6 O 0 1.5380279244203016e-13
( O 0 3.0943238528832664e-16
14 O 0 4.9087092423021235e-15
% O 0 5.134215453334082e-19
) O 0 9.10519369460475e-19
of O 0 7.754847969487898e-20
44 O 0 1.0370037178953056e-14
unrelated O 0 2.7287246016894327e-14
alleles O 0 2.107565525908111e-14
, O 0 1.9378028438062252e-14
respectively O 0 2.7763530949069526e-13
. O 0 8.934186940603994e-13

The O 0 1.2168410810226016e-12
relatively O 0 6.015131426805043e-13
high O 0 7.404098628692804e-14
residual O 0 5.201003169807983e-11
GALNS O 0 1.3665743203716829e-08
activity O 0 4.793141144404656e-12
seen O 0 2.740889926047124e-13
when O 0 1.2259643593950627e-15
the O 0 7.5432932708038e-18
T312S O 0 1.1133518288070424e-13
mutant O 0 4.509714203091396e-14
cDNA O 0 2.5814417335505435e-13
is O 0 3.4958460043042153e-15
overexpressed O 0 2.495021203530179e-11
in O 0 4.461422588955294e-16
mutant O 0 1.4897855518669623e-11
cells O 0 1.168838653252055e-13
provides O 0 3.733846962950064e-17
an O 0 6.408500370163034e-20
explanation O 0 1.4935009863347544e-15
for O 0 2.306964542199154e-17
the O 0 3.30703820989979e-14
mild O 0 3.796483127871397e-09
phenotype O 0 1.7913957817139448e-10
in O 0 1.7340981539034966e-15
patients O 0 3.6103281822463806e-14
with O 0 1.0027224833252548e-17
this O 0 1.962376286045609e-15
mutation O 0 1.5573233674848197e-11
. O 0 5.070525705037909e-13

The O 0 1.93907847542479e-14
distribution O 0 1.5653046892515066e-14
and O 0 2.3053910130635066e-16
relative O 0 3.041079626516657e-16
frequencies O 0 9.190067926203763e-17
of O 0 1.8086704759081155e-19
the O 0 3.154449626376276e-17
I113F O 0 1.3461163607397797e-12
and O 0 1.866180236533596e-15
T312S O 0 2.3361731386201123e-12
mutations O 0 8.925500854899127e-13
in O 0 5.319209082696131e-17
Australia O 0 2.4976360565799778e-14
corresponded O 0 1.5072537044339508e-16
to O 0 9.737646271590597e-18
those O 0 2.2088737428498595e-18
observed O 0 1.098356940067071e-14
in O 0 1.0408350120283703e-16
Northern O 0 6.820865650070118e-08
Ireland O 0 3.4669436765888406e-10
and O 0 3.2275838936452004e-15
are O 0 1.3216631856777866e-18
unique O 0 8.384966914869369e-18
to O 0 2.376232084211528e-16
these O 0 2.1867841658330391e-16
two O 0 1.1437798230174118e-15
populations O 0 1.114382891520549e-12
, O 0 2.263579349204666e-16
suggesting O 0 3.917896263899668e-15
that O 0 1.410650258544088e-16
both O 0 1.7909938598963804e-16
mutations O 0 4.277911778613995e-14
were O 0 1.659794312805426e-17
probably O 0 2.0900944549314543e-15
introduced O 0 9.078645665371466e-15
to O 0 5.185619135836131e-15
Australia O 0 1.4412991199835856e-12
by O 0 8.500846646881922e-18
Irish O 0 1.3212828827737205e-14
migrants O 0 5.6864963990854375e-15
during O 0 7.220470154887219e-17
the O 0 8.372436782950415e-18
19th O 0 4.262739792225412e-13
century O 0 3.1752732387868576e-11
. O 0 3.6308766323406294e-12

Haplotype O 0 9.977595993859723e-08
analysis O 0 5.301861380480055e-12
using O 0 6.76523588668751e-14
6 O 0 2.203140149698371e-13
RFLPs O 0 2.3198749865560586e-10
provides O 0 4.0681105161338444e-16
additional O 0 2.7631086587800908e-17
data O 0 1.722738806806106e-14
that O 0 3.072518419024303e-15
the O 0 5.624898574974329e-16
I113F O 0 4.4051186309790324e-11
mutation O 0 1.0699304804758988e-13
originated O 0 9.569515657865436e-16
from O 0 1.8102858045480668e-19
a O 0 2.159056707740792e-17
common O 0 2.8187056316542622e-15
ancestor O 0 2.1102897532730702e-13
. O 0 1.7013454447351029e-12

The O 0 1.3636318636767175e-12
other O 0 1.768115547636645e-14
9 O 0 8.870953017298122e-13
novel O 0 6.30908357241583e-13
mutations O 0 1.1153324097623596e-10
identified O 0 3.1640389093479104e-12
in O 0 2.430505190911255e-16
these O 0 6.248706894528954e-15
23 O 0 1.0737943737307298e-13
patients O 0 7.367155350225779e-16
were O 0 1.1544700074690266e-17
each O 0 7.391690606664801e-19
limited O 0 3.6605301309642485e-14
to O 0 3.77936317834328e-15
a O 0 5.434339772885516e-14
single O 0 1.7447240483955961e-12
family O 0 5.208349029839354e-11
. O 0 6.2746331568053204e-12

These O 0 7.458867779062267e-14
data O 0 1.2864087575660717e-14
provide O 0 2.4360929613851735e-16
further O 0 1.8356216436070453e-16
evidence O 0 6.598662474214449e-16
for O 0 4.875632486597835e-18
extensive O 0 4.235616198056125e-12
allelic O 0 1.9395039740910391e-10
heterogeneity O 0 4.3891152046171555e-08
in O 0 9.420944580007529e-11
MPS B-Disease 1 0.9999967813491821
IVA I-Disease 1 0.9999998807907104
in O 0 1.6189492454965482e-11
British O 0 9.222029007105448e-07
- O 0 2.8484735139500117e-06
Irish O 0 4.608943227069062e-10
patients O 0 2.4020553341524975e-13
and O 0 6.967257099931059e-18
provide O 0 9.501696517377449e-19
evidence O 0 2.0261579000610824e-17
for O 0 7.033529673235465e-20
their O 0 1.1851161392654424e-17
transmission O 0 2.5846024973019688e-11
to O 0 2.2344201870558777e-15
Australia O 0 1.6374971040580832e-13
by O 0 1.0245140602545968e-17
British O 0 1.2726518450190127e-10
- O 0 1.1057855325846688e-10
Irish O 0 2.6318392452352735e-13
migrants O 0 2.8166002042089196e-14
. O 0 6.790796810524714e-17
. O 0 8.302606784591285e-15

Identification O 0 5.11841350553377e-12
of O 0 1.5998123033028784e-16
constitutional O 0 5.197033775550253e-12
WT1 O 0 2.456986294419039e-06
mutations O 0 2.045621627644323e-08
, O 0 1.457936084582796e-15
in O 0 1.7061644366711483e-16
patients O 0 6.50192044844046e-14
with O 0 4.791390266316309e-14
isolated O 1 0.6886900067329407
diffuse B-Disease 1 0.9997889399528503
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 3.642340606641731e-13
and O 0 7.38964407497538e-16
analysis O 0 1.6923971337233913e-15
of O 0 2.8315904040259578e-18
genotype O 0 5.377839666642625e-12
/ O 0 3.0214689417107365e-08
phenotype O 0 1.8306160406988958e-11
correlations O 0 9.208242214521142e-14
by O 0 3.998929811542176e-18
use O 0 3.763523238713151e-15
of O 0 3.929579816166343e-18
a O 0 1.4168483586081502e-14
computerized O 0 2.2056095616562743e-08
mutation O 0 1.8112343846965473e-09
database O 0 2.2420516554433334e-09
. O 0 3.146694059832922e-12

Constitutional O 0 3.9902070536612655e-10
mutations O 0 2.1524648730064655e-10
of O 0 1.3009698978067619e-17
the O 0 6.167919221360444e-17
WT1 O 0 1.1866584104236466e-10
gene O 0 4.148113466216283e-14
, O 0 9.803019182581275e-18
encoding O 0 2.957246128748939e-16
a O 0 4.3889926957564607e-14
zinc O 0 2.627540851563026e-09
- O 0 1.9567947262544294e-09
finger O 0 1.326520617794813e-07
transcription O 0 7.692895209743256e-10
factor O 0 3.418224362415623e-13
involved O 0 5.471222433439671e-13
in O 0 6.029880913159535e-13
renal O 0 2.100269966831547e-06
and O 0 2.6263108007795744e-11
gonadal O 0 2.2745266505808104e-06
development O 0 6.449629892657516e-12
, O 0 2.093918300468539e-14
are O 0 9.353790130485159e-17
found O 0 3.1456448909431348e-15
in O 0 8.843697294353514e-18
most O 0 4.929498289563941e-16
patients O 0 1.5826238025174258e-14
with O 0 2.6258409305973153e-14
Denys B-Disease 1 0.9999864101409912
- I-Disease 1 0.9999982118606567
Drash I-Disease 1 0.9999897480010986
syndrome I-Disease 1 0.9999985694885254
( O 0 4.629973908063488e-14
DDS B-Disease 1 0.9999998807907104
) O 0 1.0152243629102387e-12
, O 0 1.3152440291389067e-13
or O 0 6.160696258694642e-11
diffuse B-Disease 1 0.9987340569496155
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 1.0384897802806492e-11
DMS B-Disease 0 1.1659195479296613e-05
) O 0 9.919681195842732e-16
associated O 0 5.390664585720739e-13
with O 0 2.8653119807375838e-11
pseudohermaphroditism B-Disease 1 1.0
and O 0 5.220759931034991e-07
/ O 0 0.0019552966114133596
or O 0 7.076946667572415e-11
Wilms B-Disease 0 0.0014613234670832753
tumor I-Disease 0 0.00036892571370117366
( O 0 1.5160716432260912e-11
WT B-Disease 1 0.999993085861206
) O 0 3.721378673965381e-12
. O 0 2.4830090240846037e-12

Most O 0 3.11431956612207e-12
mutations O 0 4.410739329330227e-09
in O 0 6.584478513642356e-13
DDS B-Disease 1 1.0
patients O 0 0.0005906714941374958
lie O 0 1.0889477097819622e-09
in O 0 3.6527409112725045e-17
exon O 0 2.6507322812424627e-12
8 O 0 2.300220560899624e-13
or O 0 8.458092493433139e-16
exon O 0 7.827214896193035e-13
9 O 0 3.253832208012508e-13
, O 0 2.362566001700968e-16
encoding O 0 2.05833261676322e-13
zinc O 0 2.3144582428358262e-06
finger O 0 0.006059896666556597
2 O 0 3.147306200379507e-12
or O 0 7.378163292999507e-13
zinc O 0 1.4916778354745475e-06
finger O 0 0.0021219057962298393
3 O 0 1.0530097844033137e-12
, O 0 3.869373896812911e-14
respectively O 0 2.6557381866684293e-15
, O 0 2.6759636923225267e-16
with O 0 3.6235976839310363e-16
a O 0 2.198786671400027e-13
hot O 0 7.127454182409565e-09
spot O 0 1.626263151921492e-10
( O 0 3.580398209527679e-16
R394W O 0 2.948976512203577e-13
) O 0 2.2593770069951008e-17
in O 0 6.141057937174826e-18
exon O 0 1.726652675004825e-11
9 O 0 1.8975772342333386e-10
. O 0 3.2600959692236087e-12

We O 0 3.5427075162353105e-10
analyzed O 0 3.5367878330888614e-13
a O 0 1.0975019661859362e-15
series O 0 7.38882018720341e-14
of O 0 7.705404127251942e-18
24 O 0 2.5974689521653105e-13
patients O 0 2.3571569551789203e-15
, O 0 7.60359109786422e-17
10 O 0 2.5639066861753807e-15
with O 0 4.1819417937252745e-13
isolated B-Disease 0 0.07028546184301376
DMS I-Disease 0 0.29925429821014404
( O 0 2.2299678854235776e-14
IDMS B-Disease 0 8.886297031551749e-09
) O 0 1.107350947659254e-15
, O 0 7.781652511151447e-16
10 O 0 3.844270413118871e-16
with O 0 2.0319817267059996e-14
DDS B-Disease 1 1.0
, O 0 2.6963310056915546e-11
and O 0 2.3233609589175253e-13
4 O 0 1.1823956527420854e-13
with O 0 9.744726455884062e-14
urogenital B-Disease 0 0.00639552203938365
abnormalities I-Disease 1 0.981616735458374
and O 0 6.715492051334593e-11
/ O 0 0.0003818655386567116
or O 0 2.998699244471936e-08
WT B-Disease 1 0.9999994039535522
. O 0 1.4113975266294432e-10

We O 0 1.0254004756404811e-08
report O 0 6.095751074047806e-12
WT1 O 0 1.3026648559844034e-07
heterozygous O 0 1.288415207856275e-10
mutations O 0 1.535718219258797e-09
in O 0 1.6184673569332071e-15
16 O 0 3.919304930512929e-13
patients O 0 2.8077618897427714e-13
, O 0 1.3697242735107203e-15
4 O 0 5.475708862029416e-14
of O 0 1.2343864907076735e-17
whom O 0 1.355784191511833e-12
presented O 0 2.2761859671399653e-13
with O 0 8.219859797160833e-13
IDMS B-Disease 0 0.0018287348793819547
. O 0 4.540533227181953e-11

One O 0 5.2138356132491737e-11
male O 0 2.430151080368148e-10
and O 0 1.1819356799704084e-13
two O 0 1.2084975489941308e-13
female O 0 7.019690384524324e-11
IDMS B-Disease 0 5.366064578993246e-05
patients O 0 8.554323221998672e-11
with O 0 1.3881678738360964e-13
WT1 O 0 0.0017873188480734825
mutations O 0 5.814957694383338e-05
underwent O 0 1.073582538424489e-07
normal O 0 6.2459020178096125e-09
puberty O 0 9.39735755878246e-08
. O 0 3.939723547397023e-12

Two O 0 4.2259827581769827e-11
mutations O 0 9.032758430116417e-10
associated O 0 1.5581484670221246e-12
with O 0 6.998273031092123e-15
IDMS B-Disease 0 1.5662927808079985e-06
are O 0 6.749040997900834e-16
different O 0 5.799399008811739e-17
from O 0 4.402314363421011e-18
those O 0 8.16406221115055e-17
described O 0 6.570486749081159e-14
in O 0 2.0422170356713953e-13
DDS B-Disease 1 1.0
patients O 0 1.1738068224076414e-06
. O 0 5.688476491065575e-13

No O 0 4.1604514278148486e-10
WT1 O 0 2.748058136603504e-08
mutations O 0 4.2974004910156793e-10
were O 0 9.294395121432503e-16
detected O 0 3.6529728894563185e-12
in O 0 2.0714314802195798e-17
the O 0 1.323819746450747e-15
six O 0 2.5045532664404353e-14
other O 0 2.2137525831428728e-15
IDMS B-Disease 0 5.122515358380042e-05
patients O 0 1.918801055544872e-12
, O 0 3.183670476346426e-16
suggesting O 0 9.52400701706435e-13
genetic O 0 2.3501597889996617e-10
heterogeneity O 0 1.7513197489438248e-11
of O 0 2.903545828079792e-16
this O 0 2.5553583554716042e-11
disease O 0 1.2078000509063713e-05
. O 0 4.878845266155507e-13

We O 0 7.203823093604456e-10
analyzed O 0 1.2387968428839713e-10
genotype O 0 6.361836751844763e-11
/ O 0 5.410214942713765e-09
phenotype O 0 3.6283861332142564e-11
correlations O 0 2.8583019198030746e-12
, O 0 9.648070340426747e-15
on O 0 1.1813849730294215e-14
the O 0 5.475386738046553e-17
basis O 0 1.221062844427098e-16
of O 0 2.204234707179509e-19
the O 0 4.926678199245176e-16
constitution O 0 3.610860254462528e-13
of O 0 4.541796970429729e-19
a O 0 9.681024368997913e-16
WT1 O 0 6.12808692679323e-09
mutation O 0 6.634589795953549e-13
database O 0 4.0372107648059194e-14
of O 0 1.2099842904060835e-18
84 O 0 1.4377023876965822e-12
germ O 0 2.3219934419671517e-08
- O 0 2.319638348069475e-08
line O 0 8.83380835148273e-09
mutations O 0 1.826357641510068e-11
, O 0 3.953730429484625e-17
to O 0 1.1732587533386785e-17
compare O 0 6.904117441598398e-14
the O 0 4.105900229331105e-17
distribution O 0 3.23840319794641e-13
and O 0 7.565324912752261e-14
type O 0 7.175183624336112e-12
of O 0 2.7293628227344973e-19
mutations O 0 3.4545569529975673e-12
, O 0 4.1135506573804854e-17
according O 0 3.831278551049942e-19
to O 0 2.1840484810239793e-17
the O 0 7.576002970074351e-16
different O 0 2.2007723334688256e-12
symptoms O 0 1.1658313425755296e-08
. O 0 1.2748122327731204e-13

This O 0 2.9930571909808634e-13
demonstrated O 0 2.3082447411781892e-14
( O 0 9.954322593454167e-17
1 O 0 4.621587519556018e-16
) O 0 1.8008394797076888e-15
the O 0 4.811303841499668e-16
association O 0 2.469109776273554e-16
between O 0 1.4908143037051821e-15
mutations O 0 4.609695004181846e-12
in O 0 6.994742491888849e-17
exons O 0 4.810893697304586e-11
8 O 0 1.393546085817765e-12
and O 0 1.2226682069137879e-13
9 O 0 1.4301373670380646e-12
and O 0 1.7435189305758242e-13
DMS B-Disease 0 2.5245617507607676e-06
; O 0 1.5071978902566827e-14
( O 0 4.359451601157799e-17
2 O 0 1.0698476110075042e-15
) O 0 1.3541015448920027e-16
among O 0 1.7727019848770768e-17
patients O 0 1.6701870828134363e-15
with O 0 6.247008275832354e-17
DMS B-Disease 0 8.249517691183428e-08
, O 0 4.540865544380479e-17
a O 0 1.205037791702047e-17
higher O 0 3.313648517555017e-18
frequency O 0 1.6984498194062337e-16
of O 0 2.2709881826125383e-19
exon O 0 1.3459109044280937e-12
8 O 0 2.1228984282278818e-12
mutations O 0 6.284026077274518e-11
among O 0 5.616686061155106e-16
46 O 0 6.77378986235766e-12
, O 0 7.717319215313004e-14
XY O 0 2.851180269658471e-08
patients O 0 1.416781459945976e-13
with O 0 3.2057528899791417e-16
female O 0 7.428176997115177e-13
phenotype O 0 1.7502168334418422e-12
than O 0 1.1897097875355822e-16
among O 0 5.464726762230909e-16
46 O 0 3.747199772696774e-11
, O 0 1.747580622964498e-13
XY O 0 1.449309507961516e-07
patients O 0 1.7939301303129818e-13
with O 0 7.37381488207577e-17
sexual O 0 9.525528559288163e-14
ambiguity O 0 3.726912008172878e-12
or O 0 2.2588055557937192e-12
male O 0 5.908230155116101e-11
phenotype O 0 1.3315519520329389e-10
; O 0 2.224132607687307e-13
and O 0 1.1534738008495138e-12
( O 0 4.18765254067764e-15
3 O 0 2.518022276147905e-14
) O 0 3.72370665508245e-16
statistically O 0 5.533770260058267e-14
significant O 0 2.9170472156216706e-15
evidence O 0 1.0102388760604986e-12
that O 0 1.3467833348112385e-13
mutations O 0 4.2419058716991476e-12
in O 0 8.359257314250608e-18
exons O 0 2.921234781849691e-11
8 O 0 2.125377998596356e-12
and O 0 6.521892807710358e-14
9 O 0 1.5493104032777288e-13
preferentially O 0 2.8731842751338055e-13
affect O 0 8.296852788136633e-13
amino O 0 1.609584319127444e-13
acids O 0 1.4540813435189601e-15
with O 0 5.467429136476701e-19
different O 0 5.3141564980785346e-18
functions O 0 1.9430771485621882e-14
. O 0 2.5632233423451833e-14
. O 0 6.057869592242249e-13

The O 0 1.9076639139886664e-12
185delAG O 0 6.001254160281633e-09
BRCA1 O 0 9.99110238986134e-11
mutation O 0 8.653396331740823e-14
originated O 0 8.539531534938088e-16
before O 0 4.230661565016763e-18
the O 0 3.3975357986061636e-20
dispersion O 0 7.942703120577643e-16
of O 0 9.877365310082837e-21
Jews O 0 8.442367220888244e-15
in O 0 8.138812688388491e-17
the O 0 1.442022108979121e-16
diaspora O 0 4.340936281493988e-15
and O 0 2.6522519261124727e-14
is O 0 1.6609416123150372e-16
not O 0 2.9699534758423254e-16
limited O 0 6.49554542436954e-15
to O 0 1.4584987473938334e-14
Ashkenazim O 0 3.6048051210713083e-09
. O 0 1.7248050860826925e-12

The O 0 1.676529227945256e-11
185delAG O 0 3.227164668828664e-08
mutation O 0 1.9010330809532405e-10
in O 0 3.7483336086282766e-16
BRCA1 O 0 2.0837779418636515e-11
is O 0 7.021641081920093e-16
detected O 0 8.365993444878206e-13
in O 0 2.694687752668277e-17
Ashkenazi O 0 3.820273958288212e-12
Jews O 0 4.572296978289396e-15
both O 0 1.670582117804212e-15
in O 0 9.496249679620192e-14
familial B-Disease 1 0.6023123860359192
breast I-Disease 1 0.999992847442627
and I-Disease 1 0.9999949932098389
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 7.006394076025657e-11
in O 0 2.074177435303125e-15
the O 0 6.492916234101262e-16
general O 0 5.199169884223011e-14
population O 0 2.8149875805322895e-15
. O 0 1.0179985516665588e-13

All O 0 8.339472341856169e-12
tested O 0 2.3934050921714523e-11
Ashkenazi O 0 2.0471995626492046e-11
mutation O 0 1.0000720954486675e-12
carriers O 0 5.6400732337518605e-14
share O 0 1.3841109163615977e-15
the O 0 6.813007602588498e-17
same O 0 3.895586263101937e-15
allelic O 0 5.296696675011203e-12
pattern O 0 2.5170012740716174e-09
at O 0 2.1547660303180421e-13
the O 0 4.74979569700185e-15
BRCA1 O 0 1.0025048569062278e-09
locus O 0 1.7588423772973982e-10
. O 0 2.4972017509394817e-11

Our O 0 1.2291985485024526e-10
previous O 0 2.2852734786991957e-13
study O 0 1.9963459071205324e-15
showed O 0 4.017300747160939e-14
that O 0 1.9213304590850948e-17
this O 0 5.550865645453037e-17
Ashkenazi O 0 9.45154510212376e-10
mutation O 0 1.2544007499393217e-11
also O 0 1.3743951723238501e-12
occurs O 0 1.7257897136029976e-15
in O 0 1.7228140397099983e-18
Iraqi O 0 2.3731082796416133e-15
Jews O 0 3.1455711990767236e-16
with O 0 6.507489849549079e-18
a O 0 1.7634021586862656e-16
similar O 0 5.5329865004721725e-15
allelic O 0 1.915343994518537e-10
pattern O 0 3.817528337890508e-08
. O 0 6.9854812038971925e-12

We O 0 3.079685839679769e-09
extended O 0 7.778474045427863e-13
our O 0 2.6668025016023794e-16
analysis O 0 2.3565533912644424e-16
to O 0 4.4626261698337835e-18
other O 0 4.396794835347628e-17
non O 0 8.740011210421617e-15
- O 0 6.279425590616228e-11
Ashkenazi O 0 4.7505121364421754e-11
subsets O 0 5.983774809198775e-14
354 O 0 8.20071549730017e-15
of O 0 5.570332472629829e-19
Moroccan O 0 4.3985340543450935e-12
origin O 0 3.059767820311047e-16
, O 0 4.571629714850306e-17
200 O 0 5.655101652291049e-17
Yemenites O 0 2.3415351688843566e-12
and O 0 1.3178334469751457e-16
150 O 0 7.684512655177955e-16
Iranian O 0 3.316009034200207e-13
Jews O 0 5.913928743418728e-13
. O 0 1.1547239943746068e-12

Heteroduplex O 0 7.823532399697797e-08
analysis O 0 1.380269162853942e-12
complemented O 0 2.7830516855637238e-15
by O 0 2.2873335300105275e-19
direct O 0 1.2050155405435694e-16
DNA O 0 2.33566963513121e-12
sequencing O 0 3.468060867238727e-14
of O 0 1.8407667897351864e-18
abnormally O 0 6.475904339685312e-14
migrating O 0 5.257447106246822e-14
bands O 0 5.436120236140644e-15
were O 0 4.972618725205408e-15
employed O 0 7.033782735942073e-13
. O 0 1.4342998631237253e-13

Four O 0 8.332630917727568e-13
of O 0 6.1639410616404926e-18
Moroccan O 0 3.5372887344925497e-12
origin O 0 2.1288062164313604e-16
( O 0 4.510614329288011e-19
1 O 0 2.3374885924769147e-19
. O 0 8.361963642419728e-19
1 O 0 1.926885804079001e-18
% O 0 9.301150326026118e-20
) O 0 7.469986870558125e-18
and O 0 5.829058396855441e-15
none O 0 3.391253274834423e-14
of O 0 3.3701574128003655e-20
the O 0 1.3033990791116464e-17
Yemenites O 0 1.4590065267050534e-12
or O 0 1.5697121934288088e-17
Iranians O 0 8.849781174671617e-16
was O 0 2.721611091943449e-16
a O 0 1.6869415946878346e-18
carrier O 0 3.946122683954852e-16
of O 0 2.906021847452887e-20
the O 0 8.220976207761138e-16
185delAG O 0 1.30627131333938e-09
mutation O 0 3.776445128833572e-11
. O 0 4.1751037306234084e-13

BRCA1 O 0 1.3914564078731928e-07
allelic O 0 2.5624855015671244e-10
patterns O 0 6.813061226296213e-09
were O 0 5.774459500108376e-15
determined O 0 1.648520932934737e-14
for O 0 1.1238616778266044e-17
four O 0 7.356399619982425e-16
of O 0 6.08900961338267e-20
these O 0 7.445552617007799e-17
individuals O 0 2.710996311208523e-19
and O 0 1.7750103481816917e-16
for O 0 2.5221415164844107e-18
12 O 0 7.23986270951681e-16
additional O 0 1.3703194465050644e-16
non O 0 1.1292917691469243e-13
- O 0 1.7885415370955116e-10
Ashkenazi O 0 5.827361371224526e-10
185delAG O 0 3.252098243478052e-11
mutation O 0 1.447172026311505e-12
carriers O 0 1.187093500755465e-13
who O 0 6.162976379231466e-11
had O 0 1.384976144436223e-06
breast B-Disease 1 0.9997003078460693
/ I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 1.0066660699470376e-10

Six O 0 3.728152786486305e-10
non O 0 1.2405197528930767e-11
- O 0 2.2825790324532136e-07
Ashkenazi O 0 1.285460342614897e-07
individuals O 0 2.6054547110293882e-15
shared O 0 6.742533879041789e-15
the O 0 2.0219654178444187e-17
common O 0 6.882626564012309e-16
Ashkenazi O 0 6.4770229110666655e-12
haplotype O 0 9.29065678556551e-12
, O 0 5.808902824359051e-15
four O 0 1.2435186937104345e-15
had O 0 7.91310308836772e-14
a O 0 2.3389269665043255e-17
closely O 0 6.352805380274024e-14
related O 0 2.473636267404122e-15
pattern O 0 5.0103299981119065e-11
, O 0 2.1853342042460174e-15
and O 0 5.256762703625441e-15
the O 0 3.654024960280983e-16
rest O 0 4.586816224148166e-14
( O 0 4.603990939472402e-16
n O 0 5.081561837982917e-10
= O 0 7.715208028002962e-08
6 O 0 1.4547708198676956e-13
) O 0 1.0491629605564358e-15
displayed O 0 2.903593367803957e-14
a O 0 1.4225843810236616e-13
distinct O 0 4.084946964022507e-11
BRCA1 O 0 3.433268247476917e-08
allelic O 0 5.9470384172755075e-09
pattern O 0 2.831405936376541e-07
. O 0 7.443129446116359e-12

We O 0 4.758476945809775e-10
conclude O 0 9.394574961713031e-13
that O 0 3.4335422841106885e-16
the O 0 1.0979290825495892e-15
185delAG O 0 8.336462187230609e-09
BRCA1 O 0 3.495543632325848e-09
mutation O 0 2.8450210937114306e-11
occurs O 0 8.870943869342292e-15
in O 0 1.62865296865579e-18
some O 0 2.7441604324883386e-16
non O 0 4.258977068585801e-13
- O 0 3.539575299527087e-09
Ashkenazi O 0 2.506046925532246e-08
populations O 0 2.419255351604477e-10
at O 0 2.7243989399530766e-13
rates O 0 6.968307631220402e-14
comparable O 0 7.384680726602266e-17
with O 0 9.084827473947928e-19
that O 0 6.157481525519005e-17
of O 0 5.6459812415751005e-18
Ashkenazim O 0 5.124475288553754e-10
. O 0 7.379622764648944e-14

The O 0 5.102182240070141e-13
majority O 0 6.228172274788668e-14
of O 0 2.256534648974246e-17
Jewish O 0 9.583997007470146e-13
185delAG O 0 4.084489135802727e-10
mutation O 0 1.482496308873038e-13
carriers O 0 5.309747155575039e-15
have O 0 2.8038954723297576e-15
a O 0 7.240801857297079e-16
common O 0 1.7932825905654648e-14
allelic O 0 1.1331464412622783e-11
pattern O 0 6.465750601591935e-09
, O 0 5.922750405217133e-15
supporting O 0 2.382052142883319e-14
the O 0 3.71488189526104e-16
founder O 0 1.2098559187909835e-13
effect O 0 4.6974173818293066e-14
notion O 0 2.104826729576459e-13
, O 0 1.6969297129032675e-14
but O 0 2.2468577223918283e-14
dating O 0 2.816322479046174e-13
the O 0 1.5316838882556634e-17
mutations O 0 4.7830903598727534e-14
origin O 0 2.0201450414703732e-18
to O 0 2.0310474887389753e-18
an O 0 8.015035046227039e-20
earlier O 0 2.3062115232916e-14
date O 0 5.919052140784808e-13
than O 0 1.4301242871552931e-15
currently O 0 7.98417728415865e-14
estimated O 0 2.358796480621955e-13
. O 0 1.9207574766810787e-11

However O 0 2.033364145462291e-12
, O 0 2.6547441935048264e-16
the O 0 3.563484979891705e-18
different O 0 7.412391938867283e-18
allelic O 0 1.8890446119249754e-13
pattern O 0 4.896303917867328e-10
at O 0 2.076847808313298e-13
the O 0 1.6818936075400828e-15
BRCA1 O 0 7.713121807917389e-11
locus O 0 2.629711769522314e-13
even O 0 4.569808073617843e-13
in O 0 3.901144241838914e-17
some O 0 4.463581728877405e-17
Jewish O 0 1.1004655303334387e-12
mutation O 0 3.625940422479629e-13
carriers O 0 8.55101105483487e-15
, O 0 5.972389077025077e-16
might O 0 5.495433752153445e-13
suggest O 0 3.4405356168221157e-13
that O 0 1.5751243633848493e-15
the O 0 1.4211448644116707e-16
mutation O 0 3.3113052230748785e-14
arose O 0 1.8335081640547478e-16
independently O 0 1.053330023843748e-14
. O 0 1.3446925440952244e-15
. O 0 1.1680185898338413e-13

Crystal O 0 1.3457083447576679e-08
structure O 0 1.7218216435965772e-11
of O 0 1.606465879452459e-16
the O 0 6.508446667892465e-14
hemochromatosis B-Disease 1 0.9999997615814209
protein O 0 1.4187867236614693e-07
HFE O 0 1.8257475531413547e-08
and O 0 3.196707425135413e-14
characterization O 0 3.0553300774810443e-12
of O 0 1.1287288912689276e-18
its O 0 2.1358084657527443e-17
interaction O 0 3.2547458050439224e-16
with O 0 2.4861695492268477e-16
transferrin O 0 1.771140040185415e-10
receptor O 0 1.992682581442029e-11
. O 0 2.2918307876484967e-12

HFE O 0 1.3324573728823452e-06
is O 0 3.9224014119175477e-13
an O 0 1.4064162849478985e-16
MHC O 0 1.5084366047912745e-11
- O 0 3.7272976372015876e-11
related O 0 1.0676513519840627e-13
protein O 0 4.3758737952592774e-12
that O 0 5.93396448616407e-16
is O 0 3.2324845218755484e-17
mutated O 0 2.7832667811103495e-13
in O 0 4.2784785601227384e-16
the O 0 1.644141230496346e-13
iron B-Disease 1 0.6329246759414673
- I-Disease 1 0.9998853206634521
overload I-Disease 1 0.9996651411056519
disease I-Disease 1 0.9999864101409912
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 5.6073965026826045e-08

HFE O 0 3.2117304726853035e-07
binds O 0 1.0562292707128051e-10
to O 0 6.123409206993183e-14
transferrin O 0 2.7054145035343424e-10
receptor O 0 1.6386382268446242e-12
( O 0 2.601055645417823e-15
TfR O 0 1.974863383935599e-09
) O 0 3.720059860607165e-15
and O 0 3.3751834081107617e-15
reduces O 0 1.7915775471239598e-13
its O 0 1.4191451387372115e-17
affinity O 0 2.892325288506633e-16
for O 0 2.6247052949960857e-17
iron O 0 1.133956151200266e-09
- O 0 8.684229030331281e-11
loaded O 0 2.1286600954129042e-12
transferrin O 0 2.8079042563300405e-11
, O 0 7.624220638234157e-15
implicating O 0 7.334673840508898e-11
HFE O 0 2.5190486141468682e-08
in O 0 6.808990898237235e-14
iron O 0 1.2419260997376114e-07
metabolism O 0 1.6041185801896063e-07
. O 0 1.114002553398441e-12

The O 0 1.151447600461486e-11
2 O 0 1.3413293913078217e-11
. O 0 2.661452221802696e-12

6 O 0 1.2935669202462918e-09
A O 0 3.626455385985494e-11
crystal O 0 1.029969110000195e-09
structure O 0 9.907907133621663e-11
of O 0 2.740457310322061e-16
HFE O 0 9.551007451591431e-08
reveals O 0 3.5932261940180288e-12
the O 0 9.981429632999775e-18
locations O 0 1.9048449612351498e-13
of O 0 1.3091758173421411e-15
hemochromatosis B-Disease 1 1.0
mutations O 0 0.001209306181408465
and O 0 1.6197978288529091e-12
a O 0 1.8790323097939328e-14
patch O 0 2.6217753301693847e-08
of O 0 3.879773203532994e-17
histidines O 0 2.7697577564822495e-09
that O 0 1.7710766392949745e-13
could O 0 2.146595618271463e-12
be O 0 5.822388541791405e-16
involved O 0 2.649636373074646e-15
in O 0 5.0100928180446536e-14
pH O 0 1.777504365918503e-08
- O 0 3.6733525110577148e-09
dependent O 0 4.608729717303639e-11
interactions O 0 9.348748337967283e-12
. O 0 7.672572971927083e-13

We O 0 1.5160124267055153e-09
also O 0 7.858430160941066e-14
demonstrate O 0 3.4326143595169714e-15
that O 0 3.8291386459722056e-15
soluble O 0 5.638535749419304e-10
TfR O 0 2.5428266781091224e-06
and O 0 8.153745690783754e-13
HFE O 0 3.396740311245594e-08
bind O 0 1.9803769735204924e-10
tightly O 0 1.0681913131804777e-09
at O 0 6.712437680342354e-13
the O 0 1.5600782524449752e-16
basic O 0 7.854519579230182e-14
pH O 0 1.0271381049300685e-13
of O 0 8.241117078569706e-20
the O 0 3.1164744261984563e-17
cell O 0 7.938414465710752e-13
surface O 0 1.0876177345894855e-12
, O 0 5.921327389865746e-15
but O 0 2.0925616925002166e-13
not O 0 9.907137230816959e-14
at O 0 1.4800099622409857e-13
the O 0 1.0971508498534756e-14
acidic O 0 2.4400148568304303e-11
pH O 0 9.357846095237043e-12
of O 0 1.1587945407986783e-16
intracellular O 0 9.723098992608925e-10
vesicles O 0 1.178390984790667e-08
. O 0 3.909672030566469e-10

TfR O 0 0.002268466865643859
HFE O 0 1.7066911368601723e-06
stoichiometry O 0 2.1697741381387914e-09
( O 0 3.5079710268342765e-14
2 O 0 1.015229126623534e-14
1 O 0 2.7134628996886587e-16
) O 0 1.319568805725833e-16
differs O 0 8.220670238284766e-14
from O 0 3.2590196156584124e-16
TfR O 0 1.6446651329715678e-07
transferrin O 0 4.642015938305377e-11
stoichiometry O 0 1.0548491333889354e-12
( O 0 3.119045303542271e-16
2 O 0 2.1471819344775524e-15
2 O 0 1.7302921172341278e-15
) O 0 2.965909687612574e-17
, O 0 2.0104209543433836e-17
implying O 0 8.441846401504801e-16
a O 0 8.637448907600154e-18
different O 0 1.6460917971247862e-18
mode O 0 1.2780489447173217e-15
of O 0 7.499841434452298e-21
binding O 0 1.2162188747599876e-16
for O 0 2.358187494836347e-18
HFE O 0 3.2785021364389877e-09
and O 0 8.887002597582697e-14
transferrin O 0 1.675966483649649e-11
to O 0 3.154310376806725e-14
TfR O 0 5.700850920220546e-07
, O 0 1.867873667153394e-13
consistent O 0 1.1043027386622994e-12
with O 0 4.634776351940359e-16
our O 0 7.199378769802791e-16
demonstration O 0 5.207166806981333e-15
that O 0 2.8233744243199687e-16
HFE O 0 1.4732332020983563e-10
, O 0 1.2334838943843128e-15
transferrin O 0 1.0673185425746912e-11
, O 0 7.591256318212683e-14
and O 0 6.561986197473058e-13
TfR O 0 8.85317376742023e-07
form O 0 3.204166736082113e-14
a O 0 1.9439443408935872e-14
ternary O 0 4.131829600684256e-11
complex O 0 6.241385186456228e-10
. O 0 3.1025584878996426e-11

Identification O 0 5.180387802755648e-12
of O 0 4.8196594906520866e-17
three O 0 1.0108771772196598e-15
novel O 0 4.449529124057189e-14
mutations O 0 7.438475183030313e-12
and O 0 1.3130768275807208e-15
a O 0 6.988395700484852e-17
high O 0 2.8578327834054577e-16
frequency O 0 3.144181429768516e-15
of O 0 5.610488989441981e-19
the O 0 4.345888089043196e-16
Arg778Leu O 0 2.694513723255909e-09
mutation O 0 4.7005949480039e-12
in O 0 1.0164647359353412e-15
Korean O 0 8.876619439490696e-10
patients O 0 4.1297670713919335e-14
with O 0 1.4859324504895056e-14
Wilson B-Disease 0 7.192350039986195e-06
disease I-Disease 0 0.0004337863065302372
. O 0 2.1299719800416117e-12

Four O 0 1.746282979331326e-11
mutations O 0 7.59700746755243e-10
- O 0 6.439007993463974e-09
- O 0 1.519892833812264e-08
R778L O 0 6.257047102664615e-10
, O 0 9.465966938854782e-16
A874V O 0 2.562603991854151e-13
, O 0 1.5548312142089798e-17
L1083F O 0 3.642421921804667e-14
, O 0 4.633659988985658e-17
and O 0 1.1268972652385515e-16
2304delC O 0 1.8306885955082786e-12
- O 0 4.862893399591728e-13
- O 0 1.0643986777039705e-12
in O 0 1.4626032890617264e-16
the O 0 2.3559859122770066e-17
copper O 0 1.0771415599470768e-14
- O 0 2.7878853320167896e-16
transporting O 0 6.995730476412482e-17
enzyme O 0 2.0490430031427746e-15
, O 0 2.5531679032084172e-17
P O 0 6.580555544921651e-11
- O 0 1.1181605120980098e-11
type O 0 2.284405303809578e-10
ATPase O 0 1.0375538622708902e-10
( O 0 9.649390864791517e-16
ATP7B O 0 8.064599335555478e-12
) O 0 1.375655787159991e-17
, O 0 8.986357825878084e-18
were O 0 3.816506128945753e-17
identified O 0 8.039434325505732e-14
in O 0 8.92902957721673e-16
Korean O 0 1.1565735924534692e-08
Patients O 0 1.3093469179974865e-13
with O 0 6.311087906478918e-15
Wilson B-Disease 0 1.078363766282564e-06
disease I-Disease 0 1.4100923181104008e-05
. O 0 8.029997565321689e-13

Arg778Leu O 0 5.789544488266074e-08
, O 0 1.2761405159596867e-13
the O 0 2.090659690605069e-16
most O 0 3.8672725192438474e-17
frequently O 0 1.7028128039553447e-12
reported O 0 1.6405668869842044e-13
mutation O 0 1.2835412969297317e-14
of O 0 1.958997142866417e-21
this O 0 6.785093214085523e-19
enzyme O 0 1.4520020099823488e-16
, O 0 3.826345938640439e-17
was O 0 2.6355263457733535e-13
found O 0 3.049273886775866e-13
in O 0 7.905824364845375e-16
six O 0 3.469079678467685e-14
of O 0 7.193053522317848e-19
eight O 0 7.747771405019512e-15
unrelated O 0 2.300975165611674e-13
patients O 0 4.738378878718988e-14
studied O 0 3.2337087888867962e-15
, O 0 6.915855993269437e-19
an O 0 1.3840757594278054e-20
allele O 0 6.552233422001889e-16
frequency O 0 3.892409127220081e-14
of O 0 2.5918032927767275e-16
37 O 0 1.428955426208134e-10
. O 0 4.5123774508604164e-12

5 O 0 1.1041769061581608e-11
% O 0 1.6622989826130122e-15
, O 0 2.1593800559509616e-15
which O 0 4.3877325754287423e-16
is O 0 2.5964828851125115e-17
considerably O 0 2.1326783926096243e-13
higher O 0 2.7490848702854383e-16
than O 0 3.617505333283461e-17
those O 0 2.1325030520249824e-17
in O 0 2.4528485965708436e-17
other O 0 4.3927594512729005e-15
Asian O 0 1.4907035675304492e-11
populations O 0 1.1997758689319404e-11
. O 0 1.380724012770354e-13

The O 0 1.6574756974904736e-13
novel O 0 5.941309320607949e-14
single O 0 4.777781242062658e-15
nucleotide O 0 9.965246943605122e-13
deletion O 0 7.435878301986776e-12
, O 0 3.3984389094358653e-15
2304delC O 0 1.5374083950359108e-10
, O 0 6.583030968216816e-14
was O 0 3.3661109923727173e-12
found O 0 9.904510073427755e-14
in O 0 2.888973155617874e-16
one O 0 1.2617981746260165e-12
patient O 0 1.7255373518931805e-10
. O 0 1.849160744232109e-13

Since O 0 9.90362739733408e-13
a O 0 2.4600197892605353e-15
mutation O 0 5.267303859247431e-14
at O 0 1.930236256136755e-15
cDNA O 0 2.8641207461266305e-11
nucleotide O 0 1.195192417258184e-10
2302 O 0 3.283314509161528e-09
( O 0 9.17315506052726e-16
2302insC O 0 7.874102411764561e-12
) O 0 1.6165299808245997e-15
had O 0 9.618741567130051e-12
been O 0 1.87326740355492e-14
previously O 0 1.3671000637961728e-13
described O 0 2.615774892696099e-13
, O 0 3.538957016704144e-15
this O 0 2.3522962566111015e-16
region O 0 3.577562237341153e-14
of O 0 2.091581884284707e-19
the O 0 8.179087119796963e-17
ATP7B O 0 4.744825365943228e-11
gene O 0 4.5327088436797336e-12
may O 0 7.030516187262305e-15
be O 0 2.018189338348114e-17
susceptible O 0 2.4977219457208294e-14
to O 0 3.816946453729427e-15
gene O 0 7.203404095434962e-08
rearrangements O 0 0.00010231780470348895
causing O 0 1.2797442650480662e-05
Wilson B-Disease 0 0.0028611854650080204
disease I-Disease 1 0.5429207682609558
. O 0 7.003090815582702e-12

Disruption O 0 7.871602258902044e-10
of O 0 6.175570972898804e-17
splicing O 0 4.984021008402895e-12
regulated O 0 3.066035110261406e-13
by O 0 5.517802161034496e-18
a O 0 2.706092654256362e-16
CUG O 0 1.2294752715913404e-10
- O 0 2.5609828927658507e-12
binding O 0 1.098787510631083e-12
protein O 0 9.486161856031572e-11
in O 0 1.4418407873889594e-12
myotonic B-Disease 1 0.9999988079071045
dystrophy I-Disease 1 0.9999984502792358
. O 0 5.906111710807238e-11

Myotonic B-Disease 1 0.9999948740005493
dystrophy I-Disease 1 0.9999996423721313
( O 0 6.894212756236584e-09
DM B-Disease 1 0.9999998807907104
) O 0 5.644946315941368e-11
is O 0 6.721167896463773e-15
caused O 0 1.0694687966976684e-14
by O 0 3.541774383944332e-18
a O 0 9.777706827179887e-16
CTG O 0 1.6524907830994806e-10
expansion O 0 6.408963529151712e-13
in O 0 1.186682571191434e-15
the O 0 5.280297090548428e-15
3 O 0 3.53642862335659e-14
untranslated O 0 7.121933598419616e-10
region O 0 9.252577003182605e-13
of O 0 1.2493754169974406e-17
the O 0 3.307669418852084e-14
DM B-Disease 1 0.9999966621398926
gene O 0 8.808859774944722e-08
. O 0 2.9190109530896624e-12

One O 0 1.7575151674709827e-13
model O 0 1.315907712656772e-11
of O 0 3.708823545045363e-15
DM B-Disease 1 0.9999997615814209
pathogenesis O 0 1.68260248756269e-05
suggests O 0 6.8735095740124486e-12
that O 0 9.735794048762968e-17
RNAs O 0 2.2264896090001818e-12
from O 0 5.3824005529753845e-18
the O 0 1.434543105839886e-17
expanded O 0 1.2985035410199158e-13
allele O 0 1.526678292790816e-14
create O 0 4.700444169363025e-15
a O 0 7.347036729541713e-15
gain O 0 1.9996787700097413e-13
- O 0 2.9070832546773673e-11
of O 0 9.204101541604093e-17
- O 0 7.20725562564084e-11
function O 0 3.0183678906975375e-13
mutation O 0 2.330779502168474e-15
by O 0 7.884961864255355e-21
the O 0 1.1743815321130062e-19
inappropriate O 0 3.9917094677804866e-16
binding O 0 3.9843617216608516e-16
of O 0 3.2322082435509556e-20
proteins O 0 2.7785131983290405e-14
to O 0 3.4189449418141815e-15
the O 0 4.077125667785973e-14
CUG O 0 1.2642391311601386e-07
repeats O 0 3.522242053577429e-08
. O 0 7.180933798978106e-12

Data O 0 2.2129394150471882e-10
presented O 0 3.663381447152614e-13
here O 0 1.5743089882939987e-13
indicate O 0 6.008389315595442e-13
that O 0 2.368116502725207e-15
the O 0 3.1269915313787006e-16
conserved O 0 4.322592631056388e-12
heterogeneous O 0 5.203736747061427e-13
nuclear O 0 1.4010391458096905e-10
ribonucleoprotein O 0 2.2898134777182833e-11
, O 0 2.869995297731347e-14
CUG O 0 6.771419536200085e-10
- O 0 1.2115150896385707e-11
binding O 0 2.8631730233236174e-13
protein O 0 3.330939257056853e-12
( O 0 2.3030002625698813e-16
CUG O 0 1.61674597320971e-11
- O 0 1.5709203686140039e-12
BP O 0 1.361401497177589e-13
) O 0 6.79745387737648e-18
, O 0 6.127068410501145e-17
may O 0 5.5831507562238876e-15
mediate O 0 1.8453634887533044e-12
the O 0 1.2050757857619428e-15
trans O 0 3.17900636370716e-11
- O 0 1.5847685663761268e-10
dominant O 0 8.194962070051659e-11
effect O 0 7.205732999214856e-14
of O 0 3.455032089008959e-19
the O 0 4.389103379139865e-17
RNA O 0 3.603516096628567e-11
. O 0 4.976265032636748e-14

CUG O 0 8.674690121779349e-08
- O 0 5.348629872337085e-10
BP O 0 2.4632268447177808e-11
was O 0 2.8545219963124367e-15
found O 0 7.874603921549663e-18
to O 0 4.597928929809695e-19
bind O 0 1.2490961939098672e-14
to O 0 3.3164595667896867e-16
the O 0 2.635553815051833e-15
human O 0 9.932671005130622e-12
cardiac O 0 1.9317499777571356e-07
troponin O 0 2.9533924816860235e-07
T O 0 2.639003682247676e-08
( O 0 4.207136945442449e-16
cTNT O 0 1.2847475904312344e-12
) O 0 6.05451103884375e-16
pre O 0 1.4640235367329585e-13
- O 0 5.3250290461825944e-12
messenger O 0 1.180985214135899e-12
RNA O 0 1.3454700895088045e-11
and O 0 8.396818659424355e-16
regulate O 0 3.95552909071323e-15
its O 0 3.945637046217222e-18
alternative O 0 3.8508018312355895e-16
splicing O 0 3.900813699830863e-11
. O 0 6.198134453599957e-13

Splicing O 0 7.068528401488194e-11
of O 0 7.765787584049374e-16
cTNT O 0 6.525174151006397e-11
was O 0 6.100981807428962e-13
disrupted O 0 2.2789710119042184e-09
in O 0 2.9595978987863314e-13
DM B-Disease 1 0.9999995231628418
striated O 0 0.14461830258369446
muscle O 1 0.9424501061439514
and O 0 1.6921819501192203e-10
in O 0 6.384969084753753e-15
normal O 0 1.488868056620518e-11
cells O 0 1.440169056059204e-13
expressing O 0 5.596725531229712e-18
transcripts O 0 3.7125413420574516e-14
that O 0 1.6650406165050376e-15
contain O 0 5.880387865010717e-13
CUG O 0 2.2576368507998268e-07
repeats O 0 4.862191715915287e-08
. O 0 2.31731647759581e-12

Altered O 0 5.38876008704392e-07
expression O 0 2.6943261857703682e-11
of O 0 6.391082756808798e-16
genes O 0 2.557230642519226e-11
regulated O 0 3.17349306555581e-11
posttranscriptionally O 0 7.803462043209919e-11
by O 0 2.1539656095938753e-16
CUG O 0 6.705218047464712e-10
- O 0 1.657879805661011e-10
BP O 0 8.852229713141035e-12
therefore O 0 6.391182918454811e-15
may O 0 2.4498482470529913e-16
contribute O 0 4.400304132552772e-16
to O 0 1.5320317443053705e-13
DM B-Disease 1 0.9999994039535522
pathogenesis O 0 1.6956435501924716e-05
. O 0 2.7896977262964473e-13
. O 0 2.0580341901152432e-13

Identification O 0 2.2267103525625e-12
of O 0 3.754642945294137e-17
a O 0 3.2805126531785167e-15
novel O 0 3.5487366083913896e-12
nonsense O 0 2.698690160229944e-09
mutation O 0 3.632116525945084e-12
and O 0 2.0029661048780352e-16
a O 0 9.869507960218287e-18
missense O 0 1.848639730878121e-12
substitution O 0 5.647756500209815e-15
in O 0 3.2318540034536298e-18
the O 0 7.377891889878921e-18
vasopressin O 0 1.1139907118778384e-14
- O 0 1.4484403260128786e-11
neurophysin O 0 1.5488754723236298e-10
II O 0 3.196503174998644e-12
gene O 0 2.6314174905901766e-13
in O 0 2.3241184483061562e-17
two O 0 3.816204029351159e-15
Spanish O 0 5.539348276947798e-13
kindreds O 0 6.661713847222472e-09
with O 0 2.3325221962244846e-12
familial B-Disease 0 0.30766984820365906
neurohypophyseal I-Disease 1 0.9979708790779114
diabetes I-Disease 1 0.9999624490737915
insipidus I-Disease 1 0.9977541565895081
. O 0 9.109635712434283e-09

Familial B-Disease 1 0.9998847246170044
neurohypophyseal I-Disease 1 0.9999116659164429
diabetes I-Disease 1 0.9999969005584717
insipidus I-Disease 1 0.9998610019683838
( O 0 7.757942199759782e-08
FNDI B-Disease 1 0.9999996423721313
) O 0 3.2266162398181253e-12
is O 0 5.3850604124537974e-14
an O 0 7.266432057841457e-14
autosomal B-Disease 1 0.9999934434890747
dominant I-Disease 1 0.9999979734420776
disease I-Disease 1 0.9999997615814209
caused O 0 1.0739183409214093e-07
by O 0 1.2729184026283313e-11
deficiency O 0 0.07909779995679855
in O 0 6.633162126156117e-16
the O 0 3.29010805416325e-14
antidiuretic O 0 1.5235550598902137e-09
hormone O 0 9.519357958148733e-13
arginine O 0 1.0399396865564195e-13
vasopressin O 0 4.3179960881835e-15
( O 0 9.587482384729558e-18
AVP O 0 4.56234815280742e-15
) O 0 3.0836316128878293e-19
encoded O 0 5.386957904560245e-19
by O 0 1.3251617460785796e-18
the O 0 3.2920943993641207e-16
AVP O 0 6.212097503066616e-10
- O 0 4.525002150757018e-09
neurophysin O 0 3.997821096390908e-08
II O 0 8.490234626457038e-10
( O 0 2.837877587140653e-15
AVP O 0 6.667325719300621e-11
- O 0 1.144516481588198e-09
NPII O 0 9.508013265602244e-10
) O 0 3.0236820991756458e-16
gene O 0 5.261262345929163e-13
on O 0 3.773249548639883e-14
chromosome O 0 9.730115380079951e-09
20p13 O 0 1.5795638130811085e-09
. O 0 1.8098779853287228e-12

In O 0 2.7051576039979763e-13
this O 0 5.53083080162141e-16
study O 0 3.220635047104163e-15
, O 0 1.5794505841629507e-15
we O 0 2.4111058811939097e-14
analyzed O 0 4.689590712693382e-15
two O 0 2.965083830489001e-17
families O 0 1.7942060338254953e-18
with O 0 4.0539800875146216e-17
FNDI B-Disease 1 0.9999161958694458
using O 0 3.7476332182600157e-16
direct O 0 1.0355444707095996e-15
automated O 0 5.0627348992769716e-14
fluorescent O 0 6.786352756875738e-14
, O 0 2.329145279151689e-14
solid O 0 7.678795750296064e-13
phase O 0 2.195336773968496e-14
, O 0 1.2038667521088557e-16
single O 0 7.594405819644635e-16
- O 0 3.644654565128358e-13
stranded O 0 6.020867398398577e-14
DNA O 0 2.0539273339298218e-14
sequencing O 0 3.2303536384431627e-16
of O 0 8.58878044379089e-20
PCR O 0 4.173672692175945e-12
- O 0 1.0528752349137083e-12
amplified O 0 3.769592277214073e-12
AVP O 0 8.399178574869381e-11
- O 0 5.773744329862218e-11
NPII O 0 1.628529977537596e-09
DNA O 0 1.2573939667248624e-09
. O 0 4.2622925588292615e-13

In O 0 4.111470482104883e-14
one O 0 9.583323353696866e-16
of O 0 3.023734947744982e-19
the O 0 1.1025410313636011e-16
families O 0 3.612237516270478e-17
, O 0 3.303515513692212e-17
affected O 0 4.11729120781512e-15
individuals O 0 1.5212597995353008e-18
presented O 0 1.3402569237180292e-16
a O 0 1.890159951028602e-15
novel O 0 2.2171537609333436e-12
nonsense O 0 4.3053996479081036e-10
mutation O 0 6.040171075978595e-13
in O 0 2.524143293566789e-18
exon O 0 3.2624578494462597e-13
3 O 0 6.365176804688441e-14
of O 0 2.7575146224130325e-19
the O 0 3.975631723650416e-16
gene O 0 2.1110838771543072e-12
, O 0 8.941806539830468e-17
consisting O 0 8.009690167000239e-19
in O 0 1.2484553233225826e-18
a O 0 1.5521720998548628e-15
G O 0 1.2823742068235333e-10
to O 0 4.163602310689775e-14
T O 0 2.5843092110733323e-09
transition O 0 2.434053121818519e-13
at O 0 4.0669277299142104e-14
nucleotide O 0 7.211882458411922e-13
2101 O 0 6.7193585764901975e-12
, O 0 1.1025795051882521e-15
which O 0 3.870165004409823e-17
produces O 0 1.0958238615685275e-16
a O 0 3.9371610753729017e-16
stop O 0 5.682211211971433e-12
signal O 0 7.902941539031372e-13
in O 0 3.696323456326258e-15
codon O 0 3.070042275954421e-10
82 O 0 4.554219848462715e-11
( O 0 1.983259883360164e-15
Glu O 0 1.176091113386235e-09
) O 0 5.213347606397448e-15
of O 0 1.907012359728496e-16
NPII O 0 2.5845506002042384e-07
. O 0 2.751524485686274e-12

The O 0 9.323119533333202e-13
premature O 0 9.198158727741212e-12
termination O 0 1.0088287762674911e-13
eliminates O 0 4.598039613987193e-13
part O 0 1.8783720052599007e-15
of O 0 1.6050431660219953e-18
the O 0 1.8576925428856342e-15
C O 0 7.926136136315876e-11
- O 0 3.913361388413472e-12
terminal O 0 6.240236192361914e-12
domain O 0 6.914699932428214e-14
of O 0 1.8691188963689301e-19
NPII O 0 2.7090727664630387e-12
, O 0 1.8149539983350098e-18
including O 0 2.8792538950897587e-19
a O 0 1.3822197341542984e-18
cysteine O 0 4.995657386096014e-17
residue O 0 7.189556363988193e-15
in O 0 8.165396784350843e-18
position O 0 5.572163891865052e-14
85 O 0 1.527042347551546e-14
, O 0 3.15078362807589e-16
which O 0 1.7957632112547937e-15
could O 0 4.963414119811549e-13
be O 0 1.25278833111761e-16
involved O 0 1.0355834739298427e-16
in O 0 3.703885488546658e-17
the O 0 1.3772323735551824e-15
correct O 0 4.903497746733265e-11
folding O 0 5.445536244153004e-10
of O 0 9.367318338531219e-18
the O 0 3.72298424185756e-15
prohormone O 0 2.69994648860461e-09
. O 0 4.796022086417384e-12

In O 0 2.5244292333609364e-13
the O 0 8.509879134916201e-15
second O 0 4.0173390330501546e-14
family O 0 5.784222825374902e-16
, O 0 3.049638315422233e-18
a O 0 1.6520995065161822e-18
G279A O 0 4.13431995818672e-15
substitution O 0 7.531020226619228e-17
at O 0 1.081558370898887e-16
position O 0 2.5018975216892616e-15
- O 0 3.4298342703291407e-14
1 O 0 1.1064209054831688e-17
of O 0 1.5453731112084832e-21
the O 0 1.5059294802970965e-19
signal O 0 4.777156634673397e-17
peptide O 0 8.16624265924524e-17
was O 0 1.665103191064016e-16
observed O 0 6.827867472159095e-16
in O 0 5.638556054806518e-18
all O 0 4.954439174695844e-16
affected O 0 2.1919739515239428e-13
individuals O 0 3.8105870891801195e-16
. O 0 6.168164395047027e-14

This O 0 1.1283148894369877e-12
missense O 0 5.5221014427786486e-09
mutation O 0 5.832966332164347e-10
, O 0 3.11873329895615e-14
which O 0 1.3686132034531479e-13
replaces O 0 3.9945780017092147e-10
Ala O 0 1.1900039287304764e-10
with O 0 1.5348973922912033e-14
Thr O 0 1.744696618288799e-07
, O 0 1.993014145374155e-14
is O 0 1.3574944412413483e-16
frequent O 0 3.0893178640245544e-12
among O 0 9.735233588237593e-14
FNDI B-Disease 1 1.0
patients O 0 3.684848692842024e-08
and O 0 9.88142707036236e-15
is O 0 5.156972693318228e-16
thought O 0 3.6553968402533443e-13
to O 0 1.5890466468921743e-16
reduce O 0 1.6027306706193484e-14
the O 0 1.1276493378514847e-17
efficiency O 0 1.9045404793603915e-16
of O 0 3.0824656113415564e-20
cleavage O 0 3.1448429201486744e-14
by O 0 3.868524374382885e-18
signal O 0 4.4499536569703527e-14
peptidases O 0 2.225560707946883e-11
. O 0 3.322135386338472e-14
. O 0 3.8423406708947005e-13

Genetic O 0 2.1476203926340531e-07
heterogeneity O 0 1.4353700450442375e-09
of O 0 8.401953584908847e-14
Saethre B-Disease 1 0.5945452451705933
- I-Disease 1 0.9997273087501526
Chotzen I-Disease 1 0.999911904335022
syndrome I-Disease 1 0.999996542930603
, O 0 5.315723078897037e-16
due O 0 1.652624542866388e-16
to O 0 6.874335170249874e-16
TWIST O 0 2.699421353113962e-09
and O 0 1.6769320307363778e-11
FGFR O 0 1.522737278492059e-07
mutations O 0 4.739782788476532e-09
. O 0 1.0649305872897918e-12

Thirty O 0 9.884011664684778e-11
- O 0 5.801742419819789e-10
two O 0 8.445362329389736e-15
unrelated O 0 8.15894172969539e-13
patients O 0 5.0037709029395264e-14
with O 0 4.227660553754421e-18
features O 0 8.163709291908461e-12
of O 0 1.418671004104052e-14
Saethre B-Disease 1 0.9932551383972168
- I-Disease 1 0.9862309098243713
Chotzen I-Disease 1 0.996813952922821
syndrome I-Disease 1 0.9999526739120483
, O 0 3.404314882870087e-16
a O 0 2.0600007295682246e-14
common O 0 9.095106612289072e-12
autosomal B-Disease 0 0.0009888558415696025
dominant I-Disease 0 0.0004306317714508623
condition I-Disease 0 0.01997995190322399
of O 0 1.75966436110871e-14
craniosynostosis B-Disease 1 0.9899111390113831
and O 0 2.516262087581822e-09
limb B-Disease 0 0.26954150199890137
anomalies I-Disease 0 1.3869343092665076e-05
, O 0 2.0851513061765498e-13
were O 0 1.58415108762462e-15
screened O 0 1.7778474872831573e-11
for O 0 7.168353144084948e-17
mutations O 0 3.554788061133074e-11
in O 0 4.821188186598534e-16
TWIST O 0 9.573980497279422e-10
, O 0 5.833332270997402e-14
FGFR2 O 0 7.2358263825123e-10
, O 0 8.163728109592417e-15
and O 0 1.2257739040368726e-13
FGFR3 O 0 1.0775232794912881e-07
. O 0 2.5739159068005613e-12

Nine O 0 8.280150870509928e-11
novel O 0 1.4473494451550106e-11
and O 0 2.3342712311691383e-12
three O 0 4.051945411143176e-14
recurrent O 0 1.8892770015099813e-07
TWIST O 0 1.2057633114181954e-07
mutations O 0 8.785385574583415e-08
were O 0 2.074353601215495e-13
found O 0 4.715876669204866e-13
in O 0 1.3918039872259165e-15
12 O 0 2.64325887566752e-13
families O 0 4.727381087635133e-15
. O 0 2.497127667405036e-13

Seven O 0 4.905141830907622e-12
families O 0 9.984518656279293e-17
were O 0 1.4155010772666704e-17
found O 0 1.3412287616761055e-16
to O 0 4.50570077305187e-17
have O 0 1.4570806448335402e-14
the O 0 3.449598587719282e-16
FGFR3 O 0 6.035113520042046e-10
P250R O 0 3.0966196403955926e-13
mutation O 0 1.7426210756517346e-13
, O 0 1.3328234155124847e-16
and O 0 1.0201784460134593e-15
one O 0 3.1412322728044135e-15
individual O 0 1.5611192757894854e-17
was O 0 4.731848932322015e-14
found O 0 2.1845769144395247e-14
to O 0 3.4248580788189638e-15
have O 0 1.6896893769140914e-13
an O 0 1.7929421680239633e-16
FGFR2 O 0 8.070904833346049e-09
VV269 O 0 1.4655504240734807e-11
- O 0 3.0645045962646167e-12
270 O 0 2.1033580422085557e-13
deletion O 0 3.2860883458774026e-10
. O 0 8.416842526767776e-13

To O 0 5.638591807008431e-13
date O 0 7.646977127039045e-13
, O 0 7.1139014987218075e-16
our O 0 8.868633481099537e-17
detection O 0 4.811214479523733e-15
rate O 0 3.272798724127872e-16
for O 0 5.4204105102485677e-20
TWIST O 0 3.006964816032465e-11
or O 0 1.420774949241737e-14
FGFR O 0 2.392896103486919e-09
mutations O 0 5.879047942913829e-11
is O 0 4.963633187942697e-16
68 O 0 7.6709488370727e-13
% O 0 2.8963428054801295e-17
in O 0 2.1569183664480037e-15
our O 0 8.65836624619476e-10
Saethre B-Disease 1 0.996538519859314
- I-Disease 1 0.999289870262146
Chotzen I-Disease 1 0.9998134970664978
syndrome I-Disease 1 0.9999971389770508
patients O 0 6.037387170060304e-12
, O 0 5.382587661229944e-17
including O 0 3.085485434655582e-15
our O 0 3.3146307421884347e-13
five O 0 1.6945871374085173e-15
patients O 0 4.764147399743653e-16
elsewhere O 0 1.73716356613961e-15
reported O 0 1.784173259437513e-14
with O 0 4.377954162387843e-15
TWIST O 0 1.3623816741414885e-08
mutations O 0 3.852852614727453e-08
. O 0 2.1889545297887336e-12

More O 0 2.9632327458618954e-15
than O 0 1.4122494302787244e-16
35 O 0 1.0878406025104353e-14
different O 0 2.8105977264040257e-16
TWIST O 0 3.6220335064562903e-10
mutations O 0 3.4366320900147684e-10
are O 0 3.4216700585637354e-16
now O 0 9.923016388072546e-15
known O 0 7.546010698082379e-15
in O 0 1.2334504365828962e-16
the O 0 2.438037378455155e-15
literature O 0 6.257920613997325e-13
. O 0 1.235525028640827e-12

The O 0 5.4452553170701926e-14
most O 0 6.304223366185912e-17
common O 0 7.345235461039818e-17
phenotypic O 0 1.806964883169053e-14
features O 0 2.3884342420510407e-11
, O 0 6.168226194570858e-13
present O 0 7.157426816112062e-16
in O 0 2.2769052123292832e-18
more O 0 5.896835136065229e-19
than O 0 3.828331502982811e-17
a O 0 1.1214308798799307e-14
third O 0 2.412579142539728e-13
of O 0 1.8924442781189774e-18
our O 0 1.4164376323320266e-14
patients O 0 4.0004593181256235e-16
with O 0 7.031497600663152e-18
TWIST O 0 1.2677071892230884e-10
mutations O 0 1.9177859300612e-10
, O 0 8.37506579454768e-16
are O 0 1.3586031279599653e-16
coronal B-Disease 0 9.47813216800597e-11
synostosis I-Disease 0 9.051527527503822e-09
, O 0 2.488934622638106e-13
brachycephaly B-Disease 0 1.254289543339837e-07
, O 0 1.1111451342360468e-10
low B-Disease 0 0.0001133322439272888
frontal I-Disease 1 0.999992847442627
hairline I-Disease 1 0.9999997615814209
, O 0 8.64446337800473e-06
facial B-Disease 1 0.9999910593032837
asymmetry I-Disease 1 0.8876951336860657
, O 0 4.521611085550603e-09
ptosis B-Disease 0 0.4740011692047119
, O 0 3.624395228385424e-11
hypertelorism B-Disease 0 0.0002768411941360682
, O 0 1.3884090543925254e-09
broad B-Disease 0 8.403007086599246e-06
great I-Disease 0 9.269262477573648e-07
toes I-Disease 0 0.00038548564771190286
, O 0 9.869420818792163e-13
and O 0 1.2518975656475306e-12
clinodactyly B-Disease 0 1.7990750222907081e-07
. O 0 6.9514559039585144e-12

Significant O 0 1.231018585678978e-11
intra O 0 1.1675659050691678e-10
- O 0 3.5362981520847825e-07
and O 0 1.5974287864706227e-11
interfamilial O 0 6.026078125387357e-08
phenotypic O 0 3.396697922930514e-10
variability O 0 3.416098515174326e-10
is O 0 5.605897508385047e-16
present O 0 1.379318294758192e-17
for O 0 2.5151468772246623e-18
either O 0 6.663247021200872e-14
TWIST O 0 9.616118035182808e-08
mutations O 0 1.952850681163909e-08
or O 0 7.794395012229727e-13
FGFR O 0 6.828296932326339e-07
mutations O 0 4.0268563594736406e-08
. O 0 6.946259973467095e-12

The O 0 1.6181241459592433e-12
overlap O 0 2.241879459852214e-10
in O 0 4.607753353944987e-15
clinical O 0 2.028561520150962e-11
features O 0 1.2598790283605e-12
and O 0 2.8656097677062786e-13
the O 0 5.879885138251027e-16
presence O 0 1.1035868399678073e-12
, O 0 7.891726348471274e-15
in O 0 1.5015713706724055e-17
the O 0 3.026068879202331e-17
same O 0 1.0979913394712124e-16
genes O 0 1.328585471449355e-15
, O 0 2.6766042609888878e-18
of O 0 1.6593731802921738e-21
mutations O 0 5.83887339113175e-15
for O 0 2.811793050986026e-20
more O 0 2.9546480475027286e-19
than O 0 3.318129809882554e-16
one O 0 4.953993487134822e-13
craniosynostotic B-Disease 0 2.462794782331912e-06
condition I-Disease 0 2.7107011746352327e-08
- O 0 7.096454229370969e-14
such O 0 9.863416105879079e-17
as O 0 3.521559807000488e-14
Saethre B-Disease 0 1.3212338778600952e-08
- I-Disease 0 7.452424094500643e-11
Chotzen I-Disease 0 2.5956400917515055e-10
, I-Disease 0 3.0587073350610847e-15
Crouzon I-Disease 0 4.4317094438639515e-10
, I-Disease 0 8.333548559341306e-14
and I-Disease 0 2.880516571795999e-12
Pfeiffer I-Disease 0 0.0018218281911686063
syndromes I-Disease 0 1.6493552266183542e-06
- O 0 1.0338532981102322e-11
support O 0 6.707311707996114e-15
the O 0 4.9478830735096466e-17
hypothesis O 0 7.837425607321643e-15
that O 0 5.900351439490161e-17
TWIST O 0 3.638121054416743e-12
and O 0 9.221085266880591e-15
FGFRs O 0 1.8632108009231096e-11
are O 0 7.967609628083288e-18
components O 0 1.0151783046466988e-15
of O 0 1.1388141874899039e-19
the O 0 1.39646665875509e-17
same O 0 2.14899901867276e-17
molecular O 0 2.1415783880149915e-15
pathway O 0 1.089443082967522e-15
involved O 0 1.4816330919054886e-18
in O 0 3.8766923176427517e-19
the O 0 1.2554429522266396e-17
modulation O 0 9.55023346104096e-14
of O 0 7.616920484778246e-16
craniofacial O 0 0.013240447267889977
and O 0 3.092128553205953e-09
limb O 1 0.5738120675086975
development O 0 3.364097542202238e-11
in O 0 7.364461891332628e-15
humans O 0 9.50077082978451e-12
. O 0 4.054324049065656e-15
. O 0 2.1670152109375118e-13

Mutation O 0 6.301315913503913e-09
analysis O 0 8.892704823383613e-13
of O 0 7.565692461523898e-16
UBE3A O 0 0.00021649202972184867
in O 0 2.2134867094791844e-07
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.9708160436948674e-07
. O 0 2.754459637807627e-12

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.2454577631190205e-09
AS B-Disease 1 0.9999996423721313
) O 0 4.73614040780862e-13
is O 0 7.566591904634764e-15
caused O 0 4.434160897075386e-14
by O 0 1.792710716271126e-15
chromosome O 0 4.474171930723969e-07
15q11 O 0 1.6755908882615245e-09
- O 0 5.648621570486512e-10
q13 O 0 1.829478062098655e-11
deletions O 0 3.794756175956593e-11
of O 0 1.2865595347246389e-16
maternal O 0 2.824329485562327e-11
origin O 0 6.822556046184218e-16
, O 0 1.4861744954481395e-16
by O 0 4.0893795134394e-16
paternal O 0 1.0525218918644441e-08
uniparental B-Disease 0 1.4092050150793511e-05
disomy I-Disease 0 2.939473461083253e-06
( O 0 2.0292649938885576e-12
UPD B-Disease 1 0.9999983310699463
) O 0 6.630946334552912e-13
15 O 0 1.0783913570607505e-14
, O 0 4.5228866083305165e-17
by O 0 1.182795351708027e-16
imprinting O 0 4.07631705456879e-05
defects O 1 0.8258988857269287
, O 0 6.536139224256818e-14
and O 0 8.690574979488067e-15
by O 0 4.2956828580726573e-16
mutations O 0 1.1592955068140398e-10
in O 0 5.118793742011924e-16
the O 0 2.3309484852414514e-15
UBE3A O 0 5.29128207915619e-09
gene O 0 7.822555381231666e-10
. O 0 2.04883527678279e-12

UBE3A O 0 3.2942062944130157e-07
encodes O 0 2.0867210737129938e-11
a O 0 6.941273050049476e-14
ubiquitin O 0 5.763967319931396e-13
- O 0 5.56913109378554e-12
protein O 0 4.0618849429796544e-12
ligase O 0 4.704700171109799e-13
and O 0 5.907930937000538e-13
shows O 0 9.022375624390122e-10
brain O 0 5.5621253380877533e-08
- O 0 2.598305182122118e-10
specific O 0 1.4637721373542134e-13
imprinting O 0 2.736195980901357e-08
. O 0 4.7113298505541135e-12

Here O 0 5.3202631189464e-10
we O 0 3.463549325816162e-12
describe O 0 1.1161271559756436e-12
UBE3A O 0 2.4637943241145877e-08
coding O 0 9.36228570935782e-06
- O 0 1.3239781537777162e-06
region O 0 1.0815787154783152e-09
mutations O 0 6.941813790461993e-11
detected O 0 2.6688316812593926e-13
by O 0 1.1279541332276952e-18
SSCP O 0 2.091410898630297e-11
analysis O 0 1.7072077800918406e-14
in O 0 4.163024329817282e-17
13 O 0 2.2174230225428804e-13
AS B-Disease 1 0.9999963045120239
individuals O 0 1.4433105784407928e-15
or O 0 1.7629332306587538e-14
families O 0 1.9581748332206383e-14
. O 0 1.831015672198663e-13

Two O 0 8.628560088652648e-10
identical O 0 2.5986235385744294e-09
de O 0 1.362510104740977e-10
novo O 0 3.208539822718848e-10
5 O 0 7.879893298198132e-14
- O 0 9.134832647250679e-12
bp O 0 8.098567931720535e-13
duplications O 0 3.858293892711195e-12
in O 0 2.273521630033635e-17
exon O 0 2.3605878536614444e-13
16 O 0 7.299826840006726e-14
were O 0 4.632672533857617e-16
found O 0 1.1194568357150367e-13
. O 0 9.557472001320289e-13

Among O 0 4.4731169587591477e-14
the O 0 5.3964035626930497e-17
other O 0 5.1844070978630593e-17
11 O 0 2.587872636384994e-15
unique O 0 8.624613215162924e-17
mutations O 0 7.324013899696891e-13
, O 0 5.241261471295095e-16
8 O 0 9.388940091972081e-15
were O 0 1.282693094018219e-16
small O 0 3.3050819026048117e-15
deletions O 0 2.3105233282194604e-09
or O 0 2.333735689506039e-13
insertions O 0 1.3602258208678109e-09
predicted O 0 4.5505172963089535e-09
to O 0 2.561743948480827e-13
cause O 0 1.0730502424116661e-11
frameshifts O 0 1.3371631268910278e-07
, O 0 1.6299872421850908e-13
1 O 0 9.268018515455004e-16
was O 0 2.6966752890092297e-15
a O 0 8.250409279189245e-17
mutation O 0 7.018163482276022e-15
to O 0 1.1138233447849058e-17
a O 0 4.483174395040785e-16
stop O 0 5.55020222489655e-12
codon O 0 2.387297716281711e-13
, O 0 1.2598242897033166e-15
1 O 0 4.700224205494535e-17
was O 0 8.965310115929999e-16
a O 0 5.578567593295193e-17
missense O 0 3.233530457280587e-11
mutation O 0 4.333514016380269e-12
, O 0 2.287895547537969e-16
and O 0 1.7575872245638056e-15
1 O 0 4.634016139870199e-16
was O 0 1.3353141021296006e-13
predicted O 0 1.26615699262006e-12
to O 0 5.473865188940598e-16
cause O 0 2.3375646595924547e-15
insertion O 0 1.3181112526060215e-14
of O 0 1.2925013054135053e-17
an O 0 1.7989925243662008e-15
isoleucine O 0 1.814410643419251e-05
in O 0 8.5245328049037e-15
the O 0 1.3466895301474948e-15
hect O 0 1.0849460219120033e-10
domain O 0 1.4616518444806464e-13
of O 0 5.461675578328512e-19
the O 0 4.6740121753717097e-17
UBE3A O 0 9.083543812959949e-12
protein O 0 2.0365972363406426e-12
, O 0 9.84560181185824e-16
which O 0 3.6435975876535884e-17
functions O 0 1.8862623024520317e-16
in O 0 1.8245763008876247e-17
E2 O 0 4.109935590641822e-13
binding O 0 3.889023028310137e-15
and O 0 5.237121994812084e-17
ubiquitin O 0 1.6151184004180004e-15
transfer O 0 2.5573242660873255e-14
. O 0 1.0758655251408289e-12

Eight O 0 6.621568527861998e-13
of O 0 3.0839844571178715e-19
the O 0 9.466824857498898e-18
cases O 0 5.123247547127706e-16
were O 0 2.0501756185421516e-16
familial O 0 7.314500394262069e-11
, O 0 8.354173472793769e-14
and O 0 4.40087927851187e-14
five O 0 7.889646035552818e-16
were O 0 1.2881611416789987e-15
sporadic O 0 1.2027511209211639e-09
. O 0 1.2140110097758061e-11

In O 0 1.6184381851185037e-13
two O 0 5.522969912354417e-15
familial O 0 3.4776859170193575e-10
cases O 0 3.1191211722833567e-13
and O 0 1.0613444801840788e-14
one O 0 1.4974372543197635e-15
sporadic O 0 1.5228257543853374e-09
case O 0 6.177283511099585e-12
, O 0 3.6664816385615414e-15
mosaicism O 0 1.20653695367956e-10
for O 0 2.7441801193869174e-17
UBE3A O 0 6.316293599262224e-10
mutations O 0 3.119463715117732e-11
was O 0 4.841999044958743e-15
detected O 0 2.1695297468260488e-13
in O 0 1.3808450220147812e-17
the O 0 4.702130188444535e-15
mother O 0 1.976460245467493e-10
of O 0 2.102951404256066e-18
three O 0 1.5145815103392163e-13
AS B-Disease 1 1.0
sons O 0 8.376779825347569e-11
, O 0 8.079701700070962e-16
in O 0 1.3136925146542563e-16
the O 0 4.424426201522476e-15
maternal O 0 4.221308198826268e-12
grandfather O 0 3.0053794197217043e-13
of O 0 8.365405489249773e-20
two O 0 9.186286188792069e-16
AS B-Disease 1 0.9999983310699463
first O 0 1.2347686892053011e-12
cousins O 0 1.93514385071758e-10
, O 0 7.376484676985956e-14
and O 0 2.8411179116803742e-14
in O 0 5.213504201613572e-16
the O 0 4.356081230590895e-15
mother O 0 3.7009150084810205e-12
of O 0 4.783988086707925e-20
an O 0 5.513199810824312e-16
AS B-Disease 1 0.9999998807907104
daughter O 0 1.3284391570778098e-05
. O 0 1.4499079888097288e-11

The O 0 1.152307094279834e-14
frequencies O 0 2.55801696963159e-14
with O 0 2.4710896628482018e-15
which O 0 4.124962785218402e-15
we O 0 1.6795672315504488e-14
detected O 0 1.171874554860286e-13
mutations O 0 2.885913757315686e-14
were O 0 6.364536082497358e-17
5 O 0 2.413947020281414e-16
( O 0 2.2474201112406468e-17
14 O 0 8.78452946218429e-16
% O 0 8.146850154246485e-19
) O 0 2.4365088843407774e-18
of O 0 8.677268736053604e-20
35 O 0 6.387238286019448e-14
in O 0 4.5030885366774274e-17
sporadic O 0 9.131322920019613e-10
cases O 0 3.762337229956669e-12
and O 0 1.4541993097975242e-13
8 O 0 1.4088986155849897e-14
( O 0 1.1772623902214965e-17
80 O 0 1.1497335117245438e-15
% O 0 3.4167228732997905e-18
) O 0 1.3326600969723422e-17
of O 0 7.666347140269025e-19
10 O 0 1.949751048208547e-15
in O 0 1.133130501288057e-16
familial O 0 7.542288460449242e-10
cases O 0 1.135083509389706e-13
. O 0 8.829216485261703e-15
. O 0 6.403244904792937e-13

The O 0 2.610145606596337e-11
hemochromatosis B-Disease 1 0.9999669790267944
845 O 0 3.2271119110305335e-10
G O 0 3.453624886073925e-10
- O 0 9.256695236714574e-12
- O 0 3.1205392003047505e-12
> O 0 1.6524559091945015e-14
A O 0 6.774370459397289e-16
and O 0 5.632603001374097e-17
187 O 0 1.3149297968561343e-14
C O 0 6.052641460946306e-12
- O 0 1.9426796976640404e-11
- O 0 6.671017627191134e-10
> O 0 4.5957911087857184e-11
G O 0 3.556534622362051e-09
mutations O 0 5.121934543161899e-10
: O 0 3.513267354446868e-14
prevalence O 0 5.235003541770311e-10
in O 0 1.7281284774494851e-15
non O 0 9.355294317003882e-12
- O 0 2.707361375087203e-07
Caucasian O 0 3.250756435591029e-06
populations O 0 8.347126367880264e-08
. O 0 1.0842297545887725e-11

Hemochromatosis B-Disease 0 0.003802143968641758
, O 0 6.060467683255411e-10
the O 0 2.163410117717035e-09
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 0 8.390606731547429e-16
iron I-Disease 0 5.35093840881018e-06
metabolism I-Disease 0 1.0975937811963377e-06
, O 0 2.1586739015234946e-13
leads O 0 9.256734961882174e-11
, O 0 6.32905254355394e-14
if O 0 1.4073376145007366e-11
untreated O 0 5.963619043036772e-10
, O 0 2.0947869909894635e-16
to O 0 3.1118330297546376e-15
progressive O 0 4.5013359706302936e-10
iron B-Disease 0 0.002018677769228816
overload I-Disease 0 0.00010815924179041758
and O 0 5.912175610189863e-11
premature B-Disease 0 1.391000647998908e-10
death I-Disease 0 7.694270914848644e-11
. O 0 1.6464423140821749e-12

The O 0 7.984463090693339e-11
hemochromatosis B-Disease 1 0.9999982118606567
gene O 0 9.847423143583e-07
, O 0 2.0969287233257167e-13
HFE O 0 3.290212191586761e-08
, O 0 5.506114769855686e-13
recently O 0 2.3710511332097894e-10
has O 0 6.946574392097116e-13
been O 0 1.0855186734437744e-15
identified O 0 1.9954029476920015e-14
, O 0 2.9980562423221e-17
and O 0 8.685560544440321e-17
characterization O 0 3.7295625030138446e-13
of O 0 1.4263510864543154e-19
this O 0 6.995143509049814e-17
gene O 0 5.037349443820505e-12
has O 0 3.578669478809804e-13
shown O 0 1.8238936836528774e-14
that O 0 1.4187297881905914e-15
it O 0 9.544615006798528e-16
contains O 0 6.168649125532961e-17
two O 0 2.2962641801172823e-15
mutations O 0 1.4652317553709437e-11
that O 0 2.313524975164783e-14
result O 0 9.131613176662119e-15
in O 0 1.8370427398994114e-17
amino O 0 4.949662438268922e-15
acid O 0 1.0510772285474509e-16
substitutions O 0 2.0675722194408769e-16
- O 0 4.957545265689249e-14
cDNA O 0 7.030563739691964e-13
nucleotides O 0 1.5281006982784812e-13
845 O 0 1.1549700811627067e-13
G O 0 1.6661814289387067e-11
- O 0 6.848671369602544e-12
- O 0 7.155967225030979e-12
> O 0 4.5299210210810945e-14
A O 0 2.0345479400746486e-15
( O 0 1.8742820802043037e-18
C282Y O 0 3.4883194812931504e-15
) O 0 1.2262243273723371e-18
and O 0 4.8276981972809995e-18
187 O 0 8.287355109343024e-15
C O 0 1.937868789048114e-11
- O 0 1.038137770192904e-10
- O 0 4.044666823688203e-09
> O 0 2.56317831542896e-11
G O 0 1.5170009692866415e-10
( O 0 5.186961365420174e-16
H63D O 0 4.448331286655005e-11
) O 0 5.58741175546505e-15
. O 0 1.5448428127007308e-13

Although O 0 2.9650975008621572e-08
hemochromatosis B-Disease 1 0.9999994039535522
is O 0 3.048356705948052e-12
common O 0 3.624251371020168e-14
in O 0 4.604463491212741e-17
Caucasians O 0 2.3953333760928786e-10
, O 0 3.968148611077898e-15
affecting O 0 1.5288798872747922e-12
> O 0 1.1881343998931815e-11
= O 0 2.2402467381166247e-10
1 O 0 2.8283441254401873e-16
/ O 0 7.921730762680546e-13
300 O 0 2.2941769503145436e-18
individuals O 0 3.617680871349202e-19
of O 0 1.8262247994701393e-19
northern O 0 5.938480374112487e-09
European O 0 7.429442477890902e-12
origin O 0 2.9428418040852874e-16
, O 0 1.4522631872976787e-15
it O 0 3.1250255679081233e-15
has O 0 1.4617132374286634e-13
not O 0 4.188036246602746e-15
been O 0 8.852110515276566e-16
recognized O 0 2.271814891732142e-16
in O 0 8.59167273250147e-18
other O 0 6.825288786230298e-16
populations O 0 4.000408337923034e-11
. O 0 1.7881440685790784e-12

The O 0 7.140077103780923e-14
present O 0 2.0122097489616418e-16
study O 0 2.077635831122095e-17
used O 0 7.386202077184874e-17
PCR O 0 3.520832930758999e-11
and O 0 5.428411389287683e-15
restriction O 0 2.2960281245709702e-11
- O 0 2.5319045904997894e-12
enzyme O 0 1.6630292520684875e-14
digestion O 0 1.496005027485075e-14
to O 0 5.561797002684047e-19
analyze O 0 6.012274270324506e-17
the O 0 1.968032378536197e-19
frequency O 0 8.973174552147459e-17
of O 0 4.1553547318572057e-20
the O 0 7.358271992929776e-18
845 O 0 1.8605150684241224e-15
G O 0 2.6119061882941275e-13
- O 0 2.695576136705225e-14
- O 0 6.295413138273503e-14
> O 0 1.1315070567655258e-15
A O 0 3.209986995924229e-16
and O 0 8.01556674758503e-17
187 O 0 2.3727914893193402e-15
C O 0 5.798127819880983e-13
- O 0 1.7176973819005292e-12
- O 0 1.804625719692421e-11
> O 0 1.5554106396961642e-12
G O 0 1.1906230341918178e-11
mutations O 0 4.695717556110757e-13
in O 0 4.6078721370809497e-17
HLA O 0 1.8040276217323736e-10
- O 0 1.0573691444984434e-12
typed O 0 2.809792600411837e-13
samples O 0 1.4626996919990358e-14
from O 0 6.147523594432846e-19
non O 0 1.6203957121409263e-14
- O 0 4.00619842855221e-10
Caucasian O 0 6.171183031256078e-08
populations O 0 2.1080844014864653e-10
, O 0 2.8098793365856356e-16
comprising O 0 4.9298343234159845e-17
Australian O 0 1.7937513385984753e-14
Aboriginal O 0 8.584805975364422e-15
, O 0 1.5898713128756651e-16
Chinese O 0 2.018283848696182e-15
, O 0 2.5852072883977807e-16
and O 0 2.172704731244219e-14
Pacific O 0 3.273025600547541e-11
Islanders O 0 3.4133480764086954e-11
. O 0 1.673593785799822e-14

Results O 0 1.90290250223768e-09
showed O 0 4.431451299663491e-12
that O 0 1.4349270169057842e-16
the O 0 7.00147044811911e-17
845 O 0 8.478355279124827e-14
G O 0 6.835311483488482e-11
- O 0 3.554264087907155e-12
- O 0 4.851435659453118e-12
> O 0 1.9766218555591214e-14
A O 0 3.8822052601176875e-15
mutation O 0 4.8974520050265244e-14
was O 0 1.1052661878178244e-15
present O 0 1.4756371698378214e-18
in O 0 5.399592674826687e-18
these O 0 9.64846561364554e-17
populations O 0 2.7336577215742418e-14
( O 0 1.6773731312533392e-19
allele O 0 9.932621013775471e-18
frequency O 0 1.4562352424247094e-15
0 O 0 3.979546339355711e-16
. O 0 2.802597309965668e-18
32 O 0 7.02651787411391e-16
% O 0 2.081068418699158e-19
) O 0 7.371280235242785e-18
, O 0 2.1105814290684572e-15
and O 0 9.907023389588848e-14
, O 0 1.8473608585115e-15
furthermore O 0 9.808612391271412e-14
, O 0 1.869137016794224e-15
it O 0 1.3011115893458297e-13
was O 0 1.0178598415511164e-11
always O 0 3.1231055068470237e-12
seen O 0 5.113136832473686e-15
in O 0 5.684012421200874e-19
conjunction O 0 1.8761949188272203e-15
with O 0 2.6207459850679333e-15
HLA O 0 6.154268561431309e-08
haplotypes O 0 4.807704234721655e-10
common O 0 6.439080497099015e-13
in O 0 2.4304310755283705e-16
Caucasians O 0 1.7093609513962882e-11
, O 0 2.9592549203229116e-16
suggesting O 0 2.9779641311223053e-15
that O 0 2.9313128915797683e-16
845 O 0 5.5955840140434546e-14
G O 0 3.552761210223743e-11
- O 0 1.224575670900896e-12
- O 0 9.226131143791338e-12
> O 0 1.2607678844065578e-13
A O 0 5.905945356246903e-14
may O 0 3.48972559833724e-14
have O 0 1.4977285277745006e-15
been O 0 5.283054606308214e-16
introduced O 0 2.3813876031845505e-15
into O 0 8.440264435126906e-17
these O 0 2.6399381568484948e-17
populations O 0 1.123160521158224e-14
by O 0 2.981132126989265e-17
Caucasian O 0 1.8669124024484063e-09
admixture O 0 5.873558861502204e-10
. O 0 1.9884836832684272e-11

187 O 0 1.2453400810574777e-10
C O 0 9.832383796037902e-10
- O 0 7.347891739506451e-11
- O 0 3.834037531902368e-10
> O 0 3.72517771837777e-12
G O 0 1.402487501134253e-11
was O 0 2.197413529348574e-15
present O 0 4.108935423832261e-19
at O 0 1.9707979276672973e-18
an O 0 7.263468112066734e-21
allele O 0 5.129052833015501e-17
frequency O 0 5.417220389988559e-15
of O 0 4.0974037609512053e-17
2 O 0 1.7205141391446466e-12
. O 0 7.755526364346121e-13

68 O 0 1.0515006643174729e-08
% O 0 1.0050677805750925e-14
in O 0 3.98641200461435e-17
the O 0 3.9320881421122365e-16
two O 0 3.942663930793858e-15
populations O 0 3.8502074792279295e-12
analyzed O 0 8.349861058652708e-13
( O 0 1.2044272496919216e-16
Australian O 0 4.964492900973172e-13
Aboriginal O 0 1.1111482827591557e-12
and O 0 3.5205924953747234e-14
Chinese O 0 8.554407995766539e-14
) O 0 1.5699295103193387e-15
. O 0 2.92581951233991e-14

In O 0 2.0629968545092525e-14
the O 0 7.941067288198258e-16
Australian O 0 2.3920505197927086e-14
Aboriginal O 0 4.765821983880375e-15
samples O 0 6.728526918709518e-16
, O 0 1.7802299901957994e-18
187 O 0 8.237048657935289e-16
C O 0 1.8819886241864398e-13
- O 0 2.0976288468785992e-13
- O 0 2.9860452218505307e-12
> O 0 1.5727782303517207e-13
G O 0 4.988605015188163e-12
was O 0 1.530639887060948e-15
found O 0 1.9800981674484147e-17
to O 0 7.333752705212479e-18
be O 0 6.275311087671468e-17
associated O 0 1.7803422988236714e-14
with O 0 7.849513614511909e-15
HLA O 0 2.8026894938193436e-07
haplotypes O 0 6.257370177564781e-10
common O 0 1.2641293177170776e-13
in O 0 7.414460552143155e-17
Caucasians O 0 1.323494352306609e-11
, O 0 4.599567309905366e-16
suggesting O 0 8.050266860461577e-14
that O 0 3.67657911832576e-15
it O 0 8.280307795221868e-15
was O 0 2.515294830057746e-15
introduced O 0 2.121485601835817e-16
by O 0 6.076115160102675e-18
recent O 0 8.228796333567545e-14
admixture O 0 1.3071604909598022e-10
. O 0 9.20953417693493e-12

In O 0 9.084712962372649e-14
the O 0 9.228716186702405e-16
Chinese O 0 6.4545672409307975e-15
samples O 0 1.6344249282638861e-15
analyzed O 0 1.3085609508317733e-16
, O 0 5.137252240157917e-19
187 O 0 4.0791590021395927e-16
C O 0 5.666231305228968e-14
- O 0 8.816936032185821e-14
- O 0 2.9762026176882728e-12
> O 0 6.215747317891984e-14
G O 0 1.966655657770211e-11
was O 0 8.67961301789788e-14
present O 0 2.442234214950563e-16
in O 0 8.272469855253789e-17
association O 0 6.680008871490792e-17
with O 0 2.852614067833636e-17
a O 0 1.612803353494036e-15
wide O 0 3.2295452661972035e-13
variety O 0 2.6706447383423315e-13
of O 0 3.019083239667647e-16
HLA O 0 1.1141857214624906e-07
haplotypes O 0 5.722456883350269e-11
, O 0 2.2302049275938667e-15
showing O 0 2.8333036939287744e-14
this O 0 1.4146265819230793e-17
mutation O 0 1.8724982552871658e-15
to O 0 1.7061374374959545e-17
be O 0 2.518634469210533e-16
widespread O 0 2.645273518121576e-15
and O 0 2.5466851934566326e-13
likely O 0 6.504698038881096e-14
to O 0 8.002796402416191e-17
predate O 0 4.870748769592037e-12
the O 0 2.216082539170198e-17
more O 0 1.6175267690314925e-18
genetically O 0 3.897113751497039e-13
restricted O 0 2.901658297319032e-12
845 O 0 2.4360190514077784e-12
G O 0 4.0140557544532385e-09
- O 0 3.3118172093615783e-10
- O 0 2.5272514636576204e-10
> O 0 1.0477467417974173e-12
A O 0 8.555778156262017e-14
mutation O 0 1.3188877941161525e-11
. O 0 1.127890370076351e-13

Genotype O 0 1.0654533610932049e-07
- O 0 4.374608124635415e-06
phenotype O 0 2.4500505446667376e-07
correlations O 0 1.952660788617777e-08
in O 0 4.484006915772554e-11
attenuated B-Disease 1 0.9965031147003174
adenomatous I-Disease 1 0.9999983310699463
polyposis I-Disease 1 0.9999319314956665
coli I-Disease 1 0.9999973773956299
. O 0 2.2557617995744295e-08

Germ O 0 7.263506267918274e-05
- O 0 1.0246837518934626e-05
line O 0 3.1315341431081833e-08
mutations O 0 2.546182535645425e-11
of O 0 3.04135513556328e-18
the O 0 8.082845780492051e-16
tumor B-Disease 0 4.1662142485909825e-11
suppressor O 0 2.965059101023293e-11
APC O 0 9.208650552164355e-13
are O 0 2.9193960379844067e-15
implicated O 0 6.988017109410549e-11
in O 0 4.6671312647905694e-11
attenuated B-Disease 1 0.9999301433563232
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.999995231628418
coli I-Disease 1 0.9999998807907104
( O 0 4.848596901751989e-08
AAPC B-Disease 1 0.9999986886978149
) O 0 4.514328906350673e-13
, O 0 1.2862805167778574e-15
a O 0 1.1037752404240674e-14
variant O 0 8.086144589469768e-06
of O 0 6.948228659098277e-10
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999759197235107
polyposis I-Disease 1 0.9999996423721313
( O 0 1.208476235747824e-10
FAP B-Disease 0 1.586987430357567e-08
) O 0 3.0766162187334523e-12
. O 0 5.19640970877977e-12

AAPC B-Disease 1 0.9999852180480957
is O 0 5.662434496983559e-12
recognized O 0 1.2782341272954151e-15
by O 0 5.475342566601843e-18
the O 0 1.4621787137969152e-17
occurrence O 0 7.091664088647656e-14
of O 0 1.422950665863323e-17
< O 0 8.529542350199648e-11
100 O 0 1.9263311377883813e-14
colonic B-Disease 0 1.2631492296577562e-08
adenomas I-Disease 0 4.733151648395051e-09
and O 0 3.8806544783165364e-13
a O 0 2.8900672680758424e-14
later O 0 1.974123295389596e-11
onset O 0 8.499948478402075e-08
of O 0 8.358394532059776e-11
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.7494808227970504e-14
age O 0 3.8572301548547155e-14
> O 0 3.791812783898729e-14
40 O 0 3.0465809996299553e-14
years O 0 2.799844537259514e-15
) O 0 8.623174873809147e-15
. O 0 1.0618107548808833e-13

The O 0 1.2474878985715976e-12
aim O 0 2.746478988246287e-13
of O 0 3.185159761272588e-19
this O 0 7.137053291450432e-18
study O 0 1.3217999599920723e-17
was O 0 1.3275056367905038e-16
to O 0 9.593597730998162e-17
assess O 0 2.4677070283030123e-12
genotype O 0 4.094945736665689e-12
- O 0 2.060077797239046e-08
phenotype O 0 2.2638291241605657e-09
correlations O 0 8.16125778069221e-10
in O 0 1.1435246846658309e-11
AAPC B-Disease 1 0.9999990463256836
families O 0 2.066707083248076e-10
. O 0 2.4807842412266634e-12

By O 0 4.776615301210763e-15
protein O 0 4.897914972906703e-12
- O 0 1.1192641952151305e-10
truncation O 0 2.642287633136675e-08
test O 0 8.100959347778769e-10
( O 0 3.833899751994273e-17
PTT O 0 2.926170861606431e-14
) O 0 1.731973410632798e-18
assay O 0 4.322196048112901e-16
, O 0 2.1052629604778455e-18
the O 0 1.072993151402375e-18
entire O 0 5.874911254905631e-15
coding O 0 3.6013416693236877e-09
region O 0 7.974299524740949e-14
of O 0 5.553504517043203e-20
the O 0 3.59163889922056e-18
APC B-Disease 0 2.9764497209159094e-14
gene O 0 3.9636447336094394e-13
was O 0 4.385494788497479e-14
screened O 0 3.181297456369969e-12
in O 0 4.36686009542162e-16
affected O 0 4.561813708899021e-13
individuals O 0 1.0489183533231365e-16
from O 0 4.137489396656668e-16
11 O 0 1.239822688958725e-10
AAPC B-Disease 1 0.9999994039535522
kindreds O 0 2.0547513202018308e-07
, O 0 4.032747239987068e-14
and O 0 2.1882871728583827e-15
their O 0 4.21198620906548e-16
phenotypic O 0 1.281187742702139e-11
differences O 0 7.274430363635176e-11
were O 0 9.389809893164958e-13
examined O 0 5.7912314943564525e-09
. O 0 3.985228379937977e-12

Five O 0 5.218581469734751e-11
novel O 0 6.930009517625013e-12
germ O 0 7.851951266957258e-08
- O 0 2.7853087658513687e-07
line O 0 3.31911653717043e-09
APC B-Disease 0 3.1032433567279583e-12
mutations O 0 6.629103082439469e-12
were O 0 1.7846785675301095e-16
identified O 0 1.2325069350532791e-13
in O 0 1.3443644247072817e-15
seven O 0 3.5829603173276325e-12
kindreds O 0 2.5391891540493816e-06
. O 0 7.35641408899923e-12

Mutations O 0 1.2077543942723423e-07
were O 0 8.649039871886505e-14
located O 0 3.706802524433214e-14
in O 0 4.593184916647805e-16
three O 0 2.3160315997655927e-15
different O 0 1.130151856989478e-16
regions O 0 7.588795179281141e-14
of O 0 2.7467222418646883e-19
the O 0 1.0937685162696802e-17
APC B-Disease 0 3.0771749826518334e-15
gene O 0 1.4231264821099043e-14
( O 0 1.166479449871893e-18
1 O 0 1.8086233783119883e-18
) O 0 1.2632109226410638e-17
at O 0 3.104766022117458e-15
the O 0 1.6479227159157386e-15
5 O 0 2.2438866357447212e-13
end O 0 5.862690432949236e-14
spanning O 0 3.9661858324512023e-13
exons O 0 1.2259760914790085e-11
4 O 0 4.7737753691452084e-14
and O 0 1.4862326389660126e-14
5 O 0 1.643678657333521e-15
, O 0 1.6749523313560114e-16
( O 0 2.536266245829213e-18
2 O 0 6.916100776692207e-17
) O 0 1.5210103011830395e-18
within O 0 1.7203512128336982e-18
exon O 0 4.406321973417747e-14
9 O 0 2.7041259856308564e-13
, O 0 3.3725065722392013e-15
and O 0 4.20008317269507e-15
( O 0 1.3095940001551785e-17
3 O 0 9.545083257199682e-17
) O 0 3.9584989602798706e-17
at O 0 5.680122476157349e-15
the O 0 3.685972396073455e-16
3 O 0 1.3066966366088225e-14
distal O 0 7.288729082094436e-13
end O 0 1.3184613990857574e-13
of O 0 6.34552323272025e-19
the O 0 4.669114008830865e-16
gene O 0 5.4378633540519417e-11
. O 0 8.296077583583306e-13

Variability O 0 1.4084761801314016e-07
in O 0 5.17117891815134e-15
the O 0 5.887201914728528e-16
number O 0 1.7358702908247536e-13
of O 0 1.7274455520535636e-12
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 3.06801251070965e-09
most O 0 1.5440107256498308e-15
apparent O 0 6.32988534634768e-14
in O 0 2.165151705366328e-17
individuals O 0 2.101644252093079e-18
with O 0 7.663084309799198e-16
mutations O 0 9.541890888531412e-11
in O 0 1.1984697758063065e-15
region O 0 3.358005280090781e-12
1 O 0 1.3284037193546979e-14
, O 0 5.581896978055362e-14
and O 0 1.9039289589350972e-10
upper O 0 0.0018167978851124644
- O 0 0.4403982162475586
gastrointestinal O 0 0.002827566582709551
manifestations O 0 5.8130601027217566e-11
were O 0 1.8043887171632737e-14
more O 0 7.643495084707166e-16
severe O 0 4.5422937633432525e-10
in O 0 1.3002915005166276e-15
them O 0 9.779059750554889e-14
. O 0 4.296871452397211e-12

In O 0 6.996568038472595e-14
individuals O 0 1.1741369544514138e-16
with O 0 3.1616330613390333e-15
mutations O 0 1.117423445440302e-10
in O 0 1.2556213122190407e-15
either O 0 5.779911705500185e-12
region O 0 4.745488446644686e-10
2 O 0 3.982453201847175e-13
or O 0 4.92667396408044e-14
region O 0 8.889538410938869e-12
3 O 0 1.1240005237320161e-14
, O 0 7.38240300206754e-16
the O 0 6.163591412395566e-17
average O 0 1.4756570938063637e-14
number O 0 1.4232607262441323e-16
of O 0 3.135253783568156e-18
adenomas B-Disease 0 3.189916664148029e-10
tended O 0 6.32279062440233e-10
to O 0 3.376022267190075e-14
be O 0 3.641183729042371e-15
lower O 0 1.1328550673494336e-14
than O 0 1.5587398080394154e-16
those O 0 1.027587218209966e-16
in O 0 1.5250199558048137e-17
individuals O 0 6.837631073703946e-19
with O 0 1.1702600581820513e-16
mutations O 0 1.3112025354367063e-11
in O 0 6.569051790565215e-16
region O 0 8.089216796403065e-12
1 O 0 1.5982453982295764e-15
, O 0 5.77110916716463e-16
although O 0 1.6615081164204903e-13
age O 0 3.877781545847357e-14
at O 0 1.1073515829339645e-14
diagnosis O 0 5.11043207751527e-09
was O 0 3.4222675556047286e-14
similar O 0 4.473654655274065e-14
. O 0 5.937735112621079e-12

In O 0 7.274621443426055e-12
all O 0 1.1846586212005406e-11
AAPC B-Disease 1 0.9999924898147583
kindreds O 0 3.5506434414855903e-07
, O 0 6.330642932615704e-15
a O 0 5.638690918333589e-16
predominance O 0 2.6882072956535552e-11
of O 0 1.98789548292225e-15
right O 0 0.00032413442386314273
- O 1 0.999936580657959
sided O 1 0.9999986886978149
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 1.624533865651756e-06
rectal B-Disease 0 0.06296000629663467
polyp I-Disease 0 5.019219315727241e-07
sparing O 0 3.4795950842880785e-11
was O 0 1.0933964671167029e-11
observed O 0 2.167757466586817e-11
. O 0 1.6218071807391765e-12

No O 0 9.418636182090268e-07
desmoid B-Disease 0 0.11510787159204483
tumors I-Disease 1 1.0
were O 0 1.4402446249506262e-11
found O 0 6.434095877611012e-13
in O 0 2.1040781218576755e-15
these O 0 1.0529730163971393e-13
kindreds O 0 1.9505168893374503e-06
. O 0 5.318472225124271e-12

Our O 0 1.4668424461183882e-11
data O 0 5.75827295459623e-14
suggest O 0 7.778900543457465e-14
that O 0 8.485308403182248e-15
, O 0 1.3802678008249629e-14
in O 0 3.301429157723072e-14
AAPC B-Disease 1 1.0
families O 0 3.0732703301715805e-14
, O 0 6.718594200088431e-18
the O 0 1.67739872215354e-19
location O 0 4.4437621849391026e-14
of O 0 6.189503527507795e-19
the O 0 2.3040635536164815e-16
APC B-Disease 0 9.804662637336037e-11
mutation O 0 2.149547900787141e-10
may O 0 8.444016970018953e-13
partially O 0 1.3910696206043127e-10
predict O 0 2.3722258532532514e-11
specific O 0 1.3703267849867612e-13
phenotypic O 0 3.662550485117322e-09
expression O 0 3.739035747685193e-09
. O 0 9.843975634638014e-11

This O 0 3.5124114445943266e-13
should O 0 1.8768553334755356e-13
help O 0 2.0276823939300177e-16
in O 0 1.857178673473698e-19
the O 0 6.263924036641002e-18
design O 0 4.3293645578257323e-13
of O 0 1.9814429976883034e-17
tailored O 0 1.126437787490886e-08
clinical O 0 1.6332752750258805e-07
- O 0 8.38698888117051e-09
management O 0 4.817190049632991e-12
protocols O 0 7.220177960284152e-14
in O 0 5.800325285661676e-18
this O 0 2.348509895259783e-18
subset O 0 5.6489630986431786e-15
of O 0 9.858521347322358e-18
FAP B-Disease 0 2.3075626132129656e-10
patients O 0 2.6247420036040747e-12
. O 0 1.3466587193240384e-15
. O 0 3.1696303567918527e-13

Wilms B-Disease 0 0.00023624028835911304
' I-Disease 0 9.941689249615138e-09
tumor I-Disease 0 7.848864242987474e-07
1 O 0 1.8022776738894908e-13
and O 0 7.468367829548128e-13
Dax O 0 3.230541551602073e-05
- O 0 4.809979081699112e-10
1 O 0 3.1578843052727226e-15
modulate O 0 6.8344739589942805e-12
the O 0 7.797757783852303e-16
orphan O 0 1.1519017076994098e-12
nuclear O 0 2.1488395101926933e-13
receptor O 0 3.153456228782714e-14
SF O 0 1.093961277121025e-08
- O 0 1.4388999713954576e-10
1 O 0 5.3294919170920104e-15
in O 0 3.3267844351955736e-17
sex O 0 3.598944601536369e-13
- O 0 1.5318212735586367e-13
specific O 0 2.3541194950300664e-15
gene O 0 3.474645701370682e-12
expression O 0 9.909844212591112e-13
. O 0 2.378122113295966e-13

Products O 0 2.377644747753038e-10
of O 0 3.7253263408962777e-16
steroidogenic O 0 1.369067748058228e-09
factor O 0 1.376472828946984e-12
1 O 0 7.083225353504046e-15
( O 0 1.8002626502706086e-15
SF O 0 0.0001410903932992369
- O 0 3.398056378500769e-07
1 O 0 9.65422837159724e-13
) O 0 4.371531280955403e-14
and O 0 2.88348490050383e-12
Wilms B-Disease 0 3.2664813716110075e-06
tumor I-Disease 0 2.3202363763630274e-07
1 O 0 4.346669423997479e-15
( O 0 2.6641385829832647e-16
WT1 O 0 6.069791891327725e-10
) O 0 3.075119763084439e-16
genes O 0 1.2248523321902599e-14
are O 0 1.9341765739980433e-18
essential O 0 7.654403810276617e-17
for O 0 1.3592029166221275e-18
mammalian O 0 2.989155147362088e-13
gonadogenesis O 0 9.760584701590247e-12
prior O 0 1.6788360303587315e-15
to O 0 1.964667377819034e-16
sexual O 0 1.1738163609512076e-13
differentiation O 0 2.7200713903496876e-11
. O 0 6.707871671313148e-12

In O 0 2.3101483291425307e-13
males O 0 2.9663909674980393e-13
, O 0 1.0102922459124392e-13
SF O 0 0.0002431595785310492
- O 0 1.8361320996973518e-07
1 O 0 1.993844000493239e-13
participates O 0 1.018861034494771e-13
in O 0 3.972387322764636e-16
sexual O 0 8.387666680187509e-15
development O 0 8.574188615893936e-18
by O 0 8.524412867437193e-20
regulating O 0 1.292000445567371e-14
expression O 0 1.7303128060138645e-14
of O 0 1.0615325640154527e-18
the O 0 6.877587247371738e-16
polypeptide O 0 2.668581466913622e-10
hormone O 0 1.036632463354524e-13
Mullerian O 0 9.253799983233169e-12
inhibiting O 0 2.736545365311649e-12
substance O 0 2.283493706622952e-11
( O 0 1.480334070927923e-14
MIS O 0 7.820897280907957e-07
) O 0 6.069154375029293e-14
. O 0 2.8202678907518486e-13

Here O 0 2.05866546032496e-10
, O 0 1.161939197202172e-13
we O 0 4.791006390984613e-14
show O 0 1.5129041140531096e-13
that O 0 3.2335484879015284e-15
WT1 O 0 9.162123149053514e-08
- O 0 1.3445223823183028e-09
KTS O 0 9.272966394746618e-09
isoforms O 0 1.6644938465731896e-12
associate O 0 2.89515698741194e-12
and O 0 2.5134243695519717e-15
synergize O 0 3.8033937110881766e-11
with O 0 8.366037355066192e-14
SF O 0 0.0007895390735939145
- O 0 5.023926519243105e-07
1 O 0 5.464088925245802e-13
to O 0 4.400425946478499e-14
promote O 0 1.4637931491923162e-11
MIS O 0 2.2506130335386842e-05
expression O 0 2.967016562993585e-11
. O 0 8.095386882546463e-13

In O 0 1.7987242554792782e-12
contrast O 0 3.772140239055588e-11
, O 0 5.292806123935456e-13
WT1 O 0 1.057919803315599e-06
missense O 0 2.5701929473598284e-08
mutations O 0 3.5715441715211682e-09
, O 0 3.411959619916853e-16
associated O 0 3.666854078948449e-14
with O 0 2.848672632418253e-13
male B-Disease 0 1.0963241692252268e-07
pseudohermaphroditism I-Disease 1 0.9999998807907104
in O 0 3.2909071023823344e-09
Denys B-Disease 1 0.9999773502349854
- I-Disease 1 0.9999921321868896
Drash I-Disease 1 0.999981164932251
syndrome I-Disease 1 0.9999991655349731
, O 0 2.0363670873244782e-13
fail O 0 2.010695603071877e-11
to O 0 1.8625664234036947e-16
synergize O 0 1.0525214033663133e-09
with O 0 1.1835694100140182e-12
SF O 0 0.026772089302539825
- O 0 1.338734250566631e-06
1 O 0 5.4890571254961884e-12
. O 0 7.537789836753461e-13

Additionally O 0 4.386898830310848e-11
, O 0 5.314237954854792e-14
the O 0 1.966888007039159e-15
X O 0 4.6758839289395837e-07
- O 0 3.9287963993217545e-09
linked O 0 3.296127371044122e-09
, O 0 8.334179937700189e-15
candidate O 0 1.8306236992319917e-14
dosage O 0 2.752395967392518e-12
- O 0 8.381114541527318e-14
sensitive O 0 1.0663513258166168e-12
sex O 0 1.8898385460708322e-12
- O 0 3.3292796687914294e-13
reversal O 0 7.94568512547944e-13
gene O 0 4.342563635073571e-13
, O 0 6.437351402156972e-16
Dax O 0 6.877769020974256e-09
- O 0 3.6878221830460856e-12
1 O 0 5.895652127168574e-16
, O 0 3.42330192047618e-16
antagonizes O 0 6.436177285573663e-11
synergy O 0 3.4868264417280137e-13
between O 0 5.97275999275268e-14
SF O 0 3.816834941972047e-05
- O 0 1.2653821990227243e-08
1 O 0 6.193924361038924e-14
and O 0 9.248740045575497e-15
WT1 O 0 1.6240313260862393e-10
, O 0 9.043246676198051e-16
most O 0 1.0852070314936339e-17
likely O 0 4.4023356881372024e-16
through O 0 3.4414309132931143e-19
a O 0 5.86028595390442e-18
direct O 0 3.130058584741149e-16
interaction O 0 8.529671753794692e-15
with O 0 4.487739119121009e-14
SF O 0 0.10025972127914429
- O 0 3.160319920425536e-06
1 O 0 1.640349661657936e-11
. O 0 2.661787240273994e-12

We O 0 2.847536095806902e-10
propose O 0 5.525085597368751e-12
that O 0 1.9568119572085062e-14
WT1 O 0 9.951477863978653e-09
and O 0 1.6734229019849112e-12
Dax O 0 7.981183784977475e-07
- O 0 6.308669558974245e-11
1 O 0 6.042650989395413e-16
functionally O 0 5.661453869999864e-15
oppose O 0 1.043479792996833e-14
each O 0 3.165781339023762e-17
other O 0 2.3851322829048025e-16
in O 0 2.2814472445291997e-15
testis O 0 4.750308590928398e-09
development O 0 9.959075639428346e-16
by O 0 1.033739688344462e-17
modulating O 0 3.074129275790205e-12
SF O 0 2.132247027475387e-05
- O 0 1.7001420715700988e-08
1 O 0 2.0660192306953817e-12
- O 0 1.3431433742994159e-09
mediated O 0 3.9533673557023974e-10
transactivation O 0 2.3102413315712056e-09
. O 0 1.1735252526678952e-13
. O 0 1.6744948255677933e-13

A O 0 1.1473873934297885e-11
mouse O 0 3.2702895946812305e-09
model O 0 5.351449061663516e-09
for O 0 2.2899716844992923e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999997615814209
imprinting O 0 0.0007387491059489548
- O 0 7.764110341668129e-05
centre O 0 1.372223152884544e-07
mutations O 0 5.137611225336514e-09
. O 0 3.43726918672696e-13

Imprinting O 0 9.44457951845834e-08
in O 0 9.161694704750908e-14
the O 0 1.5722855959895976e-14
15q11 O 0 3.065051823458731e-10
- O 0 2.6180146939225324e-10
q13 O 0 8.06235703199043e-11
region O 0 1.0627103038708674e-13
involves O 0 3.7585141505608853e-16
an O 0 2.7929703752016226e-18
imprinting O 0 2.1550417006466205e-09
centre O 0 1.4624181032818484e-10
( O 0 3.177759906910265e-17
IC O 0 5.53509730657673e-15
) O 0 1.4601943075074005e-17
, O 0 3.511479969344374e-17
mapping O 0 2.7352797896682338e-14
in O 0 2.6999765800688186e-17
part O 0 1.1295533752726837e-15
to O 0 1.206418862378933e-15
the O 0 1.9163822646608026e-17
promoter O 0 1.821681043859269e-12
and O 0 4.09779886211643e-15
first O 0 1.3163454483148363e-17
exon O 0 1.2093460727193722e-13
of O 0 8.733874244960522e-16
SNRPN O 0 1.2404292419887497e-06
. O 0 1.015420386663024e-11

Deletion O 0 1.097426327589801e-08
of O 0 1.8789944950667938e-16
this O 0 9.855748207775162e-16
IC O 0 7.126495921161435e-11
abolishes O 0 8.696665609875254e-10
local O 0 8.383848086254697e-14
paternally O 0 1.2842092840525954e-11
derived O 0 1.1997688067100394e-15
gene O 0 7.473112298254925e-13
expression O 0 5.657832058761358e-13
and O 0 6.76722621082565e-13
results O 0 2.9274216384322926e-10
in O 0 1.1682960376901974e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.406574576400814e-11
PWS B-Disease 1 0.9999855756759644
) O 0 6.544428193810958e-12
. O 0 1.3479867179075344e-12

We O 0 4.161405442459909e-09
have O 0 1.530518062547309e-14
created O 0 2.3781725837541284e-16
two O 0 9.904216491808237e-16
deletion O 0 2.7255349019372765e-11
mutations O 0 1.8645333541011944e-11
in O 0 5.509247343334187e-16
mice O 0 1.5232454586566746e-07
to O 0 3.943608406411364e-13
understand O 0 1.1270008037911339e-08
PWS B-Disease 1 0.9999998807907104
and O 0 2.6249521219851024e-12
the O 0 1.3550007233050724e-16
mechanism O 0 3.038877870249388e-15
of O 0 4.123835273109814e-20
this O 0 1.5171352702059583e-16
IC O 0 1.6585717174666392e-11
. O 0 2.0101335960337474e-13

Mice O 0 1.8564736819826066e-05
harbouring O 0 1.0533689476233121e-09
an O 0 3.1784420066608213e-15
intragenic O 0 8.395154083018497e-08
deletion O 0 4.4861177883603887e-08
in O 0 6.372295269577166e-14
Snrpn O 0 1.1335358976793941e-05
are O 0 4.708704129732788e-13
phenotypically O 0 7.2716495047586704e-09
normal O 0 5.991507290303844e-10
, O 0 4.863658524452983e-15
suggesting O 0 1.2389225658836905e-13
that O 0 5.88044915631478e-15
mutations O 0 2.36322419966406e-12
of O 0 1.6424341854018357e-19
SNRPN O 0 9.524548927331011e-10
are O 0 6.634221446735777e-17
not O 0 3.9833587817117433e-16
sufficient O 0 5.264967805906375e-16
to O 0 1.2817650688393394e-14
induce O 0 3.6364699695923264e-08
PWS B-Disease 1 0.9999977350234985
. O 0 6.057844781359734e-10

Mice O 0 1.4239882375477464e-06
with O 0 2.8605594354022285e-16
a O 0 6.29093884554831e-17
larger O 0 1.3924358738045682e-15
deletion O 0 2.8693358453124596e-12
involving O 0 6.945056915631451e-15
both O 0 3.9360391167067924e-14
Snrpn O 0 1.7264675022943266e-08
and O 0 8.042225468473524e-14
the O 0 5.9199945835232415e-15
putative O 0 6.098132665499634e-09
PWS O 1 0.9999924898147583
- O 0 8.849104915498174e-07
IC O 0 1.127438808978809e-09
lack O 0 1.1943320681398473e-12
expression O 0 1.3395147587436009e-14
of O 0 1.1817701936876654e-18
the O 0 2.833516849769951e-16
imprinted O 0 5.302893107267392e-12
genes O 0 2.5820895768746688e-11
Zfp127 O 0 1.061037480099003e-09
( O 0 6.9639991134308986e-15
mouse O 0 2.4830210110238227e-10
homologue O 0 3.03338257290342e-11
of O 0 7.766676439248399e-16
ZNF127 O 0 2.8705843035936596e-08
) O 0 1.6881810484042567e-14
, O 0 6.0958348117249716e-15
Ndn O 0 2.932396769850243e-09
and O 0 9.550665786657239e-15
Ipw O 0 7.385988487484951e-10
, O 0 2.1914387622265497e-13
and O 0 1.5712303623439082e-14
manifest O 0 3.635728836862053e-15
several O 0 2.8385799892121635e-16
phenotypes O 0 3.462454975511342e-11
common O 0 3.0477868492861937e-12
to O 0 2.2687646206165368e-10
PWS B-Disease 1 0.9999998807907104
infants O 0 0.0005505491863004863
. O 0 1.4415060291261828e-11

These O 0 4.719059412444833e-14
data O 0 1.3245067960500887e-15
demonstrate O 0 1.8268547202540653e-16
that O 0 9.135541503713248e-17
both O 0 1.9293148695785997e-16
the O 0 1.9568808951025008e-16
position O 0 4.731000544122045e-14
of O 0 1.3813328155918825e-20
the O 0 3.541301650224258e-18
IC O 0 4.235399364397891e-15
and O 0 1.215180200608417e-16
its O 0 8.916901951383844e-18
role O 0 4.0369488622186284e-14
in O 0 2.0423074765555472e-16
the O 0 6.84907201555132e-17
coordinate O 0 8.313259070935955e-14
expression O 0 1.2145968596055548e-15
of O 0 7.978794841874413e-20
genes O 0 1.4332107481601457e-14
is O 0 1.3213159766156675e-17
conserved O 0 1.4161512504925599e-14
between O 0 2.994198110479497e-14
mouse O 0 1.2017700328215142e-06
and O 0 4.9402221896643894e-11
human O 0 4.052536951848484e-12
, O 0 8.581798330775312e-14
and O 0 2.4477068524711258e-14
indicate O 0 3.9454065557144313e-13
that O 0 8.635184848089148e-16
the O 0 9.321624054313177e-17
mouse O 0 2.5021505700717483e-11
is O 0 1.8985695919139632e-17
a O 0 1.2589295185085506e-17
suitable O 0 5.4467894631442595e-15
model O 0 3.765670414379585e-11
system O 0 3.2839985071586586e-12
in O 0 5.61773585261411e-16
which O 0 5.9100440639753716e-15
to O 0 3.9451446255985695e-16
investigate O 0 1.54665827535724e-14
the O 0 1.716320858017095e-17
molecular O 0 1.9985489974646935e-14
mechanisms O 0 3.1187864926252376e-14
of O 0 8.436228305555651e-20
imprinting O 0 5.250981247040265e-11
in O 0 5.346657886801066e-15
this O 0 2.585474897869554e-15
region O 0 1.3020475268712278e-13
of O 0 5.379031446340456e-19
the O 0 1.3667433792808752e-16
genome O 0 1.1220262593385558e-13
. O 0 8.304059551974944e-16
. O 0 1.0159386353014721e-13

Mutations O 0 1.7091744908270812e-08
of O 0 4.3951851418756e-17
the O 0 1.2406657014556248e-16
ATM O 0 7.0944582673815315e-12
gene O 0 1.4926098551582e-11
detected O 0 8.993471939389153e-11
in O 0 1.388512243551132e-13
Japanese O 1 0.5514237880706787
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.022813070565462112
: O 0 5.304503598115061e-15
possible O 0 1.4221597422313793e-15
preponderance O 0 1.3166257147034788e-11
of O 0 7.39496655208324e-18
the O 0 8.180896990977229e-17
two O 0 5.603225648832051e-16
founder O 0 9.175619248777411e-13
mutations O 0 1.5190617860816324e-11
4612del165 O 0 4.8695878059057396e-12
and O 0 4.871700848177278e-14
7883del5 O 0 6.442554822960744e-10
. O 0 1.9825820672669803e-12

The O 0 6.774480743087022e-14
ATM O 0 1.1715009518020736e-10
( O 0 3.4929387941057266e-12
A O 1 0.9999992847442627
- O 1 0.9999992847442627
T O 1 1.0
, O 0 1.6856955284763608e-12
mutated O 0 5.511299749905163e-11
) O 0 1.981965775835437e-16
gene O 0 1.7538383668535412e-13
on O 0 8.565668959987106e-15
human O 0 1.5224778902866998e-12
chromosome O 0 5.252110923947839e-08
11q22 O 0 9.62218749123167e-09
. O 0 5.5975007615116645e-12

3 O 0 8.159919406836025e-10
has O 0 2.0757211921518248e-11
recently O 0 9.959703201056769e-12
been O 0 2.7950105202295336e-15
identified O 0 1.2460259112343072e-15
as O 0 1.9435251624859645e-18
the O 0 3.81100306176656e-19
gene O 0 2.752517630122864e-15
responsible O 0 3.646615142528182e-17
for O 0 3.2846882005264996e-19
the O 0 9.695035776253157e-15
human O 0 6.664575380455062e-07
recessive B-Disease 1 0.9999945163726807
disease I-Disease 1 0.9999998807907104
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.00015278712089639157
A B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
T I-Disease 1 0.9999998807907104
) O 0 2.1866021146510484e-11
. O 0 4.536260961047339e-13

In O 0 8.96750308423044e-15
order O 0 2.9091460922896824e-15
to O 0 1.5491772692860574e-17
define O 0 9.996253228384405e-14
the O 0 1.9614100067412492e-16
types O 0 2.119556700291847e-12
of O 0 2.4434003675606955e-15
disease O 0 5.4378783715947066e-06
- O 0 8.070962231876422e-10
causing O 0 8.950462766776912e-12
ATM O 0 2.861103021167821e-10
mutations O 0 3.312992380433144e-10
in O 0 1.385748654565114e-15
Japanese O 0 5.130730187374866e-07
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
patients O 0 6.440518784955884e-09
as O 0 7.499313401123335e-17
well O 0 5.157560785646528e-17
as O 0 1.16581272161866e-17
to O 0 1.822037518151577e-17
look O 0 1.0942125772627452e-14
for O 0 6.62195200078687e-19
possible O 0 8.608347138550987e-16
mutational O 0 7.2525416228153e-11
hotspots O 0 3.928130824087939e-12
, O 0 4.9643388087394075e-14
reverse O 0 3.932462355749067e-09
- O 0 1.992542068840475e-11
transcribed O 0 5.5144096754167204e-12
RNA O 0 2.675511201477576e-11
derived O 0 1.1967788068760113e-16
from O 0 2.081084186829585e-19
ten O 0 1.6439473520662578e-16
patients O 0 2.7250793609902104e-17
belonging O 0 7.560257090806037e-19
to O 0 1.0070196866074678e-17
eight O 0 2.46349315373987e-16
unrelated O 0 2.011713820700145e-13
Japanese O 0 1.3790498996968381e-05
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
families O 0 2.481332847525941e-12
was O 0 2.1159270963502265e-14
analyzed O 0 3.951125789936928e-15
for O 0 4.6267643167163226e-20
mutations O 0 1.1939932066800676e-15
by O 0 3.3996880837859354e-20
the O 0 2.0461567439584747e-19
restriction O 0 2.893012571040035e-14
endonuclease O 0 1.1240494646180821e-11
fingerprinting O 0 1.4716962024041713e-11
method O 0 1.0120864649826311e-12
. O 0 1.8602614837003734e-13

As O 0 8.405391833943288e-12
has O 0 8.133553509523384e-13
been O 0 8.270296289301796e-16
reported O 0 2.065413185397885e-15
by O 0 4.474214763420498e-19
others O 0 2.9168900380703957e-16
, O 0 2.8377231624464566e-17
mutations O 0 1.4183299886394874e-14
that O 0 2.569386929787112e-17
lead O 0 3.762197462744109e-14
to O 0 3.912513425768149e-18
exon O 0 2.9315522990895626e-13
skipping O 0 1.430300544669194e-09
or O 0 2.1018271758460605e-12
premature O 0 1.2385805272033257e-12
protein O 0 4.574310114718871e-12
truncation O 0 2.6055607671437997e-10
were O 0 1.416007588961321e-11
also O 0 5.7689887589251754e-11
predominant O 0 4.3014002082397695e-11
in O 0 1.0139557819939266e-14
our O 0 1.7695807113474876e-13
mutants O 0 1.1977271605068118e-11
. O 0 9.24934364125371e-14

Six O 0 3.2397886456925207e-12
different O 0 1.2937654292953884e-15
mutations O 0 1.3542637877003022e-13
were O 0 2.806064644298337e-17
identified O 0 2.2893731859265423e-14
on O 0 1.800874885684884e-14
12 O 0 7.832105393379939e-15
of O 0 1.4653543325468099e-19
the O 0 6.465382898755169e-16
16 O 0 4.1734773596020444e-14
alleles O 0 8.510726845489813e-14
examined O 0 1.6190518370429174e-10
. O 0 6.312249442759488e-13

Four O 0 1.9483439655468976e-13
were O 0 3.2006455460049943e-16
deletions O 0 1.075471634491565e-12
involving O 0 4.11570700209387e-14
a O 0 1.3971008865857476e-13
loss O 0 6.930428995445548e-13
of O 0 5.634937863409635e-20
a O 0 3.2830271763615595e-16
single O 0 7.194134577068103e-16
exon O 0 1.4107978836813e-13
exon O 0 1.9435246814691887e-11
7 O 0 4.475733585834751e-12
, O 0 3.3214368382668714e-15
exon O 0 4.827307824306626e-12
16 O 0 4.283057469887247e-13
, O 0 4.2483585979139675e-16
exon O 0 1.221573298244849e-12
33 O 0 1.3664757693432339e-11
or O 0 2.263865593401279e-15
exon O 0 1.0882143103296826e-10
35 O 0 2.3433304185971338e-09
. O 0 3.355318106690319e-11

The O 0 1.121529220405107e-14
others O 0 5.20960732066061e-16
were O 0 1.1860392231982149e-16
minute O 0 9.241117807841392e-16
deletions O 0 6.921871929799206e-12
, O 0 4.2730330382444e-15
4649delA O 0 4.981607140686073e-12
in O 0 1.2873345698713765e-17
exon O 0 9.802127642552505e-13
33 O 0 4.248336751833115e-11
and O 0 1.158870921994697e-14
7883del5 O 0 2.4046877770272923e-12
in O 0 9.531075449834464e-17
exon O 0 2.0518942447922406e-11
55 O 0 1.3558476563702015e-10
. O 0 1.9032154324749584e-12

The O 0 2.6853669028020777e-12
mutations O 0 1.213539407851627e-10
4612del165 O 0 8.377063799580586e-12
and O 0 1.7480255990178438e-15
7883del5 O 0 6.0010931770757e-13
were O 0 1.3356896426570952e-15
found O 0 2.735026505641181e-16
in O 0 2.92851405153094e-19
more O 0 1.0450148140832315e-19
than O 0 4.570982280584861e-18
two O 0 2.2243318459830667e-17
unrelated O 0 1.7931825136227467e-15
families O 0 1.1857897951563056e-17
; O 0 2.180526056462514e-18
44 O 0 4.961586478409445e-17
% O 0 9.221378449468182e-20
( O 0 4.210600367210821e-18
7 O 0 4.38872291576276e-15
of O 0 2.4611704471234333e-18
16 O 0 3.1592357039884195e-14
) O 0 1.9567457007031852e-17
of O 0 9.32356142763005e-21
the O 0 6.5124314265284706e-18
mutant O 0 3.0805254722966746e-13
alleles O 0 5.2781223334563525e-15
had O 0 2.4938127951568134e-11
one O 0 1.1824749350259484e-16
of O 0 3.3061959950521294e-20
the O 0 9.936984226070566e-17
two O 0 3.187538124074796e-14
mutations O 0 1.216426820382921e-10
. O 0 7.443636635892648e-13

The O 0 1.5786689718053776e-13
4612del165 O 0 1.341728551179644e-11
mutations O 0 3.6397308778024495e-12
in O 0 1.4623898723277847e-18
three O 0 8.619378319938321e-18
different O 0 1.2856408141695977e-18
families O 0 1.1619937528075945e-18
were O 0 5.966120818148436e-18
all O 0 4.701382470317141e-20
ascribed O 0 4.3934609004323455e-16
to O 0 6.100899724642417e-17
the O 0 2.834239739450873e-17
same O 0 9.684834958469373e-15
T O 0 1.377256919621317e-10
- O 0 3.5966252220388795e-13
- O 0 1.4506312004478744e-13
> O 0 5.049921493070677e-16
A O 0 2.922825158227137e-17
substitution O 0 2.0464329240553697e-16
at O 0 1.0845661981294768e-16
the O 0 5.51794939918353e-18
splice O 0 4.7078830417435213e-11
donor O 0 8.8630283464502e-15
site O 0 3.6513672673540304e-14
in O 0 2.04972317059942e-15
intron O 0 2.642605920755159e-07
33 O 0 1.7338289692858666e-09
. O 0 1.959230304035553e-12

Microsatellite O 0 1.0702437691634259e-07
genotyping O 0 2.424564105041327e-09
around O 0 3.3000205758131063e-13
the O 0 4.3681931135223617e-16
ATM O 0 1.4408380738517579e-11
locus O 0 5.641894286825822e-13
also O 0 6.593351082120891e-13
indicated O 0 7.714747894335683e-13
that O 0 1.2671787591469704e-16
a O 0 5.128507621730155e-16
common O 0 2.1565236490945832e-15
haplotype O 0 1.3288321831783634e-10
was O 0 2.1769172835889306e-12
shared O 0 3.7689231266914566e-16
by O 0 3.0860087231731536e-19
the O 0 6.414425413191963e-18
mutant O 0 1.5715288228732027e-12
alleles O 0 2.4953409361060976e-14
in O 0 2.88176358174776e-16
both O 0 5.868824306740072e-13
mutations O 0 8.704934550962662e-09
. O 0 4.493010564293742e-12

This O 0 1.7553318824511943e-12
suggests O 0 2.8236820433930054e-12
that O 0 4.373647846884002e-15
these O 0 2.2255380407522915e-16
two O 0 1.7113987032384858e-16
founder O 0 6.043593902237132e-13
mutations O 0 1.6471538022422294e-10
may O 0 1.2557991891379641e-14
be O 0 3.1517794873589546e-17
predominant O 0 1.2729753232423868e-13
among O 0 5.639959350172102e-16
Japanese O 0 1.554634372624708e-11
ATM O 0 2.0821963944706035e-11
mutant O 0 1.6206987141220708e-10
alleles O 0 9.62661547698751e-12
. O 0 1.5284366654266801e-12

W474C O 0 4.612707438234054e-10
amino O 0 6.205788378836619e-13
acid O 0 3.933155138927981e-15
substitution O 0 1.5751776735209672e-16
affects O 0 6.240104427916639e-16
early O 0 4.8572194461624045e-17
processing O 0 8.943619719733184e-16
of O 0 1.3956656584089244e-20
the O 0 2.9641650189440926e-19
alpha O 0 2.0443632354447008e-18
- O 0 4.483035362523427e-17
subunit O 0 9.46534834010549e-17
of O 0 4.973934281626816e-20
beta O 0 2.0680374258173767e-16
- O 0 2.586779802946776e-13
hexosaminidase O 0 5.021674482491578e-12
A O 0 6.159805196297163e-14
and O 0 2.7310349687563636e-15
is O 0 2.88004767828508e-17
associated O 0 4.932117675425854e-14
with O 0 3.431352830996978e-14
subacute O 0 0.0004043829394504428
G B-Disease 0 1.2152702311141184e-07
( I-Disease 0 3.675597830656366e-15
M2 I-Disease 0 3.411280424803209e-10
) I-Disease 0 3.0902311959346562e-12
gangliosidosis I-Disease 0 4.036415361952095e-07
. O 0 6.801005592027565e-11

Mutations O 0 4.22592478344086e-07
in O 0 1.3754270075314046e-14
the O 0 2.5860271633511636e-15
HEXA O 0 6.694892418224185e-10
gene O 0 2.1321983620977564e-13
, O 0 4.977508050839866e-18
encoding O 0 2.4145630382271942e-17
the O 0 1.4336889798188791e-18
alpha O 0 3.2944653719693e-18
- O 0 2.074532447987143e-16
subunit O 0 2.3904620789067226e-15
of O 0 4.423371073094161e-19
beta O 0 1.7814352254355136e-15
- O 0 2.656836773154425e-12
hexosaminidase O 0 1.385825395411322e-11
A O 0 6.8510917391442685e-15
( O 0 2.5856681603478707e-18
Hex O 0 3.13895197540711e-14
A O 0 4.348892038451074e-15
) O 0 6.605178225530366e-18
, O 0 3.4840590974743634e-18
that O 0 3.429325383522342e-17
abolish O 0 9.459832223113196e-12
Hex O 0 4.363272763929782e-12
A O 0 9.921578126128108e-15
enzyme O 0 1.5685722035488348e-13
activity O 0 2.2200448077103196e-11
cause O 0 1.7506846461401437e-06
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 0 0.4862944185733795
( O 0 4.5330427318914426e-17
TSD B-Disease 0 2.4307987914196083e-11
) O 0 4.697788721073383e-16
, O 0 8.41252794422237e-16
the O 0 4.2915927159648676e-14
fatal O 0 1.2539275076051126e-06
infantile B-Disease 0 3.0990408959041815e-06
form I-Disease 0 1.619800864618992e-12
of I-Disease 0 1.2581626228190404e-15
G I-Disease 0 2.524183457808249e-07
( I-Disease 0 2.4658729986842993e-15
M2 I-Disease 0 1.430081608688738e-10
) I-Disease 0 9.249767157727337e-14
gangliosidosis I-Disease 0 8.790859151730501e-10
, I-Disease 0 3.3494962446006804e-13
Type I-Disease 0 5.123288246977609e-07
1 I-Disease 0 3.402400540128414e-12
. O 0 1.2163171511647697e-11

Less O 0 4.8827043103161216e-11
severe O 0 5.894394305983042e-08
, O 0 2.713089356041337e-13
subacute O 0 0.00018025128520093858
( O 0 2.8853002886214396e-12
juvenile O 0 0.00013222494453657418
- O 0 0.09761413186788559
onset O 1 0.7046606540679932
) O 0 1.8131345036476176e-10
and O 0 2.8322733047758675e-09
chronic O 0 0.0001390986581100151
( O 0 3.392818930534128e-14
adult O 0 2.45199931470097e-08
- O 0 0.0001230688503710553
onset O 0 3.7167158097872743e-06
) O 0 2.2937516686374892e-15
variants O 0 7.177123478863123e-13
are O 0 2.88220350948474e-16
characterized O 0 1.4818228160360172e-14
by O 0 4.217673588628762e-18
a O 0 2.978975488461327e-15
broad O 0 2.5563856587140776e-12
spectrum O 0 1.6159519740117229e-13
of O 0 3.935507309717837e-17
clinical O 0 1.6768722521653956e-10
manifestations O 0 5.733747894878793e-13
and O 0 2.8709463886761712e-15
are O 0 1.0708101183682709e-17
associated O 0 2.2615879641577595e-14
with O 0 2.5135872116360813e-15
residual O 0 2.2852433279041406e-09
levels O 0 1.5519848860917618e-12
of O 0 1.6950176692009195e-18
Hex O 0 2.626696429808284e-11
A O 0 9.037703311426393e-14
enzyme O 0 1.3424805971745668e-12
activity O 0 1.8960846347865212e-12
. O 0 4.4124466992527533e-13

We O 0 1.2285797379441021e-10
identified O 0 4.2569469000178217e-13
a O 0 1.0401647177995165e-15
1422 O 0 2.1515319040266156e-11
G O 0 3.592414143938072e-10
- O 0 4.5285566963038093e-10
- O 0 1.6226854304690619e-09
> O 0 1.1044844726304515e-11
C O 0 2.300107587033251e-12
( O 0 4.9646697941427365e-18
amino O 0 5.958689377894423e-16
acid O 0 3.31892555763183e-17
W474C O 0 3.010571484990027e-17
) O 0 2.0230810221194022e-20
substitution O 0 7.225091261417793e-19
in O 0 3.533917719088727e-19
the O 0 1.8768587478124064e-17
first O 0 1.7447412287648653e-15
position O 0 3.390979937302344e-15
of O 0 2.0913172834239182e-20
exon O 0 1.2124392202023104e-12
13 O 0 1.6403542478331257e-13
of O 0 6.731498217644258e-18
HEXA O 0 1.8165909665412983e-08
of O 0 2.0543786555834316e-17
a O 0 4.4364956586911974e-14
non O 0 5.904504044983855e-14
- O 0 5.275498371482001e-10
Jewish O 0 8.546919422203203e-11
proband O 0 4.3656126536006923e-07
who O 0 6.194272959142433e-12
manifested O 0 1.2583270742657499e-13
a O 0 1.4514213424272264e-15
subacute O 0 1.83515656004829e-08
variant O 0 1.3368515183742602e-08
of O 0 1.6175231269552554e-15
G B-Disease 0 7.723659223302093e-08
( I-Disease 0 5.5889042275181124e-15
M2 I-Disease 0 1.2560588125154482e-09
) I-Disease 0 3.043314081643822e-12
gangliosidosis I-Disease 0 6.745232212779229e-07
. O 0 1.2110791536290577e-10

On O 0 3.8209751335172015e-11
the O 0 3.280703616756475e-13
second O 0 9.776739313960281e-12
maternally O 0 7.223071585293894e-10
inherited O 0 4.393139185765449e-10
allele O 0 1.8984359711430449e-13
, O 0 1.526657964000082e-14
we O 0 5.4580035017395487e-14
identified O 0 1.846665317406862e-13
the O 0 1.8768544186799525e-14
common O 0 8.288261188482693e-10
infantile O 1 0.929854691028595
disease O 1 0.999976634979248
- O 0 1.2432204130163882e-05
causing O 0 2.0671200218203012e-07
4 O 0 7.578938344965369e-12
- O 0 9.94084467520473e-11
bp O 0 1.563456395597962e-12
insertion O 0 1.1991820839281353e-13
, O 0 8.492204945438793e-15
+ O 0 6.500237089042404e-13
TATC O 0 1.1550820022687702e-10
1278 O 0 2.6576477563794443e-12
, O 0 4.274824407048724e-16
in O 0 2.005442154236427e-17
exon O 0 5.4008068850475155e-11
11 O 0 2.6784114856570618e-11
. O 0 5.69755397375471e-13

Pulse O 0 1.793312662812241e-07
- O 0 1.8005634760953626e-09
chase O 0 3.9434844278929404e-11
analysis O 0 1.1523334370044935e-14
using O 0 5.808437803271008e-15
proband O 0 1.1263597832211758e-09
fibroblasts O 0 9.491718522269821e-11
revealed O 0 6.5952785767431354e-12
that O 0 5.964375086552867e-16
the O 0 8.959595555211789e-17
W474C O 0 4.919098982314463e-13
- O 0 3.137471870035078e-15
containing O 0 7.456776796175653e-18
alpha O 0 2.6989352423956756e-18
- O 0 2.0607520822031527e-17
subunit O 0 1.122071692068264e-16
precursor O 0 1.2606367001788518e-15
was O 0 1.081699783049431e-14
normally O 0 1.390216647482762e-16
synthesized O 0 1.0448648374493817e-16
, O 0 3.373326579541482e-17
but O 0 3.927351110354717e-16
not O 0 1.2430770983773394e-16
phosphorylated O 0 2.1186489520229335e-14
or O 0 3.0610052825074264e-16
secreted O 0 1.8405517724067594e-15
, O 0 3.3829709866761704e-14
and O 0 3.095019357989004e-13
the O 0 5.516926332275757e-15
mature O 0 1.5500428496078786e-14
lysosomal O 0 6.65851163268727e-13
alpha O 0 1.0088734810782604e-16
- O 0 1.567880516444107e-14
subunit O 0 5.64707006470936e-14
was O 0 1.8715362376173217e-13
not O 0 1.3639973143477445e-14
detected O 0 1.665491876357006e-11
. O 0 1.678696922137804e-13

When O 0 2.9438146365023954e-11
the O 0 1.5938859314082953e-15
W474C O 0 4.923661305056282e-13
- O 0 2.096571715879108e-14
containing O 0 1.3842474474847833e-16
alpha O 0 1.1539201308850258e-16
- O 0 4.246367594031887e-15
subunit O 0 6.888964360985197e-14
was O 0 1.0827985372479504e-13
transiently O 0 3.870293408675396e-12
co O 0 1.1908795997939148e-11
- O 0 7.128037851807101e-13
expressed O 0 3.71070178766634e-17
with O 0 1.8419397318437866e-18
the O 0 1.181877856414268e-19
beta O 0 1.1556149495138918e-18
- O 0 3.636793199934727e-17
subunit O 0 1.9196612086089628e-16
to O 0 1.9684246637718214e-17
produce O 0 8.41942610113547e-17
Hex O 0 5.790390953178126e-13
A O 0 1.7178234746131893e-14
( O 0 3.8881740498340823e-17
alphabeta O 0 6.9110546278838836e-12
) O 0 2.3424820564281804e-16
in O 0 7.495709540630564e-17
COS O 0 4.541941045488329e-09
- O 0 8.075808771712545e-11
7 O 0 5.894759100332284e-14
cells O 0 1.3404655532268939e-14
, O 0 7.364341347956322e-17
the O 0 1.4552062429775832e-17
mature O 0 2.1235087863524483e-17
alpha O 0 2.1353173789628292e-19
- O 0 2.880640932220403e-17
subunit O 0 1.6595547282128063e-16
was O 0 1.3173170745146758e-14
present O 0 7.07813652514073e-18
, O 0 5.231631169905957e-17
but O 0 2.7678377032816157e-15
its O 0 1.3802762526255897e-17
level O 0 1.588434533238885e-16
was O 0 1.0875413881218177e-15
much O 0 1.3185524985380258e-16
lower O 0 1.9760489224735986e-14
than O 0 6.920005730927948e-17
that O 0 7.385417380568581e-16
from O 0 1.520702796790323e-18
normal O 0 2.216363773961021e-15
alpha O 0 7.609535548618271e-18
- O 0 6.839389237824121e-16
subunit O 0 3.904631727945666e-15
transfections O 0 1.4290630311053487e-12
, O 0 6.631565204352747e-17
although O 0 7.984652691988208e-17
higher O 0 3.0193912155533127e-18
than O 0 4.9017593998356285e-18
in O 0 3.993430532850189e-16
those O 0 8.636337871688598e-16
cells O 0 7.5843347037809e-15
transfected O 0 1.414925593817883e-14
with O 0 3.072570657134347e-19
an O 0 3.3499570806304524e-20
alpha O 0 5.474718706983855e-17
- O 0 1.8820031253904967e-13
subunit O 0 1.0239463357070155e-12
associated O 0 5.084256904375195e-10
with O 0 1.1930008196603392e-11
infantile O 0 9.94972069747746e-05
TSD B-Disease 0 2.44458010456583e-06
. O 0 3.6116287044363204e-11

Furthermore O 0 1.1578193265249226e-10
, O 0 1.7474922858984289e-15
the O 0 1.330024285950442e-17
precursor O 0 7.053672797490817e-15
level O 0 4.4171243540006705e-15
of O 0 9.25069166242553e-20
the O 0 8.695800709551483e-18
W474C O 0 9.112370282166396e-15
alpha O 0 1.4748606540377873e-18
- O 0 1.2077207520188628e-17
subunit O 0 1.3314970148566436e-16
was O 0 1.7232899076174133e-15
found O 0 2.6500190731481275e-16
to O 0 4.117789792583697e-17
accumulate O 0 7.373428582112262e-15
in O 0 9.843902584356708e-18
comparison O 0 3.4363499865725997e-14
to O 0 9.713022097371628e-16
the O 0 1.4213509316458699e-16
normal O 0 1.1601978838098655e-14
alpha O 0 1.4256562082108614e-17
- O 0 1.4083713163995002e-15
subunit O 0 1.398313160139858e-14
precursor O 0 1.657573682261812e-13
levels O 0 3.917810357818158e-13
. O 0 9.389894867510226e-14

We O 0 5.239858547056997e-10
conclude O 0 1.1463061402872121e-12
that O 0 4.832014326455628e-16
the O 0 1.3803454049247991e-16
1422 O 0 1.2323012402171152e-11
G O 0 1.37648475950769e-10
- O 0 2.4763413541961654e-11
- O 0 7.640602595060386e-10
> O 0 7.0706014827781605e-12
C O 0 8.00996335231785e-12
mutation O 0 5.334721922024832e-14
is O 0 9.459464769844523e-17
the O 0 1.4959683800752163e-17
cause O 0 5.916966123099452e-16
of O 0 3.9331771212527595e-19
Hex B-Disease 0 2.8297854726133664e-08
A I-Disease 0 3.909415013936268e-08
enzyme I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
in O 0 6.48910246825625e-16
the O 0 2.331096504248984e-14
proband O 0 3.4254131264788157e-07
. O 0 1.1486749051936584e-11

The O 0 2.1359106703363467e-13
resulting O 0 4.838650639014952e-14
W474C O 0 1.4161966738202025e-11
substitution O 0 3.702254431844909e-13
clearly O 0 2.9701264505580666e-14
interferes O 0 5.904683615968673e-14
with O 0 2.014688544559667e-18
alpha O 0 2.1758479365082204e-18
- O 0 1.9908912200810066e-17
subunit O 0 9.933081257068295e-17
processing O 0 2.4590440073052984e-15
, O 0 1.011940997661852e-17
but O 0 6.198106929661383e-18
because O 0 3.9029260922759296e-19
the O 0 4.3856635440389194e-21
base O 0 1.5215117306257436e-15
substitution O 0 8.799924286000637e-16
falls O 0 5.391044598582195e-13
at O 0 1.14755134309418e-15
the O 0 1.0346944202074707e-17
first O 0 1.1081454645637786e-15
position O 0 3.309005147458257e-15
of O 0 1.390563795798805e-20
exon O 0 1.26998753310556e-13
13 O 0 3.3301418805690985e-14
, O 0 6.505854927068368e-17
aberrant O 0 4.402625521635929e-14
splicing O 0 1.5675127862380123e-10
may O 0 2.655019433472905e-11
also O 0 4.830176243784262e-14
contribute O 0 8.521049276028999e-16
to O 0 4.7670218060501604e-15
Hex B-Disease 0 1.6046112705225823e-07
A I-Disease 0 6.091044468803375e-08
deficiency I-Disease 0 2.8899476092192344e-05
in O 0 6.113080620906751e-18
this O 0 6.828648860052937e-16
proband O 0 1.719978492964458e-09
. O 0 2.2916318839836906e-14
. O 0 1.0871276887600492e-13

Two O 0 2.0557881785787657e-11
frequent O 0 3.145894655887105e-09
missense O 0 1.916068504215218e-05
mutations O 0 0.0003906310594175011
in O 0 1.4579801366210177e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 8.917410559972083e-11

Pendred B-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
is O 0 1.4631609701609705e-07
an O 0 2.4278106138808653e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 2.0655072148656473e-05
by O 0 2.301501816816959e-13
early O 0 4.905787776010584e-08
childhood O 1 0.7779049277305603
deafness B-Disease 1 1.0
and O 0 0.00045404137927107513
goiter B-Disease 1 1.0
. O 0 2.8984876720983266e-09

A O 0 1.036590084602107e-11
century O 0 6.742849551280572e-13
after O 0 1.2392473183156678e-15
its O 0 2.0571067799616927e-18
recognition O 0 2.0417465819257873e-16
as O 0 1.6069609225645258e-14
a O 0 8.089312553138939e-11
syndrome O 0 0.0035054385662078857
by O 0 4.119612236909274e-17
Vaughan O 0 4.716369517154817e-10
Pendred O 0 1.6125078161621786e-08
, O 0 1.3452378046143604e-13
the O 0 8.501414904080878e-14
disease O 0 1.5020967580881006e-08
gene O 0 6.031873785172781e-12
( O 0 2.0126396181823733e-16
PDS O 0 1.2566794271862136e-09
) O 0 6.589255114544006e-16
was O 0 5.831619231564875e-14
mapped O 0 2.1689414153591713e-10
to O 0 3.344707865705898e-13
chromosome O 0 9.426049700778094e-07
7q22 O 0 7.227278775445711e-09
- O 0 7.20257986586148e-08
q31 O 0 1.3244105367959946e-08
. O 0 6.351382093872093e-12

1 O 0 8.440318756408605e-12
and O 0 1.1016079541625867e-12
, O 0 3.7598803194136e-14
recently O 0 2.6436346167724167e-11
, O 0 7.369122584245777e-16
found O 0 4.808530602690798e-17
to O 0 2.0355919673255533e-19
encode O 0 2.506664411358172e-15
a O 0 3.148804323836393e-14
putative O 0 9.442292434047594e-12
sulfate O 0 3.713518936798721e-10
transporter O 0 2.96206792427256e-08
. O 0 2.2569031712937893e-11

We O 0 2.432864187884576e-10
performed O 0 5.4292219998182054e-14
mutation O 0 3.748421488296554e-15
analysis O 0 6.732837257619859e-17
of O 0 1.8858482042051603e-20
the O 0 4.425941040539302e-17
PDS B-Disease 0 1.2398546189729132e-08
gene O 0 2.454672055896001e-11
in O 0 1.0502556727630632e-16
patients O 0 8.715141476057283e-15
from O 0 1.3347555936181228e-18
14 O 0 2.680022240101384e-14
Pendred B-Disease 0 1.7246960526406951e-09
families O 0 1.1701439881984979e-16
originating O 0 9.06223927245786e-16
from O 0 1.7115609299002197e-17
seven O 0 2.2329630786283635e-15
countries O 0 3.133389938852921e-17
and O 0 1.7508008230601838e-16
identified O 0 5.659966649551075e-14
all O 0 1.604757811044541e-15
mutations O 0 4.998246261322947e-11
. O 0 1.7977321562813453e-13

The O 0 2.5699410590059035e-13
mutations O 0 3.3645319603287094e-12
include O 0 7.075632550164858e-16
three O 0 6.348898398453166e-16
single O 0 1.0503322895401204e-15
base O 0 9.836907764043668e-13
deletions O 0 5.643355782680715e-10
, O 0 5.026172891515329e-14
one O 0 5.293887628308005e-16
splice O 0 7.2983978860463594e-09
site O 0 1.3104931029239708e-10
mutation O 0 2.011271982294005e-10
and O 0 7.989052128176688e-14
10 O 0 3.344553299133683e-14
missense O 0 5.589478035972206e-08
mutations O 0 1.205161055395365e-07
. O 0 1.0916626977386379e-11

One O 0 4.867210801062782e-12
missense O 0 5.934438274124432e-09
mutation O 0 2.4028778966567188e-11
( O 0 1.0051625503270005e-16
L236P O 0 5.405830947810553e-13
) O 0 8.71344169269038e-16
was O 0 2.448885007538121e-13
found O 0 2.0637288603822697e-14
in O 0 7.207972448448278e-18
a O 0 3.911532505366947e-16
homozygous O 0 9.552487754526783e-15
state O 0 1.0263033200792315e-14
in O 0 1.2293026221193103e-16
two O 0 7.138476571499615e-16
consanguineous O 0 1.6290874899071994e-11
families O 0 1.0386183532751854e-15
and O 0 5.433816412403231e-16
in O 0 2.0137972574496413e-18
a O 0 7.42014758429058e-17
heterozygous O 0 8.146059002312692e-15
state O 0 2.706557198888372e-16
in O 0 1.2035218177934211e-17
five O 0 2.4749928833133782e-17
additional O 0 5.060525551476913e-17
non O 0 6.161371326335319e-13
- O 0 4.814701526356657e-08
consanguineous O 0 6.684167033199628e-07
families O 0 8.805818053903014e-12
. O 0 1.18440944985726e-12

Another O 0 4.399023159629145e-11
missense O 0 1.198417294290266e-07
mutation O 0 1.810252642231447e-10
( O 0 3.799845387919955e-16
T416P O 0 1.3815334510072774e-12
) O 0 7.232382349801371e-16
was O 0 7.54361037611645e-14
found O 0 5.834620438703586e-15
in O 0 4.392886572389438e-18
a O 0 2.112827733974796e-16
homozygous O 0 4.4837578948623245e-15
state O 0 1.226998268986305e-15
in O 0 8.667852923631276e-17
one O 0 1.0793872984001321e-14
family O 0 4.1092749727055997e-14
and O 0 1.7939145618474112e-15
in O 0 6.342839962210705e-18
a O 0 2.3335630641913886e-16
heterozygous O 0 9.153410722526761e-15
state O 0 1.4540314744541905e-15
in O 0 3.8485990161771363e-16
four O 0 1.350770132546716e-14
families O 0 2.3768680471362384e-15
. O 0 1.293611349767118e-13

Pendred B-Disease 0 0.0001490534923505038
patients O 0 8.158983177963819e-07
in O 0 3.8065084667204124e-14
three O 0 9.418181024564015e-14
non O 0 6.600913392273977e-13
- O 0 6.457284040806144e-09
consanguineous O 0 1.4299330608480432e-08
families O 0 3.14255220424612e-14
were O 0 1.5621207929879401e-16
shown O 0 4.861299961211353e-16
to O 0 8.408958461355857e-18
be O 0 3.8043521160513275e-18
compound O 0 2.9600580663755862e-15
heterozygotes O 0 3.9525015747311765e-13
for O 0 6.870687237574066e-17
L236P O 0 4.478066528701419e-11
and O 0 8.80000011662524e-14
T416P O 0 9.931866440382464e-10
. O 0 1.2017609130055007e-12

In O 0 8.045078953066234e-14
total O 0 2.0409610382765477e-15
, O 0 2.703504068629994e-15
one O 0 3.713580482077143e-15
or O 0 1.0404187218045744e-15
both O 0 4.773609604797431e-15
of O 0 3.33033642112418e-19
these O 0 1.2421478767644218e-16
mutations O 0 8.531498126235562e-14
were O 0 6.228807655378227e-16
found O 0 5.3841361301017535e-14
in O 0 3.805880232971346e-16
nine O 0 9.178170512014541e-14
of O 0 5.834141049488303e-19
the O 0 2.6849839049965154e-15
14 O 0 1.0938959563470615e-13
families O 0 2.872062142825942e-16
analyzed O 0 3.2137057771886024e-12
. O 0 5.64927011420524e-13

The O 0 5.506455734498273e-15
identification O 0 1.4864814125426212e-15
of O 0 6.763695602602425e-19
two O 0 2.8642284115528197e-16
frequent O 0 1.3109900318108991e-11
PDS B-Disease 0 9.499843258709006e-07
mutations O 0 1.6047075890313067e-09
will O 0 1.1241972683098396e-15
facilitate O 0 1.8323055096185447e-16
the O 0 4.828087468477267e-17
molecular O 0 3.198811771021326e-10
diagnosis O 0 0.0005021708202548325
of O 0 3.713047664472002e-12
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.0966447888671738e-10

Insertional O 0 9.25025318565531e-08
mutation O 0 3.2681333767686782e-12
by O 0 1.317018607897332e-17
transposable O 0 2.810165121436281e-11
element O 0 1.5881348970278597e-12
, O 0 4.4713940937444324e-14
L1 O 0 8.179080329684396e-11
, O 0 6.764070962275151e-15
in O 0 4.3639627133464185e-16
the O 0 1.2792623405900871e-13
DMD B-Disease 1 1.0
gene O 0 1.704436613181315e-06
results O 0 1.8962802248584376e-12
in O 0 1.367490562925516e-14
X B-Disease 1 0.9997227787971497
- I-Disease 1 0.9998288154602051
linked I-Disease 1 0.9999308586120605
dilated I-Disease 1 0.9996122717857361
cardiomyopathy I-Disease 1 1.0
. O 0 1.374415581345545e-09

X B-Disease 1 0.9999550580978394
- I-Disease 1 0.9999842643737793
linked I-Disease 1 0.999982476234436
dilated I-Disease 1 0.999974250793457
cardiomyopathy I-Disease 1 1.0
( O 0 1.556171164152076e-11
XLDCM B-Disease 0 2.559887377628911e-07
) O 0 3.949784513264951e-15
is O 0 1.0175743490962444e-15
a O 0 2.2119853759533688e-14
clinical O 0 2.911308749631303e-09
phenotype O 0 1.275884398133087e-10
of O 0 5.3469384929346236e-17
dystrophinopathy B-Disease 0 7.424526415888977e-07
which O 0 6.827408647117061e-13
is O 0 5.625070099146148e-16
characterized O 0 1.0149895518247326e-13
by O 0 5.43570317829324e-16
preferential O 0 2.6961588517337987e-09
myocardial B-Disease 0 3.057416688534431e-05
involvement I-Disease 0 1.2416867881115401e-11
without O 0 2.385002528045195e-14
any O 0 1.021050572311776e-15
overt O 0 1.3555779762586262e-11
clinical O 0 1.4026073635875491e-08
signs O 0 7.722849269808929e-12
of O 0 2.343905505883953e-14
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 9.069084150326034e-09

To O 0 2.303161730343034e-13
date O 0 4.715696691644233e-13
, O 0 4.453005728437547e-16
several O 0 3.6975907764340277e-16
mutations O 0 2.1388470421851435e-12
in O 0 5.712627365508233e-16
the O 0 6.075710410041041e-14
Duchenne B-Disease 0 3.4457441415725043e-06
muscular I-Disease 0 3.001388648726788e-08
dystrophy I-Disease 0 2.877297049508343e-07
gene O 0 5.70454705695056e-09
, O 0 1.615638504058603e-12
DMD O 1 1.0
, O 0 2.224430709074632e-12
have O 0 2.5488134823212216e-13
been O 0 1.049311614838679e-14
identified O 0 7.925887051708769e-13
in O 0 3.4938978814650897e-16
patients O 0 5.1455218666625335e-14
with O 0 1.5230150023488832e-16
XLDCM B-Disease 0 4.1619077961740913e-08
, O 0 6.039681609519695e-15
but O 0 1.2349482025918786e-15
a O 0 1.0540599591182559e-17
pathogenic O 0 3.559550505234264e-15
correlation O 0 4.4992150603035894e-14
of O 0 3.696867853665881e-18
these O 0 5.312198468924393e-15
cardiospecific O 0 5.556142212981285e-09
mutations O 0 1.3594081416101744e-10
in O 0 5.389291172618743e-15
DMD O 1 0.9999998807907104
with O 0 3.10818780652547e-13
the O 0 1.0881607979051564e-13
XLDCM B-Disease 0 2.530814754209132e-06
phenotype O 0 4.839634470954479e-08
has O 0 2.5840109565966607e-11
remained O 0 1.8212831281094397e-14
to O 0 1.9216321483981052e-16
be O 0 1.5278028137315908e-14
elucidated O 0 1.497211243872698e-08
. O 0 2.423899189002432e-12

We O 0 1.002073268807635e-08
report O 0 2.3145224411634698e-14
here O 0 3.810454475584315e-17
the O 0 1.5129369925551278e-19
identification O 0 1.7295246458269113e-17
of O 0 4.6903480101926546e-20
a O 0 4.5882144214341985e-15
unique O 0 4.780244667983158e-14
de O 0 1.915966951065995e-12
novo O 0 6.009721800065426e-12
L1 O 0 3.1902280296647323e-13
insertion O 0 4.484801439453342e-15
in O 0 9.791176768623598e-17
the O 0 1.4484890731825096e-16
muscle O 0 3.956652280118211e-12
exon O 0 1.3405461636584182e-12
1 O 0 4.34960735777503e-14
in O 0 3.1782133077650626e-14
DMD O 1 1.0
in O 0 3.4139891976793513e-13
three O 0 2.051382508143091e-14
XLDCM B-Disease 0 4.934482600305046e-09
patients O 0 7.15948228978934e-14
from O 0 2.2349355156144146e-19
two O 0 1.3234909653183144e-16
unrelated O 0 9.61274029126491e-13
Japanese O 0 1.6693871174311425e-08
families O 0 1.3179008665625824e-13
. O 0 4.567786578667243e-13

The O 0 2.085650073057211e-15
insertion O 0 6.949088792460381e-14
was O 0 2.954238822973007e-14
a O 0 1.116282354222679e-16
5 O 0 2.2200278267326063e-15
- O 0 1.3190538071528035e-11
truncated O 0 4.9312460781436585e-09
form O 0 1.3349683771618492e-12
of O 0 2.5224217652759437e-17
human O 0 4.9605529102783597e-14
L1 O 0 2.1271300693070927e-12
inversely O 0 2.462829744830086e-13
integrated O 0 2.5150861211395426e-13
in O 0 6.614896601802407e-15
the O 0 3.5397418774330697e-14
5 O 0 1.0905300100449988e-12
- O 0 2.9662103884220414e-09
untranslated O 0 2.828753054018307e-07
region O 0 7.37024163921518e-10
in O 0 1.6722334085348843e-15
the O 0 9.212075562709104e-17
muscle O 0 1.5221169864885337e-13
exon O 0 2.5039979516402154e-15
1 O 0 4.8383756100639564e-17
, O 0 3.0752474135965684e-17
which O 0 2.5640410269243043e-17
affected O 0 1.2652901403723894e-16
the O 0 1.769120540978906e-18
transcription O 0 5.015144115966264e-13
or O 0 1.2453986833368654e-15
the O 0 2.947639186940299e-16
stability O 0 2.445277053758632e-13
of O 0 2.163985261795415e-19
the O 0 2.1141500318147988e-16
muscle O 0 1.9727117508971936e-11
form O 0 4.337157760160515e-17
of O 0 6.726922900730468e-20
dystrophin O 0 9.282367409435555e-12
transcripts O 0 5.711873031846726e-13
but O 0 3.147543261184521e-14
not O 0 9.223577873086124e-16
that O 0 9.44349290483286e-17
of O 0 7.329721337099625e-19
the O 0 4.63677863194855e-14
brain O 0 7.651759781346357e-10
or O 0 1.9481276672134867e-14
Purkinje O 0 2.3715871932949995e-08
cell O 0 9.775415492185857e-06
form O 0 5.618832829568099e-11
, O 0 1.2255879471012587e-11
probably O 0 3.6908607281560535e-09
due O 0 5.1642623012139455e-14
to O 0 6.233232449615565e-15
its O 0 2.533580630262631e-16
unique O 0 3.580288624640128e-16
site O 0 5.833110009552042e-14
of O 0 5.10289911912586e-18
integration O 0 7.496472193002646e-12
. O 0 1.2942215658548473e-12

We O 0 3.199363950850964e-12
speculate O 0 3.219064351558422e-14
that O 0 6.931310312051342e-18
this O 0 5.005225619470902e-20
insertion O 0 3.716637635742021e-17
of O 0 3.4557289240515494e-20
an O 0 8.927691695293986e-18
L1 O 0 8.443937993263262e-09
sequence O 0 4.9832706849883834e-08
in O 0 9.345663132265258e-12
DMD O 1 1.0
is O 0 8.480915080454066e-13
responsible O 0 1.4397857567099125e-15
for O 0 3.4105227927171875e-19
some O 0 1.1771853383474371e-18
of O 0 3.5881162730338205e-20
the O 0 2.5492751912457427e-17
population O 0 2.9032676306961784e-17
of O 0 6.860619198408619e-20
Japanese O 0 2.1337719091629737e-10
patients O 0 4.926981437040293e-15
with O 0 2.1329100248863585e-17
XLDCM B-Disease 0 2.0123935851046326e-09
. O 0 3.399996687729161e-14
. O 0 3.926937442756684e-13

Severe O 0 3.0763287668378325e-06
early O 0 2.969040568956416e-09
- O 1 0.7635972499847412
onset O 1 0.9991506338119507
obesity B-Disease 1 1.0
, O 0 5.6581271223876684e-08
adrenal B-Disease 1 0.9999958276748657
insufficiency I-Disease 1 0.9999984502792358
and O 0 8.796947614797546e-10
red O 0 1.120998476267232e-07
hair O 1 0.8942685127258301
pigmentation O 0 7.004976214375347e-05
caused O 0 1.4239920007041995e-11
by O 0 3.261059376874519e-16
POMC O 0 1.0413400985953558e-07
mutations O 0 3.980304530415424e-09
in O 0 6.383629925664144e-15
humans O 0 1.0582397458325232e-10
. O 0 2.8787920398204436e-12

Sequential O 0 1.1359824192425094e-09
cleavage O 0 2.1019745943817725e-09
of O 0 4.468283754351401e-17
the O 0 1.6445674066534275e-17
precursor O 0 9.65399343006866e-16
protein O 0 9.099319605090916e-13
pre O 0 2.1388644327879902e-11
- O 0 2.16218087878417e-09
pro O 0 3.5242835316751098e-09
- O 0 2.526452078654984e-07
opiomelanocortin O 0 7.058134965376439e-09
( O 0 1.076430327557091e-15
POMC O 0 1.3639030876921865e-11
) O 0 3.647380119158671e-17
generates O 0 2.7320235091453685e-16
the O 0 2.610985412658485e-16
melanocortin O 0 2.9975524840075707e-10
peptides O 0 2.8479040306561565e-11
adrenocorticotrophin O 0 2.2591867265830956e-10
( O 0 1.939980099645495e-15
ACTH O 0 5.5915250728177934e-12
) O 0 1.7612785941479399e-15
, O 0 4.0937364921013984e-15
melanocyte O 0 1.7369105043130162e-09
- O 0 3.9377110283567163e-07
stimulating O 0 8.579585653034627e-11
hormones O 0 1.215415008221088e-11
( O 0 5.218933947503268e-17
MSH O 0 5.679936122132689e-12
) O 0 3.030457237788047e-18
alpha O 0 5.835743711925125e-19
, O 0 6.106761167821999e-19
beta O 0 8.046746824466849e-19
and O 0 2.659757900633633e-19
gamma O 0 2.1530832798159075e-19
as O 0 5.059577188904621e-18
well O 0 5.64647672276202e-18
as O 0 5.54446911981471e-19
the O 0 1.4690033622709051e-19
opioid O 0 1.407156909381154e-16
- O 0 2.442943393285652e-15
receptor O 0 1.7591692438812602e-16
ligand O 0 4.2449079974450903e-16
beta O 0 1.0830333517215882e-14
- O 0 5.338292655143739e-11
endorphin O 0 9.909391529561162e-09
. O 0 8.911891949230089e-13

While O 0 2.0489434259494954e-13
a O 0 6.645598158008586e-16
few O 0 1.1255919080574938e-15
cases O 0 3.169385742147015e-15
of O 0 3.0579824336769126e-16
isolated O 0 0.32694298028945923
ACTH B-Disease 0 0.0415777787566185
deficiency I-Disease 0 0.2597196102142334
have O 0 4.164305619086539e-12
been O 0 2.7805728639723748e-12
reported O 0 1.900902629747847e-10
( O 0 4.578285585929778e-14
OMIM O 0 1.3335150015336694e-06
201400 O 0 1.0482414936063833e-10
) O 0 6.349795194586071e-16
, O 0 5.244702013247724e-16
an O 0 9.878370340213956e-16
inherited O 0 7.760207154206e-06
POMC O 0 0.0007486312533728778
defect O 0 0.003024148289114237
has O 0 5.6027051054119426e-11
not O 0 1.869245860527946e-13
been O 0 6.404463548034811e-14
described O 0 1.7721714124386417e-13
so O 0 4.192777852338181e-14
far O 0 4.021595881829876e-13
. O 0 5.613031740792085e-13

Recent O 0 2.8338402735528234e-09
studies O 0 8.668999545990985e-12
in O 0 2.9542807193401607e-16
animal O 0 3.2625963562737947e-12
models O 0 4.4343324043065457e-13
elucidated O 0 2.7752958351584534e-12
a O 0 4.855017623720686e-16
central O 0 1.8714057945434445e-15
role O 0 8.251357161996782e-16
of O 0 8.089245425635263e-20
alpha O 0 6.717111561558491e-17
- O 0 1.3039337676008095e-13
MSH O 0 9.109746984536926e-11
in O 0 2.2647874299456877e-17
the O 0 8.746702095725546e-18
regulation O 0 2.197473160468061e-14
of O 0 5.000912324940835e-20
food O 0 1.324520073291537e-14
intake O 0 1.9782579420483904e-15
by O 0 3.554371504568205e-20
activation O 0 2.092773070895693e-17
of O 0 2.444458296822565e-19
the O 0 5.542809541561481e-15
brain O 0 5.404351272053631e-11
melanocortin O 0 9.883704965574225e-12
- O 0 1.650011204057389e-11
4 O 0 4.138093405263443e-14
- O 0 2.1585227095305415e-12
receptor O 0 3.498008902935029e-14
( O 0 3.28399008076902e-17
MC4 O 0 3.2458378432936863e-12
- O 0 9.43965364859009e-14
R O 0 2.109106753177617e-13
; O 0 3.3716429692099163e-16
refs O 0 2.470311065080888e-12
3 O 0 2.1358105171606634e-15
- O 0 2.0181089872145508e-13
5 O 0 5.374650102246334e-16
) O 0 1.3742867205281545e-17
and O 0 7.830842758423158e-17
the O 0 1.3511133383855427e-17
linkage O 0 5.576010486674221e-11
of O 0 1.4506061261550533e-17
human O 0 1.9372635440273456e-10
obesity B-Disease 1 1.0
to O 0 2.455147359286397e-13
chromosome O 0 1.7049799350132844e-09
2 O 0 7.155711468514753e-15
in O 0 6.621756827521338e-17
close O 0 2.668965526017586e-12
proximity O 0 1.5641939132837734e-11
to O 0 3.2545878969267306e-14
the O 0 1.614206781208518e-15
POMC O 0 2.730395909367189e-10
locus O 0 3.5143932306403586e-14
, O 0 1.2815248502954981e-15
led O 0 2.0861354229359877e-15
to O 0 1.6710838392416724e-17
the O 0 1.990109203529899e-17
proposal O 0 4.037532044402813e-15
of O 0 1.7244306608196566e-19
an O 0 1.0558427814924914e-17
association O 0 2.0965697306456378e-16
of O 0 1.2109770105387237e-18
POMC O 0 2.0713092396817956e-07
with O 0 3.3089347234449562e-12
human O 0 1.0469602074181239e-07
obesity B-Disease 1 1.0
. O 0 3.902661249721717e-10

The O 0 3.3320731156888383e-14
dual O 0 3.75921516138078e-13
role O 0 2.6582380773573083e-14
of O 0 2.809512126296305e-18
alpha O 0 2.876516434985668e-14
- O 0 1.989691050807707e-10
MSH O 0 1.1920564979561732e-08
in O 0 1.3996511386772968e-16
regulating O 0 3.974608836498916e-12
food O 0 1.273974935961375e-11
intake O 0 1.3159529022033212e-11
and O 0 1.5765619265271057e-14
influencing O 0 1.242065825191041e-11
hair O 0 0.00017572547949384898
pigmentation O 0 5.029746148466074e-07
predicts O 0 9.119064531271093e-11
that O 0 1.6682576476387094e-15
the O 0 3.430987685681329e-17
phenotype O 0 2.988835849822291e-13
associated O 0 8.624391213121405e-15
with O 0 4.0004137901047086e-16
a O 0 1.0399674692370894e-13
defect O 0 4.723673452389221e-09
in O 0 4.855925007765432e-16
POMC O 0 6.240033911808496e-08
function O 0 5.976458043732702e-12
would O 0 1.947500727307247e-13
include O 0 1.5301941658218965e-10
obesity B-Disease 1 1.0
, O 0 1.874845547908399e-12
alteration O 0 7.30660154601992e-09
in O 0 6.779473358566046e-13
pigmentation O 0 0.33638089895248413
and O 0 5.099481086290325e-07
ACTH B-Disease 0 0.0005054729408584535
deficiency I-Disease 0 0.09242943674325943
. O 0 2.3233442079939604e-12

The O 0 1.3916779783695182e-13
observation O 0 1.3165007972659737e-10
of O 0 1.3888968642718214e-16
these O 0 6.825872332638649e-13
symptoms O 0 2.4901424922063597e-08
in O 0 1.4059648428567915e-17
two O 0 1.4912351732008491e-15
probands O 0 2.2303381363997232e-10
prompted O 0 1.479933085530693e-14
us O 0 1.808473311205259e-16
to O 0 6.98625992014324e-18
search O 0 6.062924193592353e-16
for O 0 4.871635549877979e-18
mutations O 0 4.591898042360931e-12
within O 0 4.125529026743641e-15
their O 0 1.766568187848601e-14
POMC O 0 7.156062764579474e-08
genes O 0 8.681004803889891e-10
. O 0 7.646539109361361e-13

Patient O 0 4.80218295706436e-06
1 O 0 1.1404387227327908e-14
was O 0 4.124131252974082e-14
found O 0 1.1371712719629337e-15
to O 0 2.823039052212415e-17
be O 0 3.3065668175357975e-17
a O 0 7.192480182755772e-18
compound O 0 8.286469112880196e-15
heterozygote O 0 8.397851912565063e-14
for O 0 2.066552768966742e-18
two O 0 7.991143081946544e-17
mutations O 0 9.15118065418323e-14
in O 0 4.245826680777004e-18
exon O 0 1.502876057109248e-12
3 O 0 1.5529050755806045e-13
( O 0 2.9085123528264586e-16
G7013T O 0 5.153778011995902e-12
, O 0 3.6899554626288e-15
C7133delta O 0 1.3344250704427907e-10
) O 0 9.754716632455731e-17
which O 0 1.2393690131273866e-17
interfere O 0 9.551649191909001e-15
with O 0 1.1835889157004858e-17
appropriate O 0 9.923763894648498e-17
synthesis O 0 2.2938742766566043e-15
of O 0 8.59580367248056e-18
ACTH O 0 4.521035022048148e-12
and O 0 3.595880595374948e-15
alpha O 0 7.722575562970485e-14
- O 0 2.661679543436435e-09
MSH O 0 1.2782822977897013e-06
. O 0 6.749119058763187e-12

Patient O 0 1.3191535799705889e-05
2 O 0 4.3657677299691056e-13
was O 0 8.782791456455642e-15
homozygous O 0 2.353895031299044e-15
for O 0 1.8692695724873855e-18
a O 0 2.252271406419262e-15
mutation O 0 1.2619708067169305e-13
in O 0 1.4411635285905155e-17
exon O 0 1.0701193403628295e-11
2 O 0 1.1810324853506193e-12
( O 0 2.9832286526477276e-15
C3804A O 0 4.169076195381649e-11
) O 0 8.833764205155512e-15
which O 0 1.584526577330138e-14
abolishes O 0 1.0056695032290008e-07
POMC O 0 1.0741063078967272e-06
translation O 0 2.4343183024910786e-09
. O 0 8.57650495761364e-12

These O 0 5.654616857218853e-13
findings O 0 4.809767154326759e-14
represent O 0 3.047813803145125e-17
the O 0 3.574078351124427e-17
first O 0 8.357858717270903e-17
examples O 0 4.839744031494915e-16
of O 0 1.3471602008791211e-18
a O 0 2.1990615925449042e-11
genetic B-Disease 1 0.9999998807907104
defect I-Disease 1 0.9999988079071045
within O 0 4.4771777194115795e-15
the O 0 2.2598524042367473e-16
POMC O 0 4.62015620206202e-10
gene O 0 1.136470952067814e-11
and O 0 5.106662112624874e-16
define O 0 1.2087971953695514e-13
a O 0 2.1552046917407662e-14
new O 0 1.3585443534025465e-11
monogenic B-Disease 0 0.0005290207336656749
endocrine I-Disease 0 4.072439332958311e-05
disorder I-Disease 0 0.0018973228288814425
resulting O 0 3.960083332760732e-14
in O 0 1.480449775628518e-14
early O 0 5.7738191117095994e-08
- O 1 0.9999713897705078
onset O 1 0.9999438524246216
obesity B-Disease 1 1.0
, O 0 2.856507137494191e-07
adrenal B-Disease 1 0.9999988079071045
insufficiency I-Disease 1 0.9999992847442627
and O 0 4.2240025366346856e-10
red O 0 2.4602289094843854e-09
hair O 0 0.000960883277002722
pigmentation O 0 1.5527853065577801e-06
. O 0 2.3191767516833606e-13
. O 0 3.575612841835024e-13

A O 0 1.5765568850412137e-09
European O 0 7.210119168377105e-10
multicenter O 0 1.2910466296034429e-07
study O 0 2.8954347600085306e-11
of O 0 1.8109691263951122e-12
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
: O 0 9.244573856426186e-12
classification O 0 2.8169107671449645e-11
of O 0 8.525684916122935e-19
105 O 0 6.515976451980376e-13
mutations O 0 3.0932595374011385e-10
and O 0 2.7175766740156768e-15
a O 0 1.3948381386523202e-16
general O 0 3.9689187228456296e-16
system O 0 5.529164264297688e-16
for O 0 1.484189364341613e-19
genotype O 0 1.8512197288609537e-15
- O 0 5.708407786178191e-14
based O 0 6.525494180043847e-16
prediction O 0 2.628148566830024e-12
of O 0 4.4627820106611884e-17
metabolic O 0 2.7037717842404163e-08
phenotype O 0 1.4136593229352457e-08
. O 0 3.2791163447759564e-12

Phenylketonuria B-Disease 0 0.00013063295045867562
( O 0 9.905814504166527e-14
PKU B-Disease 0 4.091890826174449e-09
) O 0 8.206899515441485e-14
and O 0 1.5460738592154577e-11
mild B-Disease 0 7.693497173022479e-05
hyperphenylalaninemia I-Disease 1 1.0
( O 0 1.6483490128393896e-09
MHP B-Disease 1 1.0
) O 0 1.9611465229552039e-10
are O 0 3.547186849806039e-12
allelic B-Disease 0 1.711455661279615e-05
disorders I-Disease 1 0.6871733665466309
caused O 0 8.497187870860901e-13
by O 0 4.9899058338608105e-17
mutations O 0 6.739333396899028e-11
in O 0 2.146771520544828e-16
the O 0 1.788066222863094e-15
gene O 0 1.0467231248423303e-10
encoding O 0 8.148375030270216e-11
phenylalanine O 0 3.3549378713360056e-05
hydroxylase O 0 1.6099489585030824e-05
( O 0 1.901262350681443e-13
PAH O 0 1.3912985208364148e-09
) O 0 2.7876008454135424e-14
. O 0 2.517927815033627e-13

Previous O 0 3.6691982785441724e-10
studies O 0 5.886405512328663e-12
have O 0 3.5514261887206744e-15
suggested O 0 6.8371237423275714e-15
that O 0 3.388674750371281e-17
the O 0 8.813151168693155e-18
highly O 0 1.0599041006572728e-14
variable O 0 2.0850589310672518e-10
metabolic O 0 2.1497819034266286e-05
phenotypes O 0 1.156765279120009e-06
of O 0 1.8101334233605604e-12
PAH B-Disease 1 0.9780974984169006
deficiency I-Disease 1 0.8661572337150574
correlate O 0 5.777851441735038e-08
with O 0 5.138873215848605e-10
PAH O 0 0.0006203569937497377
genotypes O 0 8.113430993716975e-08
. O 0 2.179797835288877e-11

We O 0 1.5292488109164282e-10
identified O 0 3.418765650350236e-13
both O 0 1.7051306858985836e-15
causative O 0 1.9965375186448142e-10
mutations O 0 4.251259344556502e-09
in O 0 1.2498582059250409e-15
686 O 0 3.394546102541973e-11
patients O 0 5.898527222214511e-10
from O 0 1.326407961500201e-15
seven O 0 3.502285267353855e-12
European O 0 1.2771741997319452e-11
centers O 0 1.4836186446043342e-10
. O 0 2.2975206806497006e-12

On O 0 5.750439187324208e-13
the O 0 9.30541875893265e-18
basis O 0 4.007313287050401e-18
of O 0 1.5382748271873342e-20
the O 0 7.256389811242844e-18
phenotypic O 0 3.888117258710189e-12
characteristics O 0 8.732797124322289e-11
of O 0 8.209877429174147e-17
297 O 0 1.5698609079350945e-11
functionally O 0 1.8987175720575067e-10
hemizygous O 0 1.5108598461210931e-07
patients O 0 8.579916221940209e-10
, O 0 5.527414082470423e-16
105 O 0 3.687410890951953e-14
of O 0 1.9384819973875936e-19
the O 0 4.7217712678348063e-17
mutations O 0 5.231519088918189e-14
were O 0 2.7825913264656135e-18
assigned O 0 9.629455679680091e-17
to O 0 1.0694997815599257e-17
one O 0 3.5261382715433035e-17
of O 0 6.334587905022299e-20
four O 0 1.4260494234042895e-15
arbitrary O 0 2.8918817340795044e-10
phenotype O 0 1.2000025151337468e-07
categories O 0 7.433819337876457e-09
. O 0 1.8922137468013744e-10

We O 0 2.97616598032846e-10
proposed O 0 1.4541827757143938e-13
and O 0 5.2335353661458334e-14
tested O 0 3.216917834544808e-13
a O 0 6.893313357023413e-18
simple O 0 2.3100039015546943e-16
model O 0 7.137962740137987e-15
for O 0 2.569031697073051e-19
correlation O 0 4.7666423352897905e-14
between O 0 1.7227706764207464e-15
genotype O 0 4.3485956616228297e-14
and O 0 5.54564329028652e-15
phenotypic O 0 1.1649632647436903e-10
outcome O 0 1.4119735936013456e-10
. O 0 1.6706301272928492e-11

The O 0 2.0708273691747575e-13
observed O 0 6.038746325903732e-12
phenotype O 0 2.41960462082913e-11
matched O 0 7.314664499102896e-12
the O 0 5.865413050951595e-16
predicted O 0 1.009353850500716e-10
phenotype O 0 9.922582894228427e-11
in O 0 1.0018136070466836e-15
79 O 0 5.66928578735193e-12
% O 0 1.9107458559668663e-18
of O 0 3.8236116853708265e-20
the O 0 3.8286545666428497e-16
cases O 0 5.372944114363093e-14
, O 0 3.851319558948775e-14
and O 0 1.2646913410182398e-13
in O 0 8.624744240571952e-17
only O 0 2.2718431614567568e-14
5 O 0 1.1724988721407628e-16
of O 0 1.3015685322934757e-20
184 O 0 7.662032400757826e-16
patients O 0 5.879977782479633e-15
was O 0 3.866625200783688e-16
the O 0 1.1655770578621436e-17
observed O 0 2.0082930950833175e-14
phenotype O 0 4.868967303449899e-15
more O 0 6.52712388611682e-20
than O 0 1.5764691009805095e-17
one O 0 7.382490987614936e-15
category O 0 9.442976782458867e-12
away O 0 5.268595022062117e-12
from O 0 1.889206569124353e-17
that O 0 6.395109339681808e-15
expected O 0 1.0240596348340403e-12
. O 0 1.3698779523924065e-12

Among O 0 6.920878800609209e-13
the O 0 1.0887373562916934e-14
seven O 0 1.4964150973106644e-15
contributing O 0 3.44942923406939e-15
centers O 0 4.519118640498171e-13
, O 0 1.2190111718101706e-15
the O 0 3.0030239582088484e-17
proportion O 0 1.6856382343207756e-15
of O 0 3.074704524620792e-19
patients O 0 4.861708125212811e-16
for O 0 3.0454153515999966e-20
whom O 0 5.55432114283114e-16
the O 0 5.057705279178413e-18
observed O 0 1.4481591856132896e-14
phenotype O 0 6.576380065514975e-14
did O 0 2.6865554052235563e-12
not O 0 1.0540058544917033e-13
match O 0 5.700839973699079e-12
the O 0 1.068012831764633e-15
predicted O 0 8.737395529312408e-11
phenotype O 0 7.593987071119468e-12
was O 0 1.433748085533093e-12
4 O 0 8.461937070101608e-15
% O 0 7.982977816683911e-17
- O 0 5.883403209061555e-10
23 O 0 4.351088933596259e-12
% O 0 7.300958137211079e-17
( O 0 1.063743468073116e-15
P O 0 7.698535142708351e-09
< O 0 5.171204176673827e-13
. O 0 9.142447998606923e-16
0001 O 0 1.7653854073040876e-11
) O 0 4.510790911669276e-17
, O 0 1.411855361434904e-17
suggesting O 0 6.210612858275613e-15
that O 0 2.6293878387122953e-15
differences O 0 6.7114066887796146e-15
in O 0 1.5363520200040605e-19
methods O 0 5.4319686894381346e-17
used O 0 1.9517274854400403e-18
for O 0 3.398391413552273e-20
mutation O 0 1.559121158154137e-15
detection O 0 9.296851347572951e-14
or O 0 3.8907931238819915e-13
phenotype O 0 1.3310069562066928e-06
classification O 0 1.5473879102501087e-05
may O 0 1.591847487159015e-11
account O 0 2.1586965003625273e-15
for O 0 2.6251258336195077e-17
a O 0 2.6298693769428094e-15
considerable O 0 2.909701110628371e-15
proportion O 0 5.34059626492063e-14
of O 0 2.3656942002542964e-17
genotype O 0 2.9421083624914246e-11
- O 0 2.3340488652934255e-08
phenotype O 0 1.3107944951684658e-08
inconsistencies O 0 1.1622169004965599e-08
. O 0 7.65273001218647e-12

Our O 0 6.5574230073695006e-12
data O 0 1.0649301400563957e-13
indicate O 0 7.539683531372979e-14
that O 0 3.4014071775808404e-16
the O 0 4.1454043901531675e-16
PAH O 0 1.74173994671456e-10
- O 0 4.258784297439533e-12
mutation O 0 9.281601095340042e-13
genotype O 0 2.262164963001429e-15
is O 0 3.888409382718354e-18
the O 0 3.2683146772888953e-19
main O 0 1.7966138017404265e-14
determinant O 0 1.9555258562627131e-13
of O 0 4.982753699412432e-17
metabolic O 0 1.4339343046287922e-08
phenotype O 0 2.171510887771788e-11
in O 0 4.459720582126905e-16
most O 0 6.931879793477605e-14
patients O 0 3.438918941278679e-11
with O 0 1.0170569247902606e-10
PAH B-Disease 1 0.99935382604599
deficiency I-Disease 1 0.6950749754905701
. O 0 2.227368680121633e-12

In O 0 7.428570426978517e-14
the O 0 6.819329380050772e-16
present O 0 1.0220281012724667e-16
study O 0 2.8076934621861275e-16
, O 0 1.4928386595095607e-17
the O 0 3.2872991340914773e-17
classification O 0 2.536563081974308e-13
of O 0 3.446909692381571e-19
105 O 0 3.323571235933076e-12
PAH O 0 1.3023655487387487e-09
mutations O 0 1.5069938352763046e-10
may O 0 5.560959340038772e-15
allow O 0 1.5644353369860921e-15
the O 0 2.1015100503104985e-16
prediction O 0 3.181048740391601e-12
of O 0 2.857565542546045e-20
the O 0 6.514695833455335e-17
biochemical O 0 2.2343566233318235e-11
phenotype O 0 9.135542799673657e-13
in O 0 5.554550900518083e-17
> O 0 2.283757221960975e-13
10 O 0 1.9706655622256765e-15
, O 0 1.196491742116231e-15
000 O 0 2.8702893028673387e-15
genotypes O 0 8.193030672301593e-13
, O 0 5.6084914409068945e-14
which O 0 1.918368350457833e-13
may O 0 2.6476171312316867e-14
be O 0 1.4511651348130167e-17
useful O 0 2.0240345936031078e-16
for O 0 3.2050893339635578e-18
the O 0 1.999126663346809e-16
management O 0 4.240955053498932e-14
of O 0 2.653081105524258e-18
hyperphenylalaninemia B-Disease 1 0.9999998807907104
in O 0 9.215016770480755e-12
newborns O 0 2.396879361654669e-09
. O 0 2.1397721918989254e-13

Somatic O 0 4.770674966181332e-09
instability O 0 2.3396593551439082e-09
of O 0 1.6483304828705027e-16
the O 0 1.1982914753709095e-15
CTG O 0 3.5871439152401763e-09
repeat O 0 5.1225960973066975e-11
in O 0 2.5546598392484424e-16
mice O 0 2.4810360363392014e-11
transgenic O 0 1.2393864146781342e-12
for O 0 3.866669670013419e-16
the O 0 2.1590043121355595e-12
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
region O 0 6.911012651045212e-09
is O 0 6.207749971617188e-14
age O 0 3.0195110971851288e-15
dependent O 0 1.718404989201259e-16
but O 0 3.640475185981993e-15
not O 0 3.4409241762460097e-16
correlated O 0 1.154638573642975e-15
to O 0 1.7031536315903533e-16
the O 0 1.0508407210667097e-16
relative O 0 1.7822729240796892e-13
intertissue O 0 2.6523738760886317e-10
transcription O 0 8.455279809638228e-10
levels O 0 1.1555574205845964e-11
and O 0 2.640176488891144e-12
proliferative O 0 4.224681470077485e-05
capacities O 0 3.2584836162641295e-07
. O 0 1.3351836303243658e-10

A O 0 4.1664130479013295e-11
( O 0 9.788124697156404e-15
CTG O 0 1.6317688866784863e-10
) O 0 1.1279565064088726e-14
nexpansion O 0 1.8541572444075172e-10
in O 0 1.1533361546074532e-14
the O 0 2.68640551427321e-13
3 O 0 3.7886035975098764e-10
- O 0 2.903884706029203e-06
untranslated O 0 9.206524555338547e-05
region O 0 3.5862903757788445e-08
( O 0 1.4408791703656994e-15
UTR O 0 2.7389106607711433e-12
) O 0 1.2954530994294007e-17
of O 0 1.4563100172773375e-19
the O 0 4.774756910924487e-15
DM O 1 0.999998927116394
protein O 0 2.0129780509137163e-08
kinase O 0 7.279097880008578e-10
gene O 0 1.341081967698443e-10
( O 0 4.59204618672934e-16
DMPK O 0 4.059160993441502e-11
) O 0 6.097479167373388e-17
is O 0 1.5667929076109866e-17
responsible O 0 1.855405130411574e-15
for O 0 2.268741750320385e-15
causing O 0 1.258782020840954e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.9166376818979813e-10
DM B-Disease 1 0.9999988079071045
) O 0 3.4901970202838584e-11
. O 0 7.462220077969484e-12

Major O 0 2.3094217649344273e-09
instability O 0 1.032469967299221e-07
, O 0 2.0387143850279094e-13
with O 0 1.3590287884857402e-15
very O 0 1.7365133624734738e-16
large O 0 2.1999706159372165e-16
expansions O 0 7.727637973964363e-12
between O 0 1.725849958821371e-14
generations O 0 2.856199333306237e-15
and O 0 1.799905414125104e-15
high O 0 4.961780515128815e-15
levels O 0 3.968737140157562e-16
of O 0 8.335208227012759e-20
somatic O 0 3.43776588684723e-14
mosaicism O 0 6.001522889764743e-11
, O 0 2.529574111482559e-15
is O 0 4.413416731971861e-16
observed O 0 2.854623004991397e-13
in O 0 2.8733471765102214e-14
patients O 0 6.901622502664129e-12
. O 0 1.9381734715426258e-13

There O 0 1.6304840810832388e-10
is O 0 1.9021382674521987e-15
a O 0 7.068807052796765e-16
good O 0 4.551778875691581e-15
correlation O 0 1.2865511438045051e-14
between O 0 4.457681985581101e-15
repeat O 0 2.0937937147968988e-11
size O 0 5.024335439883509e-13
( O 0 9.940553146454262e-16
at O 0 2.079748286293922e-14
least O 0 2.4693180934390194e-15
in O 0 3.159726443114323e-16
leucocytes O 0 5.882105025278861e-09
) O 0 4.70383177175645e-16
, O 0 3.2884420991746786e-16
clinical O 0 2.3707049778137756e-12
severity O 0 1.468926230652201e-10
and O 0 5.881172827383596e-13
age O 0 2.915921085318296e-13
of O 0 8.427202922382449e-17
onset O 0 9.42967215422641e-09
. O 0 1.8805543060274044e-12

The O 0 1.9783827354125094e-11
trinucleotide O 0 1.980324122996535e-05
repeat O 0 3.5637270912047825e-08
instability O 0 2.4160087819247167e-10
mechanisms O 0 8.610346593704299e-13
involved O 0 3.1301196240529107e-15
in O 0 4.670790816429073e-15
DM B-Disease 1 1.0
and O 0 2.243188412798247e-10
other O 0 5.425487533197715e-13
human O 0 9.950608870212818e-08
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.6479037635535438e-15
unknown O 0 2.17855811515677e-12
. O 0 7.464137814772176e-13

We O 0 1.0409617612339161e-09
studied O 0 9.51674394671087e-13
somatic O 0 1.6234900251412e-13
instability O 0 9.477539738254881e-14
by O 0 9.395873233662009e-19
measuring O 0 2.9159949194862422e-12
the O 0 2.558805006734068e-16
CTG O 0 1.4220195854175444e-10
repeat O 0 2.6606668257489474e-11
length O 0 1.1318476537958144e-12
at O 0 2.53479657782215e-14
several O 0 6.22586209830415e-16
ages O 0 6.280496955834991e-13
in O 0 1.318054601983718e-16
various O 0 1.861771853559611e-15
tissues O 0 2.942870122937813e-12
of O 0 5.668684454257537e-18
transgenic O 0 3.519767255433237e-10
mice O 0 7.117469280615296e-09
carrying O 0 1.2929470895892223e-14
a O 0 5.246565273973446e-15
( O 0 1.068301987637002e-15
CTG O 0 1.845872205086252e-10
) O 0 2.4241081333957947e-15
55expansion O 0 4.878903270971735e-12
surrounded O 0 5.391514803511875e-14
by O 0 2.709397935635226e-16
45 O 0 3.946365464773359e-15
kb O 0 5.18453942971453e-12
of O 0 3.780351884168408e-18
the O 0 6.665073986564804e-15
human O 0 6.428117066414885e-11
DM B-Disease 1 0.9999998807907104
region O 0 3.006267179639366e-10
, O 0 3.565908916871506e-16
using O 0 2.017143848228296e-16
small O 0 1.9860102332212165e-13
- O 0 9.014951984909203e-08
pool O 0 4.1695633057337034e-10
PCR O 0 3.2142363770581994e-10
. O 0 2.4141948748272746e-13

These O 0 3.037734994104646e-12
mice O 0 1.177693831344584e-09
have O 0 2.7670037993450438e-15
been O 0 2.852343480511658e-16
shown O 0 1.237999850542599e-15
to O 0 2.310418153605461e-16
reproduce O 0 2.1546418815798773e-10
the O 0 4.621940097020313e-16
intergenerational O 0 3.1450121912128537e-13
and O 0 3.586387473618596e-15
somatic O 0 4.165588094731318e-14
instability O 0 1.5180239877621293e-12
of O 0 1.0687284149592047e-18
the O 0 2.3995421662221703e-16
55 O 0 1.005846881479977e-13
CTG O 0 3.687416344488881e-11
repeat O 0 9.471219381690377e-13
suggesting O 0 2.8981361462830342e-15
that O 0 7.58281844201342e-18
surrounding O 0 6.089440030610557e-16
sequences O 0 2.1766860883176697e-11
and O 0 2.744990514188736e-14
the O 0 2.2711462981866278e-17
chromatin O 0 6.303662886814054e-12
environment O 0 8.721053393334621e-13
are O 0 4.87310379546526e-18
involved O 0 2.0249382718787098e-16
in O 0 1.213128951507963e-15
instability O 0 2.29140595386923e-09
mechanisms O 0 7.030128562623972e-11
. O 0 4.0718741312756324e-13

As O 0 1.1665936771286523e-13
observed O 0 1.2560514694309743e-13
in O 0 5.216204251481843e-18
some O 0 1.4869272546209811e-18
of O 0 1.9927049790101516e-19
the O 0 1.3070193508677705e-16
tissues O 0 1.2662771222207714e-13
of O 0 3.7656302199345565e-17
DM B-Disease 1 1.0
patients O 0 8.004113993820283e-08
, O 0 4.1908627955477337e-16
there O 0 1.774483202520924e-15
is O 0 5.857696051406517e-17
a O 0 1.786306458975614e-16
tendency O 0 7.305597641595052e-13
for O 0 3.107808220356861e-17
repeat O 0 1.5853755808148406e-11
length O 0 6.211472308725874e-13
and O 0 8.464612529544629e-16
somatic O 0 2.6055044742150394e-15
mosaicism O 0 1.525297249616031e-12
to O 0 4.666939119389891e-17
increase O 0 1.6495561329277348e-17
with O 0 1.194977458964777e-15
the O 0 1.2290272728839816e-14
age O 0 1.6237811334245122e-13
of O 0 4.0116856086719916e-19
the O 0 1.8091088506134957e-15
mouse O 0 9.534605105443461e-09
. O 0 5.5321294420429545e-12

Furthermore O 0 1.474057431671838e-09
, O 0 7.514649167685017e-13
we O 0 2.635697378666063e-13
observed O 0 4.731404494134591e-15
no O 0 2.783305266052308e-16
correlation O 0 3.4239305777417203e-15
between O 0 4.993676123092827e-17
the O 0 7.986723952242041e-17
somatic O 0 1.4391832452338715e-13
mutation O 0 4.659099842041492e-11
rate O 0 1.3544589928804474e-11
and O 0 4.514638988172004e-13
tissue O 0 1.4355679311961467e-08
proliferation O 0 1.0931398719549179e-07
capacity O 0 3.428105022074135e-12
. O 0 1.178442543200986e-12

The O 0 1.0286829575005887e-13
somatic O 0 1.1593850879343393e-12
mutation O 0 3.301100712227445e-11
rates O 0 1.6918478337041298e-12
in O 0 2.9279139733555634e-17
different O 0 5.395850807520517e-16
tissues O 0 1.7853802204009783e-12
were O 0 3.5030813597396616e-15
also O 0 2.9689541569590666e-14
not O 0 4.771094658097914e-16
correlated O 0 1.2835846226649838e-15
to O 0 2.0712043496582625e-15
the O 0 1.683974682788192e-14
relative O 0 3.221405087128204e-10
inter O 0 8.032201015417684e-10
- O 0 4.238355799657256e-08
tissue O 0 6.334983093658764e-10
difference O 0 3.6600412235470933e-14
in O 0 3.3830655662592555e-19
transcriptional O 0 3.002226627566752e-14
levels O 0 1.8821367226033112e-16
of O 0 8.384889954760658e-21
the O 0 3.235679755145718e-17
three O 0 3.3441159866109277e-16
genes O 0 1.0945214901786088e-14
( O 0 8.00441006635516e-18
DMAHP O 0 9.198930679688022e-12
, O 0 4.151784083493209e-15
DMPK O 0 6.291717147277609e-10
and O 0 3.3504544082706145e-13
59 O 0 6.771693665877376e-13
) O 0 1.963347760044216e-17
surrounding O 0 2.777282332401738e-15
the O 0 1.2237455142380827e-14
repeat O 0 1.4577061779874612e-10
. O 0 6.905298883153228e-15
. O 0 1.5415286777099857e-13

A O 0 1.7116707357045513e-11
novel O 0 2.8830628856502116e-11
missense O 0 5.7851952561804865e-08
mutation O 0 2.265513998622737e-09
in O 0 1.6089812231986694e-15
patients O 0 1.1898817976925546e-13
from O 0 8.974984919636093e-18
a O 0 1.446191799127361e-13
retinoblastoma B-Disease 0 0.00016176899953279644
pedigree O 0 4.333702690928476e-06
showing O 0 4.554471730311427e-11
only O 0 2.7348496731138816e-12
mild O 0 5.100425984339019e-11
expression O 0 2.0144044377977573e-14
of O 0 2.921029307758254e-18
the O 0 2.3017366482312555e-15
tumor B-Disease 0 7.189986384048552e-10
phenotype O 0 2.6506138950388447e-10
. O 0 2.57620341075418e-13

We O 0 1.500008173227485e-10
have O 0 8.67976895666347e-16
used O 0 1.7896212694751344e-16
single O 0 2.8330737456594185e-16
strand O 0 2.8905443576893175e-12
conformation O 0 3.1706567574360175e-14
polymorphism O 0 7.688976815271517e-14
analysis O 0 4.160919249126052e-14
to O 0 4.8709159027450575e-16
study O 0 1.4514887027223568e-14
the O 0 2.240162858680025e-16
27 O 0 8.141014582298614e-14
exons O 0 3.333206378009629e-13
of O 0 3.789708537667301e-18
the O 0 4.90782695160844e-16
RB1 O 0 5.255512691704212e-10
gene O 0 7.542391732874576e-13
in O 0 5.5747783616271484e-18
individuals O 0 8.654595327722613e-19
from O 0 6.341094714515795e-19
a O 0 4.00896492652042e-14
family O 0 7.555512639145778e-12
showing O 0 3.0539407114282824e-10
mild O 0 1.810494393295059e-10
expression O 0 4.861451156592438e-15
of O 0 3.286557525313293e-18
the O 0 5.153573761859133e-15
retinoblastoma B-Disease 0 3.839171540676034e-07
phenotype O 0 1.175829300592568e-08
. O 0 2.7258349657305336e-12

In O 0 2.379908641306997e-14
this O 0 8.29082836794324e-16
family O 0 4.0466006332460017e-14
affected O 0 1.2204728330397763e-14
individuals O 0 2.4358038783046984e-17
developed O 0 5.06861941307335e-10
unilateral B-Disease 1 0.9995711445808411
tumors I-Disease 1 1.0
and O 0 9.185864513483466e-09
, O 0 1.9211135842398842e-14
as O 0 3.444154812846397e-16
a O 0 2.119383583698087e-15
result O 0 4.6577308389318325e-15
of O 0 1.462774175270498e-19
linkage O 0 1.5632948269228564e-09
analysis O 0 4.917523094456755e-13
, O 0 2.4897489516432668e-15
unaffected O 0 8.72637032078849e-11
mutation O 0 1.1178571089620615e-12
carriers O 0 7.166833180518792e-14
were O 0 1.7762584141717795e-14
also O 0 9.935450899500875e-13
identified O 0 1.43274819092154e-11
within O 0 1.0468448007863902e-14
the O 0 2.5377860959061894e-14
pedigree O 0 6.582610723171456e-08
. O 0 9.110676622847702e-13

A O 0 6.784259569056483e-13
single O 0 2.0216126881788914e-15
band O 0 2.7440349657330265e-16
shift O 0 4.760824913008048e-15
using O 0 4.615421649095599e-16
SSCP O 0 4.049587401522281e-11
was O 0 6.36099847586293e-15
identified O 0 4.445065429831748e-15
in O 0 5.6416542597908356e-18
exon O 0 4.5441546359104024e-11
21 O 0 3.1764969127268117e-11
which O 0 7.61047668163201e-15
resulted O 0 1.0928860389640502e-14
in O 0 4.27421857996809e-17
a O 0 1.435136562269023e-14
missense O 0 7.794213607859035e-10
mutation O 0 2.1233430053287095e-13
converting O 0 1.5433275935778702e-15
a O 0 5.014160291433192e-16
cys O 0 6.510350480937177e-09
- O 0 1.6794360346850112e-10
- O 0 1.0190336768856056e-10
> O 0 7.252392317334128e-14
arg O 0 2.8830860225245725e-14
at O 0 2.7484977705738726e-16
nucleotide O 0 1.1050433334494018e-14
position O 0 5.1083821824308637e-14
28 O 0 3.2021978926995154e-15
in O 0 1.2793200169163503e-18
the O 0 4.20378150383124e-17
exon O 0 1.360131729466474e-10
. O 0 2.428351963956743e-11

The O 0 6.482077461594793e-12
mutation O 0 3.5474776328286994e-12
destroyed O 0 5.048217920078368e-12
an O 0 2.813955417946501e-16
NdeI O 0 3.75366475680039e-08
restriction O 0 2.7956681414309514e-10
enzyme O 0 1.1814725413283877e-11
site O 0 2.2256540360698907e-11
. O 0 5.182028417483053e-12

Analysis O 0 5.1010487500668944e-11
of O 0 3.0053619014921683e-17
all O 0 2.555546841562895e-16
family O 0 4.502832970955373e-16
members O 0 1.5916103991089877e-19
demonstrated O 0 9.822633289266132e-18
that O 0 4.0177196327466245e-19
the O 0 9.419491101306776e-18
missense O 0 4.885035154167383e-10
mutation O 0 1.6222441792668185e-11
co O 0 3.5480614973826263e-11
- O 0 1.2452230219173188e-11
segregated O 0 1.7035746424642895e-10
with O 0 9.176349729991123e-14
patients O 0 6.711237468537412e-12
with O 0 5.716082988882487e-12
tumors B-Disease 1 1.0
or O 0 1.0545589956834078e-09
who O 0 9.192783201328325e-10
, O 0 6.510674809236041e-16
as O 0 1.258497862577696e-16
a O 0 8.969243525178811e-16
result O 0 1.439933987475682e-15
of O 0 1.4438082162943642e-20
linkage O 0 6.167750338237354e-11
analysis O 0 6.526596212259872e-14
had O 0 1.7285661834190447e-12
been O 0 1.8848535013722906e-15
predicted O 0 6.452207745952926e-14
to O 0 2.7148903156409047e-17
carry O 0 1.5165233841927736e-14
the O 0 9.105832881879487e-16
predisposing O 0 5.791816803935035e-09
mutation O 0 3.634961220910782e-10
. O 0 1.2666135501548936e-12

These O 0 1.7253570534087048e-13
observations O 0 2.0564921835754257e-13
point O 0 2.4080002857147786e-13
to O 0 3.167945574378446e-16
another O 0 2.2010052878581113e-14
region O 0 2.806841131047788e-13
of O 0 2.1287553034646577e-18
the O 0 8.268876979719553e-16
RB1 O 0 1.9031301534688794e-10
gene O 0 2.5305322073898573e-13
where O 0 3.418879508519006e-15
mutations O 0 5.321074527178671e-14
only O 0 2.0815558069577593e-16
modify O 0 3.935965865297514e-13
the O 0 9.434712481892283e-16
function O 0 7.480124917906561e-14
of O 0 8.151384137979041e-20
the O 0 1.8669482307189596e-16
gene O 0 4.258640315391027e-11
and O 0 6.948492481265514e-14
raise O 0 1.502157345418338e-15
important O 0 1.0897708847181094e-16
questions O 0 1.4158041893303343e-16
for O 0 1.2368981625991448e-18
genetic O 0 3.4393041799946067e-12
counseling O 0 4.577966381563606e-16
in O 0 7.334755765102776e-19
families O 0 1.4710687547122676e-17
with O 0 6.142818591108645e-17
these O 0 6.315997521199441e-16
distinctive O 0 1.9397463236342505e-12
phenotypes O 0 3.421182434570902e-11
. O 0 6.7598400327036155e-15
. O 0 4.646803775099073e-13

Maternal B-Disease 0 0.0001286544429603964
disomy I-Disease 0 0.0006921348976902664
and O 0 8.206280472222716e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 2.0313233040081258e-10
with O 0 2.2844854458318824e-16
gamete O 0 9.163416553326087e-12
complementation O 0 5.476907816159837e-11
in O 0 1.464148892579894e-17
a O 0 2.5096098625531304e-16
case O 0 1.637996040345334e-14
of O 0 1.2463140629094125e-18
familial O 0 9.527069411152667e-11
translocation O 0 2.0541586487343722e-10
( O 0 9.080303308849243e-16
3 O 0 2.103862297862715e-14
; O 0 2.5005437512813124e-14
15 O 0 9.610493417787705e-15
) O 0 1.4835406200288726e-16
( O 0 1.5420901512338255e-17
p25 O 0 6.677624219634387e-14
; O 0 2.735715249306417e-16
q11 O 0 5.24172990169075e-13
. O 0 1.8793959092744535e-16
2 O 0 4.0315147223455184e-15
) O 0 1.7640960374887445e-15
. O 0 1.341676064952474e-13

Maternal B-Disease 0 0.0024734726175665855
uniparental I-Disease 0 0.0056386832147836685
disomy I-Disease 0 0.0007738681742921472
( I-Disease 0 4.8073095504364e-10
UPD I-Disease 1 0.9999983310699463
) I-Disease 0 7.651937894079253e-13
for I-Disease 0 1.8914440529766395e-15
chromosome I-Disease 0 4.274615548638394e-06
15 I-Disease 0 4.581616661579468e-13
is O 0 6.674532274091201e-17
responsible O 0 1.2463533953475394e-16
for O 0 1.4623613604460457e-19
an O 0 7.054411847799367e-19
estimated O 0 5.260172434754613e-15
30 O 0 7.786525703455238e-15
% O 0 2.332261586487404e-18
of O 0 9.548673784574955e-20
cases O 0 2.867906107907603e-13
of O 0 2.0070632655855292e-11
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.2815591469983456e-11
PWS B-Disease 1 0.9999936819076538
) O 0 3.2213277184611755e-12
. O 0 1.2873378578415196e-12

We O 0 5.329010122068212e-09
report O 0 3.659425007077966e-15
on O 0 2.74969042439647e-18
an O 0 1.4401447109095492e-20
unusual O 0 6.092019245934946e-16
case O 0 4.4213747653299926e-14
of O 0 5.786158990491093e-18
maternal B-Disease 0 1.9795122485621874e-10
disomy I-Disease 0 6.7129120040476664e-09
15 I-Disease 0 1.4877366645484752e-13
in O 0 1.9538546263764625e-14
PWS B-Disease 1 0.9999998807907104
that O 0 2.749258286305345e-12
is O 0 1.0594023183393194e-15
most O 0 1.3277228213321357e-17
consistent O 0 1.5556575345536958e-15
with O 0 6.023385622056808e-17
adjacent O 0 2.58520392593109e-11
- O 0 6.087415016509112e-10
1 O 0 2.3248746237349276e-15
segregation O 0 5.011054071690779e-12
of O 0 1.0323672871407811e-19
a O 0 1.7662777826026347e-15
paternal O 0 9.279132323625205e-11
t O 0 2.5736815456589568e-11
( O 0 3.276232119240008e-17
3 O 0 5.998967382723141e-16
; O 0 1.0622026092629421e-15
15 O 0 5.855978692105958e-16
) O 0 1.3381312349798904e-17
( O 0 2.074158487904014e-18
p25 O 0 4.1143883412015844e-14
; O 0 2.9915917265733246e-16
q11 O 0 1.2432260353568286e-13
. O 0 5.401841117167728e-17
2 O 0 8.203397627127651e-17
) O 0 5.550185454835334e-18
with O 0 4.252426341294258e-17
simultaneous O 0 4.127267104470089e-12
maternal O 0 2.49928167050939e-09
meiotic O 0 6.915251704597836e-11
nondisjunction O 0 8.149684260772005e-10
for O 0 3.100363356615867e-15
chromosome O 0 5.636068323155996e-08
15 O 0 1.2105889207747467e-11
. O 0 3.992562790794407e-12

The O 0 1.718710135149848e-12
patient O 0 3.1526552202176816e-11
( O 0 7.544452051580313e-16
J O 0 6.680720976426358e-10
. O 0 5.982927013921868e-15
B O 0 2.595610670841353e-10
. O 0 8.144186053647635e-17
) O 0 1.9198577467225054e-17
, O 0 1.886391872023182e-16
a O 0 1.9248537852734277e-15
17 O 0 8.992583560392051e-14
- O 0 1.2111794856980995e-12
year O 0 1.1962362558035153e-15
- O 0 4.810783715836209e-11
old O 0 2.4756920957713646e-09
white O 0 1.4403812344243594e-12
male O 0 1.9608929280670595e-13
with O 0 1.1656048974528397e-15
PWS B-Disease 1 0.9999982118606567
, O 0 6.31246009985347e-15
was O 0 1.2221126888256606e-14
found O 0 5.441514565465233e-15
to O 0 7.696012186228117e-16
have O 0 1.076308746988941e-12
47 O 0 4.167136427590812e-11
chromosomes O 0 1.097572662096813e-12
with O 0 6.741733221148397e-16
a O 0 2.899387002187892e-14
supernumerary O 0 3.427399803968001e-07
, O 0 5.871831493253765e-11
paternal O 0 1.1100388519480475e-07
der O 0 3.331037441967055e-05
( O 0 1.4800085985179406e-15
15 O 0 2.1701814200943484e-15
) O 0 9.63646884778556e-18
consisting O 0 6.0718055491112736e-18
of O 0 2.2262660424093994e-18
the O 0 4.7179437006467095e-14
short O 0 6.084330372857494e-09
arm O 0 3.9217975427163765e-06
and O 0 3.394283552143884e-13
the O 0 1.6159689273761622e-15
proximal O 0 9.088915384203311e-12
long O 0 8.866044010069629e-10
arm O 0 1.5422060073433386e-08
of O 0 1.7235050870732404e-17
chromosome O 0 6.740857205755901e-09
15 O 0 5.778792835963234e-14
, O 0 1.5016139102552034e-14
and O 0 1.8565513709711823e-12
distal O 0 4.98712097396492e-06
chromosome O 1 0.7893089056015015
arm O 0 0.002235500141978264
3p O 0 2.8707213459711056e-06
. O 0 2.9032334869505405e-10

The O 0 1.2772077232631185e-12
t O 0 1.0894791319104868e-10
( O 0 4.8053400016320587e-17
3 O 0 1.4051560587410617e-16
; O 0 9.35521685160569e-17
15 O 0 1.255534438402388e-16
) O 0 7.827523282624983e-18
was O 0 1.6772973526583967e-14
present O 0 1.388361777677173e-16
in O 0 9.915099012295883e-17
the O 0 3.291303482349622e-16
balanced O 0 9.143569046712614e-15
state O 0 3.3429696863354966e-15
in O 0 7.810559628058868e-16
the O 0 2.9344022854362007e-15
patients O 0 1.492073202187874e-13
father O 0 1.1567073796188432e-13
and O 0 1.2511031325992679e-15
a O 0 1.7576618058148114e-14
sister O 0 3.1578114345620634e-08
. O 0 5.222014227285188e-12

Fluorescent O 0 1.5822375354357376e-10
in O 0 9.773605070132808e-16
situ O 0 2.956280782239612e-13
hybridization O 0 3.839232737604635e-14
analysis O 0 3.057400786739945e-15
demonstrated O 0 7.876323795479284e-16
that O 0 2.1227081086067214e-16
the O 0 1.6438393818352624e-14
PWS B-Disease 1 0.9999996423721313
critical O 0 4.727589500430618e-11
region O 0 4.441733005705606e-12
resided O 0 5.628150723246961e-12
on O 0 2.5586112479473837e-15
the O 0 1.186147302617051e-17
derivative O 0 2.4137930085157792e-14
chromosome O 0 9.93488798173292e-12
3 O 0 7.133848595234054e-16
and O 0 1.815039987068407e-15
that O 0 1.9265874499582204e-15
there O 0 6.131204620613354e-14
was O 0 4.018712988253237e-13
no O 0 3.8766406771707e-15
deletion O 0 8.112508874304897e-14
of O 0 4.309940312682647e-19
the O 0 5.734314119463374e-14
PWS B-Disease 1 0.9999998807907104
region O 0 5.3808384831155465e-11
on O 0 7.940469028827613e-14
the O 0 1.37010575597434e-15
normal O 0 8.715616119439606e-13
pair O 0 3.783073843337953e-13
of O 0 5.365219081074469e-19
15s O 0 4.0170228356509446e-15
present O 0 1.7664722560733684e-16
in O 0 1.671437070509523e-14
J O 0 1.7281270174862584e-06
. O 0 7.15397489511882e-12

B O 0 0.0004625826550181955
. O 0 1.3522216679717758e-10

Methylation O 0 8.509283833113557e-10
analysis O 0 1.814502758115677e-12
at O 0 2.7597722555578602e-15
exon O 0 7.534850191969356e-15
alpha O 0 3.143306021217529e-15
of O 0 1.3457066377477123e-18
the O 0 2.727649642763984e-16
small O 0 4.703596995399295e-13
nuclear O 0 1.2886762768005156e-09
ribonucleoprotein O 0 9.314223697876045e-11
- O 0 3.5341632398377953e-10
associated O 0 5.590045787373654e-11
polypeptide O 0 7.18861525861314e-10
N O 0 4.4828522838269436e-11
( O 0 4.297860725363836e-17
SNRPN O 0 1.7282497048048961e-12
) O 0 6.444325924384223e-17
gene O 0 3.939526114181413e-13
showed O 0 4.210129423906639e-13
a O 0 1.0322866761153411e-15
pattern O 0 4.2337786054780224e-10
characteristic O 0 2.4512366962603505e-12
of O 0 9.280462719851926e-18
only O 0 3.999184067671885e-13
the O 0 1.0146174841323217e-14
maternal O 0 1.2368542856577847e-09
chromosome O 0 1.2833297091674467e-08
15 O 0 2.3081135527153185e-13
in O 0 8.983326506718098e-14
J O 0 3.258124343119562e-05
. O 0 9.088257056644178e-12

B O 0 0.0003396062820684165
. O 0 3.575331974925433e-10

Maternal B-Disease 0 1.725989204715006e-05
disomy I-Disease 0 4.132332520612181e-08
was O 0 1.0324890898846806e-12
confirmed O 0 4.190177122376931e-15
by O 0 4.1579908530718356e-18
polymerase O 0 3.0418285078270824e-12
chain O 0 3.879043353888223e-12
reaction O 0 2.9289446403988045e-15
analysis O 0 8.702346619872533e-16
of O 0 1.49957867189725e-18
microsatellite O 0 2.365404816462302e-10
repeats O 0 6.610372804694009e-10
at O 0 2.7962488823984194e-14
the O 0 3.7446019652744784e-17
gamma O 0 1.6134010834690897e-14
- O 0 4.624423344257167e-10
aminobutyric O 0 1.9034251952376735e-09
acid O 0 2.7358983134551096e-12
receptor O 0 8.002869607238658e-14
beta3 O 0 5.589019264756745e-12
subunit O 0 1.899464472428919e-13
( O 0 5.178500035672696e-16
GABRB3 O 0 1.1451470327550339e-10
) O 0 7.363591141462851e-15
locus O 0 9.915615203914818e-12
. O 0 1.7442790267718777e-11

A O 0 4.767759104185032e-11
niece O 0 9.56102841342954e-09
( O 0 5.835691765975273e-14
B O 0 4.940950426579604e-10
. O 0 1.2595023113042415e-15
B O 0 8.947664657810162e-12
. O 0 5.628198099176129e-18
) O 0 1.8998365844582107e-18
with O 0 6.818415378561125e-17
45 O 0 1.0346446464339076e-14
chromosomes O 0 1.1097328297179215e-13
and O 0 4.742445145085577e-15
the O 0 3.059450910874766e-17
derivative O 0 3.49466142872748e-14
3 O 0 3.559577610288576e-15
but O 0 2.2228985145644753e-13
without O 0 1.209211614709325e-14
the O 0 9.306173114564074e-16
der O 0 3.479647716631007e-07
( O 0 7.287907874122952e-17
15 O 0 1.0598019326019662e-16
) O 0 6.105623174094279e-18
demonstrated O 0 1.9618063916907846e-16
a O 0 7.941946084881035e-16
phenotype O 0 7.479904716445329e-12
consistent O 0 2.859940677834259e-14
with O 0 2.5838058459167688e-17
that O 0 3.1310990058981735e-15
reported O 0 4.0106879948230423e-13
for O 0 6.634876491062858e-18
haploinsufficiency O 0 2.7531757429422044e-10
of O 0 1.375577039565676e-17
distal O 0 3.009984761437323e-10
3 O 0 2.1688710549749857e-10
p O 0 9.601682222637464e-07
. O 0 1.9580172552768893e-11

Uniparental B-Disease 1 0.9999079704284668
disomy I-Disease 1 0.9998602867126465
associated O 0 3.609772702972691e-09
with O 0 2.9140305077800244e-13
unbalanced O 0 3.028872299637442e-07
segregation O 0 1.2394200155085855e-07
of O 0 1.2910875875722031e-16
non O 0 9.59314116859289e-13
- O 0 1.3875731674772851e-08
Robertsonian O 0 5.559579108194157e-07
translocations O 0 1.368724610983918e-06
has O 0 3.380924706863908e-11
been O 0 1.0781528325828037e-14
reported O 0 2.3416264790360707e-14
previously O 0 1.046019011425453e-13
but O 0 1.1921471839218545e-12
has O 0 1.4953502845693745e-12
not O 0 5.6439038555525234e-14
, O 0 3.0560597218262046e-15
to O 0 1.3381842393900539e-14
our O 0 4.9005705262284305e-15
knowledge O 0 6.762102907691985e-17
, O 0 1.4972071657605757e-17
been O 0 2.1178712857801034e-16
observed O 0 3.5101691196840487e-16
in O 0 1.7472819129823462e-19
a O 0 5.4571414498393484e-17
case O 0 3.897921956453991e-14
of O 0 1.2448382651631383e-15
PWS B-Disease 1 0.9999990463256836
. O 0 1.3922960007128893e-10

Furthermore O 0 5.5304631985109154e-08
, O 0 1.7499364587600374e-12
our O 0 8.556981790080066e-15
findings O 0 5.490766143216282e-15
are O 0 5.4180797479269405e-18
best O 0 1.3071951154982817e-14
interpreted O 0 6.031991397391573e-15
as O 0 8.717929908519644e-16
true O 0 1.86191479036946e-14
gamete O 0 1.4117817158376678e-11
complementation O 0 2.9492452924273493e-10
resulting O 0 1.388554527435859e-13
in O 0 1.4700057577449188e-13
maternal B-Disease 0 2.7271536964690313e-05
UPD I-Disease 1 0.9999994039535522
15 I-Disease 0 9.276349288711572e-08
and O 0 2.4694260858382222e-08
PWS B-Disease 1 0.9999971389770508

Schwartz B-Disease 0 0.3875434100627899
- I-Disease 1 0.9974036812782288
Jampel I-Disease 1 0.9987698197364807
syndrome I-Disease 1 0.9999840259552002
type I-Disease 0 6.305767215053493e-07
2 I-Disease 0 1.833050421520821e-12
and O 0 1.7162550547400457e-10
Stuve B-Disease 1 0.9998282194137573
- I-Disease 1 0.999991774559021
Wiedemann I-Disease 1 0.9999973773956299
syndrome I-Disease 1 0.9999986886978149
: O 0 1.0535385210037147e-15
a O 0 5.958891342312784e-17
case O 0 5.806576871885891e-15
for O 0 1.1192409642068219e-17
" O 0 1.4186602467856219e-14
lumping O 0 1.0705118042020345e-10
" O 0 8.152097161380489e-13
. O 0 1.3020449518910682e-13

Recent O 0 8.404054119282023e-10
studies O 0 5.522820048509125e-12
demonstrated O 0 4.335477154148934e-14
the O 0 1.3385957796119002e-17
existence O 0 2.28279561510211e-16
of O 0 1.4647732381664914e-19
a O 0 2.6558902290824615e-15
genetically O 0 9.835557932338923e-13
distinct O 0 6.672073104511261e-14
, O 0 6.198707810201954e-15
usually O 0 1.359220535569175e-15
lethal O 0 2.9556333250778074e-16
form O 0 1.4017879116356438e-17
of O 0 3.456945564560947e-18
the O 0 5.084142200122155e-13
Schwartz B-Disease 1 0.9999024868011475
- I-Disease 1 0.999922513961792
Jampel I-Disease 1 0.9998743534088135
syndrome I-Disease 1 0.9999815225601196
( O 0 2.882699817852272e-15
SJS B-Disease 0 3.1766660413268255e-07
) O 0 2.5721942682895536e-15
of O 0 6.910773071802876e-17
myotonia B-Disease 0 0.051389049738645554
and O 0 2.928125519829905e-10
skeletal B-Disease 0 0.05071883648633957
dysplasia I-Disease 1 0.9983155727386475
, O 0 7.235487816531494e-12
which O 0 4.5144151004233857e-13
we O 0 1.7879360101821784e-12
called O 0 1.0591292383052564e-12
SJS B-Disease 0 0.0002662094484549016
type I-Disease 0 2.0061273175997485e-07
2 I-Disease 0 1.204379152831836e-12
. O 0 5.564912679972833e-13

This O 0 7.959606307395006e-10
disorder O 0 4.369021098682424e-06
is O 0 4.3331415666759986e-16
reminiscent O 0 1.3557835680955838e-13
of O 0 3.237073099528533e-18
another O 0 4.4477476443625236e-14
rare O 0 7.877091340313669e-12
condition O 0 1.3723389535869046e-08
, O 0 3.653887105668817e-15
the O 0 1.946019029513274e-13
Stuve B-Disease 1 0.9993268251419067
- I-Disease 1 0.999993085861206
Wiedemann I-Disease 1 0.9999986886978149
syndrome I-Disease 1 0.9999992847442627
( O 0 5.282455584607916e-14
SWS B-Disease 0 1.1924116449790745e-07
) O 0 6.372583345482527e-15
, O 0 9.473522260986054e-15
which O 0 8.305457050458796e-15
comprises O 0 1.157415770213291e-13
campomelia B-Disease 0 3.731185138633464e-09
at O 0 5.026770015861826e-13
birth O 0 5.74392746907626e-13
with O 0 3.093867122130195e-14
skeletal B-Disease 0 0.0005184487672522664
dysplasia I-Disease 1 0.8989754915237427
, O 0 3.0828427918100365e-12
contractures B-Disease 0 7.543762308159785e-07
, O 0 1.963180703071221e-12
and O 0 2.675406554283888e-13
early B-Disease 0 3.413815237440776e-12
death I-Disease 0 1.7317550171647156e-11
. O 0 9.753247471808169e-13

To O 0 5.504654891630434e-13
test O 0 1.6078661297345975e-13
for O 0 7.313242865321803e-19
possible O 0 9.714207943497784e-16
nosologic O 0 1.864072896040625e-09
identity O 0 7.693675883012341e-13
between O 0 8.085078830391557e-13
these O 0 2.242587192335943e-12
disorders O 0 7.137333568607573e-08
, O 0 8.072826836563911e-17
we O 0 8.533483571463926e-14
reviewed O 0 2.1824789154731294e-13
the O 0 3.8498616246641373e-16
literature O 0 7.041332374482269e-15
and O 0 8.885163858460797e-16
obtained O 0 1.8112071100425222e-16
a O 0 1.3483844695447302e-17
follow O 0 3.583898467303089e-15
- O 0 2.1023862582488298e-14
up O 0 8.604673980175219e-15
of O 0 1.0526124033860457e-19
the O 0 4.224793214879067e-17
only O 0 2.870880531864522e-15
two O 0 1.2378581842821708e-15
surviving O 0 2.8720185951680577e-12
patients O 0 4.861840368231701e-15
, O 0 3.247673212283247e-18
one O 0 1.6659283533558744e-17
with O 0 4.917289897816046e-16
SJS B-Disease 0 7.605212317685073e-07
type I-Disease 0 1.1314802428330495e-09
2 I-Disease 0 5.338607685670361e-15
at O 0 6.077495277867495e-14
age O 0 5.967988147941028e-14
10 O 0 2.583462135828641e-16
years O 0 3.7084942080475587e-17
and O 0 4.6779720544001235e-17
another O 0 7.708352397478428e-16
with O 0 9.772156432034766e-15
SWS B-Disease 0 1.3735179038576462e-07
at O 0 1.0057476769811946e-12
age O 0 1.393335316915434e-13
7 O 0 9.037013487794149e-14
years O 0 2.00091001710187e-14
. O 0 4.698423182632194e-13

Patients O 0 2.1174598074935602e-08
reported O 0 2.0403726451456716e-12
as O 0 2.0394445951910783e-14
having O 0 1.1040252913263604e-11
either O 0 3.804351278446916e-11
neonatal O 1 0.9996297359466553
SJS B-Disease 1 0.9977371692657471
or O 0 1.009808348051422e-10
SWS B-Disease 0 6.298212156252703e-07
presented O 0 5.958465125921637e-15
a O 0 1.6767166745153625e-16
combination O 0 3.432129856671142e-15
of O 0 6.093729971246992e-19
a O 0 2.980767217254654e-14
severe O 0 1.2769069135387667e-10
, O 0 1.1747480971931873e-13
prenatal O 0 0.024513553828001022
- O 0 0.27913302183151245
onset O 0 0.0007900638738647103
neuromuscular B-Disease 1 0.9999854564666748
disorder I-Disease 1 0.9995647072792053
( O 0 2.714842578716882e-14
with O 0 3.1705148489241664e-12
congenital B-Disease 1 0.9999814033508301
joint I-Disease 0 5.390111255110241e-07
contractures I-Disease 1 0.9989163875579834
, O 0 2.497110926924506e-07
respiratory O 1 0.9999938011169434
and O 0 2.2645041397595378e-08
feeding O 0 6.461607426899718e-06
difficulties O 0 2.3359170153725017e-10
, O 0 6.447550737633098e-16
tendency O 0 3.8291154101643965e-12
to O 0 1.299532876633243e-15
hyperthermia B-Disease 0 2.1739259281616796e-08
, O 0 2.835130743996002e-14
and O 0 1.0414283639018779e-13
frequent O 0 3.0934381722858006e-09
death O 0 1.8832493342557655e-09
in O 0 1.8802018590061836e-13
infancy O 0 2.2090669571372956e-11
) O 0 9.184385691703892e-18
with O 0 5.446074434987879e-18
a O 0 2.612032768897765e-15
distinct O 0 1.1530381684166091e-12
campomelic B-Disease 0 3.819527591986116e-06
- I-Disease 0 1.3887450222682673e-05
metaphyseal I-Disease 0 1.7482907423982397e-05
skeletal I-Disease 0 0.00551225058734417
dysplasia I-Disease 1 0.9195630550384521
. O 0 1.9909816850738338e-10

The O 0 6.047754257023502e-14
similarity O 0 8.251905018671901e-13
of O 0 3.917396686514356e-18
the O 0 4.8709159027450575e-16
clinical O 0 5.392651603042253e-12
and O 0 1.5111874154382504e-14
radiographic O 0 7.087342964950949e-06
findings O 0 4.367873285282542e-10
is O 0 1.4116071728404248e-14
so O 0 6.311545304270435e-15
extensive O 0 1.519315923070863e-12
that O 0 3.104452805935409e-11
these O 0 7.406507698815012e-12
disorders O 0 9.441716031233227e-08
appear O 0 7.331778278029874e-15
to O 0 4.4537555643541036e-15
be O 0 3.036121836797259e-14
a O 0 1.1776780180390578e-13
single O 0 1.8656421893470387e-12
entity O 0 1.1921945652915156e-09
. O 0 4.50477127822424e-10

The O 0 6.488391638206914e-14
follow O 0 6.741508799769022e-14
- O 0 7.624722251145521e-13
up O 0 3.763610991326487e-14
observation O 0 8.119324440211684e-13
of O 0 1.535899914100512e-20
an O 0 1.781479860101367e-18
identical O 0 5.701938487340241e-12
and O 0 1.4390706237332046e-13
unique O 0 3.412757069672957e-14
pattern O 0 4.335571013314166e-09
of O 0 1.966631832512174e-16
progressive O 0 2.59405421587644e-08
bone B-Disease 0 0.011723443865776062
dysplasia I-Disease 1 0.9994646906852722
in O 0 2.569318726958897e-13
the O 0 5.981232761680111e-13
two O 0 1.6892327380640948e-12
patients O 0 1.3237153072883506e-13
( O 0 1.3135057372719418e-18
one O 0 4.451356330296116e-17
with O 0 2.5892452532760195e-15
SJS B-Disease 0 8.018162588996347e-06
type I-Disease 0 3.493352451755527e-08
2 I-Disease 0 1.1269930911346655e-14
, O 0 3.301414885217911e-15
one O 0 2.105211113127923e-14
with O 0 3.143237081205952e-13
SWS B-Disease 0 3.5700998068932677e-06
) O 0 3.132701549882731e-14
surviving O 0 4.8939090627198034e-12
beyond O 0 2.016624714440418e-12
infancy O 0 2.2259766946364223e-11
adds O 0 3.445714547023471e-11
to O 0 1.8107935991455845e-15
the O 0 2.044816613138441e-17
evidence O 0 1.7460738868766042e-14
in O 0 1.7355390760607844e-17
favor O 0 8.202873737249775e-15
of O 0 3.0179519212874704e-18
identity O 0 1.3630910636330817e-12
. O 0 1.8643322562822418e-13

The O 0 3.0700027481116166e-13
hypothesis O 0 1.0208034070813277e-11
that O 0 6.807247196212018e-15
SWS B-Disease 0 7.798830381489097e-08
and O 0 7.613572587054224e-14
SJS B-Disease 0 3.1564982236886863e-06
type I-Disease 0 4.563531064150084e-08
2 I-Disease 0 9.507626348541354e-15
are O 0 1.328741907846801e-16
the O 0 4.40576564217799e-15
same O 0 1.4901473111006425e-10
disorder O 0 1.8956287021865137e-05
should O 0 7.740861987862169e-14
be O 0 6.199360108289401e-18
testable O 0 2.9349940438289763e-16
by O 0 2.7158921864590713e-19
molecular O 0 1.663067368551114e-14
methods O 0 2.4230209852427187e-12
. O 0 3.8447431951462926e-14
. O 0 5.786725807734039e-13

A O 0 1.226238034723881e-11
mouse O 0 1.0060988486770839e-08
model O 0 4.98068086773884e-10
of O 0 1.4733292439794016e-13
severe O 1 0.9919342994689941
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9429734349250793
defects O 1 0.9999889135360718
in O 0 4.911510087524107e-11
hemostasis O 1 0.9968612194061279
and O 0 9.849003390627331e-08
thrombosis B-Disease 0 1.671767677180469e-05
. O 0 3.840468915106143e-11

von B-Disease 0 0.006079555489122868
Willebrand I-Disease 0 0.001020978786982596
factor I-Disease 0 5.5344202110063634e-08
( I-Disease 0 6.46639825019335e-11
vWf I-Disease 0 0.0005907633458264172
) I-Disease 0 8.199097464967053e-06
deficiency I-Disease 1 0.9997678399085999
causes O 0 0.010547319427132607
severe O 1 0.9999982118606567
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 5.94675810816625e-08
humans O 0 3.589748075683019e-06
. O 0 6.084127646133197e-11

We O 0 2.6581343463144558e-12
generated O 0 8.75261511361632e-17
a O 0 4.1409315267960727e-16
mouse O 0 1.449891508936707e-11
model O 0 4.468039653537925e-12
for O 0 5.0768061202931814e-17
this O 0 2.2980091950435683e-14
disease O 0 4.174375775600758e-11
by O 0 1.2446973610203975e-20
using O 0 1.0619837571251953e-15
gene O 0 2.538240104210665e-11
targeting O 0 4.789380558811729e-10
. O 0 9.146618358546466e-12

vWf B-Disease 0 3.9970116631593555e-05
- I-Disease 0 0.09409862756729126
deficient I-Disease 0 0.01120973564684391
mice O 0 0.00018009856285061687
appeared O 0 2.5789914648299828e-09
normal O 0 4.443700962752928e-11
at O 0 5.813373464254659e-14
birth O 0 1.8119899908319338e-14
; O 0 1.7935578550974988e-16
they O 0 7.298988785608713e-15
were O 0 2.4764969094252364e-15
viable O 0 4.845996108733541e-13
and O 0 6.114145648106195e-13
fertile O 0 7.635791304805295e-11
. O 0 4.8365908500436205e-11

Neither O 0 2.5670286163403944e-07
vWf O 0 3.095307693001814e-05
nor O 0 1.6180354123207508e-06
vWf O 0 1.1377737791917752e-05
propolypeptide O 0 0.0001212489150930196
( O 0 3.254809963215699e-11
von B-Disease 0 5.117896944284439e-05
Willebrand I-Disease 0 0.00010547864803811535
antigen O 0 1.1771375874047862e-08
II O 0 3.679440752080154e-08
) O 0 2.7185839232449042e-14
were O 0 4.7555455260544013e-14
detectable O 0 3.937319654340188e-12
in O 0 7.552658742048023e-16
plasma O 0 1.4741755594016581e-09
, O 0 8.710135911138561e-12
platelets O 0 7.337133504925486e-12
, O 0 2.1498192223808055e-13
or O 0 1.6980337356467187e-14
endothelial O 0 4.0332989972489096e-15
cells O 0 1.560972031023006e-15
of O 0 2.101481911435517e-20
the O 0 1.3739573206646236e-16
homozygous O 0 3.009028790024182e-12
mutant O 0 2.4805228981961136e-09
mice O 0 1.352207164018182e-06
. O 0 2.4946583427470914e-12

The O 0 8.273468715680465e-12
mutant O 0 1.2858827780348747e-08
mice O 0 5.4549250307900365e-06
exhibited O 0 3.0390261418489217e-09
defects O 0 1.5358295058831573e-05
in O 0 3.3173090349566644e-15
hemostasis O 0 1.55891029862687e-07
with O 0 9.188153981144059e-14
a O 0 7.399119294690393e-13
highly O 0 4.142251212174708e-12
prolonged O 0 1.1454719128778379e-07
bleeding O 0 7.442644709954038e-05
time O 0 5.791546062172692e-11
and O 0 2.643603001437067e-12
spontaneous O 0 5.103284548418907e-12
bleeding O 0 1.0318788099539233e-06
events O 0 6.279343906824553e-14
in O 0 3.6572320387775244e-16
approximately O 0 5.8549318652622705e-15
10 O 0 4.341995919711003e-15
% O 0 2.836922451613505e-17
of O 0 1.850928289970094e-17
neonates O 0 7.569529891782167e-09
. O 0 1.005905515133465e-11

As O 0 4.136614228239521e-12
in O 0 1.081699190126368e-15
the O 0 6.2744558490925376e-15
human O 0 5.3232218980014956e-12
disease O 0 3.931309322524612e-08
, O 0 2.32906081110713e-18
the O 0 1.786481821265475e-18
factor O 0 1.400453781804159e-14
VIII O 0 3.2735328336919167e-10
level O 0 7.350687983645465e-13
in O 0 6.341999844493372e-16
these O 0 2.2900108323292354e-14
mice O 0 4.036776601878955e-08
was O 0 1.0422794355022247e-12
reduced O 0 4.241981996244183e-14
strongly O 0 2.2217740275050184e-14
as O 0 1.294071419947584e-15
a O 0 7.689091503532575e-15
result O 0 9.96231109352862e-15
of O 0 3.6002379586759316e-19
the O 0 7.483827785962954e-16
lack O 0 1.358350484501579e-14
of O 0 5.1898016027567334e-20
protection O 0 7.646235765687126e-16
provided O 0 9.233994525452779e-17
by O 0 1.3393523190001412e-16
vWf O 0 6.432575805348506e-09
. O 0 5.513139944568479e-11

Defective O 0 5.472208067658357e-05
thrombosis B-Disease 0 3.122200041616452e-06
in O 0 5.983657156322401e-15
mutant O 0 3.427534700506385e-09
mice O 0 9.880011930363253e-05
was O 0 1.2684764350012756e-10
also O 0 4.233822927662834e-12
evident O 0 7.043754549898237e-14
in O 0 2.0022470864023796e-17
an O 0 5.458096264420418e-18
in O 0 3.015342530414335e-16
vivo O 0 4.0450812144321446e-10
model O 0 1.3432438755039966e-12
of O 0 1.1392373441399645e-16
vascular B-Disease 0 0.007381216157227755
injury I-Disease 0 0.0014547788305208087
. O 0 1.2466798426924441e-11

In O 0 4.194463109090038e-15
this O 0 2.0048455915786537e-17
model O 0 1.4830137443598568e-13
, O 0 4.21433275502717e-16
the O 0 4.576116143969447e-16
exteriorized O 0 9.818890145396608e-10
mesentery O 0 1.0763017560533328e-10
was O 0 1.149291843334857e-13
superfused O 0 2.6087259522716844e-12
with O 0 3.4897953303246227e-16
ferric O 0 5.344221939984628e-11
chloride O 0 3.2923963035058623e-12
and O 0 4.474589102021476e-12
the O 0 3.4558433910624733e-15
accumulation O 0 2.763709671272513e-13
of O 0 1.2617516106043978e-17
fluorescently O 0 7.356720121975968e-09
labeled O 0 5.405941805314285e-10
platelets O 0 4.450215196349916e-11
was O 0 1.2910256631110117e-13
observed O 0 8.21320669217333e-15
by O 0 6.52524139364865e-17
intravital O 0 1.4539297543691987e-10
microscopy O 0 5.272407510581445e-11
. O 0 2.3721614950122927e-12

We O 0 1.9480332014154556e-08
conclude O 0 5.934723198985914e-12
that O 0 2.8208782711639695e-15
these O 0 2.3905533467067893e-15
mice O 0 2.865686576924986e-09
very O 0 5.128669637957141e-14
closely O 0 5.010657444515232e-10
mimic O 0 1.0855580512725282e-05
severe O 0 0.00023897287610452622
human O 0 0.11490849405527115
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 9.678978676674888e-05
will O 0 2.32705099634245e-09
be O 0 2.6520242436562508e-14
very O 0 8.781041009930582e-17
useful O 0 1.9300795484240682e-17
for O 0 1.4425089611212877e-20
investigating O 0 4.0601396052279364e-17
the O 0 7.990097877204038e-19
role O 0 1.645603830873732e-16
of O 0 9.398413195130429e-20
vWf O 0 3.5639987055330336e-12
in O 0 3.901283999628233e-14
normal O 0 1.4967964645506981e-09
physiology O 0 4.6941868170335965e-09
and O 0 1.8484916288613595e-12
in O 0 4.208933006809301e-13
disease O 0 1.7939710517111962e-07
models O 0 5.515858494779813e-13
. O 0 9.7952645072754e-14
. O 0 1.909942906955231e-12

Oral O 0 1.7566155463555333e-07
contraceptives O 0 6.448009571613511e-06
and O 0 2.320165760905102e-11
the O 0 7.495849915165748e-14
risk O 0 9.075027534999336e-11
of O 0 1.8795852190205825e-13
hereditary B-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 5.287362908612536e-11

Hereditary B-Disease 1 0.9999947547912598
Ovarian I-Disease 1 0.999994158744812
Cancer I-Disease 1 0.9991934895515442
Clinical O 0 0.00013985195255372673
Study O 0 1.7750428904506066e-10
Group O 0 3.687430569221384e-11
. O 0 2.671991100600124e-12

BACKGROUND O 0 1.941906702995766e-06
Women O 0 3.281184213221877e-10
with O 0 7.893352651730003e-15
mutations O 0 2.038148816385643e-11
in O 0 3.8404281922607865e-17
either O 0 1.3036347819110877e-14
the O 0 2.295712549910383e-15
BRCA1 O 0 1.6696115323622251e-10
or O 0 5.0749331054536755e-15
the O 0 5.593615001254267e-16
BRCA2 O 0 3.5007108323270586e-11
gene O 0 3.147162218331001e-12
have O 0 2.8880506520350194e-14
a O 0 4.829489638877218e-16
high O 0 5.488622387530076e-14
lifetime O 0 4.277918297379557e-11
risk O 0 3.806779780290981e-09
of O 0 3.6818926379966754e-11
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 9.03202599517039e-12

Oral O 0 6.452078764596081e-07
contraceptives O 0 0.0008778830524533987
protect O 0 2.6646464903024025e-05
against O 1 0.8669451475143433
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 6.3834105441308055e-15
general O 0 5.747958126177746e-14
, O 0 9.359621909975357e-14
but O 0 4.585585925732938e-13
it O 0 4.57030899196219e-15
is O 0 1.137560615951095e-17
not O 0 1.0419945372674349e-17
known O 0 2.4917702568055462e-17
whether O 0 1.963364561736818e-15
they O 0 1.1759428879872663e-13
also O 0 1.946097092069693e-13
protect O 0 2.91163604728209e-13
against O 0 4.736739212668484e-12
hereditary B-Disease 0 2.204428892582655e-05
forms I-Disease 0 5.820166126824233e-09
of I-Disease 0 1.8242646504518234e-08
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 3.565204034772229e-11

METHODS O 0 8.374739235428308e-10
We O 0 1.836332952018238e-12
enrolled O 0 4.296072503816306e-14
207 O 0 2.973384385929201e-11
women O 0 2.0984713966498703e-11
with O 0 1.677779160047521e-08
hereditary B-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.2674914069699117e-11
161 O 0 2.4219582502732484e-12
of O 0 1.2742559841190761e-16
their O 0 5.134348892224527e-13
sisters O 0 2.0096192765439724e-10
as O 0 1.0414073151331386e-15
controls O 0 1.964235885054677e-09
in O 0 2.5133270137025967e-16
a O 0 2.778055885240818e-15
case O 0 2.3416737299220003e-12
- O 0 6.44353792544905e-10
control O 0 1.448986886032344e-08
study O 0 3.21298082540597e-13
. O 0 5.650948797981427e-14

All O 0 4.1427630640203383e-13
the O 0 3.883923042934719e-15
patients O 0 8.974861259443238e-15
carried O 0 6.18106919610833e-15
a O 0 2.0590547075861938e-17
pathogenic O 0 4.366564957379061e-14
mutation O 0 2.0799965482626304e-12
in O 0 4.804350693619445e-17
either O 0 1.9948825306492085e-13
BRCA1 O 0 2.8900623560979e-10
( O 0 6.633668757737693e-16
179 O 0 9.75177837786445e-13
women O 0 1.2436724827064038e-12
) O 0 4.0036086289751624e-14
or O 0 1.7357619248176137e-12
BRCA2 O 0 2.516244101968823e-08
( O 0 8.79419421399158e-14
28 O 0 6.744734631913829e-11
women O 0 2.3061873591356807e-12
) O 0 1.7943750597795155e-13
. O 0 6.530210400201852e-13

The O 0 3.804255521711042e-12
control O 0 8.438627929763243e-08
women O 0 6.669582963171605e-13
were O 0 2.1600709966079046e-16
enrolled O 0 3.6551120741292245e-16
regardless O 0 4.4211486869424145e-17
of O 0 2.7626497580401746e-21
whether O 0 8.118010882692905e-16
or O 0 2.275536860381496e-15
not O 0 5.330185891185696e-14
they O 0 5.151787538779963e-14
had O 0 2.2507289001300057e-12
either O 0 6.300002023968548e-14
mutation O 0 7.2729981759334095e-12
. O 0 1.9663612372492617e-13

Lifetime O 0 9.496613495585393e-10
histories O 0 3.542530158107127e-11
of O 0 1.5727810335013805e-17
oral O 0 5.442402713391747e-13
- O 0 3.915345153128469e-13
contraceptive O 0 1.2167696537834782e-11
use O 0 4.935446260798679e-15
were O 0 1.16939886390271e-16
obtained O 0 1.230203256370258e-16
by O 0 1.2344282012900615e-18
interview O 0 1.0648382869904438e-10
or O 0 2.854531472493534e-16
by O 0 4.6350362520888236e-18
written O 0 2.090605004040412e-15
questionnaire O 0 7.070020956889298e-16
and O 0 3.67957828993842e-17
were O 0 3.5014482537475757e-17
compared O 0 1.405392619161362e-15
between O 0 4.126396896701398e-14
patients O 0 1.566941194852678e-11
and O 0 1.8896825293782116e-13
control O 0 0.000855647842399776
women O 0 1.5247533053860951e-12
, O 0 4.601779124688884e-16
after O 0 9.4210412377747e-17
adjustment O 0 2.8975391998134568e-15
for O 0 7.985370927744209e-20
year O 0 5.062470976880061e-19
of O 0 6.436556527083242e-19
birth O 0 4.274863611968688e-13
and O 0 4.2131657320906846e-13
parity O 0 3.8557815273954077e-10
. O 0 3.2084079316929692e-12

RESULTS O 0 3.05333647254713e-09
The O 0 1.53788711366315e-13
adjusted O 0 8.89414319971138e-10
odds O 0 8.105756137410935e-07
ratio O 0 1.8762445819220375e-08
for O 0 2.6679837006327034e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.1422865257848525e-11
with O 0 2.3283167538743323e-16
any O 0 8.212450291751432e-16
past O 0 1.2662861346513302e-14
use O 0 3.1953751481885004e-16
of O 0 1.4947754408753077e-18
oral O 0 1.2114521625444796e-12
contraceptives O 0 8.75469154948405e-08
was O 0 3.5643965556886315e-10
0 O 0 1.2967622635418063e-11
. O 0 4.980046323238563e-13

5 O 0 1.2257160347459162e-12
( O 0 4.358956907446823e-15
95 O 0 7.62420335198577e-12
percent O 0 2.793417233637463e-11
confidence O 0 1.0637020153581034e-09
interval O 0 1.904588032425325e-12
, O 0 6.380433832126137e-17
0 O 0 4.217967585162075e-16
. O 0 2.9138716622190443e-19
3 O 0 2.5058492017034438e-17
to O 0 2.4965856721979114e-16
0 O 0 1.5839772256418666e-13
. O 0 1.0266826002571883e-15
8 O 0 4.0583188258514966e-14
) O 0 8.748784777689277e-15
. O 0 3.7504133370939996e-13

The O 0 2.120568651231558e-11
risk O 0 1.3853761887672178e-11
decreased O 0 4.785495350684288e-12
with O 0 8.919322447292297e-17
increasing O 0 1.728543841230995e-15
duration O 0 9.822954353134322e-14
of O 0 6.1919295416156626e-21
use O 0 2.4960443122654975e-15
( O 0 1.1647064337238193e-16
P O 0 1.6380048359354582e-11
for O 0 4.1129678259208806e-18
trend O 0 2.8776349358938802e-11
, O 0 1.6978351911238823e-15
< O 0 1.1477014542730923e-13
0 O 0 2.4856111956959295e-15
. O 0 6.702310529344865e-19
001 O 0 7.751192544623692e-17
) O 0 1.3026215719873469e-20
; O 0 1.2143065514447432e-20
use O 0 4.542578552711015e-18
for O 0 8.341832754647178e-18
six O 0 4.782321762176415e-15
or O 0 2.915332556238632e-16
more O 0 1.4760602934006576e-17
years O 0 5.738793801435694e-16
was O 0 4.255416023490931e-15
associated O 0 4.280797048118051e-16
with O 0 1.7795508749128933e-18
a O 0 2.5438654631268704e-16
60 O 0 5.107814500949614e-15
percent O 0 4.586919308057847e-15
reduction O 0 1.608245702138921e-14
in O 0 2.3287722458417183e-14
risk O 0 2.6239888040180404e-10
. O 0 1.6451427893582338e-12

Oral O 0 2.742851501480459e-09
- O 0 5.461762708769413e-10
contraceptive O 0 3.846750118441378e-08
use O 0 2.2132010113473655e-10
protected O 0 0.0010107922134920955
against O 1 0.927792489528656
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 2.9053532905101145e-15
for O 0 3.039371763249531e-18
carriers O 0 2.7105674763771475e-15
of O 0 2.1066678492000844e-19
the O 0 2.3967256757934314e-15
BRCA1 O 0 1.3428864964470932e-10
mutation O 0 2.1054371353995682e-13
( O 0 4.1888624743032334e-17
odds O 0 1.436979354951795e-11
ratio O 0 6.461210012116345e-14
, O 0 9.689189766609444e-16
0 O 0 2.4376187324209745e-15
. O 0 7.667111455155024e-18
5 O 0 4.692162503244593e-17
; O 0 2.0095554918120816e-16
95 O 0 1.7663073694634823e-12
percent O 0 9.603031911331605e-12
confidence O 0 2.3600779663901506e-10
interval O 0 4.4469693227279505e-13
, O 0 2.5725940744581026e-17
0 O 0 4.151510968307279e-17
. O 0 1.7915310351220754e-19
3 O 0 5.722763868345029e-18
to O 0 6.206106510647322e-17
0 O 0 1.4621586073523297e-14
. O 0 1.019131645639551e-16
9 O 0 4.093268082881567e-15
) O 0 6.871994017505777e-18
and O 0 2.8057757928284335e-17
for O 0 2.436173049012081e-19
carriers O 0 5.818683513800996e-15
of O 0 2.3178839466703134e-18
the O 0 3.926950453182754e-14
BRCA2 O 0 2.496136353169476e-10
mutation O 0 2.0458623944258347e-13
( O 0 2.6875018692509064e-17
odds O 0 1.3803429970218883e-12
ratio O 0 5.868306600202711e-14
, O 0 8.273515014501362e-16
0 O 0 3.4491264197907467e-15
. O 0 7.225618692455872e-18
4 O 0 2.0188064150850787e-16
; O 0 5.058482349189458e-16
95 O 0 1.3918751134295304e-12
percent O 0 5.812547491934605e-12
confidence O 0 1.7484035053083602e-10
interval O 0 5.702816148998868e-13
, O 0 3.486653301311452e-17
0 O 0 3.3159534646037023e-16
. O 0 8.451919017046987e-19
2 O 0 3.809071595036249e-18
to O 0 7.827557197030097e-17
1 O 0 8.200616182687105e-16
. O 0 8.218091001784553e-16
1 O 0 2.006247722273935e-15
) O 0 8.800164102203828e-15
. O 0 1.8972123134661234e-13

CONCLUSIONS O 0 2.4587828995059624e-10
Oral O 0 1.4403489685677062e-11
- O 0 3.274561871657866e-11
contraceptive O 0 3.5536866782592824e-09
use O 0 1.5084646856275419e-12
may O 0 3.305797476038652e-13
reduce O 0 9.387195881727095e-13
the O 0 1.2535958870355662e-13
risk O 0 3.905135326220943e-09
of O 0 1.45934687945104e-11
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.271441719269406e-13
women O 0 1.4056889875192768e-13
with O 0 7.416639015004375e-17
pathogenic O 0 4.680177144271436e-13
mutations O 0 3.124626599126934e-11
in O 0 1.347773149984829e-16
the O 0 1.5771934742925785e-14
BRCA1 O 0 6.751627257273185e-09
or O 0 1.4986166604544215e-12
BRCA2 O 0 1.9121580407954752e-07
gene O 0 2.1287543461312453e-07

A O 0 4.398922198722843e-11
Japanese O 0 3.747773202888993e-10
family O 0 5.159145680111443e-13
with O 0 4.97561959353094e-14
adrenoleukodystrophy B-Disease 1 0.999997615814209
with O 0 5.638179945708158e-14
a O 0 1.5142458820041962e-14
codon O 0 3.247022095642649e-11
291 O 0 1.3464963736012359e-12
deletion O 0 1.7506859850691114e-10
: O 0 4.0423810539159596e-14
a O 0 2.0486377825808082e-14
clinical O 0 2.551862610111755e-10
, O 0 4.4509023338712775e-15
biochemical O 0 6.929352230899966e-11
, O 0 1.8132622343187098e-14
pathological O 0 3.215315513838135e-10
, O 0 3.0316081676279305e-14
and O 0 7.837807009317133e-13
genetic O 0 3.2272630789975665e-08
report O 0 1.0762923755361364e-12
. O 0 3.6653522556516493e-13

We O 0 3.2174260478079475e-10
report O 0 1.1142200883999549e-14
a O 0 2.699071809914808e-16
Japanese O 0 3.1940166657362656e-12
family O 0 1.037645243708897e-13
with O 0 7.440712542633454e-13
adrenoleukodystrophy B-Disease 1 1.0
( O 0 1.4313381209440923e-12
ALD B-Disease 1 0.9999986886978149
) O 0 3.954622130184957e-16
with O 0 2.325864378425072e-18
a O 0 1.3737161809724522e-16
three O 0 6.64303800092551e-16
base O 0 2.1005617384384223e-11
pair O 0 6.093711646393274e-10
deletion O 0 1.2108319902282005e-10
( O 0 2.8613236179393295e-16
delGAG O 0 2.57404362581648e-12
291 O 0 3.143607607298399e-14
) O 0 1.6906669101099468e-16
in O 0 3.376817546424252e-16
the O 0 3.202335586375421e-13
ALD B-Disease 1 0.9999980926513672
gene O 0 1.5713438017428416e-07
. O 0 5.686613072791724e-12

A O 0 1.082464521663662e-12
variety O 0 2.7186150940573632e-14
of O 0 1.8182811255538512e-17
phenotypes O 0 2.087557036956067e-11
were O 0 5.377278127844309e-15
observed O 0 2.0829173076001434e-13
within O 0 2.0670051838222493e-15
this O 0 3.850025207902076e-15
family O 0 5.881534842488989e-12
. O 0 9.702815807755005e-13

While O 0 5.716290288337866e-12
the O 0 3.6741680390414005e-15
proband O 0 1.3153175437707887e-08
( O 0 3.2759998733937826e-14
patient O 0 1.4697444650213498e-10
1 O 0 9.556272297735115e-16
) O 0 3.919882397342302e-16
was O 0 7.042837128513066e-15
classified O 0 6.420963072220967e-14
as O 0 6.461391361870352e-15
having O 0 3.942846212284107e-14
a O 0 1.0115555976708513e-16
rare O 0 6.087863808174835e-15
intermediate O 0 7.660984409243836e-15
type O 0 1.3465029091719316e-10
of O 0 1.834977633869336e-16
adult O 0 1.2695782913851872e-07
cerebral O 0 8.280105248559266e-05
and O 0 3.6156573290924143e-09
cerebello O 0 0.036841634660959244
- O 0 0.16958539187908173
brain O 0 0.0008405909175053239
stem O 0 2.9501213971716567e-11
forms O 0 3.8648912629307697e-13
, O 0 3.5095837775658487e-14
his O 0 2.2365286977011484e-13
younger O 0 1.8811211269231798e-12
brother O 0 4.8464786871205146e-12
( O 0 3.344945549503645e-16
patient O 0 3.4296877404055293e-12
2 O 0 1.6388701571710767e-15
) O 0 2.9846171514065142e-15
and O 0 1.1905928716873793e-12
nephew O 0 2.8246734729009404e-08
( O 0 2.4415194461980226e-14
patient O 0 9.534722317239286e-11
3 O 0 2.4922574397165604e-15
) O 0 1.6362089914090405e-15
had O 0 5.440643421894542e-11
a O 0 3.0688216724750195e-12
childhood O 0 4.795254426426254e-06
ALD B-Disease 1 0.999998927116394
type O 0 0.00019870189134962857
. O 0 3.544178839298695e-11

Another O 0 1.838367236217664e-10
nephew O 0 3.7494572779905866e-08
( O 0 3.1675755226244495e-13
patient O 0 3.755209920797142e-09
4 O 0 4.573278604771969e-13
) O 0 1.649524158757465e-14
of O 0 9.534274984443819e-17
patient O 0 2.2471816407687584e-08
1 O 0 7.31847731965914e-15
was O 0 1.6174012812657929e-13
classified O 0 3.5546958714223476e-13
as O 0 8.577711566211399e-13
having O 0 3.725272174071037e-11
an O 0 7.973551425241934e-15
adolescent O 0 5.449559914438851e-09
form O 0 9.64157313015912e-12
. O 0 2.0388407975802103e-11

The O 0 1.5369194632242067e-13
tau O 0 1.107740743751251e-13
level O 0 1.4061877205186202e-13
in O 0 1.1896558685945335e-15
the O 0 1.1120832987127072e-12
cerebrospinal O 0 0.00015539654123131186
fluid O 0 4.193790203999015e-08
( O 0 2.3456434277563387e-12
CSF O 0 3.829569266144972e-07
) O 0 2.5090955653233812e-14
in O 0 2.8288202638356626e-15
patient O 0 2.470389171005394e-10
1 O 0 3.5629040674911214e-16
was O 0 1.4812690258951024e-14
as O 0 1.229593392648235e-16
high O 0 3.3944077737607637e-16
as O 0 2.7654193712776454e-16
that O 0 1.4764109319535964e-15
of O 0 2.0169809929092966e-17
patients O 0 5.718217782960111e-13
with O 0 1.704177380809635e-12
Alzheimers B-Disease 1 0.9999969005584717
disease I-Disease 1 0.9794061779975891
( O 0 3.748619746945771e-16
AD B-Disease 0 7.822383366051788e-12
) O 0 1.9600740843762898e-13
. O 0 7.00845902579933e-13

His O 0 5.675712504149555e-12
brain O 0 1.0103274553779906e-12
magnetic O 0 1.842372046210409e-14
resonance O 0 3.5295770754902034e-13
image O 0 1.2829649452192338e-12
( O 0 5.670526254609448e-17
MRI O 0 9.11508230005964e-11
) O 0 1.3112256370744965e-14
showed O 0 4.936532294053109e-10
abnormalities B-Disease 0 1.1621963494690135e-05
in I-Disease 0 1.1900922176173116e-14
the I-Disease 0 2.5836648358951164e-12
bilateral I-Disease 0 4.0522365907236235e-07
cerebellar I-Disease 0 0.0005516461678780615
hemispheres I-Disease 0 0.00032466917764395475
and O 0 2.2783579467500203e-09
brain O 0 7.455986050786123e-09
stem O 0 1.2415079814892538e-13
, O 0 9.807367803410364e-16
but O 0 4.2763617083205197e-14
not O 0 4.915363702542343e-14
in O 0 3.2757466634821127e-16
the O 0 2.8852537492431857e-14
cerebral O 0 5.539315117708554e-10
white O 0 3.1011114899962e-13
matter O 0 5.437924416318296e-15
, O 0 7.707613361231948e-17
where O 0 2.214469570062944e-16
marked O 0 1.3667583016191256e-17
reductions O 0 2.0143688624139726e-15
of O 0 1.5832002211766138e-18
the O 0 3.081993414275584e-14
cerebral O 0 1.0968386021659171e-07
blood O 0 4.989004868949376e-12
flow O 0 3.536742296597617e-12
and O 0 3.4463040060606076e-12
oxygen O 0 3.1306364835573253e-13
metabolism O 0 6.352627757166829e-09
were O 0 5.5628719404336724e-14
clearly O 0 4.4985970650652726e-14
demonstrated O 0 5.4043554153576444e-17
by O 0 1.2170385900675123e-19
positron O 0 5.916634234414894e-14
emission O 0 2.2285901016315737e-14
tomography O 0 1.4154628857898643e-10
( O 0 5.647131389894741e-15
PET O 0 7.006113744711939e-11
) O 0 2.6344996401973277e-14
. O 0 2.6328082509269324e-13

In O 0 3.0615706367656537e-13
patients O 0 8.45096648910415e-12
2 O 0 1.8908245330790177e-14
and O 0 1.9920878640243556e-13
3 O 0 1.3958083143082375e-14
, O 0 3.5197564738557834e-16
the O 0 1.7816244843596658e-16
autopsy O 0 3.6768574851464564e-09
findings O 0 1.5032136505607058e-13
showed O 0 9.777908734423524e-13
massive O 0 2.5623999450052892e-12
demyelination B-Disease 1 1.0
of I-Disease 0 4.401819485083322e-14
the I-Disease 0 8.55894538185839e-14
cerebral I-Disease 0 5.70447855618994e-10
white I-Disease 0 3.300522493656331e-14
matter I-Disease 0 1.6884111554922902e-16
with O 0 5.479665205687892e-19
sparing O 0 1.655451991783882e-15
of O 0 1.3544204685130756e-18
the O 0 1.7839104674656275e-15
U O 0 1.5912002382378887e-08
- O 0 5.370321964903724e-10
fibers O 0 1.6233624167139027e-10
, O 0 3.0875104786742304e-15
compatible O 0 9.701992457848956e-15
with O 0 8.285738758721426e-16
the O 0 8.154199835968753e-16
findings O 0 3.6602383450545783e-13
of O 0 8.773511151727287e-16
childhood O 0 4.7385921675413556e-07
ALD B-Disease 1 0.9999964237213135
. O 0 4.728175490020803e-11

Oleic O 0 2.1921188817941584e-05
and O 0 2.1731277888292766e-10
erucic O 0 1.36664127126096e-07
acids O 0 4.421314009350752e-11
( O 0 2.388664939690445e-16
Lorenzos O 0 7.08119951564612e-11
Oil O 0 7.080040763732254e-14
) O 0 3.836664851345915e-17
were O 0 1.3321619688074628e-17
administered O 0 7.106334318129274e-16
to O 0 2.238805700140287e-15
patients O 0 2.1301484407214473e-14
1 O 0 1.3514181709848807e-16
and O 0 3.1051482457349067e-13
4 O 0 6.474521304289035e-14
, O 0 4.601465404861045e-15
but O 0 1.3766553747115128e-14
sufficient O 0 9.176410843418268e-16
effectiveness O 0 5.864278789131927e-14
was O 0 1.4706780647358135e-14
not O 0 9.536280202597546e-16
obtained O 0 4.3345511777309956e-14
. O 0 8.555158128144627e-14

The O 0 8.763924915639043e-13
findings O 0 1.4760885385083772e-13
in O 0 1.2965357134151101e-17
this O 0 5.209485890546687e-17
family O 0 1.4071716848121276e-14
suggest O 0 8.996941375499085e-14
that O 0 9.500986457267827e-16
delGAG291 O 0 1.7880835700978537e-11
is O 0 1.672762089442869e-16
part O 0 4.4188894912534097e-17
of O 0 1.0206590625579758e-19
the O 0 2.8176597312528604e-17
cause O 0 2.0039528982615865e-15
of O 0 1.944697070618799e-18
Japanese O 0 3.839676665506886e-08
ALD B-Disease 1 0.9999972581863403
with O 0 2.1640319608972822e-14
phenotypic O 0 1.3536485821141753e-10
variations O 0 6.277769415419243e-08
. O 0 1.703353708082389e-10

Moreover O 0 1.4842187201491441e-10
, O 0 1.1909596640585947e-14
although O 0 1.4974429717921575e-15
the O 0 2.4199943061292174e-17
scale O 0 8.374954375833799e-12
of O 0 1.064578635941664e-17
the O 0 2.3728456994279645e-15
study O 0 1.853729233373784e-14
is O 0 1.4380943907329232e-16
limited O 0 7.153394494590834e-14
, O 0 3.405156134817476e-14
there O 0 2.7011345363116973e-14
is O 0 4.8137613620123385e-17
a O 0 1.1889923076158659e-17
possibility O 0 8.562986406643151e-16
that O 0 7.245723965753573e-15
PET O 0 1.3550023603148276e-10
can O 0 4.8467879151326346e-14
detect O 0 1.330458231649581e-13
an O 0 1.8630496292303236e-16
insidious B-Disease 0 7.354113336077717e-07
lesion I-Disease 1 0.9999954700469971
which O 0 1.0809321082660972e-07
is O 0 3.851529338516624e-12
undetectable O 0 7.401861241984609e-12
by O 0 5.195967277795733e-18
computed O 0 6.973580133490254e-12
tomogram O 0 3.2375080394331235e-09
( O 0 1.0224887283770954e-15
CT O 0 2.778997254537785e-09
) O 0 6.508539227417776e-16
or O 0 1.3246020343170956e-16
MRI O 0 9.639660597526856e-12
analysis O 0 4.8976923082736604e-15
, O 0 1.8575072544284223e-16
and O 0 3.732837405556055e-16
that O 0 7.882124912376792e-16
the O 0 2.46951476390146e-16
higher O 0 7.843462622894961e-16
level O 0 2.356409660361205e-16
of O 0 7.051928787309802e-21
tau O 0 4.0979665746399864e-17
reflects O 0 7.462696100639083e-18
the O 0 4.94365216875353e-19
process O 0 2.3324125469491947e-18
of O 0 3.2218695198698085e-19
neuronal B-Disease 0 7.533144108506917e-10
degeneration I-Disease 0 0.0008875540806911886
in O 0 2.430047829626858e-11
ALD B-Disease 1 0.9999996423721313
. O 0 6.279237130257798e-10

Lorenzos O 0 6.717062017713715e-09
Oil O 0 1.8760403387024782e-12
should O 0 8.578487956610852e-15
be O 0 2.3209275577342022e-18
given O 0 6.61947407786439e-20
in O 0 4.343246223059212e-19
the O 0 1.671153984157617e-17
early O 0 2.7992263726146077e-14
stage O 0 8.502099848803346e-13
. O 0 1.1297688392786416e-15
. O 0 3.532538709249619e-14

Nonsense O 0 4.6868265712873836e-08
mutation O 0 7.190448930716187e-11
in O 0 5.670547430433129e-17
exon O 0 1.869952977184841e-12
4 O 0 1.3981412598854104e-12
of O 0 9.629455679680091e-17
human O 0 4.640260831828558e-12
complement O 0 1.4460387748327364e-11
C9 O 0 2.0095531141905987e-11
gene O 0 2.5791671576236297e-10
is O 0 1.076537053708445e-15
the O 0 3.939891863272735e-18
major O 0 2.285183930376012e-15
cause O 0 1.3001978610243086e-14
of O 0 1.4993849668773054e-17
Japanese O 0 1.8104172738730995e-07
complement B-Disease 0 2.6351308690664155e-08
C9 I-Disease 0 1.4327526514534838e-05
deficiency I-Disease 0 0.4773736596107483
. O 0 2.5374934358585177e-12

Deficiency B-Disease 1 0.9994246959686279
of I-Disease 0 2.4321653754878737e-16
the I-Disease 0 6.130043507849257e-15
ninth I-Disease 0 1.1735975689528e-12
component I-Disease 0 1.2865518383715219e-13
of I-Disease 0 4.781477826193374e-17
human I-Disease 0 5.481503705800916e-12
complement I-Disease 0 2.7868183455348472e-11
( O 0 5.427042266407565e-16
C9 O 0 2.331448836073724e-13
) O 0 6.518400279110592e-17
is O 0 5.794464711021738e-18
the O 0 6.410826557141898e-19
most O 0 1.976288405157567e-16
common O 0 9.314544274774406e-11
complement B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
in O 0 4.0858291007256006e-14
Japan O 0 2.7520820822246606e-07
but O 0 1.692490006650893e-12
is O 0 5.84016194000276e-16
rare O 0 3.816655497912045e-15
in O 0 3.4399400298404186e-16
other O 0 3.306897941243725e-15
countries O 0 2.677079478236033e-14
. O 0 1.7130669441572238e-13

We O 0 2.991270009466973e-10
studied O 0 7.816230979508856e-14
the O 0 1.0580880805472054e-18
molecular O 0 2.1890304442695983e-15
basis O 0 7.571899624840496e-16
of O 0 5.206525576570482e-17
C9 B-Disease 0 1.5739364243927412e-05
deficiency I-Disease 0 0.1149069219827652
in O 0 6.595444490168712e-15
four O 0 4.3140656520203324e-13
Japanese O 0 2.1298696140092943e-09
C9 B-Disease 0 2.057261250243414e-09
- I-Disease 0 2.1924520865468367e-08
deficient I-Disease 0 2.8513652523542987e-06
patients O 0 3.090230071833844e-09
who O 0 1.4178838658729376e-10
had O 0 1.2251919478956097e-09
suffered O 0 7.596156592626357e-09
from O 0 6.332626344964995e-14
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 6.416332742897879e-11

Direct O 0 1.0775412680186225e-12
sequencing O 0 1.5900807146668194e-12
of O 0 3.2017567473526735e-16
amplified O 0 1.4580420204524103e-11
C9 O 0 4.384707180671299e-11
cDNA O 0 5.373165020555737e-12
and O 0 3.7358184850743575e-14
DNA O 0 3.0800469813518916e-11
revealed O 0 8.18209178388889e-15
a O 0 2.247222911382614e-17
nonsense O 0 3.3566652604156977e-13
substitution O 0 1.4397748511607166e-15
( O 0 3.2834245787432483e-18
CGA O 0 5.832879210014574e-13
- O 0 6.495830956465554e-11
- O 0 9.068868572770228e-11
> O 0 1.447878004556119e-13
TGA O 0 1.8134034204808636e-11
) O 0 3.155292357984345e-17
at O 0 5.803338373760962e-17
codon O 0 4.365796274979428e-15
95 O 0 4.950112953917743e-16
in O 0 7.112534210528288e-19
exon O 0 3.7786172303079513e-13
4 O 0 6.279323306983275e-13
in O 0 1.4018641975404558e-15
the O 0 4.386423475420849e-14
four O 0 2.021680349170718e-13
C9 B-Disease 0 1.1998136928426106e-09
- I-Disease 0 1.8607275720228245e-08
deficient I-Disease 0 1.0761800695036072e-07
individuals O 0 4.922416352971066e-15
. O 0 1.348402726281117e-13

An O 0 1.1285111012310873e-15
allele O 0 3.599787365437569e-14
- O 0 7.107022761097814e-13
specific O 0 9.793764242519223e-15
polymerase O 0 1.788011926018296e-11
chain O 0 2.962876818890514e-11
reaction O 0 7.222794953277989e-14
system O 0 2.307399571703419e-14
designed O 0 9.607638577942279e-14
to O 0 2.864403376795987e-16
detect O 0 3.149009915673351e-13
exclusively O 0 6.429621167722093e-16
only O 0 8.338445087402793e-14
one O 0 8.8326811676533285e-16
of O 0 1.7750820316535756e-19
the O 0 1.754611941927236e-16
normal O 0 3.230110677630155e-14
and O 0 8.876757056459298e-17
mutant O 0 1.3578694375501743e-13
alleles O 0 1.731216441937819e-15
indicated O 0 2.7315587400496277e-13
that O 0 2.160764319545012e-15
all O 0 4.862355245149624e-17
the O 0 7.121799419210464e-17
four O 0 5.222461045635194e-16
patients O 0 3.463283132901114e-17
were O 0 1.4786286426737253e-19
homozygous O 0 9.954284874018235e-17
for O 0 2.473415615321362e-18
the O 0 1.3785510185656e-16
mutation O 0 9.798847287235696e-15
in O 0 2.81444667224049e-18
exon O 0 3.8908378472216065e-13
4 O 0 2.0423777686434663e-12
and O 0 2.4118294167374543e-13
that O 0 6.266996199332658e-14
the O 0 3.6290914866873684e-15
parents O 0 6.0076955278490045e-15
of O 0 5.940475117231995e-20
patient O 0 2.9814099458550306e-14
2 O 0 6.275167489117129e-17
were O 0 8.992505167492782e-16
heterozygous O 0 4.0895072050961545e-11
. O 0 2.505435095501163e-12

The O 0 7.579739380635456e-14
common O 0 1.1868325807263928e-14
mutation O 0 6.502465937658491e-14
at O 0 6.283746741732733e-16
codon O 0 5.1732537253556393e-14
95 O 0 6.699078124232328e-15
in O 0 8.290282858872874e-18
exon O 0 6.796878598142042e-12
4 O 0 2.4995832226953896e-12
might O 0 5.237535231905621e-12
be O 0 2.414997076438213e-16
responsible O 0 1.4339803252383295e-16
for O 0 2.3663337763039224e-18
most O 0 4.282579099559956e-15
Japanese O 0 4.6926228236543466e-08
C9 B-Disease 0 9.119023047787778e-07
deficiency I-Disease 0 6.295388448052108e-05
. O 0 4.326899675008563e-15
. O 0 4.0581969208697277e-13

BRCA1 O 0 3.882824284318076e-09
required O 0 6.179890126245752e-15
for O 0 1.7079152140684535e-17
transcription O 0 8.386292355000435e-11
- O 0 3.0713341203636446e-08
coupled O 0 4.8641691369200046e-11
repair O 0 5.2995389326904174e-11
of O 0 1.5731943342944426e-18
oxidative O 0 3.344529243397981e-13
DNA O 0 1.8558070635776858e-09
damage O 0 8.209155022420589e-10
. O 0 7.52833906325634e-12

The O 0 1.3247339225586074e-08
breast B-Disease 1 0.9998121857643127
and I-Disease 1 0.999757707118988
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
susceptibility O 0 4.205396919587656e-07
gene O 0 3.989501173862209e-09
BRCA1 O 0 1.5428084365609607e-09
encodes O 0 1.5449321509597436e-12
a O 0 3.477987429306717e-12
zinc O 0 5.507062610377034e-07
finger O 0 4.674854608310852e-06
protein O 0 3.3009086575219726e-09
of O 0 6.942534160346952e-17
unknown O 0 7.642693769516207e-12
function O 0 3.13193602996531e-11
. O 0 3.6159556252024494e-12

Association O 0 2.8532850995105496e-12
of O 0 2.7206427364157516e-18
the O 0 4.9446190188125123e-17
BRCA1 O 0 8.385431699052884e-14
protein O 0 3.5037899028000398e-15
with O 0 2.701159944653137e-18
the O 0 1.5688262829927645e-17
DNA O 0 2.5262332156716916e-11
repair O 0 7.143516247282156e-12
protein O 0 2.258089142103195e-13
Rad51 O 0 3.770941059411115e-10
and O 0 2.408936121596223e-14
changes O 0 5.609497377235054e-14
in O 0 2.4037446738678582e-18
the O 0 5.569886312086933e-19
phosphorylation O 0 1.391315566852706e-15
and O 0 5.053429268263494e-16
cellular O 0 1.9351694183732115e-14
localization O 0 7.256954775601218e-15
of O 0 1.6223759925879624e-20
the O 0 7.38442330799564e-18
protein O 0 9.197833196038924e-14
after O 0 6.81646852627142e-16
exposure O 0 5.439999647039069e-15
to O 0 1.0371846308979493e-16
DNA O 0 5.714301254400311e-10
- O 0 5.177384996418732e-12
damaging O 0 5.078598674414236e-13
agents O 0 9.116825675468954e-14
are O 0 5.1091148024027676e-17
consistent O 0 6.016980597137688e-16
with O 0 7.289509114843096e-20
a O 0 3.192545139974191e-18
role O 0 4.088630948072264e-16
for O 0 3.385455652940439e-18
BRCA1 O 0 4.3642024130825796e-13
in O 0 2.6989998121142915e-16
DNA O 0 6.046150802241357e-10
repair O 0 7.541227198260003e-09
. O 0 7.404780456334026e-13

Here O 0 1.5708022382820985e-10
, O 0 1.8981019013486478e-14
it O 0 6.83808480708535e-16
is O 0 4.499105165719617e-17
shown O 0 2.645374526800536e-15
that O 0 3.746062925054925e-15
mouse O 0 1.620093725840377e-09
embryonic O 0 3.219769242890358e-11
stem O 0 9.101305820102823e-11
cells O 0 3.484270511000531e-11
deficient B-Disease 0 9.660359179264333e-10
in I-Disease 0 2.9624400289023837e-16
BRCA1 I-Disease 0 2.162245799075535e-10
are O 0 8.573543613539492e-16
defective O 0 1.62418472768322e-12
in O 0 2.200071333448601e-16
the O 0 3.448059370035443e-16
ability O 0 2.69401369973072e-14
to O 0 1.1753065216631148e-16
carry O 0 8.163260547405533e-15
out O 0 4.363983878582188e-14
transcription O 0 2.1873570663077935e-11
- O 0 1.9217469629517758e-11
coupled O 0 5.551057118309555e-13
repair O 0 1.2779216703937002e-12
of O 0 4.452113531428847e-20
oxidative O 0 1.4729408285511086e-14
DNA O 0 6.112615968945079e-10
damage O 0 6.741072700044981e-10
, O 0 1.540541105056123e-13
and O 0 4.624124976156108e-13
are O 0 7.659811586249244e-16
hypersensitive O 0 2.144076235999215e-11
to O 0 1.2002953435658764e-15
ionizing O 0 2.498838267382675e-13
radiation O 0 2.4168590306156146e-12
and O 0 3.0874753268069193e-15
hydrogen O 0 8.829956792057603e-15
peroxide O 0 1.403901300767174e-10
. O 0 3.643565050365227e-12

These O 0 5.7395529301507153e-11
results O 0 8.80037796108235e-12
suggest O 0 2.855315810179615e-12
that O 0 3.628262919058364e-14
BRCA1 O 0 1.5258924679351082e-10
participates O 0 4.474550477319081e-14
, O 0 2.2703693241285343e-15
directly O 0 1.37646030302376e-15
or O 0 3.963821966783323e-15
indirectly O 0 1.4222805333648225e-13
, O 0 1.5869575195371103e-15
in O 0 3.3165479758535564e-16
transcription O 0 6.199527002870298e-10
- O 0 6.227021120963627e-10
coupled O 0 1.3781226593928553e-12
repair O 0 8.672964148075113e-13
of O 0 1.3998093162899322e-19
oxidative O 0 1.7326972037603854e-14
DNA O 0 1.16769066638156e-10
damage O 0 2.001382566618748e-11
. O 0 1.7125041077044323e-14
. O 0 2.0330072261071086e-12

Truncation O 0 1.5598145637341077e-06
mutations O 0 8.121587597997859e-07
in O 0 9.571455363314649e-15
the O 0 9.372944721796131e-15
transactivation O 0 4.165513445286706e-08
region O 0 1.7611141711615375e-11
of O 0 1.2254492839537933e-16
PAX6 O 0 5.950445469693477e-08
result O 0 4.909108059295009e-13
in O 0 3.9508221286253375e-16
dominant O 0 8.150120023309171e-10
- O 0 2.8719533418097853e-08
negative O 0 2.1970576399854558e-11
mutants O 0 2.0099143183127666e-10
. O 0 1.6596394939762116e-13

PAX6 O 0 3.7216697279518485e-08
is O 0 9.702214380481137e-15
a O 0 3.4502940811783164e-17
transcription O 0 4.120498498069898e-14
factor O 0 9.360393017006802e-17
with O 0 8.928440293748346e-18
two O 0 4.5977934376253586e-17
DNA O 0 1.9952232574449447e-11
- O 0 4.496697285361062e-12
binding O 0 4.135507312031522e-13
domains O 0 1.5467255948253822e-11
( O 0 3.1125928183083247e-15
paired O 0 7.55568940746798e-11
box O 0 2.1899297653060756e-10
and O 0 1.5347700324172542e-12
homeobox O 0 1.814981324954612e-11
) O 0 1.2988141691774977e-15
and O 0 3.889481326074161e-16
a O 0 1.6113389658771313e-16
proline O 0 4.1179728897666745e-12
- O 0 4.676420383743773e-13
serine O 0 3.5618376737628354e-12
- O 0 2.2969587386637014e-13
threonine O 0 2.0780148435317614e-11
( O 0 2.8646750229091494e-17
PST O 0 1.3001552959246432e-11
) O 0 6.297427806138548e-15
- O 0 4.581113960400174e-11
rich O 0 8.276179221111679e-13
transactivation O 0 4.918555784882983e-09
domain O 0 3.123746261657345e-10
. O 0 2.848543666569836e-12

PAX6 O 0 0.00029932765755802393
regulates O 0 2.245122459498816e-06
eye O 0 0.010245603509247303
development O 0 4.245062634744556e-12
in O 0 5.652452027352919e-16
animals O 0 1.3621494611513324e-13
ranging O 0 1.17599333303444e-15
from O 0 3.6614020713123635e-18
jellyfish O 0 1.6566721003927545e-14
to O 0 3.289557006291502e-17
Drosophila O 0 1.3368933611784383e-14
to O 0 4.1519720718679405e-16
humans O 0 1.730907761956016e-13
. O 0 5.751006767161504e-14

Heterozygous O 0 3.5793476627077325e-08
mutations O 0 1.844853336763208e-08
in O 0 8.196113673176856e-16
the O 0 3.5140430248683163e-15
human O 0 5.485768089785736e-13
PAX6 O 0 1.7306447830378602e-08
gene O 0 1.7960436693442716e-08
result O 0 2.4083770459697174e-13
in O 0 1.975586228079183e-17
various O 0 9.717246674196059e-16
phenotypes O 0 3.0974025427843443e-11
, O 0 2.289232324347414e-15
including O 0 5.251576625821264e-13
aniridia B-Disease 1 1.0
, O 0 5.836600180941787e-08
Peters B-Disease 1 0.9999998807907104
anomaly I-Disease 1 0.9999984502792358
, O 0 8.635326342876226e-10
autosomal B-Disease 0 0.0007751723169349134
dominant I-Disease 0 1.585798941050598e-06
keratitis I-Disease 0 0.004693587310612202
, O 0 2.1879684730663485e-09
and O 0 1.1147374134878874e-09
familial B-Disease 0 0.18630655109882355
foveal I-Disease 0 0.004356704652309418
dysplasia I-Disease 1 0.9975466132164001
. O 0 1.915096525806348e-09

It O 0 5.914654183092338e-12
is O 0 1.9489617987901632e-16
believed O 0 2.279089951836991e-15
that O 0 1.0470348796119655e-17
the O 0 2.108108999452426e-17
mutated O 0 6.189855919491727e-12
allele O 0 4.576260160746304e-14
of O 0 1.9590085359868852e-17
PAX6 O 0 7.880345265220967e-10
produces O 0 1.2749038478566954e-14
an O 0 1.0490818207557892e-17
inactive O 0 1.9171722044110384e-13
protein O 0 2.2163872959168884e-09
and O 0 8.080254687570232e-09
aniridia B-Disease 1 1.0
is O 0 1.0931175409290006e-10
caused O 0 5.4320554131181975e-12
due O 0 3.2774103950091978e-15
to O 0 1.8761815357066537e-14
genetic O 0 7.053586159599945e-09
haploinsufficiency O 0 1.2472256116780045e-07
. O 0 4.18968028673139e-12

However O 0 8.142621993334487e-12
, O 0 2.540665266773025e-16
several O 0 7.988156629062983e-17
truncation O 0 9.291512004239166e-11
mutations O 0 3.0980848997330668e-09
have O 0 4.13908782194352e-14
been O 0 1.668066747588222e-15
found O 0 4.555131855613287e-15
to O 0 1.091731236595411e-15
occur O 0 4.459878172606742e-14
in O 0 4.625835853007641e-17
the O 0 2.0378026641744732e-15
C O 0 2.5147686710802475e-10
- O 0 2.6532664954004304e-12
terminal O 0 2.5007957510370105e-11
half O 0 3.1774585484695e-16
of O 0 8.485803566111427e-20
PAX6 O 0 1.5897326857694516e-11
in O 0 1.9894800168687667e-16
patients O 0 3.072262022151169e-14
with O 0 5.348351529179101e-15
Aniridia B-Disease 1 1.0
resulting O 0 4.329116546578776e-13
in O 0 1.8793528958826008e-16
mutant O 0 2.393476692882923e-12
proteins O 0 4.728612792125053e-13
that O 0 7.504214704333063e-15
retain O 0 6.944057416753691e-13
the O 0 8.598632729437164e-16
DNA O 0 9.4100428837951e-11
- O 0 4.4706626638538194e-13
binding O 0 6.457280456867442e-14
domains O 0 2.1719984751727983e-12
but O 0 2.6246619894837453e-12
have O 0 2.075640874454887e-12
lost O 0 4.5392693076573565e-11
most O 0 2.5603644986147204e-18
of O 0 3.0567399711737304e-20
the O 0 5.88832158640568e-17
transactivation O 0 2.546222677146659e-10
domain O 0 3.696274883391304e-11
. O 0 9.087247556001377e-13

It O 0 3.742262576211797e-12
is O 0 3.1882158668996294e-16
not O 0 2.510883323649768e-16
clear O 0 1.095146830780765e-16
whether O 0 4.8338370354790005e-17
such O 0 1.0915640799372264e-16
mutants O 0 5.94248539265152e-11
really O 0 1.752495891460537e-11
behave O 0 4.405801217561775e-14
as O 0 5.019384896530975e-16
loss O 0 1.5460987253922837e-13
- O 0 3.5695433154431244e-12
of O 0 4.7061266354734684e-17
- O 0 1.2696818596502624e-10
function O 0 2.2196658302619382e-13
mutants O 0 5.791780222736895e-14
as O 0 2.0560722251695726e-17
predicted O 0 2.9926561717023153e-14
by O 0 3.6900241252370866e-16
haploinsufficiency O 0 1.4350313826128058e-08
. O 0 9.162839757770325e-12

Contrary O 0 4.620171606406487e-11
to O 0 3.8814941759584675e-15
this O 0 1.218582758427317e-16
theory O 0 1.549150890033102e-13
, O 0 2.2876174560334736e-15
our O 0 2.2325702670990743e-16
data O 0 3.450534612065557e-15
showed O 0 2.332467444014774e-13
that O 0 8.283585177453032e-17
these O 0 1.3050258952223544e-17
mutants O 0 1.2003599510039282e-14
are O 0 7.209127192583402e-18
dominant O 0 1.5273204792901063e-12
- O 0 9.743668094586155e-10
negative O 0 2.1631416276257642e-13
in O 0 4.8685908634792934e-17
transient O 0 1.199381170552058e-13
transfection O 0 5.637583715828454e-12
assays O 0 2.0784249158984497e-13
when O 0 1.4711859456909872e-14
they O 0 5.121626008429306e-16
are O 0 7.829195841823565e-18
coexpressed O 0 8.765467518490055e-12
with O 0 5.4910380407923506e-15
wild O 0 4.996857372319141e-10
- O 0 9.821334145954097e-08
type O 0 6.163054422358982e-08
PAX6 O 0 2.964951590911369e-07
. O 0 1.3213201366379934e-11

We O 0 1.657996795412231e-10
found O 0 1.1728572994263494e-15
that O 0 8.895090852992046e-18
the O 0 1.993245748335608e-18
dominant O 0 7.900470100179191e-13
- O 0 1.9741280832263897e-10
negative O 0 4.2129328996741433e-13
effects O 0 2.871180723729161e-12
result O 0 1.0209181175346491e-15
from O 0 1.1692849040052005e-20
the O 0 7.380247596865895e-20
enhanced O 0 2.1549025074428773e-16
DNA O 0 1.275508453198182e-12
binding O 0 4.2763432430022695e-15
ability O 0 8.11711673353796e-15
of O 0 8.030187702579303e-19
these O 0 1.8627662702396875e-15
mutants O 0 7.914561367394768e-12
. O 0 1.459278390399804e-13

Kinetic O 0 5.0760957936990536e-11
studies O 0 3.6076471671142585e-12
of O 0 3.0534681616583535e-18
binding O 0 7.629610376640172e-13
and O 0 3.828857803728214e-13
dissociation O 0 1.677141498596102e-13
revealed O 0 1.2440840458510793e-14
that O 0 3.757234253999082e-18
various O 0 4.828618849302771e-18
truncation O 0 1.31244104126238e-11
mutants O 0 1.1218433300375086e-11
have O 0 1.795145249897795e-13
3 O 0 5.024463917840949e-15
- O 0 1.9895040476169967e-11
5 O 0 3.18380277654004e-13
- O 0 8.070219492672948e-11
fold O 0 1.0470221911695887e-11
higher O 0 6.264763542244682e-17
affinity O 0 1.5477005864565277e-17
to O 0 5.288955096548611e-19
various O 0 2.1150019523654975e-19
DNA O 0 8.445124482538147e-14
- O 0 2.466219805736641e-16
binding O 0 3.036012582781953e-17
sites O 0 2.6159117562797162e-15
when O 0 1.5136154777332022e-15
compared O 0 2.3870879033090004e-17
with O 0 6.880024452328564e-17
the O 0 1.070072180617645e-15
wild O 0 4.412066823000771e-10
- O 0 3.017967031837543e-08
type O 0 1.4343855880838419e-08
PAX6 O 0 1.316003164220092e-07
. O 0 6.7573494542949586e-12

These O 0 2.4880624904105586e-12
results O 0 2.5806640895423283e-13
provide O 0 3.646809695408254e-17
a O 0 8.435565387503115e-17
new O 0 1.649337684454127e-15
insight O 0 2.5727720506386995e-16
into O 0 7.523952133721084e-18
the O 0 2.8514487357866715e-18
role O 0 4.413079771677531e-16
of O 0 2.978219593033193e-19
mutant O 0 1.7810775640794696e-12
PAX6 O 0 4.825195243363112e-10
in O 0 8.711086729338777e-15
causing O 0 5.489834628558121e-11
aniridia B-Disease 1 0.9999986886978149
. O 0 8.320703609628055e-13
. O 0 9.76776927570644e-13

Reversal O 0 7.001501245440522e-08
of O 0 6.972552418250955e-13
severe O 0 1.6911467355384957e-06
hypertrophic B-Disease 1 0.9997609257698059
cardiomyopathy I-Disease 1 1.0
and O 0 2.560698542097839e-09
excellent O 0 2.974883395179262e-10
neuropsychologic O 0 2.823892941705708e-07
outcome O 0 1.3565454315411785e-11
in O 0 3.400294843326594e-14
very B-Disease 0 6.3317632387205336e-12
- I-Disease 0 1.4223986966044322e-07
long I-Disease 0 4.027592037658678e-09
- I-Disease 0 1.4204940557149826e-09
chain I-Disease 0 4.838044631583216e-09
acyl I-Disease 0 1.1733647907463673e-12
- I-Disease 0 3.110946016852273e-13
coenzyme I-Disease 0 1.2252923827470175e-13
A I-Disease 0 4.7790598382965385e-14
dehydrogenase I-Disease 0 4.750009274800959e-09
deficiency I-Disease 0 9.361419870401733e-06
. O 0 3.2862400951502724e-13

Very B-Disease 0 1.5638136341422637e-09
- I-Disease 0 1.6107901501527522e-07
long I-Disease 0 6.557157483655374e-09
- I-Disease 0 3.835511819261228e-08
chain I-Disease 0 2.4851555480154275e-08
acyl I-Disease 0 8.15317052153125e-13
- I-Disease 0 2.947327372936591e-14
coenzyme I-Disease 0 1.263371240169944e-15
A I-Disease 0 1.18134771946161e-16
dehydrogenase I-Disease 0 3.997580126082964e-14
( I-Disease 0 6.152108292608758e-16
VLCAD I-Disease 0 9.202730244517454e-10
) I-Disease 0 2.0675910256898883e-13
deficiency I-Disease 0 2.9230951881231704e-08
is O 0 2.304196431910082e-15
a O 0 1.7157885355556513e-12
disorder O 0 5.204687477089465e-05
of O 0 5.604716095946974e-18
fatty O 0 1.6984226525185164e-10
acid O 0 7.550185723479395e-15
beta O 0 6.665521878396722e-18
oxidation O 0 1.544776549313267e-15
that O 0 7.438378221474775e-15
reportedly O 0 1.4489190403033092e-10
has O 0 1.5269572065101933e-11
high O 0 9.476894095861166e-13
rates O 0 1.1828349411047157e-10
of O 0 2.1805699880248468e-16
morbidity O 0 0.06754331290721893
and O 0 4.467688441422979e-09
mortality O 0 2.7405289984017145e-06
. O 0 5.116832305085417e-12

We O 0 3.600898398903318e-11
describe O 0 3.183783057613028e-14
the O 0 9.454198607192766e-17
outcome O 0 2.5365010410460863e-16
of O 0 1.1355255144760234e-20
a O 0 3.616858478044444e-16
5 O 0 3.0541833320897995e-15
- O 0 1.8540494660379547e-12
year O 0 5.201069228552286e-16
- O 0 9.60919260828419e-11
old O 0 1.32025395060964e-08
girl O 0 1.5999338520700235e-09
with O 0 3.3516577100517475e-12
VLCAD B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
who O 0 5.038759665586257e-13
was O 0 1.5857110046761072e-15
first O 0 9.074792697782863e-17
seen O 0 4.7864307190035454e-14
at O 0 4.243825224640703e-15
5 O 0 4.905973537640729e-16
months O 0 1.8928711446740854e-17
of O 0 2.250583446358445e-19
age O 0 1.510715516442676e-13
with O 0 7.330163494419228e-13
severe O 0 2.943823176337901e-07
hypertrophic B-Disease 1 0.999961256980896
cardiomyopathy I-Disease 1 1.0
, O 0 1.2075799531885423e-05
hepatomegaly B-Disease 1 1.0
, O 0 2.9624021635754616e-07
encephalopathy B-Disease 0 0.0002374618052272126
, O 0 4.0694379289940574e-12
and O 0 1.0743977756078049e-11
hypotonia B-Disease 0 0.43750420212745667
. O 0 9.137206963272249e-11

Biochemical O 0 1.674106351856608e-05
studies O 0 9.127709432732445e-08
indicated O 0 0.028883514925837517
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 1.4874552978216826e-10
by O 0 4.137236610261472e-16
a O 0 2.616449808548471e-12
stable O 0 1.9530313477567063e-10
yet O 0 1.6479778154089575e-13
inactive O 0 2.8927062568212536e-12
enzyme O 0 7.850572622536411e-12
. O 0 1.5952502177302846e-13

Molecular O 0 8.855351119052557e-09
genetic O 0 1.745732802760358e-08
analysis O 0 2.9017248673324225e-12
of O 0 4.442062592154613e-16
her O 0 1.0396481453511797e-09
VLCAD O 0 3.169924093526788e-05
gene O 0 2.005642762981097e-08
revealed O 0 1.9462624220589753e-11
a O 0 3.5531080573407425e-14
T1372C O 0 2.2100625496346282e-10
( O 0 1.485075867245771e-15
F458L O 0 1.0745801817813039e-11
) O 0 7.527724950817053e-15
missense O 0 1.020121209727165e-09
mutation O 0 2.9706550552788258e-09
and O 0 1.0835511090809269e-12
a O 0 3.810378748636545e-11
1668 O 0 0.0001924299431266263
ACAG O 0 6.37306657154113e-05
1669 O 0 2.896691553289088e-09
splice O 0 8.564588682702379e-08
site O 0 8.07536648661511e-10
mutation O 0 2.2124508891607775e-09
. O 0 2.443618441275164e-12

After O 0 5.474685307415954e-14
initial O 0 2.280733619271138e-15
treatment O 0 9.520292879234594e-15
with O 0 2.042813016258715e-17
intravenous O 0 6.468019479385911e-13
glucose O 0 2.8848177319185098e-11
and O 0 2.0716253419737068e-13
carnitine O 0 5.858163953931239e-10
, O 0 1.722089132535562e-13
the O 0 9.821487630882857e-15
patient O 0 2.1895747714939517e-10
has O 0 3.4369414866203263e-13
thrived O 0 1.4329232245202661e-11
on O 0 2.7323480815828445e-15
a O 0 5.893002184593089e-15
low O 0 2.744574316079773e-12
- O 0 1.0781323750430616e-10
fat O 0 3.7618410608786235e-09
diet O 0 1.2241828661885279e-09
supplemented O 0 7.669350723070456e-14
with O 0 1.796599021015497e-15
medium O 0 1.5882455073334967e-10
- O 0 6.039662103773935e-10
chain O 0 1.2593044385056373e-09
triglyceride O 0 2.603968473138818e-12
oil O 0 1.5249234099306945e-14
and O 0 3.5974566589919924e-16
carnitine O 0 4.822667330588171e-13
and O 0 9.371719435698368e-17
avoidance O 0 6.4542229220377386e-15
of O 0 1.348100912030747e-18
fasting O 0 5.186299740361777e-12
. O 0 2.387967211123221e-13

Her O 0 3.488322875000449e-07
ventricular O 0 1.2048043451784451e-08
hypertrophy O 0 5.8425477789114666e-08
resolved O 0 5.355405355289555e-11
significantly O 0 3.569170653472398e-11
over O 0 1.234921778552056e-12
1 O 0 5.0783829859445476e-14
year O 0 5.266052537474452e-16
, O 0 2.3570411234233833e-14
and O 0 2.1470000256818e-13
cognitively O 0 1.3203243836787393e-12
, O 0 9.047012372923307e-15
she O 0 9.372033704657667e-11
is O 0 2.898343259073528e-17
in O 0 8.8780013015367e-19
the O 0 8.132073813374144e-18
superior O 0 6.071235280870812e-15
range O 0 1.3569995008320263e-13
for O 0 1.9100576019925528e-14
age O 0 2.5372429851566736e-11
. O 0 2.6468421638475848e-12

Clinical O 0 5.317377258506895e-07
recognition O 0 3.719166641324989e-11
of O 0 5.4816626932074897e-11
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 3.847973372231306e-13
important O 0 2.2505204622623454e-14
because O 0 3.7036243212898445e-13
it O 0 3.244732837992016e-14
is O 0 8.614025303322245e-17
one O 0 1.6673206637629236e-17
of O 0 5.831067556524786e-20
the O 0 5.509247343334187e-16
few O 0 1.0088947906272683e-12
directly O 0 2.897007503679938e-12
treatable O 0 6.013769393575785e-08
causes O 0 1.2538829295607318e-13
of O 0 8.744246375157888e-15
cardiomyopathy B-Disease 1 1.0
in O 0 3.0324931454828175e-10
children O 0 2.2186606718488378e-11
. O 0 6.317642670941245e-14
. O 0 1.2429064938715428e-12

Cloning O 0 1.947007000069334e-09
of O 0 1.7320279259710683e-16
a O 0 4.499882437562731e-15
novel O 0 6.140977347945595e-14
member O 0 6.27679895398288e-16
of O 0 1.529359345298267e-18
the O 0 5.18591559736767e-15
low O 0 1.8661627798621794e-11
- O 0 3.5190289571218614e-10
density O 0 1.2024281310224483e-12
lipoprotein O 0 7.596083761995942e-09
receptor O 0 1.7916769179393555e-09
family O 0 1.3839981938268409e-10
. O 0 3.2192579765139007e-12

A O 0 9.951571901603562e-13
gene O 0 2.050148679294539e-12
encoding O 0 4.0351629779526374e-14
a O 0 1.2288865807114427e-14
novel O 0 8.082056616835753e-13
transmembrane O 0 4.741964199778126e-12
protein O 0 1.7799511864424744e-11
was O 0 4.043604847118153e-15
identified O 0 2.1226918296922664e-16
by O 0 2.236027135529043e-19
DNA O 0 1.3144321785521496e-12
sequence O 0 8.553592133631743e-14
analysis O 0 3.2623797953601702e-15
within O 0 2.7824561155226856e-16
the O 0 1.1890514343537023e-13
insulin B-Disease 0 0.0015824084402993321
- I-Disease 1 0.9999841451644897
dependent I-Disease 1 0.9999759197235107
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 2.3701941017501005e-12
IDDM B-Disease 0 2.04942440795719e-09
) O 0 2.7340057250606212e-15
locus O 0 1.677756566488553e-12
IDDM4 O 0 1.1382164100126602e-09
on O 0 8.545704291776368e-13
chromosome O 0 4.9435289639632174e-08
11q13 O 0 7.450583261459087e-09
. O 0 8.539875404056652e-12

Based O 0 4.2045840008449187e-13
on O 0 1.5609607654848076e-14
its O 0 1.941970865299559e-16
chromosomal O 0 2.033915052379598e-06
position O 0 2.5697685646086654e-10
, O 0 2.4553975304673686e-15
this O 0 1.6605290146254957e-17
gene O 0 4.980692507733364e-13
is O 0 1.2778915587165324e-17
a O 0 7.583888813726064e-18
candidate O 0 3.210170696194665e-16
for O 0 3.3972134566612093e-19
conferring O 0 3.310083544066922e-12
susceptibility O 0 6.95800827088533e-06
to O 0 3.995212161100881e-09
diabetes B-Disease 1 0.9993718266487122
. O 0 1.1466594340703296e-10

The O 0 3.080360673566457e-13
gene O 0 9.190196346986479e-12
, O 0 8.03522982336215e-15
termed O 0 5.097165311357399e-12
low O 0 2.9174789251129596e-09
- O 0 1.4053656016699279e-08
density O 0 9.076442722411038e-12
lipoprotein O 0 1.1456828818978693e-09
receptor O 0 6.9158541740610424e-12
related O 0 2.9213819406105623e-13
protein O 0 5.5193686426813215e-11
5 O 0 8.435638391155256e-15
( O 0 2.4921219740020038e-17
LRP5 O 0 1.1076257099007503e-11
) O 0 6.824631309992216e-18
, O 0 5.124784043387329e-19
encodes O 0 2.1906153024709152e-17
a O 0 1.3130461226363828e-16
protein O 0 4.689461167474429e-13
of O 0 1.2954481363457254e-17
1615 O 0 2.6579517666686092e-12
amino O 0 2.6218922324038052e-14
acids O 0 1.7715545861057922e-15
that O 0 2.863307817433691e-18
contains O 0 3.565483448251633e-18
conserved O 0 1.279271319139328e-14
modules O 0 7.881471489985456e-14
which O 0 5.86752004540789e-15
are O 0 2.4090427656912604e-17
characteristic O 0 7.22530284842822e-14
of O 0 9.407963512290237e-18
the O 0 1.1655527075177946e-13
low O 0 1.0337167566376593e-08
- O 0 2.71296755727235e-07
density O 0 9.08309746860958e-11
lipoprotein O 0 1.8053191297440208e-07
( O 0 2.0570570529072907e-13
LDL O 0 3.745374232977383e-09
) O 0 6.137839260282607e-14
receptor O 0 5.370910313717836e-12
family O 0 1.232780804522049e-11
. O 0 1.953465384244013e-12

These O 0 3.2809025000924905e-14
modules O 0 1.1035478120777296e-14
include O 0 1.807383550379057e-16
a O 0 6.228044663981208e-17
putative O 0 1.8074749664098895e-14
signal O 0 4.984602970859635e-15
peptide O 0 1.0842233483091858e-15
for O 0 1.0852846158652125e-19
protein O 0 1.0778114783050602e-14
export O 0 3.8910159274284373e-13
, O 0 1.1294462679565034e-14
four O 0 2.126518353971047e-15
epidermal O 0 9.008300182189455e-12
growth O 0 1.3848965648311645e-13
factor O 0 7.71312182824618e-15
( O 0 2.401987444461775e-16
EGF O 0 4.2662012811334193e-11
) O 0 1.2349057450653975e-15
repeats O 0 8.645074239810313e-12
with O 0 4.330778344753159e-16
associated O 0 2.868039139514167e-12
spacer O 0 1.588873459468232e-07
domains O 0 1.1758651830007238e-08
, O 0 3.003076032206259e-13
three O 0 7.202595589178226e-15
LDL O 0 2.9898325482058397e-10
- O 0 6.455322387743934e-10
receptor O 0 3.844116865103775e-12
( O 0 5.722115193308665e-16
LDLR O 0 4.0196679318427186e-11
) O 0 5.897586538661866e-16
repeats O 0 3.037259896712663e-12
, O 0 4.322740266781512e-16
a O 0 7.377842259042168e-16
single O 0 8.775930828396061e-14
transmembrane O 0 2.5754383434911654e-12
spanning O 0 2.5817141393463805e-12
domain O 0 1.509988141468188e-11
, O 0 6.750589162370178e-15
and O 0 1.183951419332131e-15
a O 0 8.372833439215192e-15
cytoplasmic O 0 7.318554651192244e-09
domain O 0 2.855249370270485e-09
. O 0 9.126368931411388e-12

The O 0 7.615209901741266e-15
encoded O 0 3.5396456544902616e-15
protein O 0 1.870738633447111e-11
has O 0 2.5699901191542085e-13
a O 0 1.7486583590992224e-16
unique O 0 1.3361935478513727e-16
organization O 0 1.9286232142376073e-16
of O 0 2.5509859248295942e-18
EGF O 0 1.6779647893372385e-08
and O 0 7.819783232401734e-13
LDLR O 0 7.700474036198557e-09
repeats O 0 1.951568906477519e-09
; O 0 1.1197894147314466e-14
therefore O 0 2.9284196917297436e-15
, O 0 1.1659428635987941e-15
LRP5 O 0 1.3431562528865015e-09
likely O 0 3.8435847928876277e-14
represents O 0 9.265393143452435e-18
a O 0 4.5474876214923336e-17
new O 0 1.1594539559481158e-15
category O 0 3.339207165983793e-13
of O 0 3.316203058081734e-18
the O 0 3.164832558890697e-14
LDLR O 0 3.852081249533512e-07
family O 0 6.864132179318361e-11
. O 0 1.6921285336465863e-12

Both O 0 1.870945585957795e-11
human O 0 7.975661797665623e-12
and O 0 5.239433453069209e-12
mouse O 0 8.10347060564709e-08
LRP5 O 0 1.6446001893655193e-08
cDNAs O 0 5.757326212996183e-11
have O 0 2.1873893755325335e-12
been O 0 1.172755604650702e-13
isolated O 0 1.0508284242760624e-09
and O 0 1.1652454378458486e-14
the O 0 2.8105733990222105e-18
encoded O 0 6.908533066704082e-17
mature O 0 3.088003398909973e-16
proteins O 0 8.686758037269502e-16
are O 0 2.7665575056260694e-17
95 O 0 8.557966211771365e-14
% O 0 6.399105614657174e-17
identical O 0 5.035406770367845e-13
, O 0 1.0911530942572627e-14
indicating O 0 1.4013307658364282e-13
a O 0 7.925912937035637e-14
high O 0 1.439399950143097e-13
degree O 0 5.6092376769334255e-15
of O 0 8.058845891889086e-20
evolutionary O 0 3.531171259259572e-14
conservation O 0 1.4919928018205207e-14
. O 0 6.047124911543692e-16
. O 0 1.3833362623796863e-13

The O 0 2.192015828832855e-13
APC B-Disease 0 7.956912038975528e-12
variants O 0 1.0393577491718542e-11
I1307K O 0 1.3508398566397517e-10
and O 0 3.0155873864635627e-14
E1317Q O 0 6.917160420838453e-12
are O 0 6.097947947170134e-16
associated O 0 5.7051530166774e-10
with O 0 0.0023627562914043665
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 2.1820765638835837e-08
but O 0 1.77312761695525e-10
not O 0 3.1924636545443974e-12
always O 0 5.527211175727909e-13
with O 0 2.16772175552953e-17
a O 0 2.818017417384618e-15
family O 0 2.506724211884248e-13
history O 0 6.721905475813583e-13
. O 0 2.3429771577737624e-13

Classical O 1 0.7549352049827576
familial B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 0.9998418092727661
polyposis I-Disease 1 0.9999986886978149
( O 0 3.8089982556943625e-11
FAP B-Disease 0 8.633383452583132e-10
) O 0 8.470043175406831e-15
is O 0 4.889196461933581e-16
a O 0 6.196535255395541e-14
high O 0 5.069472841512379e-09
- O 1 0.9999170303344727
penetrance O 1 0.9999619722366333
autosomal B-Disease 1 0.9999983310699463
dominant I-Disease 1 0.999705970287323
disease I-Disease 1 0.9530566334724426
that O 0 8.570730934759016e-16
predisposes O 0 5.31623052871244e-12
to O 0 3.688263355497982e-17
hundreds O 0 3.65836077635419e-17
or O 0 1.7091023175091406e-16
thousands O 0 1.7263098977117301e-15
of O 0 1.6064467735655424e-13
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.00014070614997763187
carcinoma I-Disease 1 1.0
and O 0 1.4006255044662907e-09
that O 0 5.34876743590873e-12
results O 0 3.677146261094055e-12
from O 0 7.498941500719931e-17
truncating O 0 7.738549356872682e-09
mutations O 0 1.4815720872363158e-09
in O 0 1.5627228481249807e-16
the O 0 9.435684452199257e-16
APC B-Disease 0 7.882321531593739e-12
gene O 0 2.759758255255207e-10
. O 0 2.7913387747047214e-12

A O 0 3.110022005550772e-12
variant O 0 3.1536670497267494e-10
of O 0 1.9387298790153476e-15
FAP B-Disease 0 2.3777470659069877e-08
is O 0 2.756263620118382e-11
attenuated B-Disease 0 0.4575949013233185
adenomatous I-Disease 1 0.9999985694885254
polyposis I-Disease 1 0.9999338388442993
coli I-Disease 1 0.9999996423721313
, O 0 2.726898429283864e-10
which O 0 3.695137945625149e-12
results O 0 1.1310852428281226e-13
from O 0 1.3962588709852168e-17
germ O 0 1.5018990495718754e-08
- O 0 3.1571834036014934e-09
line O 0 1.181730602262121e-09
mutations O 0 9.189740982074035e-12
in O 0 5.707873376548156e-18
the O 0 1.1133395764754603e-16
5 O 0 5.329878164115958e-15
and O 0 3.064192169856088e-14
3 O 0 1.7723792785590627e-15
regions O 0 4.573973849415075e-14
of O 0 1.0179027158111901e-18
the O 0 6.404111711724345e-17
APC B-Disease 0 7.172361120820481e-13
gene O 0 1.9214681928891864e-11
. O 0 1.78344616635559e-13

Attenuated B-Disease 1 0.9954954385757446
adenomatous I-Disease 1 0.9999945163726807
polyposis I-Disease 1 0.9999771118164062
coli I-Disease 1 0.9999996423721313
patients O 0 0.005967576522380114
have O 0 6.93737012280593e-10
" O 0 2.7031384075559828e-11
multiple O 0 3.200243270384817e-08
" O 0 0.00025697387172840536
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 3.594951755985648e-13
typically O 0 3.0029810374612243e-15
fewer O 0 5.543546883742066e-16
than O 0 1.7926618530579813e-16
100 O 0 8.584670450092861e-16
) O 0 1.6110017144152261e-15
without O 0 1.7449541516719813e-15
the O 0 8.465452150953595e-16
florid O 0 1.5175348977436443e-08
phenotype O 0 3.19486520572454e-11
of O 0 1.943400134136377e-17
classical O 0 3.6168245048234793e-12
FAP B-Disease 0 1.4875553011606257e-09
. O 0 8.832526723900891e-13

Another O 0 9.133491706003749e-12
group O 0 1.0100359676239179e-13
of O 0 6.2788281769179826e-18
patients O 0 3.4566621754609367e-14
with O 0 4.25788427749923e-15
multiple O 0 4.567878020278471e-11
adenomas B-Disease 0 1.937918204930611e-05
has O 0 5.1876753559554345e-08
no O 0 4.785652776839733e-11
mutations O 0 9.652065952048261e-11
in O 0 6.759884740161363e-17
the O 0 2.2808095875385948e-17
APC B-Disease 0 2.5886245051806242e-14
gene O 0 1.3286077966967458e-12
, O 0 8.93863916600333e-16
and O 0 1.8411557068981517e-15
their O 0 1.9837736617822328e-16
phenotype O 0 4.434924649743266e-13
probably O 0 3.4476498804274225e-13
results O 0 2.2249281240907092e-15
from O 0 2.4529691581451232e-18
variation O 0 1.0913883685681469e-10
at O 0 2.6716968914985983e-11
a O 0 1.6913468509852786e-13
locus O 0 3.298398880413611e-12
, O 0 1.1188938230793921e-12
or O 0 5.0644125327323035e-15
loci O 0 4.718102688730909e-15
, O 0 3.076154096192155e-15
elsewhere O 0 1.571078336870535e-13
in O 0 2.331605623989843e-16
the O 0 2.3348287431728234e-15
genome O 0 3.343198114180712e-12
. O 0 1.447066343704742e-13

Recently O 0 1.5059438140951897e-08
, O 0 1.1109188113693491e-13
however O 0 4.155697799225998e-15
, O 0 4.000945898849152e-17
a O 0 8.33862379017884e-17
missense O 0 1.422136297613008e-10
variant O 0 4.99920216334715e-10
of O 0 6.971940100250967e-17
APC B-Disease 0 3.581540966579588e-11
( O 0 4.029193005037094e-15
I1307K O 0 8.918970596794029e-12
) O 0 3.075659746588314e-16
was O 0 2.434450193923533e-15
described O 0 2.190057683476381e-15
that O 0 2.0767970699809662e-16
confers O 0 4.729298007898064e-13
an O 0 1.7981340829439381e-16
increased O 0 5.524332102879725e-10
risk O 0 2.234348585261614e-06
of O 0 1.786852088514479e-08
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 5.377327055855474e-12
including O 0 2.8437077149166042e-15
multiple O 0 1.6043042545474395e-12
adenomas B-Disease 0 8.7930132508518e-08
, O 0 1.8784212466732564e-12
in O 0 1.2421173031101906e-12
Ashkenazim O 0 4.149537744524423e-06
. O 0 1.6553289988729958e-11

We O 0 5.134300540277081e-09
have O 0 1.9234271700320146e-14
studied O 0 1.6128227293727045e-14
a O 0 2.2075859053541757e-17
set O 0 5.029984455074679e-16
of O 0 2.901679795471837e-20
164 O 0 1.0291539755818979e-13
patients O 0 1.1847608228407035e-14
with O 0 1.2074369959815326e-14
multiple O 0 5.36990373802837e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 1.2927846910315566e-05
/ I-Disease 1 0.9893739819526672
or I-Disease 0 7.527147545260959e-07
carcinoma I-Disease 1 1.0
and O 0 6.078254699559693e-08
analyzed O 0 3.108344159841181e-08
codons O 0 1.529693705037971e-08
1263 O 0 2.4274746657226842e-09
- O 0 1.2285030770442518e-09
1377 O 0 1.226814205779192e-10
( O 0 1.4271868827733336e-15
exon O 0 4.958776987119828e-13
15G O 0 1.36038402764882e-09
) O 0 7.258279852768079e-16
of O 0 3.820464198516577e-19
the O 0 3.961200863032714e-18
APC B-Disease 0 2.504075539858184e-14
gene O 0 3.678875509349061e-14
for O 0 1.4334163204094663e-17
germ O 0 7.204042917763331e-10
- O 0 5.354777954380552e-09
line O 0 2.3247341551790868e-10
variants O 0 1.1374561709187603e-10
. O 0 3.2756030960562343e-12

Three O 0 3.194723565552726e-12
patients O 0 7.661923260562573e-14
with O 0 9.576119735527162e-17
the O 0 9.380589458842897e-17
I1307K O 0 4.199344864896926e-12
allele O 0 3.182579339091685e-15
were O 0 1.3921166482625718e-16
detected O 0 1.5694609782797297e-13
, O 0 2.340792424221755e-17
each O 0 1.0083145551383583e-18
of O 0 6.7358905466969145e-18
Ashkenazi O 0 1.2005313010376994e-07
descent O 0 3.4367764190079697e-10
. O 0 4.749639917478454e-12

Four O 0 2.3802527657212913e-11
patients O 0 7.059780277735017e-12
had O 0 1.0282205859316051e-12
a O 0 3.991513591411434e-15
germ O 0 3.534720462994301e-07
- O 0 1.4144327451504068e-06
line O 0 4.023407385034261e-09
E1317Q O 0 4.5018315464329106e-11
missense O 0 8.331999153121661e-12
variant O 0 1.2705260021145248e-12
of O 0 7.586977480283943e-20
APC O 0 1.9724115935914992e-14
that O 0 2.5395521596012147e-15
was O 0 1.4647273194681731e-13
not O 0 5.808507429379273e-14
present O 0 2.2999448559104575e-16
in O 0 6.298934704221493e-17
controls O 0 5.228251211519819e-06
; O 0 4.5870964226471175e-14
one O 0 8.019175902033722e-17
of O 0 8.05045372452208e-21
these O 0 2.0271862509986084e-17
individuals O 0 9.694757370420028e-19
had O 0 1.7941491391518238e-13
an O 0 1.516832728896917e-18
unusually O 0 1.1240734532687747e-14
large O 0 5.18378234489001e-14
number O 0 1.0443490690292823e-12
of O 0 2.701750022214908e-16
metaplastic B-Disease 0 7.863413884479087e-07
polyps I-Disease 0 2.5486158961030014e-08
of I-Disease 0 8.072361299315166e-18
the I-Disease 0 1.2621868339997983e-14
colorectum I-Disease 0 1.4787954683015414e-07
. O 0 4.5910575688368205e-12

There O 0 6.097821032835515e-12
is O 0 1.3961051146529554e-16
increasing O 0 7.976554924663559e-17
evidence O 0 1.6962954546323634e-14
that O 0 3.357539288302981e-15
there O 0 2.1655515380046564e-14
exist O 0 1.0474650660730056e-12
germ O 0 1.8147433555881776e-10
- O 0 1.49117575926061e-11
line O 0 3.383845504148497e-12
variants O 0 1.1286709786998816e-14
of O 0 1.6265224615905832e-19
the O 0 1.5527323674817184e-18
APC B-Disease 0 7.154837330513187e-15
gene O 0 1.3048387545423149e-14
that O 0 1.804138156876542e-17
predispose O 0 1.3501184253970986e-14
to O 0 6.20265154266481e-17
the O 0 8.371164413732186e-17
development O 0 2.5395714296007647e-15
of O 0 2.5431669256431816e-16
multiple O 0 0.00014225162158254534
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.003894027089700103
carcinoma I-Disease 1 1.0
, O 0 1.0160428748351436e-10
but O 0 3.3395716747541826e-12
without O 0 4.340985832921402e-15
the O 0 9.552117601128833e-16
florid O 0 4.874932102438834e-08
phenotype O 0 3.656627778347854e-11
of O 0 2.795208725939191e-18
classical O 0 7.392813032754131e-13
FAP B-Disease 0 1.428902916128516e-11
, O 0 5.883545485253468e-15
and O 0 8.862382377948801e-16
possibly O 0 2.017890296013064e-16
with O 0 8.121073303843924e-17
importance O 0 1.7954030189643033e-12
for O 0 3.581230423321813e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 4.807149522889631e-08
in O 0 2.2708172457389542e-17
the O 0 2.4479133061641072e-17
general O 0 2.0603375522197003e-15
population O 0 1.1445036391406202e-16
. O 0 3.51558324840378e-16
. O 0 7.319708397344679e-14

Genomic O 0 3.283885874338921e-08
structure O 0 6.866276644479363e-12
of O 0 4.710562970534713e-17
the O 0 7.57884355859044e-14
human O 0 6.673159358427938e-09
congenital B-Disease 1 0.9999967813491821
chloride I-Disease 1 0.9999819993972778
diarrhea I-Disease 1 1.0
( O 0 2.8087800973963795e-09
CLD B-Disease 0 0.00024189031682908535
) O 0 1.6925860940684295e-13
gene O 0 3.923215363688115e-10
. O 0 2.23278340261146e-12

Congenital B-Disease 1 0.9999953508377075
chloride I-Disease 1 0.999923586845398
diarrhea I-Disease 1 1.0
( O 0 3.380820245979521e-08
CLD B-Disease 0 0.3073544502258301
) O 0 9.663329164633083e-13
is O 0 4.44357338129516e-15
caused O 0 6.852035757363983e-14
by O 0 9.012694594837283e-17
mutations O 0 1.4907214351822518e-10
in O 0 9.293610424816211e-17
a O 0 6.729839396261289e-15
gene O 0 2.3632120565997283e-11
which O 0 1.6897199802144757e-15
encodes O 0 1.5165067823470074e-13
an O 0 8.24255384269685e-15
intestinal O 0 9.541230383547372e-08
anion O 0 7.899694093316256e-11
transporter O 0 1.3338581084099133e-07
. O 0 2.8225418530203328e-11

We O 0 4.9115080003048206e-08
report O 0 4.954390305129952e-13
here O 0 1.2622349454712023e-14
the O 0 1.5848755390225389e-16
complete O 0 2.8664831603188515e-14
genomic O 0 1.067851970043554e-11
organization O 0 5.929871834721174e-15
of O 0 2.720859406037452e-19
the O 0 4.015366039206115e-16
human O 0 1.5394044546035435e-13
CLD B-Disease 0 9.651343191308115e-08
gene O 0 7.928802059353757e-10
which O 0 3.024931176311314e-14
spans O 0 3.970380881707092e-12
approximately O 0 6.4067564662230285e-15
39kb O 0 8.426208175649208e-09
, O 0 9.37320425269117e-13
and O 0 1.7097961772533782e-13
comprises O 0 1.2081223608323421e-12
21 O 0 1.3593705154579805e-12
exons O 0 1.5551935295121666e-09
. O 0 1.0274643982843834e-11

All O 0 2.069654668999943e-13
exon O 0 7.955094916134442e-11
/ O 0 1.583760109724608e-07
intron O 0 2.5392978386662435e-07
boundaries O 0 8.79765205130667e-10
conform O 0 1.0981916070962328e-10
to O 0 7.957897303464609e-16
the O 0 1.3441797715247803e-15
GT O 0 5.389569693314833e-11
/ O 0 1.0021611096533434e-08
AG O 0 9.17791354027031e-09
rule O 0 1.0999718913495826e-09
. O 0 2.501395358206482e-12

An O 0 8.321246379870326e-16
analysis O 0 1.4343047759148193e-14
of O 0 5.878507915618351e-19
the O 0 5.78598544799858e-17
putative O 0 2.633727383318657e-13
promoter O 0 7.029642059425134e-12
region O 0 4.348067045301107e-13
sequence O 0 9.07498902413817e-12
shows O 0 7.534368636798183e-13
a O 0 1.3058619703425981e-14
putative O 0 1.2650858659257747e-11
TATA O 0 1.94225729249764e-11
box O 0 2.420124101121246e-09
and O 0 9.884534163395742e-12
predicts O 0 3.995446473670228e-10
multiple O 0 1.9857611648771423e-12
transcription O 0 2.788595465652577e-10
factor O 0 6.175583590513345e-13
binding O 0 7.020660637048481e-13
sites O 0 4.0835934633776105e-10
. O 0 5.6664777037251923e-11

The O 0 1.0651453541876341e-13
genomic O 0 4.641033390928584e-11
structure O 0 1.0874226866186554e-12
was O 0 1.4211944423088646e-15
determined O 0 3.7826476412404874e-17
using O 0 2.1888611832639353e-17
DNA O 0 3.8063982521485684e-11
from O 0 2.1100136655308906e-19
several O 0 2.975516780381676e-19
sources O 0 1.4530319160194263e-17
including O 0 6.947594520462306e-17
multiple O 0 9.00896178946016e-14
large O 0 6.526363108792788e-13
- O 0 1.0788184567900316e-08
insert O 0 3.878671606116768e-09
libaries O 0 1.2270769955691208e-09
and O 0 4.819002523957262e-15
genomic O 0 4.00732780292401e-11
DNA O 0 5.408829495401335e-10
from O 0 1.1411344332440182e-15
Finnish O 0 2.9033804693767706e-08
CLD B-Disease 0 0.006622863933444023
patients O 0 4.043478885051854e-09
and O 0 3.4326027128139466e-14
controls O 0 4.392128175823018e-05
. O 0 8.378250176965807e-11

Exon O 0 5.5905363671726604e-11
- O 0 3.1368935227149564e-10
specific O 0 1.8166211265303878e-13
primers O 0 1.4209608600879164e-08
developed O 0 1.5243856177349357e-10
in O 0 2.082969822584082e-16
this O 0 3.108497625766587e-16
study O 0 3.7573403217146684e-15
will O 0 5.27822016576176e-16
facilitate O 0 1.0047298356049617e-15
mutation O 0 2.053292736845739e-14
screening O 0 1.413723061142666e-13
studies O 0 1.3196400623725207e-15
of O 0 8.011763805398333e-20
patients O 0 4.384522479377326e-15
with O 0 4.891061522604317e-16
the O 0 1.4007043788732965e-11
disease O 0 3.2605388696538284e-05
. O 0 1.7802625693064122e-12

Genomic O 0 2.1645234216105536e-10
sequencing O 0 2.4637611829164685e-12
of O 0 1.7442870073469002e-17
a O 0 2.977113794746557e-14
BAC O 0 1.9285323560325196e-07
clone O 0 2.5218929522452527e-07
H O 1 0.9999994039535522
_ O 0 2.952461625876923e-12
RG364P16 O 0 4.106398207581741e-11
revealed O 0 1.6997876359486214e-13
the O 0 6.497517773674446e-18
presence O 0 1.1342252913723832e-15
of O 0 8.559800688017977e-20
another O 0 7.027643898538166e-16
, O 0 1.239856652642099e-16
highly O 0 4.9554765915328834e-17
homologous O 0 5.4031479540094657e-14
gene O 0 1.1597018484410526e-11
3 O 0 6.6099524704892835e-15
of O 0 2.921107269530987e-18
the O 0 7.674849491557442e-15
CLD B-Disease 0 1.544501344596938e-07
gene O 0 5.4409653865716834e-11
, O 0 4.175909752352939e-16
with O 0 1.7420259918605477e-17
a O 0 1.1531288432936127e-15
similar O 0 6.636987644583273e-15
genomic O 0 9.25261378625919e-09
structure O 0 1.562807938615407e-10
, O 0 2.2714607260810715e-15
recently O 0 6.151542491540651e-13
identified O 0 5.408079041015201e-13
as O 0 1.1582394928138368e-13
the O 0 4.996942859492037e-10
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 1.885312128635519e-09
( O 0 2.7992877189758126e-16
PDS B-Disease 0 2.248800312631971e-10
) O 0 1.2663820187809594e-15
. O 0 4.639749176494571e-15
. O 0 3.8349312332479346e-13

The O 0 1.275824714971896e-12
APCI1307K O 0 1.0099787672857019e-08
allele O 0 4.096715189305655e-10
and O 0 2.349318295458147e-09
cancer B-Disease 0 2.4784301331237657e-06
risk O 0 4.989504365227049e-10
in O 0 3.053461236502265e-15
a O 0 8.572068293903612e-13
community O 0 1.223666147250925e-14
- O 0 8.820139930920678e-12
based O 0 8.395985920158085e-16
study O 0 2.363413299346018e-16
of O 0 2.0894047190630734e-19
Ashkenazi O 0 6.703868363211463e-12
Jews O 0 2.63882584403477e-13
. O 0 1.303158020946396e-13

Mutations O 0 2.9420914415823063e-07
in O 0 4.915511340385049e-15
APC O 0 1.2824297179747646e-11
are O 0 3.083026498009703e-15
classically O 0 8.073587309809227e-08
associated O 0 1.8419987668494286e-07
with O 0 1.1004887710441835e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999814033508301
polyposis I-Disease 1 0.9999996423721313
( O 0 6.029124682144227e-12
FAP B-Disease 0 3.0356528402109006e-10
) O 0 4.679012118215123e-15
, O 0 3.1031085903979183e-15
a O 0 1.076378569608849e-12
highly O 0 2.0880045781268564e-07
penetrant O 1 0.9999701976776123
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 5.549535941895556e-08
by O 0 9.857670337290719e-15
multiple O 0 4.635311856571178e-10
intestinal O 0 0.001424640417098999
polyps B-Disease 0 1.1389406608941499e-05
and O 0 6.867452028054555e-13
, O 0 3.3785586226473333e-15
without O 0 8.419398440215786e-16
surgical O 0 3.49472362159986e-09
intervention O 0 8.182193529486514e-13
, O 0 6.338493128091739e-16
the O 0 1.7459786909612446e-16
development O 0 5.075693554693061e-13
of O 0 2.4910919681209176e-12
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.0311497709452064e-13
CRC B-Disease 0 1.20823777649548e-08
) O 0 1.3199082668849393e-13
. O 0 1.0170713013110677e-12

APC B-Disease 0 9.443705817346881e-10
is O 0 1.6952869772053625e-13
a O 0 1.825353887138781e-12
tumour O 1 0.999998927116394
- O 0 2.8232123305826917e-09
suppressor O 0 3.882422161538557e-10
gene O 0 1.2661197090757526e-10
, O 0 5.560386745766428e-15
and O 0 1.7995416134742584e-15
somatic O 0 1.4939583587152833e-13
loss O 0 8.035399429173751e-11
occurs O 0 2.7597921777727796e-12
in O 0 1.56220143158331e-12
tumours B-Disease 1 1.0
. O 0 1.3182854807780586e-09

The O 0 6.829570546248998e-13
germline O 0 1.189885828756232e-10
T O 0 5.8009490544463915e-09
- O 0 6.003213984945299e-12
to O 0 5.063601075168834e-15
- O 0 7.419374142836332e-12
A O 0 1.432926483903047e-14
transversion O 0 1.7423062775509535e-12
responsible O 0 6.580559924293747e-17
for O 0 5.633175580963985e-20
the O 0 1.052886045072436e-18
APC O 0 2.7615203198027563e-15
I1307K O 0 3.8389379701389906e-15
allele O 0 5.331764030033461e-17
converts O 0 2.9070908594873985e-17
the O 0 3.419982998889015e-18
wild O 0 3.633124210549246e-14
- O 0 3.482472827904398e-13
type O 0 5.2791195026546944e-11
sequence O 0 4.479114995570299e-12
to O 0 6.498916191983138e-15
a O 0 1.0558460356024923e-11
homopolymer O 0 0.001563409110531211
tract O 0 0.006820950191468
( O 0 1.2982929347479105e-13
A8 O 0 1.4664752967519235e-08
) O 0 9.214544478461893e-15
that O 0 7.729236630067693e-14
is O 0 2.008753813243988e-13
genetically O 0 5.295027971641275e-09
unstable O 0 8.235426503233612e-05
and O 0 5.79334180628166e-09
prone O 0 1.957746320613296e-07
to O 0 1.997386698854471e-14
somatic O 0 1.8209314264772125e-11
mutation O 0 9.837410885893405e-10
. O 0 9.019900711754181e-13

The O 0 2.85990903268335e-13
I1307K O 0 3.3510971775285725e-11
allele O 0 3.22931134957849e-13
was O 0 2.285535042473308e-13
found O 0 2.8037149696086977e-14
in O 0 1.1542333742568323e-15
6 O 0 2.676414645463865e-11
. O 0 1.6218133606915597e-12

1 O 0 1.628148570825827e-12
% O 0 1.4669120927248498e-15
of O 0 9.037374190157292e-18
unselected O 0 8.7513683411089e-08
Ashkenazi O 0 1.0775907277604801e-08
Jews O 0 3.89779224521658e-12
and O 0 1.552072950413222e-13
higher O 0 1.1752360220521237e-14
proportions O 0 2.1404805011782102e-11
of O 0 7.540991227159064e-18
Ashkenazim O 0 7.29477242500387e-11
with O 0 2.624449086058387e-14
family O 0 1.3705888637569053e-12
or O 0 6.654607200435583e-15
personal O 0 1.0561303994706655e-14
histories O 0 1.4564576975018007e-11
of O 0 5.566684647487501e-17
CRC B-Disease 0 9.377872700611078e-09
( O 0 5.238606128884571e-15
ref O 0 3.012480576103371e-08
. O 0 1.6164998688033248e-14
2 O 0 4.294229021309902e-14
) O 0 7.651491711003957e-15
. O 0 2.8923353512580463e-13

To O 0 2.3367603425167305e-13
evaluate O 0 1.0879428732684868e-13
the O 0 2.3787977337738715e-17
role O 0 1.3691391855024044e-15
of O 0 3.1019084787149182e-18
I1307K O 0 6.697418314383086e-11
in O 0 2.5406871837505354e-14
cancer B-Disease 0 3.1225206864604615e-09
, O 0 1.5312888625293106e-14
we O 0 1.09864348521449e-11
genotyped O 0 3.5064211534319156e-09
5 O 0 2.1202833867979554e-13
, O 0 6.400164686420906e-14
081 O 0 2.90809136771486e-08
Ashkenazi O 0 3.0163773701019636e-09
volunteers O 0 3.4489307975315783e-14
in O 0 4.1080148338490356e-17
a O 0 3.851244088313175e-15
community O 0 9.91159160767998e-15
survey O 0 4.111427344410945e-12
. O 0 6.443008968145744e-14

Risk O 0 1.8880049523772868e-08
of O 0 6.644663457151291e-15
developing O 0 8.113209659654785e-09
colorectal B-Disease 1 1.0
, I-Disease 0 4.134099356178922e-07
breast I-Disease 1 0.653881847858429
and I-Disease 0 7.195529172498993e-10
other I-Disease 0 1.4645149513676375e-13
cancers I-Disease 0 2.9763799602733343e-07
were O 0 1.2976701453031123e-15
compared O 0 3.2647078654156987e-15
between O 0 2.383315407820854e-14
genotyped O 0 4.940437037248557e-08
I1307K O 0 6.41908748377773e-11
carriers O 0 3.121751988854893e-13
and O 0 8.245886917344295e-15
non O 0 4.698380055949685e-16
- O 0 7.914334985981153e-12
carriers O 0 1.2680323371178082e-12
and O 0 9.287440472715777e-14
their O 0 2.0330263777338043e-16
first O 0 4.46796221270369e-16
- O 0 1.455420392494286e-13
degree O 0 5.5836619406075556e-15
relatives O 0 1.2485341028460693e-14
. O 0 1.1768555490472739e-14

Sperm O 0 1.5219162041724132e-10
DNA O 0 2.6141911552146624e-11
analysis O 0 6.27194693750277e-14
in O 0 3.548877995977978e-16
a O 0 2.84382044822562e-12
Friedreich B-Disease 1 0.9999501705169678
ataxia I-Disease 1 0.9999748468399048
premutation O 0 6.653602031292394e-05
carrier O 0 3.0025423813917484e-10
suggests O 0 5.749761777806839e-12
both O 0 2.378328120179068e-15
meiotic O 0 1.1976632359467221e-11
and O 0 3.7232840915208884e-14
mitotic O 0 1.9695003006942047e-12
expansion O 0 7.482026608517101e-13
in O 0 7.46668966246204e-16
the O 0 1.8138839988536418e-15
FRDA B-Disease 0 7.48040029918684e-09
gene O 0 4.1253431226628834e-10
. O 0 7.600227955664729e-13

Friedreich B-Disease 1 0.99981290102005
ataxia I-Disease 1 0.9999966621398926
is O 0 2.177075941744988e-07
usually O 0 1.0483255236115596e-10
caused O 0 4.174957973193845e-14
by O 0 4.560981873774248e-19
an O 0 1.2831910153879453e-18
expansion O 0 9.4032334002625e-13
of O 0 4.697589138935186e-17
a O 0 2.252988160617031e-12
GAA O 0 2.7798665591660665e-09
trinucleotide O 0 6.622328783123521e-07
repeat O 0 1.6370560462775074e-10
in O 0 2.1633033537439659e-16
intron O 0 1.2129613979894316e-09
1 O 0 3.0420209977584118e-15
of O 0 1.1399579714819116e-18
the O 0 1.1351083232198959e-15
FRDA B-Disease 0 4.453726720754503e-09
gene O 0 2.8307922672610175e-10
. O 0 1.3170043397861542e-12

Occasionally O 0 5.184500651012058e-07
, O 0 5.068399042476579e-13
a O 0 1.6520777936868472e-14
fully O 0 3.166770909087194e-14
expanded O 0 2.0114990131447213e-13
allele O 0 8.61486392205596e-13
has O 0 1.0277141550968372e-13
been O 0 2.7576976071722384e-16
found O 0 2.3459784496157685e-16
to O 0 3.9293123886743046e-17
arise O 0 1.3647904124720824e-15
from O 0 5.222430969865109e-20
a O 0 2.2476173110986794e-17
premutation O 0 3.75490350618124e-12
of O 0 2.3384072799447314e-19
100 O 0 4.0445578385931525e-17
or O 0 4.742424181020132e-16
less O 0 2.8413546573891318e-15
triplet O 0 1.7645619436734705e-06
repeats O 0 2.3770273855916457e-06
. O 0 1.3216629179968464e-11

We O 0 5.492940324813844e-09
have O 0 4.076044514932098e-14
examined O 0 8.415040582757105e-14
the O 0 8.00312710922509e-18
sperm O 0 5.953100019233729e-16
DNA O 0 1.4204201271401321e-14
of O 0 2.5609773489757427e-20
a O 0 1.9620169323177365e-15
premutation O 0 3.859197406086423e-09
carrier O 0 1.5258516672389533e-10
. O 0 2.3461532196178414e-12

This O 0 4.997135517881279e-13
mans O 0 1.2627769663264843e-10
leucocyte O 0 2.791943065627578e-10
DNA O 0 4.22386747800374e-09
showed O 0 3.317484741777177e-12
one O 0 1.1407551213023258e-16
normal O 0 2.576398601026545e-14
allele O 0 1.065709325664575e-15
and O 0 1.6147849341345783e-16
one O 0 1.5133129719929273e-18
allele O 0 7.536020367985988e-17
of O 0 1.5629112385094897e-19
approximately O 0 4.1238278140086403e-16
100 O 0 1.0644142631101999e-13
repeats O 0 1.0554453666600239e-07
. O 0 1.6633236454843825e-11

His O 0 1.659071491300068e-11
sperm O 0 2.6359196943215313e-12
showed O 0 2.12855761120255e-13
an O 0 1.4782627444996413e-18
expanded O 0 4.901118031384877e-13
allele O 0 4.1322118795282525e-13
in O 0 3.0280466481946103e-15
a O 0 4.007965292117388e-13
tight O 0 7.23602653351918e-08
range O 0 3.227303949256133e-13
centering O 0 1.6253916818704216e-14
on O 0 4.66245940035988e-15
a O 0 1.4396531960536672e-16
size O 0 3.711852534864744e-15
of O 0 2.068571916841984e-18
approximately O 0 1.1109394450919442e-14
320 O 0 9.531118082273249e-12
trinucleotide O 0 1.2344434253463987e-05
repeats O 0 9.220938750331698e-07
. O 0 9.923751924378887e-12

His O 0 1.0828558882902684e-10
affected O 0 4.865143357624113e-11
son O 0 6.299338828341661e-11
has O 0 1.8928027277053533e-13
repeat O 0 4.904804860872414e-12
sizes O 0 2.1683383441637588e-13
of O 0 1.3682397820962081e-17
1040 O 0 5.71828283509046e-13
and O 0 9.775512376571788e-15
540 O 0 3.339565386381582e-12
. O 0 9.633406268874656e-13

These O 0 3.477984027622401e-14
data O 0 9.716214141033356e-15
suggest O 0 4.543868434997173e-15
that O 0 9.513529956425479e-17
expansion O 0 1.4351043411357095e-13
occurs O 0 6.237204610621714e-15
in O 0 5.811775946881248e-18
two O 0 2.1978243403279925e-15
stages O 0 4.922081351440427e-14
, O 0 8.878314802988858e-17
the O 0 1.8199814780210152e-17
first O 0 4.361882188669725e-16
during O 0 4.109490457887381e-16
meiosis O 0 1.0114518890743719e-15
followed O 0 7.386258325466527e-17
by O 0 1.2090424677305095e-19
a O 0 2.5374880991274335e-16
second O 0 2.136325174379415e-14
mitotic O 0 2.267227898478108e-11
expansion O 0 4.51072720841772e-11
. O 0 5.687611406152149e-12

We O 0 2.111687269490403e-09
also O 0 7.661309331082403e-14
show O 0 3.2542170997837405e-13
that O 0 7.9450106500842e-15
in O 0 6.586085490785601e-17
all O 0 2.311130885508461e-17
informative O 0 3.6179541892771006e-13
carrier O 0 9.917956213245649e-13
father O 0 1.3664640436967385e-13
to O 0 2.2032291781550834e-16
affected O 0 2.0004026443664648e-14
child O 0 4.1464048313550814e-14
transmissions O 0 4.227948286611438e-12
, O 0 6.006432389966412e-16
with O 0 7.692104717363314e-17
the O 0 1.6367942250011442e-17
notable O 0 3.008506445134401e-16
exception O 0 7.273722639825064e-15
of O 0 4.889562311510804e-19
the O 0 3.504590084237399e-16
premutation O 0 4.019437560565109e-11
carrier O 0 3.8583926228715273e-14
, O 0 5.608761670886848e-17
the O 0 1.9122116200123102e-18
expansion O 0 5.276169498996458e-15
size O 0 2.803540006483113e-13
decreases O 0 7.449723476993242e-11
. O 0 1.9959291923214717e-13
. O 0 7.960156513976691e-13

The O 0 2.1692607291620009e-13
R496H O 0 1.1080383138795113e-10
mutation O 0 8.161883170189344e-13
of O 0 6.123650644966683e-19
arylsulfatase O 0 1.6917688083761817e-10
A O 0 1.4607886298159678e-12
does O 0 4.757675503563874e-11
not O 0 2.0185575433373515e-11
cause O 0 3.1136591083225085e-09
metachromatic B-Disease 1 0.9999996423721313
leukodystrophy I-Disease 1 0.9999986886978149
. O 0 1.3451250113760693e-09

Deficiency B-Disease 1 0.999224066734314
of I-Disease 0 2.74724125013618e-15
arylsulfatase I-Disease 0 1.9451135813142173e-07
A I-Disease 0 6.164575100386926e-11
( O 0 9.050295642033454e-14
ARSA O 0 3.469538569333963e-06
) O 0 7.55654219752877e-14
enzyme O 0 1.9822504748745473e-11
activity O 0 1.8474193286266427e-09
causes O 0 9.470155646340572e-07
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 0.9999998807907104
( O 0 2.5902890943285684e-10
MLD B-Disease 1 0.9999536275863647
) O 0 5.440422851804572e-12
. O 0 1.5955522493504848e-12

A O 0 5.953770896433008e-12
number O 0 8.603136107156184e-14
of O 0 9.147611723211622e-16
ARSA O 0 0.000839706277474761
gene O 0 1.9805451501042626e-08
mutations O 0 5.791040980085427e-10
responsible O 0 1.0500268325186815e-13
for O 0 2.3279095427849398e-15
MLD B-Disease 1 0.9999997615814209
have O 0 9.383964438836045e-11
been O 0 1.6043890933674365e-13
identified O 0 3.3272499339043193e-12
. O 0 1.1296816753532044e-13

Recently O 0 6.353318315888146e-09
, O 0 7.186983077894435e-14
the O 0 9.701579741045407e-16
R496H O 0 2.7397743795898322e-11
mutation O 0 5.884292077033837e-13
of O 0 4.861051463747633e-19
ARSA O 0 8.38778824174824e-09
was O 0 7.978358337217602e-15
proposed O 0 2.1906749587366926e-16
to O 0 9.965340639213373e-17
be O 0 2.7417538001269523e-16
a O 0 6.759634203697433e-15
cause O 0 1.2970610913445868e-12
of O 0 8.575117612513727e-15
MLD B-Disease 1 0.9999998807907104
( O 0 1.9275900320359085e-12
Draghia O 0 6.364333557939972e-07
et O 0 1.6305907735159053e-09
al O 0 6.391296936136825e-10
. O 0 9.815724757522917e-14
, O 0 5.6366286048652615e-15
1997 O 0 3.922815831257321e-15
) O 0 8.092197871262686e-15
. O 0 2.4889205280098636e-13

We O 0 7.330971385499652e-10
have O 0 1.5436875614046296e-14
investigated O 0 2.478889692797935e-14
the O 0 3.854223910516946e-17
R496H O 0 2.1407489496361176e-12
mutation O 0 2.0783206969646195e-14
and O 0 1.4069682129398183e-17
found O 0 4.839852292893486e-17
this O 0 3.966402174724447e-18
mutation O 0 1.2149815184427266e-15
at O 0 9.744897667712482e-17
a O 0 7.013686913149783e-17
relatively O 0 8.602634960112941e-16
high O 0 2.43310267038357e-16
frequency O 0 8.508516258904069e-15
in O 0 4.2902275026711966e-17
an O 0 4.519058085583376e-17
African O 0 1.33175178648531e-15
American O 0 2.4123821269113614e-16
population O 0 2.224799533901404e-16
( O 0 2.139781116449816e-16
f O 0 1.0370300174145086e-09
= O 0 3.1356388596748275e-09
0 O 0 2.4315800566630796e-13
. O 0 8.888451405087328e-16
09 O 0 8.30619007277135e-14
, O 0 3.1558012394971875e-15
n O 0 4.630126948512725e-09
= O 0 1.0947027107022222e-07
61 O 0 3.36577918313985e-11
subjects O 0 2.432468462765236e-11
) O 0 1.1772916354898383e-13
. O 0 6.26028471683443e-13

The O 0 2.304534167663075e-12
ARSA O 0 1.1761370188878573e-07
enzyme O 0 4.4532866977364804e-12
activity O 0 6.749591662490173e-13
in O 0 6.805890540598092e-17
subjects O 0 9.101853385568015e-13
with O 0 2.995797308683913e-14
and O 0 8.152326199089427e-14
without O 0 1.0269601491312018e-16
the O 0 1.5202621163189853e-18
R496H O 0 2.72697744376979e-13
mutation O 0 2.9605116101671936e-14
was O 0 3.2628155938115326e-15
determined O 0 3.4910239304387913e-14
and O 0 2.075348670110941e-15
found O 0 2.2011984113700853e-14
to O 0 2.0584679387468732e-15
be O 0 1.6114182471022032e-13
normal O 0 2.1515237508262786e-11
. O 0 1.308863282513395e-12

It O 0 3.316963093080716e-10
is O 0 7.306987317729635e-14
therefore O 0 1.2000485816925175e-14
concluded O 0 3.0246198069999036e-14
that O 0 1.0180280543535072e-16
the O 0 1.2964770993969046e-16
R496H O 0 3.078378871257392e-11
mutation O 0 9.801711444443542e-14
of O 0 2.2216083951752665e-18
ARSA O 0 3.018842846813641e-07
does O 0 9.715932919318604e-12
not O 0 6.458308056063228e-16
negatively O 0 1.084975817968813e-16
influence O 0 4.9568617948041096e-15
the O 0 2.94847113211318e-16
activity O 0 1.0176821679201004e-13
of O 0 2.8466231708881902e-18
ARSA O 0 2.604682265427982e-07
and O 0 4.2956706713861287e-14
is O 0 1.4869513834794493e-16
not O 0 2.707682958614832e-16
a O 0 1.261502685488301e-15
cause O 0 7.354193751370197e-13
of O 0 1.7112219031101966e-13
MLD B-Disease 1 0.9999984502792358

Down O 0 2.3679990590608213e-07
- O 0 4.3293071350092305e-09
regulation O 0 1.413002770345173e-10
of O 0 7.461336414235392e-16
transmembrane O 0 5.696400573462768e-10
carbonic O 0 7.667635970598496e-11
anhydrases O 0 5.6292757122378134e-09
in O 0 5.874603646420506e-13
renal B-Disease 0 5.866797437192872e-05
cell I-Disease 0 0.0021104710176587105
carcinoma I-Disease 1 1.0
cell O 0 0.013438498601317406
lines O 0 8.536992623930928e-08
by O 0 1.1252066308862704e-13
wild O 0 1.4026588814886054e-06
- O 0 0.04882333427667618
type O 1 0.9726945161819458
von B-Disease 1 0.9990724325180054
Hippel I-Disease 1 0.9975222945213318
- I-Disease 1 0.9007071256637573
Lindau I-Disease 0 0.3773263990879059
transgenes O 0 2.8494507205323316e-05
. O 0 3.168257323160617e-10

To O 0 9.138300359479157e-12
discover O 0 2.1612427125727862e-11
genes O 0 4.37973182026985e-12
involved O 0 2.48518707782891e-13
in O 0 1.5669165184112321e-12
von B-Disease 1 0.9999486207962036
Hippel I-Disease 1 0.9999678134918213
- I-Disease 1 0.9999730587005615
Lindau I-Disease 1 0.9997479319572449
( O 0 2.519563550851256e-11
VHL B-Disease 0 1.418551619281061e-06
) O 0 3.145234452658213e-13
- O 0 8.609686852345533e-10
mediated O 0 1.1788692244607546e-09
carcinogenesis O 0 6.319972989388134e-09
, O 0 6.408963529151712e-13
we O 0 1.1725375878568478e-11
used O 0 1.7662510343186e-11
renal B-Disease 0 1.1210754280455149e-07
cell I-Disease 0 7.245899178087711e-05
carcinoma I-Disease 1 1.0
cell O 1 0.9897328019142151
lines O 0 0.0011676312424242496
stably O 0 1.2790584150934592e-05
transfected O 0 3.185262542615419e-08
with O 0 3.963314051946831e-12
wild O 0 3.68827315355702e-08
- O 0 0.0005568964406847954
type O 0 0.022169079631567
VHL O 0 0.012122978456318378
- O 0 8.074139827840554e-07
expressing O 0 7.915195408825237e-12
transgenes O 0 1.7646902961132582e-07
. O 0 4.0215695357170844e-11

Large O 0 3.392835274881878e-12
- O 0 2.599926107738071e-10
scale O 0 1.449737274672458e-10
RNA O 0 3.8033809435233934e-10
differential O 0 3.0792070282448236e-11
display O 0 4.391529728840077e-14
technology O 0 5.069191594264666e-13
applied O 0 1.7781880568695785e-13
to O 0 2.661874516854813e-15
these O 0 1.134389721643269e-15
cell O 0 7.988697897642894e-11
lines O 0 3.237592693938751e-10
identified O 0 1.1253746415654242e-12
several O 0 4.584852759424783e-16
differentially O 0 1.4122233764346515e-11
expressed O 0 1.2914571056954428e-16
genes O 0 9.103893176430275e-15
, O 0 2.579392754630737e-18
including O 0 9.640361973338541e-19
an O 0 8.1978867844507e-18
alpha O 0 2.197180087068311e-14
carbonic O 0 7.231786783995497e-13
anhydrase O 0 1.4160933710372081e-12
gene O 0 1.3803382915844598e-11
, O 0 1.2333105490916572e-14
termed O 0 2.8452232236908515e-10
CA12 O 0 2.756844423856819e-06
. O 0 2.2566275237334565e-11

The O 0 1.728030391034193e-14
deduced O 0 3.8243381714469366e-14
protein O 0 6.908780866192801e-14
sequence O 0 3.5577755476932926e-13
was O 0 2.0708163556288608e-16
classified O 0 2.7241143390003815e-16
as O 0 4.118985697226102e-16
a O 0 2.2535960388938257e-14
one O 0 6.525083858649472e-12
- O 0 3.5895820474252105e-05
pass O 0 8.090216496725589e-09
transmembrane O 0 7.443562988207475e-10
CA O 0 1.9329710054805105e-10
possessing O 0 2.246700894241644e-16
an O 0 3.7770820392069856e-17
apparently O 0 1.883451077391851e-12
intact O 0 1.5445275809190806e-13
catalytic O 0 3.286277500125223e-13
domain O 0 2.4944725104947274e-12
in O 0 7.394945442434008e-16
the O 0 2.6467369792961947e-15
extracellular O 0 3.3660629839005196e-10
CA O 0 1.4593261994377826e-06
module O 0 2.5190893815363324e-10
. O 0 1.1035995251332253e-12

Reintroduced O 0 2.0627277663720633e-08
wild O 0 2.902594253839652e-08
- O 0 6.786496214772342e-06
type O 0 1.98461002582917e-05
VHL B-Disease 0 2.6167197574977763e-05
strongly O 0 5.529049006830489e-12
inhibited O 0 9.989129749060632e-13
the O 0 1.1956014310793279e-16
overexpression O 0 7.270230831203303e-14
of O 0 7.77262175440619e-19
the O 0 4.48573792702076e-17
CA12 O 0 2.294670876923366e-11
gene O 0 6.251454974341708e-13
in O 0 6.828358089524012e-17
the O 0 4.2270704894275396e-15
parental O 0 9.327709449280519e-07
renal B-Disease 0 9.682014933787286e-06
cell I-Disease 0 0.0006816230015829206
carcinoma I-Disease 1 1.0
cell O 0 0.42990007996559143
lines O 0 4.986861677025445e-05
. O 0 3.706972784289775e-10

Similar O 0 2.7873710284342934e-11
results O 0 1.720963649365359e-12
were O 0 6.002263929074736e-16
obtained O 0 1.822734646119502e-15
with O 0 1.1373659307221246e-16
CA9 O 0 1.7141751351701373e-09
, O 0 4.840592652628946e-16
encoding O 0 2.2015006327256656e-14
another O 0 2.722748458985902e-12
transmembrane O 0 1.124021054010882e-08
CA O 0 3.6331492481167516e-08
with O 0 1.1572352060823423e-16
an O 0 4.771620149397457e-17
intact O 0 7.852160761878668e-12
catalytic O 0 6.586607648184639e-11
domain O 0 4.040556778051041e-09
. O 0 7.358716067051851e-12

Although O 0 1.1046683012772007e-10
both O 0 3.848837413600141e-14
domains O 0 5.833138225913581e-12
of O 0 2.2196696906145953e-17
the O 0 3.553011410881461e-15
VHL B-Disease 0 2.8915634331383444e-09
protein O 0 1.3095824338144046e-12
contribute O 0 8.05846234891856e-16
to O 0 4.813176313708692e-16
regulation O 0 1.4408208784053023e-12
of O 0 5.938962824277095e-18
CA12 O 0 4.129635744476445e-09
expression O 0 5.794233230152143e-14
, O 0 2.678384088969306e-16
the O 0 9.543876731558212e-18
elongin O 0 9.251541373267447e-12
binding O 0 1.0400249319522312e-13
domain O 0 2.677430846476092e-11
alone O 0 2.5630659053477167e-11
could O 0 4.0132938639025895e-11
effectively O 0 7.654718525706983e-11
regulate O 0 3.252970115497078e-09
CA9 O 0 2.0713734556920826e-05
expression O 0 8.157774900041659e-09
. O 0 2.9638382026409005e-11

We O 0 3.307357587800652e-08
mapped O 0 3.466563214260532e-08
CA12 O 0 4.369206862975261e-07
and O 0 1.4734199103860757e-12
CA9 O 0 5.09298736517394e-08
loci O 0 3.289552874888302e-12
to O 0 3.407020623740972e-14
chromosome O 0 1.4848934304367845e-09
bands O 0 1.7910727154873962e-12
15q22 O 0 4.503345196749109e-10
and O 0 1.1751655421346485e-12
17q21 O 0 5.558367988101054e-09
. O 0 4.616469966717274e-12

2 O 0 2.7172711997147658e-11
respectively O 0 1.179440388670433e-13
, O 0 2.4816713489967182e-14
regions O 0 7.518986822052653e-11
prone O 0 3.5292629263494746e-08
to O 0 2.4793420930950636e-15
amplification O 0 2.5013942740043094e-13
in O 0 1.2868688340992847e-16
some O 0 2.9058521929160473e-15
human O 0 5.6125881719992776e-11
cancers B-Disease 0 1.5382131095975637e-05
. O 0 1.7693150547101744e-12

Additional O 0 1.969852368244665e-13
experiments O 0 3.4756863186158338e-12
are O 0 8.189358717771401e-17
needed O 0 1.738197687489089e-15
to O 0 5.129949993107876e-18
define O 0 3.7228016215541324e-14
the O 0 9.693288876678563e-17
role O 0 8.023778446135041e-14
of O 0 2.1783252183657249e-16
CA O 0 8.044228394510355e-08
IX O 0 8.398381434737701e-10
and O 0 3.6008366427475735e-11
CA O 0 1.9877811396895595e-08
XII O 0 4.2750447279416015e-12
enzymes O 0 6.720069379434479e-14
in O 0 8.385637758346149e-18
the O 0 1.1742220547928333e-16
regulation O 0 4.672865393240411e-12
of O 0 2.9716275322378163e-18
pH O 0 7.341075989285295e-13
in O 0 5.858969909549848e-17
the O 0 7.099750225151148e-16
extracellular O 0 9.973656449335788e-12
microenvironment O 0 6.622440817949382e-09
and O 0 1.7529812711548735e-14
its O 0 9.72195101577577e-17
potential O 0 1.2803717208169298e-15
impact O 0 1.460452852403149e-14
on O 0 1.2373037490409633e-11
cancer B-Disease 0 8.616049207432752e-09
cell O 0 1.9234933090750417e-10
growth O 0 6.0597451535804314e-12
. O 0 2.3247883110776024e-13

A O 0 9.483656264810958e-13
gene O 0 9.619598954208053e-13
encoding O 0 7.012142348570465e-15
a O 0 1.840481680430374e-15
transmembrane O 0 1.4779900935936452e-13
protein O 0 2.9034947731688965e-13
is O 0 1.8557013537150966e-16
mutated O 0 1.697576454406935e-11
in O 0 4.468734071476875e-14
patients O 0 4.947119602860539e-09
with O 0 4.367688234196976e-06
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 5.671017061104067e-05
optic B-Disease 1 0.9999703168869019
atrophy I-Disease 1 0.9999585151672363
( O 0 3.947640379919903e-06
Wolfram B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
) O 0 7.053212614654969e-12
. O 0 6.9411217225312516e-12

Wolfram B-Disease 1 0.9999990463256836
syndrome I-Disease 1 1.0
( O 0 3.430934147896636e-10
WFS B-Disease 0 5.379170397645794e-05
; O 0 2.4375217122507564e-11
OMIM O 0 1.96771475202695e-06
222300 O 0 2.8395633067113124e-10
) O 0 1.5194352293555497e-15
is O 0 4.9857629824809e-15
an O 0 1.1502046060388182e-12
autosomal B-Disease 1 0.9999994039535522
recessive I-Disease 1 0.9999996423721313
neurodegenerative I-Disease 1 0.9999998807907104
disorder I-Disease 1 0.999997615814209
defined O 0 1.8330441331482206e-11
by O 0 1.1086533031673049e-14
young O 0 1.7985021458222228e-11
- O 0 5.233446813690534e-07
onset O 0 1.1216459824936464e-05
non O 0 1.1459625470777723e-09
- O 0 0.0007450761622749269
immune O 0 0.00020633410895243287
insulin B-Disease 0 0.0006476854905486107
- I-Disease 1 0.9467733502388
dependent I-Disease 1 0.947027862071991
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 2.1605894851006724e-09
progressive O 0 1.9214738689043998e-09
optic B-Disease 0 0.009546938352286816
atrophy I-Disease 0 0.1585852950811386
. O 0 3.105318779894617e-10

Linkage O 0 1.3442024382470663e-08
to O 0 5.832664809034965e-14
markers O 0 9.31408616899887e-10
on O 0 3.0086027527805037e-13
chromosome O 0 9.425842328880663e-09
4p O 0 2.7804285540611318e-09
was O 0 2.5699144201585256e-11
confirmed O 0 2.1836220331916678e-11
in O 0 1.9836306720328245e-15
five O 0 3.1751727982975986e-13
families O 0 1.7284720340128915e-14
. O 0 1.6861673461567722e-13

On O 0 2.1547618290346238e-13
the O 0 7.28412732785134e-17
basis O 0 6.13993669385451e-17
of O 0 8.95583237973304e-18
meiotic O 0 4.143300813552742e-09
recombinants O 0 0.00021571561228483915
and O 0 4.735289849122637e-07
disease O 0 0.22672462463378906
- O 0 9.09869797283136e-08
associated O 0 2.9570495385655704e-08
haplotypes O 0 2.3377786817491142e-07
, O 0 1.3452378046143604e-13
the O 0 6.763757665963785e-16
WFS B-Disease 0 3.201522102980192e-10
gene O 0 1.0007418071306118e-12
was O 0 3.9985524352031173e-16
localized O 0 6.316052281879481e-14
to O 0 7.259529755760871e-15
a O 0 6.148058407859369e-13
BAC O 0 4.626131158147473e-07
/ O 0 2.925836517508884e-10
P1 O 0 4.690617685931819e-12
contig O 0 5.743886703074574e-12
of O 0 1.330555816702432e-19
less O 0 2.6424758228907156e-18
than O 0 3.143614222096321e-17
250 O 0 1.529385918310009e-14
kb O 0 9.274350531995879e-08
. O 0 4.442633413925812e-11

Mutations O 0 1.1278372085143928e-06
in O 0 3.149487244150117e-15
a O 0 9.952433842330688e-15
novel O 0 1.317423926026906e-12
gene O 0 4.8724517476284035e-11
( O 0 2.9861888210401446e-15
WFS1 O 0 3.5320996127907733e-11
) O 0 1.7836976967597442e-17
encoding O 0 2.2476437477910566e-16
a O 0 7.465436053700103e-16
putative O 0 4.217151394802013e-14
transmembrane O 0 7.507793418535212e-15
protein O 0 6.687094725611048e-14
were O 0 5.613365692001869e-16
found O 0 8.29871212709981e-15
in O 0 3.4939761658382617e-17
all O 0 2.049066508307061e-15
affected O 0 2.524289642331229e-13
individuals O 0 7.311935816556393e-18
in O 0 1.2619936469603532e-15
six O 0 1.2919666150714576e-13
WFS B-Disease 0 5.858711293882379e-10
families O 0 9.218794254516505e-16
, O 0 6.136919403677713e-16
and O 0 2.6384305506989454e-15
these O 0 4.371441418700633e-17
mutations O 0 1.9324410236061518e-13
were O 0 2.1083985126668196e-17
associated O 0 5.413295662827456e-15
with O 0 7.65896847082937e-15
the O 0 1.7295028256758549e-12
disease O 0 1.1987069683527807e-06
phenotype O 0 3.1842023462402835e-10
. O 0 4.45943818981262e-13

WFS1 O 0 1.0448874832036381e-07
appears O 0 1.8180719082994123e-11
to O 0 4.293457120185069e-15
function O 0 1.0724010655188687e-12
in O 0 1.433320184816931e-14
survival O 0 2.756993566777055e-08
of O 0 8.525332020194104e-18
islet O 0 3.897322464752051e-09
beta O 0 3.929724926542144e-13
- O 0 4.089051319766668e-09
cells O 0 2.1837929034540515e-11
and O 0 9.034733783319909e-15
neurons O 0 3.9693163306989826e-14
. O 0 1.2183788617150452e-15
. O 0 6.16287281081894e-14

Stable O 0 1.9602872658452952e-09
interaction O 0 1.6526111533930743e-13
between O 0 2.1972123590236012e-15
the O 0 8.546208404493718e-17
products O 0 1.8374309642158956e-14
of O 0 1.3771987478361015e-18
the O 0 6.047473465601487e-15
BRCA1 O 0 8.371385806782428e-10
and O 0 3.0599609218001644e-12
BRCA2 O 0 1.6674220337797863e-10
tumor B-Disease 0 3.2143922940042202e-12
suppressor O 0 2.8158512847820116e-12
genes O 0 2.777530375835946e-12
in O 0 6.169075421333446e-16
mitotic O 0 2.4160860812028062e-11
and O 0 1.198357277125417e-12
meiotic O 0 1.2228479340237186e-09
cells O 0 1.9350636648596264e-09
. O 0 2.137184179629159e-11

BRCA1 O 0 9.710576705401763e-05
and O 0 2.0468374217763596e-10
BRCA2 O 0 3.6444444684313737e-10
account O 0 1.0111277930929287e-15
for O 0 5.845814635882958e-19
most O 0 6.299195845140876e-18
cases O 0 1.2754182721413866e-16
of O 0 5.029343944310961e-19
familial O 0 2.2064992888370938e-10
, O 0 1.1796692230914632e-14
early O 0 1.021652055489819e-12
onset O 0 2.595591963583388e-09
breast B-Disease 0 9.427988516108599e-06
and I-Disease 0 6.095298203945276e-07
/ I-Disease 1 0.9999960660934448
or I-Disease 1 0.8873106241226196
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.970041408450162e-14
encode O 0 2.3629017443854358e-14
products O 0 1.7323760481691153e-11
that O 0 7.951650541357727e-15
each O 0 7.262620962797206e-18
interact O 0 3.383795192085496e-15
with O 0 2.3778124041691322e-14
hRAD51 O 0 3.6222026267296314e-08
. O 0 9.27723436267014e-12

Results O 0 1.3657658337606904e-09
presented O 0 1.2997219132112464e-14
here O 0 3.5277562765261266e-15
show O 0 2.289173624964169e-13
that O 0 8.179719244603631e-15
BRCA1 O 0 1.7287600240223355e-09
and O 0 3.743182847015802e-12
BRCA2 O 0 1.7007631414323043e-10
coexist O 0 4.977845826509286e-12
in O 0 2.237359361604348e-18
a O 0 3.759243392988912e-17
biochemical O 0 3.163512203932517e-13
complex O 0 3.222639847035372e-14
and O 0 1.1854192215506043e-13
colocalize O 0 1.7453756218088756e-09
in O 0 1.0787698113815837e-14
subnuclear O 0 7.007511015899581e-09
foci O 0 1.2706381086191598e-11
in O 0 2.4548331682964808e-17
somatic O 0 2.2984474498904776e-14
cells O 0 6.148431237881433e-14
and O 0 1.5006387741625887e-16
on O 0 1.5214007428398737e-16
the O 0 1.6743246088045633e-18
axial O 0 9.286319509313381e-15
elements O 0 1.6200370783910588e-14
of O 0 1.0752021992667437e-17
developing O 0 9.435356142228901e-13
synaptonemal O 0 1.421290862779756e-09
complexes O 0 1.9049035682172644e-09
. O 0 2.8721885980687034e-12

Like O 0 8.198811629611669e-10
BRCA1 O 0 3.059506070712814e-08
and O 0 3.946070900595622e-12
RAD51 O 0 3.149799283619359e-07
, O 0 4.170357906663896e-14
BRCA2 O 0 1.0087591872931512e-10
relocates O 0 1.1806750022103074e-11
to O 0 6.297980071620158e-15
PCNA O 0 1.4415816318447128e-09
+ O 0 2.6450239568043266e-13
replication O 0 8.21761820916922e-13
sites O 0 1.7649930453798868e-13
following O 0 2.3946968201265205e-15
exposure O 0 1.9231052297494222e-13
of O 0 7.259131087792845e-18
S O 0 1.3039077630117024e-11
phase O 0 2.6388233622282346e-15
cells O 0 1.989503786730849e-15
to O 0 3.244195414115829e-17
hydroxyurea O 0 3.975988809024056e-12
or O 0 1.3785096992396419e-15
UV O 0 2.3639513957451896e-11
irradiation O 0 4.839580819426814e-11
. O 0 1.254450428082865e-12

Thus O 0 2.6654871018716442e-11
, O 0 2.798042830418068e-13
BRCA1 O 0 1.5081649262782548e-09
and O 0 2.1288914641565126e-12
BRCA2 O 0 3.8044040140405855e-10
participate O 0 6.729326094295253e-15
, O 0 6.773107956789407e-15
together O 0 1.970433602253071e-14
, O 0 1.2451373736726374e-15
in O 0 1.869990832622501e-17
a O 0 2.4453678133389304e-15
pathway O 0 1.0634483744997869e-13
( O 0 6.906371809199603e-17
s O 0 1.3053529611395387e-12
) O 0 1.5593931152872098e-17
associated O 0 1.2700250016079817e-15
with O 0 2.5441941516150744e-17
the O 0 1.9920686289649146e-17
activation O 0 4.924402062897226e-17
of O 0 2.341460093392935e-19
double O 0 4.041049721410783e-13
- O 0 2.5283650173513195e-10
strand O 0 5.286826194605965e-07
break O 0 5.2047028020751895e-08
repair O 0 1.8415697411455767e-08
and O 0 1.6884619245295662e-13
/ O 0 4.5738413056994887e-11
or O 0 1.5485112234568297e-15
homologous O 0 6.832658354036236e-13
recombination O 0 4.819558922959655e-13
. O 0 8.082102695428084e-13

Dysfunction O 0 2.26254564950068e-06
of O 0 3.4391906703798946e-17
this O 0 3.826552072049087e-16
pathway O 0 8.440957893589285e-13
may O 0 4.2784830176336233e-14
be O 0 3.0731734401903265e-16
a O 0 9.131189871946729e-16
general O 0 4.495835060030866e-14
phenomenon O 0 3.1989261933818014e-11
in O 0 2.810179503886319e-16
the O 0 3.311363141599625e-17
majority O 0 2.3568051188684546e-16
of O 0 2.064966895711416e-20
cases O 0 1.9488428171308535e-16
of O 0 4.741153598512026e-18
hereditary B-Disease 0 0.08865633606910706
breast I-Disease 1 0.6583214402198792
and I-Disease 0 1.4581002687918954e-05
/ I-Disease 1 0.9999954700469971
or I-Disease 1 0.9875539541244507
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.439559714459253e-13
. O 0 8.024455123815943e-13

A O 0 8.865126688295533e-11
novel O 0 1.5162711364258286e-11
Arg362Ser O 0 6.664763851915723e-09
mutation O 0 2.5549685631065522e-11
in O 0 2.7632774036250516e-17
the O 0 1.0349752645690447e-16
sterol O 0 3.3405196386837588e-09
27 O 0 3.195474787553998e-11
- O 0 2.2415362968541963e-11
hydroxylase O 0 4.790296603829347e-09
gene O 0 4.83891607339082e-11
( O 0 1.0868730394217647e-16
CYP27 O 0 4.204425869958062e-12
) O 0 5.090186263009594e-17
: O 0 4.792616971194258e-17
its O 0 1.7644710414738066e-17
effects O 0 1.9416885905110953e-13
on O 0 3.3669295379078895e-14
pre O 0 5.826163661758199e-13
- O 0 7.987833078359e-14
mRNA O 0 1.7679157325643877e-15
splicing O 0 1.834567382990454e-13
and O 0 8.301018703694301e-16
enzyme O 0 6.970351437018832e-15
activity O 0 1.0476722842132219e-13
. O 0 5.363779895500159e-14

A O 0 1.0485490080369697e-11
novel O 0 3.3653791559062896e-12
C O 0 2.543223132089878e-10
to O 0 1.5820434578936145e-15
A O 0 6.975115743237253e-14
mutation O 0 4.2446796945372345e-13
in O 0 3.148426758900155e-17
the O 0 2.4264661672418323e-16
sterol O 0 7.663082612907601e-09
27 O 0 6.033407107253197e-11
- O 0 2.9041847052213576e-11
hydroxylase O 0 6.399375696020115e-09
gene O 0 1.2861513243311862e-10
( O 0 1.1909038392934147e-16
CYP27 O 0 7.862351394938294e-12
) O 0 2.304616176440116e-17
was O 0 6.549706087445519e-17
identified O 0 3.575484624340216e-16
by O 0 1.0468066811604775e-18
sequencing O 0 1.371351627090303e-13
amplified O 0 9.714889483147804e-13
CYP27 O 0 7.472607255198938e-11
gene O 0 9.15302382498151e-12
products O 0 6.688612608652528e-14
from O 0 7.214628770837492e-18
a O 0 8.176822391924021e-14
patient O 0 2.445207369916602e-09
with O 0 1.5128450575607744e-11
cerebrotendinous B-Disease 1 0.9999998807907104
xanthomatosis I-Disease 1 0.9999984502792358
( O 0 2.2098737228158638e-13
CTX B-Disease 0 1.687239681302799e-08
) O 0 4.86861961336571e-13
. O 0 1.3851113181764796e-12

The O 0 5.238231723381226e-13
mutation O 0 9.309548791580635e-12
changed O 0 4.890693698546972e-14
the O 0 4.587141998313636e-17
adrenodoxin O 0 1.648509996045322e-12
cofactor O 0 1.3481147350790507e-13
binding O 0 1.6206004908262545e-13
residue O 0 7.758785801337265e-12
362Arg O 0 5.968600613748265e-11
to O 0 1.2354105978777848e-14
362Ser O 0 1.0565601726852947e-09
( O 0 1.4356239450268732e-14
CGT O 0 5.149649151547919e-09
362Arg O 0 8.229064651921192e-10
to O 0 8.829809577731371e-14
AGT O 0 1.4544457305198932e-10
362Ser O 0 3.87926704648045e-11
) O 0 4.1067950402305404e-16
, O 0 3.067972657894185e-16
and O 0 2.0742170340934092e-15
was O 0 2.6911068520623325e-14
responsible O 0 4.282352941763039e-14
for O 0 7.566678301995384e-15
deficiency O 0 4.301891110003453e-08
in O 0 4.536571815256839e-17
the O 0 8.164688750833722e-16
sterol O 0 9.765553699025986e-09
27 O 0 9.7678488561459e-12
- O 0 9.548544680632043e-13
hydroxylase O 0 4.306802137143961e-11
activity O 0 9.69292029452673e-13
, O 0 1.709231754731393e-17
as O 0 2.234271909967994e-18
confirmed O 0 4.811083612933382e-16
by O 0 5.372384274636768e-20
expression O 0 7.74185053222164e-18
of O 0 3.0423034076626926e-20
mutant O 0 9.577120997292243e-14
cDNA O 0 2.801658102562221e-13
into O 0 7.699073448002788e-14
COS O 0 8.098399284506286e-09
- O 0 3.0077124124616716e-10
1 O 0 6.940531726814039e-14
cells O 0 1.3124780125564617e-12
. O 0 1.5386147488461593e-13

Quantitative O 0 1.5499897199067192e-10
analysis O 0 1.4431035576592532e-12
showed O 0 1.6927353616025265e-12
that O 0 1.0563953381416768e-16
the O 0 2.141690877960854e-17
expression O 0 1.3699594310327017e-15
of O 0 1.907053942097889e-18
CYP27 O 0 1.2580553265806316e-10
gene O 0 1.447276136825118e-13
mRNA O 0 2.1374162798704207e-15
in O 0 4.455756269410408e-17
the O 0 6.776851736537152e-16
patient O 0 1.330801571372553e-12
represented O 0 2.8480938632757238e-15
52 O 0 6.479040220996879e-11
. O 0 9.712666868694209e-13

5 O 0 2.5156439431572863e-12
% O 0 3.8055027739142256e-16
of O 0 2.4783267934132425e-18
the O 0 1.468010080358552e-14
normal O 0 2.2214395600794745e-10
level O 0 4.752485297659925e-12
. O 0 1.668260256500187e-12

As O 0 3.7850348262548e-14
the O 0 3.3561544423737794e-16
mutation O 0 6.7366724110467895e-15
occurred O 0 5.5593266840329395e-15
at O 0 1.783765691006096e-17
the O 0 2.3471565243800696e-19
penultimate O 0 4.972275041587059e-16
nucleotide O 0 4.9317341918468963e-17
of O 0 8.65977160427612e-21
exon O 0 4.538065412275534e-15
6 O 0 3.098283890730358e-14
( O 0 2.8525065343540043e-16
- O 0 3.5342558740714125e-11
2 O 0 2.3007503630674726e-14
position O 0 3.0347208443025006e-14
of O 0 1.8687766503904863e-19
exon O 0 4.633494976591379e-12
6 O 0 2.0994561991671823e-11
- O 0 6.902551308307636e-10
intron O 0 4.942152287412682e-08
6 O 0 3.90803356472777e-13
splice O 0 7.745954572202507e-11
site O 0 2.8333279732811745e-12
) O 0 6.352892688195062e-17
of O 0 2.175663210275331e-20
the O 0 6.63444635714433e-18
gene O 0 5.069887652059402e-13
, O 0 1.174639350868254e-15
we O 0 1.5957110756513915e-15
hypothesized O 0 1.4727539201433851e-16
that O 0 5.629037522061748e-17
the O 0 1.7362948544428618e-16
mutation O 0 2.1495988582892478e-12
may O 0 1.123966303600947e-14
partially O 0 8.259180015249279e-13
affect O 0 1.110184427027816e-12
the O 0 2.286708642620629e-16
normal O 0 3.726451147710672e-15
splicing O 0 2.5416807533976647e-14
efficiency O 0 6.679760690837247e-15
in O 0 2.8041371066759354e-18
exon O 0 8.50912439467888e-13
6 O 0 5.365603794604823e-13
and O 0 1.4090141508789952e-14
cause O 0 2.607174823187025e-15
alternative O 0 1.0213343945235552e-16
splicing O 0 9.914626628373946e-13
elsewhere O 0 8.546193266956159e-13
, O 0 1.2725419600107478e-15
which O 0 9.496383891990684e-16
resulted O 0 4.130820441565139e-15
in O 0 2.583826889391552e-16
decreased O 0 3.9904274329316536e-10
transcript O 0 7.44685757503305e-10
in O 0 1.004458340369543e-14
the O 0 6.168329735878331e-14
patient O 0 4.589606472649166e-11
. O 0 8.414751236302323e-14

Transfection O 0 1.976891894628352e-08
of O 0 3.2478501627598844e-16
constructed O 0 2.829207788185295e-12
minigenes O 0 1.235809093946827e-10
, O 0 9.594924952217171e-15
with O 0 3.004686855937876e-16
or O 0 1.9080101116008023e-15
without O 0 6.276703133380722e-16
the O 0 5.555271540267739e-17
mutation O 0 1.5371129933119954e-13
, O 0 3.7572094551243176e-16
into O 0 1.013228858318593e-14
COS O 0 7.354562825412359e-08
- O 0 5.393333002423617e-11
1 O 0 1.1552024858276096e-15
cells O 0 1.1988498606655632e-14
confirmed O 0 6.225461345840981e-15
that O 0 5.81661081756162e-18
the O 0 8.084780589032037e-18
mutant O 0 1.1716919752144395e-12
minigene O 0 8.617173641312093e-11
was O 0 1.0065794802760573e-14
responsible O 0 4.0115367885400357e-17
for O 0 1.1068166441978507e-19
a O 0 2.0635919586821697e-17
mRNA O 0 1.0817988012009651e-14
species O 0 2.744338574105058e-16
alternatively O 0 1.642288125695661e-14
spliced O 0 5.1549262636285675e-09
at O 0 5.606657499379608e-12
an O 0 3.0142845333236553e-16
activated O 0 8.60239449118616e-11
cryptic O 0 2.975460849929945e-11
5 O 0 4.135313951350323e-15
splice O 0 1.176117397916343e-10
site O 0 2.0147100134038087e-12
88 O 0 7.48634756075027e-14
bp O 0 3.2012593801939576e-14
upstream O 0 9.955851620272859e-15
from O 0 8.904354241876874e-19
the O 0 2.569092784361288e-17
3 O 0 2.6388936659628567e-15
end O 0 4.895149515366003e-16
of O 0 1.321254299961244e-19
exon O 0 1.5526904414975284e-11
6 O 0 5.3303566421858406e-11
. O 0 1.3566739962347918e-12

Our O 0 1.2091621107157557e-12
data O 0 1.5352721196670686e-14
suggest O 0 4.075786169883185e-15
that O 0 6.224458008845178e-17
the O 0 3.23196670681209e-17
C O 0 1.9567159036722875e-13
to O 0 9.672192296899888e-18
A O 0 3.5630279989992165e-15
mutation O 0 2.2242373687222233e-14
at O 0 4.0116457116830967e-16
the O 0 4.54413861534629e-18
penultimate O 0 1.0551639348778483e-14
nucleotide O 0 6.465135671013689e-16
of O 0 8.837309282213148e-21
exon O 0 1.769758622147729e-14
6 O 0 5.3081091632616387e-14
of O 0 6.942871195087536e-19
the O 0 1.4650715960095846e-16
CYP27 O 0 2.8645415900419025e-11
gene O 0 2.826020450638622e-12
not O 0 1.6006562869315226e-14
only O 0 3.410634066293959e-15
causes O 0 2.365893125941959e-13
the O 0 1.0004516746292547e-12
deficiency B-Disease 0 2.5369017748744227e-06
in I-Disease 0 4.0268531956343126e-17
the I-Disease 0 1.6035278133260094e-15
sterol I-Disease 0 6.477353764466898e-09
27 I-Disease 0 5.140269286607602e-12
- I-Disease 0 6.645963076742922e-13
hydroxylase I-Disease 0 5.1352352925526645e-11
activity I-Disease 0 1.988256087548379e-11
, O 0 1.5188276526224842e-14
but O 0 1.0203240162487415e-12
also O 0 2.8480872174552196e-12
partially O 0 2.6745330949928814e-10
leads O 0 5.782014407193503e-13
to O 0 2.4838647262552544e-17
alternative O 0 1.3191317367250498e-15
pre O 0 4.421459129811539e-14
- O 0 1.9882187530465695e-14
mRNA O 0 3.080638182735801e-16
splicing O 0 1.3700125188226709e-14
of O 0 1.004812686015115e-18
the O 0 3.003551037695167e-17
gene O 0 8.201067320905142e-13
. O 0 7.646564859162958e-14

To O 0 2.105571793309391e-11
our O 0 1.4012820106199843e-14
knowledge O 0 3.546550508257601e-16
, O 0 1.0625546573316447e-16
this O 0 8.025873748889686e-18
is O 0 3.839827659136073e-17
the O 0 7.355971603646266e-18
first O 0 3.6446281885223804e-16
report O 0 3.2659644917325096e-16
regarding O 0 3.2239384226588955e-17
effects O 0 2.1654989541992908e-13
on O 0 8.568414193769157e-15
pre O 0 2.2266369791804769e-13
- O 0 1.0654984144607086e-14
mRNA O 0 2.350681600055398e-16
splicing O 0 7.192189789421207e-15
of O 0 5.433183342129123e-20
a O 0 1.20194355718467e-17
mutation O 0 3.814763226307879e-15
at O 0 3.7850024590083034e-16
the O 0 5.009301895736199e-17
- O 0 2.919949282365053e-10
2 O 0 2.490805955587816e-13
position O 0 1.0274834368745323e-12
of O 0 4.119670677219551e-19
a O 0 2.687145956594382e-15
5 O 0 3.90242774821691e-15
splice O 0 1.5209099535340442e-09
site O 0 3.715984464580657e-10
. O 0 4.705600492593831e-12

ATM O 0 2.2999725501904322e-07
germline O 0 1.4901664258104574e-07
mutations O 0 7.971996751621191e-08
in O 0 5.652719503417003e-13
classical O 0 0.0030438746325671673
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9990746974945068
in O 0 8.081682296035703e-14
the O 0 5.252676277874707e-14
Dutch O 0 1.5522182428284736e-09
population O 0 1.030874418082384e-14
. O 0 3.709165068729696e-14

Germline O 0 1.9842070742015494e-06
mutations O 0 6.672996732959291e-08
in O 0 1.8603224478379608e-16
the O 0 5.876809879256902e-17
ATM O 0 3.4272419971448365e-12
gene O 0 2.5165736465201927e-13
are O 0 1.6865169408408652e-18
responsible O 0 4.138436485370817e-16
for O 0 2.411067637656341e-15
the O 0 8.944607543526217e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.062900188728236e-05
A B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
T I-Disease 1 0.9999998807907104
) O 0 2.3208341498603957e-11
. O 0 1.512619239932289e-12

In O 0 1.1221771775704603e-11
our O 0 3.234551027627569e-13
study O 0 6.798009031372789e-15
, O 0 2.5638467056548033e-16
we O 0 1.2587392404978838e-14
have O 0 1.4760159234326003e-16
determined O 0 2.0114269052299216e-16
the O 0 3.023896506458371e-19
ATM O 0 1.4330200979843777e-13
mutation O 0 5.036054293174703e-15
spectrum O 0 1.5026265222617782e-16
in O 0 4.7583687159843575e-17
19 O 0 5.709637678017604e-14
classical O 0 3.808099113822294e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 0 1.5693183641474207e-08
, O 0 4.932239764637289e-18
including O 0 4.2881942513665106e-19
some O 0 1.4256454548628982e-17
immigrant O 0 2.4968861613711146e-12
populations O 0 3.694748500204792e-13
, O 0 4.1465727000503374e-17
as O 0 4.59500550808881e-17
well O 0 3.44570567723326e-16
as O 0 2.513768000230761e-16
12 O 0 3.396842728786324e-16
of O 0 2.219422001719924e-19
Dutch O 0 8.514096545841898e-12
ethnic O 0 9.342036828364e-14
origin O 0 1.4258441703805108e-13
. O 0 1.8409118630532961e-13

Both O 0 3.7886485398583303e-13
the O 0 8.586373515712435e-16
protein O 0 2.3978348061455546e-13
truncation O 0 4.251078933315e-10
test O 0 3.2235332181329568e-09
( O 0 1.1316704282452275e-16
PTT O 0 6.189168101633502e-13
) O 0 1.244880219763807e-16
and O 0 3.177723180091068e-17
the O 0 7.330088295098869e-18
restriction O 0 7.55621476847268e-13
endonuclease O 0 1.4121137592582045e-10
fingerprinting O 0 6.816433528733512e-11
( O 0 2.7478987925487107e-17
REF O 0 2.0584307370598298e-13
) O 0 6.001358195255312e-20
method O 0 2.084247196245017e-18
were O 0 4.637952580735956e-19
used O 0 7.46145023428768e-16
and O 0 6.833547357466027e-16
compared O 0 4.2521176374896535e-17
for O 0 5.228014632870298e-19
their O 0 3.121684712799836e-18
detection O 0 1.2667009266856006e-15
efficiency O 0 2.0488689709593384e-17
, O 0 8.115056950415127e-19
identifying O 0 8.016117319000745e-17
76 O 0 1.2391918545982816e-13
% O 0 3.6441098606069425e-18
and O 0 2.013439243754361e-15
60 O 0 4.4817597441397516e-14
% O 0 8.262562382184997e-18
of O 0 2.902078199259055e-20
the O 0 8.520009013690652e-16
mutations O 0 5.565470306834186e-11
, O 0 1.5705413857446116e-14
respectively O 0 1.8183405356506782e-13
. O 0 9.54579514392262e-13

Most O 0 5.401398729329432e-13
patients O 0 3.889637743836882e-12
were O 0 2.999556483255475e-16
found O 0 1.8185249453112073e-16
to O 0 1.2979616569858658e-16
be O 0 1.89532240508388e-15
compound O 0 1.3073891795556403e-11
heterozygote O 0 3.256906300208584e-09
. O 0 1.861274155634529e-12

Seventeen O 0 9.448441334880542e-11
mutations O 0 1.596253823565874e-10
were O 0 2.6696640435960005e-15
distinct O 0 6.933750296335027e-16
, O 0 4.189490178656708e-15
of O 0 1.1612315058731269e-18
which O 0 2.7650740041813143e-14
10 O 0 5.445104185216579e-16
were O 0 4.0072104354130363e-16
not O 0 1.2573331658054417e-14
reported O 0 2.84748982205818e-12
previously O 0 7.691335762727292e-11
. O 0 9.749792986846195e-12

Mutations O 0 6.118897033502435e-08
are O 0 5.0470135230836345e-16
small O 0 4.971917381925081e-15
deletions O 0 2.1368817826328268e-08
or O 0 2.8099414461912886e-10
point O 0 5.171194583653005e-09
mutations O 0 8.607166535057331e-08
frequently O 0 3.828374561809511e-10
affecting O 0 5.374302565475109e-12
splice O 0 2.3504003365815151e-07
sites O 0 4.654974183893046e-09
. O 0 2.7274070155125507e-11

Moreover O 0 5.117930523823588e-10
, O 0 5.69813835872568e-14
a O 0 8.369931673744488e-14
16 O 0 2.3531940285259623e-12
. O 0 4.438656202570418e-13

7 O 0 8.780196708579879e-11
- O 0 9.141599977002812e-11
kb O 0 1.1986579784295515e-10
genomic O 0 6.459753565390969e-11
deletion O 0 5.57271416512517e-11
of O 0 4.85706889929092e-18
the O 0 5.688207935034483e-16
3 O 0 2.343905505883953e-14
end O 0 2.1081354096750236e-15
of O 0 1.89440693860567e-20
the O 0 5.672924582077484e-18
gene O 0 2.8936251452674894e-14
, O 0 5.68256537211679e-17
most O 0 1.5825842818129915e-18
likely O 0 2.759844306297936e-16
a O 0 2.470521641230284e-17
result O 0 1.0640392149206059e-16
of O 0 3.8338040207017716e-21
recombination O 0 3.547076528952736e-17
between O 0 7.621076769571305e-16
two O 0 1.3488958180410317e-14
LINE O 0 7.72898273160294e-11
elements O 0 1.3625184964657922e-13
, O 0 3.760511189552715e-14
was O 0 1.5994371625749348e-12
identified O 0 4.326116895270182e-11
. O 0 2.660655333205919e-12

The O 0 9.77671611203379e-13
most O 0 1.9462881657619346e-15
frequently O 0 3.4983062453808333e-12
found O 0 1.1146707946311889e-14
mutation O 0 9.843541827730517e-15
, O 0 7.126497639653643e-18
identified O 0 1.0636628940640085e-14
in O 0 7.870639244873697e-18
three O 0 2.0580596688662967e-15
unrelated O 0 1.6330065555000828e-12
Turkish O 0 6.40353800918092e-06
A B-Disease 1 1.0
- I-Disease 1 0.999997615814209
T I-Disease 1 1.0
individuals O 0 3.780792207628593e-14
, O 0 5.004398554353442e-15
was O 0 4.29835102244442e-14
previously O 0 2.2828749185617968e-15
described O 0 6.378904540609649e-16
to O 0 6.446957020476632e-17
be O 0 3.319851669045644e-16
a O 0 1.338107667611622e-14
Turkish O 0 3.4296755302420934e-07
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999871253967285
T I-Disease 1 0.9999990463256836
founder O 0 1.969115287492329e-10
mutation O 0 1.1619608747404087e-10
. O 0 5.457461739466485e-14

The O 0 3.1385763671169797e-13
presence O 0 3.642173910557711e-13
of O 0 3.3300587469323035e-18
a O 0 4.732864355419183e-16
founder O 0 1.8422957116012023e-13
mutation O 0 7.398371195191378e-13
among O 0 9.163039468816348e-18
relatively O 0 1.90659874295244e-15
small O 0 3.3205372892768873e-15
ethnic O 0 5.051839589015339e-12
population O 0 9.94484442712329e-15
groups O 0 3.885299630292685e-16
in O 0 5.2798888868423003e-17
Western O 0 4.13071868377024e-11
Europe O 0 1.6699474919210089e-12
could O 0 3.0705029041263113e-15
indicate O 0 2.071503643456219e-16
a O 0 5.806852878068062e-19
high O 0 7.892708423616612e-18
carrier O 0 7.067509239502893e-17
frequency O 0 1.0557553121057976e-15
in O 0 4.567132499295978e-17
such O 0 7.0404196964816024e-15
communities O 0 4.413754084442445e-12
. O 0 1.4770159921517756e-12

In O 0 3.5580217157965555e-12
patients O 0 6.300312355156379e-11
of O 0 1.2981045441648782e-17
Dutch O 0 8.639103654672908e-09
ethnic O 0 2.958149350473782e-12
origin O 0 4.743153095222892e-14
, O 0 1.589327051855407e-14
however O 0 1.1102742701184654e-14
, O 0 2.8527135280304896e-16
no O 0 2.4800893879127787e-15
significant O 0 1.0108766478240678e-16
founder O 0 8.050850974382004e-14
effect O 0 2.1703906033510023e-13
could O 0 3.7484130382958725e-12
be O 0 3.2095967254937817e-15
identified O 0 3.5592841608061976e-12
. O 0 2.351828584309934e-13

The O 0 3.4052421256022813e-13
observed O 0 8.437223359206159e-13
genetic O 0 5.47861560805385e-13
heterogeneity O 0 9.841782879112249e-14
including O 0 3.2277562648499666e-15
the O 0 1.1003656787014846e-14
relative O 0 2.019712869172352e-11
high O 0 4.804598559282613e-13
percentage O 0 6.263222904721866e-13
of O 0 3.92519038224583e-18
splice O 0 6.82452210298834e-08
- O 0 9.374381271243237e-10
site O 0 1.8036483764860556e-11
mutations O 0 1.3690860667381344e-09
had O 0 4.285355924282808e-12
no O 0 5.074504506782365e-16
reflection O 0 1.6383005539838278e-16
on O 0 2.0168599863118475e-15
the O 0 1.8128256311860476e-15
phenotype O 0 1.8364397502690366e-10
. O 0 4.3297112314703845e-13

All O 0 3.1974911000182127e-12
patients O 0 2.4279883659161783e-13
manifested O 0 2.6072805752504896e-14
classical O 0 1.8158548276137054e-10
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.999997615814209
T I-Disease 1 1.0
and O 0 1.0350613421916677e-10
increased O 0 5.379232758014052e-13
cellular O 0 1.2489980404095657e-11
radioresistant O 0 1.0973540826020312e-10
DNA O 0 6.08453001524345e-12
synthesis O 0 2.643319319938636e-13
. O 0 1.5719925903524834e-13

Determination O 0 3.6805039571596865e-10
of O 0 1.1062436406778987e-17
the O 0 4.002060276570383e-17
genomic O 0 9.589889646277605e-12
structure O 0 5.181906878419518e-13
of O 0 4.989596364914139e-19
the O 0 3.272385067647146e-17
COL4A4 O 0 5.100698335924747e-11
gene O 0 2.364410100000325e-12
and O 0 1.5500065542460887e-15
of O 0 1.1234887020884042e-17
novel O 0 2.9355586850243753e-09
mutations O 0 0.00022375702974386513
causing O 0 1.1094923138443846e-05
autosomal B-Disease 1 0.9999951124191284
recessive I-Disease 1 0.9999974966049194
Alport I-Disease 1 0.9999994039535522
syndrome I-Disease 1 0.9999996423721313
. O 0 1.0127296334871971e-08

Autosomal B-Disease 1 0.9999953508377075
recessive I-Disease 1 0.9999926090240479
Alport I-Disease 1 0.9999983310699463
syndrome I-Disease 1 0.9999990463256836
is O 0 1.6027597001325167e-12
a O 0 3.5986582637426157e-12
progressive O 0 4.4126605303063116e-07
hematuric B-Disease 1 0.9994698166847229
glomerulonephritis I-Disease 1 1.0
characterized O 0 9.068574581760913e-05
by O 0 3.7273240049984224e-12
glomerular B-Disease 1 0.9977353811264038
basement I-Disease 1 0.5460959076881409
membrane I-Disease 0 0.22555610537528992
abnormalities I-Disease 1 0.9996641874313354
and O 0 3.1195139245203396e-13
associated O 0 5.3899467354623365e-12
with O 0 3.174226831902105e-14
mutations O 0 1.0248446535854328e-09
in O 0 3.309963088782042e-16
either O 0 1.0398643345054318e-13
the O 0 5.915908496585687e-15
COL4A3 O 0 1.7559741438688548e-09
or O 0 2.2494037763763327e-15
the O 0 1.2607370735831015e-16
COL4A4 O 0 7.12011005710167e-11
gene O 0 8.513361998870039e-13
, O 0 1.433597439876391e-16
which O 0 2.1785224182237575e-18
encode O 0 2.1955869027978202e-15
the O 0 5.488336429207083e-15
alpha3 O 0 3.231603873388167e-09
and O 0 7.177862904744758e-13
alpha4 O 0 3.072476317811379e-08
type O 0 1.3652062307301094e-06
IV O 0 6.02682304062796e-09
collagen O 0 7.689380367992271e-07
chains O 0 6.85808299749624e-06
, O 0 1.0138122112646197e-11
respectively O 0 2.2860331249513477e-12
. O 0 5.92186716330545e-12

To O 0 4.512598519683386e-13
date O 0 5.4213574683095386e-14
, O 0 2.624165774713354e-16
mutation O 0 3.757096376225859e-15
screening O 0 3.1027209881212547e-13
in O 0 4.733906669165449e-18
the O 0 1.0739074134539145e-16
two O 0 3.5606097199348055e-15
genes O 0 8.612306180710849e-12
has O 0 1.139892347179483e-11
been O 0 1.8608896433340572e-13
hampered O 0 9.397004008260268e-11
by O 0 1.4028584818716344e-16
the O 0 6.503252683035725e-16
lack O 0 1.1529886169891947e-14
of O 0 5.513903245217227e-20
genomic O 0 7.845218225055461e-11
structure O 0 1.4764927128152472e-11
information O 0 4.918142173897244e-13
. O 0 2.0019045015445824e-12

We O 0 2.514689612098664e-08
report O 0 3.674171969274276e-13
here O 0 8.649492822755049e-16
the O 0 3.79425058641083e-18
complete O 0 2.298892417473494e-16
characterization O 0 1.4423847587239497e-13
of O 0 1.0693686527533207e-18
the O 0 1.9138045051742914e-16
48 O 0 5.91837234602266e-14
exons O 0 3.5542892956076655e-13
of O 0 6.028232569574124e-18
the O 0 6.361165553111776e-16
COL4A4 O 0 1.5321341972907021e-09
gene O 0 8.239547932831215e-12
, O 0 2.104341919681186e-16
a O 0 1.2598476889884845e-16
comprehensive O 0 1.9742784542072477e-14
gene O 0 1.5786405169193607e-11
screen O 0 5.528401070264977e-10
, O 0 1.0279892171879967e-12
and O 0 1.6408478308721497e-14
the O 0 2.609998354577138e-17
subsequent O 0 3.9177891671714e-16
detection O 0 9.443502566302414e-15
of O 0 1.0449270553901185e-19
10 O 0 6.324050157549869e-16
novel O 0 1.4576316228250702e-13
mutations O 0 1.9233062364953923e-10
in O 0 6.797619819733525e-15
eight O 0 3.166733195114624e-11
patients O 0 5.0274055751753366e-12
diagnosed O 0 6.782048700415544e-09
with O 0 4.76813477590099e-10
autosomal B-Disease 1 0.9999980926513672
recessive I-Disease 1 0.9999978542327881
Alport I-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999997615814209
. O 0 5.51679546489936e-09

Furthermore O 0 2.788681952026195e-09
, O 0 1.0168148739447477e-13
we O 0 8.398556643977179e-14
identified O 0 6.056867378623893e-16
a O 0 1.9354605651038788e-18
glycine O 0 1.8373247886359573e-15
to O 0 1.7635616804673964e-18
alanine O 0 2.946776462707697e-14
substitution O 0 4.338980270660541e-16
in O 0 5.483599069886041e-18
the O 0 4.3050148450456845e-17
collagenous O 0 1.6453671758398514e-10
domain O 0 3.5358586718270413e-12
that O 0 4.0425507993185894e-14
is O 0 2.252726898386648e-15
apparently O 0 7.566656177494802e-13
silent O 0 1.7681678603914674e-12
in O 0 3.029580426338741e-17
the O 0 2.2077207357940218e-17
heterozygous O 0 3.316716069541939e-14
carriers O 0 1.6934119850733204e-14
, O 0 8.879640144853515e-16
in O 0 9.238508946363849e-16
11 O 0 2.2938426331997608e-12
. O 0 3.2091836783473826e-13

5 O 0 4.272711470656304e-13
% O 0 3.9618526813554056e-17
of O 0 4.7436274889290194e-20
all O 0 1.196148826121491e-16
control O 0 4.929610053494571e-09
individuals O 0 1.8242571084328528e-16
, O 0 1.6779023035893258e-14
and O 0 2.2718095850707276e-13
in O 0 5.769238283142382e-16
one O 0 4.6886987022966287e-14
control O 0 1.3591522352029983e-09
individual O 0 1.853568934828699e-19
homozygous O 0 1.2709783967471205e-17
for O 0 5.1075094102699247e-20
this O 0 2.702974158531619e-18
glycine O 0 2.0848053101582553e-13
substitution O 0 7.242246217878737e-14
. O 0 8.854179732063414e-14

There O 0 3.5155806044073756e-10
has O 0 3.149275978886479e-12
been O 0 3.315729106751798e-14
no O 0 4.5187025779144796e-14
previous O 0 8.765316107962602e-16
finding O 0 1.0131654731226143e-17
of O 0 2.2707423003481794e-22
a O 0 1.618945745673539e-19
glycine O 0 4.90458916816756e-16
substitution O 0 3.3578430819634697e-17
that O 0 9.574732057331543e-17
is O 0 3.097215676304752e-17
not O 0 8.412399830489098e-16
associated O 0 1.7800773469177703e-14
with O 0 1.6421242459961909e-15
any O 0 2.3794106875779653e-13
obvious O 0 3.476052778950134e-11
phenotype O 0 4.087518518103295e-11
in O 0 2.6522340643051975e-16
homozygous O 0 6.9067186865556796e-12
individuals O 0 1.3348371039956838e-14
. O 0 9.337801799153e-13

Founder O 0 4.192700409078043e-09
BRCA1 O 0 5.554830408982525e-07
and O 0 7.85849857409815e-12
BRCA2 O 0 3.3563840595718375e-09
mutations O 0 1.643789410143981e-10
in O 0 1.6936186611124504e-14
French O 0 2.9212569074843486e-07
Canadian O 0 9.974999557016417e-05
breast B-Disease 1 0.9999988079071045
and I-Disease 1 0.9999958276748657
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.8038812631127055e-12
. O 0 2.7089989322950925e-13

We O 0 8.247086902279932e-10
have O 0 4.468629462907889e-15
identified O 0 5.655409866404731e-15
four O 0 5.2632781075255005e-17
mutations O 0 2.2343785553865202e-14
in O 0 1.1349982999266202e-18
each O 0 6.010662943170768e-19
of O 0 1.0176276162189703e-17
the O 0 2.5299654732302557e-11
breast B-Disease 0 0.00027860543923452497
cancer I-Disease 0 6.849259989394341e-06
- O 0 1.6945802983059366e-08
susceptibility O 0 4.889915885541996e-07
genes O 0 3.106943591291156e-09
, O 0 1.958355081831814e-13
BRCA1 O 0 5.1568931347389935e-09
and O 0 7.399899269733279e-12
BRCA2 O 0 2.654418074232723e-10
, O 0 5.383167971443042e-15
in O 0 5.346616805703124e-15
French O 0 3.604000653467665e-09
Canadian O 0 2.371772644949033e-08
breast B-Disease 0 0.09345582127571106
cancer I-Disease 0 0.05189356207847595
and O 0 1.8388640455668792e-05
breast B-Disease 1 0.9999961853027344
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.234713964100645e-13
from O 0 1.2106233221708665e-15
Quebec O 0 3.058111630593885e-08
. O 0 1.616582562258273e-11

To O 0 2.410427760168865e-12
identify O 0 2.1672394781568904e-12
founder O 0 1.7819712719302494e-12
effects O 0 3.663500613981796e-09
, O 0 1.3706907787611189e-12
we O 0 6.5239888144552616e-12
examined O 0 8.037755357126475e-12
independently O 0 3.4125003170459856e-12
ascertained O 0 6.761843307501181e-10
French O 0 7.655219236291089e-10
Canadian O 0 2.1255818286047834e-11
cancer B-Disease 0 1.6290588433776065e-08
families O 0 1.089974073363777e-17
for O 0 7.253919668988002e-20
the O 0 2.347784457862574e-18
distribution O 0 3.93519606481439e-15
of O 0 3.0821264026669243e-19
these O 0 5.788593515382735e-16
eight O 0 4.443796066256993e-14
mutations O 0 1.5295835778528222e-11
. O 0 5.67668362403545e-13

Mutations O 0 1.0603808675568871e-07
were O 0 2.531351694825667e-14
found O 0 8.334212124952185e-15
in O 0 2.851787218093328e-17
41 O 0 9.259657927571108e-13
of O 0 2.817239440783622e-18
97 O 0 6.291965559679369e-11
families O 0 5.4765443753285875e-14
. O 0 4.4264396835413944e-13

Six O 0 3.826852029709116e-12
of O 0 8.678369532503153e-18
eight O 0 5.317854954946157e-15
mutations O 0 4.041527583518306e-13
were O 0 2.115933168517667e-16
observed O 0 4.0763013353217054e-14
at O 0 6.714739170503997e-14
least O 0 1.2487110141474328e-13
twice O 0 4.327959379768487e-10
. O 0 7.742495013174366e-12

The O 0 3.6160382414079928e-12
BRCA1 O 0 7.785952438332799e-10
C4446T O 0 3.748786697732598e-11
mutation O 0 3.2821198016341757e-12
was O 0 6.081944741939422e-15
the O 0 1.3019869370494112e-18
most O 0 4.680558069149148e-18
common O 0 1.5405748423784121e-15
mutation O 0 1.1124539738829528e-13
found O 0 3.090304840367222e-14
, O 0 5.02750953068192e-16
followed O 0 1.9076753218284e-15
by O 0 4.3267141086186656e-17
the O 0 8.454617350184615e-14
BRCA2 O 0 1.571331154082145e-08
8765delAG O 0 3.3672207244705987e-09
mutation O 0 9.668612438451518e-11
. O 0 2.5719419541152255e-13

Together O 0 4.7116106155487e-11
, O 0 8.217280920649623e-15
these O 0 4.4908743877524694e-17
mutations O 0 2.595685981692658e-13
were O 0 5.638325105979493e-16
found O 0 9.369803246001354e-14
in O 0 1.235951936634375e-15
28 O 0 1.759374113410872e-12
of O 0 1.1460928598924877e-18
41 O 0 6.329275645255983e-12
families O 0 4.912319601125787e-17
identified O 0 1.0552968343472725e-14
to O 0 1.0005489339168737e-16
have O 0 1.1803804766572727e-14
a O 0 1.27647577160021e-14
mutation O 0 1.1181903493417966e-11
. O 0 2.4034620864712974e-13

The O 0 9.023269192378822e-14
odds O 0 1.7931578531055203e-12
of O 0 5.676750550904483e-20
detection O 0 7.596263468777082e-15
of O 0 1.4736893081292753e-20
any O 0 8.226806838462902e-17
of O 0 3.789446476509487e-19
the O 0 4.566211152442492e-16
four O 0 8.17404327682408e-15
BRCA1 O 0 2.399740475778067e-11
mutations O 0 1.923165966755125e-11
was O 0 2.420406540123987e-12
18 O 0 2.2475317234486175e-13
. O 0 2.7419201891615286e-13

7x O 0 2.980132585150841e-09
greater O 0 2.5042153680571166e-13
if O 0 3.879677612159127e-13
one O 0 4.4468247040283055e-17
or O 0 6.940597068788475e-18
more O 0 5.3214795280414666e-18
cases O 0 4.666467949901443e-13
of O 0 5.217056387590846e-12
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 3.9910078280386285e-13
also O 0 5.357160461766375e-12
present O 0 4.638720349101012e-16
in O 0 4.848040189817679e-16
the O 0 1.2186166450391632e-14
family O 0 9.667279129987882e-12
. O 0 5.476818542952955e-13

The O 0 3.2587328018321426e-13
odds O 0 1.3901213079953179e-12
of O 0 8.314946825649185e-20
detection O 0 6.3401648534922635e-15
of O 0 1.3694962164554182e-20
any O 0 1.2419678822631302e-16
of O 0 1.9743122044997288e-18
the O 0 2.0062629688669857e-15
four O 0 7.622188606193694e-14
BRCA2 O 0 3.6239112405356266e-11
mutations O 0 4.5142820037646914e-11
was O 0 2.430463816316397e-12
5 O 0 2.659187702935134e-13
. O 0 2.2635495908196468e-12

3x O 0 2.9226363551515533e-09
greater O 0 2.986191751774142e-13
if O 0 7.147588185381359e-13
there O 0 1.5456312055570466e-15
were O 0 1.408811138257362e-16
at O 0 1.6358961715537076e-16
least O 0 2.819508976230284e-17
five O 0 9.5628325679116e-17
cases O 0 1.4899046961989494e-15
of O 0 1.933920214182601e-16
breast B-Disease 0 0.0010184112470597029
cancer I-Disease 0 1.0689554073906038e-05
in O 0 3.0485730093636606e-15
the O 0 8.102673805347738e-14
family O 0 1.0585602706891795e-11
. O 0 9.210002552273444e-13

Interestingly O 0 6.176158473536475e-10
, O 0 9.49870878567266e-15
the O 0 1.9061675767125078e-17
presence O 0 3.652284519332612e-15
of O 0 4.652130353037538e-18
a O 0 1.106275986616223e-12
breast B-Disease 0 1.559182436494666e-07
cancer I-Disease 0 1.0137571893054087e-09
case O 0 5.777125536309859e-15
< O 0 2.71447117171017e-13
36 O 0 1.8087830224496754e-13
years O 0 6.639867450724819e-17
of O 0 3.846963446427596e-19
age O 0 2.511882303719848e-14
was O 0 1.4747504297396227e-15
strongly O 0 4.0047347169268896e-16
predictive O 0 6.542237861477049e-14
of O 0 5.925879515323497e-19
the O 0 9.667839672516634e-18
presence O 0 2.718344085865889e-15
of O 0 4.5652963961505364e-20
any O 0 2.97107361074062e-17
of O 0 7.35068946089905e-20
the O 0 2.938185240457757e-17
eight O 0 9.333233276130008e-15
mutations O 0 8.421311391282327e-12
screened O 0 2.5180384444212223e-09
. O 0 6.013023412521079e-12

Carriers O 0 1.704025635873574e-11
of O 0 2.546173594820914e-18
the O 0 2.4769385775502254e-17
same O 0 7.02080728386264e-17
mutation O 0 1.0344705388115995e-15
, O 0 3.2237029656975323e-18
from O 0 1.3723261111908872e-19
different O 0 1.6009477244988932e-16
families O 0 6.416854793020194e-16
, O 0 1.7900933844641103e-15
shared O 0 1.118803044864369e-14
similar O 0 1.0162010969305083e-15
haplotypes O 0 4.291201996606958e-13
, O 0 1.3982264027902354e-16
indicating O 0 1.5408451517677046e-15
that O 0 9.870078549404826e-17
the O 0 1.926202346097879e-18
mutant O 0 1.9292027488861628e-14
alleles O 0 4.775391762118454e-16
were O 0 1.2372256624288086e-15
likely O 0 5.605237563840017e-15
to O 0 5.589903408758517e-16
be O 0 8.79281524435345e-15
identical O 0 4.79373322721105e-13
by O 0 7.728315375858435e-16
descent O 0 3.1440645985141014e-13
for O 0 2.7608013211794354e-17
a O 0 6.324382342695958e-14
mutation O 0 2.4039964463540286e-11
in O 0 3.7056820586626744e-16
the O 0 5.271579427455287e-16
founder O 0 2.292246253920993e-12
population O 0 2.6126819349485408e-14
. O 0 2.7084825810104463e-13

The O 0 5.15838935592251e-16
identification O 0 1.8294000542605645e-16
of O 0 3.772513313888702e-19
common O 0 1.7394489033829494e-14
BRCA1 O 0 5.35226618580964e-09
and O 0 4.8700363186604534e-11
BRCA2 O 0 6.560985976733491e-09
mutations O 0 1.8442744553759383e-10
will O 0 1.3267723974257572e-15
facilitate O 0 2.6847262481618725e-16
carrier O 0 2.3170577801811913e-14
detection O 0 2.7688647815521383e-13
in O 0 8.923648800419296e-16
French O 0 5.943591396828651e-09
Canadian O 0 8.723088029682913e-08
breast B-Disease 0 0.18414686620235443
cancer I-Disease 0 0.1191135123372078
and O 0 7.2718299634289e-05
breast B-Disease 1 0.9999972581863403
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 8.296571762933524e-12
. O 0 1.9528133450574803e-12

Are O 0 3.7344276976325474e-11
Dp71 O 0 1.4113174984231591e-06
and O 0 7.609910618322502e-11
Dp140 O 0 4.508996553909128e-08
brain O 0 7.460221329580463e-10
dystrophin O 0 1.8260311318574196e-10
isoforms O 0 3.652789876129603e-13
related O 0 4.3797628826620916e-13
to O 0 5.657721673427672e-14
cognitive B-Disease 0 9.255173516464765e-09
impairment I-Disease 0 3.244479407360501e-10
in O 0 4.455240863732168e-12
Duchenne B-Disease 1 0.9404857158660889
muscular I-Disease 1 0.5007039308547974
dystrophy I-Disease 1 0.9919946193695068
? O 0 6.283256084316236e-07

Molecular O 0 3.565201023292275e-09
study O 0 1.5022857090263297e-12
and O 0 5.140928830506047e-15
neuropsychological O 0 4.79956081388816e-13
analysis O 0 1.4274317811742085e-15
were O 0 8.341805457686964e-17
performed O 0 6.413435998638486e-14
concurrently O 0 3.31175516697646e-13
on O 0 9.809254103432252e-13
49 O 0 1.3224187966898171e-08
patients O 0 1.9370364687243402e-12
with O 0 5.979464970037873e-13
Duchenne B-Disease 0 0.0009184048976749182
muscular I-Disease 0 8.026395335036796e-06
dystrophy I-Disease 0 9.841665450949222e-05
( O 0 1.3599332163855005e-12
DMD B-Disease 1 1.0
) O 0 1.631954120451251e-12
in O 0 2.024830989861984e-15
order O 0 1.658060760087801e-13
to O 0 1.6506657262363032e-15
find O 0 3.5279042955336593e-15
a O 0 9.024971444052672e-18
molecular O 0 1.895604467055316e-15
explanation O 0 8.775218981907189e-16
for O 0 4.610665029701174e-18
the O 0 1.006990460662065e-14
cognitive B-Disease 0 2.1334638500292158e-09
impairment I-Disease 0 6.491340668116075e-13
observed O 0 8.509103930362874e-14
in O 0 5.6853685747161684e-15
most O 0 3.2114894077395206e-11
DMD B-Disease 1 1.0
patients O 0 7.482557862203976e-07
. O 0 1.2421813794585845e-12

Complete O 0 2.1620384302312168e-11
analysis O 0 4.665326352776451e-14
of O 0 1.0501223312483197e-18
the O 0 2.1980149293585696e-17
dystrophin O 0 5.613508616275631e-11
gene O 0 1.659641174489579e-11
was O 0 2.0640163433645678e-14
performed O 0 7.553412071975487e-15
to O 0 9.837859202801396e-18
define O 0 3.2640997381112175e-14
the O 0 5.881497677224362e-17
localization O 0 5.959419732053193e-15
of O 0 2.7611565435537386e-19
deletions O 0 8.588168509682248e-10
and O 0 1.1007577661870105e-11
duplications O 0 6.511791106333931e-09
in O 0 5.120104949014274e-15
relation O 0 6.937382119502969e-14
to O 0 6.362281519019784e-16
the O 0 4.522733480655521e-16
different O 0 4.5013973559888953e-13
DMD B-Disease 1 0.999998927116394
promoters O 0 2.351830197255822e-08
. O 0 6.987440574063308e-12

Qualitative O 0 1.2685900940834216e-10
analysis O 0 3.220982237438913e-13
of O 0 5.248379095768318e-18
the O 0 2.307661061362148e-16
Dp71 O 0 1.6049944706608699e-10
transcript O 0 1.139316332249285e-11
and O 0 5.883051665045219e-15
testing O 0 1.1773315815636308e-14
for O 0 6.716841475456265e-21
the O 0 8.636880350175995e-20
specific O 0 1.1209667317983066e-18
first O 0 8.289112398306111e-18
exon O 0 3.4391807706823235e-15
of O 0 2.016110881622952e-18
Dp140 O 0 2.381256303252144e-11
were O 0 8.383672581028026e-14
also O 0 7.528722653984965e-13
carried O 0 2.757983598444813e-11
out O 0 1.2891764912537074e-11
. O 0 1.066507993030541e-12

Neuropsychological O 0 2.7678526137719928e-08
analysis O 0 5.64332868630002e-12
assessed O 0 3.808500552687083e-13
verbal O 0 1.0048858273270511e-10
and O 0 2.3996833708496423e-13
visuospatial O 0 2.7727931950494167e-08
intelligence O 0 2.0685161916667028e-11
, O 0 1.221933930992472e-13
verbal O 0 4.448908255683115e-11
memory O 0 5.080951215319374e-10
, O 0 1.3165202435161394e-11
and O 0 4.420097534513223e-12
reading O 0 1.552974762675241e-11
skills O 0 3.270400339427937e-10
. O 0 3.8886268879413655e-13

Comparison O 0 1.3731650538861828e-10
of O 0 4.536796808383453e-17
molecular O 0 1.0732379611758103e-12
and O 0 1.9270440007167905e-14
psychometric O 0 9.576117676601825e-10
findings O 0 1.1988413733954317e-13
demonstrated O 0 3.152829000885272e-15
that O 0 3.7660180022057213e-17
deletions O 0 1.881560011962602e-11
and O 0 3.0996496466545106e-14
duplications O 0 3.434599132878802e-11
that O 0 1.7047681896784767e-13
were O 0 2.951972925135807e-15
localized O 0 4.9064072249471735e-11
in O 0 6.872689808749832e-14
the O 0 6.193862358227185e-15
distal O 0 9.887735161889788e-13
part O 0 1.7736719143640438e-14
of O 0 4.0857738496928935e-18
the O 0 9.282910016412225e-17
gene O 0 1.7646336865698165e-12
seemed O 0 1.6291968926826668e-14
to O 0 1.8294272188718807e-17
be O 0 3.518935844513682e-17
preferentially O 0 3.808193384659091e-14
associated O 0 5.585417545139748e-12
with O 0 3.3520157136091022e-12
cognitive B-Disease 0 8.310809107570094e-07
impairment I-Disease 0 4.41949721263768e-09
. O 0 3.373682626664487e-12

Two O 0 2.020158779841852e-12
altered O 0 4.6085213423197047e-10
Dp71 O 0 3.644112789302767e-09
transcripts O 0 3.57789492477778e-11
and O 0 9.398651324712352e-15
two O 0 5.381684380001036e-17
deleted O 0 1.4559986246179268e-12
Dp140 O 0 5.35930349578051e-13
DNA O 0 1.2537685733365889e-12
sequences O 0 6.517726760862583e-14
were O 0 3.588109650419041e-16
found O 0 5.50662344702183e-15
in O 0 1.1141893887495728e-16
four O 0 6.966394014385965e-14
patients O 0 5.6089942396643847e-14
with O 0 3.4272007432521734e-13
severe O 0 1.4942442248866428e-05
cerebral B-Disease 0 0.055196668952703476
dysfunction I-Disease 0 4.692391667049378e-05
. O 0 3.3180243275143795e-11

These O 0 2.3768389600248296e-13
findings O 0 2.6610585276650757e-14
suggest O 0 5.115926535485468e-15
that O 0 6.3791407833925946e-18
some O 0 4.005357004901713e-18
sequences O 0 1.5454861782698837e-12
located O 0 1.4621516887872166e-12
in O 0 3.390499510802573e-16
the O 0 1.0646766733878637e-16
distal O 0 5.094856760329107e-14
part O 0 3.976801476150574e-15
of O 0 7.119021374482235e-19
the O 0 1.299071137797871e-16
gene O 0 9.064505222811103e-12
and O 0 7.72670162986315e-14
, O 0 2.281045697972642e-16
in O 0 5.439389161277225e-18
particular O 0 6.714527052278181e-16
, O 0 5.276606965043935e-17
some O 0 4.188625040380206e-16
DMD B-Disease 1 0.9999991655349731
isoforms O 0 2.678047453935628e-12
expressed O 0 6.951812744539633e-16
in O 0 2.6101475779596425e-17
the O 0 9.449263449134927e-16
brain O 0 3.296540540542736e-10
may O 0 1.7126340213827174e-15
be O 0 5.237918569741972e-18
related O 0 2.8769198767784453e-16
to O 0 9.741525179563209e-15
the O 0 1.6680397568833577e-13
cognitive B-Disease 0 1.5249920437554465e-08
impairment I-Disease 0 1.1486480169797808e-12
associated O 0 4.451545902728338e-12
with O 0 1.0302573377751756e-10
DMD B-Disease 1 1.0
. O 0 7.175159771888318e-11
. O 0 4.774636415405542e-12

I1307K O 0 3.99401827166912e-08
APC O 0 8.919557870079586e-10
and O 0 4.275444581702814e-12
hMLH1 O 0 4.1284565099886095e-08
mutations O 0 1.2451869757512668e-08
in O 0 7.903502435778714e-16
a O 0 1.8355254788977524e-14
non O 0 6.440207660782585e-14
- O 0 2.8243957173046397e-10
Jewish O 0 2.020313950856778e-11
family O 0 5.18420289336019e-12
with O 0 1.5215068178346496e-14
hereditary B-Disease 0 3.9499150261690374e-06
non I-Disease 0 3.566227757545448e-09
- I-Disease 1 0.9907037615776062
polyposis I-Disease 1 0.9999648332595825
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.2015953776998174e-10

We O 0 5.072274822381928e-10
describe O 0 8.216035273997391e-13
a O 0 1.2225774049818422e-13
French O 0 3.8411887559597346e-10
Canadian O 0 4.323132685168929e-10
hereditary B-Disease 1 0.9004430174827576
non I-Disease 0 7.482439104933292e-05
- I-Disease 1 0.9999960660934448
polyposis I-Disease 1 0.9999994039535522
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.505061254600484e-11
HNPCC B-Disease 0 1.9246424471930368e-06
) O 0 4.774813831538542e-14
kindred O 0 2.293091411198489e-11
which O 0 3.3051212049335643e-14
carries O 0 1.4593118651418796e-13
a O 0 1.446486126135873e-14
novel O 0 1.6257972398903142e-11
truncating O 0 5.3011849132644784e-08
mutation O 0 2.3002777460590096e-09
in O 0 6.118786439980248e-14
hMLH1 O 0 2.6001083597293473e-07
. O 0 2.5167874728726503e-11

Interestingly O 0 1.4031945050341221e-10
, O 0 1.355363931032855e-14
the O 0 2.5340832913772673e-16
I1307K O 0 3.068784918021372e-13
APC O 0 9.747361236569791e-15
polymorphism O 0 1.8609499520799017e-13
, O 0 5.98581971084608e-17
associated O 0 1.9619047004522253e-15
with O 0 2.3148985277625176e-17
an O 0 2.52817282120278e-17
increased O 0 1.6050005768875053e-10
risk O 0 4.722918944821686e-08
of O 0 5.7040188544688064e-11
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.2868434034449547e-13
is O 0 8.998132642636103e-16
also O 0 1.656568626847918e-13
present O 0 1.6357652784935772e-16
in O 0 1.1325600775376405e-16
this O 0 8.18602540489594e-15
family O 0 7.905765452009827e-12
. O 0 1.0980166428864457e-12

The O 0 1.135945450116832e-13
I1307K O 0 2.8630228396386848e-11
polymorphism O 0 1.8713178229212701e-10
has O 0 2.441158820226663e-12
previously O 0 8.794223860144734e-15
only O 0 3.402927337023366e-15
been O 0 1.5376870105996907e-14
identified O 0 6.522321745194848e-12
in O 0 5.826587707627418e-16
individuals O 0 7.007188582257567e-17
of O 0 1.1291256898087693e-17
self O 0 3.041090268496305e-09
- O 0 7.790965383946968e-08
reported O 0 7.643864013973101e-11
Ashkenazi O 0 1.488971029806052e-10
Jewish O 0 4.33546292399542e-13
origins O 0 1.3621761054197212e-12
. O 0 1.360809522791412e-13

In O 0 2.1096568502548818e-14
addition O 0 3.3819884708090027e-15
, O 0 4.5544364415635915e-15
in O 0 2.7549730065833867e-17
this O 0 6.496607709564515e-16
family O 0 2.5756222106270918e-14
, O 0 3.090855517662056e-16
there O 0 4.499776770202561e-16
appears O 0 1.2506552427525835e-14
to O 0 1.684820926936014e-16
be O 0 4.9303094294900554e-15
no O 0 3.286282175747092e-14
relationship O 0 3.760867790423509e-15
between O 0 2.2861406011503765e-17
the O 0 1.048273272386534e-18
I1307K O 0 6.779311626095097e-15
polymorphism O 0 3.9868363601799905e-14
and O 0 3.6265016834511384e-16
the O 0 1.2740608852997994e-17
presence O 0 1.9215030499890318e-13
or O 0 4.1355214744224e-14
absence O 0 6.683205150317256e-14
of O 0 8.73716470326281e-18
cancer B-Disease 0 5.7473744513591996e-11
. O 0 1.5593888205654694e-15
. O 0 1.2365335263966187e-13

Identification O 0 4.879499148485733e-12
of O 0 6.936441726981315e-18
a O 0 7.775006478889053e-16
novel O 0 7.01038077415006e-14
mutation O 0 5.069288630359103e-13
of O 0 7.283647893968304e-19
the O 0 1.5174304082485172e-16
CPO O 0 6.018767151338977e-10
gene O 0 7.52007310589331e-12
in O 0 8.122932144116453e-17
a O 0 3.224865849620756e-14
Japanese O 0 7.885220476566701e-09
hereditary B-Disease 0 1.9491502825985663e-05
coproporphyria I-Disease 0 1.7890077970150742e-06
family O 0 1.0517948734189986e-09
. O 0 3.2908456775587736e-12

Hereditary B-Disease 1 0.9954480528831482
coproporphyria I-Disease 0 0.00022636960784438998
( O 0 2.420000397990174e-12
HCP B-Disease 0 9.168486059252245e-08
) O 0 3.9133274528854733e-14
is O 0 2.3689126289923312e-14
an O 0 2.993822366664095e-13
autosomal B-Disease 1 0.9999973773956299
dominant I-Disease 1 0.9999992847442627
disease I-Disease 1 0.9999996423721313
characterized O 0 1.1576410940961068e-09
by O 0 1.9723287537692577e-14
a O 0 1.1762032459117222e-09
deficiency B-Disease 0 0.0011714190477505326
of I-Disease 0 4.7515103133714966e-18
coproporphyrinogen I-Disease 0 3.95056680702055e-08
oxidase I-Disease 0 4.917596330145102e-10
( O 0 9.368900139472992e-16
CPO O 0 2.0466500716409541e-10
) O 0 2.3883277146983194e-16
caused O 0 1.5278747480046363e-15
by O 0 1.7279741991662572e-18
a O 0 4.971746281269736e-15
mutation O 0 2.986922558248506e-12
in O 0 1.0528509684785606e-16
the O 0 1.6088399804547147e-15
CPO O 0 4.620211768724403e-09
gene O 0 1.9552005847689458e-10
. O 0 1.248878279437593e-12

Only O 0 6.242287242663735e-11
11 O 0 1.3963228360017177e-13
mutations O 0 9.304945052315827e-13
of O 0 1.313925996721907e-19
the O 0 3.728452421867238e-17
gene O 0 7.114106612832183e-12
have O 0 1.7767674809730793e-13
been O 0 3.356733971728379e-14
reported O 0 6.058540171285931e-13
in O 0 2.4849205673823857e-14
HCP B-Disease 0 0.0022606386337429285
patients O 0 7.352238262647859e-11
. O 0 2.018378275929142e-13

We O 0 2.1801158656131747e-09
report O 0 3.68066512056002e-14
another O 0 2.8276643815000157e-16
mutation O 0 4.0951444302663245e-14
in O 0 1.3210640174010838e-17
a O 0 2.1563766465265873e-14
Japanese O 0 4.399463460202924e-09
family O 0 2.052904374272302e-11
. O 0 1.8069494468406222e-12

Polymerase O 0 1.2355982015321842e-08
chain O 0 1.3612502791637837e-10
reaction O 0 5.070100697786295e-13
- O 0 7.295909536242373e-12
single O 0 1.125820035206013e-14
strand O 0 2.7487337492942965e-12
conformational O 0 1.0867373420966366e-14
polymorphism O 0 5.6778292191559526e-14
and O 0 2.354271166867184e-16
direct O 0 8.868672126977756e-16
sequence O 0 3.877267864410561e-12
analyses O 0 2.9967304679412443e-13
demonstrated O 0 3.548174429236165e-16
a O 0 5.104770449825639e-17
C O 0 4.300542940424007e-13
to O 0 1.1130126746973794e-16
T O 0 2.58342826298108e-12
substitution O 0 1.2922604635063543e-16
in O 0 4.212510068751264e-19
exon O 0 9.30504232557949e-15
1 O 0 1.213401431419183e-16
of O 0 1.1927980622166458e-19
the O 0 3.861729416523007e-17
CPO O 0 6.151674655785477e-12
gene O 0 5.704184141090002e-14
at O 0 2.9205865427917727e-16
nucleotide O 0 9.23016461304221e-15
position O 0 1.8589632871240935e-13
85 O 0 2.9841363755056527e-13
, O 0 7.965163766185043e-14
which O 0 7.466088294480477e-13
lies O 0 7.026425014738935e-12
in O 0 5.190068917545413e-16
the O 0 3.771252996691998e-16
putative O 0 2.5994812313974436e-13
presequence O 0 6.648486015198296e-13
for O 0 6.307921670025121e-19
targeting O 0 5.5070887222197565e-14
to O 0 1.015151707812155e-14
mitochondria O 0 8.703303633339488e-10
. O 0 4.415497047854933e-12

This O 0 2.0469933528170087e-14
mutation O 0 2.5061206162060347e-14
changes O 0 3.349005219601157e-16
the O 0 6.215719983046898e-19
codon O 0 2.7098735975746686e-16
for O 0 8.954999150362257e-21
glutamine O 0 7.237677496861792e-17
to O 0 6.124304634638483e-19
a O 0 3.1899780263021634e-17
termination O 0 4.2202552623339315e-15
codon O 0 1.115553978944632e-13
at O 0 2.9652228497714693e-15
amino O 0 1.0008443726561289e-13
acid O 0 4.5760158764443157e-14
position O 0 2.4147705861808644e-13
29 O 0 7.77258986339735e-12
. O 0 7.771548704051112e-13

MaeI O 0 2.3686217431873047e-08
restriction O 0 9.578743354055064e-11
analysis O 0 5.695859365759115e-13
showed O 0 3.494249974003022e-13
two O 0 1.5679879561214573e-18
other O 0 5.143607985792045e-18
carriers O 0 2.8579977960114947e-15
in O 0 4.8738312180959394e-17
the O 0 7.227725362657367e-15
family O 0 1.26067776010097e-11
. O 0 7.520240940389611e-13

The O 0 3.745220453210685e-11
C O 0 7.168752290453995e-06
- O 0 7.05458369338885e-05
T O 0 4.439900294528343e-05
mutation O 0 1.4585294083602207e-10
is O 0 1.2763089802249837e-16
located O 0 5.097711938987712e-15
within O 0 1.9676224640137674e-16
a O 0 4.195405274425181e-16
recently O 0 2.587203997046761e-13
proposed O 0 3.4290805380610264e-15
putative O 0 1.1090473428943676e-13
alternative O 0 1.3879759276999191e-15
translation O 0 3.6100940623397595e-14
initiation O 0 8.485303426863683e-16
codon O 0 3.914523598932268e-13
( O 0 5.41510968976312e-16
TIC O 0 2.733261672549503e-10
- O 0 1.4308747763036589e-11
1 O 0 5.928466183545205e-16
) O 0 4.597914040558669e-18
, O 0 2.156890404434577e-18
supporting O 0 1.30373775994165e-16
that O 0 2.033787516246251e-15
TIC O 0 1.4594644937027113e-10
- O 0 4.015732516481074e-13
1 O 0 8.419618668782072e-17
is O 0 7.885274551451598e-18
the O 0 3.7193303567900646e-18
real O 0 5.278582272346712e-16
TIC O 0 2.327689907141717e-13
rather O 0 1.377582352845173e-18
than O 0 3.537062349584924e-18
TIC O 0 3.527077241383125e-11
- O 0 2.4724796862662934e-12
2 O 0 4.3256295491041555e-15
. O 0 4.0371297566924264e-16
. O 0 3.4571107641098026e-14

Human B-Disease 0 4.362161742932358e-10
complement I-Disease 0 7.135448898409891e-10
factor I-Disease 0 6.040405651219771e-07
H I-Disease 1 1.0
deficiency I-Disease 1 0.9997711777687073
associated O 0 1.9720127966138534e-06
with O 0 3.917373760486953e-05
hemolytic B-Disease 1 0.9999904632568359
uremic I-Disease 1 0.999998927116394
syndrome I-Disease 1 0.9999990463256836
. O 0 4.890015503633549e-09

This O 0 1.4583490936127125e-13
study O 0 2.19930050699682e-15
reports O 0 4.1900631435059664e-16
on O 0 8.440171923247198e-16
six O 0 2.5149299706157162e-15
cases O 0 6.821050021604e-15
of O 0 3.22513300381232e-16
deficiency B-Disease 0 1.4504158798445133e-06
in I-Disease 0 3.302534345136826e-16
the I-Disease 0 2.301648768562978e-15
human I-Disease 0 2.5409877110402213e-14
complement I-Disease 0 2.035515717568534e-14
regulatory I-Disease 0 3.532942913372049e-14
protein I-Disease 0 2.891691443587807e-12
Factor I-Disease 0 2.0440350800843277e-11
H I-Disease 1 0.9999991655349731
( O 0 1.7508417718092276e-15
FH O 0 8.867587553140766e-09
) O 0 3.090453309361008e-17
in O 0 4.572531900064903e-19
the O 0 1.6999972964884887e-18
context O 0 5.494555556864061e-16
of O 0 4.17968242386512e-18
an O 0 2.162531221802655e-13
acute B-Disease 0 0.007202754262834787
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.0997448091076834e-10

Five O 0 2.518143842316495e-13
of O 0 1.036312938662659e-19
the O 0 6.784967172439686e-18
cases O 0 1.3493113088774837e-16
were O 0 1.9808319428261983e-16
observed O 0 1.1434756407805585e-13
in O 0 6.696059616445669e-16
children O 0 8.472467383701873e-15
presenting O 0 4.713376498995114e-13
with O 0 1.0138350603483559e-08
idiopathic O 1 0.9999997615814209
hemolytic B-Disease 1 0.9999998807907104
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 9.35257427059355e-10
HUS B-Disease 1 0.9994420409202576
) O 0 1.4991451413592927e-09
. O 0 2.8157357001568073e-10

Two O 0 8.64501544894751e-14
of O 0 7.344362950929697e-18
the O 0 1.080260081148983e-15
children O 0 2.9108223704922987e-15
exhibited O 0 1.4611536806874437e-12
a O 0 9.409275658969762e-14
homozygous O 0 9.509980714028643e-08
deficiency O 0 0.0001333958498435095
characterized O 0 1.0266248707266681e-13
by O 0 1.014716949623131e-16
the O 0 5.36062673065071e-15
absence O 0 4.493597537797399e-14
of O 0 3.2670419177448147e-20
the O 0 1.608708610111371e-18
150 O 0 7.21135561715362e-18
- O 0 1.5979892766421503e-15
kD O 0 8.486351812247994e-13
form O 0 8.808517964646123e-17
of O 0 8.299704084158335e-20
Factor O 0 3.270795960463868e-12
H O 1 0.9999998807907104
and O 0 8.606085984098292e-15
the O 0 1.1161328330551539e-17
presence O 0 8.084084142660937e-15
, O 0 1.0851289456438088e-16
upon O 0 1.621350618208172e-18
immunoblotting O 0 1.2433492278286773e-13
, O 0 7.698030639271644e-18
of O 0 1.9767053914926224e-21
the O 0 4.715864205644443e-18
42 O 0 6.738985658025741e-15
- O 0 5.080201650385597e-15
kD O 0 8.562174580450943e-11
Factor O 0 2.3644924559973468e-11
H O 1 0.9999856948852539
- O 0 2.792934882932946e-13
like O 0 1.9805468368301084e-14
protein O 0 2.8834505855050707e-13
1 O 0 5.317119624468822e-17
( O 0 3.0300180048827814e-18
FHL O 0 5.463435259756011e-12
- O 0 3.719075354212571e-14
1 O 0 9.82735649056381e-18
) O 0 8.476490417142875e-19
and O 0 5.783069884493514e-18
other O 0 2.935227573459512e-17
FH O 0 2.631557833865372e-07
- O 0 9.043807369657486e-14
related O 0 7.059163265054919e-15
protein O 0 6.76674861976867e-13
( O 0 3.7219865164550336e-17
FHR O 0 3.976769434588245e-12
) O 0 1.653608159876387e-16
bands O 0 2.88328422823423e-14
. O 0 2.973341516575301e-13

Southern O 0 1.559190415667544e-10
blot O 0 1.5361790062229375e-08
and O 0 1.999126663346809e-16
PCR O 0 1.8291516576136174e-13
analysis O 0 1.1022840098036686e-17
of O 0 3.327169678490778e-22
DNA O 0 7.429108462306613e-14
of O 0 1.03233529851553e-20
one O 0 2.171813017308997e-15
patient O 0 4.561892313556526e-13
with O 0 3.552090050793085e-15
homozygous O 0 4.540174014522336e-09
deficiency O 0 0.0003055854176636785
ruled O 0 6.254354367740689e-09
out O 0 8.348623008191947e-12
the O 0 1.6264692242463593e-16
presence O 0 6.179796105588607e-15
of O 0 1.9939282369644498e-20
a O 0 6.849512489227505e-18
large O 0 7.009300208925292e-17
deletion O 0 7.248827731641538e-13
of O 0 2.8702725230950227e-19
the O 0 1.591758608161266e-16
FH O 0 1.4005542503525703e-08
gene O 0 3.010204119389265e-13
as O 0 2.5836088114948587e-17
the O 0 6.466263581409742e-18
underlying O 0 4.914123476900973e-15
defect O 0 4.15527638339408e-12
for O 0 2.711464464415955e-17
the O 0 4.602894454475148e-12
deficiency O 0 0.00013639769167639315
. O 0 1.818563420512287e-12

The O 0 2.598091961838675e-14
other O 0 8.67976432445204e-17
four O 0 4.00526967117264e-16
children O 0 1.3499342751404096e-16
presented O 0 7.1174579783090915e-16
with O 0 1.2560346642973008e-13
heterozygous O 0 6.15483884303103e-07
deficiency O 0 0.005407997407019138
and O 0 3.3975463908193435e-14
exhibited O 0 2.996636272456499e-11
a O 0 3.528843341669974e-13
normal O 0 4.0704359327570216e-10
immunoblotting O 0 1.815045447273178e-09
pattern O 0 3.527252101509504e-11
of O 0 8.109482916309256e-20
proteins O 0 4.366895723744964e-15
of O 0 3.564217086432603e-19
the O 0 5.036265627895043e-15
FH O 0 0.0003890699881594628
family O 0 3.561037922872323e-11
. O 0 4.892301299318225e-13

Factor B-Disease 0 0.0012353243073448539
H I-Disease 1 1.0
deficiency I-Disease 1 0.9991902709007263
is O 0 7.827972211410517e-14
the O 0 4.102900202744564e-14
only O 0 8.355775804602672e-08
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 5.100270553115571e-11
with O 0 3.83734575148606e-13
HUS B-Disease 1 0.9529072046279907
. O 0 1.0375914016869103e-10

These O 0 2.2601057581440182e-13
observations O 0 2.833012958339959e-13
suggest O 0 1.4871260893187764e-14
a O 0 4.383713139396225e-18
role O 0 2.548275063710717e-16
for O 0 2.0609249629511762e-17
FH O 0 2.7417631827120204e-06
and O 0 2.5066382888620786e-13
/ O 0 3.5450867241770823e-10
or O 0 6.383751474892075e-15
FH O 0 5.142192662788148e-07
receptors O 0 4.140540991667829e-14
in O 0 2.4186928201534265e-17
the O 0 5.340498792604225e-16
pathogenesis O 0 1.582053515969406e-10
of O 0 2.284398360256993e-16
idiopathic O 0 0.12080789357423782
HUS B-Disease 1 0.9991129040718079
. O 0 5.051035700809337e-10
. O 0 1.306467573014558e-10

Further O 0 1.498073800426658e-12
evidence O 0 1.895996008035184e-14
for O 0 9.887855446590173e-19
a O 0 3.1727571185655444e-17
major O 0 1.3407947102301969e-15
ancient O 0 3.9486358518851794e-13
mutation O 0 3.0744036205732073e-09
underlying O 0 2.982337155010839e-10
myotonic B-Disease 1 0.9999974966049194
dystrophy I-Disease 1 0.9999997615814209
from O 0 3.33781057806036e-14
linkage O 0 1.256820780781709e-07
disequilibrium O 0 8.987628974388429e-10
studies O 0 2.142660614906644e-12
in O 0 3.765515407265534e-17
the O 0 8.449481874128707e-16
Japanese O 0 1.337656235778084e-10
population O 0 1.7794732430197885e-14
. O 0 3.6765273984940006e-13

The O 0 4.303372103109382e-10
myotonic B-Disease 1 0.9999915361404419
dystrophy I-Disease 1 0.9999992847442627
( O 0 2.4023200095868447e-10
DM B-Disease 1 0.9999997615814209
) O 0 5.30085047037443e-12
mutation O 0 2.39333303175826e-10
is O 0 7.048047334050746e-16
an O 0 8.021256426710415e-17
unstable O 0 9.949504331530079e-09
( O 0 6.0920456098354295e-15
CTG O 0 8.571898052478488e-11
) O 0 9.949051004497591e-16
n O 0 2.4414149087798043e-12
repeat O 0 2.010154889764415e-11
, O 0 4.522269941875136e-15
present O 0 2.335397684615582e-16
at O 0 1.485512089213607e-15
a O 0 1.2414320842931551e-17
copy O 0 1.310956145071998e-13
number O 0 1.3942430185975353e-15
of O 0 4.4642776359267456e-18
5 O 0 6.848508034545259e-14
- O 0 1.9000688522563536e-10
37 O 0 4.1599631725453e-12
repeats O 0 1.3984734203997817e-10
on O 0 1.0013059378497467e-14
normal O 0 7.054204225961924e-13
chromosomes O 0 9.647228897896945e-14
but O 0 9.80025656477147e-17
amplified O 0 1.5444583825624547e-15
to O 0 4.518059976369045e-16
50 O 0 3.633480705540922e-16
- O 0 8.305651359816896e-14
3000 O 0 1.988062348412859e-15
copies O 0 4.950172352103169e-15
on O 0 6.925599677076733e-11
DM B-Disease 1 0.999998927116394
chromosomes O 0 4.1698308450577315e-07
. O 0 2.0924163443569732e-11

Previous O 0 5.203565356382001e-10
findings O 0 2.774713401751394e-12
in O 0 3.524890975823802e-15
Caucasian O 0 2.9802538392686984e-07
populations O 0 7.45657924294818e-10
of O 0 1.5701263131306773e-16
a O 0 7.192561130020536e-11
DM B-Disease 1 1.0
founder O 0 8.255160999226518e-10
chromosome O 0 2.137301713389661e-08
raise O 0 1.1301659918517854e-14
a O 0 1.2670199404693602e-15
question O 0 2.0536364628157347e-15
about O 0 4.811959431765953e-18
the O 0 1.464467357115727e-17
molecular O 0 2.068726015957891e-14
events O 0 7.270888996979143e-16
involved O 0 6.00322531146987e-16
in O 0 7.75994593530185e-18
the O 0 6.878292666998123e-17
expansion O 0 1.1004801670627673e-12
mutation O 0 1.649155291494342e-11
. O 0 9.846702446469902e-14

To O 0 5.189760296855916e-13
investigate O 0 9.820898434764747e-13
whether O 0 7.090767758382872e-15
a O 0 2.267866394708957e-16
founder O 0 3.272763148744087e-15
chromosome O 0 8.663974919442818e-12
for O 0 3.825658220679162e-18
the O 0 1.0292555687135916e-14
DM B-Disease 1 0.9999998807907104
mutation O 0 8.705299592293159e-09
exists O 0 3.0444081907136586e-14
in O 0 1.2464144412767458e-17
the O 0 2.201414410065591e-16
Japanese O 0 3.019933192405233e-10
population O 0 1.9974951984810585e-16
, O 0 9.797795272315207e-16
we O 0 4.8075841810150954e-14
genotyped O 0 3.8499555648531525e-13
families O 0 5.087987947813673e-19
using O 0 2.4920921127818906e-18
polymorphic O 0 1.772048829830515e-14
markers O 0 3.835412820674122e-10
near O 0 1.0254522925245979e-10
the O 0 6.523929074915558e-15
( O 0 1.1771602267984013e-15
CTG O 0 4.537849263019922e-11
) O 0 9.412788304602026e-15
n O 0 3.775258994309638e-10
repeat O 0 7.687999570293869e-09
region O 0 1.197467403013519e-10
and O 0 5.745421065989076e-12
constructed O 0 7.244212341106504e-09
haplotypes O 0 1.914795006996428e-07
. O 0 1.7554799627839124e-11

Six O 0 2.2081011064739586e-12
different O 0 8.806439557551798e-16
haplotypes O 0 9.751281379588583e-12
were O 0 5.2829771027935405e-15
found O 0 7.981619244657942e-14
and O 0 1.6314871545755616e-12
DM B-Disease 1 0.9999996423721313
alleles O 0 2.0869926620203927e-10
were O 0 1.8825415672944074e-13
always O 0 1.8429997111768515e-12
haplotype O 0 8.142563706625694e-11
A O 0 1.809781274494937e-12
. O 0 6.447216350201346e-13

To O 0 1.8047820453826607e-13
find O 0 1.7641767173769704e-15
an O 0 1.0238098452099786e-19
origin O 0 9.255466148921186e-18
of O 0 1.263407233279938e-19
the O 0 1.0117176588964627e-16
( O 0 9.863072495052625e-18
CTG O 0 1.0889794925181273e-12
) O 0 1.0953724856518695e-16
n O 0 1.390978044552016e-12
repeat O 0 9.943570272730184e-12
mutation O 0 3.4614954132206055e-12
and O 0 1.4334340683966893e-15
to O 0 1.5553541908794604e-16
investigate O 0 2.4978742422447457e-14
the O 0 1.240888179953177e-16
mechanism O 0 2.925159250157525e-15
of O 0 4.676785075424269e-21
the O 0 1.4124365385332839e-18
expansion O 0 2.6835094323935825e-15
mutation O 0 7.96112036970803e-15
in O 0 7.698349207205053e-19
the O 0 2.566643998875886e-17
Japanese O 0 2.338296396786621e-11
population O 0 5.707639400240089e-16
we O 0 1.6822386040594994e-13
have O 0 1.356252849759351e-15
studied O 0 8.1791303872987e-14
90 O 0 1.880326406730748e-14
Japanese O 0 2.334015203331319e-10
DM B-Disease 1 0.9999985694885254
families O 0 2.0808753483335385e-14
comprising O 0 1.4962147475488591e-16
190 O 0 3.1666923044296885e-14
affected O 0 2.1322390196792246e-13
and O 0 7.1002685034357495e-15
130 O 0 2.5108285947334635e-14
unaffected O 0 5.630859320482351e-11
members O 0 5.618038772771871e-15
. O 0 9.61669573184068e-14

The O 0 1.540851300718682e-11
results O 0 4.323227539848595e-12
suggest O 0 9.988152882903223e-14
that O 0 1.2959776146558206e-16
a O 0 1.4413016015783628e-16
few O 0 4.984945172170326e-15
common O 0 4.605589714160344e-16
ancestral O 0 1.638325759778514e-12
mutations O 0 1.0948864211102194e-11
in O 0 2.6173562915619196e-17
both O 0 1.1140118877015198e-14
Caucasian O 0 4.082366800162163e-08
and O 0 1.7499572971257926e-11
Japanese O 0 1.21207630598974e-08
populations O 0 1.6427550986186645e-10
have O 0 1.0581225362593129e-14
originated O 0 4.486852635614237e-16
by O 0 9.395826640129067e-21
expansion O 0 6.991245337695097e-18
of O 0 4.816320710849483e-22
an O 0 3.961015432403834e-20
ancestral O 0 4.944282396696087e-12
n O 0 3.7046193890333257e-10
= O 0 4.3395978477356323e-10
5 O 0 2.567870800368531e-15
repeat O 0 4.038447094095732e-12
to O 0 3.998541339071508e-14
n O 0 1.6257128976349122e-08
= O 0 2.5487963739578845e-07
19 O 0 1.6482960829566906e-12
- O 0 1.8062027568044314e-11
37 O 0 1.4985816678293046e-13
copies O 0 3.155610064160992e-14
. O 0 4.4818643696493965e-13

These O 0 5.769067542476039e-14
data O 0 4.187540308812129e-15
support O 0 1.1324995940912506e-16
multistep O 0 1.212811535228342e-12
models O 0 1.880159873277054e-12
of O 0 1.8200309434216459e-16
triplet O 0 7.22269177799717e-08
repeat O 0 5.091622123920558e-10
expansion O 0 2.1815218360053679e-13
that O 0 2.1223365523104524e-15
have O 0 2.131357638487168e-16
been O 0 6.734349095625422e-18
proposed O 0 1.7056105234457583e-17
for O 0 1.907374060994947e-18
both O 0 8.528106172633887e-12
DM B-Disease 1 1.0
and O 0 2.1813156081407215e-07
Friedreichs B-Disease 0 0.0004296630504541099
ataxia I-Disease 1 0.9905920624732971
. O 0 2.5477018498337722e-12
. O 0 8.24838461421784e-12

The O 0 2.1327017368376507e-14
molecular O 0 4.632838709016374e-13
basis O 0 4.9953415698616305e-14
of O 0 4.438459419876112e-14
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.0840595569405042e-15
the O 0 1.4641895170741377e-15
western O 0 3.683706673029974e-10
Cape O 0 4.9406180535616073e-11
, O 0 4.500776989058326e-14
South O 0 1.1769617502821461e-09
Africa O 0 9.923864681404826e-12
. O 0 2.6634097217200642e-14

Deficiency B-Disease 1 0.9997805953025818
of I-Disease 0 3.5385232828955904e-16
the I-Disease 0 4.001697892052746e-15
sixth I-Disease 0 3.3221624236301484e-13
component I-Disease 0 5.905089514156997e-14
of I-Disease 0 1.1407763633004562e-17
human I-Disease 0 6.202924458797998e-13
complement I-Disease 0 1.0279087693867983e-12
( O 0 3.1740058304182545e-16
C6 O 0 1.3052314437600465e-11
) O 0 3.04222979137991e-15
has O 0 1.5389325013978605e-12
been O 0 1.303662717057688e-13
reported O 0 1.993441083860889e-13
in O 0 2.9255790079224487e-18
a O 0 4.329107969311394e-17
number O 0 4.5827870578246666e-17
of O 0 1.5640316481868442e-20
families O 0 3.8621822772288645e-19
from O 0 1.3630023639707367e-20
the O 0 2.0539231685791293e-18
western O 0 5.056486045845743e-12
Cape O 0 5.360267351511849e-12
, O 0 8.725857628686176e-14
South O 0 2.6140092312942897e-09
Africa O 0 1.485832637482254e-11
. O 0 6.65864797111046e-14

Meningococcal B-Disease 1 0.8639523983001709
disease I-Disease 1 0.9357152581214905
is O 0 2.8799421750375434e-14
endemic O 0 1.2828553323795955e-11
in O 0 6.691182824251852e-16
the O 0 7.487030099899167e-15
Cape O 0 1.6112878392648966e-11
and O 0 1.4506297901380172e-15
almost O 0 2.73657101728094e-16
all O 0 2.998742802230519e-17
pedigrees O 0 1.9119256958882724e-12
of O 0 9.107148032878998e-17
total O 0 5.475764286444473e-09
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.3026512744077007e-14
C6Q0 O 0 6.606544200593589e-09
) O 0 4.453110125248296e-15
have O 0 1.6570963622553753e-13
been O 0 2.6279852792065843e-14
ascertained O 0 2.1743195351836553e-12
because O 0 9.574527043594572e-14
of O 0 5.768182138936274e-16
recurrent O 1 0.9799684286117554
disease O 1 0.9940302968025208
. O 0 8.375737603483202e-12

We O 0 3.790954661297974e-09
have O 0 1.9240617671160976e-14
sequenced O 0 5.2236921656723806e-14
the O 0 1.0578181715133293e-17
expressed O 0 3.0066102411136027e-18
exons O 0 2.8459229601835584e-14
of O 0 2.351027729646818e-19
the O 0 8.130336734087783e-18
C6 O 0 2.148872307308411e-13
gene O 0 1.5436258974060695e-14
from O 0 9.698304295037262e-20
selected O 0 3.1777494513473225e-16
cases O 0 8.961451033822308e-15
and O 0 1.9359012548396393e-13
have O 0 4.272672927269072e-12
found O 0 1.1868784221494982e-13
three O 0 1.9420013320158806e-15
molecular O 0 4.2537206396131566e-11
defects O 0 3.645759761639056e-06
leading O 0 4.119797558654881e-11
to O 0 9.517728619123922e-12
total O 0 1.2437360030759237e-09
deficiency O 0 0.2875639498233795
879delG O 0 2.763400708261088e-08
, O 0 1.1492968035597961e-12
which O 0 2.9965576054573687e-14
is O 0 2.1908253070848302e-16
the O 0 1.1612632282496183e-17
common O 0 2.533503338506194e-16
defect O 0 2.6689963173592846e-12
in O 0 3.082881959778188e-17
the O 0 2.3164965361503406e-14
Cape O 0 1.2591404308093246e-10
and O 0 1.8747542851905302e-14
hitherto O 0 4.304338482863379e-11
unreported O 0 1.3185104917601276e-11
, O 0 7.707830413424682e-14
and O 0 1.0168343218212167e-13
1195delC O 0 8.873233814377102e-10
and O 0 7.903780982563419e-14
1936delG O 0 8.270222701112218e-11
, O 0 2.113892904375748e-15
which O 0 2.070967392191268e-15
have O 0 2.0696575827932814e-14
been O 0 7.291557765562451e-15
previously O 0 7.628035166408823e-14
reported O 0 8.362563571305548e-13
in O 0 1.0784895705309846e-15
African O 0 9.045636283197198e-14
- O 0 2.0081861173970594e-10
Americans O 0 2.1634636356709924e-13
. O 0 1.478513966530863e-14

We O 0 2.9491848962948097e-09
also O 0 3.9868363601799905e-14
show O 0 1.675204164839142e-13
that O 0 5.448844365074298e-16
the O 0 2.8829293108414186e-16
879delG O 0 1.2230578771976752e-09
and O 0 7.486094535068266e-13
1195delC O 0 1.3081650251933752e-07
defects O 0 1.7344822822451533e-07
are O 0 3.168898486444107e-17
associated O 0 1.0643209539607304e-13
with O 0 1.764138151966882e-13
characteristic O 0 5.832582772313799e-08
C6 O 0 1.2681845191764296e-06
/ O 0 5.013682766730199e-06
C7 O 0 1.0652294157864617e-08
region O 0 4.734458936006547e-10
DNA O 0 4.478303949895235e-08
marker O 0 3.252980940171568e-10
haplotypes O 0 3.253550207027445e-11
, O 0 8.631961993603963e-15
although O 0 5.3451285688147984e-15
small O 0 3.2113481778704668e-15
variations O 0 2.2245474906590346e-10
were O 0 8.174331437432736e-13
observed O 0 5.6199152970171085e-11
. O 0 3.4699302892821082e-12

The O 0 3.7318536932548496e-13
1936delG O 0 1.0643936426690814e-10
defect O 0 8.755846742092288e-11
was O 0 4.608192964044612e-15
observed O 0 9.079892497869824e-15
only O 0 7.936286210727481e-15
once O 0 5.278490318449958e-13
in O 0 1.7996369046808245e-16
the O 0 2.011911408075751e-15
Cape O 0 2.127844341698326e-12
, O 0 1.994023554537398e-16
but O 0 7.726807260165629e-17
its O 0 7.455634769942447e-19
associated O 0 2.5647395313207685e-14
haplotype O 0 7.981417610158914e-11
could O 0 2.9581888154328606e-12
be O 0 1.3763710469269432e-15
deduced O 0 5.973528529462646e-12
. O 0 5.652439237155416e-13

The O 0 5.725330826837974e-14
data O 0 1.7956236202250862e-14
from O 0 5.494445475668142e-18
the O 0 3.0776181132321454e-17
haplotypes O 0 4.5374683177445974e-11
indicate O 0 1.2772636680952187e-12
that O 0 6.333372072771758e-15
these O 0 5.055646906398524e-16
three O 0 1.0281131330259824e-15
molecular O 0 4.0244928917188005e-11
defects O 0 2.8729862151521957e-06
account O 0 1.6807969116316252e-15
for O 0 3.156088436605866e-16
the O 0 4.8633133110931315e-12
defects O 0 0.016652587801218033
in O 0 4.30994885166811e-15
all O 0 6.610280272239871e-15
the O 0 4.136024188476596e-15
38 O 0 2.387931866132398e-12
unrelated O 0 2.3597774125375115e-13
C6Q0 O 0 3.439630802404281e-09
individuals O 0 7.925179597085728e-16
we O 0 4.3235963312175663e-13
have O 0 1.3277039219095e-15
studied O 0 2.545032801583129e-14
from O 0 4.164417787937431e-19
the O 0 1.379376875689173e-16
Cape O 0 2.753409262742923e-12
. O 0 9.435658363584482e-14

We O 0 2.0185373372783033e-08
have O 0 8.489812585582568e-14
also O 0 9.458172118157675e-16
observed O 0 2.183809121424486e-15
the O 0 2.696909063485227e-17
879delG O 0 3.7868968377763323e-11
defect O 0 1.019554145970103e-11
in O 0 2.3531038495867493e-16
two O 0 1.7237898608524205e-11
Dutch O 1 0.8825505971908569
C6 B-Disease 1 1.0
- I-Disease 1 0.999996542930603
deficient I-Disease 1 1.0
kindreds O 0 5.776887064712355e-06
, O 0 6.550315845288424e-14
but O 0 2.717535381159498e-15
the O 0 2.5428259948819117e-17
879delG O 0 2.3217152159138443e-11
defect O 0 2.829655780522966e-12
in O 0 1.8571298698175573e-18
the O 0 6.803139007008496e-17
Cape O 0 1.7663569717128735e-13
probably O 0 1.7276810746467454e-14
did O 0 2.907008130308836e-13
not O 0 1.2341145104135436e-15
come O 0 1.3305272944809355e-16
from O 0 1.5462474265756675e-19
The O 0 7.451665944955708e-16
Netherlands O 0 7.59538487660194e-10
. O 0 8.137238001199986e-15
. O 0 7.087336766726723e-14

Complement B-Disease 1 0.9916964769363403
C7 I-Disease 1 0.9999983310699463
deficiency I-Disease 1 1.0
: O 0 4.2210044487456244e-11
seven O 0 9.779209505979963e-14
further O 0 7.893748046709781e-14
molecular O 0 1.1144679845642713e-08
defects O 1 0.5838289856910706
and O 0 1.12473723910822e-12
their O 0 8.236989683266336e-15
associated O 0 1.031328911160756e-10
marker O 0 2.410787374174106e-07
haplotypes O 0 8.315533932545804e-07
. O 0 5.217178078442686e-11

Seven O 0 1.9893247205776676e-12
further O 0 3.932344951913932e-15
molecular O 0 5.450515798248456e-13
bases O 0 1.5044500090155566e-09
of O 0 2.5844645867856286e-11
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 5.413590040657945e-13
described O 0 6.352088299799163e-11
. O 0 4.284530629589112e-12

All O 0 7.898235288451155e-14
these O 0 9.825262565561193e-17
new O 0 9.552518882987595e-16
molecular O 0 6.71714116620703e-12
defects O 0 4.243886575494571e-09
involve O 0 1.5928101995652823e-15
single O 0 9.014973351693413e-15
- O 0 5.9328106663536495e-12
nucleotide O 0 6.924010843845085e-12
events O 0 1.687006213706415e-14
, O 0 6.355053681001744e-16
deletions O 0 3.560261894325345e-12
and O 0 4.7724645009560376e-14
substitutions O 0 2.9731984696511685e-14
, O 0 2.332183459278548e-16
some O 0 7.131773397600506e-18
of O 0 7.443415244343507e-19
which O 0 3.916117918226908e-15
alter O 0 4.2761097440724427e-10
splice O 0 3.5906966289189768e-09
sites O 0 9.704676645627686e-11
, O 0 3.4562799941951355e-14
and O 0 5.2733150826675054e-14
others O 0 1.6280352716988022e-14
codons O 0 3.731707998166911e-11
. O 0 1.00699147371347e-12

They O 0 3.9485421876594984e-11
are O 0 4.8476866859110983e-17
distributed O 0 1.867048021788058e-16
along O 0 5.865377628033741e-13
the O 0 1.2661261089517701e-15
C7 O 0 9.5197990115925e-12
gene O 0 2.4451255256630056e-11
, O 0 2.520212279833031e-15
but O 0 3.831313985399432e-16
predominantly O 0 1.5299970684633208e-16
towards O 0 2.1558068474629693e-16
the O 0 1.4933863192495198e-16
3 O 0 6.564411828783451e-14
end O 0 2.402994795334956e-13
. O 0 9.302248641512856e-13

All O 0 9.150418053480158e-13
were O 0 6.9434941398437665e-15
found O 0 1.0378895873031915e-15
in O 0 3.841612880334085e-18
compound O 0 8.700534867220333e-13
heterozygous O 0 3.689906713510993e-11
individuals O 0 8.443171902188136e-15
. O 0 2.7509459011969273e-13

The O 0 1.5431195210524606e-10
C6 O 0 1.2299101399548817e-06
/ O 0 1.5136089132283814e-05
C7 O 0 4.854704016565847e-08
marker O 0 2.0733342154244383e-08
haplotypes O 0 2.1137394057291203e-08
associated O 0 1.692382067819409e-10
with O 0 4.673487074766114e-13
most O 0 7.303591325474867e-13
C7 B-Disease 0 0.00017501847469247878
defects I-Disease 1 0.9994414448738098
are O 0 3.195783915277417e-12
tabulated O 0 1.682601435959441e-07
. O 0 3.908771364306146e-13
. O 0 4.073149803551779e-12

A O 0 8.04079580696282e-11
genome O 0 6.511184820479077e-12
- O 0 1.3094238193733787e-10
wide O 0 2.9186752298869523e-13
search O 0 4.2227858579671484e-14
for O 0 3.403131551372993e-17
chromosomal O 0 3.6041956263943575e-07
loci O 0 3.668515578120202e-12
linked O 0 4.425579014366576e-09
to O 0 1.714945199737805e-11
mental O 0 4.159022864769213e-05
health O 0 6.70683925063642e-11
wellness O 0 4.5599392317630105e-11
in O 0 1.4208738138685493e-16
relatives O 0 4.669492738437406e-14
at O 0 2.3604873616725822e-14
high O 0 1.7311785414485942e-13
risk O 0 2.9407268720832436e-12
for O 0 5.930731149646163e-15
bipolar B-Disease 1 0.9997455477714539
affective I-Disease 0 0.0022216313518583775
disorder I-Disease 0 0.08120422810316086
among O 0 4.1274949372746594e-16
the O 0 2.537023554495424e-16
Old O 0 6.811758379576816e-10
Order O 0 1.0989468883504383e-12
Amish O 0 3.082249477870391e-08
. O 0 9.113496415857902e-12

Bipolar B-Disease 1 0.999805748462677
affective I-Disease 1 0.9890252947807312
disorder I-Disease 1 0.999744713306427
( O 0 4.4437539759023537e-10
BPAD B-Disease 1 1.0
; O 0 4.087559318577405e-06
manic B-Disease 1 0.9999644756317139
- I-Disease 1 0.9999992847442627
depressive I-Disease 1 0.9999998807907104
illness I-Disease 1 0.9999984502792358
) O 0 2.9767732875017605e-14
is O 0 1.1394243531328505e-16
characterized O 0 2.6931454909597842e-14
by O 0 4.993597540934635e-18
episodes O 0 4.540877222847239e-12
of O 0 1.298947259229335e-16
mania B-Disease 0 1.9649495186513377e-07
and O 0 1.8615757806789146e-12
/ O 0 9.286599578217647e-08
or O 0 4.269062046143718e-13
hypomania B-Disease 0 1.7714513660394005e-06
interspersed O 0 1.2057331133519256e-08
with O 0 2.541502707072152e-13
periods O 0 1.5369745753890385e-10
of O 0 1.4407581505333604e-15
depression B-Disease 0 5.467071240161658e-09
. O 0 1.4450033780210453e-13

Compelling O 0 2.5881347412437528e-11
evidence O 0 5.587246702624948e-13
supports O 0 8.132075335386471e-14
a O 0 6.069680869533482e-16
significant O 0 4.883939563704684e-16
genetic O 0 1.434142648387704e-11
component O 0 2.3194719934874555e-14
in O 0 7.292690301552489e-17
the O 0 1.8789810219489765e-15
susceptibility O 0 6.302611210706743e-10
to O 0 6.290015166707241e-13
develop O 0 9.594404382085031e-09
BPAD B-Disease 1 0.9999988079071045
. O 0 2.698951340196487e-10

To O 0 7.423942645530535e-13
date O 0 1.1031786378498665e-12
, O 0 2.3691836795354526e-14
however O 0 9.877394346500482e-15
, O 0 2.899240518427576e-16
linkage O 0 9.023282815379119e-11
studies O 0 8.014019948956314e-14
have O 0 1.0087315368851463e-15
attempted O 0 1.712962318647579e-13
only O 0 6.110709027916112e-16
to O 0 6.794505491344708e-16
identify O 0 6.968656879845214e-13
chromosomal O 0 1.803519040777246e-07
loci O 0 1.3164537277128574e-13
that O 0 2.86391570181177e-13
cause O 0 2.8477177213548366e-12
or O 0 3.638644493673092e-14
increase O 0 1.3113838628290436e-13
the O 0 3.3985135669198363e-13
risk O 0 4.1110687770684606e-11
of O 0 3.578077074554406e-16
developing O 0 1.553777018159508e-08
BPAD B-Disease 1 0.9999991655349731
. O 0 2.9911959020800793e-10

To O 0 4.564979375954771e-14
determine O 0 4.216795556260871e-15
whether O 0 4.911872063327171e-16
there O 0 3.5108541575801407e-15
could O 0 1.6065725410175508e-13
be O 0 6.397152806667059e-17
protective O 0 6.216446628293237e-14
alleles O 0 2.143196644460721e-15
that O 0 4.097017474222588e-15
prevent O 0 6.492975644992183e-13
or O 0 9.812686958560884e-15
reduce O 0 4.1625505126097195e-12
the O 0 8.18097217573921e-14
risk O 0 1.9765712504227206e-12
of O 0 1.7697822854689483e-18
developing O 0 9.448562592051513e-12
BPAD B-Disease 1 0.9999992847442627
, O 0 2.056356709125842e-15
similar O 0 2.3831392739369173e-17
to O 0 5.164015358684341e-18
what O 0 1.765575327591565e-17
is O 0 4.06436765621094e-18
observed O 0 5.6554071135476525e-16
in O 0 4.6678291657289983e-17
other O 0 2.213115628257878e-11
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 3.989034580084705e-14
we O 0 5.348747052907887e-12
used O 0 1.1778369946036094e-10
mental O 0 1.1200339940842241e-05
health O 0 6.631914462040811e-11
wellness O 0 2.3223009626427427e-10
( O 0 1.0199994044242334e-15
absence O 0 7.009912534336818e-14
of O 0 5.804287067205499e-18
any O 0 1.2612261061917263e-11
psychiatric B-Disease 0 0.0008860636735334992
disorder I-Disease 0 3.5423502708908927e-07
) O 0 2.1941770181114767e-18
as O 0 4.853441546868752e-17
the O 0 3.9494829695357284e-15
phenotype O 0 1.612909805714935e-09
in O 0 3.123298806541851e-14
our O 0 1.6965592342446656e-12
genome O 0 8.401593656892636e-12
- O 0 5.302552147368189e-11
wide O 0 3.617196819849511e-12
linkage O 0 6.882546088604613e-09
scan O 0 3.718084951032097e-09
of O 0 1.8853828440247653e-18
several O 0 7.165591684328001e-17
large O 0 1.2294634101485229e-14
multigeneration O 0 1.066774668601056e-08
Old O 0 5.564690486181689e-09
Order O 0 1.6479337696957003e-13
Amish O 0 3.528559389121e-10
pedigrees O 0 7.347415037495253e-11
exhibiting O 0 2.8228389406786264e-14
an O 0 3.916935781477041e-17
extremely O 0 3.1836631855103326e-13
high O 0 7.852250967499419e-12
incidence O 0 9.596303425496444e-05
of O 0 1.446884929576231e-12
BPAD B-Disease 1 0.9999998807907104
. O 0 1.2588794451318108e-09

We O 0 3.228949907452261e-08
have O 0 3.361949661804392e-14
found O 0 2.383004112624826e-16
strong O 0 8.13716262850257e-18
evidence O 0 7.22033251203329e-17
for O 0 5.324380657244843e-19
a O 0 4.3536368523237965e-16
locus O 0 3.3170083975526954e-13
on O 0 1.7196019998569345e-12
chromosome O 0 9.264693012767111e-09
4p O 0 2.6216126491895864e-10
at O 0 9.473617636895915e-14
D4S2949 O 0 1.7138587641088443e-12
( O 0 2.988396427128706e-17
maximum O 0 1.3201687168107258e-15
GENEHUNTER O 0 6.1383198524112e-10
- O 0 2.8764662526881146e-11
PLUS O 0 2.542637324645658e-13
nonparametric O 0 3.902154988022488e-10
linkage O 0 7.699508586256343e-08
score O 0 3.0747908663641965e-09
= O 0 3.341002197121412e-10
4 O 0 1.8196095604122546e-14
. O 0 1.2348828963516453e-14
05 O 0 1.8966218873206486e-10
, O 0 3.7156367392598977e-14
P O 0 4.7522119572818156e-09
= O 0 9.879596273021374e-12
5 O 0 5.813707909919927e-17
. O 0 4.580477486836357e-18
22 O 0 2.287878077483432e-16
x O 0 2.9344345963550067e-12
10 O 0 3.673060966979339e-15
( O 0 1.9139649120386776e-16
- O 0 4.0250611871295305e-11
4 O 0 1.5038036598304452e-14
) O 0 7.263566926545722e-17
; O 0 8.52221487277376e-17
SIBPAL O 0 3.3138357509454597e-12
Pempirical O 0 1.1726980064102888e-12
value O 0 2.8463529723411e-17
< O 0 6.299494143013375e-15
3 O 0 5.284465445560985e-16
x O 0 7.499089023366157e-12
10 O 0 5.733698157104131e-15
( O 0 1.9441055206755378e-16
- O 0 3.783019730807524e-11
5 O 0 3.0062592667253352e-15
) O 0 8.656547680763391e-18
) O 0 1.9526210472967508e-18
and O 0 5.1286418896871844e-17
suggestive O 0 1.690134306380625e-13
evidence O 0 4.4087243282627496e-15
for O 0 1.6006591087754643e-18
a O 0 8.133571936725151e-16
locus O 0 3.920533602624898e-12
on O 0 1.7125893758684896e-10
chromosome O 0 8.058222192630637e-06
4q O 0 8.050000133152935e-08
at O 0 6.20820343917583e-13
D4S397 O 0 4.8117725082175156e-12
( O 0 1.8959577856734393e-16
maximum O 0 1.303798111039142e-15
GENEHUNTER O 0 8.034299892045738e-10
- O 0 4.420015395356636e-11
PLUS O 0 1.070806244780724e-13
nonparametric O 0 8.607662499438007e-11
linkage O 0 1.50346686211833e-08
score O 0 5.935768543352538e-11
= O 0 1.715311746808279e-11
3 O 0 6.742813717551738e-16
. O 0 1.9864011844543953e-16
29 O 0 1.683956115825988e-13
, O 0 6.561566560410329e-15
P O 0 1.3062073200842406e-08
= O 0 1.0459323511458063e-11
2 O 0 1.267173994586642e-16
. O 0 1.0026994877042258e-17
57 O 0 1.3036893308328908e-14
x O 0 1.8908093840641627e-11
10 O 0 2.3414657121826818e-14
( O 0 5.681311498657057e-16
- O 0 2.473763902055559e-11
3 O 0 1.0614700104668619e-14
) O 0 1.0086849500730473e-16
; O 0 1.126579230836637e-16
SIBPAL O 0 7.863056560031279e-12
Pempirical O 0 1.7305553691449038e-12
value O 0 8.56121809301686e-17
< O 0 2.517398182272368e-14
1 O 0 1.6031845532241346e-16
x O 0 2.193532161465228e-11
10 O 0 2.5516723540434764e-14
( O 0 8.508965821640824e-16
- O 0 1.9599649681012465e-10
3 O 0 5.969726428955383e-15
) O 0 1.220163699101253e-17
) O 0 1.5684604830463782e-18
that O 0 8.938732902110344e-18
are O 0 1.5544932282106907e-17
linked O 0 1.0372234321431861e-10
to O 0 1.7550238606139912e-12
mental O 0 4.1689818317536265e-06
health O 0 1.5070858450094704e-10
wellness O 0 2.1730345522996686e-08
. O 0 9.701113610344203e-13

These O 0 1.074159533022423e-12
findings O 0 2.839325996539799e-13
are O 0 5.1972780281943844e-17
consistent O 0 5.03046684033814e-15
with O 0 1.4907331539783682e-17
the O 0 1.1148648478941714e-17
hypothesis O 0 8.164444699465794e-15
that O 0 7.758969034998426e-18
certain O 0 1.1448792453131682e-16
alleles O 0 6.291280888040323e-15
could O 0 1.038631962553549e-12
prevent O 0 1.461400851677716e-13
or O 0 8.696211983752044e-15
modify O 0 2.0628487806817475e-09
the O 0 4.749454003910927e-14
clinical O 0 7.472293617194481e-11
manifestations O 0 5.907164948165677e-13
of O 0 2.8599156903623153e-16
BPAD B-Disease 1 0.9999998807907104
and O 0 1.3040861793212066e-12
perhaps O 0 3.859494612735905e-15
other O 0 1.3545828184247208e-15
related O 0 1.11389106272064e-10
affective B-Disease 0 0.0004868662217631936
disorders I-Disease 0 0.38259583711624146
. O 0 3.988247232467046e-12

Segregation O 0 2.3386660075175314e-07
distortion O 0 9.709629544829568e-09
in O 0 2.0453300511591443e-11
myotonic B-Disease 1 0.9999914169311523
dystrophy I-Disease 1 0.9999988079071045
. O 0 1.3506911145100275e-09

Myotonic B-Disease 1 0.999985933303833
dystrophy I-Disease 1 0.9999984502792358
( O 0 1.5920191831497732e-09
DM B-Disease 1 0.9999998807907104
) O 0 2.7392412990656645e-11
is O 0 2.1019461399294365e-13
an O 0 9.83973712513804e-14
autosomal B-Disease 1 0.9999850988388062
dominant I-Disease 1 0.9999983310699463
disease I-Disease 1 0.9999998807907104
which O 0 3.676482035475104e-11
, O 0 1.7333782182499778e-14
in O 0 1.6412780071423246e-16
the O 0 4.560849433886372e-16
typical O 0 1.186046161456844e-12
pedigree O 0 4.6165071765358334e-11
, O 0 4.078005713842347e-17
shows O 0 4.9385536011656815e-15
a O 0 7.138609052746521e-17
three O 0 2.5506175399437937e-17
generation O 0 1.317517291927583e-15
anticipation O 0 2.5295065606050155e-15
cascade O 0 1.0897908270246504e-10
. O 0 3.87328407194798e-12

This O 0 1.4640968559048728e-12
results O 0 6.785453709329259e-12
in O 0 9.19631233144147e-13
infertility B-Disease 1 0.9967705011367798
and O 0 2.112465153913945e-06
congenital B-Disease 1 0.999998927116394
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.904754224635156e-13
CDM B-Disease 0 5.0392932882115105e-11
) O 0 1.5713965978537628e-16
with O 0 3.8027871730504385e-17
the O 0 4.543276676604398e-16
disappearance O 0 5.519313305002438e-12
of O 0 7.668172860229828e-16
DM B-Disease 1 0.9999998807907104
in O 0 8.18284445736582e-14
that O 0 1.0228610493323576e-12
pedigree O 0 6.407460784174646e-09
. O 0 1.173270194106818e-13

The O 0 3.744519631025027e-15
concept O 0 1.3395523246548116e-15
of O 0 4.3017271846818196e-19
segregation O 0 8.65399440476422e-13
distortion O 0 4.130743869786707e-14
, O 0 2.1337573887058578e-16
where O 0 9.23498528930327e-16
there O 0 2.327853830516323e-17
is O 0 2.1033124685934454e-18
preferential O 0 5.351453363831946e-15
transmission O 0 2.201834634757427e-12
of O 0 5.4883619435413784e-21
the O 0 2.8020934535750465e-19
larger O 0 1.1145165552254498e-16
allele O 0 6.354304797997253e-15
at O 0 2.728225021657142e-14
the O 0 8.139752842020384e-15
DM B-Disease 1 0.999998927116394
locus O 0 3.300521314586469e-11
, O 0 6.747764239728449e-13
has O 0 1.4549492253351781e-12
been O 0 5.6334717977741394e-14
put O 0 1.268062130993508e-11
forward O 0 1.850176641667728e-13
to O 0 2.7979653946660302e-15
explain O 0 5.140544240278544e-12
partially O 0 2.188040330516894e-12
the O 0 2.3064454036467157e-17
maintenance O 0 2.568843304306262e-13
of O 0 3.784551066548033e-18
DM B-Disease 1 0.9999997615814209
in O 0 1.8576792868200097e-14
the O 0 4.905171609197916e-15
population O 0 4.590577643357038e-15
. O 0 6.927121501193109e-14

In O 0 9.297702446278353e-14
a O 0 9.991082261648007e-15
survey O 0 2.148151041813165e-13
of O 0 5.5696556320936075e-18
DM B-Disease 1 0.9999998807907104
in O 0 1.1297748760824566e-12
Northern O 0 4.860467583966965e-07
Ireland O 0 6.37476404996562e-10
, O 0 4.6730540884641365e-15
59 O 0 1.211627694876205e-12
pedigrees O 0 1.083698322051907e-11
were O 0 2.7246561753888282e-15
ascertained O 0 2.5711596046695817e-11
. O 0 6.76769079145656e-13

Sibships O 0 3.9270073415309525e-08
where O 0 3.4194064680442837e-12
the O 0 2.3162412073328137e-17
status O 0 1.3846020895918868e-15
of O 0 3.2015071766221086e-19
all O 0 7.12174515616228e-17
the O 0 7.041160724578997e-18
members O 0 7.063297835529718e-19
had O 0 1.243187376773116e-14
been O 0 1.0667331105651196e-17
identified O 0 1.1118583276089494e-16
were O 0 1.0306128629109503e-18
examined O 0 2.0007447609738608e-15
to O 0 5.360270990047753e-18
determine O 0 3.383871213292512e-16
the O 0 1.5569316532589204e-18
transmission O 0 4.691995490052614e-12
of O 0 9.532624541986865e-20
the O 0 2.358308072954239e-15
DM B-Disease 1 0.9999990463256836
expansion O 0 5.709523132058081e-12
from O 0 6.554929898449914e-17
affected O 0 1.289583403171063e-13
parents O 0 1.0235391127591618e-14
to O 0 3.39513304572185e-16
their O 0 1.2595744149838765e-15
offspring O 0 3.296019869796635e-13
. O 0 3.2221790611120654e-14

Where O 0 1.2719038496034063e-11
the O 0 1.108982650753021e-15
transmitting O 0 2.934531437293053e-11
parent O 0 1.373716353343657e-12
was O 0 4.71015967114935e-13
male O 0 1.4748764275845927e-12
, O 0 9.639682173150088e-15
58 O 0 5.525425256225347e-11
. O 0 1.2932616132513286e-12

3 O 0 7.147410918326158e-13
% O 0 6.202130749751147e-17
of O 0 1.0063274475871557e-19
the O 0 1.4188156561556193e-16
offspring O 0 2.930292862740949e-14
were O 0 3.2443348172101014e-15
affected O 0 4.829312947804421e-13
, O 0 5.581620167688199e-14
and O 0 7.251808203413701e-15
in O 0 9.045100057078537e-18
the O 0 8.638075083323857e-18
case O 0 1.0188911676918696e-15
of O 0 3.056342092452331e-21
a O 0 2.1454534578695616e-16
female O 0 3.404967754690007e-14
transmitting O 0 8.112362344381285e-12
parent O 0 1.4689583100260806e-12
, O 0 6.490929348916888e-14
68 O 0 5.591583862596394e-10
. O 0 2.7092588155558373e-12

7 O 0 2.7356858098293024e-11
% O 0 3.3078694880342256e-15
were O 0 1.352801910477295e-14
affected O 0 1.6361188445723762e-11
. O 0 4.797476652051991e-12

Studies O 0 2.711017695056217e-11
on O 0 1.142546310112149e-14
meiotic O 0 1.1618693854242856e-11
drive O 0 3.36053164462502e-11
in O 0 7.15511092215515e-15
DM B-Disease 1 0.9999997615814209
have O 0 1.956730194541123e-10
shown O 0 4.1936336944280866e-14
increased O 0 2.0363961659655575e-15
transmission O 0 7.384812379662709e-12
of O 0 6.1493475115276545e-21
the O 0 1.5148946964204935e-19
larger O 0 9.099473782027976e-17
allele O 0 1.4016663094681536e-15
at O 0 1.1333392313820842e-14
the O 0 3.993219515767204e-15
DM B-Disease 1 0.9999990463256836
locus O 0 5.3510865877237634e-11
in O 0 8.644619715154553e-14
non O 0 2.838522125681031e-11
- O 0 5.431706813396886e-05
DM O 1 0.9999933242797852
heterozygotes O 0 4.0099028097984046e-08
for O 0 5.507256434743313e-14
CTGn O 0 1.1495023244378899e-07
. O 0 3.2489844148386737e-12

This O 0 3.612892862485395e-13
study O 0 2.9844691323989815e-15
provides O 0 3.300971106127999e-17
further O 0 1.9474819395870813e-17
evidence O 0 2.203128328294801e-16
that O 0 2.086341543109746e-16
the O 0 3.2868385069868486e-15
DM B-Disease 1 0.9999996423721313
expansion O 0 2.2434951466032693e-11
tends O 0 1.0440861500024545e-12
to O 0 6.738310546297e-17
be O 0 1.1333948814467188e-15
transmitted O 0 1.7486427236756974e-11
preferentially O 0 9.437250460264668e-12
. O 0 3.87685413286154e-12

Diagnosis O 0 0.42441993951797485
of O 0 1.3143174049101702e-11
hemochromatosis B-Disease 1 0.9999994039535522
. O 0 1.979786112826787e-08

If O 0 2.3890120104397283e-08
untreated O 0 3.954216367674235e-07
, O 0 8.380611309088959e-12
hemochromatosis B-Disease 1 1.0
can O 0 1.5812676792847924e-05
cause O 0 4.333768455211384e-09
serious O 0 2.1814607009673637e-08
illness O 0 0.05059720575809479
and O 0 3.596391847521252e-13
early B-Disease 0 1.9910254001054284e-12
death I-Disease 0 3.0662881088383553e-12
, O 0 1.7817961461743387e-14
but O 0 2.7119367949218764e-12
the O 0 8.52538119310367e-14
disease O 0 1.8312026384137425e-07
is O 0 2.073022505879544e-15
still O 0 4.900893601535172e-13
substantially O 0 6.089168613776508e-10
under O 0 1.720567438523446e-11
- O 0 0.0014985626330599189
diagnosed O 0 8.921605513023678e-06
. O 0 9.49734106463207e-13

The O 0 4.396463949867717e-15
cornerstone O 0 1.3796406999824632e-15
of O 0 2.9395372025454894e-20
screening O 0 5.0890098613008e-14
and O 0 4.5175732963838434e-18
case O 0 9.587702414772497e-18
detection O 0 1.0311216881755112e-15
is O 0 4.665367931175377e-19
the O 0 2.6618589393895175e-19
measurement O 0 4.086481654908165e-15
of O 0 8.310289152565658e-19
serum O 0 5.114146411043519e-13
transferrin O 0 5.440897840776338e-13
saturation O 0 6.860264309752062e-13
and O 0 1.1279312309457265e-13
the O 0 4.3528091423156515e-15
serum O 0 1.820625941673093e-11
ferritin O 0 2.5872288755834916e-09
level O 0 1.565459567531846e-11
. O 0 2.0467416823877205e-12

Once O 0 7.55752704861834e-09
the O 0 5.187243999138849e-14
diagnosis O 0 1.0459418220420957e-08
is O 0 2.895414708832845e-17
suspected O 0 9.729154981652499e-12
, O 0 6.08437847935512e-16
physicians O 0 1.7898748499637187e-15
must O 0 1.6659046959903554e-15
use O 0 1.6087181771168996e-14
serum O 0 8.429447417857006e-11
ferritin O 0 9.470321060689457e-08
levels O 0 1.8287332759214792e-09
and O 0 2.2187379711269273e-10
hepatic O 0 2.9715688469877932e-06
iron O 0 2.9962757253088057e-05
stores O 0 7.152037539981393e-08
on O 0 1.2256166914692557e-10
liver O 0 8.697731423978894e-09
biopsy O 0 9.494027786161041e-09
specimens O 0 1.8169597025400643e-14
to O 0 1.0887071966248152e-16
assess O 0 2.32849048202588e-12
patients O 0 6.276733690094294e-14
for O 0 4.489328387187608e-19
the O 0 3.653465521489101e-17
presence O 0 1.7988229991921373e-13
of O 0 2.6924800407005975e-16
iron B-Disease 0 1.967444404726848e-06
overload I-Disease 0 8.09913444754784e-07
. O 0 3.537045873205913e-12

Liver O 0 0.2396049052476883
biopsy O 0 0.015572912059724331
is O 0 4.60144990415811e-14
also O 0 5.350187473092275e-15
used O 0 5.36451376484566e-15
to O 0 2.696601914780174e-16
establish O 0 4.9650208396685366e-14
the O 0 1.0960119293525975e-16
presence O 0 3.8548859742325303e-13
or O 0 4.69111376263584e-14
absence O 0 5.063674089408887e-13
of O 0 3.4117365458492596e-17
cirrhosis B-Disease 0 9.729818728487771e-09
, O 0 7.289444418359051e-15
which O 0 1.7177924664310562e-12
can O 0 4.508484696685855e-10
affect O 0 5.1888036978198215e-08
prognosis O 0 4.064407221449073e-06
and O 0 3.655145847450414e-13
management O 0 1.683428049736868e-11
. O 0 1.4516359848112254e-13

A O 0 1.6468497030484863e-13
DNA O 0 1.1088199802777865e-11
- O 0 1.9154872187097244e-13
based O 0 5.2609322233083e-16
test O 0 6.377061693377956e-14
for O 0 2.840016065745423e-19
the O 0 2.1743390349938318e-17
HFE O 0 5.770301458873917e-10
gene O 0 3.9054124517656774e-12
is O 0 6.549228556077892e-18
commercially O 0 8.865956724637316e-18
available O 0 2.075624855791305e-16
, O 0 1.110935209927208e-14
but O 0 9.843590786234868e-13
its O 0 2.4920183117276386e-16
place O 0 2.4900410509551274e-13
in O 0 7.368191377399389e-17
the O 0 3.295122542150555e-16
diagnosis O 0 1.0997200927675976e-09
of O 0 8.951051275792483e-18
hemochromatosis B-Disease 1 1.0
is O 0 8.7700208206698e-11
still O 0 2.1632489636408403e-13
being O 0 5.8501986451530135e-15
evaluated O 0 5.196991383245309e-13
. O 0 7.199687894476892e-14

Currently O 0 8.070506936352917e-12
, O 0 7.185718457704184e-15
the O 0 4.597422695274812e-18
most O 0 3.193700918085081e-19
useful O 0 2.076098764107849e-17
role O 0 3.1600279339039864e-16
for O 0 3.1400293040395776e-18
this O 0 1.9209649776032444e-16
test O 0 2.0763485332128684e-13
is O 0 5.619463382100299e-19
in O 0 3.8026219773272934e-20
the O 0 3.346714080264847e-19
detection O 0 5.9725737302075785e-15
of O 0 7.026724768528721e-18
hemochromatosis B-Disease 1 1.0
in O 0 1.1558168701644722e-12
the O 0 1.0353514107250966e-14
family O 0 2.2019290619903868e-14
members O 0 1.6469389593190112e-19
of O 0 6.428329521188935e-21
patients O 0 1.8724894143807788e-17
with O 0 3.685993065249011e-20
a O 0 3.7713228769101464e-17
proven O 0 5.247746461418392e-15
case O 0 2.2366203551363708e-15
of O 0 1.955192545026025e-18
the O 0 4.412716394543159e-13
disease O 0 2.819463702508074e-07
. O 0 8.727688575104961e-14

It O 0 9.08194472317575e-13
is O 0 5.566708999684734e-16
crucial O 0 9.546318135945572e-14
to O 0 6.154887255242769e-13
diagnose O 1 0.9740351438522339
hemochromatosis B-Disease 1 1.0
before O 0 6.411989488697145e-06
hepatic B-Disease 1 0.9895162582397461
cirrhosis I-Disease 0 0.08465687185525894
develops O 0 1.6776448674704625e-08
because O 0 2.2395052392404358e-12
phlebotomy O 0 0.00015958427684381604
therapy O 0 3.7722218166891253e-06
can O 0 6.784658390657228e-10
avert O 0 8.815885621515918e-08
serious O 0 5.091596904094331e-06
chronic O 1 0.9999918937683105
disease O 1 0.999996542930603
and O 0 7.580329419720755e-11
can O 0 5.863015073437339e-10
even O 0 6.285704595709873e-11
lead O 0 4.783887064263581e-09
to O 0 1.2538947202593576e-13
normal O 0 3.580764296184924e-10
life O 0 9.825774742455717e-12
expectancy O 0 3.3686338163363416e-09
. O 0 2.7094510869526663e-15
. O 0 6.543872296252071e-14

Prevalence O 0 0.00010327078052796423
of O 0 5.279609829190849e-16
the O 0 9.341105600341789e-15
I1307K O 0 3.2869013066871844e-11
APC B-Disease 0 3.34413405170611e-13
gene O 0 4.4330636167141946e-13
variant O 0 3.951600852092341e-11
in O 0 2.9891279194879986e-16
Israeli O 0 1.1943827871174761e-11
Jews O 0 3.4562600042175803e-14
of O 0 5.759487999205393e-19
differing O 0 1.7526192704490407e-15
ethnic O 0 1.679353406553244e-13
origin O 0 2.7115203460911612e-14
and O 0 1.373954118880083e-13
risk O 0 3.044427232014313e-13
for O 0 2.507499145387032e-13
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.2007064573448254e-11

BACKGROUND O 0 8.164648534148e-06
& O 0 6.953866815706533e-09
AIMS O 0 1.0100813414848364e-11
Israeli O 0 1.5668575811811358e-11
Jews O 0 1.3102969230460726e-12
of O 0 5.248464427720309e-16
European O 0 1.4445804795426564e-11
birth O 0 2.65040729164126e-13
, O 0 1.1421889469117024e-14
i O 0 3.740317777722879e-10
. O 0 6.451631583554292e-17
e O 0 5.055202743496807e-16
. O 0 1.0152236639227687e-17
, O 0 1.381762596924674e-16
Ashkenazim O 0 1.134495275501024e-12
, O 0 3.907774061361302e-16
have O 0 1.1780997557434957e-14
the O 0 7.521007979545326e-15
highest O 0 1.954254535974087e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 1.7811236830311827e-05
of O 0 1.7480371133719706e-17
any O 0 6.936085142654133e-14
Israeli O 0 5.145950154883394e-08
ethnic O 0 7.274520985589561e-09
group O 0 1.6117988888009194e-10
. O 0 1.113575486162699e-12

The O 0 1.8922732304693657e-12
I1307K O 0 1.0754275248103795e-10
APC B-Disease 0 2.086497207648419e-12
gene O 0 2.4196311187302255e-12
variant O 0 8.154629194123686e-10
was O 0 1.5537637843010543e-10
found O 0 1.7661724947132251e-12
in O 0 4.2570744292983603e-14
6 O 0 6.238790595247679e-10
. O 0 9.321897420644376e-12

1 O 0 3.967835175006096e-13
% O 0 5.321421294526343e-17
of O 0 2.5259517430303773e-20
American O 0 1.2365178605222593e-15
Jews O 0 9.058545573533121e-15
, O 0 1.5212331626652154e-15
28 O 0 4.0255977736924735e-15
% O 0 2.1205599598470003e-19
of O 0 3.751489484644901e-19
their O 0 1.3760798923956319e-11
familial O 1 0.9999550580978394
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 7.219959075044358e-10
, O 0 2.920512952569315e-13
but O 0 8.652253913332686e-11
not O 0 1.3417080814426274e-11
in O 0 3.594851873860508e-15
non O 0 1.401448401772143e-13
- O 0 7.03771152466004e-10
Jews O 0 8.338326557000286e-12
. O 0 1.0604552175622062e-12

We O 0 1.7833945431533493e-10
assessed O 0 2.058898028196171e-13
the O 0 1.8178669595298683e-15
I1307K O 0 4.176957946189219e-10
prevalence O 0 3.765142864153859e-09
in O 0 7.115825189954361e-17
Israeli O 0 1.1458602079336688e-12
Jews O 0 3.011229020785113e-15
of O 0 3.351171355920286e-20
differing O 0 1.618633243041971e-16
ethnic O 0 4.111376292041148e-14
origin O 0 9.754837149362258e-15
and O 0 6.119229607618251e-14
risk O 0 2.424369841165508e-13
for O 0 1.004361185690493e-13
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.509740852640885e-11

METHODS O 0 3.127930206514584e-11
DNA O 0 2.7152403589414398e-11
samples O 0 1.0532537061752004e-14
from O 0 2.3250382317882845e-19
500 O 0 1.7430563280315438e-17
unrelated O 0 1.2627839922276125e-14
Jews O 0 3.84682140742304e-13
of O 0 2.3534000464204923e-16
European O 0 2.9650139982129176e-11
or O 0 2.3356852205374395e-14
non O 0 2.080105225977895e-14
- O 0 2.3069376964279797e-10
European O 0 2.1853948772160292e-13
origin O 0 4.755121204899474e-17
, O 0 2.953400400645057e-17
with O 0 5.391626925527801e-18
or O 0 2.983157065128795e-17
without O 0 3.1021228425706613e-17
a O 0 9.034272262860218e-18
personal O 0 7.366565074140661e-16
and O 0 1.8955341040283874e-13
/ O 0 1.6123355095487568e-08
or O 0 1.9034612482125152e-13
family O 0 1.5354375756948535e-12
history O 0 2.7784176530125902e-14
of O 0 1.634870652675804e-19
neoplasia B-Disease 0 2.4288511740050422e-12
, O 0 1.588713392366989e-16
were O 0 9.309009219099498e-17
examined O 0 2.537206555963678e-13
for O 0 2.470510970600382e-18
the O 0 4.106432602773344e-17
I1307K O 0 5.926982537575454e-13
variant O 0 2.451619094366586e-13
by O 0 2.9816310409757264e-18
the O 0 3.5488222109174677e-17
allele O 0 1.945279603631639e-14
- O 0 1.7922005025872156e-12
specific O 0 6.515945365871212e-15
oligonucleotide O 0 2.8174657051849294e-10
( O 0 4.6256316783626836e-14
ASO O 0 1.4089700961505969e-08
) O 0 1.6902098828953439e-15
method O 0 1.0187800039349049e-12
. O 0 3.085647243359496e-13

RESULTS O 0 1.1872363092635396e-09
In O 0 2.667453658180581e-16
persons O 0 2.313601938695953e-16
at O 0 1.19984266798304e-14
average O 0 1.6424096457856585e-11
risk O 0 3.221509448092519e-10
for O 0 4.356889848899925e-10
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 5.717048199866542e-14
I1307K O 0 2.068145307787539e-11
was O 0 1.571668820478725e-13
found O 0 2.1767147969747576e-15
in O 0 2.521710786995842e-16
5 O 0 2.569014879300058e-13
. O 0 4.092679157814e-13

0 O 0 3.0151547925072464e-11
% O 0 2.7515190312176103e-16
of O 0 1.5240769699065033e-18
120 O 0 3.722064973940564e-13
European O 0 8.348612079434048e-11
and O 0 1.1541697285399888e-11
1 O 0 1.0692658780966924e-12
. O 0 1.4184424034641152e-12

6 O 0 1.626387219344494e-10
% O 0 2.612770322836587e-15
of O 0 2.326237023291027e-18
188 O 0 1.2340477218656526e-13
non O 0 3.3295718612769143e-13
- O 0 1.151115469610886e-08
European O 0 1.487686276252509e-12
Jews O 0 1.4952213187209573e-13
( O 0 4.600781002239663e-15
P O 0 2.21002993683328e-09
= O 0 8.209965346450687e-11
0 O 0 3.912715217471198e-14
. O 0 2.238164125622301e-16
08 O 0 4.9740254775242077e-14
) O 0 8.01752789355572e-16
. O 0 4.525430391207931e-14

It O 0 1.4373001053225032e-11
occurred O 0 2.7381340250709485e-11
in O 0 5.008100829486772e-16
15 O 0 2.576409680217495e-13
. O 0 1.720746212619667e-13

4 O 0 8.809733324788294e-12
% O 0 6.617997589422305e-16
of O 0 9.125157078303257e-18
52 O 0 1.1585411449632765e-11
Ashkenazi O 0 9.006819290391377e-09
Israelis O 0 3.4652662961320857e-09
with O 0 1.3280858617709113e-12
familial O 0 1.673847873462364e-05
cancer B-Disease 0 1.3726927136303857e-05
( O 0 6.180956896480183e-13
P O 0 9.024751489050686e-05
= O 0 1.1926065326406388e-06
0 O 0 1.196457689867092e-11
. O 0 1.7365551000219498e-14
02 O 0 3.0972236494258842e-12
) O 0 9.76156568792767e-17
and O 0 1.846980328959946e-15
was O 0 1.2077831952877344e-13
not O 0 9.830019963167139e-14
detected O 0 3.2323665966060844e-10
in O 0 2.000233576590193e-15
51 O 0 1.8544649149632164e-10
non O 0 8.587856310414074e-14
- O 0 3.2588245990616826e-10
European O 0 2.679451170488345e-13
Jews O 0 8.582055659384687e-15
at O 0 4.171623035073915e-14
increased O 0 1.9410712186890278e-12
cancer B-Disease 0 1.3390959174852668e-10
risk O 0 1.1548120315910126e-12
. O 0 9.218030527259613e-14

Colorectal B-Disease 0 0.0007202629349194467
neoplasia I-Disease 0 7.082761840138119e-06
occurred O 0 1.1347356831947764e-08
personally O 0 2.499500051378334e-10
or O 0 1.2579527534656992e-13
in O 0 7.913578951477488e-16
the O 0 3.647467019445103e-15
families O 0 8.404986174618254e-17
of O 0 1.06809205457421e-19
13 O 0 7.439906480669859e-16
of O 0 4.1262269883028286e-20
20 O 0 8.258978340939702e-16
Ashkenazi O 0 4.279523783956574e-12
I1307K O 0 1.4021382254043868e-13
carriers O 0 3.968299806458983e-15
, O 0 2.4007325122108586e-16
8 O 0 1.936187297865927e-15
of O 0 6.736889780876879e-19
whom O 0 2.398393983416014e-12
also O 0 3.6498550709529454e-11
had O 0 6.98391622311334e-10
a O 0 5.272668288308982e-15
personal O 0 8.588282537393133e-14
or O 0 1.4174275089155058e-13
family O 0 1.7884441757404224e-12
history O 0 1.948689690514649e-13
of O 0 5.381889851665194e-17
noncolonic O 0 1.5284476262422686e-07
neoplasia B-Disease 0 2.83172482795635e-07
. O 0 2.2810513894411244e-11

CONCLUSIONS O 0 5.25533228046271e-10
The O 0 1.5984841556415837e-14
I1307K O 0 7.759707459920051e-11
APC O 0 1.1144722297795617e-12
variant O 0 3.9478215141386386e-10
may O 0 9.0054571059376e-14
represent O 0 5.772471302022933e-17
a O 0 1.1886448924203381e-14
susceptibility O 0 2.0163151703833648e-10
gene O 0 3.2254013349053423e-10
for O 0 2.7223301805640206e-14
colorectal B-Disease 1 1.0
, I-Disease 0 1.1468059835095801e-10
or I-Disease 0 7.283059246833423e-13
other I-Disease 0 2.220662022323072e-12
, I-Disease 0 1.2102784330281224e-09
cancers I-Disease 0 8.341208013007417e-05
in O 0 1.2431163107088413e-14
Ashkenazi O 0 2.353032790836096e-08
Jews O 0 2.0570120259910674e-11
, O 0 2.019804245731449e-12
and O 0 3.723331105237593e-12
partially O 0 6.495214366353252e-10
explains O 0 4.127198235948093e-11
the O 0 3.4788296947290277e-16
higher O 0 1.5688137773453917e-14
incidence O 0 1.5353697335740435e-06
of O 0 4.145053467130566e-10
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 6.074508300882298e-13
European O 0 1.0170182057622768e-10
Israelis O 0 5.87974613441844e-10
. O 0 2.6319760173393325e-12

Systematic O 0 6.430229126941356e-10
analysis O 0 2.7209105194631045e-12
of O 0 3.4196604728963746e-16
coproporphyrinogen O 0 3.042507756845225e-08
oxidase O 0 5.17462126481405e-08
gene O 0 1.3022366829318344e-06
defects O 0 0.00035299561568535864
in O 0 5.284914351847206e-14
hereditary B-Disease 0 0.0004024708177894354
coproporphyria I-Disease 0 1.4822598132013809e-05
and O 0 4.2554574447573046e-11
mutation O 0 6.74859779170589e-10
update O 0 1.4633403822017499e-08
. O 0 2.1854679524424547e-11

Hereditary B-Disease 1 0.9750731587409973
coproporphyria I-Disease 0 8.029002492548898e-05
( O 0 8.378912797965543e-13
HC B-Disease 0 1.191985688819841e-06
) O 0 8.656305381694873e-13
is O 0 6.069111142467665e-13
an O 0 2.390027845772247e-12
acute O 1 0.9658795595169067
hepatic B-Disease 1 0.9999784231185913
porphyria I-Disease 1 0.9999980926513672
with O 0 1.8122083247362752e-06
autosomal O 1 0.9999741315841675
dominant O 1 0.5923890471458435
inheritance O 0 2.1103610379213933e-06
caused O 0 4.367483708023201e-09
by O 0 5.985438043094003e-15
deficient B-Disease 0 8.915586136026832e-08
activity I-Disease 0 3.922627847541271e-12
of I-Disease 0 1.1372053915088403e-16
coproporphyrinogen I-Disease 0 4.4895244855069905e-08
III I-Disease 0 1.584928716047429e-10
oxidase I-Disease 0 4.533731376432648e-11
( O 0 6.182814083979674e-15
CPO O 0 2.8105043292647736e-10
) O 0 7.589490423924247e-14
. O 0 9.314641072344365e-13

Clinical O 0 2.959046696560108e-06
manifestations O 0 1.8495655007555456e-10
of O 0 1.4476943974593075e-15
the O 0 1.6364393564186064e-12
disease O 0 1.934262172653689e-06
are O 0 5.025168543373946e-17
characterized O 0 8.128342291781332e-13
by O 0 2.139610518720283e-15
acute O 0 6.111094563721053e-08
attacks O 0 2.737292788879131e-06
of O 0 2.657718663201525e-12
neurological B-Disease 1 0.9999880790710449
dysfunction I-Disease 0 4.991069999960018e-06
often O 0 1.97486327963535e-13
precipitated O 0 1.5142169134774e-14
by O 0 3.549388995073189e-18
drugs O 0 8.58708652687161e-14
, O 0 8.69474820494007e-16
fasting O 0 1.6529674493320073e-13
, O 0 4.2976024994289316e-15
cyclical O 0 1.1482993445000034e-09
hormonal O 0 4.5110221114086357e-10
changes O 0 1.1641319852540022e-11
, O 0 3.397483303805432e-13
or O 0 9.166912888491918e-12
infectious B-Disease 0 6.026335540809669e-06
diseases I-Disease 0 0.0004318100691307336
. O 0 1.5602012737314652e-11

Skin O 1 0.9999821186065674
photosensitivity O 1 0.9984583854675293
may O 0 5.201387764941501e-08
also O 0 7.033625418206846e-12
be O 0 1.2551957628663402e-14
present O 0 7.63328948118723e-14
. O 0 4.1155074140264425e-12

The O 0 7.078825102046354e-14
seven O 0 6.517433602759538e-16
exons O 0 9.346095471434064e-15
, O 0 3.410279384482186e-17
the O 0 3.8442954270605944e-18
exon O 0 6.70332821368913e-13
/ O 0 6.775389582713842e-09
intron O 0 8.246261273825439e-08
boundaries O 0 7.703911286682796e-09
and O 0 4.150622716619229e-14
part O 0 8.24371216025222e-16
of O 0 6.267772080850599e-18
3 O 0 1.5221212767104115e-15
noncoding O 0 2.2578073091694684e-11
sequence O 0 2.6862583338282953e-12
of O 0 1.0232988285371798e-18
the O 0 7.274103222316177e-17
CPO O 0 3.0823978786065354e-11
gene O 0 1.923109891818764e-12
were O 0 8.247329520332588e-16
systematically O 0 4.467287542490872e-13
analyzed O 0 2.9426395749691304e-16
by O 0 1.2965140871657359e-20
an O 0 3.2189074377950444e-20
exon O 0 1.1768286133995512e-14
- O 0 1.2726894191295024e-12
by O 0 1.9469257433432006e-16
- O 0 2.3670012130883045e-11
exon O 0 1.9813366225474027e-10
denaturing O 0 5.921810952713713e-07
gradient O 0 1.9905954662391423e-09
gel O 0 5.757891496926959e-09
electrophoresis O 0 7.645467592354294e-11
( O 0 4.173586288039061e-15
DGGE O 0 7.917434069470985e-11
) O 0 1.9043226330742695e-16
strategy O 0 2.343868490544158e-15
followed O 0 4.4655039311848554e-18
by O 0 2.1298739166091194e-20
direct O 0 3.551490364701319e-17
sequencing O 0 7.678395679694416e-14
in O 0 2.6999368423121916e-16
seven O 0 1.2482864304122921e-14
unrelated O 0 9.22369819411628e-13
heterozygous O 0 4.6845673173923075e-11
HC B-Disease 0 1.5861830604535498e-07
patients O 0 5.002256830977103e-09
from O 0 7.0914983242998785e-15
France O 0 9.471821016404647e-08
, O 0 3.8031868778397315e-13
Holland O 0 1.26871242400739e-08
, O 0 1.6962929812961575e-13
and O 0 5.762549183489785e-13
Czech O 0 1.58058549004636e-06
Republic O 0 1.5053405633125294e-08
. O 0 1.187291671228552e-11

Seven O 0 3.1055897437015645e-11
novel O 0 2.2639813201247305e-12
mutations O 0 6.015370423995137e-10
and O 0 1.9296958914680543e-14
two O 0 4.6534994196693747e-17
new O 0 2.350789067360581e-16
polymorphisms O 0 2.764365125695889e-12
were O 0 1.5579507492034447e-14
detected O 0 7.653117028993961e-10
. O 0 1.8473213410363787e-12

Among O 0 1.1226197922653558e-12
these O 0 1.6203523440540268e-14
mutations O 0 8.36397184150739e-12
two O 0 1.2656769697314886e-15
are O 0 2.92672064951667e-16
missense O 0 1.7051619005670204e-09
( O 0 3.0463408657894087e-15
G197W O 0 1.59479547623409e-11
, O 0 1.6719591816182107e-15
W427R O 0 1.3289372857369641e-12
) O 0 1.2631729550509476e-16
, O 0 1.7183394764967448e-16
two O 0 8.282799024998861e-16
are O 0 3.4376328179712163e-15
nonsense O 0 6.141727681985287e-10
( O 0 2.0662080993491034e-16
Q306X O 0 1.0230756129422924e-12
, O 0 1.4727377735778281e-15
Q385X O 0 4.732907859031354e-13
) O 0 4.106276100201449e-17
, O 0 9.687484715756401e-17
two O 0 8.02382730405423e-17
are O 0 2.3200083532785027e-17
small O 0 9.790028827221832e-15
deletions O 0 2.5292150596101237e-09
( O 0 8.428915490652899e-15
662de14bp O 0 6.061814678687272e-12
; O 0 3.0864488287539655e-16
1168del3bp O 0 3.362201467758952e-13
removing O 0 9.948411282864177e-15
a O 0 2.9650404200504544e-16
glycine O 0 1.223330789966448e-13
at O 0 3.6796940819892876e-15
position O 0 3.4655332362208257e-15
390 O 0 5.155045693363224e-16
) O 0 2.491153544028051e-16
, O 0 2.9882060300040307e-15
and O 0 1.8622309030653754e-14
one O 0 4.961834301720966e-16
is O 0 4.805209224377214e-18
a O 0 3.8780989899731865e-18
splicing O 0 9.450616504647069e-12
mutation O 0 1.0225567137825409e-12
( O 0 9.386173258849875e-17
IVS1 O 0 3.8440601396461105e-11
- O 0 1.7215128628178533e-11
15c O 0 3.4424804586791202e-12
- O 0 4.212043040741076e-12
- O 0 1.2857385295328427e-11
> O 0 5.540722503201423e-13
g O 0 6.883113003175456e-12
) O 0 4.6189944075973377e-17
which O 0 6.8411046118912094e-18
creates O 0 6.938694718815726e-17
a O 0 3.8118064195774717e-17
new O 0 9.420506680575644e-16
acceptor O 0 1.060454079149925e-14
splice O 0 8.490473601963089e-11
site O 0 4.835419564752641e-11
. O 0 1.2723326081945374e-12

The O 0 8.167536742417769e-13
pathological O 0 2.3934231332956024e-11
significance O 0 5.614485384854845e-14
of O 0 3.759228834610131e-17
the O 0 1.7333772229862648e-15
point O 0 1.6777886588728586e-12
mutations O 0 1.928667728995359e-12
G197W O 0 1.9665825500177203e-13
, O 0 8.607193453207047e-17
W427R O 0 8.464814949243199e-14
, O 0 1.0846696287932704e-16
and O 0 1.3155881479204318e-16
the O 0 1.416694864326707e-17
in O 0 1.815960156016701e-16
- O 0 1.707295971264955e-10
frame O 0 1.60023305717516e-09
deletion O 0 1.7741143623628552e-11
390delGly O 0 2.4518915543725317e-12
were O 0 1.6297537599354604e-17
assessed O 0 2.3839666199855928e-17
by O 0 5.094399424741572e-18
their O 0 3.500049405304965e-15
respective O 0 1.3240636072362616e-13
expression O 0 2.5228863628475127e-15
in O 0 4.100622568868833e-18
a O 0 4.027529498503136e-17
prokaryotic O 0 1.6655035464804916e-16
system O 0 3.7707187041907377e-17
using O 0 3.089687009241539e-17
site O 0 1.625318911575857e-12
- O 0 7.880867486376175e-11
directed O 0 9.804026340765049e-11
mutagenesis O 0 8.49837908378781e-11
. O 0 7.516512911219519e-13

These O 0 7.361944387440644e-12
mutations O 0 2.51425075203926e-10
resulted O 0 1.237175103032187e-13
in O 0 1.4295181821419734e-16
the O 0 8.836389054379934e-16
absence O 0 2.1329375508101663e-14
or O 0 9.069877921455318e-17
a O 0 3.2620795221803686e-16
dramatic O 0 5.109534757102852e-13
decrease O 0 1.6496988237274524e-12
of O 0 1.3758874969931794e-16
CPO O 0 2.169808794860728e-07
activity O 0 2.8358071446632493e-10
. O 0 3.5837257640614073e-12

The O 0 3.293341687142688e-14
two O 0 2.651849458407585e-16
polymorphisms O 0 9.258880554613436e-13
were O 0 1.371638038575923e-15
localized O 0 3.789344272392414e-12
in O 0 1.5551895912019852e-14
noncoding O 0 4.67797534042802e-08
part O 0 9.564196629769858e-14
of O 0 2.1066207774533513e-18
the O 0 1.721376255048774e-17
gene O 0 1.026538202315505e-14
1 O 0 2.281609181677719e-18
) O 0 4.372638018174752e-19
a O 0 7.232516551583952e-17
C O 0 1.122348481513713e-11
/ O 0 1.3662314335416426e-10
G O 0 9.31249608676632e-12
polymorphism O 0 1.2306541419607187e-12
in O 0 1.6966375924155831e-15
the O 0 6.322895122247169e-15
promotor O 0 1.0347736001392605e-09
region O 0 1.644496388022998e-12
, O 0 1.12507246510259e-15
142 O 0 5.8675869610107234e-15
bp O 0 1.5057496333234673e-14
upstream O 0 2.3539039251449902e-15
from O 0 1.982370003491155e-20
the O 0 3.07740203814651e-20
transcriptional O 0 7.182453463329874e-16
initiation O 0 2.0512296617095035e-18
site O 0 2.1115398468482755e-15
( O 0 3.1668927388947885e-17
- O 0 2.684716598339021e-12
142C O 0 2.5512286727646938e-11
/ O 0 1.8817896893508212e-11
G O 0 3.847202775537212e-13
) O 0 8.628590630420324e-18
, O 0 1.0455746245894012e-16
and O 0 1.8415419539220997e-15
2 O 0 1.9510223387832573e-16
) O 0 2.920784048706632e-18
a O 0 2.1572784348599256e-17
6 O 0 5.545027603212984e-16
bp O 0 3.1394592210875734e-15
deletion O 0 2.012311419385092e-14
polymorphism O 0 2.2307591836029025e-14
in O 0 1.5097157909836026e-17
the O 0 6.050282888599073e-17
3 O 0 7.763062784937175e-16
noncoding O 0 2.288006069328663e-11
part O 0 2.313152958294349e-15
of O 0 2.1516146464877138e-18
the O 0 1.1575971803183955e-16
CPO O 0 9.858706906396009e-11
gene O 0 3.531907297009418e-13
, O 0 3.1263694915580607e-17
574 O 0 5.271378786525906e-16
bp O 0 3.0642780589969394e-15
downstream O 0 1.648111286625621e-15
of O 0 8.16678649947872e-21
the O 0 2.549711446300803e-18
last O 0 8.938259589363841e-17
base O 0 1.709221516220643e-14
of O 0 9.900041367976728e-20
the O 0 9.521445082270877e-17
normal O 0 5.820598452006831e-13
termination O 0 2.0513835584639456e-13
codon O 0 7.465703944810331e-13
( O 0 2.517214418474461e-15
+ O 0 1.539537269369673e-12
574 O 0 5.13625123335637e-12
delATTCTT O 0 2.5077323551059294e-10
) O 0 1.6164574832746442e-13
. O 0 8.690152005115526e-13

Five O 0 2.705211922526818e-11
intragenic O 0 2.1776764835834683e-09
dimorphisms O 0 1.4290761907176375e-09
are O 0 2.1655928732124824e-14
now O 0 5.031259154957002e-13
well O 0 4.677834318901966e-15
characterized O 0 6.588583438592657e-14
and O 0 3.6978887732127836e-15
the O 0 3.954227730468892e-17
high O 0 2.85028916091677e-15
degree O 0 1.905348098805819e-15
of O 0 1.7984607407037384e-19
allelic O 0 1.1870148960979598e-12
heterogeneity O 0 1.4541461090811225e-10
in O 0 8.848333171848285e-15
HC B-Disease 0 1.0870002853380356e-07
is O 0 4.5872451616326554e-14
demonstrated O 0 3.752327157216344e-15
with O 0 1.796275308845858e-17
seven O 0 4.088083420681203e-17
new O 0 1.2370735042094907e-17
different O 0 9.970241188034383e-18
mutations O 0 4.981012821712698e-14
making O 0 4.826629893519887e-18
a O 0 1.325309703874747e-16
total O 0 1.4938079828385748e-16
of O 0 1.0354446730230563e-17
nineteen O 0 4.897289171412744e-12
CPO O 0 5.999998506922566e-07
gene B-Disease 0 2.009441573136428e-07
defects I-Disease 0 2.5596127670723945e-05
reported O 0 2.8779849597232454e-12
so O 0 7.046845203716179e-14
far O 0 1.8526062032109963e-13
. O 0 5.279967679435241e-14
. O 0 9.519793807422072e-13

Coincidence O 0 5.5802237830526735e-11
of O 0 9.55612247878257e-17
two O 0 1.627165114752088e-15
novel O 0 5.385782423338037e-13
arylsulfatase O 0 4.610948012295779e-10
A O 0 1.5136574990377155e-13
alleles O 0 4.5382515562360226e-13
and O 0 3.4944497382533024e-13
mutation O 0 2.361358938246516e-12
459 O 0 1.6049767309449237e-13
+ O 0 6.178411189779187e-13
1G O 0 5.561228144657093e-10
> O 0 1.0430992875010148e-11
A O 0 4.466733515180732e-13
within O 0 6.818943027147705e-15
a O 0 4.1354761412190633e-13
family O 0 3.3659988685208475e-10
with O 0 3.2795217652648034e-09
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 0.9999992847442627
: O 0 6.504298239329992e-15
molecular O 0 3.045818034702716e-15
basis O 0 2.765767713577204e-16
of O 0 1.6744210167049563e-17
phenotypic O 0 2.977858237773745e-10
heterogeneity O 0 1.505649947830534e-06
. O 0 1.7369038429748684e-09

In O 0 2.3752286148668277e-14
a O 0 2.091850523637702e-14
family O 0 2.6321992681191744e-14
with O 0 2.1682863956331037e-15
three O 0 1.095327526731216e-14
siblings O 0 1.6093203158984437e-13
, O 0 9.3775439452636e-18
one O 0 1.0962335475823127e-16
developed O 0 2.180016014713057e-13
classical O 0 3.0096922176703345e-10
late O 0 4.794467827196058e-07
infantile O 1 0.9998749494552612
metachromatic B-Disease 1 0.9999997615814209
leukodystrophy I-Disease 1 0.9999991655349731
( O 0 6.981035888253828e-11
MLD B-Disease 1 0.9999737739562988
) O 0 3.423448997159559e-14
, O 0 5.557863011100084e-15
fatal O 0 9.003512518868106e-11
at O 0 8.802909031054018e-13
age O 0 1.293732915935708e-12
5 O 0 4.803148100063735e-14
years O 0 2.5300857193827006e-15
, O 0 1.83536348384659e-15
with O 0 2.6460923025200395e-14
deficient O 0 3.937455161917569e-08
arylsulfatase O 0 5.159143112720699e-10
A O 0 7.274131926145178e-13
( O 0 1.2647889615654108e-15
ARSA O 0 5.743544750913543e-09
) O 0 6.734869607297677e-16
activity O 0 2.561729040700955e-13
and O 0 1.1521884249639236e-14
increased O 0 5.935478887900136e-13
galactosylsulfatide O 0 1.6536314717541245e-07
( O 0 4.959988040946495e-13
GS O 1 0.9999942779541016
) O 0 6.997048475560277e-14
excretion O 0 7.591173241221216e-13
. O 0 5.679868467917126e-13

The O 0 2.5137528235179285e-13
two O 0 1.8763808425591427e-15
other O 0 4.89414154615877e-16
siblings O 0 3.573201196732656e-12
, O 0 3.1098645251852186e-14
apparently O 0 5.900931826507971e-11
healthy O 0 6.346798222612096e-14
at O 0 5.405309412684269e-15
12 O 0 1.0495387387825513e-16
( O 0 2.155607240509354e-18
1 O 0 2.448241266733372e-16
/ O 0 2.602270395696271e-12
2 O 0 2.980474419140612e-16
) O 0 2.039908288819674e-17
and O 0 1.376124242701937e-15
15 O 0 1.0179548786477984e-15
years O 0 5.851755571119406e-17
, O 0 1.0379406078033738e-16
respectively O 0 5.890908213268358e-16
, O 0 4.252478936746327e-15
and O 0 2.5416095009861417e-13
their O 0 1.765268161681155e-14
father O 0 1.607585592422467e-11
, O 0 1.6138937178312128e-14
apparently O 0 2.353180367578589e-12
healthy O 0 3.994161892860584e-16
as O 0 8.146138365329383e-18
well O 0 2.5075154677119257e-15
, O 0 7.32920139204609e-16
presented O 0 8.125295683676648e-15
ARSA O 0 5.13517989020329e-07
and O 0 5.899458005442781e-11
GS O 1 0.9999990463256836
values O 0 1.7733505500638555e-14
within O 0 5.04448982812196e-17
the O 0 2.9294780064577787e-17
range O 0 1.0627994794995543e-13
of O 0 3.022749304142482e-15
MLD B-Disease 1 0.9999967813491821
patients O 0 1.908387226023933e-09
. O 0 9.502886758744333e-13

Mutation O 0 2.7890745268877026e-10
screening O 0 4.0709616233591817e-11
and O 0 2.867104882502136e-15
sequence O 0 3.2380202035289796e-13
analysis O 0 1.2019499165492192e-14
disclosed O 0 5.617463213884212e-14
the O 0 1.3799287540502562e-17
involvement O 0 7.957324815071384e-15
of O 0 1.6631717326055108e-18
three O 0 2.7166646312897207e-15
different O 0 5.407660776145847e-15
ARSA O 0 1.0955220659525367e-06
mutations O 0 2.9636978982061635e-10
being O 0 2.7910775874367543e-16
the O 0 5.642167421963348e-19
molecular O 0 4.002873573783535e-15
basis O 0 1.2048958971397697e-16
of O 0 4.613869527394204e-17
intrafamilial O 0 4.0133963352673163e-07
phenotypic O 0 8.503868720310948e-09
heterogeneity O 0 1.402427528773842e-06
. O 0 1.293399165547271e-09

The O 0 5.631866067251634e-12
late O 0 2.8061816759183955e-10
infantile O 0 0.00023863838578108698
patient O 0 8.553395218768856e-07
inherited O 0 4.387290175600356e-08
from O 0 1.0053740041613486e-15
his O 0 5.072153634599896e-12
mother O 0 4.76020167727853e-10
the O 0 1.2500197245201704e-16
frequent O 0 3.4471982560124736e-12
0 O 0 1.6561872316286919e-12
- O 0 3.9060274459323807e-10
type O 0 6.421579712423409e-09
mutation O 0 3.6084888549448024e-11
459 O 0 9.634761928166077e-14
+ O 0 4.040677501252442e-14
1G O 0 3.1103796621634316e-11
> O 0 2.4926499124326706e-13
A O 0 3.5431754101880597e-13
, O 0 3.0091407881085996e-14
and O 0 9.75227589113635e-14
from O 0 6.682047706264613e-17
his O 0 7.324457202860166e-14
father O 0 2.7703861882506786e-13
a O 0 1.1399807479000782e-16
novel O 0 1.3085822166527053e-14
, O 0 3.3342694932968924e-16
single O 0 1.3917933993140758e-15
basepair O 0 2.9091726857360944e-12
microdeletion O 0 5.782356472978922e-13
of O 0 6.807181004392221e-19
guanine O 0 2.0287375566366977e-13
at O 0 2.4712969741620423e-15
nucleotide O 0 4.5599063262270756e-14
7 O 0 6.32226503561353e-16
in O 0 6.3778751970553884e-18
exon O 0 2.6839125540079056e-12
1 O 0 2.7051782038392536e-13
( O 0 7.340816966610025e-15
7delG O 0 1.936895088761048e-09
) O 0 2.3348131154149465e-13
. O 0 4.654440895202061e-13

The O 0 6.673073118385053e-12
two O 0 4.658251323737261e-13
clinically O 0 3.492910849445252e-09
unaffected O 0 1.6612272446536736e-08
siblings O 0 8.463927891888545e-10
carried O 0 9.074992840529816e-11
the O 0 1.3805705304003116e-14
maternal O 0 3.297873640839555e-10
mutation O 0 1.857957581188896e-12
459 O 0 2.763577940708556e-13
+ O 0 1.4470526556523144e-13
1G O 0 1.049706085942681e-10
> O 0 2.2762566571216114e-12
A O 0 5.803751142868796e-12
and O 0 9.661518004903946e-14
, O 0 2.8384514519624177e-15
on O 0 9.563571180641606e-15
their O 0 1.4594106630648473e-15
paternal O 0 2.7987472907796407e-13
allele O 0 1.6810268810768048e-16
, O 0 1.2647442673425534e-17
a O 0 7.220301575478381e-18
novel O 0 4.886439475569387e-15
cytosine O 0 1.6560346572779688e-13
to O 0 4.893653443422915e-17
thymidine O 0 4.160415501691661e-12
transition O 0 1.3636884861351756e-13
at O 0 4.631402513832327e-15
nucleotide O 0 1.0573523800223514e-13
2435 O 0 1.1655712202698898e-12
in O 0 9.003617776539616e-18
exon O 0 3.286188324496536e-14
8 O 0 1.882060452580367e-13
, O 0 1.0129423494241842e-15
resulting O 0 3.49855047462568e-17
in O 0 1.987991083494365e-18
substitution O 0 2.014745368559027e-15
of O 0 2.9309058959709253e-19
alanine O 0 1.024640355201667e-11
464 O 0 5.4436557800525975e-14
by O 0 6.078578421248797e-16
valine O 0 4.045054993184749e-07
( O 0 9.147826234305514e-15
A464V O 0 2.1759056362258278e-11
) O 0 3.516740189530611e-14
. O 0 1.0687678091711797e-13

The O 0 5.855585656112938e-13
fathers O 0 4.025496515985827e-12
genotype O 0 2.532420345473241e-13
thus O 0 8.847219323522646e-15
was O 0 2.588566297076489e-13
7delG O 0 5.219674292789023e-08
/ O 0 4.6093259697954636e-07
A464V O 0 3.379691904115134e-08
. O 0 7.537534832402493e-12

Mutation O 0 1.1326727999971808e-08
A464V O 0 4.730998925950303e-11
was O 0 3.69199909902064e-14
not O 0 4.227729375181385e-16
found O 0 2.0472303526356504e-15
in O 0 4.55601552273551e-16
18 O 0 6.352493401098891e-13
unrelated O 0 8.704664211656166e-10
MLD B-Disease 1 0.9999996423721313
patients O 0 6.295383769838736e-08
and O 0 6.180741817874216e-14
50 O 0 1.8920736017443568e-13
controls O 0 4.3622570956358686e-05
. O 0 1.5921702845034247e-10

A464V O 0 4.212499238320788e-09
, O 0 6.901010524747869e-14
although O 0 4.232575187145156e-14
clearly O 0 3.186263102319953e-13
modifying O 0 2.428500282813939e-11
ARSA O 0 0.00019584811525419354
and O 0 3.669383730198206e-08
GS O 1 0.9999998807907104
levels O 0 2.873606685938057e-09
, O 0 1.1393282964202583e-13
apparently O 0 9.84123477154597e-11
bears O 0 1.4697887004699872e-11
little O 0 1.1519334680468e-14
significance O 0 1.2447533712859997e-14
for O 0 3.182029482360019e-17
clinical O 0 5.4934534568854e-13
manifestation O 0 5.339483517737822e-15
of O 0 4.484437599097827e-17
MLD B-Disease 1 0.9999969005584717
, O 0 1.5198708584003226e-14
mimicking O 0 3.3096034593449453e-12
the O 0 1.6208461430864524e-15
frequent O 0 3.349194532820121e-10
ARSA O 0 3.846006438834593e-05
pseudodeficiency O 0 4.899223426946264e-08
allele O 0 7.830690540444607e-10
. O 0 1.6170759176148408e-11

Our O 0 1.309198999210892e-10
results O 0 2.590996536246115e-13
demonstrate O 0 4.619261355324621e-16
that O 0 8.917581893847363e-18
in O 0 1.2790370177492806e-18
certain O 0 8.641087079544734e-15
genetic O 0 1.5768915062608357e-08
conditions O 0 3.3141189792473824e-09
MLD B-Disease 1 0.9999867677688599
- O 0 1.9359642777772024e-09
like O 0 1.900467561100072e-10
ARSA O 0 4.973791146767326e-05
and O 0 7.350783315374088e-10
GS O 1 0.9999988079071045
values O 0 1.1127389157664092e-12
need O 0 2.5614920070009956e-15
not O 0 4.770072990779738e-17
be O 0 4.401256813007862e-18
paralleled O 0 3.018638670190116e-13
by O 0 1.4929997545882166e-15
clinical O 0 9.797104638664678e-08
disease O 0 4.013849320472218e-05
, O 0 3.4649762061788876e-16
a O 0 1.789007911742204e-15
finding O 0 2.1231555061155052e-14
with O 0 4.712149317661132e-15
serious O 0 4.3001491039848516e-13
diagnostic O 0 1.5888167226307814e-08
and O 0 1.84999411623199e-12
prognostic O 0 3.623817747211433e-06
implications O 0 4.4116816866335284e-09
. O 0 1.9540700654796517e-11

Moreover O 0 2.015958733281309e-09
, O 0 9.65669709994399e-13
further O 0 1.0132497271775343e-11
ARSA O 0 0.00010873669816646725
alleles O 0 4.004636032506337e-12
functionally O 0 2.1650486037218947e-13
similar O 0 4.881613928868879e-15
to O 0 3.894219151925069e-15
A464V O 0 7.951669878103473e-10
might O 0 9.715808019228334e-11
exist O 0 1.2068954342858706e-11
which O 0 3.570343144938294e-14
, O 0 3.026903365474054e-15
together O 0 2.7967488435955363e-15
with O 0 2.4231838086921035e-15
0 O 0 3.868728688100065e-12
- O 0 8.100928816645592e-10
type O 0 8.83773836335422e-08
mutations O 0 1.363925949959821e-08
, O 0 1.3991836389590923e-13
may O 0 4.1672112809088e-13
cause O 0 2.1556950560545907e-13
pathological O 0 3.9729037837332726e-08
ARSA O 0 0.0010643734131008387
and O 0 2.0192311467326363e-07
GS O 1 1.0
levels O 0 1.0417622320346709e-09
, O 0 9.743754570280382e-15
but O 0 7.820674175536974e-14
not O 0 2.4800907855171417e-14
clinical O 0 6.318540742705769e-12
outbreak O 0 4.417636395581681e-12
of O 0 7.185898306621688e-18
the O 0 4.578795025425575e-13
disease O 0 1.3836692005497753e-06
. O 0 9.775731122830416e-16
. O 0 1.5446896691438672e-13

Human O 0 2.540971036069095e-05
MLH1 O 1 0.9845387935638428
deficiency O 1 0.6788861751556396
predisposes O 0 3.7082572816871107e-06
to O 0 3.902184964044153e-10
hematological B-Disease 1 0.9414231181144714
malignancy I-Disease 1 0.8722050189971924
and O 0 2.4828328282211487e-09
neurofibromatosis B-Disease 1 0.9963575005531311
type I-Disease 0 0.0017004901310428977
1 I-Disease 0 3.8195471091517774e-11
. O 0 1.745044213297131e-11

Heterozygous O 0 7.85190312768691e-09
germ O 0 1.53779495803974e-07
- O 0 4.7287420557040605e-07
line O 0 9.793569510918587e-09
mutations O 0 5.2250929277741776e-12
in O 0 1.9088298988730403e-18
the O 0 7.363751733615695e-17
DNA O 0 1.4997413033679408e-11
mismatch O 0 1.0624930796288012e-10
repair O 0 4.359001215537006e-10
genes O 0 4.398167247066098e-11
lead O 0 7.190287809599738e-10
to O 0 8.264132433932758e-12
hereditary B-Disease 1 0.9998763799667358
nonpolyposis I-Disease 1 0.9999896287918091
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.29261434678574e-09

The O 0 6.970847232778965e-10
disease O 0 9.105249887397804e-07
susceptibility O 0 1.6392369406315055e-10
of O 0 2.38189403624278e-17
individuals O 0 1.6594297008558356e-14
who O 0 6.216530623603944e-10
constitutionally O 0 2.070240157081571e-08
lack O 0 3.74062968100386e-11
both O 0 7.256796075508221e-13
wild O 0 4.736384617842759e-09
- O 0 4.495179695140905e-08
type O 0 1.1290792301110741e-08
alleles O 0 5.438241003352662e-13
is O 0 4.083242262104686e-14
unknown O 0 4.826147727982066e-12
. O 0 2.4160202918149798e-12

We O 0 2.1800659055770666e-09
have O 0 5.267605064163475e-14
identified O 0 8.493084165638043e-14
three O 0 5.800485857962185e-16
offspring O 0 5.8437751707975105e-15
in O 0 7.92212246989063e-17
a O 0 3.889563584408284e-12
hereditary B-Disease 1 0.9977632761001587
nonpolyposis I-Disease 1 0.9999758005142212
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 5.277104833112389e-07
who O 0 1.3140304400138803e-09
developed O 0 3.5100061746007327e-10
hematological B-Disease 0 8.760754099057522e-06
malignancy I-Disease 0 3.133588961645728e-06
at O 0 2.1512385785498606e-13
a O 0 2.3229596939994225e-15
very O 0 1.1339446058294868e-14
early O 0 1.0655925198211486e-13
age O 0 3.832224048185874e-14
, O 0 2.971165791748083e-16
and O 0 3.974466206314994e-15
at O 0 3.0972424637217087e-15
least O 0 1.4798553649638264e-16
two O 0 7.599966061547767e-17
of O 0 9.119162836446209e-20
them O 0 1.3402219041996162e-15
displayed O 0 1.1436637227524304e-12
signs O 0 1.1941043856836253e-12
of O 0 6.145068522374789e-17
neurofibromatosis B-Disease 0 0.0009223317611031234
type I-Disease 0 3.643955039933644e-07
1 I-Disease 0 8.8969413433726e-14
( O 0 3.828233167751591e-15
NF1 B-Disease 0 5.666335312071169e-08
) O 0 4.4612588363107664e-13
. O 0 1.1600884098836306e-12

DNA O 0 4.265192365959791e-11
sequence O 0 2.563478943007347e-13
analysis O 0 5.767895735920984e-16
and O 0 1.418917829504882e-17
allele O 0 6.056194252128622e-17
- O 0 2.1308069241346428e-14
specific O 0 1.2529753930500551e-15
amplification O 0 3.392814187149623e-13
in O 0 9.30698944256699e-16
two O 0 1.6264250959473897e-13
siblings O 0 1.667456277221202e-11
revealed O 0 1.5445599714589836e-13
a O 0 3.3951346339086263e-15
homozygous O 0 5.440041472848378e-11
MLH1 O 0 1.1818843859146e-06
mutation O 0 6.749598796540468e-11
( O 0 1.0918144575824788e-15
C676T O 0 4.467104464112026e-11
- O 0 3.824145267117274e-08
- O 0 2.775445011593547e-07
> O 0 1.6015481996145553e-10
Arg226Stop O 0 3.5980458612527855e-09
) O 0 2.545858319893523e-14
. O 0 9.648995469811739e-14

Thus O 0 2.1957912918479927e-12
, O 0 7.588526881595098e-16
a O 0 5.471797899153706e-16
homozygous O 0 2.212743009655238e-12
germ O 0 1.1235714936219665e-07
- O 0 5.982936954751494e-07
line O 0 4.918867801961824e-08
MLH1 O 0 1.6133649296534713e-06
mutation O 0 5.625988563906503e-10
and O 0 1.0063649268305178e-13
consequent O 0 3.446912200111285e-10
mismatch O 0 0.00016130752919707447
repair O 1 0.9232968688011169
deficiency O 1 0.8316600322723389
results O 0 7.795822364389804e-13
in O 0 9.845113709122384e-16
a O 0 1.3408177346185823e-11
mutator O 0 0.0018861404387280345
phenotype O 0 1.56781709392817e-07
characterized O 0 8.461728540076763e-11
by O 0 3.1435113843555906e-14
leukemia B-Disease 0 0.0019182967953383923
and O 0 2.2698577240021223e-08
/ O 1 0.9999618530273438
or O 0 0.00016648313612677157
lymphoma B-Disease 1 1.0
associated O 0 1.221579708499121e-07
with O 0 1.696424251074191e-11
neurofibromatosis B-Disease 1 0.9455181956291199
type I-Disease 0 2.1444211597554386e-05
1 I-Disease 0 1.5325724901388976e-13
. O 0 3.783598936002615e-14
. O 0 1.2634742427644619e-12

Missense O 0 7.905485290393699e-06
mutations O 0 6.165701051941141e-07
in O 0 1.0240229168028098e-15
the O 0 3.676491582764617e-17
most O 0 8.526986174624057e-19
ancient O 0 1.4573125095149392e-16
residues O 0 6.02466156390119e-13
of O 0 3.706651901047523e-19
the O 0 3.68455255709562e-16
PAX6 O 0 4.365793060401302e-09
paired O 0 2.8472847343752328e-11
domain O 0 4.053748710406563e-13
underlie O 0 1.520510280184073e-12
a O 0 1.8734128391119636e-15
spectrum O 0 1.1164203242430837e-13
of O 0 2.3295885738446346e-15
human O 0 1.1620655016031378e-07
congenital B-Disease 1 0.9999954700469971
eye I-Disease 1 0.9999747276306152
malformations I-Disease 1 0.9998291730880737
. O 0 3.391871672420166e-08

Mutations O 0 8.785402627609074e-08
of O 0 5.681983301663348e-16
the O 0 5.608895052106261e-15
human O 0 1.4300255857940813e-12
PAX6 O 0 3.2052025744633283e-06
gene O 0 2.3553216124128085e-06
underlie O 0 0.000431733118603006
aniridia B-Disease 1 0.9999998807907104
( O 0 4.856970825528606e-09
congenital B-Disease 1 0.9999228715896606
absence I-Disease 0 7.909750632251189e-11
of I-Disease 0 3.567839424072307e-17
the I-Disease 0 7.845082785164822e-15
iris I-Disease 0 4.681882881385491e-09
) O 0 9.65561825101973e-15
, O 0 3.940168148214773e-15
a O 0 6.397821454475622e-14
rare O 0 2.6753814719171487e-09
dominant O 0 0.006698679644614458
malformation B-Disease 1 0.6730976104736328
of I-Disease 0 3.915653055957543e-16
the I-Disease 0 1.13854899900373e-12
eye I-Disease 0 0.0002954812371172011
. O 0 7.012209563006522e-11

The O 0 4.818692848711746e-14
spectrum O 0 1.690650115564185e-13
of O 0 1.2598044108988357e-16
PAX6 O 0 5.715407382922422e-07
mutations O 0 1.7583403177923174e-07
in O 0 1.931195546360509e-13
aniridia B-Disease 1 1.0
patients O 0 1.2492858303403409e-08
is O 0 6.33056344386756e-17
highly O 0 1.8562171173706356e-17
biased O 0 9.821502985896124e-12
, O 0 1.4051039079812904e-14
with O 0 1.3361585812725189e-15
92 O 0 1.3330396899172148e-12
% O 0 1.1599388293708596e-18
of O 0 1.1074959662759098e-20
all O 0 2.070990129731946e-16
reported O 0 3.3031711046960233e-12
mutations O 0 9.243537879566333e-11
leading O 0 2.898437512135338e-13
to O 0 2.1175410752795722e-15
premature O 0 1.6958820686727855e-13
truncation O 0 2.797042632229907e-11
of O 0 1.56823478268034e-16
the O 0 4.685299220266118e-15
protein O 0 5.661548920649073e-12
( O 0 2.009279544359734e-16
nonsense O 0 9.650547505221652e-13
, O 0 1.6429864577076855e-18
splicing O 0 8.03326809505631e-15
, O 0 1.9188254253180392e-17
insertions O 0 4.838678082882443e-14
and O 0 4.461456470273184e-16
deletions O 0 1.035581559741261e-12
) O 0 3.961749118342714e-16
and O 0 1.512450510969196e-14
just O 0 1.6456071531487093e-12
2 O 0 1.4176964079949412e-15
% O 0 4.787915772900874e-19
leading O 0 3.8696925188439325e-17
to O 0 4.1352581203812884e-19
substitution O 0 3.899180184192468e-17
of O 0 6.1649431780279035e-21
one O 0 5.109991944724319e-17
amino O 0 4.49012271218623e-16
acid O 0 4.158974370820161e-18
by O 0 5.441749831347875e-20
another O 0 2.831865135522805e-15
( O 0 2.6092741943467947e-15
missense O 0 3.797106185032817e-09
) O 0 6.773399115894696e-13
. O 0 2.427267154631041e-12

The O 0 6.498770841129389e-14
extraordinary O 0 8.147483394092619e-16
conservation O 0 2.247866888033099e-16
of O 0 1.1376109951278087e-20
the O 0 4.09154467523637e-18
PAX6 O 0 4.234291303001347e-12
protein O 0 5.710871229039349e-13
at O 0 1.1479716831942549e-15
the O 0 2.8952823599348365e-17
amino O 0 1.918009886114555e-13
acid O 0 3.1459603260126923e-13
level O 0 2.5629055355833735e-14
amongst O 0 8.796807310633859e-15
vertebrates O 0 1.5737709746499462e-10
predicts O 0 3.1117135534941553e-08
that O 0 3.932891338986888e-12
pathological O 0 1.9664000205921184e-08
missense O 0 7.060210691633984e-07
mutations O 0 1.5597472156514414e-05
should O 0 2.5749484142134627e-11
in O 0 7.282182460795105e-17
fact O 0 3.24862173565945e-14
be O 0 6.885544804273837e-15
common O 0 5.502652133048628e-16
even O 0 1.2417038832692948e-14
though O 0 6.970541087695722e-14
they O 0 1.0561611806479687e-13
are O 0 3.2860217025278994e-16
hardly O 0 1.5999374134573197e-12
ever O 0 7.705596279323004e-14
seen O 0 3.354982036542914e-13
in O 0 1.0545005894955356e-13
aniridia B-Disease 1 0.9999998807907104
patients O 0 1.7047465661335082e-08
. O 0 1.7547618360539557e-13

This O 0 2.8217098796412543e-13
indicates O 0 3.6981892157991747e-13
that O 0 2.9180920307621087e-16
there O 0 2.6345271052406424e-16
is O 0 2.3713669635361545e-18
a O 0 8.750110410721509e-17
heavy O 0 7.376027739980362e-12
ascertainment O 0 2.1513033021669514e-10
bias O 0 1.6300658600698625e-08
in O 0 2.944492194843453e-16
the O 0 5.129541862193642e-17
selection O 0 5.721129855762992e-17
of O 0 1.4077399104127844e-19
patients O 0 6.76099739734692e-16
for O 0 2.6508442540515497e-19
PAX6 O 0 1.3992185188271833e-09
mutation O 0 2.1043943497500717e-12
analysis O 0 2.0470362126841397e-14
and O 0 5.114869861883769e-16
that O 0 3.618309180785295e-15
the O 0 1.3358381275327489e-14
missing O 0 2.2862926829514407e-10
PAX6 O 0 3.732173581738607e-06
missense O 0 2.9320292469492415e-06
mutations O 0 2.5238348371203756e-06
frequently O 0 1.1624141649235753e-08
may O 0 1.004902584755829e-11
underlie O 0 4.0636756182266254e-08
phenotypes O 0 2.0428142732953347e-08
distinct O 0 4.386972122377708e-12
from O 0 2.2777539945319225e-13
textbook O 0 0.0019802285823971033
aniridia B-Disease 1 0.9999994039535522
. O 0 2.932262654908868e-09

Here O 0 1.2820862149709455e-09
we O 0 5.072753415241715e-12
present O 0 1.9720494023032532e-15
four O 0 4.405059640216454e-15
novel O 0 1.5554937980027939e-12
PAX6 O 0 8.133712725566511e-08
missense O 0 5.353360776894078e-08
mutations O 0 8.57331627912572e-08
, O 0 8.825381967109483e-14
two O 0 9.701880649499919e-15
in O 0 1.447401747576031e-15
association O 0 1.1858091743436965e-15
with O 0 2.5623813915956126e-15
atypical O 0 1.6401362046281065e-08
phenotypes O 0 4.032305511714185e-08
ectopia B-Disease 0 4.873518832937407e-08
pupillae I-Disease 0 2.168848389771938e-08
( O 0 3.483374884111906e-14
displaced B-Disease 0 2.182256458871379e-11
pupils I-Disease 0 1.0540537193071131e-10
) O 0 6.066849800312468e-11
and O 0 1.5483371385016653e-07
congenital B-Disease 1 0.9999827146530151
nystagmus I-Disease 0 3.912536612915574e-06
( O 0 6.427592290879358e-14
searching B-Disease 0 1.113036746103191e-11
gaze I-Disease 0 1.5603038860945162e-09
) O 0 2.452589192730747e-15
, O 0 1.9839646147722795e-14
and O 0 8.223152519158672e-13
two O 0 1.135559220033543e-14
in O 0 5.52031276999888e-16
association O 0 2.0646155119721428e-17
with O 0 2.3524911155480007e-18
more O 0 6.99180831682e-17
recognizable O 0 2.215568528640688e-08
aniridia B-Disease 1 0.9999985694885254
phenotypes O 0 2.763406655503786e-06
. O 0 3.166431353229804e-11

Strikingly O 0 4.427239963522567e-10
, O 0 6.895987687133287e-13
all O 0 1.465815820332866e-15
four O 0 7.64880333430849e-16
mutations O 0 3.5796864604475953e-13
are O 0 5.091058028657164e-18
located O 0 3.7845587937384434e-14
within O 0 1.8991293946653146e-15
the O 0 3.139230098675341e-16
PAX6 O 0 1.583793429738023e-09
paired O 0 1.6072606787154164e-11
domain O 0 2.9024664616184026e-12
and O 0 1.0592012835396181e-13
affect O 0 1.921071591734491e-12
amino O 0 5.249484115628367e-13
acids O 0 8.816431200549257e-14
which O 0 2.0762266462305497e-16
are O 0 1.0122421741228826e-17
highly O 0 2.5703279304519523e-17
conserved O 0 3.826966684088856e-13
in O 0 3.746062925054925e-15
all O 0 5.9626490451646e-15
known O 0 4.382534916566594e-14
paired O 0 2.4308685273033426e-11
domain O 0 2.2709876514037663e-12
proteins O 0 1.7583217867822576e-11
. O 0 2.233162439690961e-12

Our O 0 9.014097107629127e-11
results O 0 6.021674044814906e-13
support O 0 1.1829893751925073e-16
the O 0 5.809382086188519e-18
hypothesis O 0 1.76257341106276e-14
that O 0 2.6719333375059234e-17
the O 0 4.7111538256462595e-18
under O 0 5.179564451684929e-17
- O 0 1.0598055229628714e-13
representation O 0 1.1123260380265995e-14
of O 0 1.8342907100014475e-17
missense O 0 2.2672273303214752e-07
mutations O 0 4.693506472364106e-09
is O 0 1.0432125541019743e-15
caused O 0 3.74633439911452e-15
by O 0 2.5388328631928733e-17
ascertainment O 0 2.3767166013044516e-09
bias O 0 3.247154438668076e-07
and O 0 5.873303688015696e-13
suggest O 0 3.842428762321215e-13
that O 0 1.7659735654256724e-16
a O 0 7.180148739619954e-17
substantial O 0 2.5199394505207202e-14
burden O 0 7.701814012939234e-12
of O 0 1.165715461722236e-16
PAX6 B-Disease 0 0.0007780122105032206
- I-Disease 0 4.3929907405981794e-05
related I-Disease 0 8.424088946412667e-07
disease I-Disease 1 0.9277872443199158
remains O 0 1.1068325889065228e-13
to O 0 4.4010092874813614e-16
be O 0 6.543741387310073e-16
uncovered O 0 3.130257511529955e-11
. O 0 2.2242585445459047e-14
. O 0 1.0614522905376053e-13

The O 0 6.578816809897636e-13
chromosomal O 0 5.764697164067911e-08
order O 0 1.324407163799668e-13
of O 0 3.928337969912717e-17
genes O 0 2.3864169321208273e-11
controlling O 0 8.54950421569356e-09
the O 0 6.86687238646809e-14
major O 0 3.677845788335743e-13
histocompatibility O 0 3.74396867675042e-12
complex O 0 1.6450218398296294e-14
, O 0 1.374261326083349e-16
properdin O 0 7.248361199446718e-12
factor O 0 7.608887478416371e-13
B O 0 7.096136300788203e-08
, O 0 5.823885752993807e-13
and O 0 4.320115931655266e-10
deficiency B-Disease 0 2.9482873742381344e-07
of I-Disease 0 7.79497721518923e-20
the I-Disease 0 3.383742040768056e-16
second I-Disease 0 1.7273375604349864e-15
component I-Disease 0 1.0618541610842654e-15
of I-Disease 0 1.6216971034872551e-18
complement I-Disease 0 4.13314391392583e-12
. O 0 1.592259852613298e-12

The O 0 1.6542290540849658e-13
relationship O 0 1.9082151359256852e-14
of O 0 4.1259281046830585e-20
the O 0 1.4410803555799233e-18
genes O 0 2.75771878299592e-16
coding O 0 8.996872257610589e-14
for O 0 1.3793700969440532e-18
HLA O 0 7.478477906386338e-12
to O 0 3.072960755511227e-17
those O 0 1.3750255375717715e-18
coding O 0 4.265692345791633e-13
for O 0 2.9029006106583886e-18
properdin O 0 2.979072544206929e-11
Factor O 0 1.2426434664244979e-12
B O 0 6.100348698412361e-11
allotypes O 0 9.03605749252856e-12
and O 0 5.902971931788861e-14
for O 0 9.384030265493322e-16
deficiency B-Disease 0 1.3469100501595221e-08
of I-Disease 0 6.997294638761668e-20
the I-Disease 0 1.8062532907900646e-16
second I-Disease 0 1.9469562629990814e-15
component I-Disease 0 2.43498869511975e-15
of I-Disease 0 5.039176536854802e-19
complement I-Disease 0 2.046784616793751e-12
( O 0 3.335250886845405e-15
C2 O 0 6.124373144039685e-12
) O 0 2.6094419598099103e-16
was O 0 9.827001815369482e-14
studied O 0 4.291916214788083e-12
in O 0 1.9518485929535242e-16
families O 0 9.698245342908981e-17
of O 0 3.221883581940222e-18
patients O 0 3.93354972075613e-13
with O 0 1.958602550977684e-12
connective O 1 0.999893069267273
tissue O 1 0.9986935257911682
disorders O 1 0.996096670627594
. O 0 1.0629383657978497e-11

Patients O 0 1.1246173770018686e-08
were O 0 2.214580557848814e-15
selected O 0 8.868807652249316e-16
because O 0 1.5255684890474997e-15
they O 0 6.811400092873287e-16
were O 0 6.284270446322153e-17
heterozygous O 0 3.484730475640692e-14
or O 0 6.234275253052754e-16
homozygous O 0 8.032089576781587e-11
for O 0 7.16039838533078e-10
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 5.77449303651445e-11

12 O 0 6.151088319250597e-12
families O 0 5.0735007727398685e-15
with O 0 3.520347279336493e-16
15 O 0 3.739981821416702e-14
matings O 0 2.814770638792652e-09
informative O 0 1.5737133196580544e-07
for O 0 8.400600393088098e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 2.854884297714966e-13
found O 0 1.5894500342630846e-12
. O 0 2.011991268036084e-12

Of O 0 1.641217950388782e-13
57 O 0 5.5152753891674067e-11
informative O 0 9.597629982427414e-12
meioses O 0 3.1486663276680815e-10
, O 0 8.053790962214453e-16
two O 0 3.865648267393038e-18
crossovers O 0 2.9994680106641344e-14
were O 0 1.3681368278884473e-15
noted O 0 3.623382247453649e-13
between O 0 3.9751524554682005e-13
the O 0 5.0437214405008035e-09
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999990463256836
gene O 0 2.001900815257196e-12
and O 0 1.0561299124267208e-15
the O 0 7.300679542780771e-17
HLA O 0 1.3344365612510956e-08
- O 0 7.608032426276168e-09
B O 0 1.7024572029900042e-10
gene O 0 1.8654277070522668e-13
, O 0 1.354368769724791e-18
with O 0 1.1985215381324019e-20
a O 0 7.264857840119309e-20
recombinant O 0 8.858958776655117e-18
fraction O 0 2.5493251198675164e-16
of O 0 3.000540629661066e-16
0 O 0 1.711876473908802e-11
. O 0 4.592807254302778e-13

035 O 0 0.0012223508674651384
. O 0 1.1440610236945759e-08

A O 0 8.083572006212236e-12
lod O 0 2.2670371890853858e-07
score O 0 6.976363930988327e-11
of O 0 1.4084167767984e-19
13 O 0 2.066949253177951e-16
was O 0 1.6692307561462066e-16
calculated O 0 9.72466244764927e-16
for O 0 4.2264859572845953e-17
linkage O 0 4.155269198236056e-05
between O 0 1.86795864465239e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.6091784548204376e-14
HLA O 0 5.787918588850971e-09
- O 0 2.770064178037046e-09
B O 0 7.159274562074103e-11
at O 0 3.105615529989105e-17
a O 0 2.0048512215766979e-19
maximum O 0 4.56416703612046e-19
likelihood O 0 9.589311281063912e-18
value O 0 1.0342637279420296e-18
of O 0 1.5457916492503572e-21
the O 0 2.8985930546938217e-20
recombinant O 0 3.7598584844924065e-18
fraction O 0 5.532748404804655e-17
of O 0 3.118841155367093e-17
0 O 0 5.554353851855431e-12
. O 0 1.160468612480467e-13

04 O 0 1.81378436536761e-05
. O 0 3.9062955647928277e-10

18 O 0 2.997592452036457e-10
families O 0 7.159834824901987e-15
with O 0 2.5158896589449553e-15
21 O 0 8.516929837169146e-14
informative O 0 1.2059393739681512e-13
matings O 0 1.7872311269817587e-11
for O 0 4.729182938472179e-16
both O 0 4.036671713038287e-14
properdin O 0 2.2491027706905697e-08
Factor O 0 6.231509752652187e-11
B O 0 7.273573965349556e-10
allotype O 0 2.1708730299496715e-11
and O 0 8.206007081528258e-14
HLA O 0 3.5414274179856875e-08
- O 0 5.5553392996898765e-08
B O 0 6.955338971437186e-09
were O 0 5.682503697530318e-16
found O 0 1.3549374499439125e-14
. O 0 1.0737820409310178e-13

Of O 0 6.417427895512307e-13
72 O 0 7.886871711271226e-10
informative O 0 1.5280243736981447e-10
meioses O 0 6.58969554478972e-08
, O 0 1.0917282296284483e-13
three O 0 3.5146060900200036e-15
recombinants O 0 2.788361486150137e-10
were O 0 1.2472202700415831e-14
found O 0 2.7844641130032703e-15
, O 0 2.0875894195100375e-18
giving O 0 2.600524530944476e-19
a O 0 5.93580865535446e-20
recombinant O 0 1.0144338718739031e-17
fraction O 0 1.3024354467852466e-16
of O 0 1.475154729153259e-16
0 O 0 4.836895467486002e-11
. O 0 4.5348162616525023e-13

042 O 0 7.190647738752887e-05
. O 0 6.340425517947779e-09

A O 0 4.200762567657668e-12
lod O 0 2.8659558282129183e-08
score O 0 1.3518804999057554e-11
of O 0 2.934093901750493e-19
16 O 0 1.5956312692658924e-16
between O 0 6.46579820959712e-17
HLA O 0 2.0381170529049086e-08
- O 0 1.2861526954566216e-08
B O 0 7.127695655917421e-10
and O 0 1.963514486568482e-15
Factor O 0 9.397832582665536e-14
B O 0 1.2336465182727352e-11
allotypes O 0 1.442525027380015e-13
was O 0 8.318326763180259e-16
calculated O 0 1.541420498897127e-16
at O 0 1.6360701110929153e-17
a O 0 5.804306195757164e-19
maximum O 0 2.115850251933065e-18
likelihood O 0 1.2739101729921922e-17
value O 0 8.95476883226045e-19
of O 0 7.37219318818407e-22
the O 0 3.4705516128875875e-20
recombinant O 0 9.148788801223285e-18
fraction O 0 2.5146505026826815e-16
of O 0 1.466732309981795e-16
0 O 0 9.854302270018156e-12
. O 0 2.2952595228088735e-13

04 O 0 3.7039895687485114e-05
. O 0 3.503478063215937e-10

A O 0 2.8078462881056358e-14
crossover O 0 5.905334137272164e-15
was O 0 1.5689911121632288e-13
shown O 0 3.2868133077566678e-15
to O 0 1.0243700150227268e-16
have O 0 2.3600000212663794e-15
occurred O 0 3.3577953040112886e-15
between O 0 1.080423197857056e-18
genes O 0 3.505231711694944e-16
for O 0 1.9357626411238255e-19
Factor O 0 5.354130834978217e-14
B O 0 1.2631184292954956e-11
and O 0 2.52362751667636e-15
HLA O 0 1.6819684534041812e-10
- O 0 1.4017152716316872e-10
D O 0 2.0972388756201887e-11
, O 0 5.836640003477857e-17
in O 0 5.193510137786144e-18
which O 0 3.2478392042711293e-15
HLA O 0 2.3037190211017133e-10
- O 0 2.2634168844737346e-11
D O 0 1.4201668270194534e-12
segregared O 0 1.7267925370850756e-13
with O 0 2.4357481263314123e-17
HLA O 0 3.735154546768982e-11
- O 0 1.6288576390466325e-11
A O 0 1.314803192535574e-12
and O 0 2.3079652338581225e-12
B O 0 9.377868481763585e-10
. O 0 3.4112605318617484e-14

These O 0 1.5192463172913895e-12
studies O 0 8.481040034754445e-14
suggest O 0 1.7474856155139692e-15
that O 0 3.4672319690683503e-19
the O 0 5.231084377671665e-20
genes O 0 4.237301840102094e-17
for O 0 1.1687955555870415e-18
Factor O 0 1.302571606132119e-09
B O 1 0.9956564903259277
and O 0 0.11251989752054214
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.4037177246422725e-16
located O 0 4.055734358922834e-14
outside O 0 4.1733181174079606e-14
those O 0 1.7883431844388726e-18
for O 0 1.3625448296944183e-20
HLA O 0 1.5433182076057816e-12
, O 0 6.950006579128511e-17
that O 0 4.3396730509671664e-17
the O 0 4.604829684069918e-18
order O 0 2.682207913330567e-16
of O 0 7.542681312246875e-20
genese O 0 7.488297308622105e-12
is O 0 2.4228498659526485e-16
HLA O 0 8.65063316118908e-12
- O 0 1.0683770491556888e-12
A O 0 7.337349044317376e-14
, O 0 2.6306520353860724e-15
- O 0 1.3869889611828334e-11
B O 0 1.0760692684130824e-11
, O 0 5.3484479321164104e-17
- O 0 6.840465964930847e-14
D O 0 1.470807152556975e-14
, O 0 2.8081312723407395e-17
Factor O 0 2.0252038707060244e-13
B O 0 1.3321953540312848e-09
allotype O 0 3.3202642413243666e-08
, O 0 4.981426826589086e-08
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
, O 0 5.645679734241825e-18
that O 0 7.587647625827082e-19
the O 0 5.11593838071184e-18
genes O 0 1.3147274068037174e-13
coding O 0 7.537606450114254e-08
for O 0 6.379285294455528e-11
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.0128023772296504e-13
Factor O 0 3.691369258873589e-12
B O 0 5.720233176020884e-10
allotypes O 0 2.172371223879699e-12
are O 0 1.6500471473393463e-17
approximately O 0 1.3791243539917729e-16
3 O 0 1.0407327804455926e-14
- O 0 5.828156100090576e-12
- O 0 9.355597893612178e-12
5 O 0 8.53507084767961e-16
centimorgans O 0 7.175285891706032e-14
from O 0 7.212750631407296e-20
the O 0 1.2837044360543993e-19
HLA O 0 2.412201840183703e-13
- O 0 3.984713187394403e-15
A O 0 1.6023354026945122e-15
and O 0 8.725049749836909e-16
HLA O 0 8.452764599375939e-10
- O 0 7.698087306495793e-11
B O 0 2.899809027883532e-13
loci O 0 1.897201269744678e-17
, O 0 1.271060866654192e-17
and O 0 1.872710767912698e-17
that O 0 3.705920683725784e-17
the O 0 1.9379514954414903e-17
apparent O 0 4.474906824079991e-15
lack O 0 2.2163288073821671e-16
of O 0 4.244071468140652e-21
recombinants O 0 9.300965894817534e-14
between O 0 8.51688071587565e-18
the O 0 1.6672124685388017e-17
Factor O 0 1.3851429768799162e-12
B O 0 3.722940888906123e-08
gene O 0 3.048179223696934e-06
and O 0 0.15358111262321472
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 2.5794193447836733e-09
suggests O 0 1.5265544904552453e-12
that O 0 7.916028570760947e-15
these O 0 6.39230142546166e-16
two O 0 4.8157339932203974e-14
genes O 0 3.002639525906403e-10
lie O 0 3.2995490784060166e-09
in O 0 2.5131353724982804e-16
close O 0 3.5448128807291646e-12
proximity O 0 1.313806095165626e-11
to O 0 2.4653148039720588e-14
one O 0 1.0691260871672093e-14
another O 0 5.415159423302618e-13
. O 0 5.031587993475917e-12

Distribution O 0 2.960583514455273e-11
of O 0 1.0074548464753972e-15
emerin O 0 5.7159832422826184e-09
and O 0 1.7078089159863752e-12
lamins O 0 3.817324412125345e-08
in O 0 1.1286021149212698e-14
the O 0 3.8063776848333564e-14
heart O 0 2.8346483146868273e-11
and O 0 3.721578590681592e-15
implications O 0 7.225384841217514e-14
for O 0 2.50947566077055e-16
Emery B-Disease 0 8.567242184653878e-05
- I-Disease 1 0.8753752112388611
Dreifuss I-Disease 1 0.999617338180542
muscular I-Disease 0 0.0008232538239099085
dystrophy I-Disease 0 0.04064653441309929
. O 0 7.053602493756195e-12

Emerin O 0 4.17109532691029e-07
is O 0 5.3254499605710076e-14
a O 0 3.1824090854692868e-15
nuclear O 0 9.155725223114475e-13
membrane O 0 9.245085599851599e-12
protein O 0 1.0749928031072997e-10
which O 0 7.812176741010118e-14
is O 0 1.021518028619542e-15
missing O 0 2.6292487135507088e-14
or O 0 1.1498037095800475e-15
defective O 0 1.4200808064190884e-11
in O 0 1.3112762557634244e-13
Emery B-Disease 0 0.0631835013628006
- I-Disease 1 0.9998639822006226
Dreifuss I-Disease 1 0.9999557733535767
muscular I-Disease 0 0.07840430736541748
dystrophy I-Disease 0 0.042311836034059525
( O 0 7.370458410260738e-12
EDMD B-Disease 1 0.9999966621398926
) O 0 2.7932773281891254e-12
. O 0 1.2434827473262189e-12

It O 0 2.290813892746879e-11
is O 0 8.047526094778323e-16
one O 0 9.111526796169608e-17
member O 0 4.1250037174238334e-18
of O 0 1.7090205768134778e-20
a O 0 4.2352536747309634e-15
family O 0 6.347128226648346e-13
of O 0 4.505646179131441e-18
lamina O 0 4.797938712997052e-10
- O 0 3.86829857035309e-09
associated O 0 3.487435340510103e-11
proteins O 0 1.84367208999614e-11
which O 0 3.662357858657834e-15
includes O 0 6.2147603551018435e-15
LAP1 O 0 6.755295212101942e-10
, O 0 1.63809599023311e-14
LAP2 O 0 4.372768369620417e-09
and O 0 6.4714162847923085e-12
lamin O 0 4.8128153139259666e-05
B O 0 6.928310995135689e-06
receptor O 0 4.02077190986283e-11
( O 0 5.090816074357525e-14
LBR O 0 5.070396218798123e-05
) O 0 9.10386674900232e-13
. O 0 4.996242135291151e-12

A O 0 3.5904172430295533e-12
panel O 0 6.173028125992797e-13
of O 0 1.4948674026799083e-17
16 O 0 2.8018545464433484e-14
monoclonal O 0 7.224648396891853e-12
antibodies O 0 2.7359935497739407e-11
( O 0 2.6383500825689563e-15
mAbs O 0 1.3358911199468082e-11
) O 0 6.3130864807179644e-15
has O 0 1.969378842945832e-13
been O 0 2.9719040339011744e-15
mapped O 0 2.7687500729622894e-12
to O 0 2.7710479052121503e-16
six O 0 3.766836911012149e-17
specific O 0 2.346369772219955e-18
sites O 0 9.23210177739258e-15
throughout O 0 5.486118049918224e-15
the O 0 2.6913183151611036e-17
emerin O 0 6.498993780201107e-14
molecule O 0 1.2613094825669882e-16
using O 0 4.825511760398675e-16
phage O 0 4.4817277601756633e-13
- O 0 5.094528856934566e-13
displayed O 0 1.0539209140277526e-14
peptide O 0 9.466907145426235e-16
libraries O 0 4.115027935780056e-16
and O 0 1.4611868911552396e-16
has O 0 1.3628127493589212e-16
been O 0 3.776302007889348e-18
used O 0 1.8976727626938332e-16
to O 0 8.829947898211657e-17
localize O 0 3.416411042955758e-10
emerin O 0 3.176937823923254e-08
in O 0 6.700947441243624e-14
human O 0 1.274191863132046e-10
and O 0 7.268383811487311e-11
rabbit O 0 0.05093756690621376
heart O 0 7.588572771055624e-06
. O 0 2.622061248680474e-11

Several O 0 6.915956522746125e-13
mAbs O 0 2.4082014160597964e-10
against O 0 7.678279127960874e-14
different O 0 5.1158490319707945e-15
emerin O 0 1.1052379011999847e-09
epitopes O 0 7.297280557594377e-10
did O 0 5.436994743313051e-10
not O 0 7.402545509080719e-14
recognize O 0 1.649937239785182e-13
intercalated O 0 4.1795993749316196e-12
discs O 0 5.680681702813217e-09
in O 0 1.1556097875495275e-12
the O 0 1.250704292736493e-12
heart O 0 2.5161647765337136e-10
, O 0 1.6667246238832975e-15
though O 0 4.998114755730941e-14
they O 0 1.5759274988496122e-14
recognized O 0 2.092862982119555e-15
cardiomyocyte O 0 4.9963752753179325e-12
nuclei O 0 5.070827854395689e-16
strongly O 0 1.12731564128098e-14
, O 0 7.828068328474206e-16
both O 0 1.877463265962439e-14
at O 0 2.9222529344258286e-12
the O 0 1.2338845833200114e-14
rim O 0 4.067853165423685e-09
and O 0 1.4894239270743515e-12
in O 0 6.354595753814635e-15
intranuclear O 0 2.7206361608023144e-08
spots O 0 8.822302333122423e-10
or O 0 2.149446121308199e-13
channels O 0 8.392488926034503e-10
. O 0 8.237504428576514e-12

A O 0 1.9712120824522117e-10
polyclonal O 0 8.361212877616708e-08
rabbit O 0 2.966388308323076e-07
antiserum O 0 5.490272059205381e-08
against O 0 2.7106145453204e-11
emerin O 0 3.6440312101149175e-08
did O 0 9.031547731908063e-11
recognize O 0 6.417278140087232e-14
both O 0 6.526966111547938e-15
nuclear O 0 4.417284593660753e-11
membrane O 0 8.060958150979403e-11
and O 0 1.753238769170839e-14
intercalated O 0 1.6774645908435026e-13
discs O 0 8.457028480290951e-12
but O 0 2.2036401024251584e-13
, O 0 4.994323970948579e-17
after O 0 2.5136697394457958e-18
affinity O 0 2.446390383938336e-18
purification O 0 3.9548765709413784e-17
against O 0 2.4200864540494558e-17
a O 0 2.1401471935017074e-17
pure O 0 8.13567734299467e-17
- O 0 3.1850860924415025e-12
emerin O 0 2.0753133586626227e-11
band O 0 8.050657999100796e-16
on O 0 4.5443317620193213e-17
a O 0 9.493700121036868e-17
western O 0 2.4970065945484343e-11
blot O 0 3.317576556582935e-05
, O 0 1.287374720715384e-12
it O 0 1.214713957675348e-13
stained O 0 8.218817987293292e-11
only O 0 8.894256757149572e-15
the O 0 2.5046364556637675e-16
nuclear O 0 1.0175685814794999e-11
membrane O 0 1.2823300754583045e-10
. O 0 8.437352379264684e-13

These O 0 1.9457603930850276e-12
results O 0 1.288735014971093e-13
would O 0 5.03480576661045e-15
not O 0 9.73587292870618e-16
be O 0 1.308585832424599e-16
expected O 0 2.216558168022416e-15
if O 0 1.6117164026996367e-13
immunostaining O 0 1.6705298255814682e-09
at O 0 6.430461360878298e-14
intercalated O 0 3.123549189481059e-14
discs O 0 9.241347270760869e-12
were O 0 1.406638477571831e-13
due O 0 4.5819523068551474e-15
to O 0 2.8734870110619013e-16
a O 0 1.1841999176230317e-15
product O 0 1.6913773060548971e-15
of O 0 1.098546776776881e-19
the O 0 4.986746665665348e-17
emerin O 0 3.8271604635431444e-11
gene O 0 8.594915751336529e-11
and O 0 1.600754847685265e-13
, O 0 1.2585273763819518e-15
therefore O 0 3.001937704628444e-16
, O 0 1.7774961582713116e-17
cast O 0 7.716918229915774e-15
some O 0 1.4692691736588217e-16
doubt O 0 1.0116416032787331e-14
upon O 0 2.1808004736307285e-18
the O 0 4.732534376529224e-18
hypothesis O 0 1.2807296727052747e-13
that O 0 7.401722870682345e-15
cardiac B-Disease 0 2.341256930549207e-07
defects I-Disease 0 0.003023094730451703
in O 0 2.5932526525468402e-12
EDMD B-Disease 1 1.0
are O 0 2.7548867700954993e-11
caused O 0 9.423258180707439e-12
by O 0 3.0493972253608983e-16
absence O 0 8.422555459065145e-14
of O 0 3.8521197284747335e-18
emerin O 0 3.426044559162733e-09
from O 0 3.789596553955974e-16
intercalated O 0 2.071517957169533e-10
discs O 0 1.2575912755607987e-08
. O 0 1.6337807495769852e-10

Although O 0 5.6461953168440715e-11
emerin O 0 2.3213013733425214e-09
was O 0 4.1096455665606824e-13
abundant O 0 1.9244573738541127e-15
in O 0 3.5846346977529305e-16
the O 0 2.257897399254925e-15
membranes O 0 3.054890229670093e-10
of O 0 3.856207241471664e-18
cardiomyocyte O 0 1.7651024739051557e-11
nuclei O 0 3.707168442666428e-15
, O 0 2.7351115265732617e-15
it O 0 9.59957431606465e-15
was O 0 3.5719864566186033e-13
absent O 0 1.5223543590016722e-14
from O 0 5.061430487067046e-18
many O 0 6.489866518444453e-17
non O 0 1.0583364967817893e-14
- O 0 3.299774065101957e-10
myocyte O 0 4.016666999007157e-09
cells O 0 9.257454178235314e-12
in O 0 2.460421865212685e-16
the O 0 8.814073230230691e-15
heart O 0 1.2247100555917712e-10
. O 0 6.116887053299325e-13

This O 0 7.665046779258868e-15
distribution O 0 3.7512842902516844e-14
of O 0 3.21326704829441e-18
emerin O 0 3.4167632612103205e-10
was O 0 9.971326742812606e-14
similar O 0 1.0522567219265025e-16
to O 0 3.1700006880667217e-16
that O 0 1.150084395122944e-15
of O 0 1.4708042637114038e-18
lamin O 0 1.7646136996063433e-08
A O 0 1.0521510745986618e-11
, O 0 3.4651347601587017e-16
a O 0 2.2565518543309872e-17
candidate O 0 3.8283936804950954e-15
gene O 0 1.754072554522798e-13
for O 0 2.0849072863738343e-18
an O 0 4.540019305526613e-16
autosomal O 0 3.556391448000795e-06
form O 0 1.743059308001449e-10
of O 0 3.512100332780932e-11
EDMD B-Disease 1 1.0
. O 0 1.0595112343025903e-08

In O 0 4.529163231525163e-13
contrast O 0 4.2902222573137916e-12
, O 0 2.8018668114804246e-13
lamin O 0 1.789517409633845e-05
B1 O 0 6.412356742657721e-05
was O 0 7.245486328966155e-12
absent O 0 2.822689727354638e-13
from O 0 2.8349315933152126e-17
cardiomyocyte O 0 4.2948419126664916e-11
nuclei O 0 2.6784635300718465e-14
, O 0 6.7387794055030845e-15
showing O 0 2.0820010212391216e-12
that O 0 6.663123828729023e-13
lamin O 0 8.45590911922045e-05
B1 O 0 8.196026328732842e-07
is O 0 1.589914511555975e-15
not O 0 1.5687853540960554e-16
essential O 0 4.0186109198566504e-18
for O 0 4.105862512480112e-20
localization O 0 1.0396449572072576e-15
of O 0 8.703491007706388e-20
emerin O 0 6.341483588245822e-11
to O 0 2.189965780401604e-15
the O 0 2.6076423853739093e-15
nuclear O 0 1.8192243544934428e-10
lamina O 0 4.265356956523192e-10
. O 0 6.4186060980131465e-12

Lamin O 0 0.009406322613358498
B1 O 0 0.4633823335170746
is O 0 1.8974831428320016e-10
also O 0 6.709248157044101e-10
almost O 0 3.905504045165209e-11
completely O 0 1.728675336210017e-08
absent O 0 1.473718543032465e-11
from O 0 1.837913688292536e-15
skeletal O 0 6.110878075560322e-06
muscle O 0 9.455718696926851e-08
nuclei O 0 3.6817170839809066e-11
. O 0 3.2122349485214086e-12

In O 0 1.8980747962943356e-12
EDMD B-Disease 1 0.9999827146530151
, O 0 4.438474242952689e-15
the O 0 1.672785949467638e-18
additional O 0 2.327312358087346e-17
absence O 0 8.462034478890542e-15
of O 0 2.816295214114393e-17
lamin O 0 2.418238545942586e-05
B1 O 0 8.650500603835098e-06
from O 0 3.3398085593763435e-15
heart O 0 2.105260632490058e-09
and O 0 1.4534217579464936e-11
skeletal O 0 0.0005083183641545475
muscle O 0 8.899410204321612e-07
nuclei O 0 2.2581810553423676e-12
which O 0 4.4199772964922945e-13
already O 0 1.4862285664316022e-12
lack O 0 1.307031468732872e-13
emerin O 0 4.378025941775832e-09
may O 0 5.90768007972288e-14
offer O 0 6.948995433547726e-18
an O 0 6.032781365009524e-20
alternative O 0 8.288741490519442e-16
explanation O 0 6.293900676242886e-14
of O 0 8.611622674515024e-18
why O 0 2.9036542614768734e-10
these O 0 4.056614002638558e-15
tissues O 0 1.6246982329371634e-13
are O 0 4.3226890477579826e-17
particularly O 0 2.440940795640106e-15
affected O 0 2.3764898469252893e-13
. O 0 4.2801290567600226e-15
. O 0 9.093727425810508e-14

Genetic O 0 1.2093910584098921e-07
mapping O 0 9.598087949425071e-12
of O 0 2.725132896119455e-16
the O 0 6.425925330039162e-14
copper B-Disease 0 5.540321534880377e-09
toxicosis I-Disease 0 9.731656973599456e-07
locus O 0 1.3119430888886008e-11
in O 0 8.952947161845054e-14
Bedlington O 0 9.485214036430989e-07
terriers O 0 8.489125491450977e-08
to O 0 1.532674811718926e-13
dog O 0 5.0621293823382985e-09
chromosome O 0 8.428968634177636e-10
10 O 0 5.5366600823644144e-15
, O 0 1.2318099455223015e-15
in O 0 4.989718096948985e-16
a O 0 4.551054628640361e-13
region O 0 3.2189606535837356e-10
syntenic O 0 5.356006127499313e-08
to O 0 9.134300981610347e-14
human O 0 2.863764347188491e-12
chromosome O 0 1.2493934775648086e-07
region O 0 2.1398936789207568e-10
2p13 O 0 5.063345742684078e-09
- O 0 9.830433134183636e-10
p16 O 0 1.3391170394783103e-09
. O 0 1.8150496296914786e-12

Abnormal O 1 0.9988780617713928
hepatic B-Disease 0 0.11530175805091858
copper I-Disease 0 5.1502706099881834e-08
accumulation I-Disease 0 1.5027973310210996e-10
is O 0 5.4085476196416224e-15
recognized O 0 8.515140056551598e-15
as O 0 1.20147446679153e-12
an O 0 2.6717812406928942e-09
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 6.735635134499582e-14
man O 0 5.653032708607952e-09
, O 0 3.3864831240886656e-14
mouse O 0 6.41855502081512e-09
, O 0 1.879807480465942e-13
rat O 0 6.977158761856117e-08
and O 0 1.0558374920893732e-12
dog O 0 2.907442642197111e-08
. O 0 2.2872326862349857e-12

The O 0 6.451447991280557e-13
major O 0 1.3601200244198197e-12
cause O 0 6.791254624632925e-12
of O 0 2.1993224027985064e-14
hepatic B-Disease 0 7.507947884732857e-05
copper I-Disease 0 8.427351190221088e-07
accumulation I-Disease 0 2.3078983169000367e-09
in O 0 7.440396362174903e-14
man O 0 4.0762802022698e-09
is O 0 1.3876007344559328e-14
a O 0 6.6332416413740405e-15
dysfunctional O 0 3.285010596876248e-10
ATP7B O 0 7.729133999490045e-10
gene O 0 2.5131813297107897e-10
, O 0 4.469347662143866e-14
causing O 0 5.298649713436632e-11
Wilson B-Disease 0 4.01936995331198e-06
disease I-Disease 0 0.002001294167712331
( O 0 7.373699632655384e-14
WD B-Disease 1 0.999972939491272
) O 0 3.9907147031392753e-11
. O 0 6.662567633014538e-12

Mutations O 0 7.58242151732702e-07
in O 0 4.827171309700583e-15
the O 0 1.2197088093213529e-15
ATP7B O 0 1.2948061511863784e-09
genes O 0 1.739740296269332e-11
have O 0 7.05909018305223e-13
also O 0 1.0989358023832246e-13
been O 0 5.939224941931345e-14
demonstrated O 0 1.9982975980859484e-14
in O 0 5.703090303917741e-16
mouse O 0 8.552639485515101e-08
and O 0 1.0011623474692755e-11
rat O 0 4.5487189481718815e-07
. O 0 1.8671017423116387e-12

The O 0 5.700467224992178e-13
ATP7B O 0 2.810146559895088e-09
gene O 0 3.961564409848961e-10
has O 0 1.4926546327079238e-12
been O 0 3.849437790553155e-15
excluded O 0 7.319429892911622e-14
in O 0 8.497506491568433e-18
the O 0 2.9807327228304938e-18
much O 0 2.5931580160967423e-16
rarer O 0 6.633558979896037e-11
human O 0 5.165570401977071e-11
copper B-Disease 0 2.432185226552974e-07
overload I-Disease 0 0.011832273565232754
disease O 1 0.6779631972312927
non B-Disease 0 2.8789030187548192e-11
- I-Disease 0 0.00047881747013889253
Indian I-Disease 0 0.004960569087415934
childhood I-Disease 0 0.0021779858507215977
cirrhosis I-Disease 0 5.561817943089409e-06
, O 0 3.629409971075536e-15
indicating O 0 8.294574337271154e-13
genetic O 0 4.3164261054329245e-10
heterogeneity O 0 6.210347791579807e-09
. O 0 2.6397446728498863e-11

By O 0 2.5282910683257056e-15
investigating O 0 5.964497016945625e-13
the O 0 1.340294926909999e-13
common O 0 1.6810504377406943e-11
autosomal O 0 0.00011934453505091369
recessive O 0 1.4509300854115281e-05
copper B-Disease 0 7.22943198638859e-08
toxicosis I-Disease 0 9.875196155917365e-06
( O 0 9.467241172868984e-14
CT B-Disease 0 1.394556511513656e-05
) O 0 3.116314443909335e-13
in O 0 6.512643885552699e-14
Bedlington O 0 2.8579303034348413e-05
terriers O 0 6.938672413525637e-06
, O 0 5.480967242565971e-13
we O 0 1.128172858952392e-12
have O 0 1.0835984629872387e-16
identified O 0 1.736718767963183e-16
a O 0 6.977359973740052e-19
new O 0 2.6489769248379842e-17
locus O 0 6.692513618891107e-15
involved O 0 3.0929170899765546e-14
in O 0 2.9658324407488834e-12
progressive O 0 0.4502679705619812
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.5498559033377823e-11

We O 0 4.4983808344944975e-11
examined O 0 4.678106860223075e-13
whether O 0 3.138585083086007e-15
the O 0 1.6692762047577827e-15
WD B-Disease 1 0.9535536766052246
gene O 0 3.462458098013599e-09
ATP7B O 0 3.921032831755156e-09
was O 0 2.7415159850390988e-14
also O 0 2.0328248103621373e-16
causative O 0 3.691886274232066e-14
for O 0 1.025557651994909e-18
CT B-Disease 0 7.915459954155324e-10
by O 0 2.3464963308536757e-17
investigating O 0 5.454712185816403e-15
the O 0 2.797451775062639e-16
chromosomal O 0 8.123043926389073e-07
co O 0 4.882914073078837e-09
- O 0 1.0259917915256267e-11
localization O 0 2.793788854774104e-12
of O 0 4.9312612099726385e-18
ATP7B O 0 3.0277151896740406e-09
and O 0 4.938327443368765e-15
C04107 O 0 2.892802845682295e-14
, O 0 5.4020829020607775e-19
using O 0 1.8952039594376074e-18
fluorescence O 0 1.5070754304683334e-16
in O 0 2.494222516449521e-18
situ O 0 3.134745948604224e-14
hybridization O 0 6.464747899330436e-14
( O 0 3.86965016719657e-16
FISH O 0 8.900247899790159e-11
) O 0 1.1809975401593474e-14
. O 0 2.9136583553843187e-13

C04107 O 0 4.8736861657516783e-08
is O 0 3.1656653616844374e-14
an O 0 6.594683536944722e-17
anonymous O 0 1.9201318730540165e-14
microsatellite O 0 1.2821504746796109e-08
marker O 0 9.346480034366778e-09
closely O 0 2.2707462646320842e-11
linked O 0 3.2592893661753664e-11
to O 0 3.467889088957024e-14
CT B-Disease 0 0.00017708858649712056
. O 0 2.023298542597196e-11

However O 0 4.5534839787642056e-10
, O 0 9.760281775503254e-13
BAC O 0 1.238320823659933e-08
clones O 0 2.6388989951553476e-11
containing O 0 3.9677269580767546e-14
ATP7B O 0 1.6900289168120253e-08
and O 0 1.4598881185965557e-13
C04107 O 0 3.954104058068175e-11
mapped O 0 4.0094986358818474e-11
to O 0 5.081229101350617e-15
the O 0 6.722219487867789e-15
canine O 0 3.6234058597983676e-07
chromosome O 0 4.423810878506629e-06
regions O 0 3.2040161634938613e-09
CFA22q11 O 0 1.619412978470791e-05
and O 0 9.477006852887104e-12
CFA10q26 O 0 3.32001732772369e-08
, O 0 2.7902925467133272e-14
respectively O 0 1.1397727219021885e-15
, O 0 6.37797611309012e-17
demonstrating O 0 3.747606642601296e-15
that O 0 4.509920540317347e-14
WD B-Disease 1 0.999967098236084
cannot O 0 6.230846949506486e-10
be O 0 2.1776604298510282e-16
homologous O 0 5.09862876744982e-14
to O 0 7.099374460159923e-15
CT B-Disease 0 9.815865269047208e-06
. O 0 2.5299462177996723e-11

The O 0 1.1962676942783856e-12
copper O 0 2.6660160190594695e-11
transport O 0 4.214213179809523e-12
genes O 0 2.034388065993986e-12
CTR1 O 0 1.3849548174960091e-09
and O 0 2.929847120122786e-13
CTR2 O 0 7.627764198048226e-09
were O 0 5.805763313680712e-13
also O 0 4.337613439004545e-13
excluded O 0 2.2504957966629213e-13
as O 0 6.611916422256611e-16
candidate O 0 1.6379555521704552e-14
genes O 0 1.1202850137088851e-14
for O 0 2.484422494142299e-18
CT B-Disease 0 1.4183229950504028e-06
since O 0 3.6739144712583105e-12
they O 0 2.423623842308202e-14
both O 0 1.2528416677235073e-15
mapped O 0 2.4516133567686893e-10
to O 0 2.227520468425781e-13
canine O 0 2.9915305276517756e-05
chromosome O 0 0.00021662995277438313
region O 0 2.126907787669552e-07
CFA11q22 O 0 0.00018734259356278926
. O 0 1.4213660803896744e-10

2 O 0 1.5738618186489362e-09
- O 0 2.643833795445971e-06
22 O 0 9.136845724455611e-10
. O 0 3.1614932026469145e-12

5 O 0 1.4449070828703725e-09
. O 0 1.04868148886883e-10

A O 0 2.726334132410746e-12
transcribed O 0 1.075792146337795e-11
sequence O 0 6.762791281839098e-12
identified O 0 1.7056594038642597e-13
from O 0 7.529609221930335e-18
the O 0 1.438061435857319e-16
C04107 O 0 1.9756902711054458e-11
- O 0 1.8990670581225944e-12
containing O 0 1.2097370080706832e-15
BAC O 0 7.236816007560876e-11
was O 0 6.6905734899254214e-15
found O 0 2.2777405820299005e-17
to O 0 5.789622705908582e-19
be O 0 1.9910876341174573e-18
homologous O 0 2.0715274662578604e-16
to O 0 4.7104015048791425e-17
a O 0 2.990497889401064e-15
gene O 0 9.365744291223166e-11
expressed O 0 6.05127854935879e-16
from O 0 8.376910175703102e-18
human O 0 2.647876221669593e-13
chromosome O 0 1.0252727555837282e-09
2p13 O 0 9.427284473895181e-12
- O 0 1.3786905644908032e-12
p16 O 0 1.0742702300642337e-12
, O 0 1.7420478757508334e-15
a O 0 7.712999961380894e-16
region O 0 1.620210991195789e-13
devoid O 0 1.094262636909928e-14
of O 0 7.836538517326045e-20
any O 0 3.501782103842802e-17
positional O 0 4.0860689831667685e-11
candidate O 0 5.624890830890905e-11
genes O 0 2.191200776380242e-09
. O 0 2.1014674375652298e-11

Molecular O 0 4.775340192719746e-11
analysis O 0 3.620121780470442e-13
of O 0 3.212507076106627e-18
the O 0 2.139837000772e-17
APC B-Disease 0 6.514308813513822e-14
gene O 0 9.619520756126362e-14
in O 0 1.2007886476134234e-17
205 O 0 6.947680600185571e-15
families O 0 6.122001565289788e-16
: O 0 4.176755885327687e-15
extended O 0 1.2500394816483684e-11
genotype O 0 1.3680639954216645e-11
- O 0 3.6612095577481796e-09
phenotype O 0 9.341432072318412e-10
correlations O 0 6.836299321771877e-12
in O 0 1.3185121321241332e-16
FAP B-Disease 0 3.4187263480214836e-13
and O 0 1.6396258958484847e-16
evidence O 0 5.640710033121606e-17
for O 0 6.36824187749099e-20
the O 0 1.8417350821903622e-19
role O 0 5.4878705478512033e-17
of O 0 3.295178337033835e-20
APC B-Disease 0 2.2591294086767065e-15
amino O 0 2.300490239249371e-15
acid O 0 2.3158547816378534e-15
changes O 0 2.0756358058097307e-13
in O 0 2.4596518155561853e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.0014193003298714757
. O 0 8.968389399177656e-12

BACKGROUND O 0 9.507586185009131e-08
/ O 0 1.7536530094730551e-07
AIMS O 0 1.3313938493353383e-11
The O 0 1.0892103606652639e-15
development O 0 1.3474557773274047e-14
of O 0 5.010064357737626e-14
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.19027327512642e-15
a O 0 2.711898899673668e-17
variable O 0 4.273344915775579e-14
range O 0 2.5100350942684757e-13
of O 0 7.490939686346338e-16
extracolonic O 0 0.0002589920477475971
manifestations O 0 8.926626833272167e-06
in O 0 2.8990587708221938e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999213218688965
polyposis I-Disease 1 0.9999992847442627
( O 0 8.634654406411424e-13
FAP B-Disease 0 2.1422255636061038e-10
) O 0 1.779934875976042e-14
is O 0 2.739653740752913e-15
the O 0 5.490030283343355e-16
result O 0 8.644285475953566e-15
of O 0 3.1700321788326416e-19
the O 0 5.172895430418951e-15
dominant O 0 6.104221483838046e-08
inheritance O 0 9.855289917481969e-10
of O 0 5.5040069724121565e-12
adenomatous B-Disease 1 0.9999992847442627
polyposis I-Disease 1 0.9999345541000366
coli I-Disease 1 0.999998927116394
( O 0 1.1884982201951916e-13
APC B-Disease 0 7.772234245084775e-12
) O 0 2.18601907273552e-14
gene O 0 3.1277883061342493e-10
mutations O 0 6.140315633729188e-08
. O 0 6.345449339584253e-12

In O 0 1.6896766375385647e-13
this O 0 3.7086800259003626e-16
study O 0 1.3757510452793326e-16
, O 0 4.0592858721177205e-18
direct O 0 6.291517739628199e-16
mutation O 0 6.688332071340397e-14
analysis O 0 2.208404020067215e-16
of O 0 2.71345743202481e-20
the O 0 1.3877997911690045e-17
APC B-Disease 0 3.13073067362106e-14
gene O 0 4.192355826642541e-13
was O 0 1.4714573773989348e-15
performed O 0 3.93386029385657e-15
to O 0 5.906319051301364e-17
determine O 0 1.6592913295535722e-13
genotype O 0 3.172987317768411e-13
- O 0 3.695543593362771e-10
phenotype O 0 1.252667969353638e-10
correlations O 0 1.610064187008986e-12
for O 0 1.0983312114412982e-15
nine O 0 1.3675205716087713e-12
extracolonic O 0 8.610496315952787e-09
manifestations O 0 4.697612437931653e-11
and O 0 5.491561930670227e-15
to O 0 7.414658413745678e-17
investigate O 0 1.5998810823781955e-14
the O 0 4.888748593262721e-16
incidence O 0 1.0784229065308182e-09
of O 0 1.1633692300891783e-17
APC B-Disease 0 1.951400430133532e-10
mutations O 0 1.4547071325310412e-09
in O 0 1.0639671482986623e-14
non O 0 1.4127143899145267e-10
- O 0 0.03933494910597801
FAP O 1 0.8480260968208313
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.69858057911199e-11

METHODS O 0 9.367458891906821e-11
The O 0 1.4218450694914743e-15
APC B-Disease 0 6.065914643412634e-14
gene O 0 1.5061014501521752e-12
was O 0 3.507040984658191e-14
analysed O 0 1.1072380127563966e-13
in O 0 6.557506069749649e-17
190 O 0 4.0500524619126524e-14
unrelated O 0 7.495266885447494e-13
FAP B-Disease 0 1.9773085946361846e-10
and O 0 1.0093220747034448e-12
15 O 0 6.27077464390377e-14
non O 0 3.240894965589325e-12
- O 0 0.00018076313426718116
FAP O 0 0.47413140535354614
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
patients O 0 1.991093704842295e-12
using O 0 1.0884627482101936e-15
denaturing O 0 1.2879349142735919e-08
gradient O 0 4.777080467310846e-11
gel O 0 3.6707173411976157e-10
electrophoresis O 0 5.429351846580888e-12
, O 0 5.140435433814271e-16
the O 0 6.926446903639837e-18
protein O 0 1.2317948852764993e-13
truncation O 0 7.212590941163555e-11
test O 0 2.1448882669972136e-09
, O 0 1.2673043582511805e-16
and O 0 2.934376900917563e-17
direct O 0 1.128872784299565e-15
sequencing O 0 1.1615059608560685e-11
. O 0 2.7991439461444445e-12

RESULTS O 0 3.2822644158159164e-08
Chain O 0 6.659220397331467e-10
terminating O 0 1.2453245899768373e-12
signals O 0 4.7562167149618056e-14
were O 0 4.774826897021754e-16
only O 0 1.6294447980505044e-15
identified O 0 2.3441671780782825e-12
in O 0 1.3618986419901562e-15
patients O 0 2.030528895794869e-14
belonging O 0 3.3039581545816013e-16
to O 0 2.5700269227357667e-15
the O 0 4.901035335558236e-16
FAP B-Disease 0 1.8000293963704728e-11
group O 0 1.0055733745413086e-15
( O 0 9.054420728220785e-18
105 O 0 1.005662702635926e-13
patients O 0 4.668195083962212e-13
) O 0 7.88998146059993e-15
. O 0 6.041865141873104e-13

Amino O 0 7.015149745825955e-12
acid O 0 5.010857519389435e-14
changes O 0 1.4873947258179981e-15
were O 0 2.2654010325240795e-17
identified O 0 2.6066590224737944e-14
in O 0 1.7736295521287692e-16
four O 0 7.429292776675936e-14
patients O 0 4.556923753813204e-14
, O 0 5.0503816701890524e-17
three O 0 1.9920240273862857e-16
of O 0 6.505922859276174e-19
whom O 0 8.331577344266455e-14
belonged O 0 9.396224033217382e-13
to O 0 7.079929548306279e-15
the O 0 1.0284229353264406e-15
non O 0 1.654398663962324e-14
- O 0 2.87327488190936e-11
FAP O 0 8.088788666649194e-11
group O 0 1.3562180621162073e-13
of O 0 6.701381799738976e-14
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 7.50619832956545e-09
. O 0 3.1005498732708525e-13

Genotype O 0 5.325608753992128e-07
- O 0 1.515518079031608e-06
phenotype O 0 1.4006877435690512e-08
correlations O 0 6.475049663112742e-11
identified O 0 2.828771938911956e-11
significant O 0 1.5667721568919657e-13
differences O 0 5.165651795202564e-10
in O 0 5.029797853716399e-14
the O 0 1.319980569617317e-14
nature O 0 3.57356749443663e-13
of O 0 3.615627136984598e-18
certain O 0 1.1230239286251498e-13
extracolonic O 0 3.906314205437411e-08
manifestations O 0 3.2117633205763774e-12
in O 0 5.021242545663422e-16
FAP B-Disease 0 6.240762767673047e-11
patients O 0 4.700069950206928e-14
belonging O 0 2.055500676453523e-16
to O 0 3.3571295361147467e-15
three O 0 5.4831082030434505e-14
mutation O 0 5.1164836256667456e-11
subgroups O 0 1.728429482872329e-10
. O 0 1.1982916395258947e-11

CONCLUSIONS O 0 4.373093442922027e-09
Extended O 0 2.5876717435480145e-10
genotype O 0 9.002482093123376e-11
- O 0 8.06654920637584e-09
phenotype O 0 1.1008681743973625e-09
correlations O 0 2.6248045403853837e-10
made O 0 4.5467685064019825e-13
in O 0 3.8722492348556604e-16
this O 0 1.3038181221925208e-15
study O 0 8.045074887308087e-15
may O 0 3.857390159378452e-15
have O 0 5.323556016076771e-16
the O 0 4.871409832968328e-19
potential O 0 1.1595937916578485e-18
to O 0 2.951439155412694e-18
determine O 0 4.0463653274932544e-16
the O 0 1.4720214082839873e-19
most O 0 6.226752633713795e-20
appropriate O 0 3.77986177965547e-18
surveillance O 0 6.378527480505047e-12
and O 0 1.0437419496940083e-15
prophylactic O 0 3.6780248985346375e-11
treatment O 0 1.6032449890249212e-13
regimens O 0 1.0840921259649972e-13
for O 0 9.09810656621276e-20
those O 0 1.6320930267077603e-17
patients O 0 5.034918421992435e-16
with O 0 1.114253048569515e-16
mutations O 0 9.378082754807338e-10
associated O 0 1.4031724566987425e-11
with O 0 5.782246426458415e-13
life O 0 5.930678725896144e-10
threatening O 0 1.1407943247832009e-06
conditions O 0 7.77462219048175e-08
. O 0 8.780690475933273e-13

This O 0 2.884902603264572e-13
study O 0 1.179030390842644e-14
also O 0 5.924781060829057e-16
provided O 0 5.649428516777915e-18
evidence O 0 2.428392108405652e-16
for O 0 1.92496095479359e-18
the O 0 1.805743482834936e-16
pathological O 0 2.456020803398573e-11
nature O 0 4.822330939923498e-15
of O 0 1.1256883821323358e-19
amino O 0 2.1991241123855542e-15
acid O 0 1.013645810286879e-15
changes O 0 1.7541443532705721e-15
in O 0 1.2179129406544962e-17
APC O 0 3.032951223069097e-13
associated O 0 2.5093586537567984e-14
with O 0 3.064370120890394e-16
both O 0 2.7639403352847092e-14
FAP B-Disease 0 7.120204426058763e-11
and O 0 6.218145573097522e-13
non O 0 1.9829235475832263e-11
- O 0 0.004647590685635805
FAP O 1 0.7364702820777893
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.0148256457398475e-08
. O 0 3.0409071494327724e-15
. O 0 2.7411723607130567e-13

Inherited B-Disease 1 0.9989857077598572
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.9999648332595825
and O 0 5.526369568542577e-05
cancer B-Disease 0 0.002177776535972953
risk O 0 1.0401157712891518e-10
of O 0 6.686787451174542e-18
the O 0 9.31992257688038e-16
APC O 0 3.949709656558831e-11
I1307K O 0 2.7563375193384587e-11
polymorphism O 0 1.355640738553987e-10
. O 0 1.6021851814013166e-12

Germ O 0 6.301718258328037e-06
- O 0 7.4724562182382215e-06
line O 0 5.367193978145224e-08
and O 0 1.9599085402570784e-14
somatic O 0 3.0272873509200326e-13
truncating O 0 5.106889564010508e-11
mutations O 0 1.7341744359966604e-11
of O 0 1.524675202435138e-19
the O 0 3.650259534870968e-18
APC B-Disease 0 8.165009331628434e-14
gene O 0 2.3835940816605006e-13
are O 0 4.8405907997443735e-17
thought O 0 4.284640269533804e-14
to O 0 5.1212768190968e-15
initiate O 0 4.367922967762894e-10
colorectal B-Disease 1 0.9999998807907104
tumor I-Disease 0 0.0007644671713933349
formation O 0 1.1349119560799537e-10
in O 0 4.501520578514828e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999994039535522
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 5.8717727569046474e-08
sporadic O 1 0.9877294898033142
colorectal O 1 1.0
carcinogenesis O 1 0.7000202536582947
, O 0 3.5651853691476276e-10
respectively O 0 1.0220897045387645e-10
. O 0 2.5986011953360588e-11

Recently O 0 3.3741576199730616e-09
, O 0 2.2916799954550947e-14
an O 0 2.5783019515569635e-17
isoleucine O 0 1.811565795151182e-07
- O 0 1.7087433690221587e-09
- O 0 9.44597622343224e-10
> O 0 1.0009365298407902e-12
lysine O 0 5.781892976550185e-13
polymorphism O 0 9.388556555453564e-13
at O 0 1.2484911582756435e-14
codon O 0 3.3610169768855114e-12
1307 O 0 1.1201258020079874e-12
( O 0 8.086635458837626e-17
I1307K O 0 7.73661056009331e-14
) O 0 1.7354331969423776e-17
of O 0 3.041398355750286e-20
the O 0 8.565917636949019e-18
APC B-Disease 0 4.4652855631793775e-13
gene O 0 2.909118952676426e-11
has O 0 7.497836715646827e-14
been O 0 3.693770128446319e-16
identified O 0 4.592907407478461e-15
in O 0 2.183897437844127e-18
6 O 0 6.879191633652956e-15
% O 0 9.742513402314859e-18
- O 0 1.9818610294541905e-11
7 O 0 1.0953971697801393e-13
% O 0 4.481049963617177e-18
of O 0 6.967728747976579e-20
the O 0 9.615585779866598e-16
Ashkenazi O 0 8.560199077356501e-11
Jewish O 0 3.2453469707600935e-13
population O 0 1.8908316481557746e-14
. O 0 7.732023707277338e-14

To O 0 1.6820109216032775e-13
assess O 0 1.5034007025405138e-12
the O 0 2.353319313592707e-16
risk O 0 1.2700056257293132e-15
of O 0 1.6551501364983743e-21
this O 0 3.5297835737847634e-18
common O 0 2.1071692891893413e-16
APC B-Disease 0 9.756424319698823e-14
allelic O 0 7.511128004289436e-12
variant O 0 2.7342819066689117e-06
in O 0 6.341828839850905e-09
colorectal O 1 1.0
carcinogenesis O 1 0.6882221698760986
, O 0 2.4024277678336148e-08
we O 0 8.166431086920056e-09
have O 0 1.9437674126515647e-13
analyzed O 0 1.7014742479531941e-13
a O 0 1.260246588567082e-16
large O 0 4.698310916885365e-15
cohort O 0 6.998356972057196e-14
of O 0 2.3883254068644104e-18
unselected O 0 1.828797024927553e-08
Ashkenazi O 0 3.2155256235455454e-09
Jewish O 0 4.835085023330299e-12
subjects O 0 7.654525450984107e-12
with O 0 3.142540345784858e-14
adenomatous B-Disease 0 1.030876077834364e-07
polyps I-Disease 0 2.2065535176807316e-06
and O 0 6.729772988878224e-12
. O 0 3.3181807995719126e-12
or O 0 1.0363958153902786e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.915128280027996e-14
for O 0 5.202730720074273e-18
the O 0 3.219675199956246e-16
APC O 0 2.2310348013476755e-11
I1307K O 0 5.7907616202168555e-11
polymorphism O 0 4.27736568386905e-10
. O 0 3.8906022500895254e-12

The O 0 1.1999354418076869e-12
APC O 0 1.535901267279982e-11
I1307K O 0 2.2328911289393183e-11
allele O 0 2.3867469415780884e-13
was O 0 1.472558816691897e-14
identified O 0 2.451014516130154e-14
in O 0 2.6102872060470414e-17
48 O 0 1.7071827079166019e-13
( O 0 1.1341288917437963e-17
10 O 0 8.2128843961369e-17
. O 0 3.1239614033587963e-17
1 O 0 7.313808553463213e-17
% O 0 1.3685367192565993e-18
) O 0 1.4302584550234686e-18
of O 0 2.29981878738125e-19
476 O 0 2.0670451461590744e-11
patients O 0 2.5498081077102164e-11
. O 0 5.660379391765613e-13

Compared O 0 6.056757878439636e-14
with O 0 5.701978308476674e-17
the O 0 8.99115795497273e-18
frequency O 0 4.545812375611122e-14
in O 0 1.0785877337086375e-16
two O 0 6.170346500149919e-16
separate O 0 3.057610639152627e-15
population O 0 4.3812932721450375e-16
control O 0 7.491473413834271e-11
groups O 0 9.742597311516196e-16
, O 0 1.0448928292413104e-16
the O 0 4.209847715571459e-17
APC O 0 1.8732513370339765e-12
I1307K O 0 4.305395449877292e-12
allele O 0 3.6348572399593285e-14
is O 0 2.5204222381248315e-16
associated O 0 1.9858035233007686e-15
with O 0 2.3287332889435895e-17
an O 0 1.9220635065439393e-17
estimated O 0 2.8258569529510114e-13
relative O 0 3.723990005255473e-09
risk O 0 4.0195163863998573e-10
of O 0 6.238197147947439e-17
1 O 0 8.19890921648081e-13
. O 0 1.3282479499956978e-12

5 O 0 3.6471634046186807e-10
- O 0 2.9948239443911007e-08
1 O 0 6.305153881641656e-12
. O 0 1.196151359385278e-12

7 O 0 7.133295343297874e-11
for O 0 1.9322161871806326e-13
colorectal B-Disease 1 0.9999998807907104
neoplasia I-Disease 0 0.00043255434138700366
( O 0 5.602937384885376e-12
both O 0 9.821812252397422e-10
P O 1 0.995841920375824
= O 0 0.0021240694914013147
. O 0 1.970771289216966e-11
01 O 0 4.920833185373397e-10
) O 0 1.336684313447056e-14
. O 0 3.011450138735994e-13

Furthermore O 0 1.409767025339903e-10
, O 0 1.273562317074834e-14
compared O 0 4.279182497441466e-15
with O 0 5.481223046516041e-15
noncarriers O 0 5.849524864487421e-09
, O 0 6.0207957394112395e-15
APC O 0 8.843719485028545e-13
I1307K O 0 1.2051167355697778e-12
carriers O 0 2.2176429800586234e-13
had O 0 3.4382921314767e-13
increased O 0 2.84204858913117e-15
numbers O 0 1.3116665685455192e-13
of O 0 3.060094722089128e-16
adenomas B-Disease 0 0.01839660480618477
and O 0 4.218207686790265e-05
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999426603317261
per O 0 1.0004550763135708e-13
patient O 0 4.1397321126623865e-08
( O 0 6.28232145125085e-12
P O 1 0.9578570127487183
= O 0 0.001218053512275219
. O 0 1.266703495567123e-11
03 O 0 8.377946253412816e-11
) O 0 1.3700528958244753e-16
, O 0 1.2040137917345431e-16
as O 0 1.256253092918574e-16
well O 0 6.525543413833906e-16
as O 0 1.7107263708366027e-16
a O 0 5.273633905868852e-15
younger O 0 6.775543667791872e-13
age O 0 1.3467929740461782e-14
at O 0 2.084593484158806e-14
diagnosis O 0 1.6287101667344928e-09
. O 0 9.835177377376381e-14

We O 0 7.351849129477728e-10
conclude O 0 3.2116468772630524e-12
that O 0 2.3724823752331516e-16
the O 0 6.890057160542098e-17
APC O 0 1.2043975842687682e-12
I1307K O 0 4.666479008763602e-12
variant O 0 2.9734426032490546e-10
leads O 0 1.1850434522564512e-10
to O 0 6.014072838908882e-14
increased O 0 2.2866035731539114e-09
adenoma B-Disease 1 1.0
formation O 0 7.242478144986464e-11
and O 0 1.2199381858434694e-13
directly O 0 8.156377769434381e-16
contributes O 0 6.043141654405934e-14
to O 0 5.307924340672548e-15
3 O 0 1.1354683333983026e-14
% O 0 2.4288357088245517e-17
- O 0 1.2728884786483707e-12
4 O 0 1.0752735134852021e-14
% O 0 3.3171898845525098e-18
of O 0 9.965135312305822e-20
all O 0 1.4727524484236393e-14
Ashkenazi O 0 1.950169519204792e-07
Jewish O 0 2.5669992282928433e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 1.249174288314725e-11

The O 0 3.5815016181722434e-14
estimated O 0 5.4841931675455886e-15
relative O 0 2.4741875215283926e-12
risk O 0 2.0376919823792555e-13
for O 0 5.737280391786967e-17
carriers O 0 8.181105098925556e-12
may O 0 7.538274746175105e-14
justify O 0 1.4117616038873682e-13
specific O 0 2.6986083240739824e-16
clinical O 0 2.8048274626816215e-14
screening O 0 3.869164764378234e-15
for O 0 2.9996761411349355e-20
the O 0 9.45660082757956e-20
360 O 0 6.879342193759331e-17
, O 0 4.89115039488933e-18
000 O 0 3.2558604391911438e-18
Americans O 0 2.0565114580748383e-17
expected O 0 1.711339080059933e-17
to O 0 3.3779624305664744e-17
harbor O 0 1.5505964025795682e-13
this O 0 1.1742074881422462e-18
allele O 0 1.0592481848126987e-16
, O 0 1.902130008880963e-16
and O 0 7.449107905455e-16
genetic O 0 9.780246057466968e-12
testing O 0 2.927718560207654e-13
in O 0 4.779250228803769e-18
the O 0 1.6172384180058595e-16
setting O 0 3.4030720949540516e-14
of O 0 8.060913946818045e-18
long O 0 1.472790639445165e-12
- O 0 1.5975354719643953e-11
term O 0 7.487433118175471e-14
- O 0 8.324909771956213e-13
outcome O 0 1.7093389149871324e-14
studies O 0 2.550980116367333e-15
may O 0 1.4442563569008513e-17
impact O 0 1.3455025722905955e-16
significantly O 0 2.1893449553278543e-10
on O 0 1.2759614946844522e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 1.923528358815929e-08
in O 0 2.539966100632071e-17
this O 0 2.6342356729672277e-16
population O 0 7.095800828155457e-15
. O 0 1.0438306171029268e-13

Localization O 0 2.918267849594258e-10
of O 0 8.229662927681925e-17
human O 0 3.649737575963513e-14
BRCA1 O 0 4.6409295850757815e-10
and O 0 1.2468028996390212e-12
its O 0 1.8050495722687215e-14
loss O 0 2.973736187850129e-11
in O 0 4.386111936702849e-15
high O 0 2.6447139617191695e-11
- O 0 6.56773693208379e-08
grade O 0 8.24741774874127e-10
, O 0 7.144208185108636e-13
non B-Disease 0 1.730652982034897e-10
- I-Disease 1 0.5122620463371277
inherited I-Disease 1 0.997275173664093
breast I-Disease 1 0.9772567749023438
carcinomas I-Disease 1 0.9999998807907104
. O 0 1.035571806085045e-08

Although O 0 1.3731951773593432e-12
the O 0 2.224765652583514e-16
link O 0 1.5890923559663817e-12
between O 0 6.90313894913773e-15
the O 0 2.095708250492677e-14
BRCA1 O 0 1.7026189880198217e-07
tumour B-Disease 1 0.9999988079071045
- O 0 3.990197061654044e-11
suppressor O 0 3.3420793910110547e-10
gene O 0 2.4962911737702598e-08
and O 0 3.1536204758708664e-09
hereditary B-Disease 1 0.9999915361404419
breast I-Disease 1 0.9999998807907104
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 5.519247168669916e-13
established O 0 4.148665308181419e-15
, O 0 6.22198837840834e-17
the O 0 2.038258228933753e-18
role O 0 2.136299466929466e-15
, O 0 2.3683139143414764e-16
if O 0 1.8889779165507086e-15
any O 0 1.1876459884508746e-17
, O 0 4.650677741163834e-17
of O 0 9.08347606762217e-19
BRCA1 O 0 2.3957138495234176e-09
in O 0 5.99605922638885e-13
non B-Disease 0 2.2575599167851124e-09
- I-Disease 0 0.047169558703899384
familial I-Disease 0 0.07508283108472824
cancers I-Disease 1 0.6701428294181824
is O 0 1.863598861275191e-14
unclear O 0 2.914938256048938e-12
. O 0 4.808045237988945e-13

BRCA1 O 0 1.146814611274749e-06
mutations O 0 6.445385558606631e-09
are O 0 6.9454012345245095e-15
rare O 0 2.8986823791959937e-12
in O 0 2.571814018258872e-13
sporadic B-Disease 1 0.5611563920974731
cancers I-Disease 1 0.9999779462814331
, O 0 9.975235915060665e-12
but O 0 1.3180177435567764e-11
loss O 0 2.358148669823895e-13
of O 0 1.1197059017496226e-18
BRCA1 O 0 1.275227423658265e-10
resulting O 0 1.6436660577184305e-15
from O 0 7.938060255061056e-18
reduced O 0 4.494431357030676e-13
expression O 0 9.735963120774405e-13
or O 0 2.8657190010751565e-13
incorrect O 0 1.6046854123263898e-10
subcellular O 0 4.308139622821727e-08
localization O 0 2.7824258522213263e-11
is O 0 1.9003602394167935e-16
postulated O 0 1.5558543426589903e-14
to O 0 1.020186175189103e-15
be O 0 6.916895928871442e-16
important O 0 3.583677815220329e-16
in O 0 2.21021727937927e-15
non B-Disease 0 1.672300666000215e-11
- I-Disease 0 0.00010658823157427832
familial I-Disease 1 0.9995836615562439
breast I-Disease 1 0.9999971389770508
and I-Disease 1 0.9999879598617554
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 2.43858294668442e-10

Epigenetic O 0 1.4934541923139477e-06
loss O 0 7.501689935907052e-09
, O 0 2.5421133839458043e-13
however O 0 2.5069684284236005e-13
, O 0 1.7043934284212935e-14
has O 0 8.107392795303481e-13
not O 0 3.561506304309474e-15
received O 0 4.267325104897257e-18
general O 0 5.821144462150125e-16
acceptance O 0 1.2057839053058474e-15
due O 0 6.716085857598925e-17
to O 0 2.21822228997875e-17
controversy O 0 9.472686027708877e-16
regarding O 0 2.1434573717897976e-16
the O 0 3.797800266573479e-17
subcellular O 0 6.620767128984184e-11
localization O 0 1.5472020366280592e-13
of O 0 1.5482076895310533e-18
BRCA1 O 0 2.8815498164663778e-12
proteins O 0 2.652177251687843e-13
, O 0 2.903048937377109e-15
reports O 0 1.7545265980638443e-14
of O 0 8.867407185841427e-19
which O 0 1.6577729044110062e-13
have O 0 3.191274826862267e-13
ranged O 0 1.0105698016685954e-13
from O 0 8.185821217843272e-19
exclusively O 0 4.0210991287700467e-16
nuclear O 0 4.349379797291553e-12
, O 0 2.3089456397662185e-17
to O 0 8.295723225761635e-18
conditionally O 0 4.3152974412135475e-14
nuclear O 0 2.5675516400480713e-12
, O 0 8.20461788396729e-17
to O 0 1.0789334290302357e-16
the O 0 1.979072999501886e-15
ER O 0 6.414117251551943e-06
/ O 0 5.834913663349539e-10
golgi O 0 4.801973749191113e-11
, O 0 3.1056052729495096e-16
to O 0 9.430965419891866e-17
cytoplasmic O 0 2.4947023613552943e-11
invaginations O 0 2.857950542889398e-10
into O 0 2.9608485598736113e-15
the O 0 5.89983646992801e-16
nucleus O 0 1.973525272510549e-14
. O 0 1.0274124080797073e-13

In O 0 1.1317795049130101e-14
an O 0 2.3624837468608556e-17
attempt O 0 1.0498092195901365e-12
to O 0 2.921113397284965e-14
resolve O 0 2.0670075893958195e-13
this O 0 8.651568053475822e-17
issue O 0 1.398697204878143e-14
, O 0 1.5848901238710994e-13
we O 0 1.266687171819214e-10
have O 0 7.050075041988013e-13
comprehensively O 0 1.1044513220648255e-10
characterized O 0 2.3686746466154707e-13
19 O 0 3.037187404244905e-14
anti O 0 7.631958433285124e-12
- O 0 1.2438932550651316e-08
BRCA1 O 0 2.3906254753569556e-08
antibodies O 0 1.0933573491023196e-10
. O 0 7.497440710803327e-13

These O 0 5.754828037718429e-13
reagents O 0 4.132008971091672e-12
detect O 0 2.4248888487454767e-12
a O 0 4.624356258502355e-16
220 O 0 1.2244459257821673e-14
- O 0 4.757591456211463e-12
kD O 0 8.343394308774066e-10
protein O 0 4.584687230552165e-12
localized O 0 4.533000494064132e-13
in O 0 4.8678298573157447e-17
discrete O 0 1.4763962621899829e-12
nuclear O 0 1.1557438339693249e-09
foci O 0 4.168511369417871e-11
in O 0 1.841668585347714e-15
all O 0 2.6045903139067152e-15
epithelial O 0 3.0676277490426784e-12
cell O 0 2.55586773967309e-09
lines O 0 1.0817762657877594e-10
, O 0 1.4951762057461866e-16
including O 0 2.1039395128567913e-17
those O 0 1.4397457410205996e-17
derived O 0 1.9699807890273806e-16
from O 0 2.297578563493184e-15
breast B-Disease 0 5.809992558170052e-07
malignancies I-Disease 0 0.0005082003772258759
. O 0 3.6758388000102116e-10

Immunohistochemical O 0 1.9054367612625356e-06
staining O 0 1.0903865366174159e-08
of O 0 1.2278604849991388e-14
human O 0 1.270357707916503e-10
breast O 0 3.743242268683389e-05
specimens O 0 1.7955701370198085e-09
also O 0 6.775240785072967e-11
revealed O 0 3.033933937413025e-10
BRCA1 O 0 6.561123200299335e-09
nuclear O 0 2.0874545147986368e-10
foci O 0 4.236686834691028e-10
in O 0 1.7530691254121628e-13
benign O 0 0.0005670513492077589
breast O 0 0.002017984166741371
, O 0 1.6507960276523903e-10
invasive B-Disease 0 0.0001329998194705695
lobular I-Disease 1 0.9999256134033203
cancers I-Disease 1 0.9999985694885254
and O 0 3.8945307778703864e-07
low B-Disease 0 0.00011362527584424242
- I-Disease 1 0.8118607401847839
grade I-Disease 0 1.570074527990073e-05
ductal I-Disease 1 0.9361676573753357
carcinomas I-Disease 1 0.9999998807907104
. O 0 3.644991011242382e-07

Conversely O 0 7.925989309320869e-10
, O 0 1.3175890229127213e-13
BRCA1 O 0 2.3286972350433643e-10
expression O 0 8.637454358521868e-13
was O 0 5.432311501671339e-13
reduced O 0 8.025496500002616e-13
or O 0 1.6714029520224077e-13
undetectable O 0 5.3358189394669964e-11
in O 0 7.572213821124368e-17
the O 0 2.241128740937691e-16
majority O 0 6.625936236313856e-14
of O 0 2.2966560519693956e-17
high O 0 2.2474097235991586e-11
- O 0 3.267697223918731e-08
grade O 0 1.8389388622974678e-10
, O 0 3.0889329180432135e-13
ductal B-Disease 0 5.8555349824018776e-05
carcinomas I-Disease 1 1.0
, O 0 4.487822613530312e-11
suggesting O 0 7.683560385163268e-12
that O 0 3.553555290736893e-14
absence O 0 2.3599562720146537e-14
of O 0 9.096098843769729e-19
BRCA1 O 0 1.4342883825069208e-10
may O 0 1.4071905736468514e-14
contribute O 0 6.086673541595485e-17
to O 0 8.079577821502426e-16
the O 0 4.084032353262061e-16
pathogenesis O 0 9.871722363163915e-12
of O 0 3.8134296090181815e-20
a O 0 3.9730980363469415e-17
significant O 0 4.925212832246426e-16
percentage O 0 3.821539981165023e-13
of O 0 6.815714137552772e-16
sporadic B-Disease 0 0.0919228196144104
breast I-Disease 1 0.9983716607093811
cancers I-Disease 1 0.9947860240936279
. O 0 2.100056023177088e-12
. O 0 4.995346150615809e-12

